<SEC-DOCUMENT>0001638833-21-000146.txt : 20211103
<SEC-HEADER>0001638833-21-000146.hdr.sgml : 20211103
<ACCEPTANCE-DATETIME>20211103070326
ACCESSION NUMBER:		0001638833-21-000146
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		72
CONFORMED PERIOD OF REPORT:	20210930
FILED AS OF DATE:		20211103
DATE AS OF CHANGE:		20211103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Surgery Partners, Inc.
		CENTRAL INDEX KEY:			0001638833
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
		IRS NUMBER:				473620923
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37576
		FILM NUMBER:		211373671

	BUSINESS ADDRESS:	
		STREET 1:		310 SEVEN SPRINGS WAY
		STREET 2:		SUITE 500
		CITY:			BRENTWOOD
		STATE:			TN
		ZIP:			37027
		BUSINESS PHONE:		615-234-5900

	MAIL ADDRESS:	
		STREET 1:		310 SEVEN SPRINGS WAY
		STREET 2:		SUITE 500
		CITY:			BRENTWOOD
		STATE:			TN
		ZIP:			37027
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>sgry-20210930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:4fc50bef-303f-4567-8d1f-fa45eceeed5f,g:878f1ef0-0d6b-4fb6-8cd6-b11c4615e811,d:dcac93ae85504379b4049f3f4d6efdb8--><html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:sgry="http://www.surgerypartners.com/20210930" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>sgry-20210930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80L2ZyYWc6YjkzZGVjOWVmMDJlNGIxZjgxYzIxMzIzOGViZDI5OTYvdGFibGU6ODg1MTUyZjZhNDQ1NDQ1YzkwZWVlOWNhNzY0Y2ZkMmIvdGFibGVyYW5nZTo4ODUxNTJmNmE0NDU0NDVjOTBlZWU5Y2E3NjRjZmQyYl80LTEtMS0xLTEyNzEy_4c1dddcb-0259-4aeb-bdf5-e8a656739f46">0001638833</ix:nonNumeric><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" format="ixt:date-month-day" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80L2ZyYWc6YjkzZGVjOWVmMDJlNGIxZjgxYzIxMzIzOGViZDI5OTYvdGFibGU6ODg1MTUyZjZhNDQ1NDQ1YzkwZWVlOWNhNzY0Y2ZkMmIvdGFibGVyYW5nZTo4ODUxNTJmNmE0NDU0NDVjOTBlZWU5Y2E3NjRjZmQyYl81LTEtMS0xLTEyNzEy_df5bd1a5-578c-41a8-bfe6-2a7a0791fa18">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80L2ZyYWc6YjkzZGVjOWVmMDJlNGIxZjgxYzIxMzIzOGViZDI5OTYvdGFibGU6ODg1MTUyZjZhNDQ1NDQ1YzkwZWVlOWNhNzY0Y2ZkMmIvdGFibGVyYW5nZTo4ODUxNTJmNmE0NDU0NDVjOTBlZWU5Y2E3NjRjZmQyYl85LTEtMS0xLTEyNzEy_9f3fc2fe-03ab-4dea-bcd7-fb682aad53b2">2021</ix:nonNumeric><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80L2ZyYWc6YjkzZGVjOWVmMDJlNGIxZjgxYzIxMzIzOGViZDI5OTYvdGFibGU6ODg1MTUyZjZhNDQ1NDQ1YzkwZWVlOWNhNzY0Y2ZkMmIvdGFibGVyYW5nZTo4ODUxNTJmNmE0NDU0NDVjOTBlZWU5Y2E3NjRjZmQyYl8xMC0xLTEtMS0xMjcxMg_e7bd594e-a186-46b1-8828-c0c50908fd32">Q3</ix:nonNumeric><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80L2ZyYWc6YjkzZGVjOWVmMDJlNGIxZjgxYzIxMzIzOGViZDI5OTYvdGFibGU6ODg1MTUyZjZhNDQ1NDQ1YzkwZWVlOWNhNzY0Y2ZkMmIvdGFibGVyYW5nZTo4ODUxNTJmNmE0NDU0NDVjOTBlZWU5Y2E3NjRjZmQyYl8xMS0xLTEtMS0xMjcxMg_e6c8e8bb-db6a-4b75-9b79-124e1a4bd0d3">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="sgry-20210930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i2b2125d4d75646e88ad9f2ad3127cbad_I20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-10-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9055b0c653648f0919c1c9b458ca340_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7ea101365284e93a6ac503e7e44170b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c05ce754df645d98f80d7ffa09f927e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9aa0d95886f432db9278aadacd55da4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40304b7c460b45958fb265491cf6bb14_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7bf9f7034fb4595a4b18217e2ceaeb0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5484a5886424dc6b347b2b8ba32b919_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac8c4f727e89495faa49068c7628988d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3af38d809db4b7a8d26a05b63fa42b5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a44af99afa44f24bc727649252223dc_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6453064d41354fd1bc9110d0cd3c3e4c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9d3034dcc144fa3a6b470e98cc8e6c7_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib36db35e625047569233e786bdc89d3a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e786c45dae04a89a45c7c72c011e04a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icde2fc5b1e01435d98af7a6ea3c9d3ee_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7bc8516124c4fafb914be3b2c9936ba_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a8fd0aa6b7a4d549e90dc2fb6ab3ff3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie80e658267b44f07b2ddd4012b02d206_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ab7dd37d1e7404696a9549accda39b9_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee943e15508949c2baaacaa9fdc9724c_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30ed8caf27dd4768b110022f3860e021_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5827f320e258406b952e1a452a006818_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie856a8782f374508af805ab30b4d7f1a_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25643604ef6c4d269d4585afa6c3ba1b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53a6a629d2c54847bafd53081201b921_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cddba9fa8504c48ac5dd4b5006afdd6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99bd0353d66749c5b88fe887803a2f51_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5379e81f3c3549b4ab8058d34662a9dc_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6936b3e1ceae47a881d3535da654ef72_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib382c78377b74941b68729e139319e6b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbf85fe5fc0e4c159aecfae0b8c53435_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8af1e4e9ef8b4538abb29b36d015c7ae_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7899289c9f0473bb1689d5ee1c73d47_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i694eeba75abb4a6e87f66ac345a9c219_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73f4af3ea9df4ed2b218df3257e2721c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9016d0b2b49e436eb7581ad09f123943_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53ed285db0384407b947ec9264dbbe9e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0ba3f14ca9b4ad5bc0acd92524c74d0_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia878eeebac2e40afa6724b929ac0040e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c4b9a7850e5426e85fd9a49ad79c29f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e1addbe96484bc7b75825f9c8dc7a58_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bada32aacf64a1ead6b4b370e83e526_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34d67e0b428b44e281d788187793a269_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4a87dd7e0b445fca10ae39b0ed707d3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87973734c6ee4a99945e9948dbf8e70c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i723b8483c8a44fa3831eba25ac4e8771_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if614186fb0024af2a131eccab2af782d_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04307c27f0e44baa8e6d7ba57acdb88e_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie870b4adc63f46feb66eb8a8c8e4d011_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae6e1dc8f3104428a423e41e99d59cf9_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec6e709cf8ff41aaa43ed32125aaa1ad_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73a098cbb4e54750892085bb826f7c51_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65bbc1666baf4ab58e1d5def95db43cd_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0302db6bf7784a859b41b1557a29eada_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02e8e2f7aa5d4308af89bd5d9eaa7cab_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b951a38115c49a0a25b0d9d1a4a8894_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28fe5537d2e64becaa3ad572da05ec1b_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19264b0de7ab4eb8b0352aece77637f2_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfdd711a02e74ca889726084c6b89bb3_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i645577772ef04b6580b69faed65e927c_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46f6e83b5d4c4d579db2515cc00632b1_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d60bb0e88bd464082a32b07117af980_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81ab0a7efcd546818b950401c349d061_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3eb05b01366a444c95e4e82842f9a25b_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib021d0c212de49bca1b78b3cc314c610_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04dd444ed05f4a46a5ab9054213d6ca2_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2409f81f8b64985bad5ef07e2f6ea31_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic66bbcb9058847ae98f2300c873039bd_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5e06688327645e0bf1b08b54c9f4601_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife84e5119b9d41d2997dd2e6bc21006f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae7a31bb630448b9a2fada4b9475deaa_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9544c9d9dc744b44bb14b59cccb2d54b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddbb89f01a7d4e139ba298e541047140_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ef302e3ae1f4cd8bde62e0c447620d0_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i394e252b2ffa4fd0b8c8e8d0f831e656_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95271104483f4cd2a13aa0fd11c4c9c4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42f848f9a2a94d5e9604c62328ab388a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c4b6f5d56814c14aba12fdc98258eea_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i219bd4659c5a4f2ba0b0d28c6bdde0d5_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i711cc27756dd4866a36dee4b75131f1d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id38661458bd24a6c81732c5d5160d949_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="surgical_facility"><xbrli:measure>sgry:surgical_facility</xbrli:measure></xbrli:unit><xbrli:context id="i0b8f04298f2f4487880978d9ac283c40_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:FacilitiesAmbulatorySurgeryCentersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifac1f29acb89455b90f5cd970447f0a9_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:FacilitiesSurgicalHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="state"><xbrli:measure>sgry:state</xbrli:measure></xbrli:unit><xbrli:context id="i40f463b41ec94ef59b20aaf801aebf70_D20200327-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-27</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbd2503cfbf74ec8aa4c1f9de99fff89_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="physician_practice"><xbrli:measure>sgry:physician_practice</xbrli:measure></xbrli:unit><xbrli:context id="i32be3c0b3a7f46518fcdfa2dab23569e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i894cda222d3d4b14afb4128bc02678fd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i962fa35551cd479c8e9aed5680bfb517_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017TermLoanMaturing2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c9c6ffb79ae4ec5815bfd1526797134_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017TermLoanMaturing2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icaca869429314f97a2375ca94953fd78_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017TermLoanMaturing2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42b70d9ee17d4631895533f028803e8b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017TermLoanMaturing2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i2bacc8e8772841cdbb2620ef10c4ca4f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i667f3ee4fc3f4e098746acef1144296f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2b7f57e6dc049148da6841ad22d457f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbfc05d48fc543a19f054a1cc19d7fe1_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaffb336a9a3b4525984047c9cd6a707e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8eddef2cc304b9c98cff9dfa3b5279d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95aa1f95aa154cc1b14c588d17ea7543_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7fe14d003214347b2cc288cb20c5df6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c4016e7689e4c859eccdeea6ca19ac5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d8af47260764ab4a3254e17e605316e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a36782fa2bc4df19287a1556d0bf2c4_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if728a9865da84a0380fd1550912931a8_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54e5084300b248e6920827b61dce0943_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f1c728ff4fa4a09ab6c46f289cf0c49_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i843b1778208d4e50b16f7c11bdf1e6fb_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c8ee242dc044d2c9036d788a9a56762_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4af18ac975044d50a2ea274814e3f36d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i882ea7583a5546c7a0376ce43d387ecf_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63770fd818324501b078a13e278a2991_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85aeab70f1b346e3b6010265e0f54c1b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f0e94193ec74331b69bee876be7394b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32c65d19973748b8abb14d3b08023423_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0fb8315dd704b23a2452d16f9d4169f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1699c2a292e44cc0ba2155cd47ae8171_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11b91707b010413287ffa0b97b9edd79_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7cab1a6fb67e44eb9f664045e38c77fb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic18ae544123642ddbc9fb91be061be82_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i201f9b152e43400da5c39192eee73807_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0962a819986d4646b1b65ccf8a64364a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72f9be049f1c4e16b1369f54ef365688_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c428e120f3b4e7b8ec14607857cd6c0_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:PrivateInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife562b2a0b4b43f7a740f883ebb3f9b2_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:PrivateInsuranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a422701acfb4654890456c3f48a79f6_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:PrivateInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b1711cca24e4b1bab0201cd8a60b43d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:PrivateInsuranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie849beb4c21f4b39aabfc1121489da56_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GovernmentContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02b93a2c47cf40a48adee19c7d6fa0d4_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GovernmentContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e24a27c70c5488b809dc406c7f2b718_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GovernmentContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc799fec3e51413a9fc7c55e26f13cb5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GovernmentContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib90d2af58a99466c8a29503e4f921426_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SelfPayRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9f0bd05efdd438c8ab2afdf0d745752_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SelfPayRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d82a46716de4518ac0b5840519715d5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SelfPayRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7663ed8a8ac40619a7d5b3ba42a13f6_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SelfPayRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b7a80a48aef4f70976ee8453ca6ce93_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherPatientServiceRevenueSourcesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9d4994c80754a68880bfc13a642ede4_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherPatientServiceRevenueSourcesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i234d99c99d2f4f739eae5fea2587ff52_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherPatientServiceRevenueSourcesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55e1271c0167429bb3d4328fcd101340_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherPatientServiceRevenueSourcesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69813463e96b4ad5ad2215be2f949b59_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7bc8fed1453459e9f611c96dc337763_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd4def59018047f1a3fb46e36d9c173d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id87e71179efc435cbf5d5497ee13da93_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01a782bdc9ca4f1981073ae5a91b46ed_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4692edb42bed4c66adc2020e302cbcf8_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b478a448f1d417c80797c7716cbfd28_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:PrivateInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8180fc2d8a6249dd8811a378d0ecb43e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:PrivateInsuranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3eb8b684a6d444be9b221c39b9fae635_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:PrivateInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45a407f7ad6e40059d9b211fc5bb9365_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:PrivateInsuranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cab09bbdad14d0b965a11a034a5990c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GovernmentContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica4a944ad4a44a4aa65601825760e1cb_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GovernmentContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i260cb7274b4b4e4c94ee4d68c91b5dbd_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GovernmentContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc0ac37030af4e318d33ccfd2ab4e424_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GovernmentContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1004335253334a8c93031def1519e24f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SelfPayRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50ffceccf0314f6a82061db05cc97ce3_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SelfPayRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33d0674cc1fd4188a31803833a52a9c8_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SelfPayRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77d5c398e437417096ffee0b774a3695_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SelfPayRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8665a6cd8314ab9a760fa0b0a9f8993_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherPatientServiceRevenueSourcesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id077ce6df7bb4afaa072fd999ff742a6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherPatientServiceRevenueSourcesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebfa8b8fa273451ba8ff90cbb6df3b55_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherPatientServiceRevenueSourcesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a43941cb1cc4a9a9cc87de4189023a4_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherPatientServiceRevenueSourcesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c0a49e90fc4404c8e52a743f9dac439_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if78e1d4ca8e44e09afc12dd31cc9f3f1_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39f55b837d7e4a3ba4f01efb13d89635_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1f02fe0e7044c94a65bd438e74a232f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83f6dd0a92d3471a856b0a9062de35ee_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31b97175fcb54075b8a9d18788bcd4e8_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18304528b10e4cf5ad801229a9076ceb_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">sgry:SurgicalFacilitiesNewMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28bb531c0e434976827266bc64ff25c5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">sgry:SurgicalFacilitiesExistingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e305bdf3ff54b04a60b6fe6642b9f6a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">sgry:SurgicalFacilitiesExistingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a13579da2b047bbaec50c1bfea80ffd_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017TermLoanMaturing2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fc897253a9442a9a2188353b29a9de9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017TermLoanMaturing2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6be5a05e68144411af66ad15197c0602_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic05baa9bdba04592bd63550510944a35_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf48234a181c4a79a5fb7a98c7b58186_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">sgry:NotesPayableAndSecuredLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id74f0993fe00448b8bee613cc4480b55_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">sgry:NotesPayableAndSecuredLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36f0d89975a14bafb53bb8f74a75d68d_I20210127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017SeniorSecuredCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a3f44c7bfb64dcc8cb79cb5bf1acee6_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i297477a2c42e4f71ac25067c3ed77ad7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i131b465568af4c979a7999024ec537d2_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017SeniorSecuredCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8cd6f59f10b43cba5e2609681a2b8ed_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017SeniorSecuredCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia69846ae143244c7b534d9be52a586b8_I20210503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2198de7087442b19f4693243784c6b6_I20210503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i959e09a7ea984f0da5610e0124ec6404_D20210503-20210503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-03</xbrli:startDate><xbrli:endDate>2021-05-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebb24a566b9144d8b8d7fdb1d5cc3aad_D20210503-20210503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-03</xbrli:startDate><xbrli:endDate>2021-05-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i216348724a3a425d96f16ce750304715_D20210503-20210503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:FederalFundsEffectiveSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-03</xbrli:startDate><xbrli:endDate>2021-05-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie83b774759cc472b85d1d0d1561fafb6_D20210503-20210503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">sgry:OneMonthLondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-03</xbrli:startDate><xbrli:endDate>2021-05-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb8c8ccf05034972b3907a963deb3f26_D20210503-20210503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-03</xbrli:startDate><xbrli:endDate>2021-05-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea9e184d11334ae0bf911f88c3c9df84_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47cc30be5f9646198974e49f2c9e62ac_D20170831-20170831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:MajorityShareholderMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-08-31</xbrli:startDate><xbrli:endDate>2017-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b26b76efac540d991bd9159654d84be_I20170831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:MajorityShareholderMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6b9767d8d5b496f900fae3b3d1d446a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="lease_renewal_option"><xbrli:measure>sgry:lease_renewal_option</xbrli:measure></xbrli:unit><xbrli:context id="id264cc07d6a44dcc9fd4169a79dd9ff8_D20210517-20210517"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">sgry:ConversionOfSeriesAPreferredStockIntoCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-17</xbrli:startDate><xbrli:endDate>2021-05-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i518a3c2c62754078a7891bd9741853b1_I20210517"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">sgry:ConversionOfSeriesAPreferredStockIntoCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i909487bf12ef47639fb9b75fbee5e586_I20210517"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57cb9c1772694302ba3eea3dd06765c8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2547d9c927b94663bfad99cb87818db1_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00ee4c8851df48caa969c447c0623250_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4346577dec794239931317575c5f8e9c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4f417c62ec54180ac8803b4615fe4f2_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ThreePayFixedInterestRateSwapsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb9ae4c2db2641b79a0f5be58b08a21c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ThreePayFixedInterestRateSwapsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i794be503a719415da656f24f25e586f6_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ThreeReceiveFixedInterestRateSwapsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id89e28dd0e71485f834aa4d7bf9df97f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe696861f1c44c73a063d43906a9e50e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="interest_rate_cap"><xbrli:measure>sgry:interest_rate_cap</xbrli:measure></xbrli:unit><xbrli:context id="ie418b260d34a48179bdbb66a998bcef5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2a4a57522444f5a9676cde41ceac59b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if49ae29f929f42ada509df5619f333a8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1fca4d2f481407caeb5d56d7e7b7136_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ddeec416d7940a3b12a296f74c3903a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3536b9c7d5144d1da0598b1b21687583_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e920f1f29fa4053be880fffd25a4918_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7495d32d52cd4da7bc6c8619c45a887b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fa37eb2bae649c99d96bc2572e45115_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:InterestRateCapOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58ed36c033be416a89ff87077161fdf4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:InterestRateCapOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c4ccb8fa70f4bc2a4428f508fe28abf_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:InterestRateCapTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb17c059c9044d64a267e4e97184de8e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:InterestRateCapTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ed85bf6cfba4944b0e52d8ec460f7ae_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i868a7c854f3f4197b6fb56be16cb8ff6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fb04a4c58d74fb494b82609189a5eb9_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71181849cd1a430e8336d8791688e295_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9c29b53a6e548b8889f9b102d76603f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapSixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c36d93181114c73a3df7489d3e1fcee_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapSixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i720356769cb94b1ab627aaf16068270d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ReceiveFixedSwapOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f56d30ff3394bbaad99a11dd5142150_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ReceiveFixedSwapOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic24c1d36e32e4b2e9a6ee11412475f2f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ReceiveFixedSwapTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7bfba01da58476bbd4fc84970535d16_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ReceiveFixedSwapTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f8bf0021814474c81ca8bbbc00fa691_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ReceiveFixedSwapThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2640e344b23640b5b12ef1711c6f7c00_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ReceiveFixedSwapThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07615d50aa95456b8dd258c5dcc40329_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapSevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3059028e583a4104804a186f6de5c099_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapSevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85fde8cb3f9949af8bacf04f0259be1c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0873884b62114aea86cd9f3b89d0b590_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48af39d8cccf4a5691cd76b4715ca6a3_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapNineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37cfcc38e9e146619f3cc3c95a7adf45_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapNineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00125affeb654327acf6e06c632b8f66_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapTenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c6267b72cab412abdf10d903fe10285_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapTenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf8a876d526646558f40ab931121afc0_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib62a37350e4a421d8bc7b5bcf8967a8e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7b61f220e42445f91138f5f8e598c8e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7662430cb53043369eb6d812bbbc2d36_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i454dcfeb7551452b9a0a7e150c838cfb_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06a53c3ba45b4d8cbbe78361c63c0b54_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i808ef80af90c47f68c7968b13ae34c7e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9032094a43424c8ea3085296aae5d36c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6c750f147ed4f38954df76797436ad8_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c6a16294f3e464bbdbc6cc59d2922fb_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6af2f02ead9e4c9f87a0e450cf3f134f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7109ce10eb84b6b9880cfb4246c23ef_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54804f8602fa4a35a8b9674c532d6b4b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2c4350be42c47498a9bab682e3c418b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78eea1b8023b40d48343347521f72035_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7791d5655eb846eb8e57e1bf970fb10f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3173a5d521c49e1a9e897a1d64450e8_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib68ac7c0981b4940a6352b394b343b73_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2a1bea4a7df41318981b1d3405801df_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c7a094bccf049e5a50369c2dc0775bf_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1dfc84c1f55d48fdbe932272d2d40dc1_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic30bbc4807ee4a90b1e5e73a917f7981_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec7a2ccc58c14483aefa7eef623648ff_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21ccc0b58d41465bb76c786bd6c59944_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e6bf043d8e543ca9a60ab545728b68d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id809a0ee79f9462cbd0b84dc0a1f8ba6_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27cea47c34d24be486efd529a214dfe3_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37ed33a1a2e84bac96ea96cc638d09be_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d1f48dd9e4b49d78df2715069875ead_D20210127-20210127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgry:PublicStockOfferingFirmSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-27</xbrli:startDate><xbrli:endDate>2021-01-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7415e8f12eb4b0f857512e10ff2b1df_I20210127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia81e7b3e0bbf4ed8817112cf8a395a4d_D20210127-20210127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-27</xbrli:startDate><xbrli:endDate>2021-01-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i606fa788b0c34beca685e0fe3cef5cca_D20210201-20210201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgry:PublicStockOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3967e790bb894cf8acd4602519023b78_D20210401-20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if703c13f85f14316b033116a88b9d2f6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:FederalFundsEffectiveSwapRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3adc24f120064bdb80d18207eba230d9_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualRiskOrUncertaintyByNatureAxis">sgry:MateriallyMoreRestrictiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i403f136aa2eb4d108d1df4f2b90ccdd5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:UnusualRiskOrUncertaintyByNatureAxis">sgry:NotMateriallyMoreRestrictiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>sgry:segment</xbrli:measure></xbrli:unit><xbrli:context id="ic1b634056ada477481858c03f1bb914f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if166aaf3eb59483bb7262ede561423c7_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02f0df4797ab4a1e9bacd76ffdc57ab6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfbed4bef98e44fea406cc92949cdb3d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4894cd8d6cd44708c0cbc6ef5c7418f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i086a33999d294178ad7e9154bb2b9765_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic567b93a1ce84e17ad9837f0055b163b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb2d426435c8450cafd7728d9d2dc8f3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib98011fc87b240309c26b764d426abd9_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:OpticalServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18afa682ccf34322b6bcdd13fdbfa4af_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:OpticalServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24645f34e6a44361a5fbad3eb0ddf170_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:OpticalServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idff1d62b1cb640b687f9fb96f5b4bb00_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:OpticalServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22e6f85fd88d44d89f23a959137fd882_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11790ef5309b4773a0839312e45271b1_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cd422f84ed747328d3a0d61c7f136fa_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69c8d97578e54edc825c05346d77f05a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07b5831fa25c4593977edb314caf0810_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f0d8a6647ac43d3acecd87aa3917e60_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cebdc44291f4ef09e8f91e82d5fb5b1_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98faa269bef74b28b6fbd87fbc70f99e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if61366db2c44498391f1d66e8a6f3a10_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic360167dd83a4d318b00e5cd3eb72bd0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0613206f307d4141bf872d310477a2cb_D20211001-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">sgry:SurgicalFacilitiesExistingMarketsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzMtNi0xLTEtMTI3MTI_4f0eb82c-7974-4547-a439-39ca1842fe73 id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzMtOC0xLTEtMTI3MTI_273a7f14-a739-4182-a3d3-05f17b106441 id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzYtMi0xLTEtMTI3MTI_cc9caa97-f852-4b67-8131-f88f3d64052d id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzMtMi0xLTEtMTI3MTI_ad685e45-a25b-4ec6-9a56-2b2a3487e7bf id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzYtNC0xLTEtMTI3MTI_be5b1b69-bfc0-452c-9d3f-d7450ecfab16 id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzYtOC0xLTEtMTI3MTI_3f297b3b-19ae-4564-a4f4-e76d87e5c80f id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzYtNi0xLTEtMTI3MTI_9855857c-965c-4348-adf6-292a3c982615 id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzMtNC0xLTEtMTI3MTI_968f5681-1769-41d6-a061-1929f8ad5a8f" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RleHRyZWdpb246MmEzZmUxMGU0YzU4NDk4MTk4MjBmZmYyMjBmMmU5OWZfMzg3_4763b7d7-48c3-4c3b-a9bc-dbbdb07c3ab4" order="1"></ix:relationship></ix:resources></ix:header></div><div id="idcac93ae85504379b4049f3f4d6efdb8_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington,&#160;D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">_____________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">Form&#160;<ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGV4dHJlZ2lvbjo5NzAxYjc1ZWM1MzI0MTVmOGM5NWM0MjcyNmEzNDNiNl8yMzQ3_2652b8f6-a674-4dd3-a84c-5e38c9865676">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">_____________________________________</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGV4dHJlZ2lvbjo5NzAxYjc1ZWM1MzI0MTVmOGM5NWM0MjcyNmEzNDNiNl8yMzM4_bf43f8f2-7a78-44ef-b488-2c5c219aba89">&#9746;</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGV4dHJlZ2lvbjo5NzAxYjc1ZWM1MzI0MTVmOGM5NWM0MjcyNmEzNDNiNl8yOTg_38fc45fc-5141-4906-958a-d19d0ff1fef3">September&#160;30, 2021</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">or</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGV4dHJlZ2lvbjo5NzAxYjc1ZWM1MzI0MTVmOGM5NWM0MjcyNmEzNDNiNl8yMzQ5_32eacc9a-74bb-4ff8-b65e-2b7438a876ba">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number:&#160; <ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGV4dHJlZ2lvbjo5NzAxYjc1ZWM1MzI0MTVmOGM5NWM0MjcyNmEzNDNiNl8yMzUy_d444c225-b898-4ae5-ad6e-f93b9b401c6f">001-37576</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">_____________________________________</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGV4dHJlZ2lvbjo5NzAxYjc1ZWM1MzI0MTVmOGM5NWM0MjcyNmEzNDNiNl8yMzUz_39a5e540-5bc4-433f-9eb8-a0358ce50eba">Surgery Partners, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">_____________________________________</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.583%"><tr><td style="width:1.0%"></td><td style="width:47.064%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.065%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGFibGU6NjYzM2FhZGM5NmVkNGNjYTkwMGI4OTljMDVmMWU2MTcvdGFibGVyYW5nZTo2NjMzYWFkYzk2ZWQ0Y2NhOTAwYjg5OWMwNWYxZTYxN18wLTAtMS0xLTEyNzEy_4da4e01e-28e4-4abf-9350-e9b5c292169b">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGFibGU6NjYzM2FhZGM5NmVkNGNjYTkwMGI4OTljMDVmMWU2MTcvdGFibGVyYW5nZTo2NjMzYWFkYzk2ZWQ0Y2NhOTAwYjg5OWMwNWYxZTYxN18wLTItMS0xLTEyNzEy_5efe7b96-9fbc-4df5-bb1e-a506477bdae9">47-3620923</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGV4dHJlZ2lvbjo5NzAxYjc1ZWM1MzI0MTVmOGM5NWM0MjcyNmEzNDNiNl8yMzM5_836534cb-1a0a-4cda-b4b6-f606f6891901">310 Seven Springs Way, Suite&#160;500</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGV4dHJlZ2lvbjo5NzAxYjc1ZWM1MzI0MTVmOGM5NWM0MjcyNmEzNDNiNl8yMzQ0_f5f8346c-fc87-4501-aa3c-4879a54270c4">Brentwood</ix:nonNumeric>, <ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGV4dHJlZ2lvbjo5NzAxYjc1ZWM1MzI0MTVmOGM5NWM0MjcyNmEzNDNiNl8yMzQw_37fdfd3b-3f8f-4832-a7e2-b9a2014988fd">Tennessee</ix:nonNumeric> <ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGV4dHJlZ2lvbjo5NzAxYjc1ZWM1MzI0MTVmOGM5NWM0MjcyNmEzNDNiNl8yMzQ1_d379cc99-b4d8-4449-8863-e430210ddc03">37027</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Address of principal executive offices and zip code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGV4dHJlZ2lvbjo5NzAxYjc1ZWM1MzI0MTVmOGM5NWM0MjcyNmEzNDNiNl8yMzU0_fce232b2-6706-4731-9374-50197513f144">615</ix:nonNumeric>) <ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGV4dHJlZ2lvbjo5NzAxYjc1ZWM1MzI0MTVmOGM5NWM0MjcyNmEzNDNiNl8yMzQ2_16b860d1-29cb-4ec0-a08f-0ebb3b8faddd">234-5900</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">_____________________________________</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"><tr><td style="width:1.0%"></td><td style="width:33.164%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.167%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGFibGU6MGJlYzliYTgyNDc1NDA1YzkwMWU0ZGMxNGVhNGZiZmQvdGFibGVyYW5nZTowYmVjOWJhODI0NzU0MDVjOTAxZTRkYzE0ZWE0ZmJmZF8xLTAtMS0xLTEyNzEy_b74dbc41-162c-4b3d-9073-6a05d49f3039">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGFibGU6MGJlYzliYTgyNDc1NDA1YzkwMWU0ZGMxNGVhNGZiZmQvdGFibGVyYW5nZTowYmVjOWJhODI0NzU0MDVjOTAxZTRkYzE0ZWE0ZmJmZF8xLTItMS0xLTEyNzEy_6d315e76-5e9e-4cbb-a587-bc2a0dbb315b">SGRY</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGFibGU6MGJlYzliYTgyNDc1NDA1YzkwMWU0ZGMxNGVhNGZiZmQvdGFibGVyYW5nZTowYmVjOWJhODI0NzU0MDVjOTAxZTRkYzE0ZWE0ZmJmZF8xLTQtMS0xLTEyNzEy_2d0ce03e-acea-4982-a6bd-58a229e1fbed">The Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;&#160;<ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGV4dHJlZ2lvbjo5NzAxYjc1ZWM1MzI0MTVmOGM5NWM0MjcyNmEzNDNiNl8yMzM3_43aaf038-3bcc-408b-9fe0-5d3411f97e71">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160; <ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGV4dHJlZ2lvbjo5NzAxYjc1ZWM1MzI0MTVmOGM5NWM0MjcyNmEzNDNiNl8yMzUw_eac8ab86-4073-47d8-911c-93f341803b97">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act.&#160;</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.250%"><tr><td style="width:1.0%"></td><td style="width:46.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.593%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Large accelerated filer&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">o</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGFibGU6Yjc1NjQxYzMxZTAzNDExOWI4YmNjN2VkNjg1OTNhMWEvdGFibGVyYW5nZTpiNzU2NDFjMzFlMDM0MTE5YjhiY2M3ZWQ2ODU5M2ExYV8wLTItMS0xLTEyNzEyL3RleHRyZWdpb246ZmJjOTFiN2NkMDQ0NGRmN2E2OWM3NjA4NTE5YWE5ZTFfNA_0fc0a868-7b2b-4bfe-b03e-744a6ace4812">Accelerated filer</ix:nonNumeric>&#160;&#9746;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">o</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller reporting company&#160;<ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGFibGU6Yjc1NjQxYzMxZTAzNDExOWI4YmNjN2VkNjg1OTNhMWEvdGFibGVyYW5nZTpiNzU2NDFjMzFlMDM0MTE5YjhiY2M3ZWQ2ODU5M2ExYV8xLTItMS0xLTEyNzEyL3RleHRyZWdpb246ZmJmN2QxZGYxZGI5NDk1ZWFjZmIyN2UwZjk2MmU1Y2NfMzA_65fdf92e-fb09-4415-96ec-042aae9c728b">&#9744;</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company&#160;<ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGFibGU6Yjc1NjQxYzMxZTAzNDExOWI4YmNjN2VkNjg1OTNhMWEvdGFibGVyYW5nZTpiNzU2NDFjMzFlMDM0MTE5YjhiY2M3ZWQ2ODU5M2ExYV8yLTItMS0xLTEyNzEyL3RleHRyZWdpb246ZGFhZGM1MWQxYWRkNDg3ZTllNjcxZDI2MTczZDJiZTFfMjg_defeac8d-11b6-4fe2-8cb0-3e5f11050368">&#9744;</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).&#160;&#160;Yes&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGV4dHJlZ2lvbjo5NzAxYjc1ZWM1MzI0MTVmOGM5NWM0MjcyNmEzNDNiNl8yMzUx_6d2a51fb-8698-4721-bbd4-4d491ac20d9b">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">As of October&#160;29, 2021, there were <ix:nonFraction unitRef="shares" contextRef="i2b2125d4d75646e88ad9f2ad3127cbad_I20211029" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGV4dHJlZ2lvbjo5NzAxYjc1ZWM1MzI0MTVmOGM5NWM0MjcyNmEzNDNiNl8yMjgx_248ff61b-d1e1-4cd1-81f5-4871573d62a3">82,436,720</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">shares of the registrant&#8217;s common stock outstanding.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="idcac93ae85504379b4049f3f4d6efdb8_7"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FORM 10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:11.567%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.800%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Page</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_10">PART I - FINANCIAL INFORMATION</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_10">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_10">Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_13">1</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_13">Condensed Consolidated Balance Sheets (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_13">1</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_16">Condensed Consolidated Statements of Operations (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_16">2</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_19">Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_19">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_22">Condensed Consolidated Statements of Stockholders' Equity (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_22">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_25">Condensed Consolidated Statements of Cash Flows (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_25">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_28">Notes to Condensed Consolidated Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_28">7</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_64">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_64">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_64">22</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_94">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_94">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_94">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_97">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_97">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_97">31</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_100">PART II - OTHER INFORMATION</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_103">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_103">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_103">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_106">Item 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_106">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_106">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_109">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_109">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_109">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_112">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_112">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_112">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_115">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_115">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_115">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_118">Item 5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_118">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_118">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_121">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_121">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_121">34</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_124">Signatures</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_124">35</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="idcac93ae85504379b4049f3f4d6efdb8_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div></div><div style="margin-bottom:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div style="margin-bottom:4pt;text-align:center"><span><br/></span></div><div id="idcac93ae85504379b4049f3f4d6efdb8_13"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item&#160;1.&#160;&#160;Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Dollars in millions, except per share amounts)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.953%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfNC0yLTEtMS0xMjcxMg_a6f30eb6-3a3b-4426-adc4-9fbea9bfc9db">330.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfNC00LTEtMS0xMjcxMg_f475c554-713a-4cc0-ba16-8c9e5ef63f7d">317.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfNS0yLTEtMS0xMjcxMg_cb482968-8b7d-4547-9066-f44df07d2d48">393.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfNS00LTEtMS0xMjcxMg_e0999b99-ae1a-446d-b716-8f565672ccca">382.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfNi0yLTEtMS0xMjcxMg_52a02887-ec8b-4388-b26c-8dcdfb8d62ba">59.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfNi00LTEtMS0xMjcxMg_cf9d0b47-ee95-44af-98fd-eb9263b0087d">56.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfNy0yLTEtMS0xMjcxMg_c5476082-643d-43fe-b846-56748fb45536">29.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfNy00LTEtMS0xMjcxMg_398704f4-6c73-4e21-90e3-d7e9a8a878a7">17.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfOC0yLTEtMS0xMjcxMg_9c0d7b3b-c4c3-44c8-bdd6-18011386c3a8">28.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfOC00LTEtMS0xMjcxMg_5fe5967c-f00a-4be6-867b-d53965cedf7e">27.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfOS0yLTEtMS0xMjcxMg_67a62398-847d-4924-afbf-1a902f4e27ba">841.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfOS00LTEtMS0xMjcxMg_2dd974e2-063d-4309-9123-4a9eb694fd08">801.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment, net of accumulated depreciation of $<ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMTAtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo2YzEyMjJjMzQ5ZTY0ODgwOTZlNGJlYjc3NjYzN2NkNV82Mw_803685eb-1d40-45f1-88f2-4698a5629c41">254.0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMTAtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo2YzEyMjJjMzQ5ZTY0ODgwOTZlNGJlYjc3NjYzN2NkNV83MA_3d79c90c-9465-49fe-926c-632681d5addf">189.3</ix:nonFraction>, respectively</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMTAtMi0xLTEtMTI3MTI_e9ecc2f0-4e54-499d-b3fc-10eb6948e0c0">542.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMTAtNC0xLTEtMTI3MTI_836d81e5-0adf-4ec4-9ea5-b4287b989efa">544.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill and other intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMTEtMi0xLTEtMTI3MTI_4cc7b11e-3f53-45bb-aa35-4d45797c9980">3,659.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMTEtNC0xLTEtMTI3MTI_c35a57ec-3a29-4034-af4f-85220fcb23fa">3,514.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in and advances to affiliates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMTItMi0xLTEtMTI3MTI_af2714be-e808-4665-87c9-137c0276049c">89.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMTItNC0xLTEtMTI3MTI_29d6535a-4d83-4e49-b641-ad4f80e1f0ca">90.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use operating lease assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMTMtMi0xLTEtMTI3MTI_e6fd8b2c-ef7d-454a-bdda-a8b3ae1410a7">320.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMTMtNC0xLTEtMTI3MTI_bf6acb9a-3ffc-4159-9d2e-86f33c1ae513">310.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMTQtMi0xLTEtMTI3MTI_dd1299cd-1b72-46a9-958d-4e0fed0be54e">128.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMTQtNC0xLTEtMTI3MTI_3bc687f3-0e67-404e-8f55-21e49248a453">124.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMTUtMi0xLTEtMTI3MTI_146595a3-dcaf-44ab-96bf-adbba9990c7d">50.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMTUtNC0xLTEtMTI3MTI_906f7e8d-fbb8-4143-9872-1a11571f2484">27.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMTYtMi0xLTEtMTI3MTI_6f449f33-1296-4d90-adbb-1e5159b9965f">5,631.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMTYtNC0xLTEtMTI3MTI_52cf2c5e-40b1-45f4-9871-903f6daf3646">5,413.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjAtMi0xLTEtMTI3MTI_08c02d11-a49a-4ab0-8ecc-af51dacd4a85">116.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjAtNC0xLTEtMTI3MTI_bf5abe1b-0d91-4759-9ac9-c338f7ca716e">100.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued payroll and benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjEtMi0xLTEtMTI3MTI_509f4fdc-aa5a-4c3a-bf42-b158f7d06c4f">73.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjEtNC0xLTEtMTI3MTI_c4bcde61-09e4-4791-9244-8d266f15d141">65.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare accelerated payments and deferred governmental grants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="sgry:MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjItMi0xLTEtMTI3MTI_e2f8636a-f46c-43fa-a098-cd0b0ae67653">81.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="sgry:MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjItNC0xLTEtMTI3MTI_7a444372-2f0b-4966-a017-3ce85328a5b7">109.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjMtMi0xLTEtMTI3MTI_19f093fd-7d41-49a4-ad6c-ea06d4a14fae">208.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjMtNC0xLTEtMTI3MTI_08be4c76-e2af-4c79-b9b0-8d5f1dea64d3">217.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current maturities of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjQtMi0xLTEtMTI3MTI_f6d20049-8d6b-4507-bf46-3fb0f654a691">60.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjQtNC0xLTEtMTI3MTI_3419960c-0a83-4751-b795-51c03f573a36">64.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjUtMi0xLTEtMTI3MTI_38c4f67b-ef86-4a38-a209-061ae91aab82">540.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjUtNC0xLTEtMTI3MTI_f75dbb5e-9aae-4765-981f-590039326790">556.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt, less current maturities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjYtMi0xLTEtMTI3MTI_83cd88b5-ee76-4804-9762-5f6afce1af50">2,791.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjYtNC0xLTEtMTI3MTI_2581e6e1-d869-439f-a87a-d4836c6bfa19">2,792.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjctMi0xLTEtMTI3MTI_9b34eb7b-9087-4ce8-8091-9663fc5d2253">312.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjctNC0xLTEtMTI3MTI_5ec1bcd3-0f6d-44e9-97f8-ff25cb90d823">300.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjgtMi0xLTEtMTI3MTI_56ab25e7-40a5-4f06-a8e7-304684eebea2">124.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjgtNC0xLTEtMTI3MTI_c8f34808-5ee0-4975-a914-c82f01fc0b67">139.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-controlling interests&#8212;redeemable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzAtMi0xLTEtMTI3MTI_7fa969a7-ee7c-4126-bcfe-377c8efe24cd">310.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzAtNC0xLTEtMTI3MTI_87111d3d-4983-463b-8cde-1a60bd0ae4c9">306.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Redeemable preferred stock - Series A; shares authorized - <ix:nonFraction unitRef="shares" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzEtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo3Y2QzNjg3MzI1NTY0NDhjODI1ZTRiNzc2ZmRmM2EwOF82Mw_0d38a78e-9722-4b2c-82a5-25c11ed04b35"><ix:nonFraction unitRef="shares" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzEtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo3Y2QzNjg3MzI1NTY0NDhjODI1ZTRiNzc2ZmRmM2EwOF82Mw_f5bdc294-1765-47f2-879c-ca596c6e618b">310,000</ix:nonFraction></ix:nonFraction>; shares issued or outstanding - <ix:nonFraction unitRef="shares" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzEtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo3Y2QzNjg3MzI1NTY0NDhjODI1ZTRiNzc2ZmRmM2EwOF85OA_4f7d6699-11f7-430a-9b3a-63da3e692daf"><ix:nonFraction unitRef="shares" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzEtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo3Y2QzNjg3MzI1NTY0NDhjODI1ZTRiNzc2ZmRmM2EwOF85OA_a4028762-efef-4602-a22a-43747a2e0682">none</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzEtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo3Y2QzNjg3MzI1NTY0NDhjODI1ZTRiNzc2ZmRmM2EwOF8xMDU_094aeadd-7895-4d1b-b84d-3957da5feb4e"><ix:nonFraction unitRef="shares" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzEtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo3Y2QzNjg3MzI1NTY0NDhjODI1ZTRiNzc2ZmRmM2EwOF8xMDU_939dd8ac-b539-4ebf-aaec-c30695ae543b">310,000</ix:nonFraction></ix:nonFraction>, respectively; redemption value - $<ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:RedeemableNoncontrollingInterestEquityPreferredRedemptionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzEtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo3Y2QzNjg3MzI1NTY0NDhjODI1ZTRiNzc2ZmRmM2EwOF8xNDI_773499ae-378c-4e8d-a0b8-a711fc72dfca">&#8212;</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:RedeemableNoncontrollingInterestEquityPreferredRedemptionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzEtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo3Y2QzNjg3MzI1NTY0NDhjODI1ZTRiNzc2ZmRmM2EwOF8xNDk_3a2e4863-4e0c-4c11-bbde-5777b019870a">434.5</ix:nonFraction>, respectively</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzEtMi0xLTEtMTI3MTI_80cad896-6064-49bb-b0e7-1de361268599">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzEtNC0xLTEtMTI3MTI_2c0a6159-d8b1-414a-8f31-91183840f977">434.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stockholders' equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzQtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjoyYzY3MDdmNDRhNmU0NzJhYjhiMzI1NmYwNjBiOGIzZV8yMQ_2d0151c8-95fd-4128-a374-9e7d8f209c97"><ix:nonFraction unitRef="usdPerShare" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzQtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjoyYzY3MDdmNDRhNmU0NzJhYjhiMzI1NmYwNjBiOGIzZV8yMQ_e6eea99a-6c50-4bdf-989a-79e430ee591a">0.01</ix:nonFraction></ix:nonFraction> par value; shares authorized - <ix:nonFraction unitRef="shares" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzQtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjoyYzY3MDdmNDRhNmU0NzJhYjhiMzI1NmYwNjBiOGIzZV81NQ_8d99257d-46b3-4bcc-83e9-cdec817139be"><ix:nonFraction unitRef="shares" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzQtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjoyYzY3MDdmNDRhNmU0NzJhYjhiMzI1NmYwNjBiOGIzZV81NQ_d379f60c-e5af-49b2-9dbf-584cae015423">20,000,000</ix:nonFraction></ix:nonFraction>; shares issued or outstanding - <ix:nonFraction unitRef="shares" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzQtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjoyYzY3MDdmNDRhNmU0NzJhYjhiMzI1NmYwNjBiOGIzZV85MA_1010415c-97c1-4ca4-9711-2ef5857575a4"><ix:nonFraction unitRef="shares" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzQtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjoyYzY3MDdmNDRhNmU0NzJhYjhiMzI1NmYwNjBiOGIzZV85MA_71c2a624-a36d-44ec-879f-3e394f883c02"><ix:nonFraction unitRef="shares" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzQtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjoyYzY3MDdmNDRhNmU0NzJhYjhiMzI1NmYwNjBiOGIzZV85MA_80be2081-857f-4ac3-8339-e85cd98049b9"><ix:nonFraction unitRef="shares" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzQtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjoyYzY3MDdmNDRhNmU0NzJhYjhiMzI1NmYwNjBiOGIzZV85MA_dfe3f2bf-007f-4ef5-b0f8-34ae5e9f5eb6">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzQtMi0xLTEtMTI3MTI_5c68fb06-6166-4ddb-bc31-7bf343266821">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzQtNC0xLTEtMTI3MTI_8d3950e8-7ca2-44f4-9048-0166a085bf46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzUtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo0YzhmMjg4OTY4NmI0OTA2YWEyNmY2Y2NmNDJhOTdkOF8xOA_00c39c81-0092-4f34-8b57-97a04111c3ee"><ix:nonFraction unitRef="usdPerShare" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzUtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo0YzhmMjg4OTY4NmI0OTA2YWEyNmY2Y2NmNDJhOTdkOF8xOA_99953a10-a4bd-41d1-ba70-dc77533f1139">0.01</ix:nonFraction></ix:nonFraction> par value; shares authorized - <ix:nonFraction unitRef="shares" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzUtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo0YzhmMjg4OTY4NmI0OTA2YWEyNmY2Y2NmNDJhOTdkOF81Mg_057f4f82-fd06-4c5f-9a90-94ed734a2808"><ix:nonFraction unitRef="shares" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzUtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo0YzhmMjg4OTY4NmI0OTA2YWEyNmY2Y2NmNDJhOTdkOF81Mg_38c943fd-3432-413e-b321-8aa4f7ffaf93">300,000,000</ix:nonFraction></ix:nonFraction>; shares issued and outstanding - <ix:nonFraction unitRef="shares" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzUtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo0YzhmMjg4OTY4NmI0OTA2YWEyNmY2Y2NmNDJhOTdkOF84OA_16809d8a-409f-4e1f-b390-49bbd691df25"><ix:nonFraction unitRef="shares" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzUtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo0YzhmMjg4OTY4NmI0OTA2YWEyNmY2Y2NmNDJhOTdkOF84OA_716ad421-0ccf-473a-b56b-6fb43326e225">82,458,385</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzUtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo0YzhmMjg4OTY4NmI0OTA2YWEyNmY2Y2NmNDJhOTdkOF85NQ_0bd5c636-5948-4f4a-b4c2-4fa37c0e530d"><ix:nonFraction unitRef="shares" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzUtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo0YzhmMjg4OTY4NmI0OTA2YWEyNmY2Y2NmNDJhOTdkOF85NQ_8f92704d-53cc-4638-8a24-90b1a7c7f36b">50,461,706</ix:nonFraction></ix:nonFraction>, respectively</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="us-gaap:CommonStockValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzUtMi0xLTEtMTI3MTI_d63faebf-a4db-4744-9c0e-44d8f9923d4d">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:CommonStockValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzUtNC0xLTEtMTI3MTI_e3efb40f-ce33-46f9-afc7-7aa30531d4f7">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzYtMi0xLTEtMTI3MTI_51e9655e-d7d7-4b40-a523-8814a00485de">1,306.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzYtNC0xLTEtMTI3MTI_36d2626d-db29-4c23-8cab-88ddcbb65e7b">607.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzctMi0xLTEtMTI3MTI_3af8053f-ff1c-4e21-a76a-8ff8575f897c">47.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzctNC0xLTEtMTI3MTI_d609cd2b-c92e-4efd-87ae-8fbaed1af4f3">61.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained deficit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzgtMi0xLTEtMTI3MTI_bda693ff-0f09-4386-b13b-46b6d3f42664">502.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzgtNC0xLTEtMTI3MTI_5ea9b4ed-21d9-4ea3-a8a3-6ee6eb6a7a2a">431.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Surgery Partners, Inc. stockholders' equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzktMi0xLTEtMTI3MTI_85c5ce38-79ee-4d37-ae19-2166c10c70e2">756.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzktNC0xLTEtMTI3MTI_c7b3c6fc-bcbb-439e-a7fb-4d476f2a23cc">115.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-controlling interests&#8212;non-redeemable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfNDAtMi0xLTEtMTI3MTI_2e518cc3-4be0-4a8b-9639-37e076b11eb6">795.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfNDAtNC0xLTEtMTI3MTI_601fd415-7234-4360-ba57-8e3862686921">766.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stockholders' equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfNDEtMi0xLTEtMTI3MTI_793e7087-621f-4068-8665-e8f36fcc01d3">1,552.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfNDEtNC0xLTEtMTI3MTI_f748ed6b-30c2-4c31-a1f0-587604b01ed7">882.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities and stockholders' equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfNDItMi0xLTEtMTI3MTI_622ba33f-c9cf-4d77-9534-0c631c68879f">5,631.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfNDItNC0xLTEtMTI3MTI_f5976f33-22b8-4e43-bdd0-2f71dcf9a1d6">5,413.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to unaudited condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="idcac93ae85504379b4049f3f4d6efdb8_16"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited, dollars in millions, except per share amounts, shares in thousands)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.968%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.968%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.968%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.975%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMy0yLTEtMS0xMjcxMg_923f17f1-0594-4b21-81d4-3d60df6fafc7">559.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMy00LTEtMS0xMjcxMg_13fa2a76-52e0-41b7-82e3-69bb5136f8af">496.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMy02LTEtMS0xMjcxMg_f8afb80b-3586-435e-ac7c-77df724d1ab7">1,614.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMy04LTEtMS0xMjcxMg_b9b9c57c-336b-407f-95e9-5a4dfa244ed6">1,311.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Salaries and benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="us-gaap:LaborAndRelatedExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfNS0yLTEtMS0xMjcxMg_803c8061-df35-4f70-b9b4-c7d2a184b4bb">162.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" name="us-gaap:LaborAndRelatedExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfNS00LTEtMS0xMjcxMg_520c8f92-ba8b-4968-a4a9-5a71d59e2f91">141.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:LaborAndRelatedExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfNS02LTEtMS0xMjcxMg_87739226-2e8c-4561-a83d-e837d63fd388">468.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:LaborAndRelatedExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfNS04LTEtMS0xMjcxMg_f2c52207-4c84-4eb4-90f3-4e1e82eaccca">398.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="us-gaap:SuppliesExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfNi0yLTEtMS0xMjcxMg_18a7daf6-eb4a-46f7-b89c-0118bca494bb">160.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" name="us-gaap:SuppliesExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfNi00LTEtMS0xMjcxMg_b00db77a-efdd-454e-b56c-c03dbbdb4bf1">142.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:SuppliesExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfNi02LTEtMS0xMjcxMg_4e1cda6d-5477-47cb-a6ab-cb19102498be">464.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:SuppliesExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfNi04LTEtMS0xMjcxMg_253e1428-b970-4850-ad84-0d3017cb5081">382.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional and medical fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="us-gaap:ProfessionalFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfNy0yLTEtMS0xMjcxMg_0f6ed289-9d5a-4e59-8fda-7337577d9974">56.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" name="us-gaap:ProfessionalFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfNy00LTEtMS0xMjcxMg_7bb56835-fbe4-40cb-b8d6-7103a26afc7a">46.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:ProfessionalFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfNy02LTEtMS0xMjcxMg_c0281d64-3a8f-46f1-902d-96cfd902f468">169.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:ProfessionalFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfNy04LTEtMS0xMjcxMg_fe262fd1-6097-4b41-8c13-3202b6c11ead">138.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="sgry:OperatingAndFinanceLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfOC0yLTEtMS0xMjcxMg_b602f995-f020-4624-b39c-a40e0ad6450f">23.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" name="sgry:OperatingAndFinanceLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfOC00LTEtMS0xMjcxMg_daf68f81-a1e6-4ef7-be85-3f2c95be3029">21.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="sgry:OperatingAndFinanceLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfOC02LTEtMS0xMjcxMg_12b68522-afb3-44a5-bdb6-6f8690c3951d">68.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="sgry:OperatingAndFinanceLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfOC04LTEtMS0xMjcxMg_b6ad6c3c-3201-4dc5-91e2-80153834fcdc">64.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="us-gaap:OtherCostAndExpenseOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfOS0yLTEtMS0xMjcxMg_c23f56a7-0249-436e-8208-256fda2bfa93">34.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" name="us-gaap:OtherCostAndExpenseOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfOS00LTEtMS0xMjcxMg_7190ea23-e71a-4340-b57c-e5ef3ced5cec">29.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:OtherCostAndExpenseOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfOS02LTEtMS0xMjcxMg_3d65bbb4-4fc6-443c-a5ae-5af30a568eda">98.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:OtherCostAndExpenseOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfOS04LTEtMS0xMjcxMg_08a1912c-d1a4-4dd2-8e8d-e2d17220ee9d">83.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="us-gaap:OperatingCostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTAtMi0xLTEtMTI3MTI_c089830a-569e-4d75-9eec-7825b6362034">436.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" name="us-gaap:OperatingCostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTAtNC0xLTEtMTI3MTI_e8cc4ec3-6238-4ea8-8b01-2b451f79b1fe">381.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingCostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTAtNi0xLTEtMTI3MTI_68f93426-ec60-45ed-ab98-82abc7a24a54">1,270.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingCostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTAtOC0xLTEtMTI3MTI_b2c80fd3-7508-4548-9205-2bf17338a72a">1,067.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTEtMi0xLTEtMTI3MTI_88208a6e-fc8b-4f56-ae49-c3f3a2601645">25.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTEtNC0xLTEtMTI3MTI_4f652a06-c513-41d3-8b2d-89b901f49454">25.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTEtNi0xLTEtMTI3MTI_eedd423d-1e77-44f2-93b3-3cf8c2accad6">76.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTEtOC0xLTEtMTI3MTI_efdeb28b-a2b6-44b5-a2d3-c058f51f658a">73.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTItMi0xLTEtMTI3MTI_b798d976-e342-41ed-af9f-798744943b2c">25.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTItNC0xLTEtMTI3MTI_52693c4c-c908-4f64-8aa0-8b35fbf81bbb">24.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTItNi0xLTEtMTI3MTI_7f963b62-5799-4826-9f72-95f6f137030d">76.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTItOC0xLTEtMTI3MTI_f8e6c16d-853c-4fb5-81e2-14682b23b0f5">69.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from equity investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTMtMi0xLTEtMTI3MTI_f81d17c0-cd38-4abf-a6f4-5a475717b9dd">2.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTMtNC0xLTEtMTI3MTI_407200fd-8585-4e67-ae29-252efb099000">3.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTMtNi0xLTEtMTI3MTI_83eeb351-41c5-4708-bd53-a57bd7a0a9c4">8.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTMtOC0xLTEtMTI3MTI_f7acc92e-3d07-4c19-86ea-9088abda3294">7.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on disposals and deconsolidations, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" sign="-" name="sgry:GainLossOnDispositionOfAssetsAndDeconsolidation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTQtMi0xLTEtMTI3MTI_cf2684c5-6f85-4f6e-b1b6-3fefd9fb0c38">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" sign="-" name="sgry:GainLossOnDispositionOfAssetsAndDeconsolidation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTQtNC0xLTEtMTI3MTI_b9d821f1-63b0-4b1f-a2e9-78de1cee06f2">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" sign="-" name="sgry:GainLossOnDispositionOfAssetsAndDeconsolidation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTQtNi0xLTEtMTI3MTI_44f40701-2a55-49ef-b74c-3ed8d1bcb5bb">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" sign="-" name="sgry:GainLossOnDispositionOfAssetsAndDeconsolidation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTQtOC0xLTEtMTI3MTI_9a351211-9672-4410-ac1f-e3f57c285afb">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTUtMi0xLTEtMTI3MTI_6a5f7e23-27c1-4148-9edc-c0efabaf9f11">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTUtNC0xLTEtMTI3MTI_d0c089d9-412e-48d0-b8a7-5dc0049a8c2e">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTUtNi0xLTEtMTI3MTI_92a4e7fc-7894-4eae-941e-85c9b8099db5">24.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTUtOC0xLTEtMTI3MTI_0dcd233b-880d-43b1-9f7f-84d534333bc8">15.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTYtMi0xLTEtMTY5OTU_9b2326c7-1f82-4251-81cb-e38ab61f4bc1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTYtNC0xLTEtMTcwMDQ_15664651-1fa9-46c0-a211-abc8ea405629">33.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTYtNi0xLTEtMTcwMTI_9f7aca16-83fe-42a2-9acf-633c2f2c9d97">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTYtOC0xLTEtMTcwMjA_c59ca081-18c8-45bf-b1ce-073483076f8d">33.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Grant funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" format="ixt:fixed-zero" name="sgry:GrantRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTYtMi0xLTEtMTI3MTI_afd09345-87b0-4d81-b9ea-176106e17ddd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" sign="-" name="sgry:GrantRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTYtNC0xLTEtMTI3MTI_a33b8406-e4fc-4ea8-8f12-dfa0c0e6e849">9.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="sgry:GrantRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTYtNi0xLTEtMTI3MTI_21fb4bf2-d0b4-46b0-b087-15436edf7375">20.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="sgry:GrantRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTYtOC0xLTEtMTI3MTI_7ca6618a-ee28-499c-92d4-4d7759adf84c">33.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Gain) loss on debt extinguishment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTctMi0xLTEtMTI3MTI_b4fb98e3-a591-46f4-83a9-c4bd6caf6d6c">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTctNC0xLTEtMTI3MTI_35c318e6-1acf-4ae1-b326-835709f8c534">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTctNi0xLTEtMTI3MTI_4052c5fd-b59c-4c9d-bd70-04387cb4e744">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTctOC0xLTEtMTI3MTI_7be0f9eb-9065-4220-9cd7-f74ae4e17e6d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Litigation settlement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTgtMi0xLTEtMTI3MTI_1b4fb7a9-c464-4287-8804-652efc63ac3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTgtNC0xLTEtMTI3MTI_998e8c41-5222-482c-a39c-67cf1cc9a6d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTgtNi0xLTEtMTI3MTI_466498c1-c08a-41ec-93ac-a677995382c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTgtOC0xLTEtMTI3MTI_f995d071-cc0d-454d-9b50-554f899c1ec2">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" sign="-" name="us-gaap:OtherNonrecurringIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTktMi0xLTEtMTI3MTI_617395ba-de60-4ba9-943f-3a37fd9a11d6">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:OtherNonrecurringIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTktNC0xLTEtMTI3MTI_9953bcc9-f3e7-4e01-8992-5f4255883c87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:OtherNonrecurringIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTktNi0xLTEtMTI3MTI_b830e054-f4f8-4e29-876c-f0ed866f9246">3.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:OtherNonrecurringIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTktOC0xLTEtMTI3MTI_e6795b18-d4fc-43bc-84a4-149f76374f25">1.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjAtMi0xLTEtMTI3MTI_d5f0ae9e-5a2a-4f6c-a60c-cde07450fb2f">495.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjAtNC0xLTEtMTI3MTI_f46eafd1-b948-4863-b4aa-22a5fa0447fd">477.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjAtNi0xLTEtMTI3MTI_755d3c69-1b97-4d50-b25a-21b40a43531d">1,427.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjAtOC0xLTEtMTI3MTI_944c5d27-d82d-4604-9cb5-87c6b6eb6b3e">1,225.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjEtMi0xLTEtMTI3MTI_063088a5-0e10-44ad-adf0-94a8e301f29a">63.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjEtNC0xLTEtMTI3MTI_6182a64b-fe3d-4bfa-b55f-e17df9e2978b">18.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjEtNi0xLTEtMTI3MTI_f5692a52-f7b4-4591-9756-2094e359d491">187.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjEtOC0xLTEtMTI3MTI_d63604e0-c474-4eb6-8a16-6d5430c5bde4">86.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjItMi0xLTEtMTI3MTI_87199e04-1976-46fe-945a-c67c8bc3a6cc">54.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjItNC0xLTEtMTI3MTI_36c871ac-2ba6-413b-945d-2cd76167dc4f">51.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjItNi0xLTEtMTI3MTI_5f569a29-b23a-4150-8854-b74980a5f27e">160.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjItOC0xLTEtMTI3MTI_b014ca9b-2b68-419a-a3fd-1bf46d4431ed">147.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjMtMi0xLTEtMTI3MTI_034c4fea-694e-48af-bdd3-8805e6784f33">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjMtNC0xLTEtMTI3MTI_13e41418-de19-4c92-9bdb-2f95e5b882f0">33.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjMtNi0xLTEtMTI3MTI_92814818-118c-47ab-a797-aef127bb6e04">26.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjMtOC0xLTEtMTI3MTI_8802fa4c-90d2-4daf-be11-29d4fb3d9172">61.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjQtMi0xLTEtMTI3MTI_0a8159fc-bcec-4cbd-974c-9e756c59a6da">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjQtNC0xLTEtMTI3MTI_7c7502a8-361a-4b3a-9e03-9e94498ac06e">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjQtNi0xLTEtMTI3MTI_4c6e16eb-e472-43dd-a963-e6e19af300b9">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjQtOC0xLTEtMTI3MTI_d2baa323-2740-4633-97d1-aa430baa2594">14.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjUtMi0xLTEtMTI3MTI_52ac0e62-cd10-4e29-a4c1-c4c2ac3799b6">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjUtNC0xLTEtMTI3MTI_a74b984a-4216-4caf-abf0-ce070f23c7fc">34.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjUtNi0xLTEtMTI3MTI_b2168d8e-d1db-41db-a0d4-5517c790866b">27.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjUtOC0xLTEtMTI3MTI_ebf4c4b7-1b78-4b19-82a1-077e647b671a">46.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Net income attributable to non-controlling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjYtMi0xLTEtMTI3MTI_5c144b3a-2617-47c5-b37f-0d9f59b94977">31.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjYtNC0xLTEtMTI3MTI_951aecb5-369f-4b7a-bfcf-dc23b3f77e5b">27.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjYtNi0xLTEtMTI3MTI_b1fb2fde-3f6e-4f2f-8d89-ea066d3bb5c2">98.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjYtOC0xLTEtMTI3MTI_1cc5e4e5-1d88-48ae-8b7c-4880b9db89aa">75.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss attributable to Surgery Partners, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjctMi0xLTEtMTI3MTI_6e544045-c907-43cf-8098-ff4e66fc7a9f">22.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjctNC0xLTEtMTI3MTI_efab8ef4-0170-4770-b6bb-a99816e563fe">61.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjctNi0xLTEtMTI3MTI_72d6ccde-9df8-48a6-95ba-305be7fad3e6">70.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjctOC0xLTEtMTI3MTI_3c96f6be-ac9d-4a89-88ec-695c816da8c7">121.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Amounts attributable to participating securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjgtMi0xLTEtMTI3MTI_f25396e8-45c3-4ec7-bd8b-dbf127c9d6cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjgtNC0xLTEtMTI3MTI_cfdc8745-7774-4438-8642-4283ceaec163">10.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjgtNi0xLTEtMTI3MTI_2d71a8b2-0372-4ca0-b269-3f026b17c88b">10.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjgtOC0xLTEtMTI3MTI_3c4d847c-b8ea-4d8f-8951-878656483cc9">29.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss attributable to common stockholders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjktMi0xLTEtMTI3MTI_c715c1de-ec05-4944-81e0-66c83b6a693d">22.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjktNC0xLTEtMTI3MTI_ed238a85-a17d-4e4e-afc5-1878f1ced894">71.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjktNi0xLTEtMTI3MTI_f57c07f6-a466-4721-9cd1-2d0b1b7824a4">81.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjktOC0xLTEtMTI3MTI_7db769f7-bc01-48b9-9381-a3a41226986f">150.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share attributable to common stockholders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzItMi0xLTEtMTI3MTI_0cbde892-b9da-4f3a-b671-edb30dcdd9bd">0.28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzItNC0xLTEtMTI3MTI_cac5d8a2-65d7-4b05-8a66-a5e8be116871">1.46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzItNi0xLTEtMTI3MTI_5c68fb1b-5804-44ab-a8db-5a7d1d3ac08f">1.19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzItOC0xLTEtMTI3MTI_22ef134a-712e-4886-82f2-97b5023cc78b">3.09</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzMtMi0xLTEtMTI3MTI_ad685e45-a25b-4ec6-9a56-2b2a3487e7bf">0.28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzMtNC0xLTEtMTI3MTI_968f5681-1769-41d6-a061-1929f8ad5a8f">1.46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzMtNi0xLTEtMTI3MTI_4f0eb82c-7974-4547-a439-39ca1842fe73">1.19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzMtOC0xLTEtMTI3MTI_273a7f14-a739-4182-a3d3-05f17b106441">3.09</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzUtMi0xLTEtMTI3MTI_73635dc4-f3a4-49ca-8761-5975522fc6b3">80,726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzUtNC0xLTEtMTI3MTI_2a511397-13dd-4b63-aef8-a62a7c79d6d7">48,883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzUtNi0xLTEtMTI3MTI_33cd84d6-e33a-4643-b7cf-74ab021c2bb7">68,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzUtOC0xLTEtMTI3MTI_97c5c9be-6133-405d-b7eb-a7561fa14f13">48,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzYtMi0xLTEtMTI3MTI_cc9caa97-f852-4b67-8131-f88f3d64052d">80,726</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzYtNC0xLTEtMTI3MTI_be5b1b69-bfc0-452c-9d3f-d7450ecfab16">48,883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzYtNi0xLTEtMTI3MTI_9855857c-965c-4348-adf6-292a3c982615">68,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzYtOC0xLTEtMTI3MTI_3f297b3b-19ae-4564-a4f4-e76d87e5c80f">48,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RleHRyZWdpb246MmEzZmUxMGU0YzU4NDk4MTk4MjBmZmYyMjBmMmU5OWZfMzg3_4763b7d7-48c3-4c3b-a9bc-dbbdb07c3ab4" footnoteRole="http://www.xbrl.org/2003/role/footnote">The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in those periods.</ix:footnote></span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to unaudited condensed consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="idcac93ae85504379b4049f3f4d6efdb8_19"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited, dollars in millions)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.221%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfMy0yLTEtMS0xMjcxMg_52ac0e62-cd10-4e29-a4c1-c4c2ac3799b6">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfMy00LTEtMS0xMjcxMg_a74b984a-4216-4caf-abf0-ce070f23c7fc">34.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfMy02LTEtMS0xMjcxMg_b2168d8e-d1db-41db-a0d4-5517c790866b">27.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfMy04LTEtMS0xMjcxMg_ebf4c4b7-1b78-4b19-82a1-077e647b671a">46.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative activity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfNS0yLTEtMS0xMjcxMg_4d24f276-a959-4f4c-a1ec-23e8af91d421">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfNS00LTEtMS0xMjcxMg_815c68cf-356d-4150-8cc9-a23c47328c71">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfNS02LTEtMS0xMjcxMg_7bbe628e-1f6e-4ca1-94de-2625648c658e">13.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfNS04LTEtMS0xMjcxMg_09f4bcdd-abba-46eb-9c72-af38cce7bcf7">14.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfNi0yLTEtMS0xMjcxMg_e79109dd-a86a-48f4-b60f-2d68d9c1c584">14.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfNi00LTEtMS0xMjcxMg_c1daa70a-b211-4a4d-8fde-26e02d7a5dce">31.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfNi02LTEtMS0xMjcxMg_c0eed380-2b67-4743-a373-d5b67a7c6744">40.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfNi04LTEtMS0xMjcxMg_4ef4de39-9b1b-41bf-8cb5-e9ddc28b0ed9">61.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Comprehensive income attributable to non-controlling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfNy0yLTEtMS0xMjcxMg_bc6230f4-3895-4326-84c2-5312c1b0745c">31.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfNy00LTEtMS0xMjcxMg_871d5026-4d6e-4eaf-a17f-a39534088658">27.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfNy02LTEtMS0xMjcxMg_87bded83-03e2-4914-ada0-df8a298dd551">98.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfNy04LTEtMS0xMjcxMg_78fd731d-3d3d-4cd6-99c6-5959d76092d2">75.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive loss attributable to Surgery Partners, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfOC0yLTEtMS0xMjcxMg_0d294bc3-9559-4763-bb50-1866f2bf2044">16.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfOC00LTEtMS0xMjcxMg_4e2e6fab-6781-4012-a891-51722dca55f2">58.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfOC02LTEtMS0xMjcxMg_43f26ffd-d271-4c1f-9257-53111b84be69">57.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfOC04LTEtMS0xMjcxMg_a00f9811-2ac2-4623-add2-d6b9c6ca0d50">136.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to unaudited condensed consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="idcac93ae85504379b4049f3f4d6efdb8_22"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited, dollars in millions, shares in thousands)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.792%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.792%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.913%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.797%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional <br/>Paid-in Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained Deficit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-Controlling Interests&#8212;  <br/>Non-Redeemable</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if7ea101365284e93a6ac503e7e44170b_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMS0xLTEtMS0xMjcxMg_77b20a60-019f-4676-8348-f6faa1b9a11a">50,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7ea101365284e93a6ac503e7e44170b_I20201231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMS0zLTEtMS0xMjcxMg_0b86ecd1-bf46-4834-a88c-ab897ce76d23">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c05ce754df645d98f80d7ffa09f927e_I20201231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMS01LTEtMS0xMjcxMg_720e6527-e5fe-477d-88c2-719895833565">607.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9aa0d95886f432db9278aadacd55da4_I20201231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMS03LTEtMS0xMjcxMg_08e1824c-dedc-4926-88ac-4b3dad5b2645">61.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40304b7c460b45958fb265491cf6bb14_I20201231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMS05LTEtMS0xMjcxMg_bf4b01e9-9713-406d-8692-92341fd070f6">431.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7bf9f7034fb4595a4b18217e2ceaeb0_I20201231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMS0xMS0xLTEtMTI3MTI_8bde8e2c-40a1-43a0-b4e5-48a50bc7799a">766.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMS0xMy0xLTEtMTI3MTI_b5862a96-80bc-4e40-b419-affce737ec4a">882.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5484a5886424dc6b347b2b8ba32b919_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMi05LTEtMS0xMjcxMg_b905ef59-c0bf-4c05-84f8-e84670757e5f">21.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac8c4f727e89495faa49068c7628988d_D20210101-20210331" decimals="-5" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMi0xMS0xLTEtMTI3MTI_39b4280b-d55b-4f7d-8729-162c70ec2457">21.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3af38d809db4b7a8d26a05b63fa42b5_D20210101-20210331" decimals="-5" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMi0xMy0xLTEtMTI3MTI_9bbbcc6d-5b9e-4a6c-a3c3-ca2b3576f388">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a44af99afa44f24bc727649252223dc_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMy0xLTEtMS0xMjcxMg_c75bc749-28f2-4163-8295-a06d06f70af5">812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6453064d41354fd1bc9110d0cd3c3e4c_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMy01LTEtMS0xMjcxMg_413bae54-f983-490f-9da2-e00a4219bbf1">2.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib3af38d809db4b7a8d26a05b63fa42b5_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMy0xMy0xLTEtMTI3MTI_b4b79088-87f1-438e-b8dd-dc587564e5ee">2.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Preferred dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6453064d41354fd1bc9110d0cd3c3e4c_D20210101-20210331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfNC01LTEtMS0xMjcxMg_854999d9-fa70-491f-8821-24ae3086085b">10.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib3af38d809db4b7a8d26a05b63fa42b5_D20210101-20210331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfNC0xMy0xLTEtMTI3MTI_2cace298-6c4d-4e3a-9dfc-1e60fd4e8bf0">10.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity offering</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a44af99afa44f24bc727649252223dc_D20210101-20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfNS0xLTEtMS0xMjcxMg_c161f3e6-1102-41b2-bd3a-f341e408639d">8,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a44af99afa44f24bc727649252223dc_D20210101-20210331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfNS0zLTEtMS0xMjcxMg_14d50bbf-6964-40bf-ac76-f96eb61c69be">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6453064d41354fd1bc9110d0cd3c3e4c_D20210101-20210331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfNS01LTEtMS0xMjcxMg_4d5d2cda-1ebc-48c3-9438-3fef016b39a3">248.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3af38d809db4b7a8d26a05b63fa42b5_D20210101-20210331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfNS0xMy0xLTEtMTI3MTI_3451a64b-d968-48d1-8844-c4d97b22487b">248.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9d3034dcc144fa3a6b470e98cc8e6c7_D20210101-20210331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfNi03LTEtMS0xMjcxMg_0c6e7b59-a251-4871-a1c7-6305300eb006">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3af38d809db4b7a8d26a05b63fa42b5_D20210101-20210331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfNi0xMy0xLTEtMTI3MTI_679cf7a4-9942-4c06-9688-73df95644447">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition and disposal of shares of non-controlling interests, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6453064d41354fd1bc9110d0cd3c3e4c_D20210101-20210331" decimals="-5" name="sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfNy01LTEtMS0xMjcxMg_3a1292d8-96ac-4bd0-91a4-8a0711b3895c">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac8c4f727e89495faa49068c7628988d_D20210101-20210331" decimals="-5" name="sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfNy0xMS0xLTEtMTI3MTI_d52573c9-bfb7-44c7-b5af-81cf4e008067">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3af38d809db4b7a8d26a05b63fa42b5_D20210101-20210331" decimals="-5" name="sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfNy0xMy0xLTEtMTI3MTI_ff8c662d-2ece-4667-96a5-2d063a71ae74">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to non-controlling interests&#8212;non-redeemable holders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac8c4f727e89495faa49068c7628988d_D20210101-20210331" decimals="-5" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfOC0xMS0xLTEtMTI3MTI_56c6578c-51e8-4aa6-a631-96649f488171">20.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib3af38d809db4b7a8d26a05b63fa42b5_D20210101-20210331" decimals="-5" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfOC0xMy0xLTEtMTI3MTI_d71d89b6-3d80-49d1-8bdd-988d0c9ef309">20.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib36db35e625047569233e786bdc89d3a_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfOS0xLTEtMS0xMjcxMg_a0cffa87-f2fa-403d-b490-b1bdabf5ba57">59,899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib36db35e625047569233e786bdc89d3a_I20210331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfOS0zLTEtMS0xMjcxMg_757c78d7-3e70-4a74-b802-7a83ec618d53">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e786c45dae04a89a45c7c72c011e04a_I20210331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfOS01LTEtMS0xMjcxMg_465a12de-766d-4f94-bd7a-893331c3d3a0">843.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icde2fc5b1e01435d98af7a6ea3c9d3ee_I20210331" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfOS03LTEtMS0xMjcxMg_3318c4c5-64a7-4493-a716-ad7b4a81b622">54.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7bc8516124c4fafb914be3b2c9936ba_I20210331" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfOS05LTEtMS0xMjcxMg_41b5f0a6-1c5b-4583-bce4-06384aa325ee">452.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a8fd0aa6b7a4d549e90dc2fb6ab3ff3_I20210331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfOS0xMS0xLTEtMTI3MTI_78d0af70-d9d7-4f0b-8d7e-ac649bd8362a">768.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie80e658267b44f07b2ddd4012b02d206_I20210331" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfOS0xMy0xLTEtMTI3MTI_d599d83a-58eb-4303-9fe2-64ecd06a4745">1,105.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ab7dd37d1e7404696a9549accda39b9_D20210401-20210630" decimals="-5" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTAtOS0xLTEtMTI3MTI_5cf43282-00d1-461a-b4f0-80586b5c5de3">26.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee943e15508949c2baaacaa9fdc9724c_D20210401-20210630" decimals="-5" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTAtMTEtMS0xLTEyNzEy_e2eecc5c-81ab-49f3-8fbe-dabe9857a6e4">22.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30ed8caf27dd4768b110022f3860e021_D20210401-20210630" decimals="-5" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTAtMTMtMS0xLTEyNzEy_20bc210e-8276-44ec-bac9-0959b8183aad">4.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5827f320e258406b952e1a452a006818_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTEtMS0xLTEtMTI3MTI_a8b62a89-3524-4394-a052-203a15a2ed31">29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie856a8782f374508af805ab30b4d7f1a_D20210401-20210630" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTEtNS0xLTEtMTI3MTI_874c1ad0-9479-492b-9688-074144b5c1d4">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30ed8caf27dd4768b110022f3860e021_D20210401-20210630" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTEtMTMtMS0xLTEyNzEy_c4919841-9b3b-4065-ae61-db8bc55a1fc7">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Preferred share conversion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5827f320e258406b952e1a452a006818_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTItMS0xLTEtMTI3MTI_fc4669ee-f903-4639-9ada-0f3cc104bde8">22,609</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5827f320e258406b952e1a452a006818_D20210401-20210630" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTItMy0xLTEtMTI3MTI_941c4aef-88a7-4653-9c1c-29490726b8f0">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie856a8782f374508af805ab30b4d7f1a_D20210401-20210630" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTItNS0xLTEtMTI3MTI_39edf9cd-6669-40ed-97d1-266e74f704a5">439.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30ed8caf27dd4768b110022f3860e021_D20210401-20210630" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTItMTMtMS0xLTEyNzEy_ced44369-002f-4be2-aecc-493615d84280">439.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25643604ef6c4d269d4585afa6c3ba1b_D20210401-20210630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTMtNy0xLTEtMTI3MTI_04e179ba-091d-4a6f-88c2-6baa49978490">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30ed8caf27dd4768b110022f3860e021_D20210401-20210630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTMtMTMtMS0xLTEyNzEy_46e71a46-18ad-4002-b47c-df29c89d83cb">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition and disposal of shares of non-controlling interests, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie856a8782f374508af805ab30b4d7f1a_D20210401-20210630" decimals="-5" name="sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTQtNS0xLTEtMTI3MTI_2a5782bc-e534-4713-a623-cd6410cd3b88">11.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee943e15508949c2baaacaa9fdc9724c_D20210401-20210630" decimals="-5" sign="-" name="sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTQtMTEtMS0xLTEyNzEy_369cd299-673c-4370-8c7b-03f3da62d85a">6.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30ed8caf27dd4768b110022f3860e021_D20210401-20210630" decimals="-5" name="sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTQtMTMtMS0xLTEyNzEy_a7dea6cc-482b-4d11-b462-cdd67e283423">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to non-controlling interests&#8212;non-redeemable holders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee943e15508949c2baaacaa9fdc9724c_D20210401-20210630" decimals="-5" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTUtMTEtMS0xLTEyNzEy_debb4605-cbee-4221-9acb-813fab652654">22.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30ed8caf27dd4768b110022f3860e021_D20210401-20210630" decimals="-5" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTUtMTMtMS0xLTEyNzEy_9aef913b-b6e2-41fc-ad83-7734a5027701">22.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i53a6a629d2c54847bafd53081201b921_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTYtMS0xLTEtMTI3MTI_1510a955-faa3-43fa-a621-e53594685142">82,479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53a6a629d2c54847bafd53081201b921_I20210630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTYtMy0xLTEtMTI3MTI_81954441-ef91-41be-82a4-6707ade8e4b5">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cddba9fa8504c48ac5dd4b5006afdd6_I20210630" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTYtNS0xLTEtMTI3MTI_939bc7e1-0e72-4cc9-aa08-8c1e9a568a73">1,298.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99bd0353d66749c5b88fe887803a2f51_I20210630" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTYtNy0xLTEtMTI3MTI_31053033-85af-4fc5-acbb-e0d862d9f301">54.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5379e81f3c3549b4ab8058d34662a9dc_I20210630" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTYtOS0xLTEtMTI3MTI_18905a7b-e485-4656-9da6-142a0edd6ea6">479.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6936b3e1ceae47a881d3535da654ef72_I20210630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTYtMTEtMS0xLTEyNzEy_fa4da3d5-4290-4c90-82c9-39f28c0fec01">762.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib382c78377b74941b68729e139319e6b_I20210630" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTYtMTMtMS0xLTEyNzEy_5f27f287-0d0a-4d2b-96d5-cc7865d23cc9">1,527.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idbf85fe5fc0e4c159aecfae0b8c53435_D20210701-20210930" decimals="-5" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTktOS0xLTEtMTMxNTU_58c08e10-5bce-4e27-9d10-987c2e3ba865">22.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af1e4e9ef8b4538abb29b36d015c7ae_D20210701-20210930" decimals="-5" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTktMTEtMS0xLTEzMTY1_8cb8064c-30da-424f-9ae4-f9b8b39225bd">21.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTktMTMtMS0xLTE3NjUy_fda159fd-d901-4af4-aae3-da2f9b723322">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia7899289c9f0473bb1689d5ee1c73d47_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMjAtMS0xLTEtMTMwOTU_5567594f-0ebc-4215-9f20-58270791411f">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i694eeba75abb4a6e87f66ac345a9c219_D20210701-20210930" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMjAtNS0xLTEtMTMxMTg_d1289671-eb36-442a-be90-8234c6043395">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMjAtMTMtMS0xLTE3NjUy_322322e0-25b3-470b-b571-0682cc877b22">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73f4af3ea9df4ed2b218df3257e2721c_D20210701-20210930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMjItNy0xLTEtMTMxMzc_0b829693-a83d-4cbd-aec2-14e01fe9934d">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMjItMTMtMS0xLTE3NjUy_56dd8b9b-c65b-452a-a5d1-a72dadd094d5">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition and disposal of shares of non-controlling interests, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i694eeba75abb4a6e87f66ac345a9c219_D20210701-20210930" decimals="-5" name="sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMjMtNS0xLTEtMTMxMTg_5d7c7660-4e5a-4905-9ded-f7d139bd9fd9">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af1e4e9ef8b4538abb29b36d015c7ae_D20210701-20210930" decimals="-5" name="sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMjMtMTEtMS0xLTEzMTY1_d950aba8-a224-4151-a580-24a4baa11fc5">33.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMjMtMTMtMS0xLTE3NjUy_ede2cbaa-56b8-4f8a-84b8-c42357bf0db3">37.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to non-controlling interests&#8212;non-redeemable holders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8af1e4e9ef8b4538abb29b36d015c7ae_D20210701-20210930" decimals="-5" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMjQtMTEtMS0xLTEzMTY1_57d618e8-3617-437d-8b03-2b6170d30937">21.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMjQtMTMtMS0xLTE3NjUy_43783f72-c477-456f-b1c4-6096d7193afc">21.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9016d0b2b49e436eb7581ad09f123943_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMjUtMS0xLTEtMTczMDM_f6ec02e6-de4c-4dcb-b701-fe8215520521">82,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9016d0b2b49e436eb7581ad09f123943_I20210930" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMjUtMy0xLTEtMTczMDY_dd7bd5f6-8899-4487-ad26-e414451aea82">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53ed285db0384407b947ec9264dbbe9e_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMjUtNS0xLTEtMTczMDY_fa93c408-64da-4dae-9463-a8766409466d">1,306.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0ba3f14ca9b4ad5bc0acd92524c74d0_I20210930" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMjUtNy0xLTEtMTczMDY_50634665-4d23-4dca-8154-bb696cbbb275">47.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia878eeebac2e40afa6724b929ac0040e_I20210930" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMjUtOS0xLTEtMTczMDY_d2096a11-e711-4bd3-9e2d-8e33d4178e95">502.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4b9a7850e5426e85fd9a49ad79c29f_I20210930" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMjUtMTEtMS0xLTE3MzA2_25cf9b89-ee17-4427-9086-b42a154fbc67">795.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMjUtMTMtMS0xLTE3MzA2_c69da91b-80ad-4558-be47-476a960a44d3">1,552.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify;text-indent:9pt"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to unaudited condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited, dollars in millions, shares in thousands)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.792%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.792%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.913%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.797%"></td><td style="width:0.1%"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional <br/>Paid-in Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained Deficit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-Controlling Interests&#8212;  <br/>Non-Redeemable</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5e1addbe96484bc7b75825f9c8dc7a58_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMy0xLTEtMS0xMjg5OA_12285b9f-edfa-4b8f-a763-d0a51825a4a3">49,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e1addbe96484bc7b75825f9c8dc7a58_I20191231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMy0zLTEtMS0xMjg5OA_f7086e38-48c5-433f-80a0-b16eaaa7db22">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bada32aacf64a1ead6b4b370e83e526_I20191231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMy01LTEtMS0xMjg5OA_2c40c138-e839-444b-9b49-e3f7f77c6109">662.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i34d67e0b428b44e281d788187793a269_I20191231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMy03LTEtMS0xMjg5OA_d66289de-d955-4c86-a4f2-b02114eef459">50.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4a87dd7e0b445fca10ae39b0ed707d3_I20191231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMy05LTEtMS0xMjg5OA_4af77536-71ba-4539-9ca2-cf648b793ef1">315.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87973734c6ee4a99945e9948dbf8e70c_I20191231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMy0xMS0xLTEtMTI4OTg_60056665-caca-4ec0-986c-a661a5d9e9b2">686.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723b8483c8a44fa3831eba25ac4e8771_I20191231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMy0xMy0xLTEtMTczMTg_2de5ae27-e2d1-4815-af96-58c8ce3f88b5">983.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if614186fb0024af2a131eccab2af782d_D20200101-20200331" decimals="-5" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfNC05LTEtMS0xMjg5OA_59ce5f97-d170-4dae-bb77-32b1b5f18951">27.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04307c27f0e44baa8e6d7ba57acdb88e_D20200101-20200331" decimals="-5" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfNC0xMS0xLTEtMTI4OTg_ffda7fe7-c027-4637-b07d-b26da278883a">13.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie870b4adc63f46feb66eb8a8c8e4d011_D20200101-20200331" decimals="-5" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfNC0xMy0xLTEtMTczMjE_413eed7a-ecd6-47c3-9580-c0127574d6f4">13.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iae6e1dc8f3104428a423e41e99d59cf9_D20200101-20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfNS0xLTEtMS0xMjg5OA_ad3f9e05-c5bc-46b1-9359-c81989e9fe3e">1,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec6e709cf8ff41aaa43ed32125aaa1ad_D20200101-20200331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfNS01LTEtMS0xMjg5OA_b7dc8ba7-0832-4ff0-851b-538c7da404de">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie870b4adc63f46feb66eb8a8c8e4d011_D20200101-20200331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfNS0xMy0xLTEtMTczMjM_4060b8a1-2a09-4aa7-9d94-971ccf7d911e">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Preferred dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec6e709cf8ff41aaa43ed32125aaa1ad_D20200101-20200331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfNi01LTEtMS0xMjg5OA_9730c584-2cb8-4060-b1cf-a6447c5bcd5f">9.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie870b4adc63f46feb66eb8a8c8e4d011_D20200101-20200331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfNi0xMy0xLTEtMTczMjU_e1af7278-f708-45f6-b488-ddc4b9075a0f">9.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73a098cbb4e54750892085bb826f7c51_D20200101-20200331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfNy03LTEtMS0xMjg5OA_09a33005-4f40-4215-905e-ad52364623d3">25.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie870b4adc63f46feb66eb8a8c8e4d011_D20200101-20200331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfNy0xMy0xLTEtMTczMjc_d2d3655b-75e3-4829-bc2a-c388562ffd95">25.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition and disposal of shares of non-controlling interests, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec6e709cf8ff41aaa43ed32125aaa1ad_D20200101-20200331" decimals="-5" sign="-" name="sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfOC01LTEtMS0xMjg5OA_e03af7a4-3381-4af1-ab81-e5199b766ad5">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04307c27f0e44baa8e6d7ba57acdb88e_D20200101-20200331" decimals="-5" name="sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfOC0xMS0xLTEtMTI4OTg_3f491faf-dd99-47e1-964a-7fb3e612a98f">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie870b4adc63f46feb66eb8a8c8e4d011_D20200101-20200331" decimals="-5" name="sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfOC0xMy0xLTEtMTczMjk_49db42ba-edf9-4274-bcc5-1754dda16543">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to non-controlling interests&#8212;non-redeemable holders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04307c27f0e44baa8e6d7ba57acdb88e_D20200101-20200331" decimals="-5" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfOS0xMS0xLTEtMTI4OTg_441588e7-5421-4e1d-89ec-196ab306a7fd">14.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie870b4adc63f46feb66eb8a8c8e4d011_D20200101-20200331" decimals="-5" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfOS0xMy0xLTEtMTczMzE_e9857fb4-f623-45bd-87e0-51e14fc7038a">14.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at March 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i65bbc1666baf4ab58e1d5def95db43cd_I20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTAtMS0xLTEtMTczMzM_e2ff6a20-69ee-4f9e-9e24-e9e7155ab032">50,518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65bbc1666baf4ab58e1d5def95db43cd_I20200331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTAtMy0xLTEtMTczMzU_60586ec8-d008-4f3a-bcad-bac43046933d">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0302db6bf7784a859b41b1557a29eada_I20200331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTAtNS0xLTEtMTczMzU_5103ecff-cf61-4a26-b7db-ff35e44356e4">655.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02e8e2f7aa5d4308af89bd5d9eaa7cab_I20200331" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTAtNy0xLTEtMTczMzU_d3ce52b2-3ac0-4658-bb1c-550973296176">75.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b951a38115c49a0a25b0d9d1a4a8894_I20200331" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTAtOS0xLTEtMTczMzU_6c5011ea-d0ea-4a20-a4ef-d5cf4370f9f3">343.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28fe5537d2e64becaa3ad572da05ec1b_I20200331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTAtMTEtMS0xLTE3MzM1_0dbc2c6b-43d9-4788-b9ed-64571a68a669">686.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19264b0de7ab4eb8b0352aece77637f2_I20200331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTAtMTMtMS0xLTE3MzM1_32fe007b-d3a2-41e1-867b-60bc38e2e5c5">923.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idfdd711a02e74ca889726084c6b89bb3_D20200401-20200630" decimals="-5" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTEtOS0xLTEtMTI4OTg_eab270d4-f810-44a3-b92e-48e0123f453d">32.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i645577772ef04b6580b69faed65e927c_D20200401-20200630" decimals="-5" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTEtMTEtMS0xLTEyODk4_24ec75ba-26a3-4c4e-805e-ea63f86403e0">22.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46f6e83b5d4c4d579db2515cc00632b1_D20200401-20200630" decimals="-5" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTEtMTMtMS0xLTE3MzQy_0b05ed3e-23a6-4c8c-805a-500aade4b461">9.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5d60bb0e88bd464082a32b07117af980_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTItMS0xLTEtMTI4OTg_33da8cf0-8cda-45e0-aee4-10354887ab8c">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81ab0a7efcd546818b950401c349d061_D20200401-20200630" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTItNS0xLTEtMTI4OTg_3fbe78a8-9539-406f-a293-0ea7491a2e5b">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46f6e83b5d4c4d579db2515cc00632b1_D20200401-20200630" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTItMTMtMS0xLTE3MzQ0_bf0356dc-3833-4afe-9c46-367d6e487085">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Preferred dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81ab0a7efcd546818b950401c349d061_D20200401-20200630" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTMtNS0xLTEtMTI4OTg_1adca598-ef4b-4ba3-9bc9-f545734cbc45">9.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46f6e83b5d4c4d579db2515cc00632b1_D20200401-20200630" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTMtMTMtMS0xLTE3MzQ2_4491942e-821f-4b1f-9801-de9d21307c84">9.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3eb05b01366a444c95e4e82842f9a25b_D20200401-20200630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTQtNy0xLTEtMTI4OTg_e4de5d4e-cfcb-460a-8daf-8a6116c9269b">7.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46f6e83b5d4c4d579db2515cc00632b1_D20200401-20200630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTQtMTMtMS0xLTE3MzQ4_2d755ec4-8080-44de-ad44-b16ec8538abe">7.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition and disposal of shares of non-controlling interests, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81ab0a7efcd546818b950401c349d061_D20200401-20200630" decimals="-5" sign="-" name="sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTUtNS0xLTEtMTI4OTg_112caad3-657c-4b75-bc4b-518f129d28e5">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i645577772ef04b6580b69faed65e927c_D20200401-20200630" decimals="-5" name="sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTUtMTEtMS0xLTEyODk4_5330893a-3bde-4bc4-9b81-7c95ee74961f">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46f6e83b5d4c4d579db2515cc00632b1_D20200401-20200630" decimals="-5" name="sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTUtMTMtMS0xLTE3MzUw_62ba47b7-f0c0-43f3-b216-cecd6568db30">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to non-controlling interests&#8212;non-redeemable holders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i645577772ef04b6580b69faed65e927c_D20200401-20200630" decimals="-5" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTYtMTEtMS0xLTEyODk4_ebb23b78-7cad-4204-9276-4d161ee71cd6">20.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46f6e83b5d4c4d579db2515cc00632b1_D20200401-20200630" decimals="-5" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTYtMTMtMS0xLTE3MzUy_5c335c46-f354-48de-be8f-078a80778d37">20.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib021d0c212de49bca1b78b3cc314c610_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTctMS0xLTEtMTczNTQ_fa6067e7-b07d-44b8-baf9-20da1221815b">50,551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib021d0c212de49bca1b78b3cc314c610_I20200630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTctMy0xLTEtMTczNTQ_0991c43a-40e7-4573-9161-466430b093b8">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04dd444ed05f4a46a5ab9054213d6ca2_I20200630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTctNS0xLTEtMTczNTQ_f8f0e093-2c5e-4a92-ab1b-5a1defd95d6e">648.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2409f81f8b64985bad5ef07e2f6ea31_I20200630" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTctNy0xLTEtMTczNTQ_52083e62-e111-4521-8669-fd05f343d3c4">68.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic66bbcb9058847ae98f2300c873039bd_I20200630" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTctOS0xLTEtMTczNTQ_64c2dbdd-cf82-48a7-9666-b6b6a896914f">375.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5e06688327645e0bf1b08b54c9f4601_I20200630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTctMTEtMS0xLTE3MzU0_21b27b31-46b9-456f-8c6d-616c1641b2dc">691.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife84e5119b9d41d2997dd2e6bc21006f_I20200630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTctMTMtMS0xLTE3MzU0_60ba6e9e-f98f-4bfd-a0cf-18f76097f913">895.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae7a31bb630448b9a2fada4b9475deaa_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTgtOS0xLTEtMTM0NDY_6c9538fc-e7f0-4ac5-b0d7-76d3e48f19a6">61.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9544c9d9dc744b44bb14b59cccb2d54b_D20200701-20200930" decimals="-5" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTgtMTEtMS0xLTEzNDU1_e688f8ef-2502-4170-a034-af68844fdf2f">19.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTgtMTMtMS0xLTE3MzYw_f443e041-73b6-4a50-826c-8fd853c7973c">42.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iddbb89f01a7d4e139ba298e541047140_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTktMS0xLTEtMTMzNzI_8dfc6178-0f99-4a18-93e2-7e9811e4ea90">56</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ef302e3ae1f4cd8bde62e0c447620d0_D20200701-20200930" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTktNS0xLTEtMTM0MDg_0e5899a4-42ed-4561-9411-162d03d02193">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTktMTMtMS0xLTE3MzYz_bcf67a25-2a9c-4bf1-9c02-4df3aeb598e1">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Preferred dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ef302e3ae1f4cd8bde62e0c447620d0_D20200701-20200930" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMjAtNS0xLTEtMTM0MDg_9aaa16d7-8794-4463-860e-a7b1f9917791">10.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMjAtMTMtMS0xLTE3MzY2_8b9b0a82-e0b5-47d4-bc06-e1803b8ab45e">10.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394e252b2ffa4fd0b8c8e8d0f831e656_D20200701-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMjEtNy0xLTEtMTM0MzA_94d0aaea-1b3f-4d84-9277-93f3f8545737">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMjEtMTMtMS0xLTE3MzY5_a2a4fc5c-fab0-46ce-9c94-45627652a2f9">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition and disposal of shares of non-controlling interests, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ef302e3ae1f4cd8bde62e0c447620d0_D20200701-20200930" decimals="-5" sign="-" name="sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMjItNS0xLTEtMTM0MDg_d356cce4-07f7-42a3-a26b-9e5396dc6042">37.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9544c9d9dc744b44bb14b59cccb2d54b_D20200701-20200930" decimals="-5" name="sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMjItMTEtMS0xLTEzNDU1_3a05b309-71c1-481b-b574-ae25256d0cec">7.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" sign="-" name="sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMjItMTMtMS0xLTE3Mzcy_f7546349-0c37-4efe-9c3f-c4b00ac39e5b">30.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to non-controlling interests&#8212;non-redeemable holders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9544c9d9dc744b44bb14b59cccb2d54b_D20200701-20200930" decimals="-5" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMjMtMTEtMS0xLTEzNDU1_f1d5eb4b-9b37-440c-a96a-bdd01121818c">18.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMjMtMTMtMS0xLTE3Mzc1_d2e831a2-10d6-4bc9-80b5-b6db80a14a39">18.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i95271104483f4cd2a13aa0fd11c4c9c4_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMjQtMS0xLTEtMTczNTY_d45dea1c-e0a4-436d-b1bd-7f668687fc66">50,495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95271104483f4cd2a13aa0fd11c4c9c4_I20200930" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMjQtMy0xLTEtMTczNTg_bb4a39c8-e9c8-494e-9b9f-fdd74ebac700">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f848f9a2a94d5e9604c62328ab388a_I20200930" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMjQtNS0xLTEtMTczNTg_faf002aa-94ba-47c8-9075-3246a6a3031c">603.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c4b6f5d56814c14aba12fdc98258eea_I20200930" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMjQtNy0xLTEtMTczNTg_589804c7-2631-4e87-8137-e88b53296e2e">65.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i219bd4659c5a4f2ba0b0d28c6bdde0d5_I20200930" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMjQtOS0xLTEtMTczNTg_919cb33e-56bd-463c-bc47-6cfb5665b33a">437.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i711cc27756dd4866a36dee4b75131f1d_I20200930" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMjQtMTEtMS0xLTE3MzU4_93b45a1c-5de0-44b9-a239-d5887d230179">699.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38661458bd24a6c81732c5d5160d949_I20200930" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMjQtMTMtMS0xLTE3MzU4_6a6870da-8db1-4120-ace4-081a850acca5">800.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify;text-indent:9pt"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to unaudited condensed consolidated financial statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="idcac93ae85504379b4049f3f4d6efdb8_25"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited, dollars in millions)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:73.266%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.971%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.973%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMy0yLTEtMS0xMjcxMg_b2168d8e-d1db-41db-a0d4-5517c790866b">27.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMy00LTEtMS0xMjcxMg_ebf4c4b7-1b78-4b19-82a1-077e647b671a">46.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net income (loss) to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfNS0yLTEtMS0xMjcxMg_54fdefc8-77dd-4422-a6ca-465fbfa260e8">76.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfNS00LTEtMS0xMjcxMg_b7509724-6c83-44a1-b48b-988edea19353">69.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" sign="-" name="sgry:NoncashInterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfNi0yLTEtMS0xMjcxMg_51e7fda5-f0c5-4da9-8f5b-fbc7da5f5689">12.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" sign="-" name="sgry:NoncashInterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfNi00LTEtMS0xMjcxMg_50908dd6-8426-43cd-81ae-dd04a73cc4a9">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfNy0yLTEtMS0xMjcxMg_b7506d86-b441-4bee-ab01-d7f8e17929c2">13.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfNy00LTEtMS0xMjcxMg_e57c28b1-5989-488f-a449-1be3d16a8d7b">9.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on disposals and deconsolidations, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" sign="-" name="sgry:GainLossOnDispositionOfAssetsAndDeconsolidation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfOC0yLTEtMS0xMjcxMg_4634cd15-f1ea-4c50-88d5-ed40e3c270a7">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" sign="-" name="sgry:GainLossOnDispositionOfAssetsAndDeconsolidation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfOC00LTEtMS0xMjcxMg_c53e6dd4-91e6-486e-bd55-f67f56f0fdab">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfOS0yLTEtMS0xMzUxNQ_9e1e6309-77bc-4eab-883e-42ae78c697e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfOS00LTEtMS0xMzUwMQ_cc35bcfc-6a86-46be-b7f8-4327ad3ec715">33.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on debt extinguishment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfOS0yLTEtMS0xMjcxMg_fa7a788a-b836-4e4b-b235-554beab406d8">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfOS00LTEtMS0xMjcxMg_7e186f84-5eea-48f1-876b-2cd873d0a66e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMTAtMi0xLTEtMTI3MTI_2306a02d-ef6b-458c-a45b-5f1e3de26ef4">2.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMTAtNC0xLTEtMTI3MTI_c9013359-141f-47ed-8408-8e3f5079a39c">15.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from equity investments, net of distributions received</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMTEtMi0xLTEtMTI3MTI_c4fa1ebd-8624-4fda-b7b5-7c6959531733">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMTEtNC0xLTEtMTI3MTI_6216a2ee-f67f-4ac5-9de3-f3d11e0eea8f">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMTItMi0xLTEtMTI3MTI_14d6c15a-d079-4803-ac16-2e753f85a246">30.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMTItNC0xLTEtMTI3MTI_2c762cff-8371-47e9-88c1-1bcb07889da9">29.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of acquisitions and divestitures:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMTQtMi0xLTEtMTI3MTI_e0fbd85a-ca4c-4241-92fd-9771cb5132fb">18.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMTQtNC0xLTEtMTI3MTI_29637577-6eb2-40bb-a624-900e84eca1f6">11.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare accelerated payments and deferred governmental grants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" sign="-" name="sgry:IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMTUtMi0xLTEtMTI3MTI_ab78b834-9a39-4ff0-b577-e8d587ae6df0">48.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="sgry:IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMTUtNC0xLTEtMTI3MTI_235d3ed6-8b73-4045-bd6a-b8385a3b44aa">141.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOJ settlement payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="sgry:IncreaseDecreaseInSettlementPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMTYtMi0xLTEtMTI3MTI_cf85a980-6960-431f-a262-04cd83f8c530">32.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" format="ixt:fixed-zero" name="sgry:IncreaseDecreaseInSettlementPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMTYtNC0xLTEtMTI3MTI_ee70319b-5dc0-4b4f-b7b6-78317f2140a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other operating assets and liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMTctMi0xLTEtMTI3MTI_eed1bf03-f0e0-4358-8552-a4fb2049b9b3">2.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMTctNC0xLTEtMTI3MTI_59cf80c3-1983-45a8-84e4-c793d2154e77">19.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMTgtMi0xLTEtMTI3MTI_cff36ccd-c086-425a-824e-e52fee0e100a">67.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMTgtNC0xLTEtMTI3MTI_ff4017bd-0828-4108-b35b-de43fc3bd74f">238.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMjEtMi0xLTEtMTI3MTI_c2d23bb9-1a5e-4239-9824-34488c0774e1">43.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMjEtNC0xLTEtMTI3MTI_c429a8c1-9f61-4c88-a458-46fd4b4b747c">27.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments for acquisitions, net of cash acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMjItMi0xLTEtMTI3MTI_7bfe2294-c9c2-44c7-97e7-4d637d11aae4">101.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMjItNC0xLTEtMTI3MTI_1d95bcf7-1733-4663-8328-b2fda9ef2cb2">14.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from disposals of facilities and other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:ProceedsFromSaleOfProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMjMtMi0xLTEtMTI3MTI_190e00be-6331-478d-8049-94eea64abce0">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:ProceedsFromSaleOfProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMjMtNC0xLTEtMTI3MTI_e0daf8c8-2986-4a3a-9a48-cb6c90484dfd">48.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMjQtMi0xLTEtMTI3MTI_57fb167c-c870-4bde-9148-540ac2f14413">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMjQtNC0xLTEtMTI3MTI_3bd114d8-ae4c-43f9-859d-3c0281a567c9">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash (used in) provided by investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMjUtMi0xLTEtMTI3MTI_ba8faab5-c687-4db5-a8e7-f9b58c619bf1">141.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMjUtNC0xLTEtMTI3MTI_03d63dc9-16bf-4422-a534-fed3185b8935">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal payments on long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMjgtMi0xLTEtMTI3MTI_4296db0c-a6bc-4eaf-940e-931124c9c745">328.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMjgtNC0xLTEtMTI3MTI_062e1220-d017-4947-889c-9f189a7c9fd4">197.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Borrowings of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMjktMi0xLTEtMTI3MTI_1e7c3bf0-f65c-47b9-9ff1-84fcac89210f">293.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMjktNC0xLTEtMTI3MTI_2c3324fd-a9da-43f2-b9e9-7d0635a66da5">428.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments of debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzAtMi0xLTEtMTI3MTI_680038d6-f6da-4f6c-875b-facc76152250">11.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzAtNC0xLTEtMTI3MTI_72a609a2-4551-4c44-8c42-c3e91f9aee0e">8.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from equity offering</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzItMi0xLTEtMTI3MTI_7db28c25-1fda-4426-84d3-b4b5935a0443">260.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzItNC0xLTEtMTI3MTI_087cda11-f860-4e80-84ed-c68ed7b04306">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments of equity offering costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzMtMi0xLTEtMTI3MTI_2736205c-36ed-4d85-a06f-31d41a8acdde">12.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzMtNC0xLTEtMTI3MTI_aef3a03e-32f3-49e8-972c-07aa030d32e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payment of preferred dividends</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzQtMi0xLTEtMTI3MTI_c78ece95-db8f-410b-a192-b9652e49d82b">5.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzQtNC0xLTEtMTI3MTI_881ea479-4f62-41ff-981b-ec8fde873307">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distributions to non-controlling interest holders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:PaymentsOfDividendsMinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzUtMi0xLTEtMTI3MTI_23ec4f2a-8049-44f4-9204-3dd91099742b">97.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:PaymentsOfDividendsMinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzUtNC0xLTEtMTI3MTI_89e70c83-9575-4e36-a683-65e757d10561">82.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receipts (payments) related to ownership transactions with non-controlling interest holders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:ProceedsFromMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzYtMi0xLTEtMTI3MTI_90c9e762-f30e-42e9-8e0d-4219937f8a5a">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzYtNC0xLTEtMTI3MTI_17d0328e-2ac2-418f-8191-86af90f5b625">27.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other financing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzctMi0xLTEtMTI3MTI_ac5bdd37-4e49-49da-8020-c49ce6ce362d">14.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzctNC0xLTEtMTI3MTI_8db82329-0344-423c-b1a6-ce5ca3bc857b">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzgtMi0xLTEtMTI3MTI_f5923ebf-7413-4cfe-acbf-f10493386ad3">86.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzgtNC0xLTEtMTI3MTI_2df64786-8702-4e74-994e-f5219fd1bfd0">112.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net increase in cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzktMi0xLTEtMTI3MTI_0c8d7286-ca1e-42f7-9a4f-68c7a7f68b8e">12.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzktNC0xLTEtMTI3MTI_f804921c-8740-431d-bdfc-f5f3a2d6aa02">357.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfNDAtMi0xLTEtMTI3MTI_8dbdaafa-ca1c-4d84-abd0-923ee33e15b8">318.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723b8483c8a44fa3831eba25ac4e8771_I20191231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfNDAtNC0xLTEtMTI3MTI_951e5fc4-a327-4ffc-891e-cc4ef6f0ef12">93.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfNDEtMi0xLTEtMTI3MTI_3514ff68-0e4e-40b8-9a4c-95dcc935faaa">330.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38661458bd24a6c81732c5d5160d949_I20200930" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfNDEtNC0xLTEtMTI3MTI_516f2cea-573b-4a0f-871c-d4ff46a88629">450.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to unaudited condensed consolidated financial statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="idcac93ae85504379b4049f3f4d6efdb8_28"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="text-align:center"><span><br/></span></div><div id="idcac93ae85504379b4049f3f4d6efdb8_31"></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1.  <ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjc5NzY_fdbf38c1-7c38-436b-b43f-9396839b677b" continuedAt="i774f002a1b884e67ae59d5c32c6d9763" escape="true">Organization and Summary of Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i774f002a1b884e67ae59d5c32c6d9763" continuedAt="i8b281e257c8b448da6d2e7f9d7726725"><div style="margin-bottom:6pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Organization</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Surgery Partners, Inc., a Delaware corporation, acting through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The surgical facilities, which include ambulatory surgery centers ("ASCs") and surgical hospitals, primarily provide non-emergency surgical procedures across many specialties, including, among others, gastroenterology, general surgery, ophthalmology, orthopedics and pain management. The Company's surgical hospitals also provide services such as diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy and wound care. Ancillary services are comprised of multi-specialty physician practices, urgent care facilities and anesthesia services. Unless the context otherwise indicates, Surgery Partners, Inc. and its subsidiaries are referred to herein as "Surgery Partners," "we," "us," "our" or the "Company."</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, the Company owned or operated a portfolio of <ix:nonFraction unitRef="surgical_facility" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="INF" name="sgry:NumberOfSurgicalFacilitiesOwned" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMTAyMQ_4a3ea481-4da2-431e-bf21-a1fff8e2ef45">127</ix:nonFraction> surgical facilities, comprised of <ix:nonFraction unitRef="surgical_facility" contextRef="i0b8f04298f2f4487880978d9ac283c40_I20210930" decimals="INF" name="sgry:NumberOfSurgicalFacilitiesOwned" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMTA1OA_24d6163e-8256-496f-90d1-af648b677de2">110</ix:nonFraction> ASCs and <ix:nonFraction unitRef="surgical_facility" contextRef="ifac1f29acb89455b90f5cd970447f0a9_I20210930" decimals="INF" name="sgry:NumberOfSurgicalFacilitiesOwned" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMTA3MA_160931c3-f106-468a-936a-2671cbe9f625">17</ix:nonFraction> surgical hospitals in <ix:nonFraction unitRef="state" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="INF" name="us-gaap:NumberOfStatesInWhichEntityOperates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMTA5NQ_54ce3d84-279d-462a-ac00-85a2295fb50b">31</ix:nonFraction> states. The Company owns these facilities in partnership with physicians and, in some cases, health care systems in the markets and communities it serves.&#160;The Company owned a majority interest in <ix:nonFraction unitRef="surgical_facility" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="INF" name="sgry:NumberOfSurgicalFacilitiesOwnedMajorityInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMTI5NA_19cfd159-1751-4121-94ba-a7cba7aab273">90</ix:nonFraction> of the surgical facilities and consolidated <ix:nonFraction unitRef="surgical_facility" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="INF" name="sgry:NumberOfSurgicalFacilitiesOwnedConsolidated" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMTM0MQ_927d5789-cfbb-4a84-996c-9c302d882268">110</ix:nonFraction> of the facilities for financial reporting purposes.</span></div><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjc4OTk_6f8f5bc4-5fc2-4e9c-b7db-f460f45ecb85" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation of the Company's financial position and results of operations have been included. The Company&#8217;s fiscal year ends on December&#160;31 and interim results are not necessarily indicative of results for a full year or any other interim period. The information contained in these condensed consolidated financial statements should be read in conjunction with the Company&#8217;s consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2020 (the "2020 Annual Report on Form 10-K").</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjgwMTA_fd600d45-9f6e-4745-bbb2-c6d606f666b3" escape="true">The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, as well as interests in partnerships and limited liability companies controlled by the Company through its ownership of a majority voting interest or other rights granted to the Company by contract to manage and control the affiliate's business. All significant intercompany balances and transactions are eliminated in consolidation.</ix:nonNumeric></span></div><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjc4OTE_ae09fedb-8ccc-4c70-af48-b9d00be8dd8b" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Reclassifications</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain reclassifications have been made to the comparative periods' financial statements to conform to the current year presentation.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjc5NDE_0af3dda6-2869-411f-8354-3e845a54b3b1" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. Actual results could differ from those estimates.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">COVID-19 Pandemic</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The COVID-19 global pandemic has significantly affected the Company's facilities, employees, patients, communities, business operations and financial performance, as well as the United States economy and financial markets. The impact of COVID-19 on the Company's surgical facilities varies based on the market in which the facility operates, the type of surgical facility and the procedures that are typically performed. Although the Company cannot provide any certainty regarding the length and severity of the impact of the COVID-19 pandemic, surgical case volumes continue to improve in 2021 as government restrictions ease and public sentiment changes.  The Company has implemented new clinical safety measures to provide a safe environment for its patients, surgeons and employees. </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CARES Act </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">On March 27, 2020, the Coronavirus Aid, Relief and Economic Security Act (the &#8220;CARES Act&#8221;) was signed into law to provide stimulus funding for the United States economy. As part of the CARES Act, the United States government announced that it would offer relief to eligible health care providers, including distribution of direct grants to hospitals, ASCs and other health care providers based on how much they bill Medicare. Payments received from these grants are not required to be repaid provided the recipients attest to and comply with certain terms and conditions, including limitations on balance billing and not using funds received from the grants to reimburse expenses or losses that other sources are obligated to reimburse. The Company has received approximately $<ix:nonFraction unitRef="usd" contextRef="i40f463b41ec94ef59b20aaf801aebf70_D20200327-20210930" decimals="-6" format="ixt:num-dot-decimal" name="sgry:ProceedsFromGovernmentAssistance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfNDk4NA_41a995dc-ef26-4fff-8d4b-42aa927a1b32">67</ix:nonFraction>&#160;million of the grant funds distributed under the CARES Act and other governmental assistance programs, including approximately $<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="sgry:ProceedsFromGovernmentAssistance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfNTExMw_0c5459c4-2e01-4a66-9fbe-2ce3e7b8c9fe">8</ix:nonFraction>&#160;million during the nine months ended September&#160;30, 2021. The Company did <ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="sgry:ProceedsFromGovernmentAssistance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjc0ODc3OTEwNjU2Mg_a5e68178-9e68-44de-88b0-b2b8c07f44b6">no</ix:nonFraction>t receive any grant funds during the three months ended September&#160;30, 2021. The recognition of amounts received is conditioned upon attestation with terms and conditions that funds will be used for COVID-19 related healthcare expenses or lost revenues.</span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i8b281e257c8b448da6d2e7f9d7726725" continuedAt="i8d66ab4db6c64d0aab4f5160a0978120"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The Company&#8217;s assessment of whether the terms and conditions for amounts received are reasonably assured of having been met considers, among other things, the CARES Act, the COVID-19 Economic Relief Bill, enacted on December 27, 2020, and all frequently asked questions and other interpretive guidance issued by the United States Department of Health and Human Services ("HHS"), including in the Provider Relief Fund Reporting Portal and associated user guides. This guidance sets forth the allowable methods for quantifying eligible healthcare related expenses and lost revenues. Only healthcare related expenses attributable to COVID-19 that another source has not reimbursed and is not obligated to reimburse are eligible to be claimed. Based on guidance, the Company estimates approximately $<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="sgry:GrantRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfNjE2Mg_58863437-ddc5-4885-9786-1d2dc254889a">20.0</ix:nonFraction>&#160;million of grant funds received qualified for recognition as a reduction in operating expenses for the nine months ended September 30, 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Amounts received, but not recognized as a reduction to operating expenses, are reflected as a component of Medicare accelerated payments and deferred governmental grants in the condensed consolidated balance sheets as of both September&#160;30, 2021 and December 31, 2020. Any unrecognized amounts may be recognized as a reduction in operating expenses in subsequent periods if the underlying conditions for recognition are met. HHS&#8217; interpretation of the underlying terms and conditions of grant funds received through the CARES Act and other governmental assistance programs, including auditing and reporting requirements, may evolve. Additional guidance or new and amended interpretations of existing guidance on the terms and conditions of such payments may result in the Company&#8217;s inability to recognize certain payments, changes in the estimate of amounts recognized, or the derecognition of amounts previously recognized, which may be material.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">As a way to increase cash flow to Medicare providers impacted by the COVID-19 pandemic, the CARES Act expanded the Medicare Accelerated and Advance Payment Program, which allowed for most providers and suppliers, including the Company&#8217;s surgical hospitals and ASCs to request an advance payment of anticipated Medicare revenues. The Company received approximately $<ix:nonFraction unitRef="usd" contextRef="ifbd2503cfbf74ec8aa4c1f9de99fff89_D20200101-20201231" decimals="-6" format="ixt:num-dot-decimal" name="sgry:CoronavirusAidReliefandEconomicSecurityActCARESActGovernmentGrantReceivedAcceleratedPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfODE2MQ_18eed761-2fe5-4268-b88c-6dcf653ccdcd">120</ix:nonFraction>&#160;million of accelerated payments during the year ended December 31, 2020. The payments received were deferred and included in the condensed consolidated balance sheets. During the three and nine months ended September 30, 2021, approximately $<ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="sgry:CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMTA5OTUxMTY2NDYxNQ_eb96eedb-96c4-43ad-8db8-7c0823e2fbb3">18</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="sgry:CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMTA5OTUxMTY1ODg2Mg_86c5cabc-d7a5-4ab9-b7e9-d63550ba31bb">38</ix:nonFraction>&#160;million, respectively, has been repaid in accordance with the terms of the program. These repayments are included as a component of the change in Medicare accelerated payments and deferred government grants in the condensed consolidated statements of cash flows. Under these terms, repayment started one year after the initial funding by offsetting 25% of new claims paid by CMS.  After 11 months of repayment at this level, the repayments will increase to 50% of new claims paid by CMS for a period of six months. Any outstanding amounts due at the end of the repayment period are subject to interest at a rate of 4%. As of September 30, 2021 and December 31, 2020, the current portion of deferred accelerated payments was approximately $<ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="sgry:CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMTA5OTUxMTY1ODgzNw_abf39d7f-73a3-4ba8-a996-3d71a1e8a3b0">80</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="sgry:CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfODU1Nw_7cbc9db1-842c-41b5-b9d1-db6d7c4f2ee9">95</ix:nonFraction>&#160;million, respectively, and is included as a component of Medicare accelerated payments and deferred governmental grants in the condensed consolidated balance sheets. The long-term portion is included as a component of other long-term liabilities in the condensed consolidated balance sheets. The Company does not expect to receive additional Medicare accelerated payments. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The CARES Act also provided for the deferral of the Company's portion of social security payroll taxes during 2020. Under the CARES Act, half of the deferred amount will be paid in each of December 2021 and December 2022. As of both September&#160;30, 2021 and December 31, 2020, the Company had deferred approximately $<ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="sgry:DeferredEmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfOTIyMQ_1462ca5b-fa4f-47a8-89d8-8362d35ff41b"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="sgry:DeferredEmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfOTIyMQ_f03eba5b-b457-4a98-8f1b-772578e6c436">16.9</ix:nonFraction></ix:nonFraction>&#160;million. The current portion is included as a component of accrued payroll and benefits and the long term portion is included as a component of other long-term liabilities in the condensed consolidated balance sheets. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is closely monitoring legislative actions and regulatory guidance at the federal, state and local levels with respect to the CARES Act as other governmental assistance might become available to the Company.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:ConsolidationVariableInterestEntityPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjc5MDI_05aa557c-62bf-40aa-a079-c18a97bebafd" continuedAt="i22326031f8144d7bb5fe2156d4e97a3a" escape="true">Variable Interest Entities</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><ix:continuation id="i22326031f8144d7bb5fe2156d4e97a3a" continuedAt="i938ab6c431c14dbc97c897d7add689a6"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the accounts of variable interest entities ("VIE") in which the Company is the primary beneficiary under the provisions of the Financial Accounting Standards Board's ("FASB") Accounting Standards Codification 810, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Consolidation</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i938ab6c431c14dbc97c897d7add689a6">". The Company has the power to direct the activities that most significantly impact a VIE's economic performance. Additionally, the Company would absorb the majority of the expected losses from any of these entities should such expected losses occur.</ix:continuation> As of September&#160;30, 2021, the Company's consolidated VIEs include <ix:nonFraction unitRef="surgical_facility" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="INF" format="ixt-sec:numwordsen" name="sgry:VariableInterestEntityNumberOfFacilities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMTAzOTk_b9e01055-9be7-4750-b6d9-8e322885fcc3">four</ix:nonFraction> surgical facilities and <ix:nonFraction unitRef="physician_practice" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="INF" format="ixt-sec:numwordsen" name="sgry:VariableInterestEntityNumberOfFacilities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMTA0MjY_c33ba645-9467-418b-bda0-ef86faf346a3">three</ix:nonFraction> physician practices. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The total assets (excluding goodwill and intangible assets, net) of the consolidated VIEs included in the accompanying condensed consolidated balance sheets as of September&#160;30, 2021 and December&#160;31, 2020 were $<ix:nonFraction unitRef="usd" contextRef="i32be3c0b3a7f46518fcdfa2dab23569e_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMTA2Mjk_b23adc03-9df4-42b0-a1d3-6744e3d1b60e">26.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i894cda222d3d4b14afb4128bc02678fd_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMTA2MzY_ad982901-4986-404e-a323-01255dab9163">27.7</ix:nonFraction> million, respectively, and the total liabilities of the consolidated VIEs were $<ix:nonFraction unitRef="usd" contextRef="i32be3c0b3a7f46518fcdfa2dab23569e_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMTA3MTA_c1fe13fc-4edc-42c8-98f1-25b7193c43a7">19.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i894cda222d3d4b14afb4128bc02678fd_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMTA3MTc_96ca5d22-e49f-4be2-87ac-fb3910ff1325">21.1</ix:nonFraction> million, respectively.</span></div><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjgwMTU_711c72c3-4a5e-4894-a0da-200763b99842" continuedAt="i97bb640c69164cdf91a97e4fbbe63ec6" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value of a financial instrument is the amount at which the instrument could be exchanged in an orderly transaction between market participants to sell the asset or transfer the liability. The Company uses fair value measurements based on inputs classified into the following hierarchy:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These may include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Level 3: Unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, depending on the nature of the item being valued.</span></div></ix:nonNumeric></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i8d66ab4db6c64d0aab4f5160a0978120" continuedAt="i349b72880cb04617a9545c08e06db5b6"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i97bb640c69164cdf91a97e4fbbe63ec6" continuedAt="if27d3725adc54557ba687404111ead7e">The carrying amounts reported in the condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, restricted invested assets and accounts payable approximate their fair values under Level 3 calculations.</ix:continuation></span></div><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjc5MzY_3c1962d2-4b8e-4a5e-85fc-9c2dba196180" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of the carrying amounts and estimated fair values of the Company's long-term debt follows (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.191%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.840%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.787%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.840%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.787%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.840%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.787%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.840%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.788%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior secured term loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i962fa35551cd479c8e9aed5680bfb517_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjk0NjBkNTY0ZjRlMDQ2YjM4MzkyNmU1ODVhYWUzZWFhL3RhYmxlcmFuZ2U6OTQ2MGQ1NjRmNGUwNDZiMzgzOTI2ZTU4NWFhZTNlYWFfMy0yLTEtMS0xMjcxMg_a2058325-0db5-4b82-bf14-2f2318687a84">1,534.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c9c6ffb79ae4ec5815bfd1526797134_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjk0NjBkNTY0ZjRlMDQ2YjM4MzkyNmU1ODVhYWUzZWFhL3RhYmxlcmFuZ2U6OTQ2MGQ1NjRmNGUwNDZiMzgzOTI2ZTU4NWFhZTNlYWFfMy00LTEtMS0xMjcxMg_f6bc7fb9-6c34-4c15-8891-3296e6c0179f">1,539.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaca869429314f97a2375ca94953fd78_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjk0NjBkNTY0ZjRlMDQ2YjM4MzkyNmU1ODVhYWUzZWFhL3RhYmxlcmFuZ2U6OTQ2MGQ1NjRmNGUwNDZiMzgzOTI2ZTU4NWFhZTNlYWFfMy02LTEtMS0xMjcxMg_d14fc880-542d-442e-9a24-3ed4e9de2cd8">1,523.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42b70d9ee17d4631895533f028803e8b_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjk0NjBkNTY0ZjRlMDQ2YjM4MzkyNmU1ODVhYWUzZWFhL3RhYmxlcmFuZ2U6OTQ2MGQ1NjRmNGUwNDZiMzgzOTI2ZTU4NWFhZTNlYWFfMy04LTEtMS0xMjcxMg_933b30e7-e11f-4686-a84b-683e30d9ab26">1,533.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2bacc8e8772841cdbb2620ef10c4ca4f_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjk0NjBkNTY0ZjRlMDQ2YjM4MzkyNmU1ODVhYWUzZWFhL3RhYmxlcmFuZ2U6OTQ2MGQ1NjRmNGUwNDZiMzgzOTI2ZTU4NWFhZTNlYWFfNC0wLTEtMS0xMjcxMi90ZXh0cmVnaW9uOjc5ODY5NjA4NDU1YTRlYTI4OTJiZDdiZDA0OGJmNDYwXzQ_f0c6d9e6-2846-442a-b8d8-c284cfbfcc32">6.750</ix:nonFraction>% senior unsecured notes due 2025</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i667f3ee4fc3f4e098746acef1144296f_I20210930" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjk0NjBkNTY0ZjRlMDQ2YjM4MzkyNmU1ODVhYWUzZWFhL3RhYmxlcmFuZ2U6OTQ2MGQ1NjRmNGUwNDZiMzgzOTI2ZTU4NWFhZTNlYWFfNC0yLTEtMS0xMjcxMg_9558abaa-0dec-4215-9d0c-43de9e341797">370.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2b7f57e6dc049148da6841ad22d457f_I20201231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjk0NjBkNTY0ZjRlMDQ2YjM4MzkyNmU1ODVhYWUzZWFhL3RhYmxlcmFuZ2U6OTQ2MGQ1NjRmNGUwNDZiMzgzOTI2ZTU4NWFhZTNlYWFfNC00LTEtMS0xMjcxMg_0485e223-4ef5-40f9-80e7-61e4395ed6f0">370.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbfc05d48fc543a19f054a1cc19d7fe1_I20210930" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjk0NjBkNTY0ZjRlMDQ2YjM4MzkyNmU1ODVhYWUzZWFhL3RhYmxlcmFuZ2U6OTQ2MGQ1NjRmNGUwNDZiMzgzOTI2ZTU4NWFhZTNlYWFfNC02LTEtMS0xMjcxMg_0cffab92-992e-4f39-ade5-2665ada50428">376.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaffb336a9a3b4525984047c9cd6a707e_I20201231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjk0NjBkNTY0ZjRlMDQ2YjM4MzkyNmU1ODVhYWUzZWFhL3RhYmxlcmFuZ2U6OTQ2MGQ1NjRmNGUwNDZiMzgzOTI2ZTU4NWFhZTNlYWFfNC04LTEtMS0xMjcxMg_8dad8da5-e6f8-4d70-8614-daf638532517">376.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic8eddef2cc304b9c98cff9dfa3b5279d_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjk0NjBkNTY0ZjRlMDQ2YjM4MzkyNmU1ODVhYWUzZWFhL3RhYmxlcmFuZ2U6OTQ2MGQ1NjRmNGUwNDZiMzgzOTI2ZTU4NWFhZTNlYWFfNS0wLTEtMS0xMjcxMi90ZXh0cmVnaW9uOjA3NDEzODA2YWRjOTQyZmViMDM5Y2Q5NWI5ZDA5MDYxXzQ_d6d418ae-2acc-4fef-b739-0bdd367cc2a5">10.000</ix:nonFraction>% senior unsecured notes due 2027</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95aa1f95aa154cc1b14c588d17ea7543_I20210930" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjk0NjBkNTY0ZjRlMDQ2YjM4MzkyNmU1ODVhYWUzZWFhL3RhYmxlcmFuZ2U6OTQ2MGQ1NjRmNGUwNDZiMzgzOTI2ZTU4NWFhZTNlYWFfNS0yLTEtMS0xMjcxMg_08e443be-b55b-449b-859c-b53ffba8a3b1">545.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7fe14d003214347b2cc288cb20c5df6_I20201231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjk0NjBkNTY0ZjRlMDQ2YjM4MzkyNmU1ODVhYWUzZWFhL3RhYmxlcmFuZ2U6OTQ2MGQ1NjRmNGUwNDZiMzgzOTI2ZTU4NWFhZTNlYWFfNS00LTEtMS0xMjcxMg_c258d77a-770b-4f59-b24b-3da3eb255635">545.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4016e7689e4c859eccdeea6ca19ac5_I20210930" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjk0NjBkNTY0ZjRlMDQ2YjM4MzkyNmU1ODVhYWUzZWFhL3RhYmxlcmFuZ2U6OTQ2MGQ1NjRmNGUwNDZiMzgzOTI2ZTU4NWFhZTNlYWFfNS02LTEtMS0xMjcxMg_2bbd5135-7daf-4967-b88e-118f5cbb1041">589.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d8af47260764ab4a3254e17e605316e_I20201231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjk0NjBkNTY0ZjRlMDQ2YjM4MzkyNmU1ODVhYWUzZWFhL3RhYmxlcmFuZ2U6OTQ2MGQ1NjRmNGUwNDZiMzgzOTI2ZTU4NWFhZTNlYWFfNS04LTEtMS0xMjcxMg_da7d6111-e636-40c6-8449-3efae94f2623">596.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="if27d3725adc54557ba687404111ead7e">The fair values in the table above were based on Level 2 inputs using quoted prices for identical liabilities in inactive markets. The carrying amounts related to the Company's other long-term debt obligations, including finance lease obligations, approximate their fair values based on Level 3 inputs.</ix:continuation></span></div><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjc5ODQ_bfa62db0-ec0f-41d5-a7e2-07155b7fae3b" continuedAt="i8eae946362de4bc0ab08f66c174b8d2a" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Revenues</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's revenues generally relate to contracts with patients in which the performance obligations are to provide health care services. The Company recognizes revenues in the period in which its obligations to provide health care services are satisfied and reports the amount that reflects the consideration the Company expects to be entitled to receive. The contractual relationships with patients, in most cases, also involve a third-party payor (e.g., Medicare, Medicaid and private insurance organizations, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by or negotiated with the third-party payors. The payment arrangements with third-party payors for the services provided to the related patients typically specify payments at amounts less than the Company's standard charges. The Company continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjc5NDM_4992e91c-53bd-4675-98f1-827b2fbf4369" continuedAt="i94a5e9959e504694b5117a3a07b20dee" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of revenues by service type as a percentage of total revenues follows:</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.221%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Surgical facilities revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a36782fa2bc4df19287a1556d0bf2c4_D20210701-20210930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfMy0yLTEtMS0xMjcxMg_fcb24031-9bb7-49bd-9ba6-e9b51053d740">95.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if728a9865da84a0380fd1550912931a8_D20200701-20200930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfMy00LTEtMS0xMjcxMg_69524143-6e99-4647-af7d-fb113d3875db">95.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i54e5084300b248e6920827b61dce0943_D20210101-20210930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfMy02LTEtMS0xMjcxMg_c8b433f3-7577-482f-88ac-65c05eb8edaf">95.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1f1c728ff4fa4a09ab6c46f289cf0c49_D20200101-20200930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfMy04LTEtMS0xMjcxMg_2149b0e0-8585-4c6a-bbbb-2e8bd2ccf733">95.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Ancillary services revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i843b1778208d4e50b16f7c11bdf1e6fb_D20210701-20210930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfNC0yLTEtMS0xMjcxMg_01daebb3-1a65-4259-a08d-dfb6ae6b7916">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5c8ee242dc044d2c9036d788a9a56762_D20200701-20200930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfNC00LTEtMS0xMjcxMg_0cbe5044-3df0-4c74-b173-ae60f77fea4b">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4af18ac975044d50a2ea274814e3f36d_D20210101-20210930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfNC02LTEtMS0xMjcxMg_bd50a4ea-299a-4450-9f27-8856aa3093c1">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i882ea7583a5546c7a0376ce43d387ecf_D20200101-20200930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfNC04LTEtMS0xMjcxMg_0275439b-cccd-4aa1-ad05-9c519828dd23">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total patient service revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i63770fd818324501b078a13e278a2991_D20210701-20210930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfNS0yLTEtMS0xMjcxMg_55cd6d91-7c36-471a-9918-14a404ed5a47">98.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i85aeab70f1b346e3b6010265e0f54c1b_D20200701-20200930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfNS00LTEtMS0xMjcxMg_68517e8c-8788-4cf8-a243-4784d887201b">98.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8f0e94193ec74331b69bee876be7394b_D20210101-20210930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfNS02LTEtMS0xMjcxMg_e0063a1d-de20-47b5-883c-da56dbc57c17">98.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i32c65d19973748b8abb14d3b08023423_D20200101-20200930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfNS04LTEtMS0xMjcxMg_0ceb32b0-a2ad-4881-89db-e5c4a4f5eaf9">98.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other service revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if0fb8315dd704b23a2452d16f9d4169f_D20210701-20210930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfNi0yLTEtMS0xMjcxMg_ab17d337-b6fd-47e5-92ad-0089b1a86ad2">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1699c2a292e44cc0ba2155cd47ae8171_D20200701-20200930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfNi00LTEtMS0xMjcxMg_d5ce42a3-8caf-4fa0-9ad0-d3345be911d4">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i11b91707b010413287ffa0b97b9edd79_D20210101-20210930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfNi02LTEtMS0xMjcxMg_601c682e-49fb-4ff9-8216-c17aff69f4e4">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7cab1a6fb67e44eb9f664045e38c77fb_D20200101-20200930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfNi04LTEtMS0xMjcxMg_df565f03-b7ae-409d-9337-117a532704bd">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic18ae544123642ddbc9fb91be061be82_D20210701-20210930" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfNy0yLTEtMS0xMjcxMg_801cc903-ae62-4719-b595-51ab8cee2c72">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i201f9b152e43400da5c39192eee73807_D20200701-20200930" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfNy00LTEtMS0xMjcxMg_c1f38e1b-8988-4818-b908-c0a43dbdbdf9">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0962a819986d4646b1b65ccf8a64364a_D20210101-20210930" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfNy02LTEtMS0xMjcxMg_16ad5433-649a-47e5-9cbe-dc47bc8d0d3d">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i72f9be049f1c4e16b1369f54ef365688_D20200101-20200930" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfNy04LTEtMS0xMjcxMg_8af22b4d-8fb3-41c7-99e9-2c668ab967cd">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><ix:continuation id="i8eae946362de4bc0ab08f66c174b8d2a" continuedAt="iec7fad4b049f437c9db3b8934e891744"><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Patient service revenues.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">This revenue is related to charging facility fees in exchange for providing patient care. The fee charged for health care procedures performed in surgical facilities varies depending on the type of service provided, but usually includes all charges for usage of an operating room, a recovery room, special equipment, medical supplies, nursing staff and medications. The fee does not normally include professional fees charged by the patient&#8217;s surgeon, anesthesiologist or other attending physician, which are billed directly by such physicians to the patient or third-party payor. However, in several surgical facilities, the Company charges for anesthesia services. Ancillary service revenues include fees for patient visits to the Company's physician practices, pharmacy services and diagnostic tests ordered by physicians.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Patient service revenues are recognized as performance obligations are satisfied. Performance obligations are based on the nature of services provided. Typically, the Company recognizes revenue at a point in time in which services are rendered and the Company has no obligation to provide further patient services. As the Company primarily performs outpatient procedures, performance obligations are generally satisfied same day and revenue is recognized on the date of service.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company determines the transaction price based on gross charges for services provided, net of estimated contractual adjustments and discounts from third-party payors. The Company estimates its contractual adjustments and discounts based on contractual agreements, its discount policies and historical experience. Changes in estimated contractual adjustments and discounts are recorded in the period of change. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other service revenues.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Other service revenues include management and administrative service fees derived from the non-consolidated facilities that the Company accounts for under the equity method, management of surgical facilities in which it does not own an interest, and management services provided to physician practices for which the Company is not required to provide capital or additional </span></div></ix:continuation></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i349b72880cb04617a9545c08e06db5b6" continuedAt="i0ae090b1c20f4ac6bca65e168c788371"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="iec7fad4b049f437c9db3b8934e891744">assets. These agreements typically require the Company to provide recurring management services over a multi-year period, which are billed and collected on a monthly basis. The fees derived from these management arrangements are based on a predetermined percentage of the revenues of each facility or practice and are recognized in the period in which management services are rendered and billed. For the three and nine months ended September 30, 2020, other service revenues also includes optical service revenues, which consisted of handling charges billed to the members of the Company's optical products purchasing organization. The Company sold its optical products purchasing organization on December 31, 2020.</ix:continuation></span></div><ix:continuation id="i94a5e9959e504694b5117a3a07b20dee" continuedAt="ic941e5f3256e49078d72da056e6bc9eb"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth patient service revenues by type of payor and as a percentage of total patient service revenues for the Company's consolidated surgical facilities (dollars in millions):</span></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.238%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.840%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.815%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.840%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.815%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.840%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.887%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Private insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c428e120f3b4e7b8ec14607857cd6c0_D20210701-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfNC0yLTEtMS0xMjcxMg_db7a4d3e-45e6-49b6-952f-d8f9b50696d4">271.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife562b2a0b4b43f7a740f883ebb3f9b2_D20210701-20210930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfNC00LTEtMS0xMjcxMg_898f5610-7ff4-4dda-88d6-23a76b5baf63">49.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a422701acfb4654890456c3f48a79f6_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfNC02LTEtMS0xMjcxMg_d9338fb9-aa39-4a03-bbfa-f221e4d97513">257.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0b1711cca24e4b1bab0201cd8a60b43d_D20200701-20200930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfNC04LTEtMS0xMjcxMg_bb6d858f-9ce6-4a6d-a689-1ada69ae0dc0">52.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie849beb4c21f4b39aabfc1121489da56_D20210701-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfNS0yLTEtMS0xMjcxMg_af072f62-bd10-4115-9a83-f3111a011f1a">248.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i02b93a2c47cf40a48adee19c7d6fa0d4_D20210701-20210930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfNS00LTEtMS0xMjcxMg_5b135d7b-07f4-4389-93cc-25ca4968cc5a">45.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e24a27c70c5488b809dc406c7f2b718_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfNS02LTEtMS0xMjcxMg_67715473-6b00-49d9-9bea-0ee334485bbe">188.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibc799fec3e51413a9fc7c55e26f13cb5_D20200701-20200930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfNS04LTEtMS0xMjcxMg_bd78cc8a-a53f-4ed9-9802-5ee34be32c88">38.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Self-pay</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib90d2af58a99466c8a29503e4f921426_D20210701-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfNi0yLTEtMS0xMjcxMg_09b127e7-4b8e-48e0-8557-7f626f039d23">15.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if9f0bd05efdd438c8ab2afdf0d745752_D20210701-20210930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfNi00LTEtMS0xMjcxMg_85fe40a0-e939-406e-9188-f526875d2ece">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d82a46716de4518ac0b5840519715d5_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfNi02LTEtMS0xMjcxMg_40904fe1-8111-44c5-a8f0-9bf7f9a7a11f">19.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic7663ed8a8ac40619a7d5b3ba42a13f6_D20200701-20200930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfNi04LTEtMS0xMjcxMg_94f6c668-b3e6-4946-a9ae-275388f07a84">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b7a80a48aef4f70976ee8453ca6ce93_D20210701-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfNy0yLTEtMS0xMjcxMg_bd51971a-c08e-47d8-ad2c-72cd01c98ade">16.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id9d4994c80754a68880bfc13a642ede4_D20210701-20210930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfNy00LTEtMS0xMjcxMg_3c746732-759d-4a12-bd3c-05a96b95e417">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d99c99d2f4f739eae5fea2587ff52_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfNy02LTEtMS0xMjcxMg_93101bf4-85f2-4b92-8933-a83480b4a90d">24.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i55e1271c0167429bb3d4328fcd101340_D20200701-20200930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfNy04LTEtMS0xMjcxMg_a753aebb-1e0c-4bdd-a1a6-52830f163dc7">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total patient service revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69813463e96b4ad5ad2215be2f949b59_D20210701-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfOC0yLTEtMS0xMjcxMg_a9f1eaed-9442-4ebf-8563-7a0cd76019bb">551.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id7bc8fed1453459e9f611c96dc337763_D20210701-20210930" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfOC00LTEtMS0xMjcxMg_bba8a493-2a3f-4193-aa17-48220ee9ecb2">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd4def59018047f1a3fb46e36d9c173d_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfOC02LTEtMS0xMjcxMg_146b8fd8-fdff-4811-9397-10f465392142">489.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id87e71179efc435cbf5d5497ee13da93_D20200701-20200930" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfOC04LTEtMS0xMjcxMg_45c1fb32-1d45-446e-ad74-648bd2cfb99a">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other service revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a782bdc9ca4f1981073ae5a91b46ed_D20210701-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfOS0yLTEtMS0xMjcxMg_56460c95-ab2d-4098-8183-6cdcf4c03b23">7.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4692edb42bed4c66adc2020e302cbcf8_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfOS02LTEtMS0xMjcxMg_8998d8bc-4ae9-4286-935b-83985721d837">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 20.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfMTAtMi0xLTEtMTI3MTI_d61b842c-919b-4382-ab3d-61794b150044">559.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfMTAtNi0xLTEtMTI3MTI_202b4ed7-15ea-4472-b130-aabe092d9f28">496.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.238%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.840%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.815%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.840%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.815%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.840%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.887%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Private insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b478a448f1d417c80797c7716cbfd28_D20210101-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfNC0yLTEtMS0xMjcxMg_8fa0acae-c133-4885-90ca-4ad84c043c09">790.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8180fc2d8a6249dd8811a378d0ecb43e_D20210101-20210930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfNC00LTEtMS0xMjcxMg_76b666ef-a8c8-4e58-89a4-826af3307d26">49.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3eb8b684a6d444be9b221c39b9fae635_D20200101-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfNC02LTEtMS0xMjcxMg_bc575323-b657-4743-adaa-92b967e76419">682.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i45a407f7ad6e40059d9b211fc5bb9365_D20200101-20200930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfNC04LTEtMS0xMjcxMg_5e233b35-e190-4f66-a2bf-70de7f343600">52.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cab09bbdad14d0b965a11a034a5990c_D20210101-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfNS0yLTEtMS0xMjcxMg_a083c5a0-f508-4d13-bdcc-4127c61bd54f">700.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ica4a944ad4a44a4aa65601825760e1cb_D20210101-20210930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfNS00LTEtMS0xMjcxMg_710da7d4-c235-43b1-82ee-9dcb93e22e27">44.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i260cb7274b4b4e4c94ee4d68c91b5dbd_D20200101-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfNS02LTEtMS0xMjcxMg_28956d63-f181-4a89-8a33-74f42af244b9">505.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifc0ac37030af4e318d33ccfd2ab4e424_D20200101-20200930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfNS04LTEtMS0xMjcxMg_b89e5418-b3f8-4a18-af85-96b7e809e1c5">39.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Self-pay</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1004335253334a8c93031def1519e24f_D20210101-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfNi0yLTEtMS0xMjcxMg_fd83307c-91c0-44a1-91e8-554675452a3c">46.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i50ffceccf0314f6a82061db05cc97ce3_D20210101-20210930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfNi00LTEtMS0xMjcxMg_a0b52bcb-0100-43be-aefb-23ae62a4c185">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33d0674cc1fd4188a31803833a52a9c8_D20200101-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfNi02LTEtMS0xMjcxMg_60f7c702-3b05-4cf3-883d-55232e47f405">43.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i77d5c398e437417096ffee0b774a3695_D20200101-20200930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfNi04LTEtMS0xMjcxMg_4c6fbd73-a147-4668-a3e0-3f1d5583b058">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8665a6cd8314ab9a760fa0b0a9f8993_D20210101-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfNy0yLTEtMS0xMjcxMg_acce34a0-900a-4b54-aabf-d42b238a3095">55.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id077ce6df7bb4afaa072fd999ff742a6_D20210101-20210930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfNy00LTEtMS0xMjcxMg_0a5dc1b9-d8e0-4849-abb1-b24903c11f0f">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebfa8b8fa273451ba8ff90cbb6df3b55_D20200101-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfNy02LTEtMS0xMjcxMg_1d6ae83b-a55e-4a80-9fa8-0f329df6b69d">62.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9a43941cb1cc4a9a9cc87de4189023a4_D20200101-20200930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfNy04LTEtMS0xMjcxMg_4e870c47-bab4-4946-8928-d8040095d722">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total patient service revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0a49e90fc4404c8e52a743f9dac439_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfOC0yLTEtMS0xMjcxMg_6e954beb-3d48-467a-a31c-1ae9c5d54889">1,593.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if78e1d4ca8e44e09afc12dd31cc9f3f1_D20210101-20210930" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfOC00LTEtMS0xMjcxMg_ce7bb12a-c145-4d1f-9a06-783ed936ba40">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f55b837d7e4a3ba4f01efb13d89635_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfOC02LTEtMS0xMjcxMg_a9538476-6480-4f60-ae6e-fb185288142b">1,293.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia1f02fe0e7044c94a65bd438e74a232f_D20200101-20200930" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfOC04LTEtMS0xMjcxMg_13ab9eb9-082f-4848-81a2-1a217afb2da2">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other service revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83f6dd0a92d3471a856b0a9062de35ee_D20210101-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfOS0yLTEtMS0xMjcxMg_c985af1a-43f4-41b0-88e7-4f01e8811db5">21.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31b97175fcb54075b8a9d18788bcd4e8_D20200101-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfOS02LTEtMS0xMjcxMg_21c9500a-780e-430e-a354-4d9723988486">18.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 20.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfMTAtMi0xLTEtMTI3MTI_2ff08688-8e26-455c-8af5-5ab76800e3dd">1,614.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfMTAtNi0xLTEtMTI3MTI_73540f50-9a3b-4a21-9b3b-f74e046ef8f3">1,311.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:continuation id="ic941e5f3256e49078d72da056e6bc9eb" continuedAt="i528cb69ee62b4f5891abe81879436efb">(1)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"><ix:continuation id="i528cb69ee62b4f5891abe81879436efb">Other is comprised of anesthesia service agreements, automobile liability, letters of protection and other payor types.</ix:continuation> </span></div><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjc5NzQ_ee697aff-5d8c-444e-bbbd-2756480ea842" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cash, Cash Equivalents and Restricted Cash</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. The Company maintains its cash and cash equivalent balances at high credit quality financial institutions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December 31, 2020, cash, cash equivalents and restricted cash reported within the condensed consolidated statement of cash flows includes $<ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashAndInvestmentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMTcxMTc_da8ea5af-c984-4297-b608-d3b81bac25a1">0.3</ix:nonFraction> million of restricted investments, which are reflected in other long-term assets in the condensed consolidated balance sheets. These restricted investments represented restricted cash held in accordance with the provisions of a long-term operating lease agreement held as security for performance under the Company's covenants and obligations within the agreement. The restrictions were released during the nine months ended September 30, 2021.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjc5MzI_d4c345a2-8750-4bf2-a515-d38813b74072" continuedAt="i3e815310960f40639c882ec9ea49864f" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Accounts Receivable</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable from third-party payors are recorded net of estimated implicit price concessions, which are estimated based on the historical trend of the Company's surgical hospitals&#8217; cash collections and contractual write-offs, and for the Company's surgical facilities in general, established fee schedules, relationships with payors and procedure statistics. While changes in estimated reimbursement from third-party payors remain a possibility, the Company expects that any such changes would be minimal and, therefore, would not have a material effect on its financial condition or results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable consists of receivables from federal and state agencies (under the Medicare and Medicaid programs), private insurance organizations, employers and patients. Management recognizes that revenues and receivables from government agencies are significant to the Company's operations, but it does not believe that there is significant credit risk associated with these government agencies. Concentration of credit risk with respect to other payors is limited because of the large number of such payors. </span></div></ix:nonNumeric></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i0ae090b1c20f4ac6bca65e168c788371" continuedAt="i71a2ae65c3134e1e927ed5468f088527"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i3e815310960f40639c882ec9ea49864f" continuedAt="i1cfb1ed294d44e6ca70ef9cdef1b8d6a">The Company recognizes that final reimbursement of accounts receivable is subject to final approval by each third-party payor. However, because the Company has contracts with its third-party payors and also verifies insurance coverage of the patient before medical services are rendered, the amounts that are pending approval from third-party payors are not considered significant. Amounts are classified outside of self-pay if the Company has an agreement with the third-party payor or has verified a patient&#8217;s coverage prior to services rendered. The Company's policy is to collect co-payments and deductibles prior to providing medical services. Patient services of the Company are primarily non-emergency, which allows the surgical facilities to control the procedures for which third-party reimbursement is sought and obtained. The Company does not require collateral from self-pay patients.</ix:continuation></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i1cfb1ed294d44e6ca70ef9cdef1b8d6a">The Company's collection policies and procedures are based on the type of payor, size of claim and estimated collection percentage for each patient account. The Company analyzes accounts receivable at each of its surgical facilities to ensure the proper collection and aged category. Collection efforts include direct contact with third-party payors or patients, written correspondence and the use of legal or collection agency assistance, as required.</ix:continuation> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjgwMzA_a4aaf693-f753-4d77-a783-59792dd260ab" continuedAt="ibe1dd5f8656a4496b6284adf62def8a4" escape="true">Goodwill</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="ibe1dd5f8656a4496b6284adf62def8a4">Goodwill represents the fair value of the consideration provided in an acquisition over the fair value of net assets acquired and is not amortized. Additions to goodwill include amounts resulting from new business combinations and incremental ownership purchases in the Company's subsidiaries.</ix:continuation> A summary of the Company's acquisitions and dispositions for the nine months ended September&#160;30, 2021 is included in Note 2. "Acquisitions."</span></div><div style="text-indent:18pt"><span><br/></span></div><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjc5OTk_b219ed38-8320-4d50-bf8a-c5cac0e6f46d" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of activity related to goodwill for the nine months ended September&#160;30, 2021 is as follows (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.167%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.592%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjYyMzdlYmZlZDI1NjQ1YTFiNTE0MTI5OTEyOTZkM2ExL3RhYmxlcmFuZ2U6NjIzN2ViZmVkMjU2NDVhMWI1MTQxMjk5MTI5NmQzYTFfMC0yLTEtMS0xMjcxMg_2fbf1e3a-1111-4bb7-b451-a87c9508f157">3,468.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions, including post acquisition adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjYyMzdlYmZlZDI1NjQ1YTFiNTE0MTI5OTEyOTZkM2ExL3RhYmxlcmFuZ2U6NjIzN2ViZmVkMjU2NDVhMWI1MTQxMjk5MTI5NmQzYTFfMS0yLTEtMS0xMjcxMg_6ea8ec2e-88f6-4c6e-9a15-05c0351555d2">145.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Divestitures and deconsolidations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="sgry:GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjYyMzdlYmZlZDI1NjQ1YTFiNTE0MTI5OTEyOTZkM2ExL3RhYmxlcmFuZ2U6NjIzN2ViZmVkMjU2NDVhMWI1MTQxMjk5MTI5NmQzYTFfMi0yLTEtMS0xMjcxMg_49f69dec-48c3-4ea7-8990-6f2e21885f67">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjYyMzdlYmZlZDI1NjQ1YTFiNTE0MTI5OTEyOTZkM2ExL3RhYmxlcmFuZ2U6NjIzN2ViZmVkMjU2NDVhMWI1MTQxMjk5MTI5NmQzYTFfMy0yLTEtMS0xMjcxMg_04150163-8b6c-4a90-9f85-28207b15d304">3,613.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:11pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A detailed evaluation of potential impairment indicators was performed as of September 30, 2021, which specifically considered the ongoing impact of the COVID-19 pandemic. On the basis of available evidence as of September 30, 2021, no indicators of impairment were identified. Future estimates of fair value could be adversely affected if the actual outcome of one or more of the Company's assumptions changes materially in the future, including a material decline in the Company&#8217;s stock price and the fair value of its long-term debt, lower than expected surgical case volumes, higher market interest rates or increased operating costs. Such changes impacting the calculation of fair value, the risks of which are amplified by the COVID-19 pandemic, could result in a material impairment charge in the future.</span></div><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjc4OTM_b33770fd-db83-47cb-ac16-9dd11d966c09" continuedAt="ib19a4b527ef54ebc8a017697a9eb2cfa" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Derivative Instruments and Hedging Activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company records all derivatives on the balance sheet at fair value and any financing elements treated as debt instruments are recorded at amortized cost. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="sgry:RedeemableNoncontrollingInterestPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjc5NDA_a87ce89f-3c88-4468-bbb6-486b2cdcef51" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Non-Controlling Interests&#8212;Redeemable</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Each partnership and limited liability company through which the Company owns and operates its surgical facilities is governed by a partnership or operating agreement, respectively.&#160;In certain circumstances, the applicable partnership or operating agreements for the Company's surgical facilities provide that the facilities will purchase all of the physician limited partners&#8217; or physician minority members&#8217;, as applicable, ownership if certain adverse regulatory events occur, such as it becoming illegal for the physician(s) to own an interest in a surgical facility, refer patients to a surgical facility or receive cash distributions from a surgical facility.&#160;The non-controlling interests</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">redeemable are reported outside of stockholders' equity in the condensed consolidated balance sheets.</span></div></ix:nonNumeric></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i71a2ae65c3134e1e927ed5468f088527"><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:RedeemableNoncontrollingInterestTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjc5MDQ_0a06a1d7-0c91-47e8-8ee1-d21088baa9d4" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of activity related to non-controlling interests&#8212;redeemable for the nine months ended September&#160;30, 2021 and 2020 is as follows (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.590%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.443%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at&#160;beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmFhMjE0MDg0ZTMwMDRkYTBiODdiZWRiNWQ3MGQ0M2NlL3RhYmxlcmFuZ2U6YWEyMTQwODRlMzAwNGRhMGI4N2JlZGI1ZDcwZDQzY2VfMi0yLTEtMS0xMjcxMg_1c3d886b-a44f-47c5-8cf6-854543aeb4d6">306.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723b8483c8a44fa3831eba25ac4e8771_I20191231" decimals="-5" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmFhMjE0MDg0ZTMwMDRkYTBiODdiZWRiNWQ3MGQ0M2NlL3RhYmxlcmFuZ2U6YWEyMTQwODRlMzAwNGRhMGI4N2JlZGI1ZDcwZDQzY2VfMi00LTEtMS0xMjcxMg_f0b938ab-fd36-4def-a5b9-f27a9a66bdce">321.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests&#8212;redeemable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmFhMjE0MDg0ZTMwMDRkYTBiODdiZWRiNWQ3MGQ0M2NlL3RhYmxlcmFuZ2U6YWEyMTQwODRlMzAwNGRhMGI4N2JlZGI1ZDcwZDQzY2VfMy0yLTEtMS0xMjcxMg_b781b9d3-f1a2-408c-be3a-6893dd6cc77a">33.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmFhMjE0MDg0ZTMwMDRkYTBiODdiZWRiNWQ3MGQ0M2NlL3RhYmxlcmFuZ2U6YWEyMTQwODRlMzAwNGRhMGI4N2JlZGI1ZDcwZDQzY2VfMy00LTEtMS0xMjcxMg_a1b8ce6a-6259-41b7-9b8c-78ea6484d9c2">19.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition (disposal) of shares of non-controlling interests, net&#8212;redeemable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="sgry:RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmFhMjE0MDg0ZTMwMDRkYTBiODdiZWRiNWQ3MGQ0M2NlL3RhYmxlcmFuZ2U6YWEyMTQwODRlMzAwNGRhMGI4N2JlZGI1ZDcwZDQzY2VfNC0yLTEtMS0xMjcxMg_b4f225f2-ba0b-4263-bfef-b3ce6ad8d147">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" sign="-" name="sgry:RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmFhMjE0MDg0ZTMwMDRkYTBiODdiZWRiNWQ3MGQ0M2NlL3RhYmxlcmFuZ2U6YWEyMTQwODRlMzAwNGRhMGI4N2JlZGI1ZDcwZDQzY2VfNC00LTEtMS0xMjcxMg_148bc8f6-e4d3-4a41-a3a6-f0f61081e3f4">7.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distributions to non-controlling interest&#8212;redeemable holders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="sgry:RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmFhMjE0MDg0ZTMwMDRkYTBiODdiZWRiNWQ3MGQ0M2NlL3RhYmxlcmFuZ2U6YWEyMTQwODRlMzAwNGRhMGI4N2JlZGI1ZDcwZDQzY2VfNS0yLTEtMS0xMjcxMg_9fe4afa9-7033-41e5-977b-afa050e9f2af">32.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="sgry:RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmFhMjE0MDg0ZTMwMDRkYTBiODdiZWRiNWQ3MGQ0M2NlL3RhYmxlcmFuZ2U6YWEyMTQwODRlMzAwNGRhMGI4N2JlZGI1ZDcwZDQzY2VfNS00LTEtMS0xMjcxMg_83cb0feb-bc23-454e-aff7-383b48c70476">27.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at&#160;end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmFhMjE0MDg0ZTMwMDRkYTBiODdiZWRiNWQ3MGQ0M2NlL3RhYmxlcmFuZ2U6YWEyMTQwODRlMzAwNGRhMGI4N2JlZGI1ZDcwZDQzY2VfNi0yLTEtMS0xMjcxMg_a7782aa1-e3c6-472a-9262-bca93951c1a3">310.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38661458bd24a6c81732c5d5160d949_I20200930" decimals="-5" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmFhMjE0MDg0ZTMwMDRkYTBiODdiZWRiNWQ3MGQ0M2NlL3RhYmxlcmFuZ2U6YWEyMTQwODRlMzAwNGRhMGI4N2JlZGI1ZDcwZDQzY2VfNi00LTEtMS0xMjcxMg_b676cf6d-7bb5-4a9d-86c7-01b9790e438b">304.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjc4OTg_8e7afdd0-68ea-4f49-a126-06036b8edb5b" escape="true"><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Income Taxes </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company uses the asset and liability method to account for income taxes. Under this method, deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. If a carryforward exists, the Company makes a determination as to whether the carryforward will be utilized in the future. A valuation allowance is established for certain carryforwards when their recoverability is deemed to be uncertain. The carrying value of the net deferred tax assets assumes that the Company will be able to generate sufficient future taxable income in certain tax jurisdictions, based on estimates and assumptions. If our expectations for future operating results on a consolidated basis or at the state jurisdiction level vary from actual results due to changes in health care regulations, general economic conditions, or other factors, we may need to adjust the valuation allowance, for all or a portion of our deferred tax assets. Our income tax expense in future periods will be reduced or increased to the extent of offsetting decreases or increases, respectively, in our valuation allowance in the period when the change in circumstances occurs. These changes could have a significant impact on our future earnings.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company and certain of its subsidiaries file a consolidated federal income tax return. The partnerships, limited liability companies, and certain non-consolidated physician practice corporations also file separate income tax returns. The Company's allocable portion of each partnership's and limited liability company's income or loss is included in taxable income of the Company. The remaining income or loss of each partnership and limited liability company is allocated to the other owners.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's effective tax rate was (<ix:nonFraction unitRef="number" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjU4OTk_bfd40b54-0ca7-411b-84c3-c296317e2043">4.9</ix:nonFraction>)% for the nine months ended September&#160;30, 2021 compared to <ix:nonFraction unitRef="number" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjU5NDE_35fe6f20-5584-44a5-bb12-504e935c7105">23.7</ix:nonFraction>% for the nine months ended September&#160;30, 2020. For the nine months ended September&#160;30, 2021, the effective tax rate differed from 21% primarily due to discrete tax benefits of (a) $<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMTA5OTUxMTY2NDg2OQ_da8c6504-139b-4a9c-955c-2bcd96dfebe8">4.4</ix:nonFraction>&#160;million related to the vesting of restricted stock awards, and (b) $<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationDispositionOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjYxMzE_329c782f-e035-4a37-b744-e6e66230c9e5">3.0</ix:nonFraction>&#160;million related to entity divestitures. For the nine months ended September&#160;30, 2020, the effective tax rate differed from 21% primarily due to (a) discrete tax benefits of $<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="sgry:EffectiveIncomeTaxRateReconciliationCoronavirusAidReliefAndEconomicSecurityActCARESActAndTaxSettlementAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjYyNzA_9633bee8-3f96-4f81-8afe-2aa429e17819">6.9</ix:nonFraction> million attributable to the release of federal and state valuation allowances on the Company&#8217;s Internal Revenue Code Section 163(j) interest carryforwards as a result of the increase in deductible interest expense allowed under the CARES Act, and $<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationTaxSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjE5OTAyMzI5Mjg0OQ_ef9caae5-7ff8-4021-9a1c-5028271f1068">5.0</ix:nonFraction>&#160;million attributable to a portion of the payments under the Settlement Agreement, as defined in Note 9. "Commitments and Contingencies," being classified as "restitution" for income tax purposes, and (b) a discrete tax expense of $<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjE5OTAyMzI5MzAzMA_5b3c245e-6e9e-40e1-b3f6-4ccc205ca5e4">5.0</ix:nonFraction>&#160;million attributable to the impairment of goodwill. Based upon the application of interim accounting guidance, the tax rate as a percentage of net income after income attributable to non-controlling interests will vary based upon the relative net income from period to period.</span></div><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjc5NjM_c42742f4-821b-40aa-b84c-73d6188f4b8d" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In March 2020, the FASB issued Accounting Standard Update ("ASU") 2020-04,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The ASU provides optional guidance for a limited period of time to ease the potential burden in accounting for or recognizing the effects of reference rate reform on financial reporting and applies only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The ASU is effective as of March 12, 2020 through December 31, 2022. Entities may adopt ASU 2020-04 as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020 or prospectively from a date within an interim period that includes or is subsequent to March 12, 2020, up to the date that the financial statements are available to be issued. The Company is evaluating the impact of this ASU on its consolidated financial statements.</span></div></ix:nonNumeric></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><div id="idcac93ae85504379b4049f3f4d6efdb8_34"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2.  <ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNC9mcmFnOjE4YjM5Y2RmN2RlZjQ0MTI5MzVmYmM3MjJhM2Y1ODNlL3RleHRyZWdpb246MThiMzljZGY3ZGVmNDQxMjkzNWZiYzcyMmEzZjU4M2VfMTQxOQ_bbbdaeab-42fe-44db-b958-1e5a6ea47ef1" continuedAt="icb3f6ba193ea432f9818b3bfbfdb8e85" escape="true">Acquisitions</ix:nonNumeric></span></div><ix:continuation id="icb3f6ba193ea432f9818b3bfbfdb8e85"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021, the Company acquired controlling interests in <ix:nonFraction unitRef="surgical_facility" contextRef="i18304528b10e4cf5ad801229a9076ceb_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfBusinessesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNC9mcmFnOjE4YjM5Y2RmN2RlZjQ0MTI5MzVmYmM3MjJhM2Y1ODNlL3RleHRyZWdpb246MThiMzljZGY3ZGVmNDQxMjkzNWZiYzcyMmEzZjU4M2VfMTA5OTUxMTYyOTQ4OQ_de3ab0fb-2af3-42b2-93d4-e627f6359050">four</ix:nonFraction> surgical facilities in new markets and <ix:nonFraction unitRef="surgical_facility" contextRef="i28bb531c0e434976827266bc64ff25c5_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfBusinessesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNC9mcmFnOjE4YjM5Y2RmN2RlZjQ0MTI5MzVmYmM3MjJhM2Y1ODNlL3RleHRyZWdpb246MThiMzljZGY3ZGVmNDQxMjkzNWZiYzcyMmEzZjU4M2VfMTQw_787bbb3e-e4e2-4521-8c9c-9b621cc78c16">two</ix:nonFraction> surgical facilities in existing markets that were merged into existing facilities for aggregate cash consideration of $<ix:nonFraction unitRef="usd" contextRef="i28bb531c0e434976827266bc64ff25c5_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNC9mcmFnOjE4YjM5Y2RmN2RlZjQ0MTI5MzVmYmM3MjJhM2Y1ODNlL3RleHRyZWdpb246MThiMzljZGY3ZGVmNDQxMjkzNWZiYzcyMmEzZjU4M2VfMjYx_23b4988b-4857-4fec-95d2-181528354c44">101.0</ix:nonFraction>&#160;million, net of cash acquired. The cash consideration was funded through available resources. The total consideration was allocated to the assets acquired and liabilities assumed based upon the respective acquisition date fair values. <ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNC9mcmFnOjE4YjM5Y2RmN2RlZjQ0MTI5MzVmYmM3MjJhM2Y1ODNlL3RleHRyZWdpb246MThiMzljZGY3ZGVmNDQxMjkzNWZiYzcyMmEzZjU4M2VfMTQyNw_40368756-2686-4061-9078-8d776f83486b" continuedAt="icc345d6b4de74d179b0d086b4d20d61f" escape="true">The aggregate amounts preliminarily recognized for each major class of assets acquired and liabilities assumed for the acquisitions are as follows (in millions):</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><ix:continuation id="icc345d6b4de74d179b0d086b4d20d61f"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.955%"></td><td style="width:0.1%"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consideration</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28bb531c0e434976827266bc64ff25c5_D20210101-20210930" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNC9mcmFnOjE4YjM5Y2RmN2RlZjQ0MTI5MzVmYmM3MjJhM2Y1ODNlL3RhYmxlOjg4MDQwOTQ2NDBjYzRhYjI5ZTMxMTNiODhjZjRmMjhkL3RhYmxlcmFuZ2U6ODgwNDA5NDY0MGNjNGFiMjllMzExM2I4OGNmNGYyOGRfMS0yLTEtMS0xMjcxMg_7618914f-a8e7-4a95-8cc1-024fed182c04">103.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of non-controlling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e305bdf3ff54b04a60b6fe6642b9f6a_I20210930" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNC9mcmFnOjE4YjM5Y2RmN2RlZjQ0MTI5MzVmYmM3MjJhM2Y1ODNlL3RhYmxlOjg4MDQwOTQ2NDBjYzRhYjI5ZTMxMTNiODhjZjRmMjhkL3RhYmxlcmFuZ2U6ODgwNDA5NDY0MGNjNGFiMjllMzExM2I4OGNmNGYyOGRfMi0yLTEtMS0xMjcxMg_089fb67b-ff44-43bf-b2a0-e533b8fe4a0e">46.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aggregate acquisition date fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e305bdf3ff54b04a60b6fe6642b9f6a_I20210930" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNC9mcmFnOjE4YjM5Y2RmN2RlZjQ0MTI5MzVmYmM3MjJhM2Y1ODNlL3RhYmxlOjg4MDQwOTQ2NDBjYzRhYjI5ZTMxMTNiODhjZjRmMjhkL3RhYmxlcmFuZ2U6ODgwNDA5NDY0MGNjNGFiMjllMzExM2I4OGNmNGYyOGRfMy0yLTEtMS0xMjcxMg_56107f80-d846-47f3-88aa-4ccd2969ff79">149.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net assets acquired:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e305bdf3ff54b04a60b6fe6642b9f6a_I20210930" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNC9mcmFnOjE4YjM5Y2RmN2RlZjQ0MTI5MzVmYmM3MjJhM2Y1ODNlL3RhYmxlOjg4MDQwOTQ2NDBjYzRhYjI5ZTMxMTNiODhjZjRmMjhkL3RhYmxlcmFuZ2U6ODgwNDA5NDY0MGNjNGFiMjllMzExM2I4OGNmNGYyOGRfNS0yLTEtMS0xMjcxMg_b0b7d8c8-a599-4cf9-b600-59fb728a0b90">6.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e305bdf3ff54b04a60b6fe6642b9f6a_I20210930" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNC9mcmFnOjE4YjM5Y2RmN2RlZjQ0MTI5MzVmYmM3MjJhM2Y1ODNlL3RhYmxlOjg4MDQwOTQ2NDBjYzRhYjI5ZTMxMTNiODhjZjRmMjhkL3RhYmxlcmFuZ2U6ODgwNDA5NDY0MGNjNGFiMjllMzExM2I4OGNmNGYyOGRfNi0yLTEtMS0xMjcxMg_da367f36-b8d8-46b4-92b0-17da44d96f37">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e305bdf3ff54b04a60b6fe6642b9f6a_I20210930" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNC9mcmFnOjE4YjM5Y2RmN2RlZjQ0MTI5MzVmYmM3MjJhM2Y1ODNlL3RhYmxlOjg4MDQwOTQ2NDBjYzRhYjI5ZTMxMTNiODhjZjRmMjhkL3RhYmxlcmFuZ2U6ODgwNDA5NDY0MGNjNGFiMjllMzExM2I4OGNmNGYyOGRfNy0yLTEtMS0xMjcxMg_56fd3a24-87ab-465d-b90f-a7d37c93ea76">145.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use operating lease assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e305bdf3ff54b04a60b6fe6642b9f6a_I20210930" decimals="-5" name="sgry:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingRightOfUseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNC9mcmFnOjE4YjM5Y2RmN2RlZjQ0MTI5MzVmYmM3MjJhM2Y1ODNlL3RhYmxlOjg4MDQwOTQ2NDBjYzRhYjI5ZTMxMTNiODhjZjRmMjhkL3RhYmxlcmFuZ2U6ODgwNDA5NDY0MGNjNGFiMjllMzExM2I4OGNmNGYyOGRfOC0yLTEtMS0xMjcxMg_f1cdeff2-3b93-4c1f-81cd-5df151e32d59">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e305bdf3ff54b04a60b6fe6642b9f6a_I20210930" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNC9mcmFnOjE4YjM5Y2RmN2RlZjQ0MTI5MzVmYmM3MjJhM2Y1ODNlL3RhYmxlOjg4MDQwOTQ2NDBjYzRhYjI5ZTMxMTNiODhjZjRmMjhkL3RhYmxlcmFuZ2U6ODgwNDA5NDY0MGNjNGFiMjllMzExM2I4OGNmNGYyOGRfOS0yLTEtMS0xODI0OQ_48142c42-a2f2-4b7e-ad8b-ff720338191b">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e305bdf3ff54b04a60b6fe6642b9f6a_I20210930" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNC9mcmFnOjE4YjM5Y2RmN2RlZjQ0MTI5MzVmYmM3MjJhM2Y1ODNlL3RhYmxlOjg4MDQwOTQ2NDBjYzRhYjI5ZTMxMTNiODhjZjRmMjhkL3RhYmxlcmFuZ2U6ODgwNDA5NDY0MGNjNGFiMjllMzExM2I4OGNmNGYyOGRfOS0yLTEtMS0xMjcxMg_75c14d35-54f1-43f7-a87f-96b4f8fc8159">8.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e305bdf3ff54b04a60b6fe6642b9f6a_I20210930" decimals="-5" name="sgry:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNC9mcmFnOjE4YjM5Y2RmN2RlZjQ0MTI5MzVmYmM3MjJhM2Y1ODNlL3RhYmxlOjg4MDQwOTQ2NDBjYzRhYjI5ZTMxMTNiODhjZjRmMjhkL3RhYmxlcmFuZ2U6ODgwNDA5NDY0MGNjNGFiMjllMzExM2I4OGNmNGYyOGRfMTAtMi0xLTEtMTI3MTI_550021d0-c488-4f4d-a240-de4e73a8bb90">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e305bdf3ff54b04a60b6fe6642b9f6a_I20210930" decimals="-5" name="sgry:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNC9mcmFnOjE4YjM5Y2RmN2RlZjQ0MTI5MzVmYmM3MjJhM2Y1ODNlL3RhYmxlOjg4MDQwOTQ2NDBjYzRhYjI5ZTMxMTNiODhjZjRmMjhkL3RhYmxlcmFuZ2U6ODgwNDA5NDY0MGNjNGFiMjllMzExM2I4OGNmNGYyOGRfMTEtMi0xLTEtMTI3MTI_69cc16b7-18ad-4365-8b9d-5ecf947364c4">7.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aggregate acquisition date fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e305bdf3ff54b04a60b6fe6642b9f6a_I20210930" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNC9mcmFnOjE4YjM5Y2RmN2RlZjQ0MTI5MzVmYmM3MjJhM2Y1ODNlL3RhYmxlOjg4MDQwOTQ2NDBjYzRhYjI5ZTMxMTNiODhjZjRmMjhkL3RhYmxlcmFuZ2U6ODgwNDA5NDY0MGNjNGFiMjllMzExM2I4OGNmNGYyOGRfMTItMi0xLTEtMTI3MTI_e2e3d99f-2cc0-4f62-afc2-a54274d709f1">149.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values assigned to certain assets acquired and liabilities assumed by the Company have been estimated on a preliminary basis and are subject to change as new facts and circumstances emerge that were present at the date of acquisition. During the nine months ended September&#160;30, 2021, no significant changes were made to the purchase price allocation of assets and liabilities, existing at the date of acquisition, related to individual acquisitions completed in 2020. The goodwill acquired was allocated to the Company's Surgical Facility services reportable segment. The results of operations of the acquisitions were included in the Company&#8217;s results of operations beginning on the dates of acquisition and were not considered significant for the nine months ended September&#160;30, 2021.</span></div></ix:continuation><div id="idcac93ae85504379b4049f3f4d6efdb8_37"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">3.  <ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfMzE5OA_53c7e382-7283-4d31-bc83-00fa4d6cdd1c" continuedAt="ibb7e210ade4a48f3a11667d6b9e5d2e7" escape="true">Long-Term Debt</ix:nonNumeric></span></div><ix:continuation id="ibb7e210ade4a48f3a11667d6b9e5d2e7" continuedAt="i30757176e44140c3914819b2b0a18bef"><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfMzIxMQ_3d9c2cc5-5c06-45fd-aa2d-d815563f76b8" continuedAt="i0bdf2c5928a246048dc1e2832cda9ccf" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of long-term debt follows (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.953%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior secured term loan </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a13579da2b047bbaec50c1bfea80ffd_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfMi0yLTEtMS0xMjcxMg_548465d1-7b36-4c35-a085-6cf7ebe42900">1,534.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fc897253a9442a9a2188353b29a9de9_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfMi00LTEtMS0xMjcxMg_b9287b32-3607-42c8-9a77-60d48bc259e4">1,539.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2bacc8e8772841cdbb2620ef10c4ca4f_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfMy0wLTEtMS0xMjcxMi90ZXh0cmVnaW9uOjgwMzY4NzZlMDczYTRiMDY5NzZkMjYxODdhYjhhY2EwXzQ_f0c6d9e6-2846-442a-b8d8-c284cfbfcc32">6.750</ix:nonFraction>% senior unsecured notes due 2025</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bacc8e8772841cdbb2620ef10c4ca4f_I20210930" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfMy0yLTEtMS0xMjcxMg_cfda8ba5-d14e-4b7e-8904-7e97562723ae">370.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6be5a05e68144411af66ad15197c0602_I20201231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfMy00LTEtMS0xMjcxMg_d472eb1c-d421-4f18-9971-282360060e5e">370.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic8eddef2cc304b9c98cff9dfa3b5279d_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfNC0wLTEtMS0xMjcxMi90ZXh0cmVnaW9uOjg2ZTBiOTJhMWYzYjQ1NDI4NWFhMTAyYmQwYjI3MWRmXzQ_d6d418ae-2acc-4fef-b739-0bdd367cc2a5">10.000</ix:nonFraction>% senior unsecured notes due 2027</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8eddef2cc304b9c98cff9dfa3b5279d_I20210930" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfNC0yLTEtMS0xMjcxMg_16d7c374-c74f-4288-b1dc-76f3234a8238">545.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05baa9bdba04592bd63550510944a35_I20201231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfNC00LTEtMS0xMjcxMg_b6d0ed3d-aff3-4a10-be20-e8649fd58df9">545.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Notes payable and other secured loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf48234a181c4a79a5fb7a98c7b58186_I20210930" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfNS0yLTEtMS0xMjcxMg_1e2fa849-567a-414e-8c4d-caf6de6190b3">140.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id74f0993fe00448b8bee613cc4480b55_I20201231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfNS00LTEtMS0xMjcxMg_8ee7d042-b1ba-425d-9a7d-f7e3db0fab2b">137.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfNi0yLTEtMS0xMjcxMg_6c930d7f-379d-4351-a2ec-70db0abcca16">279.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfNi00LTEtMS0xMjcxMg_1393b0a8-e4fa-44fe-9753-175e3c11aacc">281.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: unamortized debt issuance costs and discounts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfNy0yLTEtMS0xMjcxMg_ea8514c6-4fd2-49df-b4c4-2a3e62f7bbaa">17.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfNy00LTEtMS0xMjcxMg_bee23882-6da8-4335-adb2-cb231ba92cea">16.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfOC0yLTEtMS0xMjcxMg_291503ac-bc91-443a-9159-9d3adaf8df98">2,852.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfOC00LTEtMS0xMjcxMg_db3160cc-067e-41ff-86c5-a48d2fcd61ca">2,856.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Current maturities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfOS0yLTEtMS0xMjcxMg_f6d20049-8d6b-4507-bf46-3fb0f654a691">60.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfOS00LTEtMS0xMjcxMg_3419960c-0a83-4751-b795-51c03f573a36">64.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfMTAtMi0xLTEtMTI3MTI_b8073610-3b0e-4cef-8f46-112ae3ae21af">2,791.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfMTAtNC0xLTEtMTI3MTI_8270fd72-29e6-40cf-891a-9baf9fa8b587">2,792.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;margin-top:4pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><ix:continuation id="i0bdf2c5928a246048dc1e2832cda9ccf" continuedAt="if5c2b76dd4384b2c93d6c2467e8f2f46"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Includes unamortized fair value discount of $<ix:nonFraction unitRef="usd" contextRef="i0a13579da2b047bbaec50c1bfea80ffd_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfMTIz_690c3332-96bf-4d12-a5b7-efbc711d2b4a">3.1</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">and $<ix:nonFraction unitRef="usd" contextRef="i4fc897253a9442a9a2188353b29a9de9_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfMTMw_2c4b1061-bd00-4290-8a1f-e69cb355dfd1">3.7</ix:nonFraction> million as of September&#160;30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:continuation id="if5c2b76dd4384b2c93d6c2467e8f2f46">December&#160;31, 2020, respectively.</ix:continuation> </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facility</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On January 27, 2021, the Company entered into an amendment to the credit agreement governing its revolving credit facility (the "Revolver"), which amended and supplemented the credit agreement, dated as of August 31, 2017 (the "Credit Agreement"), to provide for an extension of the maturity date of the Revolver to February 1, 2026 and a $<ix:nonFraction unitRef="usd" contextRef="i36f0d89975a14bafb53bb8f74a75d68d_I20210127" decimals="INF" format="ixt:num-dot-decimal" name="sgry:LineOfCreditFacilityMaximumBorrowingCapacityIncrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfNTA1_4cd15cdf-669c-45f7-aed0-0702c01d8af2">50.0</ix:nonFraction>&#160;million increase in the outstanding commitments under the Revolver. The maturity extension and the additional commitments became effective on February 1, 2021. As of September 30, 2021, </span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i30757176e44140c3914819b2b0a18bef"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">the Company's availability on the Revolver was $<ix:nonFraction unitRef="usd" contextRef="i4a3f44c7bfb64dcc8cb79cb5bf1acee6_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfNzI4_9edc86f8-4b86-45d4-8339-76e957f76752">163.0</ix:nonFraction> million (including outstanding letters of credit of $<ix:nonFraction unitRef="usd" contextRef="i297477a2c42e4f71ac25067c3ed77ad7_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfNzc1_f03dfa30-a5ae-4915-8032-b24de9c09d2f">7.0</ix:nonFraction> million). There were <ix:nonFraction unitRef="usd" contextRef="i131b465568af4c979a7999024ec537d2_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:LineOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfNzkx_c076a459-318a-4527-825b-d3c66f87985f"><ix:nonFraction unitRef="usd" contextRef="if8cd6f59f10b43cba5e2609681a2b8ed_I20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:LineOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfNzkx_c1b41368-04c5-4185-b462-2c53e5fb9f7a">no</ix:nonFraction></ix:nonFraction> outstanding borrowings under the Revolver as of both September 30, 2021 and December 31, 2020.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Sixth Amendment to Credit Agreement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On May 3, 2021, the Company entered into a sixth amendment to the Credit Agreement. The sixth amendment provides for, among other things, a new tranche of term loans under the Credit Agreement in an aggregate original principal amount of approximately $<ix:nonFraction unitRef="usd" contextRef="ia69846ae143244c7b534d9be52a586b8_I20210503" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfMTI3Mg_8c74fe31-ee85-4cc0-b958-bf74ac7e4e61">1.545</ix:nonFraction>&#160;billion (the &#8220;New Term Loans&#8221;), which New Term Loans replace or refinance in full all of the existing term loans outstanding under the Credit Agreement. The New Term Loans mature on August 31, 2026 (or, if at least $<ix:nonFraction unitRef="usd" contextRef="ia69846ae143244c7b534d9be52a586b8_I20210503" decimals="-6" format="ixt:num-dot-decimal" name="sgry:DebtInstrumentCovenantMaturityMinimumAmountOfOtherExistingDebtRemaining" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfMTQ4Mg_ee4c8c1d-ede7-48b4-87f2-9b21282d3b3a">185</ix:nonFraction>&#160;million of the Borrower&#8217;s <ix:nonFraction unitRef="number" contextRef="ic2198de7087442b19f4693243784c6b6_I20210503" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfMTUwMw_893ecef7-fd41-4f08-abab-2f81c7c3aaff">6.750</ix:nonFraction>% senior unsecured notes due 2025 shall have not either been repaid, repurchased or redeemed or refinanced with indebtedness having a maturity date not earlier than <ix:nonNumeric contextRef="i959e09a7ea984f0da5610e0124ec6404_D20210503-20210503" format="ixt-sec:durday" name="sgry:DebtInstrumentCovenantMaturityMinimumMaturityDateForOtherExistingDebtRemaining" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfMTY2OQ_dbf010c0-8dc1-454a-8fb8-86059356b86c">91</ix:nonNumeric> days after August 31, 2026 by no later than April 1, 2025, then April 1, 2025). The New Term Loans bear interest at a rate per annum equal to (x) LIBOR plus a margin of <ix:nonFraction unitRef="number" contextRef="iebb24a566b9144d8b8d7fdb1d5cc3aad_D20210503-20210503" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfMTgzNg_a70911eb-b8d1-4042-aaa5-fd9c8bbf7259">3.75</ix:nonFraction>% per annum (LIBOR with respect to the New Term Loans shall be subject to a floor of <ix:nonFraction unitRef="number" contextRef="iebb24a566b9144d8b8d7fdb1d5cc3aad_D20210503-20210503" decimals="INF" name="sgry:DebtInstrumentBasisSpreadOnVariableRateFloor" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfMTkyMg_66c067c3-3a5c-472e-aa88-983358f155e9">0.75</ix:nonFraction>%) or (y) an alternate base rate (which will be the highest of (i) the prime rate, (ii) <ix:nonFraction unitRef="number" contextRef="i216348724a3a425d96f16ce750304715_D20210503-20210503" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfMjAxMQ_7cdd9677-a22c-4dca-a9ee-2c481948fab4">0.5</ix:nonFraction>% per annum above the federal funds effective rate and (iii) one-month LIBOR plus <ix:nonFraction unitRef="number" contextRef="ie83b774759cc472b85d1d0d1561fafb6_D20210503-20210503" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfMjA5NA_91897f0c-14c2-419e-9df1-1a4249731717">1.00</ix:nonFraction>% per annum (the alternate base rate with respect to the New Term Loans shall be subject to a floor of <ix:nonFraction unitRef="number" contextRef="icb8c8ccf05034972b3907a963deb3f26_D20210503-20210503" decimals="INF" name="sgry:DebtInstrumentBasisSpreadOnVariableRateFloor" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfMjE5OA_0d73c2bf-ca4b-4ca8-ad9b-52d31b693424">1.75</ix:nonFraction>%)) plus a margin of <ix:nonFraction unitRef="number" contextRef="icb8c8ccf05034972b3907a963deb3f26_D20210503-20210503" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfMjIyMA_d5b6f0b1-0095-4362-83ab-7b2bccb579e9">2.75</ix:nonFraction>% per annum. The New Term Loans are subject to quarterly amortization in an aggregate original principal amount of approximately <ix:nonFraction unitRef="number" contextRef="i959e09a7ea984f0da5610e0124ec6404_D20210503-20210503" decimals="INF" name="sgry:DebtInstrumentQuarterlyAmortizationPercentPerAnnum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfMjM1MA_1b3d3cb4-7a5b-4881-8729-3a06f4a7a2e7">1.00</ix:nonFraction>% per annum. Voluntary prepayments of the New Term Loans are permitted, in whole or in part, with prior notice, without premium or penalty (except LIBOR breakage costs and a call premium in the case of certain repricing events within a specified period of time after May 3, 2021, as further set forth in the sixth amendment).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In connection with the sixth amendment, the Company recorded debt issuance costs and discount of $<ix:nonFraction unitRef="usd" contextRef="iea9e184d11334ae0bf911f88c3c9df84_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfMTY0OTI2NzQ0NTAxNg_c970c832-a3d5-435f-bf04-405b9db703b8">11.9</ix:nonFraction>&#160;million, and a debt extinguishment loss of $<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfMTY0OTI2NzQ0NDk2MQ_03e9fa42-2e44-424a-a7f9-ed0eb98e2db8">9.1</ix:nonFraction>&#160;million, included in loss on debt extinguishment in the accompanying condensed consolidated statement of operations for the nine months ended September 30, 2021. The loss includes the partial write-off of unamortized debt issuance costs and discounts related to the prior existing term loans, and a portion of debt issuance costs incurred with the New Term Loans.</span></div></ix:continuation><div id="idcac93ae85504379b4049f3f4d6efdb8_40"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:LesseeFinanceLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RleHRyZWdpb246NjQxZjg2MWMxMjU1NDJhMjkyOGQ0ZjQzOGFmZTNhZGNfNTQz_91aaf87f-6532-4a0c-8792-84a74757c3de" continuedAt="i2f4e0ed123364a6a9b1b86836b80fa9b" escape="true"><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RleHRyZWdpb246NjQxZjg2MWMxMjU1NDJhMjkyOGQ0ZjQzOGFmZTNhZGNfNTQz_e61f3199-e77d-4cdf-9d74-ff3c0944e572" continuedAt="i602aac235337470d9c46180e08a2683f" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i2f4e0ed123364a6a9b1b86836b80fa9b"><ix:continuation id="i602aac235337470d9c46180e08a2683f"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's operating leases are primarily for real estate, including medical office buildings, and corporate and other administrative offices. The Company's finance leases are primarily for medical equipment and information technology and telecommunications assets. </span></div><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RleHRyZWdpb246NjQxZjg2MWMxMjU1NDJhMjkyOGQ0ZjQzOGFmZTNhZGNfNTU2_6f275cbc-29cd-4c7e-9818-81dced5b5509" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents the components of the Company's lease expense and their classification in the condensed consolidated statement of operations (in millions):</span></div><div style="margin-bottom:12pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.632%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.633%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOjMyNjEzN2Q0NWI2YzQ2MzlhNDUwYTg2NWY1ZWYwN2Q4L3RhYmxlcmFuZ2U6MzI2MTM3ZDQ1YjZjNDYzOWE0NTBhODY1ZjVlZjA3ZDhfMi0yLTEtMS0xMjcxMg_3f0013f6-3282-46b2-a40e-c6ec72738af3">56.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOjMyNjEzN2Q0NWI2YzQ2MzlhNDUwYTg2NWY1ZWYwN2Q4L3RhYmxlcmFuZ2U6MzI2MTM3ZDQ1YjZjNDYzOWE0NTBhODY1ZjVlZjA3ZDhfMi00LTEtMS0xMjcxMg_6ee4daa5-63d7-4a3a-8e1b-750bfbe33374">54.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of leased assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOjMyNjEzN2Q0NWI2YzQ2MzlhNDUwYTg2NWY1ZWYwN2Q4L3RhYmxlcmFuZ2U6MzI2MTM3ZDQ1YjZjNDYzOWE0NTBhODY1ZjVlZjA3ZDhfNC0yLTEtMS0xMjcxMg_22c31635-77a5-4ada-97ff-528fb842199d">20.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOjMyNjEzN2Q0NWI2YzQ2MzlhNDUwYTg2NWY1ZWYwN2Q4L3RhYmxlcmFuZ2U6MzI2MTM3ZDQ1YjZjNDYzOWE0NTBhODY1ZjVlZjA3ZDhfNC00LTEtMS0xMjcxMg_87cfbf42-92c7-42dc-9fb6-ac2c5b48ce98">19.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOjMyNjEzN2Q0NWI2YzQ2MzlhNDUwYTg2NWY1ZWYwN2Q4L3RhYmxlcmFuZ2U6MzI2MTM3ZDQ1YjZjNDYzOWE0NTBhODY1ZjVlZjA3ZDhfNS0yLTEtMS0xMjcxMg_f909f215-c164-459a-9fad-925911507e71">18.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOjMyNjEzN2Q0NWI2YzQ2MzlhNDUwYTg2NWY1ZWYwN2Q4L3RhYmxlcmFuZ2U6MzI2MTM3ZDQ1YjZjNDYzOWE0NTBhODY1ZjVlZjA3ZDhfNS00LTEtMS0xMjcxMg_8067ca61-e05a-4ab4-92f8-d3e1fae0a9a7">15.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="sgry:FinanceLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOjMyNjEzN2Q0NWI2YzQ2MzlhNDUwYTg2NWY1ZWYwN2Q4L3RhYmxlcmFuZ2U6MzI2MTM3ZDQ1YjZjNDYzOWE0NTBhODY1ZjVlZjA3ZDhfNi0yLTEtMS0xMjcxMg_3584ddfd-5202-4bed-b9bb-2503ddeaf358">39.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="sgry:FinanceLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOjMyNjEzN2Q0NWI2YzQ2MzlhNDUwYTg2NWY1ZWYwN2Q4L3RhYmxlcmFuZ2U6MzI2MTM3ZDQ1YjZjNDYzOWE0NTBhODY1ZjVlZjA3ZDhfNi00LTEtMS0xMjcxMg_5c9101ef-b0db-4275-bc53-af0b274b01ef">34.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Variable and short-term lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="sgry:VariableAndShortTermLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOjMyNjEzN2Q0NWI2YzQ2MzlhNDUwYTg2NWY1ZWYwN2Q4L3RhYmxlcmFuZ2U6MzI2MTM3ZDQ1YjZjNDYzOWE0NTBhODY1ZjVlZjA3ZDhfNy0yLTEtMS0xMjcxMg_b16e3f48-aa64-4c87-9420-317bd1087701">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="sgry:VariableAndShortTermLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOjMyNjEzN2Q0NWI2YzQ2MzlhNDUwYTg2NWY1ZWYwN2Q4L3RhYmxlcmFuZ2U6MzI2MTM3ZDQ1YjZjNDYzOWE0NTBhODY1ZjVlZjA3ZDhfNy00LTEtMS0xMjcxMg_4f1e02d3-a22d-47ac-a9bb-5141935876fd">12.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOjMyNjEzN2Q0NWI2YzQ2MzlhNDUwYTg2NWY1ZWYwN2Q4L3RhYmxlcmFuZ2U6MzI2MTM3ZDQ1YjZjNDYzOWE0NTBhODY1ZjVlZjA3ZDhfOC0yLTEtMS0xMjcxMg_c3975373-86b9-45bc-bfcc-6781ae3ee2d9">110.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOjMyNjEzN2Q0NWI2YzQ2MzlhNDUwYTg2NWY1ZWYwN2Q4L3RhYmxlcmFuZ2U6MzI2MTM3ZDQ1YjZjNDYzOWE0NTBhODY1ZjVlZjA3ZDhfOC00LTEtMS0xMjcxMg_b2db5fbd-fc1e-4123-a9ad-2c8b21770833">102.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents supplemental cash flow information (dollars in millions):</span></div><div style="margin-bottom:12pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.840%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.632%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.633%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities: </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash outflows from operating leases </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOmJjNjAzNWNmYzMyNzQ2NWU5NTM2ZDE5YWU0YTgyM2JhL3RhYmxlcmFuZ2U6YmM2MDM1Y2ZjMzI3NDY1ZTk1MzZkMTlhZTRhODIzYmFfMy0xLTEtMS0xMjcxMg_60254ecb-e0fd-4a46-be5e-982565fa6ea2">55.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOmJjNjAzNWNmYzMyNzQ2NWU5NTM2ZDE5YWU0YTgyM2JhL3RhYmxlcmFuZ2U6YmM2MDM1Y2ZjMzI3NDY1ZTk1MzZkMTlhZTRhODIzYmFfMy0zLTEtMS0xMjcxMg_6117550e-947a-44cd-880d-c4f7f18528fe">49.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash outflows from finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOmJjNjAzNWNmYzMyNzQ2NWU5NTM2ZDE5YWU0YTgyM2JhL3RhYmxlcmFuZ2U6YmM2MDM1Y2ZjMzI3NDY1ZTk1MzZkMTlhZTRhODIzYmFfNC0xLTEtMS0xMjcxMg_d204edc0-ca57-4ff1-86ba-5083164da590">18.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOmJjNjAzNWNmYzMyNzQ2NWU5NTM2ZDE5YWU0YTgyM2JhL3RhYmxlcmFuZ2U6YmM2MDM1Y2ZjMzI3NDY1ZTk1MzZkMTlhZTRhODIzYmFfNC0zLTEtMS0xMjcxMg_8690769d-498a-41a1-accd-880d08a647e3">15.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing cash outflows from finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOmJjNjAzNWNmYzMyNzQ2NWU5NTM2ZDE5YWU0YTgyM2JhL3RhYmxlcmFuZ2U6YmM2MDM1Y2ZjMzI3NDY1ZTk1MzZkMTlhZTRhODIzYmFfNS0xLTEtMS0xMjcxMg_b033d822-ba23-42d4-b296-e6565b94f258">15.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOmJjNjAzNWNmYzMyNzQ2NWU5NTM2ZDE5YWU0YTgyM2JhL3RhYmxlcmFuZ2U6YmM2MDM1Y2ZjMzI3NDY1ZTk1MzZkMTlhZTRhODIzYmFfNS0zLTEtMS0xMjcxMg_d86e2c78-5943-4d97-afd8-af6735614d22">12.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOmJjNjAzNWNmYzMyNzQ2NWU5NTM2ZDE5YWU0YTgyM2JhL3RhYmxlcmFuZ2U6YmM2MDM1Y2ZjMzI3NDY1ZTk1MzZkMTlhZTRhODIzYmFfOC0xLTEtMS0xMjcxMg_6dfeafcc-d71a-442b-848c-dd0bcf9da9f1">44.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOmJjNjAzNWNmYzMyNzQ2NWU5NTM2ZDE5YWU0YTgyM2JhL3RhYmxlcmFuZ2U6YmM2MDM1Y2ZjMzI3NDY1ZTk1MzZkMTlhZTRhODIzYmFfOC0zLTEtMS0xMjcxMg_b771e85e-7fa7-4446-9134-996b9310fc69">53.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOmJjNjAzNWNmYzMyNzQ2NWU5NTM2ZDE5YWU0YTgyM2JhL3RhYmxlcmFuZ2U6YmM2MDM1Y2ZjMzI3NDY1ZTk1MzZkMTlhZTRhODIzYmFfOS0xLTEtMS0xMjcxMg_f8d07cd7-b64c-4c12-9cae-9577cd385e6f">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOmJjNjAzNWNmYzMyNzQ2NWU5NTM2ZDE5YWU0YTgyM2JhL3RhYmxlcmFuZ2U6YmM2MDM1Y2ZjMzI3NDY1ZTk1MzZkMTlhZTRhODIzYmFfOS0zLTEtMS0xMjcxMg_462bfaa3-8d76-4a2b-ba68-bd2e082391a9">11.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><div id="idcac93ae85504379b4049f3f4d6efdb8_43"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">5.  <ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="sgry:RedeemablePreferredStockTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80My9mcmFnOjliNjVlODVhZjQ0YjRiMTFiOGMzZjJiMTkxY2I3Y2MyL3RleHRyZWdpb246OWI2NWU4NWFmNDRiNGIxMWI4YzNmMmIxOTFjYjdjYzJfMTM4OA_95d98e08-e2ca-45d6-91d0-af869858e3c3" continuedAt="i1f8b4e4db576457fb590de80b04df83a" escape="true">Redeemable Preferred Stock</ix:nonNumeric></span></div><ix:continuation id="i1f8b4e4db576457fb590de80b04df83a"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On August 31, 2017, the Company issued <ix:nonFraction unitRef="shares" contextRef="i47cc30be5f9646198974e49f2c9e62ac_D20170831-20170831" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80My9mcmFnOjliNjVlODVhZjQ0YjRiMTFiOGMzZjJiMTkxY2I3Y2MyL3RleHRyZWdpb246OWI2NWU4NWFmNDRiNGIxMWI4YzNmMmIxOTFjYjdjYzJfNzU_bf8bc1e0-46bb-4beb-beeb-22c8afc90845">310,000</ix:nonFraction> shares of Series A Preferred Stock to Bain Capital Private Equity, L.P. ("Bain Capital") at a purchase price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i3b26b76efac540d991bd9159654d84be_I20170831" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80My9mcmFnOjliNjVlODVhZjQ0YjRiMTFiOGMzZjJiMTkxY2I3Y2MyL3RleHRyZWdpb246OWI2NWU4NWFmNDRiNGIxMWI4YzNmMmIxOTFjYjdjYzJfMTkw_cfad6cf1-34a2-4366-8aa2-4be1fa09ceb8">1,000</ix:nonFraction> per share for an aggregate purchase price of $<ix:nonFraction unitRef="usd" contextRef="i47cc30be5f9646198974e49f2c9e62ac_D20170831-20170831" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80My9mcmFnOjliNjVlODVhZjQ0YjRiMTFiOGMzZjJiMTkxY2I3Y2MyL3RleHRyZWdpb246OWI2NWU4NWFmNDRiNGIxMWI4YzNmMmIxOTFjYjdjYzJfMjM4_aba68f67-ec34-44b3-a4d5-8870eead94f0">310.0</ix:nonFraction> million.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pursuant to the Certificate of Designations, Preferences, Rights and Limitations of <ix:nonFraction unitRef="number" contextRef="if6b9767d8d5b496f900fae3b3d1d446a_D20210101-20210930" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80My9mcmFnOjliNjVlODVhZjQ0YjRiMTFiOGMzZjJiMTkxY2I3Y2MyL3RleHRyZWdpb246OWI2NWU4NWFmNDRiNGIxMWI4YzNmMmIxOTFjYjdjYzJfMzI2_befe6cdc-4122-4fa5-b31e-989c373c6888">10.00</ix:nonFraction>% Series A Convertible Perpetual Participating Preferred Stock of Surgery Partners, Inc. (the &#8220;Certificate of Designation&#8221;), the Company was permitted to require the conversion of all, but not less than all, of the Series A Preferred Stock pursuant to the terms and conditions of the Certificate of Designation, after the second anniversary of the date of issuance, if the volume weighted average closing price of the Common Stock for any <ix:nonFraction unitRef="lease_renewal_option" contextRef="if6b9767d8d5b496f900fae3b3d1d446a_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="sgry:TemporaryEquityThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80My9mcmFnOjliNjVlODVhZjQ0YjRiMTFiOGMzZjJiMTkxY2I3Y2MyL3RleHRyZWdpb246OWI2NWU4NWFmNDRiNGIxMWI4YzNmMmIxOTFjYjdjYzJfNzUz_a1ee2172-9f06-414b-8c8f-2297479bc816">twenty</ix:nonFraction> out of <ix:nonFraction unitRef="lease_renewal_option" contextRef="if6b9767d8d5b496f900fae3b3d1d446a_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="sgry:TemporaryEquityThresholdConsecutiveTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80My9mcmFnOjliNjVlODVhZjQ0YjRiMTFiOGMzZjJiMTkxY2I3Y2MyL3RleHRyZWdpb246OWI2NWU4NWFmNDRiNGIxMWI4YzNmMmIxOTFjYjdjYzJfNzYz_2125482d-95cd-4ac4-9a15-85c4a9803bbf">thirty</ix:nonFraction> consecutive trading days prior to such date, equals or exceeds $<ix:nonFraction unitRef="usdPerShare" contextRef="if6b9767d8d5b496f900fae3b3d1d446a_D20210101-20210930" decimals="INF" name="sgry:TemporaryEquityThresholdSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80My9mcmFnOjliNjVlODVhZjQ0YjRiMTFiOGMzZjJiMTkxY2I3Y2MyL3RleHRyZWdpb246OWI2NWU4NWFmNDRiNGIxMWI4YzNmMmIxOTFjYjdjYzJfODI5_6cedf1c9-dd41-4c4e-a3a6-1da2d7d148ff">42.00</ix:nonFraction> per share. In accordance with such provision, on May 17, 2021, the Company converted all outstanding shares of Series A Preferred Stock into approximately <ix:nonFraction unitRef="shares" contextRef="id264cc07d6a44dcc9fd4169a79dd9ff8_D20210517-20210517" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConversionOfStockSharesIssued1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80My9mcmFnOjliNjVlODVhZjQ0YjRiMTFiOGMzZjJiMTkxY2I3Y2MyL3RleHRyZWdpb246OWI2NWU4NWFmNDRiNGIxMWI4YzNmMmIxOTFjYjdjYzJfOTg3_577f7cd0-aabf-4111-85db-066aad282cf6">22.609</ix:nonFraction>&#160;million shares of common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i518a3c2c62754078a7891bd9741853b1_I20210517" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80My9mcmFnOjliNjVlODVhZjQ0YjRiMTFiOGMzZjJiMTkxY2I3Y2MyL3RleHRyZWdpb246OWI2NWU4NWFmNDRiNGIxMWI4YzNmMmIxOTFjYjdjYzJfMTAxNA_ed6cc676-5784-4e56-bdb4-05c9cf6af0f7">0.01</ix:nonFraction> par value per share. Following the conversion, <ix:nonFraction unitRef="shares" contextRef="i909487bf12ef47639fb9b75fbee5e586_I20210517" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80My9mcmFnOjliNjVlODVhZjQ0YjRiMTFiOGMzZjJiMTkxY2I3Y2MyL3RleHRyZWdpb246OWI2NWU4NWFmNDRiNGIxMWI4YzNmMmIxOTFjYjdjYzJfMTA2NA_4fb382cb-d54f-4067-af09-81f547a1f640">no</ix:nonFraction> shares of Series A Preferred Stock remain outstanding. The conversion of the Series A Preferred Stock into common stock was a non-cash transaction, and therefore had no impact on the condensed consolidated statements of cash flows.</span></div><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:TemporaryEquityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80My9mcmFnOjliNjVlODVhZjQ0YjRiMTFiOGMzZjJiMTkxY2I3Y2MyL3RleHRyZWdpb246OWI2NWU4NWFmNDRiNGIxMWI4YzNmMmIxOTFjYjdjYzJfMTM5MA_8be98624-3a41-483d-8317-4ae2f489801d" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of activity related to the Series A Preferred Stock follows (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.614%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.442%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57cb9c1772694302ba3eea3dd06765c8_I20201231" decimals="-5" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80My9mcmFnOjliNjVlODVhZjQ0YjRiMTFiOGMzZjJiMTkxY2I3Y2MyL3RhYmxlOjdlODc1MDRmM2M3ODQ1YzU5ZTA4MTI0MjI1YWFlODRjL3RhYmxlcmFuZ2U6N2U4NzUwNGYzYzc4NDVjNTllMDgxMjQyMjVhYWU4NGNfMC0yLTEtMS0xMjcxMg_6f6fcd42-64e4-446e-a734-74a71422bab8">434.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends accrued</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6b9767d8d5b496f900fae3b3d1d446a_D20210101-20210930" decimals="-5" name="us-gaap:TemporaryEquityAccretionOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80My9mcmFnOjliNjVlODVhZjQ0YjRiMTFiOGMzZjJiMTkxY2I3Y2MyL3RhYmxlOjdlODc1MDRmM2M3ODQ1YzU5ZTA4MTI0MjI1YWFlODRjL3RhYmxlcmFuZ2U6N2U4NzUwNGYzYzc4NDVjNTllMDgxMjQyMjVhYWU4NGNfMS0yLTEtMS0xMjcxMg_2d1e4db8-f470-4063-86c4-973e7445cb55">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6b9767d8d5b496f900fae3b3d1d446a_D20210101-20210930" decimals="-5" name="us-gaap:TemporaryEquityDividendsAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80My9mcmFnOjliNjVlODVhZjQ0YjRiMTFiOGMzZjJiMTkxY2I3Y2MyL3RhYmxlOjdlODc1MDRmM2M3ODQ1YzU5ZTA4MTI0MjI1YWFlODRjL3RhYmxlcmFuZ2U6N2U4NzUwNGYzYzc4NDVjNTllMDgxMjQyMjVhYWU4NGNfMi0yLTEtMS0xMjcxMg_8284fa80-b77b-4cfa-9d43-3d9e51457ea7">5.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Redeemable preferred stock conversion to common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6b9767d8d5b496f900fae3b3d1d446a_D20210101-20210930" decimals="-5" name="us-gaap:ReclassificationsOfTemporaryToPermanentEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80My9mcmFnOjliNjVlODVhZjQ0YjRiMTFiOGMzZjJiMTkxY2I3Y2MyL3RhYmxlOjdlODc1MDRmM2M3ODQ1YzU5ZTA4MTI0MjI1YWFlODRjL3RhYmxlcmFuZ2U6N2U4NzUwNGYzYzc4NDVjNTllMDgxMjQyMjVhYWU4NGNfMy0yLTEtMS0xMjcxMg_54d5ef1b-7595-429a-bf16-2de2ecd35885">439.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2547d9c927b94663bfad99cb87818db1_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80My9mcmFnOjliNjVlODVhZjQ0YjRiMTFiOGMzZjJiMTkxY2I3Y2MyL3RhYmxlOjdlODc1MDRmM2M3ODQ1YzU5ZTA4MTI0MjI1YWFlODRjL3RhYmxlcmFuZ2U6N2U4NzUwNGYzYzc4NDVjNTllMDgxMjQyMjVhYWU4NGNfNC0yLTEtMS0xMjcxMg_19f5c817-e3eb-45ea-a107-2eb0f55ae0ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="idcac93ae85504379b4049f3f4d6efdb8_46"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">6.  <ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfNTE2OA_bb316a30-bba3-4b94-9c3c-6aa948fab2d9" continuedAt="i7ab8995b245746289c83fffd1718808f" escape="true">Derivatives and Hedging Activities</ix:nonNumeric></span></div><ix:continuation id="i7ab8995b245746289c83fffd1718808f" continuedAt="i9a210a62f1a240a985ca9270989454c3"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps and interest rate caps as part of its interest rate risk management strategy. During 2021 and 2020, such derivatives have been used to hedge the variable cash flows associated with existing variable-rate debt.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="ib19a4b527ef54ebc8a017697a9eb2cfa">For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in accumulated other comprehensive income ("OCI") and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings, as documented at hedge inception in accordance with the Company&#8217;s accounting policy election. Amounts reported in accumulated OCI related to derivatives will be reclassified to interest expense as interest payments are made on the Company&#8217;s variable-rate debt.</ix:continuation> Over the next 12 months, the Company estimates that an additional $<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfMTEwMw_edea3f07-d554-4973-bf7a-b691a562659a">26.3</ix:nonFraction> million will be reclassified as an increase to interest expense.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In May 2021, the Company entered into additional interest rate swap agreements to match the terms of the New Term Loan and effectively extend the termination date to March 31, 2025. As of September&#160;30, 2021, the Company had <ix:nonFraction unitRef="lease_renewal_option" contextRef="i00ee4c8851df48caa969c447c0623250_I20210930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfInterestRateDerivativesHeld" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfNTE3Ng_4be4923c-09df-4745-aad0-3ed34869f171">nine</ix:nonFraction> interest rate swaps with a total net hedged notional amount of $<ix:nonFraction unitRef="usd" contextRef="i4346577dec794239931317575c5f8e9c_I20210930" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfMTQyNw_5ff338ad-94a2-43fb-9f87-4d88ff35656d">1.2</ix:nonFraction>&#160;billion. Of the <ix:nonFraction unitRef="lease_renewal_option" contextRef="i00ee4c8851df48caa969c447c0623250_I20210930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfInterestRateDerivativesHeld" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfNTE3MQ_bb48121a-2e76-4653-9878-e5392d5f7b3d">nine</ix:nonFraction> interest rate swaps, three are pay-fixed, receive 1-Month LIBOR (subject to a minimum of <ix:nonFraction unitRef="number" contextRef="ie4f417c62ec54180ac8803b4615fe4f2_I20210930" decimals="INF" name="us-gaap:DerivativeVariableInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfMTUzMA_fc44a9c7-85dc-43e0-a59b-124671844c29">0.75</ix:nonFraction>%) interest rate swaps designated in cash flow hedging relationships with a total notional amount of $<ix:nonFraction unitRef="usd" contextRef="i4346577dec794239931317575c5f8e9c_I20210930" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfMTYzMg_f8846b9d-5a58-4d67-b467-710d39d68aec">1.2</ix:nonFraction>&#160;billion and a termination date of March 31, 2025. The remaining six interest rate swaps are undesignated and consist of three pay-fixed, receive 1-Month LIBOR (subject to a minimum of <ix:nonFraction unitRef="number" contextRef="ifb9ae4c2db2641b79a0f5be58b08a21c_I20210930" decimals="INF" name="us-gaap:DerivativeVariableInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfMTc5Nw_92ecf8d2-5bbd-4368-b392-5a1fa66d304a">1.00</ix:nonFraction>%) interest rate swaps and three pay 1-Month LIBOR (subject to a minimum of <ix:nonFraction unitRef="number" contextRef="i794be503a719415da656f24f25e586f6_I20210930" decimals="INF" name="us-gaap:DerivativeVariableInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfMTg3Mg_d05108fd-db44-4057-ad3a-b00a861c02a6">1.00</ix:nonFraction>%), receive-fixed interest rate swaps with a termination date of November 30, 2023. The pay-floating, receive-fixed swaps are designed to economically offset the undesignated pay-fixed, receive-floating swaps. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Concurrently with the May 2021 transactions, the four previously existing interest rate swap positions were amended, de-designated or terminated and replaced with the new interest rate swaps discussed above. The Company voluntarily de-designated an aggregate notional amount of $<ix:nonFraction unitRef="usd" contextRef="id89e28dd0e71485f834aa4d7bf9df97f_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfMjM0Nw_ae796054-d5f8-4f18-82f8-33401b8062bd">435</ix:nonFraction>&#160;million (the effects of which are offset by the pay-floating, receive-fixed interest rate swaps) and terminated an aggregate notional amount of $<ix:nonFraction unitRef="usd" contextRef="i00ee4c8851df48caa969c447c0623250_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfMjQ4Ng_acc00b4d-7763-46de-acdc-7065daa47a40">435</ix:nonFraction>&#160;million. No cash was exchanged between the Company and the counterparties due to the transactions described above, therefore the non-cash transactions had no impact on the condensed consolidated statements of cash flows. The amount of unrealized losses recorded in OCI related to the de-designated and terminated notional amounts at the time of the de-designation and termination was $<ix:nonFraction unitRef="usd" contextRef="ibe696861f1c44c73a063d43906a9e50e_D20210701-20210930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfMjg2NQ_06bc0ee5-47a9-42c3-ad41-421488d6e78d">55.0</ix:nonFraction>&#160;million. This amount will be amortized to interest expense over the remaining term of the original interest rate swaps. The liability of the de-designated and terminated notional amounts was blended into the fixed rate of the new pay-fixed interest rate swaps.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The pay-fixed, receive floating interest rate swaps entered into in May 2021 did not meet the requirements to be considered derivatives in their entirety as a result of the financing component. Accordingly, the swaps are considered hybrid instruments, consisting of a financing element treated as a debt instrument and an embedded at-market derivative that was designated as a cash flow hedge. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Within the Company&#8217;s condensed consolidated balance sheets, the financing elements treated as debt instruments described above are carried at amortized cost and the embedded at-market derivatives and the undesignated swaps are recorded at fair value. The cash flows related to the portion treated as debt are classified as financing activities in the condensed consolidated statements of cash flows while the </span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i9a210a62f1a240a985ca9270989454c3" continuedAt="i7a29d5a43d734f9cb9cdbf0709770558"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">portion treated as an at-market derivative are classified as operating activities. Cash settlements related to the undesignated swaps will offset and are classified as operating activities in the condensed consolidated cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In September 2021, the Company entered into interest rate cap agreements to more effectively hedge the interest rate risk. As of September&#160;30, 2021, the Company had <ix:nonFraction unitRef="interest_rate_cap" contextRef="ie418b260d34a48179bdbb66a998bcef5_I20210930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfInterestRateDerivativesHeld" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfMTA5OTUxMTYzMzQwMg_b8bbe6e4-d474-4e1f-a06b-cf322cd7d65b">two</ix:nonFraction> interest rate caps with a total hedged notional amount of $<ix:nonFraction unitRef="usd" contextRef="if2a4a57522444f5a9676cde41ceac59b_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfMTA5OTUxMTYzMzM4Nw_7449aa7b-d571-4a8f-a344-8b9988c0ac82">337.5</ix:nonFraction>&#160;million, and each has a termination date of March 31, 2025. Within the Company&#8217;s condensed consolidated balance sheets, the interest rate caps are recorded at fair value. The cash flows related to the interest rate caps are classified as operating activities in the condensed consolidated statements of cash flows.</span></div><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfNTE4MA_f378927d-6fb6-41a6-89f0-00a6277aa8c3" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The key terms of interest rate swaps and interest rate caps outstanding are presented below:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.352%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.144%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.144%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.743%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount (in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Status</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount (in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Status</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 7, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49ae29f929f42ada509df5619f333a8_I20210930" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfMi00LTEtMS0xMjcxMg_edfd1bbd-9fc0-44e5-b79e-b2d1279b074d">435.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1fca4d2f481407caeb5d56d7e7b7136_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfMi04LTEtMS0xMjcxMg_354669f8-92ad-469e-8239-cfee18d87d86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 7, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddeec416d7940a3b12a296f74c3903a_I20210930" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfMy00LTEtMS0xMjcxMg_277d2fc7-6021-4752-99b7-6d998a7b689b">330.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3536b9c7d5144d1da0598b1b21687583_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfMy04LTEtMS0xMjcxMg_d1bb1899-9516-4bdf-b13d-99dd2fb5ccdc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 7, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e920f1f29fa4053be880fffd25a4918_I20210930" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfNC00LTEtMS0xMjcxMg_b9c99cca-404c-45ea-9f2b-d76e7cd10138">435.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7495d32d52cd4da7bc6c8619c45a887b_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfNC04LTEtMS0xMjcxMg_e548cc4a-e9d8-4ee5-9bf6-a797a476f7ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate cap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fa37eb2bae649c99d96bc2572e45115_I20210930" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfNS00LTEtMS0xODQzNw_28e89fa6-0a6b-455e-a827-27b30cfe6e47">168.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ed36c033be416a89ff87077161fdf4_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfNS04LTEtMS0xODQ0Mw_eb48801e-f578-49a4-bf31-8d2f7d5561c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate cap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c4ccb8fa70f4bc2a4428f508fe28abf_I20210930" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfNi00LTEtMS0xODQzNw_abf46cde-1d72-4405-a7f6-f6b0804e6145">168.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb17c059c9044d64a267e4e97184de8e_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfNi04LTEtMS0xODQ0Mw_3654bf6c-f17e-41ac-be49-b943a3713f64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed85bf6cfba4944b0e52d8ec460f7ae_I20210930" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfNS00LTEtMS0xMjcxMg_87082501-56cc-4196-8892-76d6d2c8d8a8">165.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i868a7c854f3f4197b6fb56be16cb8ff6_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfNS04LTEtMS0xMjcxMg_6c4a0524-72c3-4761-b426-66c424c86d6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fb04a4c58d74fb494b82609189a5eb9_I20210930" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfNi00LTEtMS0xMjcxMg_f76ed8c0-ba83-4668-a7a6-9a0f95949956">120.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71181849cd1a430e8336d8791688e295_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfNi04LTEtMS0xMjcxMg_e4b8e557-5e96-4eae-bf2e-c567523c667a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 28, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9c29b53a6e548b8889f9b102d76603f_I20210930" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfNy00LTEtMS0xMjcxMg_7f9b1ed0-a4ea-4806-9e80-44f98a436fc6">150.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c36d93181114c73a3df7489d3e1fcee_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfNy04LTEtMS0xMjcxMg_81dd540a-b419-434e-8f02-51633e485ea1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Receive-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">April 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i720356769cb94b1ab627aaf16068270d_I20210930" decimals="-5" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfOC00LTEtMS0xMjcxMg_d2ebe0a7-531c-480b-9eda-dcb77087cb2d">165.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f56d30ff3394bbaad99a11dd5142150_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfOC04LTEtMS0xMjcxMg_496b2e7a-b36e-4d7a-864c-41f77337c80f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Receive-fixed swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">April 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic24c1d36e32e4b2e9a6ee11412475f2f_I20210930" decimals="-5" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfOS00LTEtMS0xMjcxMg_7851f75c-6ed8-4def-9ca5-f7f82b62218b">120.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7bfba01da58476bbd4fc84970535d16_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfOS04LTEtMS0xMjcxMg_878be688-ac9f-4b32-bb4d-dc618e703aac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Receive-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">April 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8f8bf0021814474c81ca8bbbc00fa691_I20210930" decimals="-5" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfMTAtNC0xLTEtMTI3MTI_223690b6-f8d2-4788-91f4-759a6415c42f">150.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2640e344b23640b5b12ef1711c6f7c00_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfMTAtOC0xLTEtMTI3MTI_e9141f9a-4f6f-4c6e-87d7-81d2a1947734">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07615d50aa95456b8dd258c5dcc40329_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfMTEtNC0xLTEtMTI3MTI_c21acf7a-86c3-42c7-b46f-7d07911af0a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Terminated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3059028e583a4104804a186f6de5c099_I20201231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfMTEtOC0xLTEtMTI3MTI_9d567955-2ae6-4486-adc3-6ff80cbb3907">330.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85fde8cb3f9949af8bacf04f0259be1c_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfMTItNC0xLTEtMTI3MTI_40bab659-b8dc-49ca-b926-bad71b872463">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Terminated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0873884b62114aea86cd9f3b89d0b590_I20201231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfMTItOC0xLTEtMTI3MTI_1c0134d7-529d-497d-b9e9-0f9e705cdef5">330.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48af39d8cccf4a5691cd76b4715ca6a3_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfMTMtNC0xLTEtMTI3MTI_f63460ea-eced-49e1-88b8-b84e660e467a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Terminated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37cfcc38e9e146619f3cc3c95a7adf45_I20201231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfMTMtOC0xLTEtMTI3MTI_da31525d-763f-408d-aa09-b94bf119aabd">240.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 28, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00125affeb654327acf6e06c632b8f66_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfMTQtNC0xLTEtMTI3MTI_a05b30f6-28ad-4522-bc6e-9c66104f3245">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Terminated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c6267b72cab412abdf10d903fe10285_I20201231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfMTQtOC0xLTEtMTI3MTI_6fbf307d-1bab-4381-860d-4e939875d327">300.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfMTUtNC0xLTEtMTI3MTI_d304cf4f-5f77-4afc-a977-c9b3b30fe095">1,537.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfMTUtOC0xLTEtMTI3MTI_bb3e200f-eaf3-4f35-9d8e-6890826a4512">1,200.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our interest rate swap agreements, excluding the portion treated as debt, are recognized at fair value in the condensed consolidated balance sheets and are valued using pricing models that rely on market observable inputs such as yield curve data, which are classified as Level 2 inputs within the fair value hierarchy.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value of the interest rate caps are determined using the market standard methodology of discounting the future expected cash receipts that would occur if variable interest rates rise above the strike rate of the caps. The variable interest rates used in the calculation of projected receipts on the caps are based on an expectation of future interest rates derived from observable market interest rate curves and volatilities. The interest rate caps are classified using Level 2 inputs within the fair value hierarchy.</span></div><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfNTE3Nw_9cd594b5-5f9b-472c-abef-0360e34ac6e9" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents the fair values of our derivatives and their location on the condensed consolidated balance sheets (in millions):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.995%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.989%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.576%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf8a876d526646558f40ab931121afc0_I20210930" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfMy00LTEtMS0xMjcxMg_124d7094-90c4-42fd-a980-18167f1c4c9b">15.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf8a876d526646558f40ab931121afc0_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfMy02LTEtMS0xMjcxMg_3193677c-791c-48cb-8a36-979c976268fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib62a37350e4a421d8bc7b5bcf8967a8e_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfMy04LTEtMS0xMjcxMg_33bd5413-38e8-4ad5-be85-d1c4ebd16adc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib62a37350e4a421d8bc7b5bcf8967a8e_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfMy0xMC0xLTEtMTI3MTI_f5a51985-7359-4ae3-b916-265faa312e8a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7b61f220e42445f91138f5f8e598c8e_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfNC00LTEtMS0xMjcxMg_6f2c3763-2eae-4a1e-b4ce-3e36fc7f992c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7b61f220e42445f91138f5f8e598c8e_I20210930" decimals="-5" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfNC02LTEtMS0xMjcxMg_820e9368-7375-4d77-bdad-7b1e241caeb8">15.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7662430cb53043369eb6d812bbbc2d36_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfNC04LTEtMS0xMjcxMg_3b2f92ae-518d-4080-9b03-539646477b5b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7662430cb53043369eb6d812bbbc2d36_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfNC0xMC0xLTEtMTI3MTI_722ac99a-5963-4089-8dfa-ea961aae3487">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives in cash flow hedging relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i454dcfeb7551452b9a0a7e150c838cfb_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfNy00LTEtMS0xMjcxMg_e8d1ae48-3a37-496f-aa6e-1b58a6af5543">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i454dcfeb7551452b9a0a7e150c838cfb_I20210930" decimals="-5" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfNy02LTEtMS0xMjcxMg_96d75a8c-2155-497f-b04b-d28c6e506a09">51.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06a53c3ba45b4d8cbbe78361c63c0b54_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfNy04LTEtMS0xMjcxMg_080c1c8c-70e8-4879-b0e7-8ced1a4a6123">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06a53c3ba45b4d8cbbe78361c63c0b54_I20201231" decimals="-5" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfNy0xMC0xLTEtMTI3MTI_2f0cb1f9-a3b9-43aa-b007-617c104e29f6">61.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate caps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808ef80af90c47f68c7968b13ae34c7e_I20210930" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfOC00LTEtMS0xODUwMg_b02eb53c-212d-496e-af35-76015cb1cc7c">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808ef80af90c47f68c7968b13ae34c7e_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfOC02LTEtMS0xODUxNA_41e8fbbf-63e6-4e08-bd7f-4037c6f1b7c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9032094a43424c8ea3085296aae5d36c_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfOC04LTEtMS0xODUxNA_9f8733e4-c098-4fd3-babb-92414feefd92">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9032094a43424c8ea3085296aae5d36c_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfOC0xMC0xLTEtMTg1MTQ_20b00ddc-bd42-4168-bdb5-b597be021453">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfOC00LTEtMS0xMjcxMg_77a08169-9e4b-4355-b86e-b8708e27cd16">17.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfOC02LTEtMS0xMjcxMg_62db887f-f01a-4796-bc8b-cd56d52d8f03">66.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfOC04LTEtMS0xMjcxMg_3f678f93-1a36-4569-8ab0-82942980276b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfOC0xMC0xLTEtMTI3MTI_8d0e3b34-8370-4136-a1f0-54569089c416">61.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">The balance as of September&#160;30, 2021 includes $<ix:nonFraction unitRef="usd" contextRef="i00ee4c8851df48caa969c447c0623250_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="sgry:DerivativeLiabilityNotionalAmountFinancingComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfNDczOQ_be420321-5be3-43b6-873d-c8adb4ae26c9">49.4</ix:nonFraction> million related to the financing component of the pay-fixed, receive floating interest rate swaps.</span></div></ix:nonNumeric></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i7a29d5a43d734f9cb9cdbf0709770558"><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfNTE3MA_425c481d-8a61-4dcd-8420-1f03dae00885" escape="true"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents the pre-tax effect of the interest rate swaps and caps on the Company's accumulated OCI and condensed consolidated statement of operations (in millions):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.334%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.253%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain recognized in income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6c750f147ed4f38954df76797436ad8_D20210701-20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjEzMTMyMzI0OTA1NTRhMjJhMmJiZmEwMmRkMTFlZjA4L3RhYmxlcmFuZ2U6MTMxMzIzMjQ5MDU1NGEyMmEyYmJmYTAyZGQxMWVmMDhfMy0zLTEtMS0xMjcxMg_8d871e3b-23a5-4a24-bb2d-a85eea0f8299">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c6a16294f3e464bbdbc6cc59d2922fb_D20200701-20200930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjEzMTMyMzI0OTA1NTRhMjJhMmJiZmEwMmRkMTFlZjA4L3RhYmxlcmFuZ2U6MTMxMzIzMjQ5MDU1NGEyMmEyYmJmYTAyZGQxMWVmMDhfMy01LTEtMS0xMjcxMg_a3116c9a-b468-47a3-9e83-fcc291d6b6da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af2f02ead9e4c9f87a0e450cf3f134f_D20210101-20210930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjEzMTMyMzI0OTA1NTRhMjJhMmJiZmEwMmRkMTFlZjA4L3RhYmxlcmFuZ2U6MTMxMzIzMjQ5MDU1NGEyMmEyYmJmYTAyZGQxMWVmMDhfMy03LTEtMS0xMjcxMg_c7d5a3c6-c084-4e81-b362-2d7b16559d2a">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7109ce10eb84b6b9880cfb4246c23ef_D20200101-20200930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjEzMTMyMzI0OTA1NTRhMjJhMmJiZmEwMmRkMTFlZjA4L3RhYmxlcmFuZ2U6MTMxMzIzMjQ5MDU1NGEyMmEyYmJmYTAyZGQxMWVmMDhfMy05LTEtMS0xMjcxMg_9c9dfba4-5638-472f-a6dc-969cac441294">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives in cash flow hedging relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss recognized in OCI (effective portion)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54804f8602fa4a35a8b9674c532d6b4b_D20210701-20210930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjEzMTMyMzI0OTA1NTRhMjJhMmJiZmEwMmRkMTFlZjA4L3RhYmxlcmFuZ2U6MTMxMzIzMjQ5MDU1NGEyMmEyYmJmYTAyZGQxMWVmMDhfNi0zLTEtMS0xMjcxMg_54c04522-6b8a-4a81-9a18-7b3c7debd3b7">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2c4350be42c47498a9bab682e3c418b_D20200701-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjEzMTMyMzI0OTA1NTRhMjJhMmJiZmEwMmRkMTFlZjA4L3RhYmxlcmFuZ2U6MTMxMzIzMjQ5MDU1NGEyMmEyYmJmYTAyZGQxMWVmMDhfNi01LTEtMS0xMjcxMg_85c14ac2-9217-464e-afd6-8847b5e3c2fb">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78eea1b8023b40d48343347521f72035_D20210101-20210930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjEzMTMyMzI0OTA1NTRhMjJhMmJiZmEwMmRkMTFlZjA4L3RhYmxlcmFuZ2U6MTMxMzIzMjQ5MDU1NGEyMmEyYmJmYTAyZGQxMWVmMDhfNi03LTEtMS0xMjcxMg_48fb764f-c0c0-4786-8310-54efaf6793f4">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7791d5655eb846eb8e57e1bf970fb10f_D20200101-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjEzMTMyMzI0OTA1NTRhMjJhMmJiZmEwMmRkMTFlZjA4L3RhYmxlcmFuZ2U6MTMxMzIzMjQ5MDU1NGEyMmEyYmJmYTAyZGQxMWVmMDhfNi05LTEtMS0xMjcxMg_41d68d58-193a-4347-8045-4ca92570feaa">29.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss reclassified from accumulated OCI into income (effective portion) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3173a5d521c49e1a9e897a1d64450e8_D20210701-20210930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjEzMTMyMzI0OTA1NTRhMjJhMmJiZmEwMmRkMTFlZjA4L3RhYmxlcmFuZ2U6MTMxMzIzMjQ5MDU1NGEyMmEyYmJmYTAyZGQxMWVmMDhfNy0zLTEtMS0xMjcxMg_bb7fd536-dc49-4ef8-a98b-17edd35efd21">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68ac7c0981b4940a6352b394b343b73_D20200701-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjEzMTMyMzI0OTA1NTRhMjJhMmJiZmEwMmRkMTFlZjA4L3RhYmxlcmFuZ2U6MTMxMzIzMjQ5MDU1NGEyMmEyYmJmYTAyZGQxMWVmMDhfNy01LTEtMS0xMjcxMg_719ca020-9269-448f-b9d7-8d5f598ae83e">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2a1bea4a7df41318981b1d3405801df_D20210101-20210930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjEzMTMyMzI0OTA1NTRhMjJhMmJiZmEwMmRkMTFlZjA4L3RhYmxlcmFuZ2U6MTMxMzIzMjQ5MDU1NGEyMmEyYmJmYTAyZGQxMWVmMDhfNy03LTEtMS0xMjcxMg_00085593-6ae1-4da4-8caf-d9cd51d17876">18.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c7a094bccf049e5a50369c2dc0775bf_D20200101-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjEzMTMyMzI0OTA1NTRhMjJhMmJiZmEwMmRkMTFlZjA4L3RhYmxlcmFuZ2U6MTMxMzIzMjQ5MDU1NGEyMmEyYmJmYTAyZGQxMWVmMDhfNy05LTEtMS0xMjcxMg_3b9fce1f-20d1-48cb-8405-dc59ea38efac">14.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Includes amortization of accumulated OCI related to de-designated and terminated interest rate swaps of $<ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfNTExNA_55d1f93d-9822-4c6d-81ed-1d1f0a2b22d8">5.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfMTA5OTUxMTYzMzk2OQ_dd7b72fb-8267-456b-8774-0874d2177776">8.6</ix:nonFraction> million for the three and nine months ended September&#160;30, 2021, respectively.</span></div></ix:nonNumeric></ix:continuation><div id="idcac93ae85504379b4049f3f4d6efdb8_49"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">7.  <ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RleHRyZWdpb246NzQ2YWUxOGUwNjRkNGZmMzk1YWRlMzg5N2NiNDk5YjNfMTkwOA_3d77d1c0-306b-4bff-9546-99e2178b4090" continuedAt="i21d66269934c4aad822434ace7ccf043" escape="true">Earnings Per Share</ix:nonNumeric></span></div><ix:continuation id="i21d66269934c4aad822434ace7ccf043" continuedAt="ib17d59c0f6ef47339863e88cbb8d7f78"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic and diluted earnings per share are calculated based on the weighted-average number of shares outstanding in each period and dilutive stock options, unvested shares and warrants, to the extent such securities exist and have a dilutive effect on earnings per share. The Company computes basic and diluted earnings per share using the two-class method. The two-class method of computing earnings per share is an earnings allocation method that determines earnings per share for common shares and participating securities according to their participation rights in dividends and undistributed earnings.</span></div><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RleHRyZWdpb246NzQ2YWUxOGUwNjRkNGZmMzk1YWRlMzg5N2NiNDk5YjNfMTkwNQ_4ac57ac2-f2ec-4d98-9714-65e99adb5808" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (dollars in millions, except per share amounts; shares in thousands): </span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.253%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss attributable to Surgery Partners, Inc.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMy0xLTEtMS0xMjcxMg_6e544045-c907-43cf-8098-ff4e66fc7a9f">22.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMy0zLTEtMS0xMjcxMg_efab8ef4-0170-4770-b6bb-a99816e563fe">61.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMy01LTEtMS0xMjcxMg_72d6ccde-9df8-48a6-95ba-305be7fad3e6">70.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMy03LTEtMS0xMjcxMg_3c96f6be-ac9d-4a89-88ec-695c816da8c7">121.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: amounts allocated to participating securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfNC0xLTEtMS0xMjcxMg_b47643af-cd0a-4b34-9d77-76d791270079">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfNC0zLTEtMS0xMjcxMg_2bc45596-c434-490f-80eb-473e983647b0">10.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfNC01LTEtMS0xMjcxMg_d9fa3455-0087-40fc-8f47-dd297d5b031c">10.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfNC03LTEtMS0xMjcxMg_a151e27a-ae02-4063-bc52-a151fd98b084">29.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss attributable to common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfNS0xLTEtMS0xMjcxMg_82a0a716-8e6f-4209-bba1-7772e9628c73">22.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfNS0zLTEtMS0xMjcxMg_bf5ba131-bcbf-470d-a9a1-2ce79cff5eff">71.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfNS01LTEtMS0xMjcxMg_0c0aa7da-fa2f-4b69-8f5c-795551662a1d">81.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfNS03LTEtMS0xMjcxMg_240253ec-b5bd-4545-8484-a4eccd43218d">150.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding- basic and diluted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfOC0xLTEtMS0xMjcxMg_4f044aee-9189-444a-9e4d-21d5f67f1423"><ix:nonFraction unitRef="shares" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfOC0xLTEtMS0xMjcxMg_fd7e5903-26a8-4350-b997-17dbda7ff6c8">80,726</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfOC0zLTEtMS0xMjcxMg_b200075e-2890-441c-a09d-82c69b6bde31"><ix:nonFraction unitRef="shares" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfOC0zLTEtMS0xMjcxMg_ec0a039a-c111-4595-bc00-4132aef4aa76">48,883</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfOC01LTEtMS0xMjcxMg_42a0d0f5-c0eb-413e-ba48-1b3679e8829d"><ix:nonFraction unitRef="shares" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfOC01LTEtMS0xMjcxMg_c2b225ab-9965-43b8-b6f1-8365537b5d7f">68,350</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfOC03LTEtMS0xMjcxMg_26141137-ca14-4628-ab72-d2e1c2e9a9b7"><ix:nonFraction unitRef="shares" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfOC03LTEtMS0xMjcxMg_b8815c8a-60fd-4776-8f83-35bbb63e466b">48,736</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Loss per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic and diluted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMTEtMS0xLTEtMTI3MTI_8336c9a8-7529-46eb-8a61-0085c1b9fad5"><ix:nonFraction unitRef="usdPerShare" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMTEtMS0xLTEtMTI3MTI_95fa4b91-948a-4a0d-ab3e-a247b1927f30">0.28</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMTEtMy0xLTEtMTI3MTI_f8559cf1-5a15-4354-9ed8-0cca6b857bff"><ix:nonFraction unitRef="usdPerShare" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMTEtMy0xLTEtMTI3MTI_ff4d4114-fb01-407f-9544-4b5b1ffad941">1.46</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMTEtNS0xLTEtMTI3MTI_04883c53-d3f9-4dc5-b856-b9b2f476a091"><ix:nonFraction unitRef="usdPerShare" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMTEtNS0xLTEtMTI3MTI_b9732faf-160d-41f3-ad8a-93edcf40a35d">1.19</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMTEtNy0xLTEtMTI3MTI_03387df3-c25a-4fc3-8ece-a5e98eb6b8d1"><ix:nonFraction unitRef="usdPerShare" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMTEtNy0xLTEtMTI3MTI_e44fcf20-f4c1-4b80-a994-acbd27ab1593">3.09</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1dfc84c1f55d48fdbe932272d2d40dc1_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMTQtMS0xLTEtMTI3MTI_2be42dbd-0903-4c29-9257-c456dbaf1fea">1,974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic30bbc4807ee4a90b1e5e73a917f7981_D20200701-20200930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMTQtMy0xLTEtMTI3MTI_a6d44346-3721-4fdc-8d42-2e2e35e44131">810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iec7a2ccc58c14483aefa7eef623648ff_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMTQtNS0xLTEtMTI3MTI_fc0cbd7c-072d-4a1d-902b-2493b17852b7">1,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i21ccc0b58d41465bb76c786bd6c59944_D20200101-20200930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMTQtNy0xLTEtMTI3MTI_50540804-da53-4c2b-af35-dfa506fd06c7">285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2e6bf043d8e543ca9a60ab545728b68d_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMTUtMS0xLTEtMTI3MTI_75fc1ce3-baac-4f38-bc80-d3179282f9f2">1,461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id809a0ee79f9462cbd0b84dc0a1f8ba6_D20200701-20200930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMTUtMy0xLTEtMTI3MTI_b034ff91-bccc-47a3-b581-875f1a5c6d6e">986</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i27cea47c34d24be486efd529a214dfe3_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMTUtNS0xLTEtMTI3MTI_44002281-a151-43cf-8b4b-c878f068cd9f">1,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i37ed33a1a2e84bac96ea96cc638d09be_D20200101-20200930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMTUtNy0xLTEtMTI3MTI_2c9a8f16-a2a5-44cc-ab78-7124239ee07a">848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Includes dividends accrued for the Series A Preferred Stock. The Series A Preferred Stock does not participate in undistributed losses.</span></div><div style="margin-bottom:9pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in each period.</span></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On January 27, 2021, the Company entered into an underwriting agreement relating to a public offering of <ix:nonFraction unitRef="shares" contextRef="i7d1f48dd9e4b49d78df2715069875ead_D20210127-20210127" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RleHRyZWdpb246NzQ2YWUxOGUwNjRkNGZmMzk1YWRlMzg5N2NiNDk5YjNfMTIxNQ_04f0fe8e-a856-4f53-a7d8-e3971b95c0af">7,500,000</ix:nonFraction> shares (the &#8220;Firm Shares&#8221;) of the Company&#8217;s common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="if7415e8f12eb4b0f857512e10ff2b1df_I20210127" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RleHRyZWdpb246NzQ2YWUxOGUwNjRkNGZmMzk1YWRlMzg5N2NiNDk5YjNfMTI3Ng_1dbacdbf-1970-4319-bad0-e3751e3b6c97">0.01</ix:nonFraction> par value per share, at a price to the public of $<ix:nonFraction unitRef="usdPerShare" contextRef="if7415e8f12eb4b0f857512e10ff2b1df_I20210127" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RleHRyZWdpb246NzQ2YWUxOGUwNjRkNGZmMzk1YWRlMzg5N2NiNDk5YjNfMTMyOA_e8245556-2912-482b-b4d0-c5e0b8549c94">30.25</ix:nonFraction> per share. In addition, the Company granted the underwriters an option to purchase up to an additional <ix:nonFraction unitRef="shares" contextRef="ia81e7b3e0bbf4ed8817112cf8a395a4d_D20210127-20210127" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RleHRyZWdpb246NzQ2YWUxOGUwNjRkNGZmMzk1YWRlMzg5N2NiNDk5YjNfMTQzNA_9f368627-cf71-4b59-bdf3-da9405773967">1,125,000</ix:nonFraction> shares of common stock at the same price per share as the Firm Shares. On February 1, 2021, the Company completed the public offering pursuant to which the Company sold <ix:nonFraction unitRef="shares" contextRef="i606fa788b0c34beca685e0fe3cef5cca_D20210201-20210201" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RleHRyZWdpb246NzQ2YWUxOGUwNjRkNGZmMzk1YWRlMzg5N2NiNDk5YjNfMTYwNg_4a890151-a75b-4069-b7b4-20284903f048">8,625,000</ix:nonFraction> shares of common stock (including the Firm Shares and the option shares), resulting in gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="i606fa788b0c34beca685e0fe3cef5cca_D20210201-20210201" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RleHRyZWdpb246NzQ2YWUxOGUwNjRkNGZmMzk1YWRlMzg5N2NiNDk5YjNfMTcxNA_1960b5a3-c555-4015-a182-31e7b737c0b9">260.9</ix:nonFraction>&#160;million. In connection with the offering, the Company incurred underwriting discounts, commissions and other related costs of $<ix:nonFraction unitRef="usd" contextRef="i606fa788b0c34beca685e0fe3cef5cca_D20210201-20210201" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RleHRyZWdpb246NzQ2YWUxOGUwNjRkNGZmMzk1YWRlMzg5N2NiNDk5YjNfMTgzNQ_b588f814-2274-4926-89f6-f3c0e6199ddf">12.7</ix:nonFraction>&#160;million, which were recognized as a direct reduction of proceeds received.</span></div></ix:continuation><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="ib17d59c0f6ef47339863e88cbb8d7f78">On May 17, 2021, the Company converted all outstanding shares of Series A Preferred Stock into approximately <ix:nonFraction unitRef="shares" contextRef="id264cc07d6a44dcc9fd4169a79dd9ff8_D20210517-20210517" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConversionOfStockSharesIssued1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RleHRyZWdpb246NzQ2YWUxOGUwNjRkNGZmMzk1YWRlMzg5N2NiNDk5YjNfMTA5OTUxMTYyOTkyOA_577f7cd0-aabf-4111-85db-066aad282cf6">22.609</ix:nonFraction>&#160;million shares of common stock. See Note 5. "Redeemable Preferred Stock" for further discussion.</ix:continuation> </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><div id="idcac93ae85504379b4049f3f4d6efdb8_52"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">8.  <ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:OtherLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RleHRyZWdpb246OTEyMTNmODY5ODUxNGIwZDk0ODYzNTZkMWI0MWY0ZjRfMTc1_ea933ab5-e595-4c3f-a18f-54dbe5d371f6" continuedAt="i2e0d98586cf143f6b49e87591351e5e6" escape="true">Other Current Liabilities</ix:nonNumeric></span></div><ix:continuation id="i2e0d98586cf143f6b49e87591351e5e6"><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:OtherCurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RleHRyZWdpb246OTEyMTNmODY5ODUxNGIwZDk0ODYzNTZkMWI0MWY0ZjRfMTcy_daf3ab84-0653-4634-a5e4-68ea36535208" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of other current liabilities is as follows (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.953%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RhYmxlOjAxM2ZjZjAwYjdhMDRmNTRhNTg4NzM4ZWEzMDAyOWNiL3RhYmxlcmFuZ2U6MDEzZmNmMDBiN2EwNGY1NGE1ODg3MzhlYTMwMDI5Y2JfMi0yLTEtMS0xMjcxMg_ff8dbbcc-ceb1-4301-8a21-14b46a4b185d">40.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RhYmxlOjAxM2ZjZjAwYjdhMDRmNTRhNTg4NzM4ZWEzMDAyOWNiL3RhYmxlcmFuZ2U6MDEzZmNmMDBiN2EwNGY1NGE1ODg3MzhlYTMwMDI5Y2JfMi00LTEtMS0xMjcxMg_ae2d8c60-6da1-41bc-b4fc-a44df62ace13">39.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="us-gaap:InterestPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RhYmxlOjAxM2ZjZjAwYjdhMDRmNTRhNTg4NzM4ZWEzMDAyOWNiL3RhYmxlcmFuZ2U6MDEzZmNmMDBiN2EwNGY1NGE1ODg3MzhlYTMwMDI5Y2JfNC0yLTEtMS0xMjcxMg_62665806-e2d3-4f47-be78-393702c8661e">37.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:InterestPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RhYmxlOjAxM2ZjZjAwYjdhMDRmNTRhNTg4NzM4ZWEzMDAyOWNiL3RhYmxlcmFuZ2U6MDEzZmNmMDBiN2EwNGY1NGE1ODg3MzhlYTMwMDI5Y2JfNC00LTEtMS0xMjcxMg_0aa5eca0-ea0d-44c5-9779-c1921e880235">24.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost report liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="sgry:CostReportLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RhYmxlOjAxM2ZjZjAwYjdhMDRmNTRhNTg4NzM4ZWEzMDAyOWNiL3RhYmxlcmFuZ2U6MDEzZmNmMDBiN2EwNGY1NGE1ODg3MzhlYTMwMDI5Y2JfNS0yLTEtMS0xOTc1NA_f9cf445c-60be-45ec-89f7-574a8dad4cee">28.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="sgry:CostReportLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RhYmxlOjAxM2ZjZjAwYjdhMDRmNTRhNTg4NzM4ZWEzMDAyOWNiL3RhYmxlcmFuZ2U6MDEzZmNmMDBiN2EwNGY1NGE1ODg3MzhlYTMwMDI5Y2JfNS00LTEtMS0xOTc1NA_1d7583a6-329f-4803-abc1-65af2b78749b">16.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts due to patients and payors</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="srt:PayablesToCustomers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RhYmxlOjAxM2ZjZjAwYjdhMDRmNTRhNTg4NzM4ZWEzMDAyOWNiL3RhYmxlcmFuZ2U6MDEzZmNmMDBiN2EwNGY1NGE1ODg3MzhlYTMwMDI5Y2JfNi0yLTEtMS0xMjcxMg_dc438090-f1ec-4a9c-9a1f-b68e731fb094">28.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="srt:PayablesToCustomers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RhYmxlOjAxM2ZjZjAwYjdhMDRmNTRhNTg4NzM4ZWEzMDAyOWNiL3RhYmxlcmFuZ2U6MDEzZmNmMDBiN2EwNGY1NGE1ODg3MzhlYTMwMDI5Y2JfNi00LTEtMS0xMjcxMg_74f97e9c-b916-40fa-b584-8a7b60a431ef">20.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax receivable agreement liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="sgry:TaxReceivableAgreementLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RhYmxlOjAxM2ZjZjAwYjdhMDRmNTRhNTg4NzM4ZWEzMDAyOWNiL3RhYmxlcmFuZ2U6MDEzZmNmMDBiN2EwNGY1NGE1ODg3MzhlYTMwMDI5Y2JfNy0yLTEtMS0xMjcxMg_e579e329-504e-4fde-b92e-47030e5a68b5">21.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="sgry:TaxReceivableAgreementLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RhYmxlOjAxM2ZjZjAwYjdhMDRmNTRhNTg4NzM4ZWEzMDAyOWNiL3RhYmxlcmFuZ2U6MDEzZmNmMDBiN2EwNGY1NGE1ODg3MzhlYTMwMDI5Y2JfNy00LTEtMS0xMjcxMg_321efb3a-a81a-48b5-a80f-81bfa15b5f33">21.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued legal settlement </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:LitigationReserveCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RhYmxlOjAxM2ZjZjAwYjdhMDRmNTRhNTg4NzM4ZWEzMDAyOWNiL3RhYmxlcmFuZ2U6MDEzZmNmMDBiN2EwNGY1NGE1ODg3MzhlYTMwMDI5Y2JfOC0yLTEtMS0xOTc3NQ_9ff9c79a-6391-4bab-9735-a8df6abecce7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:LitigationReserveCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RhYmxlOjAxM2ZjZjAwYjdhMDRmNTRhNTg4NzM4ZWEzMDAyOWNiL3RhYmxlcmFuZ2U6MDEzZmNmMDBiN2EwNGY1NGE1ODg3MzhlYTMwMDI5Y2JfOC00LTEtMS0xOTc3NQ_72c48fe8-7841-4e74-93df-60ff444f89d3">32.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RhYmxlOjAxM2ZjZjAwYjdhMDRmNTRhNTg4NzM4ZWEzMDAyOWNiL3RhYmxlcmFuZ2U6MDEzZmNmMDBiN2EwNGY1NGE1ODg3MzhlYTMwMDI5Y2JfOC0yLTEtMS0xMjcxMg_f132c6ab-6128-4b6a-882b-e503a2d2e090">53.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RhYmxlOjAxM2ZjZjAwYjdhMDRmNTRhNTg4NzM4ZWEzMDAyOWNiL3RhYmxlcmFuZ2U6MDEzZmNmMDBiN2EwNGY1NGE1ODg3MzhlYTMwMDI5Y2JfOC00LTEtMS0xMjcxMg_b4ae9115-6573-4b51-baca-04373a53b74c">62.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RhYmxlOjAxM2ZjZjAwYjdhMDRmNTRhNTg4NzM4ZWEzMDAyOWNiL3RhYmxlcmFuZ2U6MDEzZmNmMDBiN2EwNGY1NGE1ODg3MzhlYTMwMDI5Y2JfOS0yLTEtMS0xMjcxMg_e8f4f651-ad37-4846-a83f-49be78ff9032">208.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RhYmxlOjAxM2ZjZjAwYjdhMDRmNTRhNTg4NzM4ZWEzMDAyOWNiL3RhYmxlcmFuZ2U6MDEzZmNmMDBiN2EwNGY1NGE1ODg3MzhlYTMwMDI5Y2JfOS00LTEtMS0xMjcxMg_355c346a-b572-40c3-8107-96f4c01e81ac">217.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:1pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">See Note 9. "Commitments and Contingencies" for further discussion.</span></div></ix:nonNumeric></ix:continuation><div id="idcac93ae85504379b4049f3f4d6efdb8_55"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">9.  <ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfOTIwNA_04ec6fed-2367-4788-b76a-dd5e95b1a011" continuedAt="ic5b7e8c42bd144afa5cf0d3eabf865e3" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="ic5b7e8c42bd144afa5cf0d3eabf865e3" continuedAt="i9ce2f751dba74b129b29801169a6d71f"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Professional, General and Workers' Compensation Liability Risks</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is subject to claims and legal actions in the ordinary course of business, including claims relating to patient treatment, employment practices and personal injuries. The Company maintains professional, general and workers' compensation liability insurance in excess of self-insured retentions, through third party commercial insurance carriers. Although management believes the coverage is sufficient for the Company's operations, some claims may potentially exceed the scope of coverage in effect. Plaintiffs in these matters may request punitive or other damages that may not be covered by insurance. The Company is not aware of any such proceedings that are reasonably possible to have a material adverse effect on the Company's business, financial position, results of operations or liquidity. Total professional, general and workers' compensation claim liabilities as of September&#160;30, 2021 and December&#160;31, 2020 were $<ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:SelfInsuranceReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfMTAwNw_1d6418fa-07b3-4b94-bdf1-7634297d860f">22.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:SelfInsuranceReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfMTAxNA_3d615818-aa65-4af0-a07e-ecf9c3435449">21.4</ix:nonFraction> million, respectively. Expected insurance recoveries of $<ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EstimatedInsuranceRecoveries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfMTA2NQ_250e9503-cf71-41d6-a852-a5927f722b17"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EstimatedInsuranceRecoveries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfMTA2NQ_e1df788b-d6f3-4071-9d47-4639e7c9340c">10.5</ix:nonFraction></ix:nonFraction> million as of both September&#160;30, 2021 and December&#160;31, 2020, are included as a component of other current assets and other long-term assets in the condensed consolidated balance sheets. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Laws and Regulations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Laws and regulations governing the Company's business, including those relating to the Medicare and Medicaid programs, are complex and subject to interpretation. These laws and regulations govern every aspect of how the Company's surgical facilities conduct their operations, from licensing requirements to how and whether the Company's facilities may receive payments pursuant to the Medicare and Medicaid programs. Compliance with such laws and regulations can be subject to future government agency review and interpretation as well as legislative changes to such laws. Noncompliance with such laws and regulations may subject the Company to significant regulatory sanctions including fines, penalties, and exclusion from the Medicare, Medicaid and other federal health care programs. From time to time, governmental regulatory agencies will conduct inquiries of the Company's practices, including, but not limited to, the Company's compliance with federal and state fraud and abuse laws, billing practices and relationships with physicians.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Government Settlement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 14, 2020, Logan Laboratories, LLC ("Logan Labs"), a toxicology laboratory based in Tampa, Florida, that provides urine testing services and Tampa Pain Relief Centers, Inc. ("Tampa Pain" and, together with Logan Labs, the "Companies"), a pain management medical practice based in Tampa, Florida, both indirect wholly-owned subsidiaries of the Company, entered into a settlement agreement (the "Settlement Agreement") with the United States of America, acting through the United States Department of Justice (&#8220;DOJ&#8221;) and on behalf of the Office of Inspector General of the Department of Health and Human Services ("OIG"), the Defense Health Agency, acting on behalf of the TRICARE Program, the Office of Personnel Management, as the administrator of the Federal Employees Health Benefits Program, the Office of Workers Compensation Programs of the United States Department of Labor, which administers federal workers compensation claims for federal employees, including the United States Postal Service, and the United States Department of Veterans Affairs and certain other parties to resolve the pending DOJ investigation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Under the terms of the Settlement Agreement, the Companies paid $<ix:nonFraction unitRef="usd" contextRef="i3967e790bb894cf8acd4602519023b78_D20210401-20210401" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfMzUzNA_cdaa8185-ed8c-45a4-b284-ab1310ff14cd">30.7</ix:nonFraction>&#160;million plus accrued interest on April 1, 2021, representing the final payment related to the resolution of the DOJ Investigation.</span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i9ce2f751dba74b129b29801169a6d71f" continuedAt="i11f686427cb144b8b630833b5185b127"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Stockholder Litigation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December 4, 2017, a purported Company stockholder filed an action in the Delaware Court of Chancery (the "Delaware Action"). That action is captioned Witmer v. H.I.G. Capital, L.L.C., et al., C.A. No. 2017-0862. The plaintiff in the Delaware Action asserted claims against (i) certain current and former members of the Company&#8217;s Board of Directors (together, the "Directors"); (ii) H.I.G. Capital, LLC and certain of its affiliates (collectively, "H.I.G."); and (iii) Bain Capital Private Equity, L.P. and certain of its affiliates (collectively, "Bain Capital" and, together with the Directors and H.I.G., the "Defendants"). The plaintiff asserted derivative claims on behalf of the Company, which is a nominal defendant in the Delaware Action, as well as putatively direct claims on behalf of a purported class of Company stockholders. The plaintiff in the Delaware Action asserted that the Defendants breached their fiduciary duties in connection with the transactions in which (i) the Company acquired National Surgical Healthcare; (ii) Bain Capital acquired preferred equity in the Company; and (iii) Bain Capital acquired H.I.G.'s equity stake in the Company, and that, in the alternative, Bain Capital aided and abetted those purported breaches. The plaintiff also asserted an unjust enrichment claim against Bain Capital.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On January 2, 2018, the Defendants moved to dismiss the plaintiff&#8217;s complaint. On December 19, 2018, the Court of Chancery issued a decision on that motion. Following that decision, all of the Directors have been dismissed from the Delaware Action. The Court did not dismiss the plaintiff&#8217;s breach of fiduciary duty claim against H.I.G. or the aiding and abetting claim asserted against Bain Capital. However, the Court dismissed the plaintiff&#8217;s breach of fiduciary duty and unjust enrichment claims against Bain Capital. In addition, the Court dismissed all of the plaintiff&#8217;s claims that were asserted on behalf of a putative class of Company stockholders. Accordingly, all of the plaintiff&#8217;s remaining claims in the Delaware Action are asserted derivatively on the Company&#8217;s behalf. Discovery in the Delaware Action principally concluded on July 30, 2021, and the Defendants moved for summary judgment with respect to the remaining claims asserted against them. While those motions were pending, the parties to the Delaware Action reached an agreement-in-principle to settle the Delaware Action. The parties are currently negotiating the final terms of that settlement, which will be subject to approval by the Court of Chancery. Because the plaintiff in the Delaware Action asserts only derivative claims on the Company&#8217;s behalf, the Company will be the beneficiary of any settlement that is ultimately approved by the Court of Chancery.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Acquired Facilities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company, through its wholly-owned subsidiaries or controlled partnerships and limited liability companies, has acquired and will continue to acquire surgical facilities with prior operating histories. Such facilities may have unknown or contingent liabilities, including liabilities for failure to comply with health care laws and regulations, such as billing and reimbursement laws and regulations, the Stark Law, the Anti-Kickback Statute, the FCA, and similar fraud and abuse laws. Although the Company attempts to assure that no such liabilities exist, obtain indemnification from prospective sellers covering such matters and institute policies designed to conform centers to its standards following completion of acquisitions, there can be no assurance that the Company will not become liable for past activities that may later be asserted to be improper by private plaintiffs or government agencies. There can be no assurance that any such matter will be covered by indemnification or, if covered, that the liability sustained will not exceed contractual limits or the financial capacity of the indemnifying party.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company cannot predict whether federal or state statutory or regulatory provisions will be enacted that would prohibit or otherwise regulate relationships which the Company has established or may establish with other health care providers or have materially adverse effects on its business or revenues arising from such future actions. Management believes, however, that it will be able to adjust the Company's operations so as to be in compliance with any statutory or regulatory provision as may be applicable.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Potential Physician Investor Liability</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A majority of the physician investors in the partnerships and limited liability companies which operate the Company's surgical facilities carry general and professional liability insurance on a claims-made basis. Each partnership or limited liability company may, however, be liable for damages to persons or property arising from occurrences at the surgical facilities. Although the various physician investors and other surgeons generally are required to obtain general and professional liability insurance with tail coverage that extends beyond the period of any claims-made policies, such individuals may not be able to obtain coverage in amounts sufficient to cover all potential liability. Since most insurance policies contain exclusions, the physician investors will not be insured against all possible occurrences. In the event of an uninsured or underinsured loss, the value of an investment in the partnership interests or limited liability company membership units and the amount of distributions could be adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Tax Receivable Agreement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On May 9, 2017, the Company entered into an agreement to amend that certain Income Tax Receivable Agreement, dated September 30, 2015 (as amended, the "TRA"), by and between the Company, and the other parties referred to therein, which amendment became effective on August 31, 2017. Pursuant to the amendment to the TRA, the Company agreed to make payments to H.I.G., the Company's former controlling shareholder, in its capacity as the stockholders representative pursuant to a fixed payment schedule. The amounts payable under the TRA are calculated as the product of (i) an annual base amount and (ii) the maximum corporate federal income tax rate for the applicable year plus <ix:nonFraction unitRef="number" contextRef="if703c13f85f14316b033116a88b9d2f6_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfNzQ4OQ_ff0961eb-e568-41dc-87f6-bc3d20c59a00">three</ix:nonFraction> percent. The amounts payable under the TRA are related to the Company&#8217;s projected realized tax savings over the next <ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" format="ixt-sec:durwordsen" name="sgry:CollaborativeTaxAgreementProjectedTaxSavingsTerm" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfNzYwOQ_5f101fd2-4f74-49c5-93e4-02a4f644bc08">five years</ix:nonNumeric> and are not dependent on the Company&#8217;s actual tax savings over such period. The calculation of amounts payable pursuant to the TRA is thus dependent on the maximum corporate federal income tax rate. To the extent that the Company is unable to make payments under the TRA, such payments will be deferred and will accrue interest at a rate of the LIBOR plus <ix:nonFraction unitRef="number" contextRef="i3adc24f120064bdb80d18207eba230d9_D20210101-20210930" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfNzk2OA_cc0e8492-f3da-447d-b77f-accadfde6dc3">500</ix:nonFraction> basis points until paid. If the terms of credit agreements and other debt documents cause the Company to be unable to make payments under the TRA and </span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i11f686427cb144b8b630833b5185b127"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">such terms are not materially more restrictive than those existing as of September 30, 2015, such payments will be deferred and will accrue interest at a rate of LIBOR plus <ix:nonFraction unitRef="number" contextRef="i403f136aa2eb4d108d1df4f2b90ccdd5_D20210101-20210930" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfODI5NA_22d8fddf-02ba-4023-bc71-5fb29e74a732">300</ix:nonFraction> basis points until paid.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Assuming the Company's tax rate is <ix:nonFraction unitRef="number" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfODM1Nw_f52c1326-fa7a-477b-a0be-f12bb0c3e980">24</ix:nonFraction>%, calculated as the maximum corporate federal tax rate plus <ix:nonFraction unitRef="number" contextRef="if703c13f85f14316b033116a88b9d2f6_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="sgry:CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfODQxOQ_5a77f997-5be6-4c2d-8762-8f79b5b54e7d">three</ix:nonFraction> percent, throughout the remaining term of the TRA, the Company estimates the total remaining amounts payable under the TRA was approximately $<ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:TaxesPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfODU2Mw_169921a9-6970-4f0e-ab65-c13043c88751"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:TaxesPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfODU2Mw_1df1b7a7-81be-4026-9314-16559d6c5a3e">43.2</ix:nonFraction></ix:nonFraction> million as of both September&#160;30, 2021 and December&#160;31, 2020. As a result of the amendment to the TRA, the Company was required to value the liability under the TRA by discounting the fixed payment schedule using the Company&#8217;s incremental borrowing rate. The carrying value of the liability under the TRA, reflecting the discount, was $<ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="sgry:DeferredIncomeTaxLiabilitiesNetOfDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfODg2MQ_114d8917-4712-41e1-8c48-419f99473752">39.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="sgry:DeferredIncomeTaxLiabilitiesNetOfDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfODg2OA_ebb66492-3a95-4c6f-b6fa-9ca0278f5758">37.0</ix:nonFraction> million as of September&#160;30, 2021 and December&#160;31, 2020, respectively. The current portion of the liability was $<ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="sgry:DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfODk0Mw_8395beb3-359a-447b-956a-d88eabe1108f"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="sgry:DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfODk0Mw_c87613ed-c23d-440a-8171-39571891f7d3">21.2</ix:nonFraction></ix:nonFraction> million as of both September&#160;30, 2021 and December&#160;31, 2020, and is included as a component of other current liabilities in the condensed consolidated balance sheets. The long-term portion is included as a component of other long-term liabilities in the condensed consolidated balance sheets.</span></div></ix:continuation><div id="idcac93ae85504379b4049f3f4d6efdb8_58"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">10.  <ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfMTkyMA_2b4742b2-54c5-47db-86b8-81ab8ce687c5" continuedAt="i0b6522d25fd144608784c63c6caeed26" escape="true">Segment Reporting</ix:nonNumeric></span></div><ix:continuation id="i0b6522d25fd144608784c63c6caeed26" continuedAt="i38af9d27b9f048c5917f66f432533aa9"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company currently operates in&#160;<ix:nonFraction unitRef="segment" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfNjI_9c117fc6-f373-451f-a720-7c3ed3f2896c">two</ix:nonFraction>&#160;major lines of business that are also the Company's reportable operating segments - the operation of surgical facilities and the operation of ancillary services. The Surgical Facility Services segment consists of the operation of ASCs and surgical hospitals and includes anesthesia services. The Ancillary Services segment consists of multi-specialty physician practices and a diagnostic laboratory, which was closed during the third quarter of 2020. The Optical Services segment for the three and nine months ended September 30, 2020 reflected in the table below consisted of an optical products group purchasing organization, which was sold on December 31, 2020. "All other" primarily consists of the Company's corporate general and administrative functions.</span></div><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfMTkwMw_2fd01142-a6b0-43f6-96c6-5b7474605d6d" continuedAt="i82c4f5d986d245f089592a4699bf5679" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following tables present financial information for each reportable segment (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.252%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Surgical Facility Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1b634056ada477481858c03f1bb914f_D20210701-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMy0yLTEtMS0xMjcxMg_d79e9a8a-54cf-4852-af5b-bf962bb04605">542.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if166aaf3eb59483bb7262ede561423c7_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMy00LTEtMS0xMjcxMg_ca9cba7d-6681-444c-98fa-fbb4680f52b6">478.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02f0df4797ab4a1e9bacd76ffdc57ab6_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMy02LTEtMS0xMjcxMg_e297b635-3243-49ba-86be-ec78a9225eca">1,563.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbed4bef98e44fea406cc92949cdb3d_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMy04LTEtMS0xMjcxMg_1c526fdf-f703-4ebc-91ab-6c490fa46eff">1,262.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ancillary Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4894cd8d6cd44708c0cbc6ef5c7418f_D20210701-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfNC0yLTEtMS0xMjcxMg_cc70cea8-0dfb-48da-9f62-39d93a4aaf50">17.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i086a33999d294178ad7e9154bb2b9765_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfNC00LTEtMS0xMjcxMg_2142d557-5d48-4478-8ad8-72f3c14ce8c3">16.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic567b93a1ce84e17ad9837f0055b163b_D20210101-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfNC02LTEtMS0xMjcxMg_11067ea2-2f60-45f1-a14f-092916e48443">51.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb2d426435c8450cafd7728d9d2dc8f3_D20200101-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfNC04LTEtMS0xMjcxMg_63cf9aab-ecac-40c8-9282-5f1da58451d6">46.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Optical Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib98011fc87b240309c26b764d426abd9_D20210701-20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfNS0yLTEtMS0xMjcxMg_a2c485ee-8f50-477a-9b3c-db94acc1c7b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18afa682ccf34322b6bcdd13fdbfa4af_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfNS00LTEtMS0xMjcxMg_c4062734-edcd-4f7d-92c1-bd28c18d361c">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24645f34e6a44361a5fbad3eb0ddf170_D20210101-20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfNS02LTEtMS0xMjcxMg_b6e4cdf8-62aa-45d7-9a2d-1412a649be03">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idff1d62b1cb640b687f9fb96f5b4bb00_D20200101-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfNS04LTEtMS0xMjcxMg_4c3d5869-a849-49f8-a94e-c65f2d1b03d3">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfNi0yLTEtMS0xMjcxMg_c5c8b3ff-a6da-41c7-bc9a-3591e26a9858">559.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfNi00LTEtMS0xMjcxMg_52984abc-5b3a-493d-9b54-0ccd42428868">496.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfNi02LTEtMS0xMjcxMg_a3c21aa8-f654-4004-bf68-4122969cfca2">1,614.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfNi04LTEtMS0xMjcxMg_867b128e-73b4-49c7-b3c4-f282046c7451">1,311.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted EBITDA:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Surgical Facility Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1b634056ada477481858c03f1bb914f_D20210701-20210930" decimals="-5" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfOS0yLTEtMS0xMjcxMg_7abb6f02-f1a0-410e-b146-2fa1dff4c3f7">96.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if166aaf3eb59483bb7262ede561423c7_D20200701-20200930" decimals="-5" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfOS00LTEtMS0xMjcxMg_28a035ed-0bae-4289-b647-7db806181e99">82.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02f0df4797ab4a1e9bacd76ffdc57ab6_D20210101-20210930" decimals="-5" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfOS02LTEtMS0xMjcxMg_027a1252-5e22-4cf4-9314-6cb3717f92ff">287.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbed4bef98e44fea406cc92949cdb3d_D20200101-20200930" decimals="-5" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfOS04LTEtMS0xMjcxMg_a073556f-02c0-4d61-9828-37b4a90f28f3">229.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ancillary Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4894cd8d6cd44708c0cbc6ef5c7418f_D20210701-20210930" decimals="-5" format="ixt:fixed-zero" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTAtMi0xLTEtMTI3MTI_85a2ebc9-0a18-4ef3-9386-5f76f30589cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i086a33999d294178ad7e9154bb2b9765_D20200701-20200930" decimals="-5" sign="-" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTAtNC0xLTEtMTI3MTI_1252d29c-380e-470e-9dd1-d1b82c2e0f04">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic567b93a1ce84e17ad9837f0055b163b_D20210101-20210930" decimals="-5" sign="-" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTAtNi0xLTEtMTI3MTI_7df4a351-57a8-4b1b-a30d-077e76332e9d">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb2d426435c8450cafd7728d9d2dc8f3_D20200101-20200930" decimals="-5" sign="-" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTAtOC0xLTEtMTI3MTI_c7952324-7c4d-4cf2-82bf-6935601711e4">3.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Optical Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib98011fc87b240309c26b764d426abd9_D20210701-20210930" decimals="-5" format="ixt:fixed-zero" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTEtMi0xLTEtMTI3MTI_cdb072f2-7195-480b-911e-095d05f6cffe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18afa682ccf34322b6bcdd13fdbfa4af_D20200701-20200930" decimals="-5" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTEtNC0xLTEtMTI3MTI_bb9467b9-c31d-49df-9c93-8f26ca009b51">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24645f34e6a44361a5fbad3eb0ddf170_D20210101-20210930" decimals="-5" format="ixt:fixed-zero" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTEtNi0xLTEtMTI3MTI_95b1a2d4-2a52-4f60-988c-8a02502647b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idff1d62b1cb640b687f9fb96f5b4bb00_D20200101-20200930" decimals="-5" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTEtOC0xLTEtMTI3MTI_0c36829f-c93d-4b30-b65b-039b69260a36">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22e6f85fd88d44d89f23a959137fd882_D20210701-20210930" decimals="-5" sign="-" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTItMi0xLTEtMTI3MTI_df1b71c9-b16e-4c1a-97e9-966a1bc7b8df">20.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11790ef5309b4773a0839312e45271b1_D20200701-20200930" decimals="-5" sign="-" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTItNC0xLTEtMTI3MTI_415f1c3a-fde8-4e6e-af10-6fa5b64e7faf">21.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3cd422f84ed747328d3a0d61c7f136fa_D20210101-20210930" decimals="-5" sign="-" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTItNi0xLTEtMTI3MTI_907e491e-8b0c-450f-ad87-34500a05494d">61.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69c8d97578e54edc825c05346d77f05a_D20200101-20200930" decimals="-5" sign="-" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTItOC0xLTEtMTI3MTI_06d313ac-0ee0-4633-b795-851d45a3aa24">61.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTMtMi0xLTEtMTI3MTI_7929a0fa-dc30-41df-804a-b1814b640ea6">76.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTMtNC0xLTEtMTI3MTI_93c4c363-f77a-4890-91c3-fd56befa0e3f">61.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTMtNi0xLTEtMTI3MTI_a3bf6f13-930c-4798-95eb-eb343f91092d">225.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTMtOC0xLTEtMTI3MTI_37a85b94-c9f7-478f-8e65-3d1e48ac25ae">165.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reconciliation of Adjusted EBITDA:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTYtMi0xLTEtMTI3MTI_ea73942b-1fb8-4051-919e-affe3c5131fd">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTYtNC0xLTEtMTI3MTI_63b78bfa-26f9-4386-8775-56174991d362">33.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTYtNi0xLTEtMTI3MTI_07c31c86-d860-461e-9652-b9cd488d500b">26.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTYtOC0xLTEtMTI3MTI_22320998-bf21-4f81-8a29-7cac24374aba">61.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTgtMi0xLTEtMTI3MTI_364fdc28-b4bb-4f1a-a4e5-99c460ebc799">31.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTgtNC0xLTEtMTI3MTI_3c44bdc8-cce7-451c-bfa3-b60aeac18d03">27.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTgtNi0xLTEtMTI3MTI_a13fcfd2-cff9-453c-b109-18ea175af2d4">98.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTgtOC0xLTEtMTI3MTI_6e178dd6-3c7a-4fd3-8f98-44b0a89ad6c7">75.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTktMi0xLTEtMTI3MTI_ade47da1-e518-4ab9-8f5b-4b13ce4d2924">25.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTktNC0xLTEtMTI3MTI_b9ea6f20-1e9f-40cf-ba6d-d616d59742ec">24.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTktNi0xLTEtMTI3MTI_3ea7f7aa-e3ed-4df5-b576-5ea9400217f9">76.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTktOC0xLTEtMTI3MTI_475faa68-315d-416f-8fb3-a67f544b0ce1">69.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjAtMi0xLTEtMTI3MTI_9206c103-6787-4e59-b51d-3d158cbba7de">54.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjAtNC0xLTEtMTI3MTI_8729cc78-0a7c-434a-aaa0-5fc51919a3c7">51.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjAtNi0xLTEtMTI3MTI_936825e2-127c-4d8e-9e5c-dda4e615760b">160.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjAtOC0xLTEtMTI3MTI_ffceb7fb-4a83-46ff-84d2-0f05450e647b">147.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjEtMi0xLTEtMTI3MTI_5bfb7ba2-5884-4489-9417-e81ed6b69d2f">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjEtNC0xLTEtMTI3MTI_06b5ac50-54a1-4e1c-ad85-a8570a7e6663">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjEtNi0xLTEtMTI3MTI_57556161-07c5-4d8a-9245-adae455f7cfb">13.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjEtOC0xLTEtMTI3MTI_fc9ab289-51c1-4735-b381-d2033702f30a">9.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction, integration and acquisition costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="sgry:BusinessCombinationIntegrationRelatedCostsAndMergerCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjItMi0xLTEtMTI3MTI_b39621f0-7f9b-44ba-ad59-4ccfedff9226">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" name="sgry:BusinessCombinationIntegrationRelatedCostsAndMergerCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjItNC0xLTEtMTI3MTI_9ac9aa04-5fb9-4d0d-92dd-29cb37f1a6e4">7.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="sgry:BusinessCombinationIntegrationRelatedCostsAndMergerCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjItNi0xLTEtMTI3MTI_fd3274a8-e833-4df0-8a2e-857fd2605999">31.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="sgry:BusinessCombinationIntegrationRelatedCostsAndMergerCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjItOC0xLTEtMTI3MTI_3d43715d-0d02-492d-9535-73e71a5290c4">30.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjMtMi0xLTEtMTcyNjk_f59be8fd-567c-4157-8ac7-fedb060c15b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjMtNC0xLTEtMTcyNzU_0a958c36-0fff-4b1f-a5fe-a0717ea7cb16">33.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjMtNi0xLTEtMTcyODE_7abbfcfa-3230-4554-87b2-07a7c448085d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjMtOC0xLTEtMTcyODc_c53a3a69-570a-469d-9e04-ff2295fb3877">33.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on disposals and deconsolidations, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" sign="-" name="sgry:GainLossOnDispositionOfAssetsAndDeconsolidation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjMtMi0xLTEtMTI3MTI_278cf1ef-435a-4ed1-8a0a-d8c7a12f5fc5">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" sign="-" name="sgry:GainLossOnDispositionOfAssetsAndDeconsolidation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjMtNC0xLTEtMTI3MTI_65ed2414-fd0d-48a4-89d0-06d900dc3cbc">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" sign="-" name="sgry:GainLossOnDispositionOfAssetsAndDeconsolidation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjMtNi0xLTEtMTI3MTI_091abf0b-56fd-41b7-b6e7-d9123a33b532">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" sign="-" name="sgry:GainLossOnDispositionOfAssetsAndDeconsolidation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjMtOC0xLTEtMTI3MTI_278ef910-6c6b-4574-b888-bc0f283b6571">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Litigation settlement and other litigation costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" sign="-" name="sgry:GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjQtMi0xLTEtMTI3MTI_0bcf86a1-74df-48e9-b4d0-fca6b25ec353">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" sign="-" name="sgry:GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjQtNC0xLTEtMTI3MTI_d24920f7-5f99-4485-9411-2220cc7cc523">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" sign="-" name="sgry:GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjQtNi0xLTEtMTI3MTI_c8c7d125-5b32-4cb1-9e36-6e4602026712">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" sign="-" name="sgry:GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjQtOC0xLTEtMTI3MTI_3390ab97-5b67-4f7f-acc8-0117f9346b5a">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Gain) loss on debt extinguishment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjUtMi0xLTEtMTI3MTI_00316ded-3d7d-490e-bbda-c554b72be746">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjUtNC0xLTEtMTI3MTI_116fc734-8b77-4abe-9796-5098434d7d9e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjUtNi0xLTEtMTI3MTI_d0c02bd0-481b-42db-a00f-76d474a90b0e">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjUtOC0xLTEtMTI3MTI_582d3c86-94db-4396-93a2-e4f9d324860d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on escrow release </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" format="ixt:fixed-zero" name="sgry:BusinessCombinationGainLossOnAcquisitionEscrow" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjYtMi0xLTEtMTI3MTI_3c97355a-2403-4db8-a96a-b8afe33b720b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" format="ixt:fixed-zero" name="sgry:BusinessCombinationGainLossOnAcquisitionEscrow" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjYtNC0xLTEtMTI3MTI_cb6f576b-0e3a-42e4-be42-488c610ed16d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" format="ixt:fixed-zero" name="sgry:BusinessCombinationGainLossOnAcquisitionEscrow" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjYtNi0xLTEtMTI3MTI_cd8bc50a-9960-40d5-8cef-5bad46c43f24">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="sgry:BusinessCombinationGainLossOnAcquisitionEscrow" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjYtOC0xLTEtMTI3MTI_43d2ed96-da49-4c19-9e2c-e4fae2c587df">0.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hurricane-related operating losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="us-gaap:UnusualOrInfrequentItemNetGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjgtMi0xLTEtMTg4Mjg_84840592-4c87-4963-820e-0364e6b5d73f">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:UnusualOrInfrequentItemNetGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjgtNC0xLTEtMTg4Mjg_3dedddae-567c-4670-b2ec-b5e26ff6929e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:UnusualOrInfrequentItemNetGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjgtNi0xLTEtMTg4Mjg_4f96a77f-8794-44a4-a05d-e56812efd77c">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:UnusualOrInfrequentItemNetGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjgtOC0xLTEtMTg4Mjg_5d9ded59-a12b-48a4-b7ba-c242ddab4023">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjctMi0xLTEtMTI3MTI_712cf07e-c097-4011-b32d-49415e62e162">76.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjctNC0xLTEtMTI3MTI_7e8673e8-e0db-42ce-8b15-59e9fe2ca8d0">61.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjctNi0xLTEtMTI3MTI_eaaf9578-2bd2-400a-bf2c-f71b9402985f">225.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjctOC0xLTEtMTI3MTI_0f6efa1b-518d-448f-bff1-115c539d42c9">165.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i38af9d27b9f048c5917f66f432533aa9"><ix:continuation id="i82c4f5d986d245f089592a4699bf5679"><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">This amount includes transaction and integration costs of $<ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfOTc1_2dedcc8e-3230-47fd-92ee-91ee0217a559">10.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfOTgy_88f94287-37f0-4cc5-a412-d07c381b19c8">5.4</ix:nonFraction> million for the three months ended September&#160;30, 2021 and 2020, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $<ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfMTEyNw_9c482296-0cc9-4524-a0ef-a70f27878fc1">2.1</ix:nonFraction> million for the three months ended September 30, 2020. </span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">This amount includes transaction and integration costs of $<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfMTIzOA_3ba2086c-3ad8-4b6a-9976-f802c72183b4">24.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfMTI0NQ_78acc6f2-b711-44bc-b83c-6208c1a493fe">15.8</ix:nonFraction> million for the nine months ended September&#160;30, 2021 and 2020, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfMTM4Mw_9f7ee5e5-60dc-4af0-bae3-6d34ae3671cd">6.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfMTM5MA_f4f8dad6-2909-4e1e-8ece-1b61bf0c5e6c">14.4</ix:nonFraction> million for the nine months ended September&#160;30, 2021 and 2020, respectively. </span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">This amount includes other litigation costs of $<ix:nonFraction unitRef="usd" contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfMTQ5MA_2624d6b7-e156-47c0-8785-00bd0be321c4">2.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfMTQ5Nw_77e3dfe4-558e-4c9b-98c0-d68244ff2366">1.1</ix:nonFraction> million for the three months ended September&#160;30, 2021 and 2020, respectively. </span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">This amount includes other litigation costs of $<ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfMTU5Nw_572e738d-2d41-4cf0-b244-8c6066d14ba7">4.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfMTYwNA_24a4eb60-6317-4dae-88e2-e17cafc47bc8">3.7</ix:nonFraction> million for the nine months ended September&#160;30, 2021 and 2020, respectively. This amount further includes litigation settlement costs of $<ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfMTcwOA_95e5f95f-047e-498d-896a-0deba9f930df">1.2</ix:nonFraction> million for the nine months ended September&#160;30, 2020, with <ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfNDk0NzgwMjMyNjk0Ng_cd32b844-f16e-4255-93ea-6e216cfd4fc9">no</ix:nonFraction> comparable costs for the nine months ended September&#160;30, 2021.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Included in other income in the condensed consolidated statement of operations for the nine months ended September&#160;30, 2020.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Reflects losses incurred in the month of September 2021 at a surgical facility that was closed following Hurricane Ida.</span></div></ix:continuation><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfMTkxMw_6431b71c-5c28-4c24-89ae-7e47e484aeca" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.953%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Surgical Facility Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07b5831fa25c4593977edb314caf0810_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjE0MzU4MjAwOGUyZTQyNWQ4OWU2MDMxZGFhNDMwNzA5L3RhYmxlcmFuZ2U6MTQzNTgyMDA4ZTJlNDI1ZDg5ZTYwMzFkYWE0MzA3MDlfMi0yLTEtMS0xMjcxMg_4c36664b-60b2-4cf6-8789-5295511ea090">5,124.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f0d8a6647ac43d3acecd87aa3917e60_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjE0MzU4MjAwOGUyZTQyNWQ4OWU2MDMxZGFhNDMwNzA5L3RhYmxlcmFuZ2U6MTQzNTgyMDA4ZTJlNDI1ZDg5ZTYwMzFkYWE0MzA3MDlfMi00LTEtMS0xMjcxMg_164eecfc-c6bf-47b7-973f-0b7660816554">4,962.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ancillary Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cebdc44291f4ef09e8f91e82d5fb5b1_I20210930" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjE0MzU4MjAwOGUyZTQyNWQ4OWU2MDMxZGFhNDMwNzA5L3RhYmxlcmFuZ2U6MTQzNTgyMDA4ZTJlNDI1ZDg5ZTYwMzFkYWE0MzA3MDlfMy0yLTEtMS0xMjcxMg_c7c537da-f8e4-47f5-b1c4-a378be9d5b38">32.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98faa269bef74b28b6fbd87fbc70f99e_I20201231" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjE0MzU4MjAwOGUyZTQyNWQ4OWU2MDMxZGFhNDMwNzA5L3RhYmxlcmFuZ2U6MTQzNTgyMDA4ZTJlNDI1ZDg5ZTYwMzFkYWE0MzA3MDlfMy00LTEtMS0xMjcxMg_e1f83db6-391c-473e-afa6-57dfd3ea797c">35.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if61366db2c44498391f1d66e8a6f3a10_I20210930" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjE0MzU4MjAwOGUyZTQyNWQ4OWU2MDMxZGFhNDMwNzA5L3RhYmxlcmFuZ2U6MTQzNTgyMDA4ZTJlNDI1ZDg5ZTYwMzFkYWE0MzA3MDlfNC0yLTEtMS0xMjcxMg_3be6260c-0725-43c4-9cc9-0ca41b04d0af">474.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic360167dd83a4d318b00e5cd3eb72bd0_I20201231" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjE0MzU4MjAwOGUyZTQyNWQ4OWU2MDMxZGFhNDMwNzA5L3RhYmxlcmFuZ2U6MTQzNTgyMDA4ZTJlNDI1ZDg5ZTYwMzFkYWE0MzA3MDlfNC00LTEtMS0xMjcxMg_2dcb9225-ea1b-484f-998b-9c659a68e7f8">415.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjE0MzU4MjAwOGUyZTQyNWQ4OWU2MDMxZGFhNDMwNzA5L3RhYmxlcmFuZ2U6MTQzNTgyMDA4ZTJlNDI1ZDg5ZTYwMzFkYWE0MzA3MDlfNS0yLTEtMS0xMjcxMg_d5ab3200-a6a8-4e28-907c-756fd54f014e">5,631.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjE0MzU4MjAwOGUyZTQyNWQ4OWU2MDMxZGFhNDMwNzA5L3RhYmxlcmFuZ2U6MTQzNTgyMDA4ZTJlNDI1ZDg5ZTYwMzFkYWE0MzA3MDlfNS00LTEtMS0xMjcxMg_a45b8d92-6e2d-4baf-8cb1-fc33b1889109">5,413.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfMTkyMw_e13098a1-816e-4124-87bb-16264fc9ba51" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.953%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash purchases of property and equipment:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Surgical Facility Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02f0df4797ab4a1e9bacd76ffdc57ab6_D20210101-20210930" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjJhNjgzMDlmNDFkNDQwNWQ5MGRhNzQ2ZWU4ODdmYWUzL3RhYmxlcmFuZ2U6MmE2ODMwOWY0MWQ0NDA1ZDkwZGE3NDZlZTg4N2ZhZTNfMy0yLTEtMS0xMjcxMg_becf9c35-2e31-400c-9667-52ff2b4b509f">42.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbed4bef98e44fea406cc92949cdb3d_D20200101-20200930" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjJhNjgzMDlmNDFkNDQwNWQ5MGRhNzQ2ZWU4ODdmYWUzL3RhYmxlcmFuZ2U6MmE2ODMwOWY0MWQ0NDA1ZDkwZGE3NDZlZTg4N2ZhZTNfMy00LTEtMS0xMjcxMg_d82ca97d-2ef6-43c8-aeb4-592f84081f76">24.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ancillary Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic567b93a1ce84e17ad9837f0055b163b_D20210101-20210930" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjJhNjgzMDlmNDFkNDQwNWQ5MGRhNzQ2ZWU4ODdmYWUzL3RhYmxlcmFuZ2U6MmE2ODMwOWY0MWQ0NDA1ZDkwZGE3NDZlZTg4N2ZhZTNfNC0yLTEtMS0xMjcxMg_45452b23-5aea-43f0-93ab-6ac2e4103487">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb2d426435c8450cafd7728d9d2dc8f3_D20200101-20200930" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjJhNjgzMDlmNDFkNDQwNWQ5MGRhNzQ2ZWU4ODdmYWUzL3RhYmxlcmFuZ2U6MmE2ODMwOWY0MWQ0NDA1ZDkwZGE3NDZlZTg4N2ZhZTNfNC00LTEtMS0xMjcxMg_93881e6c-24f0-4a75-b7ed-b4ceb3da4eb2">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cd422f84ed747328d3a0d61c7f136fa_D20210101-20210930" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjJhNjgzMDlmNDFkNDQwNWQ5MGRhNzQ2ZWU4ODdmYWUzL3RhYmxlcmFuZ2U6MmE2ODMwOWY0MWQ0NDA1ZDkwZGE3NDZlZTg4N2ZhZTNfNi0yLTEtMS0xMjcxMg_2ac45b66-9338-4adf-a087-d8b9ee125abc">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69c8d97578e54edc825c05346d77f05a_D20200101-20200930" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjJhNjgzMDlmNDFkNDQwNWQ5MGRhNzQ2ZWU4ODdmYWUzL3RhYmxlcmFuZ2U6MmE2ODMwOWY0MWQ0NDA1ZDkwZGE3NDZlZTg4N2ZhZTNfNi00LTEtMS0xMjcxMg_d92519f6-38f6-4cda-a52f-b8cca22496c4">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cash purchases of property and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjJhNjgzMDlmNDFkNDQwNWQ5MGRhNzQ2ZWU4ODdmYWUzL3RhYmxlcmFuZ2U6MmE2ODMwOWY0MWQ0NDA1ZDkwZGE3NDZlZTg4N2ZhZTNfNy0yLTEtMS0xMjcxMg_032f7460-5ec7-4414-b289-c5ab8458cb73">43.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjJhNjgzMDlmNDFkNDQwNWQ5MGRhNzQ2ZWU4ODdmYWUzL3RhYmxlcmFuZ2U6MmE2ODMwOWY0MWQ0NDA1ZDkwZGE3NDZlZTg4N2ZhZTNfNy00LTEtMS0xMjcxMg_5c0c5c79-4202-4f04-af9d-d2d6672627c7">27.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div id="idcac93ae85504379b4049f3f4d6efdb8_61"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">11.  <ix:nonNumeric contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF82MS9mcmFnOmI4ODcxNGM1ZDlmYTQyNGY4MzQ5NjZjMjhiMDVlYzk0L3RleHRyZWdpb246Yjg4NzE0YzVkOWZhNDI0ZjgzNDk2NmMyOGIwNWVjOTRfMzg2_1954f42f-3a15-4037-97e4-d47d684331d2" continuedAt="ice3b0f38b3d74790a6433547ad564ea6" escape="true">Subsequent Events</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="ice3b0f38b3d74790a6433547ad564ea6">In October 2021, the Company completed the acquisition of additional interest in one of its consolidated Surgical Facilities for a market-based acquisition price of $<ix:nonFraction unitRef="usd" contextRef="i0613206f307d4141bf872d310477a2cb_D20211001-20211031" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF82MS9mcmFnOmI4ODcxNGM1ZDlmYTQyNGY4MzQ5NjZjMjhiMDVlYzk0L3RleHRyZWdpb246Yjg4NzE0YzVkOWZhNDI0ZjgzNDk2NmMyOGIwNWVjOTRfMjE5OTAyMzI1NjcyNg_3d0044ed-caec-4d86-a35f-6b04ad389814">31.8</ix:nonFraction>&#160;million.</ix:continuation></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="idcac93ae85504379b4049f3f4d6efdb8_64"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 2.  Management's Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the condensed consolidated financial statements and related notes included elsewhere in this report and our 2020 Annual Report on Form 10-K. Unless the context otherwise indicates, the terms "Surgery Partners," "we," "us," "our" or the "Company," as used herein, refer to Surgery Partners, Inc. and its subsidiaries. Unless the context implies otherwise, the term &#8220;affiliates&#8221; means direct and indirect subsidiaries of Surgery Partners, Inc. and partnerships and joint ventures in which such subsidiaries are partners. The terms &#8220;facilities&#8221; or &#8220;hospitals&#8221; refer to entities owned and operated by affiliates of Surgery Partners, Inc. and the term &#8220;employees&#8221; refers to employees of affiliates of Surgery Partners, Inc.</span></div><div id="idcac93ae85504379b4049f3f4d6efdb8_67"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cautionary Note Regarding Forward-Looking Statements</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">This report contains forward-looking statements, which are based on our current expectations, estimates and assumptions about future events. All statements other than statements of current or historical fact contained in this report are forward-looking statements. These statements include, but are not limited to, statements regarding our future financial position, business strategy, budgets, effective tax rate, projected costs and plans and objectives of management for future operations. The words "projections," "believe," "continue," "drive," "estimate," "expect," "intend," "may," "plan," "will," "could," "would" and similar expressions are generally intended to identify forward-looking statements. These statements involve risks, uncertainties and other factors that may cause actual results to differ from the expectations expressed in the statements. Many of these factors are beyond our ability to control or predict. These factors include, without limitation, the continuing effects of the COVID-19 outbreak in the United States and the regions in which we operate; the impact to the state and local economies of restrictive orders, vaccine and other mandates and the pandemic generally; our ability to respond nimbly to challenging economic conditions; the unpredictability of our case volume in the current environment; our ability to preserve or raise sufficient funds to continue operations throughout this period of uncertainty; the impact of our cost-cutting measures on our future performance; our ability to cause distributions from our subsidiaries; the responsiveness of our payors, including Medicaid and Medicare, to the challenging operating conditions, including their willingness and ability to continue paying in a timely manner and to advance payments in a timely manner, if at all; the impact of COVID-19 related stimulus programs, including the CARES Act, and uncertainty in how these programs may be administered, monitored and modified in the future; our ability to execute on our operational and strategic initiatives; the timing and impact of our portfolio optimization efforts; our ability to continue to improve same-facility volume and revenue growth on the timeline anticipated, if at all; our ability to successfully integrate acquisitions; the anticipated impact and timing of our ongoing efficiency efforts; the impact of adverse weather conditions and other events outside of our control; and the risks and uncertainties set forth under the heading "Risk Factors" in our 2020 Annual Report on Form 10-K and discussed from time to time in our reports filed with the SEC.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Considering these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this report may not occur, and actual results could differ materially from those anticipated or implied in the forward-looking statements. When you consider these forward-looking statements, you should keep in mind these risk factors and other cautionary statements in this report.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">These forward-looking statements speak only as of the date made. Other than as required by law, we undertake no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events or otherwise.</span></div><div id="idcac93ae85504379b4049f3f4d6efdb8_70"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Executive Overview</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total revenues for the third quarter of 2021 increased 12.7% to&#160;$559.2 million&#160;from&#160;$496.1 million&#160;for the third quarter of 2020. Same-facility revenues for the third quarter of 2021 increased 8.3% from the same period last year, with a 2.0% increase in revenue per case and a 6.2% increase in same-facility cases. The increase in same-facility revenues is attributable to the Company's recovery from the negative impacts of the COVID-19 pandemic in the third quarter of 2020. For the third quarter of 2021, the Company&#8217;s net loss attributable to common stockholders and Adjusted EBITDA was&#160;$22.9 million and $76.4 million, respectively,&#160;compared to $71.6 million&#160;and $61.1 million for the same period last year. A reconciliation of non-GAAP financial measures appears below under "Certain Non-GAAP Metrics." The increase in Adjusted EBITDA was primarily attributable to the Company's recovery from the negative impacts of the COVID-19 pandemic in the third quarter of 2020 and acquisitions completed since the prior-year period.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We&#160;had cash and cash equivalents of&#160;$330.4 million&#160;and $163.0 million of borrowing capacity under our revolving credit facility at September&#160;30, 2021. Operating cash inflows were $14.9 million in the third quarter of 2021, a decrease of $12.0 million compared to the prior-year period. Net operating cash flows, including operating cash flows less distributions to non-controlling interests, were an outflow of&#160;$19.2 million for the third quarter of 2021, compared to an outflow of $3.7 million for the third quarter of 2020. The decrease in operating cash flows and net operating cash flows compared to the same period in 2020 is primarily due to receipts of government grants provided through the CARES Act and actions taken to significantly reduce cash operating expenses and defer non-essential expenditures during the third quarter of 2020 and the repayment of funds under the Medicare Accelerated and Advance Payment Program in 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Impact of COVID-19</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The COVID-19 global pandemic has significantly affected our facilities, employees, patients, communities, business operations and financial performance, as well as the U.S. economy and financial markets. The COVID-19 pandemic materially impacted our financial performance for the year ended December 31, 2020, and has continued to impact our financial performance during the nine months ended September&#160;30, 2021. The impact of the COVID-19 pandemic on our surgical facilities varies based on the market in which the facility operates, the type of surgical facility and the procedures typically performed. Although we cannot provide any certainty regarding the </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">length and severity of the impact of the COVID-19 pandemic, which is difficult to predict and is dependent on factors beyond our control, we continue to see improvement in surgical case volumes as states re-open and allow for non-emergent procedures. We cannot predict if or when utilization may return to pre-pandemic levels.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is monitoring legislative actions at federal and state levels, including the impact of the CARES Act and other governmental assistance that might be available.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Executive Order</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 9, 2021, President Biden issued an executive order that is intended to promote competition in the American economy. Among other things, the executive order encourages the Federal Trade Commission (&#8220;FTC&#8221;) to ban or limit non-compete agreements, encourages the DOJ and the FTC to review and revise their merger guidelines to ensure that patients are not harmed by healthcare mergers, and instructs HHS to support existing price transparency rules and implement the legislation that was recently adopted to address surprise billing. We cannot predict how, if at all, the various initiatives set forth in the executive order will be implemented by the regulatory agencies involved or the impact that the executive order will have on operations.</span></div><div id="idcac93ae85504379b4049f3f4d6efdb8_76"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Revenues</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our revenues consist of patient service revenues and other service revenues. Patient service revenues consist of revenue from our surgical facility services and ancillary services segments. Specifically, patient service revenues include fees for surgical or diagnostic procedures performed at surgical facilities that we consolidate for financial reporting purposes, as well as for patient visits to our physician practices, anesthesia services, pharmacy services and diagnostic screens ordered by our physicians. Other service revenues include management and administrative service fees derived from our non-consolidated facilities that we account for under the equity method, management of surgical facilities and physician practices in which we do not own an interest and management services we provide to physician practices for which we are not required to provide capital or additional assets. For the three and nine months ended September&#160;30, 2020, other service revenues also includes optical service revenues, which consisted of handling charges billed to the members of our optical products purchasing organization, which was sold on December 31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes our revenues by service type as a percentage of total revenues for the periods indicated: </span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.253%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Surgical facilities revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ancillary services revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total patient service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other service revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Payor Mix</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth by type of payor the percentage of our patient service revenues generated at the surgical facilities which we consolidate for financial reporting purposes in the periods indicated: </span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.253%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Private insurance payors</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government payors</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Self-pay payors</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other payors </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:1pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Other is comprised of anesthesia service agreements, automobile liability, letters of protection and other payor types. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Surgical Case Mix</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We primarily operate multi-specialty surgical facilities where physicians perform a variety of procedures in various specialties. We believe this diversification helps to protect us from adverse pricing and utilization trends in any individual procedure type and results in greater consistency in our case volume. </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth the percentage of cases in each specialty performed at the surgical facilities which we consolidate for financial reporting purposes for the periods indicated:</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.253%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Orthopedic and pain management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ophthalmology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General surgery</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div id="idcac93ae85504379b4049f3f4d6efdb8_79"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Critical Accounting Policies </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of significant accounting policies is disclosed in our 2020 Annual Report on Form 10-K under the caption &#8220;Critical Accounting Policies&#8221; in the Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations section. There have been no material changes in the nature of our critical accounting policies or the application of those policies since December 31, 2020.</span></div><div id="idcac93ae85504379b4049f3f4d6efdb8_82"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Three Months Ended September&#160;30, 2021 Compared to Three Months Ended September&#160;30, 2020 </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes certain results from the statements of operations for the three months ended September&#160;30, 2021 and 2020 (dollars in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">559.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">496.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">436.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">381.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from equity investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on disposals and deconsolidations, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Grant funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on debt extinguishment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">495.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">477.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(54.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(51.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) before income taxes </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less:  Net income attributable to non-controlling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss attributable to Surgery Partners, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(61.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Overview.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the three months ended September&#160;30, 2021, our revenues increased 12.7% to $559.2 million compared to $496.1 million for the three months ended September&#160;30, 2020. We incurred a net loss attributable to Surgery Partners, Inc. of $22.9 million for the 2021 period, compared to $61.6 million for the 2020 period. The increase in revenues was primarily attributable to increases in surgical case volumes and case mix recovery as the Company continues to recover from the COVID-19 pandemic that began in the first quarter of 2020 and acquisitions completed since the prior-year period.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Revenues.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenues for the three months ended September&#160;30, 2021 compared to the three months ended September&#160;30, 2020 were as follows (dollars in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.411%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient service revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">551.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">489.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other service revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">559.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">496.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Patient service revenues increased 12.6% to $551.4 million for the three months ended September&#160;30, 2021 compared to $489.8 million for the three months ended September&#160;30, 2020. The increase of 12.6% was driven by a 6.2% increase in same-facility case volume and a 2.0% increase in same-facility revenue per case, primarily resulting from case count and case mix recovery from the impacts of the COVID-19 pandemic that we began experiencing in the first quarter of 2020 and acquisitions completed since the prior-year period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Cost of Revenues.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cost of revenues were $436.7 million for the three months ended September&#160;30, 2021 compared to $381.9 million for the three months ended September&#160;30, 2020. The increase was primarily driven by case count and case mix recovery from the impacts of the COVID-19 pandemic that the Company began experiencing in the first quarter of 2020. As a percentage of revenues, cost of revenues increased to 78.1% for the 2021 period compared to 77.0% for the 2020 period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  General and administrative expenses were $25.5 million for the three months ended September&#160;30, 2021 compared to $25.2 million for the three months ended September&#160;30, 2020. As a percentage of revenues, general and administrative expenses decreased to 4.6% for the 2021 period compared to 5.1% for the 2020 period. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Depreciation and Amortization.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Depreciation and amortization was $25.2 million and $24.1 million for the three months ended September&#160;30, 2021 and 2020, respectively. As a percentage of revenues, depreciation and amortization expenses was 4.5% for the 2021 period compared to 4.9% for the 2020 period. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Transaction and Integration Costs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  We incurred $10.2 million of transaction and integration costs for the three months ended September&#160;30, 2021 compared to $5.4 million for the three months ended September&#160;30, 2020. The increase primarily relates to costs for ongoing development initiatives and the integration of acquisitions we completed in 2021 and 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Impairment Charges.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  For the three months ended September&#160;30, 2020, we recorded non-cash impairment charges of $28.6 million and $4.9 million for the Ancillary Services and Alliance reporting units, respectively. The impairment charges were the result of a September 30, 2020 valuation which determined the carrying value for both the Ancillary Services and Alliance reporting units exceeded the fair value. There were no impairment charges in the 2021 period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Grant Funds.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Grant funds were $9.9&#160;million for the three months ended September&#160;30, 2020, representing recognition of government grants provided through the CARES Act in the 2020 period. For further discussion on grant fund recognition, see Note 1. "Organization and Summary of Accounting Polices - COVID-19 Pandemic" to our condensed consolidated financial statements included elsewhere in this report.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense, Net.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  Interest expense, net, increased to $54.2 million for the three months ended September&#160;30, 2021 compared to $51.5 million for the three months ended September&#160;30, 2020. The increase primarily relates to the 2020 Incremental Term Loans, which were fully drawn on April 22, 2020 and the issuance of additional 2027 Unsecured Notes in the amount of $115.0 million effective July 30, 2020. As a percentage of revenues, interest expense, net was 9.7% for the 2021 period compared to 10.4% for the 2020 period. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Income Tax Expense.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160; The income tax expense was $1.2 million and $1.3 million for the three months ended September&#160;30, 2021 and 2020, respectively. The effective tax rate was 12.8% for the three months ended September&#160;30, 2021 compared to (3.9)% for the three months ended September&#160;30, 2020. For the three months ended September&#160;30, 2021, the effective tax rate differed from 21% primarily due to the reversal of the Company's earnings attributable to minority interest. For the three months ended September&#160;30, 2020, the effective tax rate differed from 21% primarily due to the discrete tax expense attributable to the impairment of goodwill. Based upon the application of interim accounting guidance, the tax rate as a percentage of net income after income attributable to non-controlling interests will vary based upon the relative net income from period to period.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Net Income Attributable to Non-Controlling Interests. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Net income attributable to non-controlling interests was $31.1 million for the three months ended September&#160;30, 2021 compared to $27.3 million for the three months ended September&#160;30, 2020. As a percentage of revenues, net income attributable to non-controlling interests was 5.6% for the 2021 period and 5.5% for the 2020 period.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Nine Months Ended September&#160;30, 2021 Compared to Nine Months Ended September&#160;30, 2020 </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes certain results from the statements of operations for the nine months ended September&#160;30, 2021 and 2020 (dollars in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,614.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,311.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,270.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,067.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from equity investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on disposals and deconsolidations, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Grant funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on debt extinguishment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Litigation settlement</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,427.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,225.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(160.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(147.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) before income taxes </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(61.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(46.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less:  Net income attributable to non-controlling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(98.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(75.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss attributable to Surgery Partners, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(121.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Overview.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021, our revenues increased 23.1% to $1,614.9 million compared to $1,311.8 million for the nine months ended September&#160;30, 2020. We incurred a net loss attributable to Surgery Partners, Inc. of $70.8 million for the 2021 period, compared to $121.6 million for the 2020 period. The increase in revenues was primarily attributable to increases in surgical case volumes as the Company continues to recover from the COVID-19 pandemic that began in the first quarter of 2020 and acquisitions completed since the prior-year period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Revenues.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenues for the nine months ended September&#160;30, 2021 compared to the nine months ended September&#160;30, 2020 were as follows (dollars in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.411%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient service revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,593.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,293.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other service revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,614.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,311.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Patient service revenues increased 23.2% to $1,593.0 million for the nine months ended September&#160;30, 2021 compared to $1,293.5 million for the nine months ended September&#160;30, 2020. The increase of 23.2% was driven by a 22.4% increase in same-facility case volume partially offset by a 1.1% decrease in same-facility revenue per case. The increase was primarily driven by case count recovery from the impacts of the COVID-19 pandemic that the Company began experiencing in the first quarter of 2020 and acquisitions completed since the prior-year period. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Cost of Revenues.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cost of revenues were $1,270.6 million for the nine months ended September&#160;30, 2021 compared to $1,067.4 million for the nine months ended September&#160;30, 2020. The increase was primarily driven by case count and recovery from the impacts of the COVID-19 pandemic that the Company began experiencing in the first quarter of 2020 and acquisitions completed since the prior-year period. As a percentage of revenues, cost of revenues decreased to 78.7% for the 2021 period compared to 81.4% for the 2020 period, as lower acuity procedures with lower cost of sales returned from COVID-19 related lows experienced in the 2020 period.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  General and administrative expenses were $76.8 million for the nine months ended September&#160;30, 2021 compared to $73.3 million for the nine months ended September&#160;30, 2020. As a percentage of revenues, general and administrative expenses decreased to 4.8% for the 2021 period compared to 5.6% for the 2020 period. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Depreciation and Amortization.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Depreciation and amortization was $76.1 million and $69.3 million for the nine months ended September&#160;30, 2021 and 2020, respectively. The increase is primarily due to acquisitions completed in 2021 and 2020. As a percentage of revenues, depreciation and amortization expenses was 4.7% for the 2021 period compared to 5.3% for the 2020 period. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Loss on Disposals and Deconsolidations, Net.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  The net loss on disposals and deconsolidations was $2.0 million for the 2021 period, related to disposals of other long-lived assets. The net loss on disposals and deconsolidations was $7.1 million for the 2020 period, including a $5.1 million gain on the sale of certain assets related to our anesthesia business, offset by a $6.6 million loss on the sale of interests in surgical facilities and the closure of a diagnostic laboratory and $5.6 million primarily related to disposals of other long-lived assets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Transaction and Integration Costs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  We incurred $24.7 million of transaction and integration costs for the nine months ended September&#160;30, 2021 compared to $15.8 million for the nine months ended September&#160;30, 2020. The increase primarily relates to costs for ongoing development initiatives and the integration of acquisitions we completed in 2021 and 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Grant Funds.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021, the Company received approximately $8&#160;million of additional grants from HHS. Based on guidance from HHS and other authorities, the Company updated its estimate of the amount of grant funds received that qualify for recognition, resulting in the recognition of $20.0 million during the nine months ended September&#160;30, 2021. Grant funds were $33.2&#160;million for the nine months ended September&#160;30, 2020. For further discussion, see Note 1. "Organization and Summary of Accounting Polices - COVID-19 Pandemic" to our condensed consolidated financial statements included elsewhere in this report.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Loss on Debt Extinguishment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  The net loss on debt extinguishment was $9.1 million for the 2021 period. See Note 3. "Long-Term Debt" to our condensed financial statements included elsewhere in this report.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense, Net.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  Interest expense, net, increased to $160.9 million for the nine months ended September&#160;30, 2021 compared to $147.8 million for the nine months ended September&#160;30, 2020. The increase primarily relates to the 2020 Incremental Term Loans, which were fully drawn on April 22, 2020 and the issuance of additional 2027 Unsecured Notes in the amount of $115.0 million effective July 30, 2020. As a percentage of revenues, interest expense, net was 10.0% for the 2021 period compared to 11.3% for the 2020 period. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Income Tax Benefit.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160; The income tax benefit was $1.3 million for the nine months ended September&#160;30, 2021 compared to $14.5 million for the 2020 period. The effective tax rate was (4.9)% for the nine months ended September&#160;30, 2021 compared to 23.7% for the nine months ended September&#160;30, 2020. For the nine months ended September&#160;30, 2021, the effective tax rate differed from 21% primarily due to discrete tax benefits of (a) $4.4&#160;million related to the vesting of restricted stock awards, and (b) $3.0&#160;million related to entity divestitures. For the nine months ended September 30, 2020, the effective tax rate differed from 21% primarily due to (a) discrete tax benefits of $6.9 million attributable to the release of federal and state valuation allowances on the Company&#8217;s Internal Revenue Code Section 163(j) interest carryforwards as a result of the increase in deductible interest expense allowed under the CARES Act, and $5.0&#160;million attributable to a portion of the payments under the Settlement Agreement, as defined in Note 9. "Commitments and Contingencies," being classified as &#8220;restitution&#8221; for income tax purposes, and (b) a discrete tax expense of $5.0&#160;million attributable to the impairment of goodwill. Based upon the application of interim accounting guidance, the tax rate as a percentage of net income after income attributable to non-controlling interests will vary based upon the relative net income from period to period.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Net Income Attributable to Non-Controlling Interests. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Net income attributable to non-controlling interests was $98.6 million for the nine months ended September&#160;30, 2021 compared to $75.0 million for the nine months ended September&#160;30, 2020. As a percentage of revenues, net income attributable to non-controlling interests was 6.1% for the 2021 period and 5.7% for the 2020 period.</span></div><div id="idcac93ae85504379b4049f3f4d6efdb8_85"></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The primary source of our operating cash flow is the collection of accounts receivable from federal and state agencies (under the Medicare and Medicaid programs), private insurance companies and individuals. During the nine months ended September&#160;30, 2021, our cash flow provided by operating activities was $67.4 million compared to $238.0 million in the nine months ended September&#160;30, 2020. The decrease is primarily due to the final DOJ settlement payment in second quarter of 2021, receipts of government grants and Medicare advance payments provided through the CARES Act, as well as actions taken to significantly reduce cash operating expenses and defer non-essential expenditures, during the 2020 period and the repayment of Medicare advance payments in the 2021 period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net cash used in investing activities during the nine months ended September&#160;30, 2021, was $141.7 million, which included $43.5 million related to purchases of property and equipment. We paid $101.0 million in cash for acquisitions (net of cash acquired), which included four surgical facilities in a new markets and two surgical facilities in existing markets that were merged into existing facilities. Additionally, we received cash proceeds of $2.5 million related to the disposal of certain long-lived assets.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Net cash provided by investing activities during the nine months ended September 30, 2020, was $6.8 million, which included $27.8 million related to purchases of property and equipment. We paid $14.2 million in cash for acquisitions (net of cash acquired), which included a surgical facility in a new market and four surgical facilities in existing markets that were merged into existing facilities. </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Additionally, we received cash proceeds of $48.3 million related to the sale of certain assets related to our anesthesia business and the sale of interests in two surgery centers, one of which was previously accounted for as an equity method investment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net cash provided by financing activities during the nine months ended September&#160;30, 2021 was $86.5 million. During this period, we received net proceeds of $248.2 million from an equity offering. We made distributions to non-controlling interest holders of $97.5 million and received proceeds related to ownership transactions with consolidated affiliates of $2.4 million. We made repayments on our long-term debt of $328.4 million and paid debt issuance costs of $11.7 million, which were partially offset by borrowings of $293.0 million (see Note 3. "Long-Term Debt"). We also paid a cash dividend of $5.1 million related to the Series A Preferred Stock. On May 17, 2021, we issued 22.609&#160;million shares of our common stock, $0.01 par value per share to Bain Capital, as a result of the conversion of all outstanding shares of our Series A Preferred Stock at a conversion price of $19.00 per share. As a result of such conversion, we currently have no shares of Series A Preferred Stock issued or outstanding.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net cash provided by financing activities during the nine months ended September 30, 2020 was $112.5 million. During this period, we made distributions to non-controlling interest holders of $82.3 million and payments related to ownership transactions with consolidated affiliates of $27.3 million. Additionally, we made repayments on our long-term debt of $197.3 million, which was offset by borrowings of $428.0 million. In connection with the 2020 Incremental Term Loans, which were fully drawn on April 22, 2020, and the issuance of additional 2027 Unsecured Notes in the amount of $115.0 million effective July 30, 2020, we paid debt issuance costs of $8.3 million.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Debt</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, the carrying value of our total indebtedness was $2.853 billion, which includes unamortized fair value discount of $3.1 million and unamortized deferred financing costs and issuance discount of $17.2 million.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Term Loan and Revolving Credit Facility</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, we had term loan borrowings with a carrying value of $1.535 billion, consisting of outstanding aggregate principal of $1.538 billion and unamortized fair value discount of $3.1 million.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On May 3, 2021, the Company entered into a sixth amendment to credit agreement, dated as of May 3, 2021 (the &#8220;Sixth Amendment&#8221;), which amended the credit agreement, originally dated as of August 31, 2017 (the &#8220;Credit Agreement&#8221;). The Sixth Amendment provides for, among other things, a new tranche of term loans under the Credit Agreement in an aggregate original principal amount of approximately $1.545&#160;billion (the &#8220;New Term Loans&#8221;), which New Term Loans replace or refinance in full all of the existing term loans outstanding under the Credit Agreement (as in effect immediately prior to the Sixth Amendment), all as further set forth in the Sixth Amendment. See Note 3. "Long-Term Debt" for further discussion.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On January 27, 2021, the Company entered into an amendment to the Credit Agreement with respect to the revolving credit facility (the "Revolver"), to provide for an extension of the maturity date of the Revolver to February 1, 2026 and an increase in the outstanding commitments under the Revolver in an amount equal to $50.0&#160;million. The maturity extension and the additional commitments became operative on February 1, 2021. As of September&#160;30, 2021, the Company's availability on the Revolver was $163.0 million (including outstanding letters of credit of $7.0 million).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Revolver may be utilized for working capital, capital expenditures and general corporate purposes. Subject to certain conditions and requirements set forth in the credit agreement, we may request one or more additional incremental term loan facilities or one or more increases in the commitments on the Revolver.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Revolver and the Term Loans, together the "Senior Secured Credit Facilities" bear interest at a rate per annum equal to (x) LIBOR plus a margin ranging from 3.00% to 3.25% per annum, depending on our first lien net leverage ratio or (y) an alternate base rate (which will be the highest of (i) the prime rate, (ii) 0.5% per annum above the federal funds effective rate and (iii) one-month LIBOR plus 1.00% per annum (solely with respect to the Term Loan, the alternate base rate shall not be less than 2.00% per annum)) plus a margin ranging from 2.00% to 2.25% per annum. In addition, we are required to pay a commitment fee of 0.50% per annum in respect of unused commitments on the Revolver.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Senior Unsecured Notes</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have $545.0 million aggregate principal amount of senior unsecured notes due April 15, 2027, which bear interest at the rate of 10.000% per year, payable semi-annually on April 15 and October 15 of each year.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have $370.0 million aggregate principal amount of senior unsecured notes due July 1, 2025, which bear interest at the rate of 6.750% per year, payable semi-annually on January 1 and July 1 of each year.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other Debt</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We and certain of our subsidiaries have other debt consisting of outstanding bank indebtedness of $140.5 million, which is collateralized by the real estate and equipment owned by the surgical facilities to which the loans were made, and right-of-use finance lease obligations of $279.9 million for which we are liable to various vendors for several property and equipment leases classified as finance leases.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pursuant to the CARES Act, repayment of certain advanced payments and other deferrals received as part of relief during 2020 began in 2021. We received approximately $120&#160;million of accelerated payments during the year ended December 31, 2020. During the nine months ended September 30, 2021, approximately $38&#160;million has been repaid. See Note 1. "Organization and Summary of Accounting Policies" to our condensed consolidated financial statements included elsewhere in this report, for further discussion on the repayment terms related to certain relief previously received by us. In addition to the continued repayment of the advanced payments received under the CARES Act, we anticipate additional cash outflows during the fourth quarter of 2021 from the partial repayment of payroll taxes deferred in 2020 pursuant to the CARES Act (see Note 1. "Organization and Summary of Accounting Policies" for further discussion of the amounts deferred and repayment terms) and a scheduled payment related to the tax receivable agreement (see Note 9. "Commitments and Contingencies" for further discussion of the tax receivable agreement).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Capital Resources</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to cash flows from operations, available cash and capacity on our Revolver, other sources of capital include funds we have received under the CARES Act as well as continued access to the capital markets. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As previously noted in Note 7. "Earning Per Share" to our condensed consolidated financial statements included elsewhere in this report, on February 1, 2021, we completed a public offering pursuant to which the Company sold 8,625,000 shares of common stock, resulting in net proceeds of $248.3&#160;million.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As previously noted in Note 1. "Organization and Summary of Accounting Policies" to our condensed consolidated financial statements included elsewhere in this report, for the nine months ended September 30, 2021, we received additional relief via the CARES Act, including approximately $8&#160;million in direct grant payments, which are not required to be repaid, subject to certain terms and conditions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Summary</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The COVID-19 pandemic has resulted in, and may continue to result in, significant disruptions of financial and capital markets, which could reduce our ability to access capital and negatively affect our liquidity in the future. Additionally, while we have received grants and accelerated payments under the CARES Act and other government assistance programs and may receive additional amounts in the future, there is no assurance regarding the extent to which anticipated negative impacts arising from the COVID-19 pandemic will be offset by amounts and benefits received under the CARES Act or future legislation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Although we have seen continued improvement in surgical case volumes as states continue to re-open and allow for non-emergent procedures, broad economic factors resulting from the current COVID-19 pandemic, including increased unemployment rates and reduced consumer spending, could negatively affect our payor mix, increase the relative proportion of lower margin services we provide and reduce patient volumes, as well as diminish our ability to collect outstanding receivables. Business closings and layoffs in the areas in which we operate may lead to increases in the uninsured and underinsured populations and adversely affect demand for our services, as well as the ability of payors to pay for services as rendered. Any increase in the amount or deterioration in the collectability of patient accounts receivable will adversely affect our cash flows and results of operations, requiring an increased level of working capital. If general economic conditions continue to deteriorate or remain uncertain for an extended period of time, our liquidity and ability to repay our outstanding debt may be harmed.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Based on our current level of operations, we believe cash flows from operations, available cash, available capacity on our Revolver, funds we have received under the CARES Act, funds we may receive in the future and continued access to capital markets, will be adequate to meet our short-term (i.e., 12 months) and long-term (beyond 12 months) liquidity needs.</span></div><div id="idcac93ae85504379b4049f3f4d6efdb8_88"></div><div style="margin-bottom:5pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Certain Non-GAAP Metrics</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Adjusted EBITDA and Adjusted EBITDA excluding grant funds are not measurements of financial performance under GAAP and should not be considered in isolation or as a substitute for net income, operating income or any other measure calculated in accordance with GAAP. The items excluded from these non-GAAP metrics are significant components in understanding and evaluating our financial performance. We believe such adjustments are appropriate, as the magnitude and frequency of such items can vary significantly and are not related to the assessment of normal operating performance. Our calculation of Adjusted EBITDA and Adjusted EBITDA excluding grant funds may not be comparable to similarly titled measures reported by other companies. We use Adjusted EBITDA and Adjusted EBITDA excluding grant funds as measures of financial performance. Adjusted EBITDA and Adjusted EBITDA excluding grant funds are key measures used by our management to assess operating performance, make business decisions and allocate resources.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table reconciles Adjusted EBITDA and Adjusted EBITDA excluding grant funds to income (loss) before income taxes, the most directly comparable GAAP financial measure (in millions and unaudited):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.253%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Condensed Consolidated Statements of Operations Data:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(61.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Plus (minus):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(98.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(75.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">147.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction, integration and acquisition costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on disposals and deconsolidations, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Litigation settlement and other litigation costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Gain) loss on debt extinguishment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on escrow release </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hurricane-related operating losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Impact of grant funds </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA excluding grant funds</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">211.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">This amount includes transaction and integration costs of $10.2 million and $5.4 million for the three months ended September&#160;30, 2021 and 2020, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $2.1 million for the three months ended September 30, 2020. This amount includes transaction and integration costs of $24.7 million and $15.8 million for the nine months ended September&#160;30, 2021 and 2020, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $6.3 million and $14.4 million for the nine months ended September&#160;30, 2021 and 2020, respectively. </span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">This amount includes other litigation costs of $2.5 million and $1.1 million for the three months ended September&#160;30, 2021 and 2020, respectively. This amount includes other litigation costs of $4.3 million and $3.7 million for the nine months ended September&#160;30, 2021 and 2020, respectively. This amount further includes litigation settlement costs of $1.2 million for the nine months ended September&#160;30, 2020. </span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Included in other income in the condensed consolidated statement of operations for the nine months ended September&#160;30, 2020.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Reflects losses incurred in the month of September 2021 at a surgical facility that was closed following Hurricane Ida.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Represents the impact of grant funds recognized, net of amounts attributable to non-controlling interests.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We use Credit Agreement EBITDA as a measure of liquidity and to determine our compliance under certain covenants pursuant to our credit facilities. Credit Agreement EBITDA is determined on a trailing twelve-month basis. We have included it because we believe that it provides investors with additional information about our ability to incur and service debt and make capital expenditures. Credit Agreement EBITDA is not a measurement of liquidity under GAAP and should not be considered in isolation or as a substitute for any other measure calculated in accordance with GAAP. The items excluded from Credit Agreement EBITDA are significant components in understanding and evaluating our liquidity. Our calculation of Credit Agreement EBITDA may not be comparable to similarly titled measures reported by other companies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">When we use the term &#8220;Credit Agreement EBITDA,&#8221; we are referring to Adjusted EBITDA, as defined above, further adjusted for acquisitions and synergies. These adjustments do not relate to our historical financial performance and instead relate to estimates compiled by our management and calculated in conformance with the definition of &#8220;Consolidated EBITDA&#8221; used in the credit agreements governing our credit facilities. </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table reconciles Credit Agreement EBITDA to cash flows from operating activities, the most directly comparable GAAP financial measure (in millions and unaudited):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.852%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.907%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended September 30, 2021</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Plus (minus):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(40.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from equity investments, net of distributions received</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of acquisitions and divestitures</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">173.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(141.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">214.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction, integration and acquisition costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Litigation settlement and other litigation costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hurricane-related operating losses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions and synergies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Credit Agreement EBITDA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">383.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:1pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Represents impact of acquisitions as if each acquisition had occurred on October 1, 2020. Further this includes revenue synergies from other business initiatives, de novo facilities and an adjustment for the effects of adopting the new lease accounting standard, as defined in the credit agreement governing the Senior Secured Credit Facilities.</span></div><div id="idcac93ae85504379b4049f3f4d6efdb8_91"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Please refer to Note 1. "Organization and Summary of Accounting Policies - Recent Accounting Pronouncements" to our condensed consolidated financial statements included elsewhere in this report for a discussion of the impact of the adoption of recently issued accounting standards and accounting standards not yet adopted.</span></div><div id="idcac93ae85504379b4049f3f4d6efdb8_94"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 3.  Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are subject to market risk primarily from exposure to changes in interest rates based on our financing, investing and cash management activities.&#160;We utilize a balanced mix of maturities along with both fixed rate and variable rate debt to manage our exposures to changes in interest rates.&#160;Additionally, we periodically enter into interest rate swap and cap agreements to manage our exposure to interest rate fluctuations. Our interest rate swap and cap agreements involve the exchange of fixed and variable rate interest payments between two parties, based on common notional principal amounts and maturity dates. The notional amounts of the interest rate swap and cap agreements represent balances used to calculate the exchange of cash flows and are not our assets or liabilities. Our credit risk related to these agreements is considered low because the interest rate swap and cap agreements are with creditworthy financial institutions. The interest payments under these agreements are settled on a net basis. These derivatives have been recognized in the financial statements at their respective fair values. Changes in the fair value of these derivatives, which are designated as cash flow hedges, are included in other comprehensive income.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our variable rate debt instruments are primarily indexed to the prime rate or LIBOR.&#160;Without derivatives, interest rate changes would result in gains or losses in the market value of our fixed rate debt portfolio due to differences in market interest rates and the rates at the inception of the debt agreements. Based on our indebtedness and the effectiveness of our interest rate swap and cap agreements at September&#160;30, 2021, we do not expect changes in interest rates to have a material effect on our net earnings or cash flows in 2021.</span></div><div id="idcac93ae85504379b4049f3f4d6efdb8_97"></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 4.  Controls and Procedures</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">An evaluation was performed under the supervision and with the participation of our management, including the chief executive officer and the chief financial officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities and Exchange Act of 1934, as amended) as of September&#160;30, 2021. Based on that evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were effective. </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting during the quarter ended September&#160;30, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="idcac93ae85504379b4049f3f4d6efdb8_100"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PART II - OTHER INFORMATION</span></div><div id="idcac93ae85504379b4049f3f4d6efdb8_103"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 1.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Stockholder Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.  Please refer to the disclosure in Note 9. "Commitments and Contingencies - Stockholder Litigation" to our condensed consolidated financial statements included elsewhere in this report, which is incorporated into this item by reference.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other Litigation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  In addition, we are, from time to time, subject to claims and suits, or threats of claims or suits, relating to our business, including claims for damages for personal injuries, breach of management contracts and employment related claims. In certain of these actions, plaintiffs request payment for damages, including punitive damages, which may not be covered by insurance or may otherwise have a material adverse effect on our business or results of operations.</span></div><div id="idcac93ae85504379b4049f3f4d6efdb8_106"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 1A.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Risk Factors</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There have been no material changes with respect to the risk factors discussed in our 2020 Annual Report on Form 10-K.</span></div><div id="idcac93ae85504379b4049f3f4d6efdb8_109"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 2.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company did not repurchase any shares of common stock during the three months ended September 30, 2021. At September 30, 2021, the Company continued to have authority to repurchase up to $46.0 million of shares of common stock  under its Board-authorized share repurchase program.</span></div><div id="idcac93ae85504379b4049f3f4d6efdb8_112"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 3.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Defaults Upon Senior Securities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">None.</span></div><div id="idcac93ae85504379b4049f3f4d6efdb8_115"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 4.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Mine Safety Disclosures</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="idcac93ae85504379b4049f3f4d6efdb8_118"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 5.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Other Information</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-top:5pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="idcac93ae85504379b4049f3f4d6efdb8_121"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 6.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Exhibits</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.855%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.840%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.905%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:9pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2021q3exhibit311.htm">Certification of Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2021q3exhibit312.htm">Certification of Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2021q3exhibit321.htm">Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Instance Document - the instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The cover page from the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2021, formatted in Inline XBRL (included in Exhibit 101).</span></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><div id="idcac93ae85504379b4049f3f4d6efdb8_124"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idcac93ae85504379b4049f3f4d6efdb8_7">Table of Contents</a></span></div></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-bottom:12pt;margin-top:5pt;padding-left:180pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:304.50pt"><tr><td style="width:1.0pt"></td><td style="width:22.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:277.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SURGERY PARTNERS,&#160;INC.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:45pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">/s/  Thomas F. Cowhey</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thomas F. Cowhey</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial and Accounting Officer)</span></div></td></tr></table></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Date: November&#160;3, 2021 </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>a2021q3exhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i1b6959964db9460d8e6c5edd43fe0124_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-left:18pt;text-align:right;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="padding-left:18pt;text-align:right;text-indent:-18pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div style="text-align:center"><font><br></font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">I, J. Eric Evans, certify that&#58; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1. &#160;&#160;&#160;&#160;I have reviewed this quarterly report on Form 10-Q of Surgery Partners, Inc.&#59;</font></div><div style="text-align:justify;text-indent:13.5pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2. &#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-align:justify;text-indent:13.5pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3. &#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-align:justify;text-indent:13.5pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4. &#160;&#160;&#160;&#160;The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:20.25pt"><font><br></font></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c) &#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5. &#160;&#160;&#160;&#160;The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:20.25pt"><font><br></font></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:180pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:304.50pt"><tr><td style="width:1.0pt"></td><td style="width:22.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:277.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:32pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47;  J. Eric Evans</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">J. Eric Evans</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer</font></div></td></tr></table></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Date&#58;  November&#160;3, 2021 </font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>a2021q3exhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i63691cfc4e1d4a51b5fe0045367e1eb7_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:right;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="padding-left:18pt;text-align:right;text-indent:-18pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div style="text-align:center"><font><br></font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">I, Thomas F. Cowhey, certify that&#58; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1. &#160;&#160;&#160;&#160;I have reviewed this quarterly report on Form 10-Q of Surgery Partners, Inc.&#59;</font></div><div style="text-align:justify;text-indent:13.5pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2. &#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-align:justify;text-indent:13.5pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3. &#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-align:justify;text-indent:13.5pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4. &#160;&#160;&#160;&#160;The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:20.25pt"><font><br></font></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5. &#160;&#160;&#160;&#160;The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:20.25pt"><font><br></font></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="padding-left:36pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:180pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:304.50pt"><tr><td style="width:1.0pt"></td><td style="width:22.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:277.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:32pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47;  Thomas F. Cowhey</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thomas F. Cowhey</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></div></td></tr></table></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Date&#58;  November&#160;3, 2021</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>a2021q3exhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i33de5ef228c34aac9b5a20669b2fbf0e_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350, </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In connection with the quarterly report of Surgery Partners, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the period ended September&#160;30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), each of the undersigned certifies, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The Report fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:180pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:304.50pt"><tr><td style="width:1.0pt"></td><td style="width:22.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:277.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:32pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47;  J. Eric Evans</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">J. Eric Evans</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer</font></div></td></tr></table></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Date&#58;  November&#160;3, 2021 </font></div><div style="padding-left:180pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:304.50pt"><tr><td style="width:1.0pt"></td><td style="width:22.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:277.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:32pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47;  Thomas F. Cowhey</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thomas F. Cowhey</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></div></td></tr></table></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Date&#58;  November&#160;3, 2021 </font></div><div style="margin-bottom:8pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>sgry-20210930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:4fc50bef-303f-4567-8d1f-fa45eceeed5f,g:878f1ef0-0d6b-4fb6-8cd6-b11c4615e811-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sgry="http://www.surgerypartners.com/20210930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.surgerypartners.com/20210930">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sgry-20210930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sgry-20210930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sgry-20210930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sgry-20210930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.surgerypartners.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" roleURI="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS">
        <link:definition>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofAccountingPolicies" roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPolicies">
        <link:definition>2101101 - Disclosure - Organization and Summary of Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofAccountingPoliciesPolicies" roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Organization and Summary of Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofAccountingPoliciesTables" roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesTables">
        <link:definition>2303301 - Disclosure - Organization and Summary of Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofAccountingPoliciesOrganizationDetails" roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesOrganizationDetails">
        <link:definition>2404401 - Disclosure - Organization and Summary of Accounting Policies - Organization (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofAccountingPoliciesCARESACTDetails" roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCARESACTDetails">
        <link:definition>2405402 - Disclosure - Organization and Summary of Accounting Policies - CARES ACT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails" roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails">
        <link:definition>2406403 - Disclosure - Organization and Summary of Accounting Policies - Variable Interest Entities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails" roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails">
        <link:definition>2407404 - Disclosure - Organization and Summary of Accounting Policies - Carrying Amount and Fair Value of Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails" roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails">
        <link:definition>2408405 - Disclosure - Organization and Summary of Accounting Policies - Schedule of Revenues by Service Type (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails" roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails">
        <link:definition>2409406 - Disclosure - Organization and Summary of Accounting Policies - Schedule of Revenues by Sources (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails" roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails">
        <link:definition>2410407 - Disclosure - Organization and Summary of Accounting Policies - Cash, Cash Equivalents and Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofAccountingPoliciesRollforwardofGoodwillDetails" roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesRollforwardofGoodwillDetails">
        <link:definition>2411408 - Disclosure - Organization and Summary of Accounting Policies - Rollforward of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofAccountingPoliciesScheduleofNonControllingInterestsRedeemableDetails" roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofNonControllingInterestsRedeemableDetails">
        <link:definition>2412409 - Disclosure - Organization and Summary of Accounting Policies - Schedule of Non-Controlling Interests - Redeemable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofAccountingPoliciesIncomeTaxesDetails" roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesIncomeTaxesDetails">
        <link:definition>2413410 - Disclosure - Organization and Summary of Accounting Policies - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Acquisitions" roleURI="http://www.surgerypartners.com/role/Acquisitions">
        <link:definition>2114102 - Disclosure - Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsTables" roleURI="http://www.surgerypartners.com/role/AcquisitionsTables">
        <link:definition>2315302 - Disclosure - Acquisitions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsNarrativeDetails" roleURI="http://www.surgerypartners.com/role/AcquisitionsNarrativeDetails">
        <link:definition>2416411 - Disclosure - Acquisitions - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsSummaryDetails" roleURI="http://www.surgerypartners.com/role/AcquisitionsSummaryDetails">
        <link:definition>2417412 - Disclosure - Acquisitions - Summary (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebt" roleURI="http://www.surgerypartners.com/role/LongTermDebt">
        <link:definition>2118103 - Disclosure - Long-Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTables" roleURI="http://www.surgerypartners.com/role/LongTermDebtTables">
        <link:definition>2319303 - Disclosure - Long-Term Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtSummaryDetails" roleURI="http://www.surgerypartners.com/role/LongTermDebtSummaryDetails">
        <link:definition>2420413 - Disclosure - Long-Term Debt - Summary (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtSummaryDetails_1" roleURI="http://www.surgerypartners.com/role/LongTermDebtSummaryDetails_1">
        <link:definition>2420413 - Disclosure - Long-Term Debt - Summary (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtNarrativeDetails" roleURI="http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails">
        <link:definition>2421414 - Disclosure - Long-Term Debt - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.surgerypartners.com/role/Leases">
        <link:definition>2122104 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.surgerypartners.com/role/LeasesTables">
        <link:definition>2323304 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseExpenseandCashFlowInformationDetails" roleURI="http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails">
        <link:definition>2424415 - Disclosure - Leases - Lease Expense and Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemablePreferredStock" roleURI="http://www.surgerypartners.com/role/RedeemablePreferredStock">
        <link:definition>2125105 - Disclosure - Redeemable Preferred Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemablePreferredStockTables" roleURI="http://www.surgerypartners.com/role/RedeemablePreferredStockTables">
        <link:definition>2326305 - Disclosure - Redeemable Preferred Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemablePreferredStockNarrativeDetails" roleURI="http://www.surgerypartners.com/role/RedeemablePreferredStockNarrativeDetails">
        <link:definition>2427416 - Disclosure - Redeemable Preferred Stock - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemablePreferredStockSummaryDetails" roleURI="http://www.surgerypartners.com/role/RedeemablePreferredStockSummaryDetails">
        <link:definition>2428417 - Disclosure - Redeemable Preferred Stock - Summary (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandHedgingActivities" roleURI="http://www.surgerypartners.com/role/DerivativesandHedgingActivities">
        <link:definition>2129106 - Disclosure - Derivatives and Hedging Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandHedgingActivitiesTables" roleURI="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesTables">
        <link:definition>2330306 - Disclosure - Derivatives and Hedging Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandHedgingActivitiesNarrativeDetails" roleURI="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails">
        <link:definition>2431418 - Disclosure - Derivatives and Hedging Activities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails" roleURI="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails">
        <link:definition>2432419 - Disclosure - Derivatives and Hedging Activities - Interest Rate Swaps and Interest Rate Caps Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandHedgingActivitiesDerivativesandtheirlocationonthecondensedconsolidatedbalancesheetsDetails" roleURI="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesandtheirlocationonthecondensedconsolidatedbalancesheetsDetails">
        <link:definition>2433420 - Disclosure - Derivatives and Hedging Activities - Derivatives and their location on the condensed consolidated balance sheets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails" roleURI="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails">
        <link:definition>2434421 - Disclosure - Derivatives and Hedging Activities - Pre-tax Effect of Derivatives on AOCI and Statement of Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.surgerypartners.com/role/EarningsPerShare">
        <link:definition>2135107 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.surgerypartners.com/role/EarningsPerShareTables">
        <link:definition>2336307 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareSummaryDetails" roleURI="http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails">
        <link:definition>2437422 - Disclosure - Earnings Per Share - Summary (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareNarrativeDetails" roleURI="http://www.surgerypartners.com/role/EarningsPerShareNarrativeDetails">
        <link:definition>2438423 - Disclosure - Earnings Per Share - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherCurrentLiabilities" roleURI="http://www.surgerypartners.com/role/OtherCurrentLiabilities">
        <link:definition>2139108 - Disclosure - Other Current Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherCurrentLiabilitiesTables" roleURI="http://www.surgerypartners.com/role/OtherCurrentLiabilitiesTables">
        <link:definition>2340308 - Disclosure - Other Current Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherCurrentLiabilitiesSummaryDetails" roleURI="http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails">
        <link:definition>2441424 - Disclosure - Other Current Liabilities - Summary (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.surgerypartners.com/role/CommitmentsandContingencies">
        <link:definition>2142109 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails">
        <link:definition>2443425 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://www.surgerypartners.com/role/SegmentReporting">
        <link:definition>2144110 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://www.surgerypartners.com/role/SegmentReportingTables">
        <link:definition>2345309 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails" roleURI="http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails">
        <link:definition>2446426 - Disclosure - Segment Reporting - Revenues and Operating Income by Reportable Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails" roleURI="http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails">
        <link:definition>2447427 - Disclosure - Segment Reporting - Assets and Cash Purchases of Property and Equipment by Operating Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.surgerypartners.com/role/SubsequentEvents">
        <link:definition>2148111 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsNarrativeDetails" roleURI="http://www.surgerypartners.com/role/SubsequentEventsNarrativeDetails">
        <link:definition>2449428 - Disclosure - Subsequent Events - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="sgry_TemporaryEquityThresholdSharePrice" abstract="false" name="TemporaryEquityThresholdSharePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest" abstract="false" name="NumberOfSurgicalFacilitiesOwnedMajorityInterest" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate" abstract="false" name="CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="sgry_DerivativeLiabilityNotionalAmountFinancingComponent" abstract="false" name="DerivativeLiabilityNotionalAmountFinancingComponent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_NotMateriallyMoreRestrictiveMember" abstract="true" name="NotMateriallyMoreRestrictiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_SurgicalFacilitiesNewMarketsMember" abstract="true" name="SurgicalFacilitiesNewMarketsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_ProceedsFromGovernmentAssistance" abstract="false" name="ProceedsFromGovernmentAssistance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_ReceiveFixedSwapOneMember" abstract="true" name="ReceiveFixedSwapOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_SelfPayRevenueMember" abstract="true" name="SelfPayRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_MateriallyMoreRestrictiveMember" abstract="true" name="MateriallyMoreRestrictiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_PayFixedSwapNineMember" abstract="true" name="PayFixedSwapNineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_AncillaryServicesMember" abstract="true" name="AncillaryServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments" abstract="false" name="CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_TaxReceivableAgreementLiabilityCurrent" abstract="false" name="TaxReceivableAgreementLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_BusinessCombinationGainLossOnAcquisitionEscrow" abstract="false" name="BusinessCombinationGainLossOnAcquisitionEscrow" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingRightOfUseAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_LineOfCreditFacilityMaximumBorrowingCapacityIncrease" abstract="false" name="LineOfCreditFacilityMaximumBorrowingCapacityIncrease" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_CashFlowLesseeAbstract" abstract="true" name="CashFlowLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sgry_ProductsAndServicesLineItems" abstract="true" name="ProductsAndServicesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sgry_SeniorUnsecuredNotesDue2025Member" abstract="true" name="SeniorUnsecuredNotesDue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_FinanceLeaseCost1Abstract" abstract="true" name="FinanceLeaseCost1Abstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sgry_PublicStockOfferingFirmSharesMember" abstract="true" name="PublicStockOfferingFirmSharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_ThreePayFixedInterestRateSwapsMember" abstract="true" name="ThreePayFixedInterestRateSwapsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_DebtInstrumentQuarterlyAmortizationPercentPerAnnum" abstract="false" name="DebtInstrumentQuarterlyAmortizationPercentPerAnnum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" abstract="false" name="NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_PublicStockOfferingMember" abstract="true" name="PublicStockOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_FinanceLeaseCost" abstract="false" name="FinanceLeaseCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_TemporaryEquityThresholdTradingDays" abstract="false" name="TemporaryEquityThresholdTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sgry_FacilitiesSurgicalHospitalsMember" abstract="true" name="FacilitiesSurgicalHospitalsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants" abstract="false" name="IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_OpticalServicesMember" abstract="true" name="OpticalServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_PayFixedSwapEightMember" abstract="true" name="PayFixedSwapEightMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_HealthcareOrganizationPatientServiceMember" abstract="true" name="HealthcareOrganizationPatientServiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_EffectiveIncomeTaxRateReconciliationCoronavirusAidReliefAndEconomicSecurityActCARESActAndTaxSettlementAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationCoronavirusAidReliefAndEconomicSecurityActCARESActAndTaxSettlementAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation" abstract="false" name="GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_CostReportLiabilitiesCurrent" abstract="false" name="CostReportLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent" abstract="false" name="MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_OperatingAndFinanceLeaseExpense" abstract="false" name="OperatingAndFinanceLeaseExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_PayFixedSwapFourMember" abstract="true" name="PayFixedSwapFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_NotesPayableAndSecuredLoansMember" abstract="true" name="NotesPayableAndSecuredLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_SaleOfStockTable" abstract="true" name="SaleOfStockTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="sgry_OneMonthLondonInterbankOfferedRateLIBORMember" abstract="true" name="OneMonthLondonInterbankOfferedRateLIBORMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_ReceiveFixedSwapThreeMember" abstract="true" name="ReceiveFixedSwapThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" abstract="false" name="RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_DebtInstrumentCovenantMaturityMinimumAmountOfOtherExistingDebtRemaining" abstract="false" name="DebtInstrumentCovenantMaturityMinimumAmountOfOtherExistingDebtRemaining" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_PayFixedSwapSevenMember" abstract="true" name="PayFixedSwapSevenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember" abstract="true" name="ConversionOfSeriesAPreferredStockIntoCommonStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_CoronavirusAidReliefandEconomicSecurityActCARESActGovernmentGrantReceivedAcceleratedPayments" abstract="false" name="CoronavirusAidReliefandEconomicSecurityActCARESActGovernmentGrantReceivedAcceleratedPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_ReceiveFixedSwapTwoMember" abstract="true" name="ReceiveFixedSwapTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_TemporaryEquityThresholdConsecutiveTradingDays" abstract="false" name="TemporaryEquityThresholdConsecutiveTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sgry_DebtInstrumentBasisSpreadOnVariableRateFloor" abstract="false" name="DebtInstrumentBasisSpreadOnVariableRateFloor" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="sgry_PayFixedSwapOneMember" abstract="true" name="PayFixedSwapOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_A2017SeniorSecuredCreditFacilityMember" abstract="true" name="A2017SeniorSecuredCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_PayFixedSwapFiveMember" abstract="true" name="PayFixedSwapFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_NumberOfSurgicalFacilitiesOwned" abstract="false" name="NumberOfSurgicalFacilitiesOwned" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sgry_DebtInstrumentCovenantMaturityMinimumMaturityDateForOtherExistingDebtRemaining" abstract="false" name="DebtInstrumentCovenantMaturityMinimumMaturityDateForOtherExistingDebtRemaining" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sgry_SaleOfStockLineItems" abstract="true" name="SaleOfStockLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sgry_GainLossOnDispositionOfAssetsAndDeconsolidation" abstract="false" name="GainLossOnDispositionOfAssetsAndDeconsolidation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_DeferredEmployeeRelatedLiabilitiesCurrent" abstract="false" name="DeferredEmployeeRelatedLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments" abstract="false" name="CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm" abstract="false" name="CollaborativeTaxAgreementProjectedTaxSavingsTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization" abstract="false" name="EarningsBeforeInterestTaxesDepreciationAndAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_NoncashInterestIncomeExpenseNet" abstract="false" name="NoncashInterestIncomeExpenseNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_FacilitiesAmbulatorySurgeryCentersMember" abstract="true" name="FacilitiesAmbulatorySurgeryCentersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_RedeemableNoncontrollingInterestRollForward" abstract="true" name="RedeemableNoncontrollingInterestRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sgry_SurgicalFacilityServicesMember" abstract="true" name="SurgicalFacilityServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_PayFixedSwapThreeMember" abstract="true" name="PayFixedSwapThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_A2017TermLoanMaturing2024Member" abstract="true" name="A2017TermLoanMaturing2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_VariableInterestEntityNumberOfFacilities" abstract="false" name="VariableInterestEntityNumberOfFacilities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sgry_OtherPatientServiceRevenueSourcesMember" abstract="true" name="OtherPatientServiceRevenueSourcesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_InterestRateCapOneMember" abstract="true" name="InterestRateCapOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_OtherServicesMember" abstract="true" name="OtherServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_PrivateInsuranceMember" abstract="true" name="PrivateInsuranceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_PayFixedSwapTenMember" abstract="true" name="PayFixedSwapTenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_NumberOfSurgicalFacilitiesOwnedConsolidated" abstract="false" name="NumberOfSurgicalFacilitiesOwnedConsolidated" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sgry_IncreaseDecreaseInSettlementPayments" abstract="false" name="IncreaseDecreaseInSettlementPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_SurgicalFacilitiesExistingMarketsMember" abstract="true" name="SurgicalFacilitiesExistingMarketsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_SeniorUnsecuredNotesDue2027Member" abstract="true" name="SeniorUnsecuredNotesDue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_PayFixedSwapSixMember" abstract="true" name="PayFixedSwapSixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_ThreeReceiveFixedInterestRateSwapsMember" abstract="true" name="ThreeReceiveFixedInterestRateSwapsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember" abstract="true" name="A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_RedeemableNoncontrollingInterestPolicyTextBlock" abstract="false" name="RedeemableNoncontrollingInterestPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="sgry_PayFixedSwapTwoMember" abstract="true" name="PayFixedSwapTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount" abstract="false" name="DeferredIncomeTaxLiabilitiesNetOfDiscount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent" abstract="false" name="DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts" abstract="false" name="BusinessCombinationIntegrationRelatedCostsAndMergerCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_RedeemablePreferredStockTextBlock" abstract="false" name="RedeemablePreferredStockTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_GrantRevenue" abstract="false" name="GrantRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests" abstract="false" name="RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_InterestRateCapTwoMember" abstract="true" name="InterestRateCapTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts" abstract="false" name="GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_VariableAndShortTermLeaseCost" abstract="false" name="VariableAndShortTermLeaseCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>sgry-20210930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:4fc50bef-303f-4567-8d1f-fa45eceeed5f,g:878f1ef0-0d6b-4fb6-8cd6-b11c4615e811-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="sgry-20210930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_5b52036d-7706-4cb6-bad1-f07374f61c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_b8591fba-95c5-4979-a482-491908caf344" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5b52036d-7706-4cb6-bad1-f07374f61c6e" xlink:to="loc_us-gaap_AccountsPayableCurrent_b8591fba-95c5-4979-a482-491908caf344" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_a5bf4877-7a4c-46ba-8ea7-f9376e4883f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5b52036d-7706-4cb6-bad1-f07374f61c6e" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_a5bf4877-7a4c-46ba-8ea7-f9376e4883f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent_0a16e555-319f-45f9-81df-20c104947d7b" xlink:href="sgry-20210930.xsd#sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5b52036d-7706-4cb6-bad1-f07374f61c6e" xlink:to="loc_sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent_0a16e555-319f-45f9-81df-20c104947d7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_a694552f-1827-4c8c-a864-31133925a237" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5b52036d-7706-4cb6-bad1-f07374f61c6e" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_a694552f-1827-4c8c-a864-31133925a237" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_dc54ff0b-6c68-4894-963a-62ad0769a9f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5b52036d-7706-4cb6-bad1-f07374f61c6e" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_dc54ff0b-6c68-4894-963a-62ad0769a9f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4a09e6d4-3273-4754-b68e-d25eb7741090" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_470db2ea-da6a-473f-9691-0e7063b2cd45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4a09e6d4-3273-4754-b68e-d25eb7741090" xlink:to="loc_us-gaap_PreferredStockValue_470db2ea-da6a-473f-9691-0e7063b2cd45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_ce1dc89a-7d7c-4496-8052-38bb323680b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4a09e6d4-3273-4754-b68e-d25eb7741090" xlink:to="loc_us-gaap_CommonStockValueOutstanding_ce1dc89a-7d7c-4496-8052-38bb323680b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_bae3ebea-6a81-40af-86c6-f77c4c14ac7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4a09e6d4-3273-4754-b68e-d25eb7741090" xlink:to="loc_us-gaap_AdditionalPaidInCapital_bae3ebea-6a81-40af-86c6-f77c4c14ac7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ed2dcdb8-79d3-4d3e-9830-5a739a9a14de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4a09e6d4-3273-4754-b68e-d25eb7741090" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ed2dcdb8-79d3-4d3e-9830-5a739a9a14de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_dc025687-a2f9-4e84-911d-d81c86bfdf6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4a09e6d4-3273-4754-b68e-d25eb7741090" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_dc025687-a2f9-4e84-911d-d81c86bfdf6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_bea6b1d2-e013-446b-af39-b23bdba70258" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_66fe0df9-5214-4a84-96bc-d99e1fb27587" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_bea6b1d2-e013-446b-af39-b23bdba70258" xlink:to="loc_us-gaap_LiabilitiesCurrent_66fe0df9-5214-4a84-96bc-d99e1fb27587" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_7e54e677-fdb6-4512-bad1-ee1c8c767c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_bea6b1d2-e013-446b-af39-b23bdba70258" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_7e54e677-fdb6-4512-bad1-ee1c8c767c2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2578fdbe-d337-4ec0-9e70-7b78a366a0eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_bea6b1d2-e013-446b-af39-b23bdba70258" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2578fdbe-d337-4ec0-9e70-7b78a366a0eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_14aeb9e6-65df-4b05-8e55-947b5774716e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_bea6b1d2-e013-446b-af39-b23bdba70258" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_14aeb9e6-65df-4b05-8e55-947b5774716e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_b21d349f-4f56-41fa-ac49-c8e70425fe44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_bea6b1d2-e013-446b-af39-b23bdba70258" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_b21d349f-4f56-41fa-ac49-c8e70425fe44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_2ceb5ecd-9f4e-4166-9dd2-cc7e93508edc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_bea6b1d2-e013-446b-af39-b23bdba70258" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_2ceb5ecd-9f4e-4166-9dd2-cc7e93508edc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ad56de32-79c0-45be-a300-5c2ec463a13e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_bea6b1d2-e013-446b-af39-b23bdba70258" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ad56de32-79c0-45be-a300-5c2ec463a13e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f9f0d989-9972-45c9-9b70-47fa87f8aa33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c1be3bf1-351a-4ba7-bf57-f6dbe73d0a49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f9f0d989-9972-45c9-9b70-47fa87f8aa33" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c1be3bf1-351a-4ba7-bf57-f6dbe73d0a49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_b4aa98b6-6baf-484f-920a-79d3ce60bc56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f9f0d989-9972-45c9-9b70-47fa87f8aa33" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_b4aa98b6-6baf-484f-920a-79d3ce60bc56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_06b2e169-6272-4cf8-8584-6ab1e08fec98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f9f0d989-9972-45c9-9b70-47fa87f8aa33" xlink:to="loc_us-gaap_InventoryNet_06b2e169-6272-4cf8-8584-6ab1e08fec98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_c8fb4fa5-db9e-4648-adc7-cc26ef01f8a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f9f0d989-9972-45c9-9b70-47fa87f8aa33" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_c8fb4fa5-db9e-4648-adc7-cc26ef01f8a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_6a3030bb-214c-41f0-b368-90434ac0778a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f9f0d989-9972-45c9-9b70-47fa87f8aa33" xlink:to="loc_us-gaap_OtherAssetsCurrent_6a3030bb-214c-41f0-b368-90434ac0778a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_4cab0802-12b2-4b2d-9af6-e9c2500aab18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_7d2b3234-d86e-41df-8bae-4fe240932419" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4cab0802-12b2-4b2d-9af6-e9c2500aab18" xlink:to="loc_us-gaap_AssetsCurrent_7d2b3234-d86e-41df-8bae-4fe240932419" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_c56ac88a-a2f9-4d9b-b1d0-6619d8014b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4cab0802-12b2-4b2d-9af6-e9c2500aab18" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_c56ac88a-a2f9-4d9b-b1d0-6619d8014b8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_4de4478e-f6de-40ce-a6b5-3d3750d87f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4cab0802-12b2-4b2d-9af6-e9c2500aab18" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_4de4478e-f6de-40ce-a6b5-3d3750d87f3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_bb3c4c1f-64cc-4b8d-bea5-23ca603bd3ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4cab0802-12b2-4b2d-9af6-e9c2500aab18" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_bb3c4c1f-64cc-4b8d-bea5-23ca603bd3ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_05dee92e-d586-4e1e-baa1-737b90d1ddb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4cab0802-12b2-4b2d-9af6-e9c2500aab18" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_05dee92e-d586-4e1e-baa1-737b90d1ddb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_510e43d6-0dd2-4ea5-be55-b785d036c322" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4cab0802-12b2-4b2d-9af6-e9c2500aab18" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_510e43d6-0dd2-4ea5-be55-b785d036c322" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_26043e93-0d1b-4211-a8b2-e761c68f0283" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4cab0802-12b2-4b2d-9af6-e9c2500aab18" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_26043e93-0d1b-4211-a8b2-e761c68f0283" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2bdf1c67-018f-4e1a-bcaa-e10bbd2e979f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9cff0c02-a617-47e9-96b4-33a758160ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2bdf1c67-018f-4e1a-bcaa-e10bbd2e979f" xlink:to="loc_us-gaap_StockholdersEquity_9cff0c02-a617-47e9-96b4-33a758160ce1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_2f80d699-23ac-44bf-910e-03ef8e49d838" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2bdf1c67-018f-4e1a-bcaa-e10bbd2e979f" xlink:to="loc_us-gaap_MinorityInterest_2f80d699-23ac-44bf-910e-03ef8e49d838" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="sgry-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_bfd9b5f2-8f86-42c9-9541-e5124a9bbc98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_d15bdf12-5eee-46f5-beea-1ac3320ee31b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_bfd9b5f2-8f86-42c9-9541-e5124a9bbc98" xlink:to="loc_us-gaap_LaborAndRelatedExpense_d15bdf12-5eee-46f5-beea-1ac3320ee31b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SuppliesExpense_0b7f3d0f-d697-46ba-a9a6-9997deaaaa86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SuppliesExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_bfd9b5f2-8f86-42c9-9541-e5124a9bbc98" xlink:to="loc_us-gaap_SuppliesExpense_0b7f3d0f-d697-46ba-a9a6-9997deaaaa86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees_ed375fd7-7e4a-4baf-9fed-5fd037c20c24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalFees"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_bfd9b5f2-8f86-42c9-9541-e5124a9bbc98" xlink:to="loc_us-gaap_ProfessionalFees_ed375fd7-7e4a-4baf-9fed-5fd037c20c24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_OperatingAndFinanceLeaseExpense_bad56df0-0cf8-48dc-9b56-41e4b4c288ed" xlink:href="sgry-20210930.xsd#sgry_OperatingAndFinanceLeaseExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_bfd9b5f2-8f86-42c9-9541-e5124a9bbc98" xlink:to="loc_sgry_OperatingAndFinanceLeaseExpense_bad56df0-0cf8-48dc-9b56-41e4b4c288ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_71d08047-db51-46dc-be62-d278308b78a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_bfd9b5f2-8f86-42c9-9541-e5124a9bbc98" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating_71d08047-db51-46dc-be62-d278308b78a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b520b392-813c-448a-8c33-30e20be2a712" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_7a7478f2-cc5e-4481-ab0e-df8c798f46f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_b520b392-813c-448a-8c33-30e20be2a712" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_7a7478f2-cc5e-4481-ab0e-df8c798f46f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_55ce845e-2af5-47ea-b717-b31b0907c0de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_b520b392-813c-448a-8c33-30e20be2a712" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_55ce845e-2af5-47ea-b717-b31b0907c0de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_e9f2443e-6acb-408c-941c-ab469218f0f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_c3199c36-b2fa-43e7-b9ec-2c9501a3b8b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_e9f2443e-6acb-408c-941c-ab469218f0f5" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_c3199c36-b2fa-43e7-b9ec-2c9501a3b8b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5fcbb227-6c64-4b10-b493-2e51efb64de0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_e9f2443e-6acb-408c-941c-ab469218f0f5" xlink:to="loc_us-gaap_OperatingIncomeLoss_5fcbb227-6c64-4b10-b493-2e51efb64de0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_72bb0f6c-7083-4cad-ba6a-7319683d06c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_63676f2f-a592-44c2-9649-cfe3b8ee0acd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_72bb0f6c-7083-4cad-ba6a-7319683d06c0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_63676f2f-a592-44c2-9649-cfe3b8ee0acd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_30fafd99-391c-4336-a605-6a3b33263d17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_72bb0f6c-7083-4cad-ba6a-7319683d06c0" xlink:to="loc_us-gaap_OperatingExpenses_30fafd99-391c-4336-a605-6a3b33263d17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_90cc7339-25ff-4b86-8803-e7e584e8461e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e7233c76-43e5-4015-beaf-7320856d952e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_90cc7339-25ff-4b86-8803-e7e584e8461e" xlink:to="loc_us-gaap_ProfitLoss_e7233c76-43e5-4015-beaf-7320856d952e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8a09fa8d-aa26-4b00-9f5e-e9b843b3e08c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_90cc7339-25ff-4b86-8803-e7e584e8461e" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8a09fa8d-aa26-4b00-9f5e-e9b843b3e08c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_9686a06e-9bdc-4b44-80ad-e32c21786916" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_a987ce6a-9f7b-4c67-95f9-55f4251ffd0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_9686a06e-9bdc-4b44-80ad-e32c21786916" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_a987ce6a-9f7b-4c67-95f9-55f4251ffd0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_5ad0fdb2-ff81-411e-b259-865228660d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_9686a06e-9bdc-4b44-80ad-e32c21786916" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_5ad0fdb2-ff81-411e-b259-865228660d6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_58c2c149-ceef-49ec-91c9-1a74cdaffe6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_9686a06e-9bdc-4b44-80ad-e32c21786916" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_58c2c149-ceef-49ec-91c9-1a74cdaffe6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_289cf146-ff46-45c8-85f2-281a61564045" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_9686a06e-9bdc-4b44-80ad-e32c21786916" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_289cf146-ff46-45c8-85f2-281a61564045" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation_5f5de798-8ca0-4587-995e-3e0d4fec9869" xlink:href="sgry-20210930.xsd#sgry_GainLossOnDispositionOfAssetsAndDeconsolidation"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_9686a06e-9bdc-4b44-80ad-e32c21786916" xlink:to="loc_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation_5f5de798-8ca0-4587-995e-3e0d4fec9869" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_cacbe23e-6794-4ab6-bf71-2fed2e31840f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_9686a06e-9bdc-4b44-80ad-e32c21786916" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_cacbe23e-6794-4ab6-bf71-2fed2e31840f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_7ba8c1e7-5297-4a39-88e9-70b67d42112d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_9686a06e-9bdc-4b44-80ad-e32c21786916" xlink:to="loc_us-gaap_AssetImpairmentCharges_7ba8c1e7-5297-4a39-88e9-70b67d42112d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_GrantRevenue_8f9ba977-1ce5-4724-9041-5bedfe1ce44e" xlink:href="sgry-20210930.xsd#sgry_GrantRevenue"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_9686a06e-9bdc-4b44-80ad-e32c21786916" xlink:to="loc_sgry_GrantRevenue_8f9ba977-1ce5-4724-9041-5bedfe1ce44e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_333246c7-f195-48a1-a7e9-b25d77924faa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_9686a06e-9bdc-4b44-80ad-e32c21786916" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_333246c7-f195-48a1-a7e9-b25d77924faa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_ffa64f80-1d82-45ae-bdbd-29802494d67b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_9686a06e-9bdc-4b44-80ad-e32c21786916" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_ffa64f80-1d82-45ae-bdbd-29802494d67b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonrecurringIncomeExpense_73eeb3c4-8944-4b15-aae2-349bf3aa9572" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonrecurringIncomeExpense"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_9686a06e-9bdc-4b44-80ad-e32c21786916" xlink:to="loc_us-gaap_OtherNonrecurringIncomeExpense_73eeb3c4-8944-4b15-aae2-349bf3aa9572" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_41844b38-5c23-46b1-bffc-a155e7ba6033" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ac770040-8733-48e9-9171-edb7b114159b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_41844b38-5c23-46b1-bffc-a155e7ba6033" xlink:to="loc_us-gaap_NetIncomeLoss_ac770040-8733-48e9-9171-edb7b114159b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_aed75147-c825-4358-8698-c961d681dfcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_41844b38-5c23-46b1-bffc-a155e7ba6033" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_aed75147-c825-4358-8698-c961d681dfcb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="sgry-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:calculationLink xlink:role="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_d8582377-b250-4adc-982f-2b390aab7dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1cd5a798-8206-4130-985b-739d4674c952" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_d8582377-b250-4adc-982f-2b390aab7dc1" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1cd5a798-8206-4130-985b-739d4674c952" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_36381dd0-25bc-44f1-9960-c2403e03c99b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_d8582377-b250-4adc-982f-2b390aab7dc1" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_36381dd0-25bc-44f1-9960-c2403e03c99b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_fef50f3f-f13a-43a4-b63e-ab5a316ed57f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ce241a63-1636-4c8d-addb-2f8c9e608956" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_fef50f3f-f13a-43a4-b63e-ab5a316ed57f" xlink:to="loc_us-gaap_ProfitLoss_ce241a63-1636-4c8d-addb-2f8c9e608956" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_cf3c69e1-c23a-42d4-a458-dae99a2ae69c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_fef50f3f-f13a-43a4-b63e-ab5a316ed57f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_cf3c69e1-c23a-42d4-a458-dae99a2ae69c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="sgry-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_737235c2-65b7-4b2a-9562-f336b7176319" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8f5de3db-f61d-4896-95e8-31d48fd5f383" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_737235c2-65b7-4b2a-9562-f336b7176319" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8f5de3db-f61d-4896-95e8-31d48fd5f383" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_65732595-d726-4995-87cb-2e8647f48641" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_737235c2-65b7-4b2a-9562-f336b7176319" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_65732595-d726-4995-87cb-2e8647f48641" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5b92962c-68bb-416f-b65c-e31a29b9ba9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_737235c2-65b7-4b2a-9562-f336b7176319" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5b92962c-68bb-416f-b65c-e31a29b9ba9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1b3d4940-8bf8-4d85-b26c-58c559b1e625" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6a63f1ce-3a1e-452b-905c-2030ae0b6b64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1b3d4940-8bf8-4d85-b26c-58c559b1e625" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6a63f1ce-3a1e-452b-905c-2030ae0b6b64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_0b7c8142-00f2-4e40-a7fa-d61399f8e781" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1b3d4940-8bf8-4d85-b26c-58c559b1e625" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_0b7c8142-00f2-4e40-a7fa-d61399f8e781" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_2f2cd6f5-467f-4c37-8a24-504cdbe7a527" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1b3d4940-8bf8-4d85-b26c-58c559b1e625" xlink:to="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_2f2cd6f5-467f-4c37-8a24-504cdbe7a527" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_79f75768-030f-46c5-a708-42a47c8c9a80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1b3d4940-8bf8-4d85-b26c-58c559b1e625" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_79f75768-030f-46c5-a708-42a47c8c9a80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5263d090-fb62-464b-8550-c5625be275e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_eb95beb0-b040-4968-9ff7-8a56afb7fa8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5263d090-fb62-464b-8550-c5625be275e6" xlink:to="loc_us-gaap_ProfitLoss_eb95beb0-b040-4968-9ff7-8a56afb7fa8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_60588f3f-2754-42b2-840a-e46424716c80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5263d090-fb62-464b-8550-c5625be275e6" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_60588f3f-2754-42b2-840a-e46424716c80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NoncashInterestIncomeExpenseNet_41d72713-3822-491d-a6f5-d1b5f1cd2cc2" xlink:href="sgry-20210930.xsd#sgry_NoncashInterestIncomeExpenseNet"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5263d090-fb62-464b-8550-c5625be275e6" xlink:to="loc_sgry_NoncashInterestIncomeExpenseNet_41d72713-3822-491d-a6f5-d1b5f1cd2cc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_53e96b48-08d0-49a1-a8d3-a6a00b20533d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5263d090-fb62-464b-8550-c5625be275e6" xlink:to="loc_us-gaap_ShareBasedCompensation_53e96b48-08d0-49a1-a8d3-a6a00b20533d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation_68ba203b-988d-4771-97f5-fedabca91f45" xlink:href="sgry-20210930.xsd#sgry_GainLossOnDispositionOfAssetsAndDeconsolidation"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5263d090-fb62-464b-8550-c5625be275e6" xlink:to="loc_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation_68ba203b-988d-4771-97f5-fedabca91f45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_930acd7d-39dd-4705-b124-5448534c0dad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5263d090-fb62-464b-8550-c5625be275e6" xlink:to="loc_us-gaap_AssetImpairmentCharges_930acd7d-39dd-4705-b124-5448534c0dad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_80850b87-7af8-4a43-8fc7-7a1abeffc6e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5263d090-fb62-464b-8550-c5625be275e6" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_80850b87-7af8-4a43-8fc7-7a1abeffc6e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_048dcf3f-c618-4539-b93f-551dac05114f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5263d090-fb62-464b-8550-c5625be275e6" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_048dcf3f-c618-4539-b93f-551dac05114f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_734cbebe-2a72-40fe-8d77-9b0e9e1170e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5263d090-fb62-464b-8550-c5625be275e6" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_734cbebe-2a72-40fe-8d77-9b0e9e1170e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_1d07b001-357f-4d82-a216-f65529646f26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5263d090-fb62-464b-8550-c5625be275e6" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_1d07b001-357f-4d82-a216-f65529646f26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_8a569e4d-e254-45df-857c-511d7ab5b41e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5263d090-fb62-464b-8550-c5625be275e6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_8a569e4d-e254-45df-857c-511d7ab5b41e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants_ae4dbc57-3e47-4c80-9324-dffced16404b" xlink:href="sgry-20210930.xsd#sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5263d090-fb62-464b-8550-c5625be275e6" xlink:to="loc_sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants_ae4dbc57-3e47-4c80-9324-dffced16404b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_IncreaseDecreaseInSettlementPayments_8b309282-24cc-46b5-911f-11e8e717ae9e" xlink:href="sgry-20210930.xsd#sgry_IncreaseDecreaseInSettlementPayments"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5263d090-fb62-464b-8550-c5625be275e6" xlink:to="loc_sgry_IncreaseDecreaseInSettlementPayments_8b309282-24cc-46b5-911f-11e8e717ae9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_aedf03a3-5695-477e-b05d-d2e23015f7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5263d090-fb62-464b-8550-c5625be275e6" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_aedf03a3-5695-477e-b05d-d2e23015f7f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c731ec51-fdf3-4fec-bb31-99f9b0e9f7ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_125ceab2-b403-4737-a489-eb34f9444f45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c731ec51-fdf3-4fec-bb31-99f9b0e9f7ec" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_125ceab2-b403-4737-a489-eb34f9444f45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_761af48a-abaf-4c56-b2b6-6623f7588927" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c731ec51-fdf3-4fec-bb31-99f9b0e9f7ec" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_761af48a-abaf-4c56-b2b6-6623f7588927" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_1f5bf9e8-d8bc-4425-841b-45af161bf3c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c731ec51-fdf3-4fec-bb31-99f9b0e9f7ec" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_1f5bf9e8-d8bc-4425-841b-45af161bf3c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_cdcef33a-1ce0-4f33-9f9a-436f3cdb15bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c731ec51-fdf3-4fec-bb31-99f9b0e9f7ec" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_cdcef33a-1ce0-4f33-9f9a-436f3cdb15bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_a0b7c602-6aea-4e82-ae7a-f8a943fce90d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c731ec51-fdf3-4fec-bb31-99f9b0e9f7ec" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_a0b7c602-6aea-4e82-ae7a-f8a943fce90d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_6729c152-6207-47f3-802f-3006157d80f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c731ec51-fdf3-4fec-bb31-99f9b0e9f7ec" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_6729c152-6207-47f3-802f-3006157d80f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest_8d5406d6-0858-4855-9a6e-80b89011e906" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c731ec51-fdf3-4fec-bb31-99f9b0e9f7ec" xlink:to="loc_us-gaap_PaymentsOfDividendsMinorityInterest_8d5406d6-0858-4855-9a6e-80b89011e906" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_dc1e5703-6df0-4fcd-87cd-0624d7aa5356" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c731ec51-fdf3-4fec-bb31-99f9b0e9f7ec" xlink:to="loc_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_dc1e5703-6df0-4fcd-87cd-0624d7aa5356" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_4d9d61a8-5c74-405b-9d20-c3440da5f847" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c731ec51-fdf3-4fec-bb31-99f9b0e9f7ec" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_4d9d61a8-5c74-405b-9d20-c3440da5f847" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_53bc9982-e71a-43a2-9065-48112c3b1f05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c731ec51-fdf3-4fec-bb31-99f9b0e9f7ec" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_53bc9982-e71a-43a2-9065-48112c3b1f05" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/AcquisitionsSummaryDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#AcquisitionsSummaryDetails"/>
  <link:calculationLink xlink:role="http://www.surgerypartners.com/role/AcquisitionsSummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_57f871f5-f127-4454-ac2d-628b49c091ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_4ea2a32b-c0fb-4008-8025-d5c3fe48418f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_57f871f5-f127-4454-ac2d-628b49c091ef" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_4ea2a32b-c0fb-4008-8025-d5c3fe48418f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_50f697da-eb4f-450e-9c10-16af05fbf86a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_57f871f5-f127-4454-ac2d-628b49c091ef" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_50f697da-eb4f-450e-9c10-16af05fbf86a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_cb970dc0-bf67-4ad0-ba10-f062ee6ddea2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_57f871f5-f127-4454-ac2d-628b49c091ef" xlink:to="loc_us-gaap_Goodwill_cb970dc0-bf67-4ad0-ba10-f062ee6ddea2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingRightOfUseAssets_15bf3180-e2ca-4e7d-bd3d-6cfda4942aaa" xlink:href="sgry-20210930.xsd#sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingRightOfUseAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_57f871f5-f127-4454-ac2d-628b49c091ef" xlink:to="loc_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingRightOfUseAssets_15bf3180-e2ca-4e7d-bd3d-6cfda4942aaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_791566cd-7846-4976-bde4-ce066e0d5f95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_57f871f5-f127-4454-ac2d-628b49c091ef" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_791566cd-7846-4976-bde4-ce066e0d5f95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt_21bced19-ba20-4d07-aced-7ca431b7ca34" xlink:href="sgry-20210930.xsd#sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_57f871f5-f127-4454-ac2d-628b49c091ef" xlink:to="loc_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt_21bced19-ba20-4d07-aced-7ca431b7ca34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability_ae032241-1626-48c8-b46c-1af39a5101af" xlink:href="sgry-20210930.xsd#sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_57f871f5-f127-4454-ac2d-628b49c091ef" xlink:to="loc_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability_ae032241-1626-48c8-b46c-1af39a5101af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_0368eecd-42f2-4010-b349-5d799a120c79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_57f871f5-f127-4454-ac2d-628b49c091ef" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_0368eecd-42f2-4010-b349-5d799a120c79" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/LongTermDebtSummaryDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#LongTermDebtSummaryDetails"/>
  <link:calculationLink xlink:role="http://www.surgerypartners.com/role/LongTermDebtSummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_e28f01a0-4597-47f0-8685-f79fc00a9965" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_075913d9-9ade-43be-a7e9-50fca2d8f0fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_e28f01a0-4597-47f0-8685-f79fc00a9965" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_075913d9-9ade-43be-a7e9-50fca2d8f0fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_8ab2a178-918f-475b-9ab6-c4cea3781f91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_e28f01a0-4597-47f0-8685-f79fc00a9965" xlink:to="loc_us-gaap_FinanceLeaseLiability_8ab2a178-918f-475b-9ab6-c4cea3781f91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_12f1909d-1844-4e5e-aabe-2280e4b5ac4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_e28f01a0-4597-47f0-8685-f79fc00a9965" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_12f1909d-1844-4e5e-aabe-2280e4b5ac4c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/LongTermDebtSummaryDetails_1" xlink:type="simple" xlink:href="sgry-20210930.xsd#LongTermDebtSummaryDetails_1"/>
  <link:calculationLink xlink:role="http://www.surgerypartners.com/role/LongTermDebtSummaryDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_dcbd015c-271b-448f-91b6-a24aee6ab2ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_9634cd69-90cc-4235-8f63-5c2677b6cc2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_dcbd015c-271b-448f-91b6-a24aee6ab2ea" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_9634cd69-90cc-4235-8f63-5c2677b6cc2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_a76df91f-6098-4ea5-afb5-56102314d806" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_dcbd015c-271b-448f-91b6-a24aee6ab2ea" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_a76df91f-6098-4ea5-afb5-56102314d806" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#LeasesLeaseExpenseandCashFlowInformationDetails"/>
  <link:calculationLink xlink:role="http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_0897a557-3932-475d-8cd4-3b8a430861fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_a1e5b451-536a-41ea-bd71-4e4583226062" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_0897a557-3932-475d-8cd4-3b8a430861fa" xlink:to="loc_us-gaap_OperatingLeaseCost_a1e5b451-536a-41ea-bd71-4e4583226062" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_FinanceLeaseCost_27e4160a-9db2-4fde-88f2-cb6830f28537" xlink:href="sgry-20210930.xsd#sgry_FinanceLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_0897a557-3932-475d-8cd4-3b8a430861fa" xlink:to="loc_sgry_FinanceLeaseCost_27e4160a-9db2-4fde-88f2-cb6830f28537" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_VariableAndShortTermLeaseCost_d25470d8-26ad-424d-b875-118a5325fa89" xlink:href="sgry-20210930.xsd#sgry_VariableAndShortTermLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_0897a557-3932-475d-8cd4-3b8a430861fa" xlink:to="loc_sgry_VariableAndShortTermLeaseCost_d25470d8-26ad-424d-b875-118a5325fa89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_FinanceLeaseCost_2ae61804-a0af-4b67-bbee-a4bf705b33ff" xlink:href="sgry-20210930.xsd#sgry_FinanceLeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_10060ddc-24f9-48fa-9242-1fbc8a768b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sgry_FinanceLeaseCost_2ae61804-a0af-4b67-bbee-a4bf705b33ff" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_10060ddc-24f9-48fa-9242-1fbc8a768b3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_02bb159c-bb20-40e2-bd37-7b42335a947f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sgry_FinanceLeaseCost_2ae61804-a0af-4b67-bbee-a4bf705b33ff" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_02bb159c-bb20-40e2-bd37-7b42335a947f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#OtherCurrentLiabilitiesSummaryDetails"/>
  <link:calculationLink xlink:role="http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_e8d6f919-86f6-4dd7-99a3-97e418fee6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_ad2bdbf4-b5f3-4201-a9cd-f12b66dca074" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_e8d6f919-86f6-4dd7-99a3-97e418fee6b8" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_ad2bdbf4-b5f3-4201-a9cd-f12b66dca074" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_f8da1e22-f248-4577-bf5a-55c5fe8e7f15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_e8d6f919-86f6-4dd7-99a3-97e418fee6b8" xlink:to="loc_us-gaap_LitigationReserveCurrent_f8da1e22-f248-4577-bf5a-55c5fe8e7f15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_e1869d91-3d18-4497-8830-f85912a3f6d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_e8d6f919-86f6-4dd7-99a3-97e418fee6b8" xlink:to="loc_us-gaap_InterestPayableCurrent_e1869d91-3d18-4497-8830-f85912a3f6d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_TaxReceivableAgreementLiabilityCurrent_228d2e67-a34d-45c6-af6d-cfa7a709b189" xlink:href="sgry-20210930.xsd#sgry_TaxReceivableAgreementLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_e8d6f919-86f6-4dd7-99a3-97e418fee6b8" xlink:to="loc_sgry_TaxReceivableAgreementLiabilityCurrent_228d2e67-a34d-45c6-af6d-cfa7a709b189" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_PayablesToCustomers_ea7ce135-071c-4b5c-b46b-e78bedaf0d68" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_PayablesToCustomers"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_e8d6f919-86f6-4dd7-99a3-97e418fee6b8" xlink:to="loc_srt_PayablesToCustomers_ea7ce135-071c-4b5c-b46b-e78bedaf0d68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_CostReportLiabilitiesCurrent_167a7716-cdaa-48c4-9aa2-f35a8c723f9e" xlink:href="sgry-20210930.xsd#sgry_CostReportLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_e8d6f919-86f6-4dd7-99a3-97e418fee6b8" xlink:to="loc_sgry_CostReportLiabilitiesCurrent_167a7716-cdaa-48c4-9aa2-f35a8c723f9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_fd05e4f6-92a1-458b-9532-047425037dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_e8d6f919-86f6-4dd7-99a3-97e418fee6b8" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_fd05e4f6-92a1-458b-9532-047425037dd8" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>sgry-20210930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:4fc50bef-303f-4567-8d1f-fa45eceeed5f,g:878f1ef0-0d6b-4fb6-8cd6-b11c4615e811-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="sgry-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="i2f708fae59d34766a20db4e6cae97042_CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_59b0599c-41f9-45b7-a717-5359c2d2bc25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3511347a-77f2-435b-9760-db7e0bcc1318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_59b0599c-41f9-45b7-a717-5359c2d2bc25" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3511347a-77f2-435b-9760-db7e0bcc1318" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_e96da1d5-cd70-4320-979c-466a9c52e6e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3511347a-77f2-435b-9760-db7e0bcc1318" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_e96da1d5-cd70-4320-979c-466a9c52e6e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0d2ea42c-ebc7-4c95-b5bb-8150b5ab30c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3511347a-77f2-435b-9760-db7e0bcc1318" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0d2ea42c-ebc7-4c95-b5bb-8150b5ab30c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_9200eb12-b0d3-4cd1-93ea-8248c6d650f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3511347a-77f2-435b-9760-db7e0bcc1318" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_9200eb12-b0d3-4cd1-93ea-8248c6d650f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_7198e261-a78f-497c-9267-c81872cec03e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3511347a-77f2-435b-9760-db7e0bcc1318" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_7198e261-a78f-497c-9267-c81872cec03e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_d895b278-0076-4904-a725-6f63d5f8a209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3511347a-77f2-435b-9760-db7e0bcc1318" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_d895b278-0076-4904-a725-6f63d5f8a209" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_629f9cad-9f34-4781-adba-602b4d0c535e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3511347a-77f2-435b-9760-db7e0bcc1318" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_629f9cad-9f34-4781-adba-602b4d0c535e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_2f88ccf8-a70a-40de-867a-8319a881a3a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3511347a-77f2-435b-9760-db7e0bcc1318" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_2f88ccf8-a70a-40de-867a-8319a881a3a2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_c96e8456-9c5e-4ca3-8f83-d4874b67d6b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3511347a-77f2-435b-9760-db7e0bcc1318" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_c96e8456-9c5e-4ca3-8f83-d4874b67d6b5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_df6aa87c-515f-4506-abcf-824815be0f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3511347a-77f2-435b-9760-db7e0bcc1318" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_df6aa87c-515f-4506-abcf-824815be0f8c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_8faddab2-da3b-49f2-adf2-0d419d69a1ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3511347a-77f2-435b-9760-db7e0bcc1318" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_8faddab2-da3b-49f2-adf2-0d419d69a1ab" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_c3977ccd-3f07-425a-8e47-e5b02748bd03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3511347a-77f2-435b-9760-db7e0bcc1318" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_c3977ccd-3f07-425a-8e47-e5b02748bd03" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet_f7bfd6ab-6d08-424b-8faf-5c5fa2c35998" xlink:href="sgry-20210930.xsd#sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3511347a-77f2-435b-9760-db7e0bcc1318" xlink:to="loc_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet_f7bfd6ab-6d08-424b-8faf-5c5fa2c35998" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_d2b2fb82-32ea-4a3b-be9d-b4325357d36a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3511347a-77f2-435b-9760-db7e0bcc1318" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_d2b2fb82-32ea-4a3b-be9d-b4325357d36a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_b7cccf99-38ea-4f0d-a644-1d4790e0296f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6cde8613-ce31-4ff3-8729-b134f6830d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f197ab62-be17-41fd-b0df-034e3887d0f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_59b0599c-41f9-45b7-a717-5359c2d2bc25" xlink:to="loc_us-gaap_StatementTable_f197ab62-be17-41fd-b0df-034e3887d0f9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a49a9b16-bf1c-4022-910f-9b1d4391d9ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f197ab62-be17-41fd-b0df-034e3887d0f9" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a49a9b16-bf1c-4022-910f-9b1d4391d9ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a49a9b16-bf1c-4022-910f-9b1d4391d9ef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a49a9b16-bf1c-4022-910f-9b1d4391d9ef" xlink:to="loc_us-gaap_EquityComponentDomain_a49a9b16-bf1c-4022-910f-9b1d4391d9ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ea9ebae6-9f63-4f4b-81b8-72bddd789271" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a49a9b16-bf1c-4022-910f-9b1d4391d9ef" xlink:to="loc_us-gaap_EquityComponentDomain_ea9ebae6-9f63-4f4b-81b8-72bddd789271" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_47038b5d-8f8b-457e-8d16-6c391c627ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ea9ebae6-9f63-4f4b-81b8-72bddd789271" xlink:to="loc_us-gaap_CommonStockMember_47038b5d-8f8b-457e-8d16-6c391c627ec6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_01009fe2-5798-4cf3-b38e-70a78770b9ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ea9ebae6-9f63-4f4b-81b8-72bddd789271" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_01009fe2-5798-4cf3-b38e-70a78770b9ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_88bd6740-2d26-4aea-95ac-c08b52719ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ea9ebae6-9f63-4f4b-81b8-72bddd789271" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_88bd6740-2d26-4aea-95ac-c08b52719ea8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_cb2051d3-0dd3-4813-867e-52380d55bd8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ea9ebae6-9f63-4f4b-81b8-72bddd789271" xlink:to="loc_us-gaap_RetainedEarningsMember_cb2051d3-0dd3-4813-867e-52380d55bd8c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_f9159629-627e-41bb-ad05-8fdfea189f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ea9ebae6-9f63-4f4b-81b8-72bddd789271" xlink:to="loc_us-gaap_NoncontrollingInterestMember_f9159629-627e-41bb-ad05-8fdfea189f0c" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesOrganizationDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#OrganizationandSummaryofAccountingPoliciesOrganizationDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesOrganizationDetails" xlink:type="extended" id="i66c695ea763c4a72b9daa5f09f0381ea_OrganizationandSummaryofAccountingPoliciesOrganizationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ProductsAndServicesLineItems_8f6a585d-771c-4e04-a7c7-150d18517d3a" xlink:href="sgry-20210930.xsd#sgry_ProductsAndServicesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NumberOfSurgicalFacilitiesOwned_ba8f0595-20a0-44c0-9b5e-d7f7180fbcef" xlink:href="sgry-20210930.xsd#sgry_NumberOfSurgicalFacilitiesOwned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sgry_ProductsAndServicesLineItems_8f6a585d-771c-4e04-a7c7-150d18517d3a" xlink:to="loc_sgry_NumberOfSurgicalFacilitiesOwned_ba8f0595-20a0-44c0-9b5e-d7f7180fbcef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates_118bb147-3c04-4416-9776-fb7106176429" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sgry_ProductsAndServicesLineItems_8f6a585d-771c-4e04-a7c7-150d18517d3a" xlink:to="loc_us-gaap_NumberOfStatesInWhichEntityOperates_118bb147-3c04-4416-9776-fb7106176429" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest_1dce8fe6-85e1-4249-950b-aafcb6dc44d3" xlink:href="sgry-20210930.xsd#sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sgry_ProductsAndServicesLineItems_8f6a585d-771c-4e04-a7c7-150d18517d3a" xlink:to="loc_sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest_1dce8fe6-85e1-4249-950b-aafcb6dc44d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NumberOfSurgicalFacilitiesOwnedConsolidated_61a12b27-c822-4c96-9e28-4b65823b8fd4" xlink:href="sgry-20210930.xsd#sgry_NumberOfSurgicalFacilitiesOwnedConsolidated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sgry_ProductsAndServicesLineItems_8f6a585d-771c-4e04-a7c7-150d18517d3a" xlink:to="loc_sgry_NumberOfSurgicalFacilitiesOwnedConsolidated_61a12b27-c822-4c96-9e28-4b65823b8fd4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AirlineProductsAndServicesTable_92e2e558-dbe9-43f6-bda4-bc463f09a93f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AirlineProductsAndServicesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sgry_ProductsAndServicesLineItems_8f6a585d-771c-4e04-a7c7-150d18517d3a" xlink:to="loc_us-gaap_AirlineProductsAndServicesTable_92e2e558-dbe9-43f6-bda4-bc463f09a93f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b045dc52-b55a-4e5f-9a68-7e5419529e72" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AirlineProductsAndServicesTable_92e2e558-dbe9-43f6-bda4-bc463f09a93f" xlink:to="loc_srt_ProductOrServiceAxis_b045dc52-b55a-4e5f-9a68-7e5419529e72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b045dc52-b55a-4e5f-9a68-7e5419529e72_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_b045dc52-b55a-4e5f-9a68-7e5419529e72" xlink:to="loc_srt_ProductsAndServicesDomain_b045dc52-b55a-4e5f-9a68-7e5419529e72_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d8c4af9d-cbc3-407b-9426-36a7e6f45b78" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_b045dc52-b55a-4e5f-9a68-7e5419529e72" xlink:to="loc_srt_ProductsAndServicesDomain_d8c4af9d-cbc3-407b-9426-36a7e6f45b78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_FacilitiesAmbulatorySurgeryCentersMember_33ac05d0-79b1-4c1b-85db-fe1094eb670b" xlink:href="sgry-20210930.xsd#sgry_FacilitiesAmbulatorySurgeryCentersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d8c4af9d-cbc3-407b-9426-36a7e6f45b78" xlink:to="loc_sgry_FacilitiesAmbulatorySurgeryCentersMember_33ac05d0-79b1-4c1b-85db-fe1094eb670b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_FacilitiesSurgicalHospitalsMember_4234cac8-b607-43f0-8c2b-8475fe9e6806" xlink:href="sgry-20210930.xsd#sgry_FacilitiesSurgicalHospitalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d8c4af9d-cbc3-407b-9426-36a7e6f45b78" xlink:to="loc_sgry_FacilitiesSurgicalHospitalsMember_4234cac8-b607-43f0-8c2b-8475fe9e6806" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails" xlink:type="extended" id="i8383e29498b548119bba7cb740fcfbe6_OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_5ca74159-9aa9-4b9f-8f03-7d4ed5734d31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_VariableInterestEntityNumberOfFacilities_44594fc3-acf5-466f-9a83-432f514f76e8" xlink:href="sgry-20210930.xsd#sgry_VariableInterestEntityNumberOfFacilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_5ca74159-9aa9-4b9f-8f03-7d4ed5734d31" xlink:to="loc_sgry_VariableInterestEntityNumberOfFacilities_44594fc3-acf5-466f-9a83-432f514f76e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_739f89a8-96aa-4e87-bea3-4bbefe62b5ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_5ca74159-9aa9-4b9f-8f03-7d4ed5734d31" xlink:to="loc_us-gaap_Assets_739f89a8-96aa-4e87-bea3-4bbefe62b5ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_ca7977c6-c3ab-4ad7-af43-9db16f412dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_5ca74159-9aa9-4b9f-8f03-7d4ed5734d31" xlink:to="loc_us-gaap_Liabilities_ca7977c6-c3ab-4ad7-af43-9db16f412dcb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_182f6d90-1eef-4af2-87f0-376d02a9f21d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_5ca74159-9aa9-4b9f-8f03-7d4ed5734d31" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_182f6d90-1eef-4af2-87f0-376d02a9f21d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_2e11e6e1-63c3-4e93-8d81-24748e08e225" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_182f6d90-1eef-4af2-87f0-376d02a9f21d" xlink:to="loc_srt_ConsolidatedEntitiesAxis_2e11e6e1-63c3-4e93-8d81-24748e08e225" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_2e11e6e1-63c3-4e93-8d81-24748e08e225_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_2e11e6e1-63c3-4e93-8d81-24748e08e225" xlink:to="loc_srt_ConsolidatedEntitiesDomain_2e11e6e1-63c3-4e93-8d81-24748e08e225_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_2974eb6c-3665-4c56-ac75-f447c91c3968" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_2e11e6e1-63c3-4e93-8d81-24748e08e225" xlink:to="loc_srt_ConsolidatedEntitiesDomain_2974eb6c-3665-4c56-ac75-f447c91c3968" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_d47124b7-5ff3-4c9c-b4a3-1a03f602e7bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_2974eb6c-3665-4c56-ac75-f447c91c3968" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_d47124b7-5ff3-4c9c-b4a3-1a03f602e7bd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails" xlink:type="extended" id="i9b9cc4262d184f6bb9e44e194fc70692_OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_73071f82-a181-46c2-a666-73fb9e6b60ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_56fd4ffa-6428-424c-be87-b8a5e8338bec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_73071f82-a181-46c2-a666-73fb9e6b60ef" xlink:to="loc_us-gaap_LongTermDebt_56fd4ffa-6428-424c-be87-b8a5e8338bec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_7575e590-b38c-4f9c-889d-826054755e11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_73071f82-a181-46c2-a666-73fb9e6b60ef" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_7575e590-b38c-4f9c-889d-826054755e11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_6e770c1d-ce7f-4b1a-99a4-81f7c9eb9c31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_73071f82-a181-46c2-a666-73fb9e6b60ef" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_6e770c1d-ce7f-4b1a-99a4-81f7c9eb9c31" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c5415087-26fd-48c1-b6ea-6aad2d928943" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_6e770c1d-ce7f-4b1a-99a4-81f7c9eb9c31" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c5415087-26fd-48c1-b6ea-6aad2d928943" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c5415087-26fd-48c1-b6ea-6aad2d928943_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c5415087-26fd-48c1-b6ea-6aad2d928943" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c5415087-26fd-48c1-b6ea-6aad2d928943_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_bfe100d8-b242-4216-87a3-cc65bf71f9cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c5415087-26fd-48c1-b6ea-6aad2d928943" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_bfe100d8-b242-4216-87a3-cc65bf71f9cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_c0601f08-4190-4bbb-801a-4485ee2e1af9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_bfe100d8-b242-4216-87a3-cc65bf71f9cf" xlink:to="loc_us-gaap_SecuredDebtMember_c0601f08-4190-4bbb-801a-4485ee2e1af9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_53862c66-a6b5-42ff-8bb8-15c886c4147c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_bfe100d8-b242-4216-87a3-cc65bf71f9cf" xlink:to="loc_us-gaap_SeniorNotesMember_53862c66-a6b5-42ff-8bb8-15c886c4147c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_dced37c1-d2c1-40fc-bcb1-914ac89dc8b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_6e770c1d-ce7f-4b1a-99a4-81f7c9eb9c31" xlink:to="loc_us-gaap_DebtInstrumentAxis_dced37c1-d2c1-40fc-bcb1-914ac89dc8b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dced37c1-d2c1-40fc-bcb1-914ac89dc8b8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_dced37c1-d2c1-40fc-bcb1-914ac89dc8b8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dced37c1-d2c1-40fc-bcb1-914ac89dc8b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8cea8921-e35d-42ff-9dd0-969c10ed7d12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_dced37c1-d2c1-40fc-bcb1-914ac89dc8b8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8cea8921-e35d-42ff-9dd0-969c10ed7d12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_A2017TermLoanMaturing2024Member_e222a3ae-9727-43ec-9f92-74aa8931ba94" xlink:href="sgry-20210930.xsd#sgry_A2017TermLoanMaturing2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8cea8921-e35d-42ff-9dd0-969c10ed7d12" xlink:to="loc_sgry_A2017TermLoanMaturing2024Member_e222a3ae-9727-43ec-9f92-74aa8931ba94" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SeniorUnsecuredNotesDue2025Member_687f41e9-34ee-4b1a-a81e-c10721b7ba07" xlink:href="sgry-20210930.xsd#sgry_SeniorUnsecuredNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8cea8921-e35d-42ff-9dd0-969c10ed7d12" xlink:to="loc_sgry_SeniorUnsecuredNotesDue2025Member_687f41e9-34ee-4b1a-a81e-c10721b7ba07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SeniorUnsecuredNotesDue2027Member_e902476b-6356-446e-b074-e3c7fe90fa2e" xlink:href="sgry-20210930.xsd#sgry_SeniorUnsecuredNotesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8cea8921-e35d-42ff-9dd0-969c10ed7d12" xlink:to="loc_sgry_SeniorUnsecuredNotesDue2027Member_e902476b-6356-446e-b074-e3c7fe90fa2e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_d4bddab4-958c-4107-a26c-27ce6d3881af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_6e770c1d-ce7f-4b1a-99a4-81f7c9eb9c31" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_d4bddab4-958c-4107-a26c-27ce6d3881af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d4bddab4-958c-4107-a26c-27ce6d3881af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_d4bddab4-958c-4107-a26c-27ce6d3881af" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d4bddab4-958c-4107-a26c-27ce6d3881af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_1136f1cb-2b82-4670-913f-35e9305cebd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_d4bddab4-958c-4107-a26c-27ce6d3881af" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_1136f1cb-2b82-4670-913f-35e9305cebd9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8133943f-37c8-4653-9de8-e6bd61bd3827" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_1136f1cb-2b82-4670-913f-35e9305cebd9" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8133943f-37c8-4653-9de8-e6bd61bd3827" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_dcbe2476-3358-41d5-90b8-30cdbca160ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_1136f1cb-2b82-4670-913f-35e9305cebd9" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_dcbe2476-3358-41d5-90b8-30cdbca160ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_4b72ef77-10f1-43a4-a477-38be275a0568" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_1136f1cb-2b82-4670-913f-35e9305cebd9" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_4b72ef77-10f1-43a4-a477-38be275a0568" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bd4997b1-31b4-4cdc-86e4-5950346e56a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_6e770c1d-ce7f-4b1a-99a4-81f7c9eb9c31" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bd4997b1-31b4-4cdc-86e4-5950346e56a7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bd4997b1-31b4-4cdc-86e4-5950346e56a7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bd4997b1-31b4-4cdc-86e4-5950346e56a7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bd4997b1-31b4-4cdc-86e4-5950346e56a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_84f84939-06f7-487d-810a-420e2dff9b78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bd4997b1-31b4-4cdc-86e4-5950346e56a7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_84f84939-06f7-487d-810a-420e2dff9b78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_f37eff34-ada8-4793-a0c5-e570ce8979c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_84f84939-06f7-487d-810a-420e2dff9b78" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_f37eff34-ada8-4793-a0c5-e570ce8979c1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails" xlink:type="extended" id="idd8a98f430774d5e9ca3863facb1771c_OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_3595624d-7b20-469d-869e-9f2fe191ce81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_1e300284-d55e-4da5-9605-ef4bdc5964a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_3595624d-7b20-469d-869e-9f2fe191ce81" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_1e300284-d55e-4da5-9605-ef4bdc5964a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_7a410a55-5b7c-42d7-974d-d6abc68a8ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_3595624d-7b20-469d-869e-9f2fe191ce81" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_7a410a55-5b7c-42d7-974d-d6abc68a8ee5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_964abef4-0a50-4f78-b841-8a45cab24626" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_7a410a55-5b7c-42d7-974d-d6abc68a8ee5" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_964abef4-0a50-4f78-b841-8a45cab24626" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_964abef4-0a50-4f78-b841-8a45cab24626_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_964abef4-0a50-4f78-b841-8a45cab24626" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_964abef4-0a50-4f78-b841-8a45cab24626_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_5632d618-e5c3-41fb-a48d-6c47d835eb5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_964abef4-0a50-4f78-b841-8a45cab24626" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_5632d618-e5c3-41fb-a48d-6c47d835eb5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_423e0678-453a-4f4a-9a39-ea93bda82bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_5632d618-e5c3-41fb-a48d-6c47d835eb5f" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_423e0678-453a-4f4a-9a39-ea93bda82bd2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_acb78d08-6379-4b94-a7f6-1db0ddef24f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_7a410a55-5b7c-42d7-974d-d6abc68a8ee5" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_acb78d08-6379-4b94-a7f6-1db0ddef24f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_acb78d08-6379-4b94-a7f6-1db0ddef24f2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_acb78d08-6379-4b94-a7f6-1db0ddef24f2" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_acb78d08-6379-4b94-a7f6-1db0ddef24f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_572f8f27-0757-4f58-a495-c52af53e209d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_acb78d08-6379-4b94-a7f6-1db0ddef24f2" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_572f8f27-0757-4f58-a495-c52af53e209d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_629a7c1e-e584-48b1-b197-be79d1ebac58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_572f8f27-0757-4f58-a495-c52af53e209d" xlink:to="loc_us-gaap_SalesRevenueNetMember_629a7c1e-e584-48b1-b197-be79d1ebac58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_18370c23-1855-4768-869b-c8f42631c7fd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_7a410a55-5b7c-42d7-974d-d6abc68a8ee5" xlink:to="loc_srt_ProductOrServiceAxis_18370c23-1855-4768-869b-c8f42631c7fd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_18370c23-1855-4768-869b-c8f42631c7fd_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_18370c23-1855-4768-869b-c8f42631c7fd" xlink:to="loc_srt_ProductsAndServicesDomain_18370c23-1855-4768-869b-c8f42631c7fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2d668b59-4a81-433a-85e4-0c6e6f7dd60d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_18370c23-1855-4768-869b-c8f42631c7fd" xlink:to="loc_srt_ProductsAndServicesDomain_2d668b59-4a81-433a-85e4-0c6e6f7dd60d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_HealthcareOrganizationPatientServiceMember_38c20205-0a69-4389-a717-84ae9d04c452" xlink:href="sgry-20210930.xsd#sgry_HealthcareOrganizationPatientServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2d668b59-4a81-433a-85e4-0c6e6f7dd60d" xlink:to="loc_sgry_HealthcareOrganizationPatientServiceMember_38c20205-0a69-4389-a717-84ae9d04c452" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SurgicalFacilityServicesMember_3a18259c-380d-47c9-8380-ff91e89b7a2a" xlink:href="sgry-20210930.xsd#sgry_SurgicalFacilityServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sgry_HealthcareOrganizationPatientServiceMember_38c20205-0a69-4389-a717-84ae9d04c452" xlink:to="loc_sgry_SurgicalFacilityServicesMember_3a18259c-380d-47c9-8380-ff91e89b7a2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_AncillaryServicesMember_e6657e55-0376-464b-986a-ed383b856abf" xlink:href="sgry-20210930.xsd#sgry_AncillaryServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sgry_HealthcareOrganizationPatientServiceMember_38c20205-0a69-4389-a717-84ae9d04c452" xlink:to="loc_sgry_AncillaryServicesMember_e6657e55-0376-464b-986a-ed383b856abf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_OtherServicesMember_11438caf-f74a-47ab-9188-56d16ddd0dea" xlink:href="sgry-20210930.xsd#sgry_OtherServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2d668b59-4a81-433a-85e4-0c6e6f7dd60d" xlink:to="loc_sgry_OtherServicesMember_11438caf-f74a-47ab-9188-56d16ddd0dea" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails" xlink:type="extended" id="i82b2162fc5764cf19cf5d78c192d2f57_OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_a4e08ff0-e2ef-4768-86b6-fc2b0f155d93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_324665a3-3f82-44e6-90b6-d8ba39c023f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4e08ff0-e2ef-4768-86b6-fc2b0f155d93" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_324665a3-3f82-44e6-90b6-d8ba39c023f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_aba39dfb-7f6b-43d6-b54e-4f3ac064ef5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4e08ff0-e2ef-4768-86b6-fc2b0f155d93" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_aba39dfb-7f6b-43d6-b54e-4f3ac064ef5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_58614a3a-e597-4cfe-831c-472db270ff2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4e08ff0-e2ef-4768-86b6-fc2b0f155d93" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_58614a3a-e597-4cfe-831c-472db270ff2c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_360d6425-6b59-4193-9267-c3698d08d8e6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_58614a3a-e597-4cfe-831c-472db270ff2c" xlink:to="loc_srt_ProductOrServiceAxis_360d6425-6b59-4193-9267-c3698d08d8e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_360d6425-6b59-4193-9267-c3698d08d8e6_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_360d6425-6b59-4193-9267-c3698d08d8e6" xlink:to="loc_srt_ProductsAndServicesDomain_360d6425-6b59-4193-9267-c3698d08d8e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0d16651a-0b21-445d-8b45-cb99fe8f7bda" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_360d6425-6b59-4193-9267-c3698d08d8e6" xlink:to="loc_srt_ProductsAndServicesDomain_0d16651a-0b21-445d-8b45-cb99fe8f7bda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_HealthcareOrganizationPatientServiceMember_8efa0768-6b88-4f6a-96fe-8f782f1a3511" xlink:href="sgry-20210930.xsd#sgry_HealthcareOrganizationPatientServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0d16651a-0b21-445d-8b45-cb99fe8f7bda" xlink:to="loc_sgry_HealthcareOrganizationPatientServiceMember_8efa0768-6b88-4f6a-96fe-8f782f1a3511" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PrivateInsuranceMember_f0f7e804-334f-4993-9220-7b4f9b22d6f0" xlink:href="sgry-20210930.xsd#sgry_PrivateInsuranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sgry_HealthcareOrganizationPatientServiceMember_8efa0768-6b88-4f6a-96fe-8f782f1a3511" xlink:to="loc_sgry_PrivateInsuranceMember_f0f7e804-334f-4993-9220-7b4f9b22d6f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentContractMember_4c48418a-e6ae-4096-b3ac-540a58a6883d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GovernmentContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sgry_HealthcareOrganizationPatientServiceMember_8efa0768-6b88-4f6a-96fe-8f782f1a3511" xlink:to="loc_us-gaap_GovernmentContractMember_4c48418a-e6ae-4096-b3ac-540a58a6883d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SelfPayRevenueMember_ee474379-30ec-4fee-a84c-dbfc18f7982d" xlink:href="sgry-20210930.xsd#sgry_SelfPayRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sgry_HealthcareOrganizationPatientServiceMember_8efa0768-6b88-4f6a-96fe-8f782f1a3511" xlink:to="loc_sgry_SelfPayRevenueMember_ee474379-30ec-4fee-a84c-dbfc18f7982d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_OtherPatientServiceRevenueSourcesMember_e4c3d32f-b605-43d4-8b61-8e2463496864" xlink:href="sgry-20210930.xsd#sgry_OtherPatientServiceRevenueSourcesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sgry_HealthcareOrganizationPatientServiceMember_8efa0768-6b88-4f6a-96fe-8f782f1a3511" xlink:to="loc_sgry_OtherPatientServiceRevenueSourcesMember_e4c3d32f-b605-43d4-8b61-8e2463496864" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_OtherServicesMember_7d64e3b8-9eb3-4417-91a2-9852ff8585b6" xlink:href="sgry-20210930.xsd#sgry_OtherServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0d16651a-0b21-445d-8b45-cb99fe8f7bda" xlink:to="loc_sgry_OtherServicesMember_7d64e3b8-9eb3-4417-91a2-9852ff8585b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_ca56bb75-1dd9-4883-9445-e12c13c09e54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_58614a3a-e597-4cfe-831c-472db270ff2c" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_ca56bb75-1dd9-4883-9445-e12c13c09e54" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ca56bb75-1dd9-4883-9445-e12c13c09e54_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ca56bb75-1dd9-4883-9445-e12c13c09e54" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ca56bb75-1dd9-4883-9445-e12c13c09e54_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_55b7f792-aa6b-4f44-bc02-9503607965f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ca56bb75-1dd9-4883-9445-e12c13c09e54" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_55b7f792-aa6b-4f44-bc02-9503607965f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_30831abe-ad5f-42e7-a0fd-256c5c8e74ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_55b7f792-aa6b-4f44-bc02-9503607965f3" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_30831abe-ad5f-42e7-a0fd-256c5c8e74ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0267a68d-8aa3-423f-abf0-7d765de3fc4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_58614a3a-e597-4cfe-831c-472db270ff2c" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0267a68d-8aa3-423f-abf0-7d765de3fc4f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0267a68d-8aa3-423f-abf0-7d765de3fc4f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0267a68d-8aa3-423f-abf0-7d765de3fc4f" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0267a68d-8aa3-423f-abf0-7d765de3fc4f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_56691ec0-6760-4948-9b37-9a281074367d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0267a68d-8aa3-423f-abf0-7d765de3fc4f" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_56691ec0-6760-4948-9b37-9a281074367d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_d84d2408-2be4-4b38-a57f-8145943b019e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_56691ec0-6760-4948-9b37-9a281074367d" xlink:to="loc_us-gaap_SalesRevenueNetMember_d84d2408-2be4-4b38-a57f-8145943b019e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/AcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#AcquisitionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/AcquisitionsNarrativeDetails" xlink:type="extended" id="i5ef71bbe5c0b487ca7de8b6de74c6eb4_AcquisitionsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_7eab7de3-5dfc-4055-9eb9-ad7a39515e19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_6239af42-52d1-437a-be26-5d4d6a8c3252" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7eab7de3-5dfc-4055-9eb9-ad7a39515e19" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_6239af42-52d1-437a-be26-5d4d6a8c3252" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_edb2aadc-8bb8-455b-8f7f-f6518402cb50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7eab7de3-5dfc-4055-9eb9-ad7a39515e19" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_edb2aadc-8bb8-455b-8f7f-f6518402cb50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_15f201c9-d774-4741-afc9-fad3ea2701e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7eab7de3-5dfc-4055-9eb9-ad7a39515e19" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_15f201c9-d774-4741-afc9-fad3ea2701e8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_733283eb-7213-4536-879d-42c12d8dd3f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_15f201c9-d774-4741-afc9-fad3ea2701e8" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_733283eb-7213-4536-879d-42c12d8dd3f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_733283eb-7213-4536-879d-42c12d8dd3f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_733283eb-7213-4536-879d-42c12d8dd3f6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_733283eb-7213-4536-879d-42c12d8dd3f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fd4bff1e-4e6d-4f03-bae8-c202a7b9ce2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_733283eb-7213-4536-879d-42c12d8dd3f6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fd4bff1e-4e6d-4f03-bae8-c202a7b9ce2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SurgicalFacilitiesNewMarketsMember_6ae2c861-ea75-452d-997f-ec18cf7e8046" xlink:href="sgry-20210930.xsd#sgry_SurgicalFacilitiesNewMarketsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fd4bff1e-4e6d-4f03-bae8-c202a7b9ce2c" xlink:to="loc_sgry_SurgicalFacilitiesNewMarketsMember_6ae2c861-ea75-452d-997f-ec18cf7e8046" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SurgicalFacilitiesExistingMarketsMember_d99581f3-912b-4919-b880-fee73a973752" xlink:href="sgry-20210930.xsd#sgry_SurgicalFacilitiesExistingMarketsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fd4bff1e-4e6d-4f03-bae8-c202a7b9ce2c" xlink:to="loc_sgry_SurgicalFacilitiesExistingMarketsMember_d99581f3-912b-4919-b880-fee73a973752" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/AcquisitionsSummaryDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#AcquisitionsSummaryDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/AcquisitionsSummaryDetails" xlink:type="extended" id="i29ce6ab251de4429881ac95873a6df5f_AcquisitionsSummaryDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_f3825a2c-a8d3-4b2c-bbd7-5eee4c38aec5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_d19c7148-b82a-4a78-a249-5f1aa6e894a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3825a2c-a8d3-4b2c-bbd7-5eee4c38aec5" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_d19c7148-b82a-4a78-a249-5f1aa6e894a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_0968a95f-0341-4198-87ed-a8c8ccc84f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3825a2c-a8d3-4b2c-bbd7-5eee4c38aec5" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_0968a95f-0341-4198-87ed-a8c8ccc84f7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_706da4b0-cdbd-47f1-adeb-72ddd97a9ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3825a2c-a8d3-4b2c-bbd7-5eee4c38aec5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_706da4b0-cdbd-47f1-adeb-72ddd97a9ed8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_b0240f86-6a63-41ea-9b1e-4ff8a8eabc7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3825a2c-a8d3-4b2c-bbd7-5eee4c38aec5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_b0240f86-6a63-41ea-9b1e-4ff8a8eabc7f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_bc0d357e-8e71-427a-a6ea-4e89ec4e6463" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_b0240f86-6a63-41ea-9b1e-4ff8a8eabc7f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_bc0d357e-8e71-427a-a6ea-4e89ec4e6463" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_24e1413d-91f5-4196-9340-cced3f40fe83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_b0240f86-6a63-41ea-9b1e-4ff8a8eabc7f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_24e1413d-91f5-4196-9340-cced3f40fe83" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_eae7f238-63f8-4a1c-80a6-47c3223da8b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_b0240f86-6a63-41ea-9b1e-4ff8a8eabc7f" xlink:to="loc_us-gaap_Goodwill_eae7f238-63f8-4a1c-80a6-47c3223da8b7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingRightOfUseAssets_848e2197-9d33-40df-9cdc-cf551a4395d0" xlink:href="sgry-20210930.xsd#sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_b0240f86-6a63-41ea-9b1e-4ff8a8eabc7f" xlink:to="loc_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingRightOfUseAssets_848e2197-9d33-40df-9cdc-cf551a4395d0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_e70fe001-493d-4e11-b0f2-9463853f147a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_b0240f86-6a63-41ea-9b1e-4ff8a8eabc7f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_e70fe001-493d-4e11-b0f2-9463853f147a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_5fd3286d-a16a-4a56-aa7c-3b3494c062ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_b0240f86-6a63-41ea-9b1e-4ff8a8eabc7f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_5fd3286d-a16a-4a56-aa7c-3b3494c062ea" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt_d38f364c-da58-4a34-905a-55667969e083" xlink:href="sgry-20210930.xsd#sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_b0240f86-6a63-41ea-9b1e-4ff8a8eabc7f" xlink:to="loc_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt_d38f364c-da58-4a34-905a-55667969e083" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability_5b0f9b1f-440c-4db4-81ec-d5b5013d6cb5" xlink:href="sgry-20210930.xsd#sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_b0240f86-6a63-41ea-9b1e-4ff8a8eabc7f" xlink:to="loc_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability_5b0f9b1f-440c-4db4-81ec-d5b5013d6cb5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_815b0d96-2025-47dd-9f87-3d6b11623e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_273258a7-af94-4a5c-aa83-11550fe038e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3825a2c-a8d3-4b2c-bbd7-5eee4c38aec5" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_273258a7-af94-4a5c-aa83-11550fe038e9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5034efc0-fb47-4178-a5a7-654bf785c578" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_273258a7-af94-4a5c-aa83-11550fe038e9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5034efc0-fb47-4178-a5a7-654bf785c578" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5034efc0-fb47-4178-a5a7-654bf785c578_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5034efc0-fb47-4178-a5a7-654bf785c578" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5034efc0-fb47-4178-a5a7-654bf785c578_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_06c2a69f-565b-4904-90a5-fc4c423a7843" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5034efc0-fb47-4178-a5a7-654bf785c578" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_06c2a69f-565b-4904-90a5-fc4c423a7843" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SurgicalFacilitiesExistingMarketsMember_3eeca084-e506-4ff8-8a2c-16cd497bfc4d" xlink:href="sgry-20210930.xsd#sgry_SurgicalFacilitiesExistingMarketsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_06c2a69f-565b-4904-90a5-fc4c423a7843" xlink:to="loc_sgry_SurgicalFacilitiesExistingMarketsMember_3eeca084-e506-4ff8-8a2c-16cd497bfc4d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/LongTermDebtSummaryDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#LongTermDebtSummaryDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/LongTermDebtSummaryDetails" xlink:type="extended" id="i4d25527adffa40dba986729b7315c46f_LongTermDebtSummaryDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2cc05c55-5d32-41d5-9219-2765ebdedacc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_ad5468f4-8083-4840-94e8-0c6192e601db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cc05c55-5d32-41d5-9219-2765ebdedacc" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_ad5468f4-8083-4840-94e8-0c6192e601db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_a93e3b22-d7c2-4e14-9d98-7f89e88f22f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cc05c55-5d32-41d5-9219-2765ebdedacc" xlink:to="loc_us-gaap_FinanceLeaseLiability_a93e3b22-d7c2-4e14-9d98-7f89e88f22f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_c2452554-ec71-4709-b669-134f401a681b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cc05c55-5d32-41d5-9219-2765ebdedacc" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_c2452554-ec71-4709-b669-134f401a681b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_53b062e3-c2d2-471e-b6b6-683df7a8aa8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cc05c55-5d32-41d5-9219-2765ebdedacc" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_53b062e3-c2d2-471e-b6b6-683df7a8aa8d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_f620fc60-f776-47d2-a37f-6ea8acc6ed45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cc05c55-5d32-41d5-9219-2765ebdedacc" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_f620fc60-f776-47d2-a37f-6ea8acc6ed45" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_736f4f88-0509-4c2e-87db-74eaa954b4e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cc05c55-5d32-41d5-9219-2765ebdedacc" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_736f4f88-0509-4c2e-87db-74eaa954b4e2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_30ae6f05-cca3-43cf-8f4b-a35ff9124c59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cc05c55-5d32-41d5-9219-2765ebdedacc" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_30ae6f05-cca3-43cf-8f4b-a35ff9124c59" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_c04d1972-0c01-4e97-8d34-1d809ac97f58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cc05c55-5d32-41d5-9219-2765ebdedacc" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_c04d1972-0c01-4e97-8d34-1d809ac97f58" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_27d3a536-907b-4015-acce-dc7959d7adef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cc05c55-5d32-41d5-9219-2765ebdedacc" xlink:to="loc_us-gaap_DebtInstrumentTable_27d3a536-907b-4015-acce-dc7959d7adef" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b8900527-791c-4437-8d2e-cd145163d78b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_27d3a536-907b-4015-acce-dc7959d7adef" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b8900527-791c-4437-8d2e-cd145163d78b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b8900527-791c-4437-8d2e-cd145163d78b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b8900527-791c-4437-8d2e-cd145163d78b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b8900527-791c-4437-8d2e-cd145163d78b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6b02ab2d-61a8-47f7-a1be-13b8f86a19cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b8900527-791c-4437-8d2e-cd145163d78b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6b02ab2d-61a8-47f7-a1be-13b8f86a19cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_f8b7a2ab-1742-4918-be26-bd19b7bd4846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6b02ab2d-61a8-47f7-a1be-13b8f86a19cc" xlink:to="loc_us-gaap_SecuredDebtMember_f8b7a2ab-1742-4918-be26-bd19b7bd4846" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_98956455-2184-498b-8b79-70c6ae620624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6b02ab2d-61a8-47f7-a1be-13b8f86a19cc" xlink:to="loc_us-gaap_SeniorNotesMember_98956455-2184-498b-8b79-70c6ae620624" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NotesPayableAndSecuredLoansMember_887d6fa6-03b4-4518-ac05-60ca6599a1d5" xlink:href="sgry-20210930.xsd#sgry_NotesPayableAndSecuredLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6b02ab2d-61a8-47f7-a1be-13b8f86a19cc" xlink:to="loc_sgry_NotesPayableAndSecuredLoansMember_887d6fa6-03b4-4518-ac05-60ca6599a1d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_eeecef8c-f733-406d-94c9-f1542ee742ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_27d3a536-907b-4015-acce-dc7959d7adef" xlink:to="loc_us-gaap_DebtInstrumentAxis_eeecef8c-f733-406d-94c9-f1542ee742ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_eeecef8c-f733-406d-94c9-f1542ee742ac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_eeecef8c-f733-406d-94c9-f1542ee742ac" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_eeecef8c-f733-406d-94c9-f1542ee742ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3acbc753-b50e-4beb-bb17-bcd8eee16fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_eeecef8c-f733-406d-94c9-f1542ee742ac" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3acbc753-b50e-4beb-bb17-bcd8eee16fc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_A2017TermLoanMaturing2024Member_f405b4ab-70af-457c-b9ab-19341b87e0ee" xlink:href="sgry-20210930.xsd#sgry_A2017TermLoanMaturing2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3acbc753-b50e-4beb-bb17-bcd8eee16fc4" xlink:to="loc_sgry_A2017TermLoanMaturing2024Member_f405b4ab-70af-457c-b9ab-19341b87e0ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SeniorUnsecuredNotesDue2025Member_1fb3632d-371f-4371-a147-13c301958cb0" xlink:href="sgry-20210930.xsd#sgry_SeniorUnsecuredNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3acbc753-b50e-4beb-bb17-bcd8eee16fc4" xlink:to="loc_sgry_SeniorUnsecuredNotesDue2025Member_1fb3632d-371f-4371-a147-13c301958cb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SeniorUnsecuredNotesDue2027Member_d168798b-8f14-4727-84db-7b36e3819cad" xlink:href="sgry-20210930.xsd#sgry_SeniorUnsecuredNotesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3acbc753-b50e-4beb-bb17-bcd8eee16fc4" xlink:to="loc_sgry_SeniorUnsecuredNotesDue2027Member_d168798b-8f14-4727-84db-7b36e3819cad" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#LongTermDebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails" xlink:type="extended" id="i6582061ebf51497db35201f294598dfc_LongTermDebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ed67b7a6-828f-47e6-b7f4-1fd07b3f6bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_LineOfCreditFacilityMaximumBorrowingCapacityIncrease_e8359e2a-8a42-431e-aba9-5f41497c2979" xlink:href="sgry-20210930.xsd#sgry_LineOfCreditFacilityMaximumBorrowingCapacityIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed67b7a6-828f-47e6-b7f4-1fd07b3f6bdc" xlink:to="loc_sgry_LineOfCreditFacilityMaximumBorrowingCapacityIncrease_e8359e2a-8a42-431e-aba9-5f41497c2979" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_39057f61-ea9f-46a5-89a9-b47c4a38d05a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed67b7a6-828f-47e6-b7f4-1fd07b3f6bdc" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_39057f61-ea9f-46a5-89a9-b47c4a38d05a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_ba2133df-16a0-40c3-b9fa-663724330e72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed67b7a6-828f-47e6-b7f4-1fd07b3f6bdc" xlink:to="loc_us-gaap_LineOfCredit_ba2133df-16a0-40c3-b9fa-663724330e72" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_41ac3518-128a-4d03-966f-70b7a30918ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed67b7a6-828f-47e6-b7f4-1fd07b3f6bdc" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_41ac3518-128a-4d03-966f-70b7a30918ce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DebtInstrumentCovenantMaturityMinimumAmountOfOtherExistingDebtRemaining_87d2e11b-fede-45e8-924d-299244ee44a1" xlink:href="sgry-20210930.xsd#sgry_DebtInstrumentCovenantMaturityMinimumAmountOfOtherExistingDebtRemaining"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed67b7a6-828f-47e6-b7f4-1fd07b3f6bdc" xlink:to="loc_sgry_DebtInstrumentCovenantMaturityMinimumAmountOfOtherExistingDebtRemaining_87d2e11b-fede-45e8-924d-299244ee44a1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e5db7e3d-2bb4-42b0-8a8a-242210e9915f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed67b7a6-828f-47e6-b7f4-1fd07b3f6bdc" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e5db7e3d-2bb4-42b0-8a8a-242210e9915f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DebtInstrumentCovenantMaturityMinimumMaturityDateForOtherExistingDebtRemaining_c82b057e-9722-415a-b6af-0ca60f560472" xlink:href="sgry-20210930.xsd#sgry_DebtInstrumentCovenantMaturityMinimumMaturityDateForOtherExistingDebtRemaining"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed67b7a6-828f-47e6-b7f4-1fd07b3f6bdc" xlink:to="loc_sgry_DebtInstrumentCovenantMaturityMinimumMaturityDateForOtherExistingDebtRemaining_c82b057e-9722-415a-b6af-0ca60f560472" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_b5dd612d-7ace-4579-956d-492b0f50ab3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed67b7a6-828f-47e6-b7f4-1fd07b3f6bdc" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_b5dd612d-7ace-4579-956d-492b0f50ab3b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DebtInstrumentBasisSpreadOnVariableRateFloor_81b38f64-680a-4d9d-ac0b-49ca73fc95c7" xlink:href="sgry-20210930.xsd#sgry_DebtInstrumentBasisSpreadOnVariableRateFloor"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed67b7a6-828f-47e6-b7f4-1fd07b3f6bdc" xlink:to="loc_sgry_DebtInstrumentBasisSpreadOnVariableRateFloor_81b38f64-680a-4d9d-ac0b-49ca73fc95c7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DebtInstrumentQuarterlyAmortizationPercentPerAnnum_8f6e36de-6026-407e-aa75-f55ad1bb0652" xlink:href="sgry-20210930.xsd#sgry_DebtInstrumentQuarterlyAmortizationPercentPerAnnum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed67b7a6-828f-47e6-b7f4-1fd07b3f6bdc" xlink:to="loc_sgry_DebtInstrumentQuarterlyAmortizationPercentPerAnnum_8f6e36de-6026-407e-aa75-f55ad1bb0652" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_e6e63990-25ea-4186-85ac-c2d361062a82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed67b7a6-828f-47e6-b7f4-1fd07b3f6bdc" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_e6e63990-25ea-4186-85ac-c2d361062a82" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_479cdc79-3ef2-4f76-864b-e787b5563480" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed67b7a6-828f-47e6-b7f4-1fd07b3f6bdc" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_479cdc79-3ef2-4f76-864b-e787b5563480" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_19321f02-f1c9-4685-b7a8-440e95c28658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed67b7a6-828f-47e6-b7f4-1fd07b3f6bdc" xlink:to="loc_us-gaap_DebtInstrumentTable_19321f02-f1c9-4685-b7a8-440e95c28658" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_d1f32f95-b2fc-4c76-9796-83b7c1b5e688" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_19321f02-f1c9-4685-b7a8-440e95c28658" xlink:to="loc_us-gaap_CreditFacilityAxis_d1f32f95-b2fc-4c76-9796-83b7c1b5e688" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d1f32f95-b2fc-4c76-9796-83b7c1b5e688_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_d1f32f95-b2fc-4c76-9796-83b7c1b5e688" xlink:to="loc_us-gaap_CreditFacilityDomain_d1f32f95-b2fc-4c76-9796-83b7c1b5e688_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_96659b30-13aa-4bf4-a041-30ff089b5de5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_d1f32f95-b2fc-4c76-9796-83b7c1b5e688" xlink:to="loc_us-gaap_CreditFacilityDomain_96659b30-13aa-4bf4-a041-30ff089b5de5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_965f3693-5d5c-47ae-88fc-c186618d0e63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_96659b30-13aa-4bf4-a041-30ff089b5de5" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_965f3693-5d5c-47ae-88fc-c186618d0e63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_673c58d6-c953-4a13-a380-93858ca81f31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_96659b30-13aa-4bf4-a041-30ff089b5de5" xlink:to="loc_us-gaap_LetterOfCreditMember_673c58d6-c953-4a13-a380-93858ca81f31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_50484e52-9057-4d81-ae69-566ac2d6ac81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_19321f02-f1c9-4685-b7a8-440e95c28658" xlink:to="loc_us-gaap_DebtInstrumentAxis_50484e52-9057-4d81-ae69-566ac2d6ac81" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_50484e52-9057-4d81-ae69-566ac2d6ac81_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_50484e52-9057-4d81-ae69-566ac2d6ac81" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_50484e52-9057-4d81-ae69-566ac2d6ac81_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a9923f57-1f0b-4686-aedb-3e0a33a17d30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_50484e52-9057-4d81-ae69-566ac2d6ac81" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a9923f57-1f0b-4686-aedb-3e0a33a17d30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_A2017SeniorSecuredCreditFacilityMember_fa68ef2c-774c-4e49-bc75-ebafaab19ab8" xlink:href="sgry-20210930.xsd#sgry_A2017SeniorSecuredCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9923f57-1f0b-4686-aedb-3e0a33a17d30" xlink:to="loc_sgry_A2017SeniorSecuredCreditFacilityMember_fa68ef2c-774c-4e49-bc75-ebafaab19ab8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember_91ccc2d0-d1b2-41a2-b059-590272943b15" xlink:href="sgry-20210930.xsd#sgry_A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9923f57-1f0b-4686-aedb-3e0a33a17d30" xlink:to="loc_sgry_A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember_91ccc2d0-d1b2-41a2-b059-590272943b15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SeniorUnsecuredNotesDue2025Member_ab92ef38-c0a0-4d60-9fe4-11f2f950da18" xlink:href="sgry-20210930.xsd#sgry_SeniorUnsecuredNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9923f57-1f0b-4686-aedb-3e0a33a17d30" xlink:to="loc_sgry_SeniorUnsecuredNotesDue2025Member_ab92ef38-c0a0-4d60-9fe4-11f2f950da18" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_131b9b85-565d-4bd0-84f8-085e1b574646" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_19321f02-f1c9-4685-b7a8-440e95c28658" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_131b9b85-565d-4bd0-84f8-085e1b574646" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_131b9b85-565d-4bd0-84f8-085e1b574646_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_131b9b85-565d-4bd0-84f8-085e1b574646" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_131b9b85-565d-4bd0-84f8-085e1b574646_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9a417d78-2790-4c76-9d60-9604ba9d636b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_131b9b85-565d-4bd0-84f8-085e1b574646" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9a417d78-2790-4c76-9d60-9604ba9d636b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_ebfd7d56-fdad-441d-885a-b52246b86884" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9a417d78-2790-4c76-9d60-9604ba9d636b" xlink:to="loc_us-gaap_SecuredDebtMember_ebfd7d56-fdad-441d-885a-b52246b86884" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_ce0d174d-1dcc-4d33-9c70-8e3bb9b3b671" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9a417d78-2790-4c76-9d60-9604ba9d636b" xlink:to="loc_us-gaap_SeniorNotesMember_ce0d174d-1dcc-4d33-9c70-8e3bb9b3b671" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_9fd2a0da-f446-4c9d-889d-9d7abdd74fba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_19321f02-f1c9-4685-b7a8-440e95c28658" xlink:to="loc_us-gaap_VariableRateAxis_9fd2a0da-f446-4c9d-889d-9d7abdd74fba" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_9fd2a0da-f446-4c9d-889d-9d7abdd74fba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_9fd2a0da-f446-4c9d-889d-9d7abdd74fba" xlink:to="loc_us-gaap_VariableRateDomain_9fd2a0da-f446-4c9d-889d-9d7abdd74fba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_21df4002-27de-483d-a1b1-97930cf942af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_9fd2a0da-f446-4c9d-889d-9d7abdd74fba" xlink:to="loc_us-gaap_VariableRateDomain_21df4002-27de-483d-a1b1-97930cf942af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_da4bea5c-3f83-43e5-860a-59d09388eb79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_21df4002-27de-483d-a1b1-97930cf942af" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_da4bea5c-3f83-43e5-860a-59d09388eb79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_34eb4a77-1860-436d-8f9b-9e2e1d5c17b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_21df4002-27de-483d-a1b1-97930cf942af" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_34eb4a77-1860-436d-8f9b-9e2e1d5c17b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_OneMonthLondonInterbankOfferedRateLIBORMember_d01ba07e-a2c3-4a14-8a93-e098232264da" xlink:href="sgry-20210930.xsd#sgry_OneMonthLondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_21df4002-27de-483d-a1b1-97930cf942af" xlink:to="loc_sgry_OneMonthLondonInterbankOfferedRateLIBORMember_d01ba07e-a2c3-4a14-8a93-e098232264da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_365a6146-6d72-4b8e-9712-7e3c7f968db6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_21df4002-27de-483d-a1b1-97930cf942af" xlink:to="loc_us-gaap_BaseRateMember_365a6146-6d72-4b8e-9712-7e3c7f968db6" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/RedeemablePreferredStockNarrativeDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#RedeemablePreferredStockNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/RedeemablePreferredStockNarrativeDetails" xlink:type="extended" id="ie9653158ff7448babf4d456609f433f4_RedeemablePreferredStockNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_19ebaf9b-54bb-41b7-9f07-f25bfbebcac4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_cc87c0a6-61ed-47c4-b8f7-b86d2231c61c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_19ebaf9b-54bb-41b7-9f07-f25bfbebcac4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_cc87c0a6-61ed-47c4-b8f7-b86d2231c61c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_b8245fd3-7fd9-42de-b64e-c7f1d8db32a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_19ebaf9b-54bb-41b7-9f07-f25bfbebcac4" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_b8245fd3-7fd9-42de-b64e-c7f1d8db32a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_ecb80ec6-a8fb-42f3-aafe-82f4d337da3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_19ebaf9b-54bb-41b7-9f07-f25bfbebcac4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_ecb80ec6-a8fb-42f3-aafe-82f4d337da3f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_985d2735-4ebd-4cd6-88be-c43ffc202ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_19ebaf9b-54bb-41b7-9f07-f25bfbebcac4" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_985d2735-4ebd-4cd6-88be-c43ffc202ca9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_TemporaryEquityThresholdTradingDays_d27dbfa2-9e16-438f-b49b-fa7cdddf37e0" xlink:href="sgry-20210930.xsd#sgry_TemporaryEquityThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_19ebaf9b-54bb-41b7-9f07-f25bfbebcac4" xlink:to="loc_sgry_TemporaryEquityThresholdTradingDays_d27dbfa2-9e16-438f-b49b-fa7cdddf37e0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_TemporaryEquityThresholdConsecutiveTradingDays_0e28749b-e8be-472c-adcf-eb4175741d57" xlink:href="sgry-20210930.xsd#sgry_TemporaryEquityThresholdConsecutiveTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_19ebaf9b-54bb-41b7-9f07-f25bfbebcac4" xlink:to="loc_sgry_TemporaryEquityThresholdConsecutiveTradingDays_0e28749b-e8be-472c-adcf-eb4175741d57" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_TemporaryEquityThresholdSharePrice_9ce8ba3e-b6bd-4f32-acae-8e1588155649" xlink:href="sgry-20210930.xsd#sgry_TemporaryEquityThresholdSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_19ebaf9b-54bb-41b7-9f07-f25bfbebcac4" xlink:to="loc_sgry_TemporaryEquityThresholdSharePrice_9ce8ba3e-b6bd-4f32-acae-8e1588155649" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1_30dacdf7-566e-47bf-8054-3b8aaac2d679" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_19ebaf9b-54bb-41b7-9f07-f25bfbebcac4" xlink:to="loc_us-gaap_ConversionOfStockSharesIssued1_30dacdf7-566e-47bf-8054-3b8aaac2d679" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_cccfd50c-5cc6-4ab5-b734-b57a28522787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_19ebaf9b-54bb-41b7-9f07-f25bfbebcac4" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_cccfd50c-5cc6-4ab5-b734-b57a28522787" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_4675a0a9-fdd0-4dd6-a0fe-c74a92daa87c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_19ebaf9b-54bb-41b7-9f07-f25bfbebcac4" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_4675a0a9-fdd0-4dd6-a0fe-c74a92daa87c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_fa26a78c-d4a8-47e2-8272-ee91c1c4ec39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TemporaryEquityLineItems_19ebaf9b-54bb-41b7-9f07-f25bfbebcac4" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_fa26a78c-d4a8-47e2-8272-ee91c1c4ec39" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_58fc9286-448c-4724-b03d-df494441b274" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_fa26a78c-d4a8-47e2-8272-ee91c1c4ec39" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_58fc9286-448c-4724-b03d-df494441b274" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_58fc9286-448c-4724-b03d-df494441b274_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_58fc9286-448c-4724-b03d-df494441b274" xlink:to="loc_us-gaap_RelatedPartyDomain_58fc9286-448c-4724-b03d-df494441b274_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_844ece92-a6b5-4d4c-81e1-76c342475a84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_58fc9286-448c-4724-b03d-df494441b274" xlink:to="loc_us-gaap_RelatedPartyDomain_844ece92-a6b5-4d4c-81e1-76c342475a84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MajorityShareholderMember_9d264421-1cf8-4cf2-a02b-b94eecb7b061" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MajorityShareholderMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_844ece92-a6b5-4d4c-81e1-76c342475a84" xlink:to="loc_us-gaap_MajorityShareholderMember_9d264421-1cf8-4cf2-a02b-b94eecb7b061" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_9c1d9906-d545-4ceb-a33b-2e60a24e46e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_fa26a78c-d4a8-47e2-8272-ee91c1c4ec39" xlink:to="loc_us-gaap_StatementClassOfStockAxis_9c1d9906-d545-4ceb-a33b-2e60a24e46e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9c1d9906-d545-4ceb-a33b-2e60a24e46e5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_9c1d9906-d545-4ceb-a33b-2e60a24e46e5" xlink:to="loc_us-gaap_ClassOfStockDomain_9c1d9906-d545-4ceb-a33b-2e60a24e46e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_819b213c-8e22-467e-81be-57ad36a10da9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_9c1d9906-d545-4ceb-a33b-2e60a24e46e5" xlink:to="loc_us-gaap_ClassOfStockDomain_819b213c-8e22-467e-81be-57ad36a10da9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_c7e9ee5a-ff05-4f9d-b21c-cf080c594ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_819b213c-8e22-467e-81be-57ad36a10da9" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_c7e9ee5a-ff05-4f9d-b21c-cf080c594ce2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_fb51aede-f730-4c1b-8495-b8008f17b10b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_819b213c-8e22-467e-81be-57ad36a10da9" xlink:to="loc_us-gaap_CommonClassAMember_fb51aede-f730-4c1b-8495-b8008f17b10b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_f7772f74-fa57-4d44-92bf-898809053082" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_fa26a78c-d4a8-47e2-8272-ee91c1c4ec39" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_f7772f74-fa57-4d44-92bf-898809053082" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_f7772f74-fa57-4d44-92bf-898809053082_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_f7772f74-fa57-4d44-92bf-898809053082" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_f7772f74-fa57-4d44-92bf-898809053082_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_6d710b63-ba01-4665-af26-6282e56b5021" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_f7772f74-fa57-4d44-92bf-898809053082" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_6d710b63-ba01-4665-af26-6282e56b5021" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember_9a3d265f-f4f3-4845-9701-61d70af96dc4" xlink:href="sgry-20210930.xsd#sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_6d710b63-ba01-4665-af26-6282e56b5021" xlink:to="loc_sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember_9a3d265f-f4f3-4845-9701-61d70af96dc4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/RedeemablePreferredStockSummaryDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#RedeemablePreferredStockSummaryDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/RedeemablePreferredStockSummaryDetails" xlink:type="extended" id="ia43162b170e24f09958dcd56b60cc504_RedeemablePreferredStockSummaryDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_ed172468-c2b8-4f13-b9dd-b87d42fb43f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_13ed5db2-6449-43e7-8936-2b2da7bd520a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_ed172468-c2b8-4f13-b9dd-b87d42fb43f9" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_13ed5db2-6449-43e7-8936-2b2da7bd520a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_7e1fd268-c1f9-44fb-91cc-f9bb215d031c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_13ed5db2-6449-43e7-8936-2b2da7bd520a" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_7e1fd268-c1f9-44fb-91cc-f9bb215d031c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionOfDividends_ab052ad0-2626-4b37-85dc-be119ef80f00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionOfDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_13ed5db2-6449-43e7-8936-2b2da7bd520a" xlink:to="loc_us-gaap_TemporaryEquityAccretionOfDividends_ab052ad0-2626-4b37-85dc-be119ef80f00" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDividendsAdjustment_394024a9-bc4b-436c-a648-c501962030b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDividendsAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_13ed5db2-6449-43e7-8936-2b2da7bd520a" xlink:to="loc_us-gaap_TemporaryEquityDividendsAdjustment_394024a9-bc4b-436c-a648-c501962030b7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_fabd8edb-39af-4c4c-95dc-36e5b4c9b6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_13ed5db2-6449-43e7-8936-2b2da7bd520a" xlink:to="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_fabd8edb-39af-4c4c-95dc-36e5b4c9b6b8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_da0d394c-3061-4e23-b178-22ebbe9bcb25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_fbea4ff2-68e4-47f0-9d71-b0c2d1afe49f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TemporaryEquityLineItems_ed172468-c2b8-4f13-b9dd-b87d42fb43f9" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_fbea4ff2-68e4-47f0-9d71-b0c2d1afe49f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_de75f39d-10e2-44b6-9cfc-0f06323904fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_fbea4ff2-68e4-47f0-9d71-b0c2d1afe49f" xlink:to="loc_us-gaap_StatementClassOfStockAxis_de75f39d-10e2-44b6-9cfc-0f06323904fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_de75f39d-10e2-44b6-9cfc-0f06323904fc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_de75f39d-10e2-44b6-9cfc-0f06323904fc" xlink:to="loc_us-gaap_ClassOfStockDomain_de75f39d-10e2-44b6-9cfc-0f06323904fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_88c21e65-ce71-47f0-b764-042fac133f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_de75f39d-10e2-44b6-9cfc-0f06323904fc" xlink:to="loc_us-gaap_ClassOfStockDomain_88c21e65-ce71-47f0-b764-042fac133f1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_5f703b1b-f758-46da-a1ce-3a798918c710" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_88c21e65-ce71-47f0-b764-042fac133f1b" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_5f703b1b-f758-46da-a1ce-3a798918c710" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#DerivativesandHedgingActivitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails" xlink:type="extended" id="i5788a5cfbd804fe5b8ae3225f4f785a8_DerivativesandHedgingActivitiesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6fcd9aa7-d230-49ae-ac27-b46df5783e32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_d0c23119-a59a-4733-9714-135f81e7a5da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6fcd9aa7-d230-49ae-ac27-b46df5783e32" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_d0c23119-a59a-4733-9714-135f81e7a5da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_6f808d8d-1489-4937-8dd8-7b357f9dfb8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6fcd9aa7-d230-49ae-ac27-b46df5783e32" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_6f808d8d-1489-4937-8dd8-7b357f9dfb8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_4f88d8c8-f04f-4942-a8ee-db16127bd5c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6fcd9aa7-d230-49ae-ac27-b46df5783e32" xlink:to="loc_us-gaap_DerivativeNotionalAmount_4f88d8c8-f04f-4942-a8ee-db16127bd5c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate_c9017855-7d21-43b4-9cd8-6686f571400d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6fcd9aa7-d230-49ae-ac27-b46df5783e32" xlink:to="loc_us-gaap_DerivativeVariableInterestRate_c9017855-7d21-43b4-9cd8-6686f571400d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_8d4f32ce-79e5-4d07-924e-c658d0de255f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6fcd9aa7-d230-49ae-ac27-b46df5783e32" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_8d4f32ce-79e5-4d07-924e-c658d0de255f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b8853ecc-007b-4417-b4ee-30a7cf70cc31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6fcd9aa7-d230-49ae-ac27-b46df5783e32" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b8853ecc-007b-4417-b4ee-30a7cf70cc31" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3b8b7cd8-5957-4eea-b168-138cdffafc5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b8853ecc-007b-4417-b4ee-30a7cf70cc31" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3b8b7cd8-5957-4eea-b168-138cdffafc5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3b8b7cd8-5957-4eea-b168-138cdffafc5f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3b8b7cd8-5957-4eea-b168-138cdffafc5f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3b8b7cd8-5957-4eea-b168-138cdffafc5f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_dcf9eff7-0cd2-42a1-bfb9-ff5f176e9e11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3b8b7cd8-5957-4eea-b168-138cdffafc5f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_dcf9eff7-0cd2-42a1-bfb9-ff5f176e9e11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_732879c8-a5de-461a-8798-80ab1222afcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_dcf9eff7-0cd2-42a1-bfb9-ff5f176e9e11" xlink:to="loc_us-gaap_InterestRateSwapMember_732879c8-a5de-461a-8798-80ab1222afcb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ThreePayFixedInterestRateSwapsMember_b68faa5e-7eae-4e65-82f1-2a95b634fa78" xlink:href="sgry-20210930.xsd#sgry_ThreePayFixedInterestRateSwapsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_dcf9eff7-0cd2-42a1-bfb9-ff5f176e9e11" xlink:to="loc_sgry_ThreePayFixedInterestRateSwapsMember_b68faa5e-7eae-4e65-82f1-2a95b634fa78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ThreeReceiveFixedInterestRateSwapsMember_7af76a4d-ed01-4618-bfe2-9519e821b824" xlink:href="sgry-20210930.xsd#sgry_ThreeReceiveFixedInterestRateSwapsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_dcf9eff7-0cd2-42a1-bfb9-ff5f176e9e11" xlink:to="loc_sgry_ThreeReceiveFixedInterestRateSwapsMember_7af76a4d-ed01-4618-bfe2-9519e821b824" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_42cc1680-0a23-479c-ac06-d2aead625345" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_dcf9eff7-0cd2-42a1-bfb9-ff5f176e9e11" xlink:to="loc_us-gaap_InterestRateCapMember_42cc1680-0a23-479c-ac06-d2aead625345" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_5d53f483-8fb6-447e-bdb3-ad36822d44d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b8853ecc-007b-4417-b4ee-30a7cf70cc31" xlink:to="loc_us-gaap_HedgingDesignationAxis_5d53f483-8fb6-447e-bdb3-ad36822d44d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5d53f483-8fb6-447e-bdb3-ad36822d44d5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_5d53f483-8fb6-447e-bdb3-ad36822d44d5" xlink:to="loc_us-gaap_HedgingDesignationDomain_5d53f483-8fb6-447e-bdb3-ad36822d44d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_6caaf833-9c3a-4c26-83b2-38049ce38eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_5d53f483-8fb6-447e-bdb3-ad36822d44d5" xlink:to="loc_us-gaap_HedgingDesignationDomain_6caaf833-9c3a-4c26-83b2-38049ce38eb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_a33aa44e-78d7-4619-8109-2b6e479a1914" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_6caaf833-9c3a-4c26-83b2-38049ce38eb8" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_a33aa44e-78d7-4619-8109-2b6e479a1914" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_acfa6052-a794-4ba0-afb3-e2eb7704884e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_6caaf833-9c3a-4c26-83b2-38049ce38eb8" xlink:to="loc_us-gaap_NondesignatedMember_acfa6052-a794-4ba0-afb3-e2eb7704884e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_f1dd60b1-c49e-4438-bb21-dff88420b8d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b8853ecc-007b-4417-b4ee-30a7cf70cc31" xlink:to="loc_us-gaap_VariableRateAxis_f1dd60b1-c49e-4438-bb21-dff88420b8d3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_f1dd60b1-c49e-4438-bb21-dff88420b8d3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_f1dd60b1-c49e-4438-bb21-dff88420b8d3" xlink:to="loc_us-gaap_VariableRateDomain_f1dd60b1-c49e-4438-bb21-dff88420b8d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_4b1431c6-6267-45fb-9b04-b3b53ca85214" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_f1dd60b1-c49e-4438-bb21-dff88420b8d3" xlink:to="loc_us-gaap_VariableRateDomain_4b1431c6-6267-45fb-9b04-b3b53ca85214" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_71bcf92f-155f-4f1a-94e7-7addd44f5037" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_4b1431c6-6267-45fb-9b04-b3b53ca85214" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_71bcf92f-155f-4f1a-94e7-7addd44f5037" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dff39e48-e04c-4e95-a59d-46457c37e39e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b8853ecc-007b-4417-b4ee-30a7cf70cc31" xlink:to="loc_srt_RangeAxis_dff39e48-e04c-4e95-a59d-46457c37e39e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dff39e48-e04c-4e95-a59d-46457c37e39e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_dff39e48-e04c-4e95-a59d-46457c37e39e" xlink:to="loc_srt_RangeMember_dff39e48-e04c-4e95-a59d-46457c37e39e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0bd9629c-0067-4b64-abfb-b99dc026c161" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_dff39e48-e04c-4e95-a59d-46457c37e39e" xlink:to="loc_srt_RangeMember_0bd9629c-0067-4b64-abfb-b99dc026c161" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f716f381-464b-443d-8ced-3a1794346615" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0bd9629c-0067-4b64-abfb-b99dc026c161" xlink:to="loc_srt_MinimumMember_f716f381-464b-443d-8ced-3a1794346615" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails" xlink:type="extended" id="i7d269b00377b4c0b8f089ad4b7eff9c2_DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_e1447b66-fd60-4e6d-8a1d-2c46dd70bb8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_ab0ecff9-5ba7-4f8a-9c2a-101e9bc3c6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_e1447b66-fd60-4e6d-8a1d-2c46dd70bb8f" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_ab0ecff9-5ba7-4f8a-9c2a-101e9bc3c6d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_7a2c88fa-692a-4d7d-b237-81f54faa0cea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_e1447b66-fd60-4e6d-8a1d-2c46dd70bb8f" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_7a2c88fa-692a-4d7d-b237-81f54faa0cea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_8eab7b32-4324-4ad3-903c-06f2ddd0ece0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_e1447b66-fd60-4e6d-8a1d-2c46dd70bb8f" xlink:to="loc_us-gaap_DerivativeNotionalAmount_8eab7b32-4324-4ad3-903c-06f2ddd0ece0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_88ac633c-01ac-4f29-847c-361201ea5d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_e1447b66-fd60-4e6d-8a1d-2c46dd70bb8f" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_88ac633c-01ac-4f29-847c-361201ea5d0c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6e4df3d3-f532-4973-95ad-23ee714f3fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_88ac633c-01ac-4f29-847c-361201ea5d0c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6e4df3d3-f532-4973-95ad-23ee714f3fb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6e4df3d3-f532-4973-95ad-23ee714f3fb4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6e4df3d3-f532-4973-95ad-23ee714f3fb4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6e4df3d3-f532-4973-95ad-23ee714f3fb4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4157557d-46c2-450b-8993-a68a99fb1c77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6e4df3d3-f532-4973-95ad-23ee714f3fb4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4157557d-46c2-450b-8993-a68a99fb1c77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapOneMember_76e644d4-5d3b-455c-8548-3b18c5151f3d" xlink:href="sgry-20210930.xsd#sgry_PayFixedSwapOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4157557d-46c2-450b-8993-a68a99fb1c77" xlink:to="loc_sgry_PayFixedSwapOneMember_76e644d4-5d3b-455c-8548-3b18c5151f3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapTwoMember_9d296e1d-6f49-4da1-8760-44607e5bd38c" xlink:href="sgry-20210930.xsd#sgry_PayFixedSwapTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4157557d-46c2-450b-8993-a68a99fb1c77" xlink:to="loc_sgry_PayFixedSwapTwoMember_9d296e1d-6f49-4da1-8760-44607e5bd38c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapThreeMember_a114d95a-2173-41e3-a2b4-a2cd87dc793e" xlink:href="sgry-20210930.xsd#sgry_PayFixedSwapThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4157557d-46c2-450b-8993-a68a99fb1c77" xlink:to="loc_sgry_PayFixedSwapThreeMember_a114d95a-2173-41e3-a2b4-a2cd87dc793e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_InterestRateCapOneMember_ff8c4b9c-ce76-4aff-888c-d5b690e9e362" xlink:href="sgry-20210930.xsd#sgry_InterestRateCapOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4157557d-46c2-450b-8993-a68a99fb1c77" xlink:to="loc_sgry_InterestRateCapOneMember_ff8c4b9c-ce76-4aff-888c-d5b690e9e362" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_InterestRateCapTwoMember_00ad0805-5a67-4e67-a92e-9ec604c18f07" xlink:href="sgry-20210930.xsd#sgry_InterestRateCapTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4157557d-46c2-450b-8993-a68a99fb1c77" xlink:to="loc_sgry_InterestRateCapTwoMember_00ad0805-5a67-4e67-a92e-9ec604c18f07" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapFourMember_fac80c51-87c0-4ac0-90d1-30d5ba4c9c16" xlink:href="sgry-20210930.xsd#sgry_PayFixedSwapFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4157557d-46c2-450b-8993-a68a99fb1c77" xlink:to="loc_sgry_PayFixedSwapFourMember_fac80c51-87c0-4ac0-90d1-30d5ba4c9c16" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapFiveMember_b7fba556-6748-4f71-93e8-da64101d5c9e" xlink:href="sgry-20210930.xsd#sgry_PayFixedSwapFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4157557d-46c2-450b-8993-a68a99fb1c77" xlink:to="loc_sgry_PayFixedSwapFiveMember_b7fba556-6748-4f71-93e8-da64101d5c9e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapSixMember_5fab6149-456c-4bf7-a6ef-595aa5180d28" xlink:href="sgry-20210930.xsd#sgry_PayFixedSwapSixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4157557d-46c2-450b-8993-a68a99fb1c77" xlink:to="loc_sgry_PayFixedSwapSixMember_5fab6149-456c-4bf7-a6ef-595aa5180d28" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ReceiveFixedSwapOneMember_8daae23c-8004-41ff-9de9-269256ccfae1" xlink:href="sgry-20210930.xsd#sgry_ReceiveFixedSwapOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4157557d-46c2-450b-8993-a68a99fb1c77" xlink:to="loc_sgry_ReceiveFixedSwapOneMember_8daae23c-8004-41ff-9de9-269256ccfae1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ReceiveFixedSwapTwoMember_19b0de84-5956-430c-9262-c3f143a340ad" xlink:href="sgry-20210930.xsd#sgry_ReceiveFixedSwapTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4157557d-46c2-450b-8993-a68a99fb1c77" xlink:to="loc_sgry_ReceiveFixedSwapTwoMember_19b0de84-5956-430c-9262-c3f143a340ad" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ReceiveFixedSwapThreeMember_f2065cef-2de2-4947-ae17-a10e63f196d6" xlink:href="sgry-20210930.xsd#sgry_ReceiveFixedSwapThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4157557d-46c2-450b-8993-a68a99fb1c77" xlink:to="loc_sgry_ReceiveFixedSwapThreeMember_f2065cef-2de2-4947-ae17-a10e63f196d6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapSevenMember_fb9b0051-5c6c-4bce-b198-76a92f215093" xlink:href="sgry-20210930.xsd#sgry_PayFixedSwapSevenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4157557d-46c2-450b-8993-a68a99fb1c77" xlink:to="loc_sgry_PayFixedSwapSevenMember_fb9b0051-5c6c-4bce-b198-76a92f215093" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapEightMember_b4f3ba12-4eb4-49dd-8f4a-0ea991c7b1b0" xlink:href="sgry-20210930.xsd#sgry_PayFixedSwapEightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4157557d-46c2-450b-8993-a68a99fb1c77" xlink:to="loc_sgry_PayFixedSwapEightMember_b4f3ba12-4eb4-49dd-8f4a-0ea991c7b1b0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapNineMember_6ba22721-4450-4643-adce-15eb81db1cb2" xlink:href="sgry-20210930.xsd#sgry_PayFixedSwapNineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4157557d-46c2-450b-8993-a68a99fb1c77" xlink:to="loc_sgry_PayFixedSwapNineMember_6ba22721-4450-4643-adce-15eb81db1cb2" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapTenMember_3ce78b4d-6744-4934-9603-270a7098926c" xlink:href="sgry-20210930.xsd#sgry_PayFixedSwapTenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4157557d-46c2-450b-8993-a68a99fb1c77" xlink:to="loc_sgry_PayFixedSwapTenMember_3ce78b4d-6744-4934-9603-270a7098926c" xlink:type="arc" order="14"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesandtheirlocationonthecondensedconsolidatedbalancesheetsDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#DerivativesandHedgingActivitiesDerivativesandtheirlocationonthecondensedconsolidatedbalancesheetsDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesandtheirlocationonthecondensedconsolidatedbalancesheetsDetails" xlink:type="extended" id="iaa7c165fe3524113a53762373e455d73_DerivativesandHedgingActivitiesDerivativesandtheirlocationonthecondensedconsolidatedbalancesheetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_0405fcdd-8b1a-4f30-a5c0-e08e39e8d2ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_c9af1a88-9c0b-4143-9a32-9b196dcce7eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_0405fcdd-8b1a-4f30-a5c0-e08e39e8d2ad" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_c9af1a88-9c0b-4143-9a32-9b196dcce7eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_290a7c9e-f9da-4758-ba80-d42bae14b48e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_0405fcdd-8b1a-4f30-a5c0-e08e39e8d2ad" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_290a7c9e-f9da-4758-ba80-d42bae14b48e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DerivativeLiabilityNotionalAmountFinancingComponent_88065988-162b-4179-82a8-46912a25b350" xlink:href="sgry-20210930.xsd#sgry_DerivativeLiabilityNotionalAmountFinancingComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_0405fcdd-8b1a-4f30-a5c0-e08e39e8d2ad" xlink:to="loc_sgry_DerivativeLiabilityNotionalAmountFinancingComponent_88065988-162b-4179-82a8-46912a25b350" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_adc94c73-5f18-4b0d-8bfa-44a3a21a845f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_0405fcdd-8b1a-4f30-a5c0-e08e39e8d2ad" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_adc94c73-5f18-4b0d-8bfa-44a3a21a845f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_1bc4777e-dfa7-4aae-8e4b-2a1587e22e23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_adc94c73-5f18-4b0d-8bfa-44a3a21a845f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_1bc4777e-dfa7-4aae-8e4b-2a1587e22e23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1bc4777e-dfa7-4aae-8e4b-2a1587e22e23_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1bc4777e-dfa7-4aae-8e4b-2a1587e22e23" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1bc4777e-dfa7-4aae-8e4b-2a1587e22e23_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7f39da99-984e-4333-9e5e-7bb49ec340c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1bc4777e-dfa7-4aae-8e4b-2a1587e22e23" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7f39da99-984e-4333-9e5e-7bb49ec340c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_ce8cb295-0e39-4f01-b848-83b35bba7351" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7f39da99-984e-4333-9e5e-7bb49ec340c3" xlink:to="loc_us-gaap_InterestRateSwapMember_ce8cb295-0e39-4f01-b848-83b35bba7351" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_9d9ec1aa-156b-46a5-96b6-6cb19a6220cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7f39da99-984e-4333-9e5e-7bb49ec340c3" xlink:to="loc_us-gaap_InterestRateCapMember_9d9ec1aa-156b-46a5-96b6-6cb19a6220cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_c420a9e0-edd8-452e-baaf-3607edf6f89c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_adc94c73-5f18-4b0d-8bfa-44a3a21a845f" xlink:to="loc_us-gaap_HedgingDesignationAxis_c420a9e0-edd8-452e-baaf-3607edf6f89c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_c420a9e0-edd8-452e-baaf-3607edf6f89c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_c420a9e0-edd8-452e-baaf-3607edf6f89c" xlink:to="loc_us-gaap_HedgingDesignationDomain_c420a9e0-edd8-452e-baaf-3607edf6f89c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_48d7ae84-189a-402c-91da-dc6ee1a94170" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_c420a9e0-edd8-452e-baaf-3607edf6f89c" xlink:to="loc_us-gaap_HedgingDesignationDomain_48d7ae84-189a-402c-91da-dc6ee1a94170" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_c29a70e7-faa6-4acc-ada1-e5e0ed609379" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_48d7ae84-189a-402c-91da-dc6ee1a94170" xlink:to="loc_us-gaap_NondesignatedMember_c29a70e7-faa6-4acc-ada1-e5e0ed609379" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_d137d2f2-a5d6-4b88-86b9-48cff32c7526" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_48d7ae84-189a-402c-91da-dc6ee1a94170" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_d137d2f2-a5d6-4b88-86b9-48cff32c7526" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_18ffe66e-c802-409d-b7d7-8dff8327c21c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_adc94c73-5f18-4b0d-8bfa-44a3a21a845f" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_18ffe66e-c802-409d-b7d7-8dff8327c21c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_18ffe66e-c802-409d-b7d7-8dff8327c21c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_18ffe66e-c802-409d-b7d7-8dff8327c21c" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_18ffe66e-c802-409d-b7d7-8dff8327c21c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_821e06ee-8f58-4334-be44-714df43869f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_18ffe66e-c802-409d-b7d7-8dff8327c21c" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_821e06ee-8f58-4334-be44-714df43869f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_b4633a1f-8a7d-4197-b663-9c4dad9dca71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_821e06ee-8f58-4334-be44-714df43869f3" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_b4633a1f-8a7d-4197-b663-9c4dad9dca71" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_da17e793-d43a-4ec6-a67a-29cdd792c037" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_821e06ee-8f58-4334-be44-714df43869f3" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_da17e793-d43a-4ec6-a67a-29cdd792c037" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails" xlink:type="extended" id="i9f4840adbe5b422db657220dbf13948b_DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6a41299e-5ea2-4a52-9a47-c21549e3e593" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_9450c216-4090-4457-8e81-cc6f661622cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6a41299e-5ea2-4a52-9a47-c21549e3e593" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_9450c216-4090-4457-8e81-cc6f661622cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_7948b863-c321-4ff1-bcd3-64c7a6ae6785" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6a41299e-5ea2-4a52-9a47-c21549e3e593" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_7948b863-c321-4ff1-bcd3-64c7a6ae6785" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_418b7a44-cf50-416c-b39b-f084eb5f5b0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6a41299e-5ea2-4a52-9a47-c21549e3e593" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_418b7a44-cf50-416c-b39b-f084eb5f5b0f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_aae4421f-70da-47f1-a0cc-5f6f77d1c4d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6a41299e-5ea2-4a52-9a47-c21549e3e593" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_aae4421f-70da-47f1-a0cc-5f6f77d1c4d7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_735b6c20-bdff-4e47-9299-1f2a14708502" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_aae4421f-70da-47f1-a0cc-5f6f77d1c4d7" xlink:to="loc_us-gaap_HedgingDesignationAxis_735b6c20-bdff-4e47-9299-1f2a14708502" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_735b6c20-bdff-4e47-9299-1f2a14708502_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_735b6c20-bdff-4e47-9299-1f2a14708502" xlink:to="loc_us-gaap_HedgingDesignationDomain_735b6c20-bdff-4e47-9299-1f2a14708502_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_8ca64242-2f7a-441d-bc81-cf85dd85595f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_735b6c20-bdff-4e47-9299-1f2a14708502" xlink:to="loc_us-gaap_HedgingDesignationDomain_8ca64242-2f7a-441d-bc81-cf85dd85595f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_38dae39e-fa77-4d9a-a67e-5de70d33b414" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_8ca64242-2f7a-441d-bc81-cf85dd85595f" xlink:to="loc_us-gaap_NondesignatedMember_38dae39e-fa77-4d9a-a67e-5de70d33b414" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_bc0ea1fe-10f4-4e13-a6eb-fcf2c4cf0c09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_8ca64242-2f7a-441d-bc81-cf85dd85595f" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_bc0ea1fe-10f4-4e13-a6eb-fcf2c4cf0c09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_0c5c5e17-9f05-4e0b-ac43-19b6a53d62bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_aae4421f-70da-47f1-a0cc-5f6f77d1c4d7" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_0c5c5e17-9f05-4e0b-ac43-19b6a53d62bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_0c5c5e17-9f05-4e0b-ac43-19b6a53d62bd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0c5c5e17-9f05-4e0b-ac43-19b6a53d62bd" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_0c5c5e17-9f05-4e0b-ac43-19b6a53d62bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_793379a1-8fe9-4c31-9505-2e54b4221c10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0c5c5e17-9f05-4e0b-ac43-19b6a53d62bd" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_793379a1-8fe9-4c31-9505-2e54b4221c10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_5215fe29-049a-479c-8d69-094a0a80d58b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_793379a1-8fe9-4c31-9505-2e54b4221c10" xlink:to="loc_us-gaap_OtherIncomeMember_5215fe29-049a-479c-8d69-094a0a80d58b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_dec7f5f1-78a5-47be-8ce5-9e79ad8d1bca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_793379a1-8fe9-4c31-9505-2e54b4221c10" xlink:to="loc_us-gaap_InterestExpenseMember_dec7f5f1-78a5-47be-8ce5-9e79ad8d1bca" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#EarningsPerShareSummaryDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails" xlink:type="extended" id="i198147f4668542629f2f6902633c42b2_EarningsPerShareSummaryDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_d5c18272-4f24-416e-8c98-b9463b43c7ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract_2ae328f5-23ef-445e-b1f3-47da04561e54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_d5c18272-4f24-416e-8c98-b9463b43c7ac" xlink:to="loc_us-gaap_NetIncomeLossAbstract_2ae328f5-23ef-445e-b1f3-47da04561e54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2a77d0da-d205-4f63-b946-2c48ebe82b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAbstract_2ae328f5-23ef-445e-b1f3-47da04561e54" xlink:to="loc_us-gaap_NetIncomeLoss_2a77d0da-d205-4f63-b946-2c48ebe82b5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_07f8c627-17a1-42af-96fe-535f365570bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAbstract_2ae328f5-23ef-445e-b1f3-47da04561e54" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_07f8c627-17a1-42af-96fe-535f365570bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_4c318c6d-63fc-4be6-8802-494ae02fb273" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAbstract_2ae328f5-23ef-445e-b1f3-47da04561e54" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_4c318c6d-63fc-4be6-8802-494ae02fb273" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8d2bfe35-75a0-4d64-a056-98142ec7bd3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_d5c18272-4f24-416e-8c98-b9463b43c7ac" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8d2bfe35-75a0-4d64-a056-98142ec7bd3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_420afc78-a57b-4338-80db-bb3881bdd598" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8d2bfe35-75a0-4d64-a056-98142ec7bd3c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_420afc78-a57b-4338-80db-bb3881bdd598" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0d4fd7f6-c181-49ba-beb5-a49bf63cfd53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8d2bfe35-75a0-4d64-a056-98142ec7bd3c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0d4fd7f6-c181-49ba-beb5-a49bf63cfd53" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_d6dc6792-6ef0-4163-ad04-8b990e979502" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_d5c18272-4f24-416e-8c98-b9463b43c7ac" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_d6dc6792-6ef0-4163-ad04-8b990e979502" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_54d66930-216c-4c75-990d-133b54ef7852" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_d6dc6792-6ef0-4163-ad04-8b990e979502" xlink:to="loc_us-gaap_EarningsPerShareBasic_54d66930-216c-4c75-990d-133b54ef7852" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_08e7a91e-f9b7-466d-9b33-2adedca32ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_d6dc6792-6ef0-4163-ad04-8b990e979502" xlink:to="loc_us-gaap_EarningsPerShareDiluted_08e7a91e-f9b7-466d-9b33-2adedca32ea7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ced3996f-a175-4a89-9296-c3ce5fcbe74d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_d5c18272-4f24-416e-8c98-b9463b43c7ac" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ced3996f-a175-4a89-9296-c3ce5fcbe74d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_265d99f1-380e-4e7d-852b-981ef0fd581d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_d5c18272-4f24-416e-8c98-b9463b43c7ac" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_265d99f1-380e-4e7d-852b-981ef0fd581d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3c46acb9-0b4c-4ec2-b3a7-0af13f87e496" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_265d99f1-380e-4e7d-852b-981ef0fd581d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3c46acb9-0b4c-4ec2-b3a7-0af13f87e496" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3c46acb9-0b4c-4ec2-b3a7-0af13f87e496_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3c46acb9-0b4c-4ec2-b3a7-0af13f87e496" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3c46acb9-0b4c-4ec2-b3a7-0af13f87e496_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b49433b8-8687-486f-950a-257177ff8bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3c46acb9-0b4c-4ec2-b3a7-0af13f87e496" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b49433b8-8687-486f-950a-257177ff8bc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_27321d67-2198-4ecd-bd92-3ad67146d9cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b49433b8-8687-486f-950a-257177ff8bc5" xlink:to="loc_us-gaap_EmployeeStockOptionMember_27321d67-2198-4ecd-bd92-3ad67146d9cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_2121948e-7dfd-4030-9a09-e04bd426af96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b49433b8-8687-486f-950a-257177ff8bc5" xlink:to="loc_us-gaap_RestrictedStockMember_2121948e-7dfd-4030-9a09-e04bd426af96" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/EarningsPerShareNarrativeDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#EarningsPerShareNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/EarningsPerShareNarrativeDetails" xlink:type="extended" id="i628c608cce034f68aa12ac2410d76b91_EarningsPerShareNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SaleOfStockLineItems_5f91f719-82e0-4316-bd5a-7b883b37d7ea" xlink:href="sgry-20210930.xsd#sgry_SaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_1eb6b911-f167-4c6a-93a8-16d095128cf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sgry_SaleOfStockLineItems_5f91f719-82e0-4316-bd5a-7b883b37d7ea" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_1eb6b911-f167-4c6a-93a8-16d095128cf1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_2f52c296-359a-4664-80c3-3e179dfff911" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sgry_SaleOfStockLineItems_5f91f719-82e0-4316-bd5a-7b883b37d7ea" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_2f52c296-359a-4664-80c3-3e179dfff911" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_bac726a5-6709-450e-a5d7-ce553fd7e87e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sgry_SaleOfStockLineItems_5f91f719-82e0-4316-bd5a-7b883b37d7ea" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_bac726a5-6709-450e-a5d7-ce553fd7e87e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_eeb0ee72-5ce7-4c16-8da3-80a277547f62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sgry_SaleOfStockLineItems_5f91f719-82e0-4316-bd5a-7b883b37d7ea" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_eeb0ee72-5ce7-4c16-8da3-80a277547f62" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_cf3b680a-5d98-4fca-a3ad-187d65f5de3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sgry_SaleOfStockLineItems_5f91f719-82e0-4316-bd5a-7b883b37d7ea" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_cf3b680a-5d98-4fca-a3ad-187d65f5de3b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1_e2ea1c0a-5b09-4e3c-8f38-5ab4c3e5261e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sgry_SaleOfStockLineItems_5f91f719-82e0-4316-bd5a-7b883b37d7ea" xlink:to="loc_us-gaap_ConversionOfStockSharesIssued1_e2ea1c0a-5b09-4e3c-8f38-5ab4c3e5261e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1_708d3c98-1d04-4c4a-8497-a2dc7f443745" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SaleOfStockTable_2d4bbb6d-2539-4c89-bc51-2562aa3d4df9" xlink:href="sgry-20210930.xsd#sgry_SaleOfStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sgry_SaleOfStockLineItems_5f91f719-82e0-4316-bd5a-7b883b37d7ea" xlink:to="loc_sgry_SaleOfStockTable_2d4bbb6d-2539-4c89-bc51-2562aa3d4df9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_9f9b821a-3d80-4fde-9303-d36470aac80d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sgry_SaleOfStockTable_2d4bbb6d-2539-4c89-bc51-2562aa3d4df9" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_9f9b821a-3d80-4fde-9303-d36470aac80d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_9f9b821a-3d80-4fde-9303-d36470aac80d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_9f9b821a-3d80-4fde-9303-d36470aac80d" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_9f9b821a-3d80-4fde-9303-d36470aac80d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c9d5eb48-b02b-4301-b60a-2aec8d8ea3cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_9f9b821a-3d80-4fde-9303-d36470aac80d" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c9d5eb48-b02b-4301-b60a-2aec8d8ea3cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PublicStockOfferingMember_b1552b6c-b2b4-42fb-96a7-2dc8109ad280" xlink:href="sgry-20210930.xsd#sgry_PublicStockOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c9d5eb48-b02b-4301-b60a-2aec8d8ea3cf" xlink:to="loc_sgry_PublicStockOfferingMember_b1552b6c-b2b4-42fb-96a7-2dc8109ad280" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PublicStockOfferingFirmSharesMember_a15dd971-e46b-4cb7-b36d-5d7e07f6f117" xlink:href="sgry-20210930.xsd#sgry_PublicStockOfferingFirmSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sgry_PublicStockOfferingMember_b1552b6c-b2b4-42fb-96a7-2dc8109ad280" xlink:to="loc_sgry_PublicStockOfferingFirmSharesMember_a15dd971-e46b-4cb7-b36d-5d7e07f6f117" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_5d3e367e-3196-4ec8-b36f-b7bd247743cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sgry_PublicStockOfferingMember_b1552b6c-b2b4-42fb-96a7-2dc8109ad280" xlink:to="loc_us-gaap_OverAllotmentOptionMember_5d3e367e-3196-4ec8-b36f-b7bd247743cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_5966a485-ecfc-4828-ae2c-914ac79e84b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sgry_SaleOfStockTable_2d4bbb6d-2539-4c89-bc51-2562aa3d4df9" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_5966a485-ecfc-4828-ae2c-914ac79e84b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_5966a485-ecfc-4828-ae2c-914ac79e84b7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_5966a485-ecfc-4828-ae2c-914ac79e84b7" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_5966a485-ecfc-4828-ae2c-914ac79e84b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_d500a70f-6287-4152-a9a4-aba08e37cbe1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_5966a485-ecfc-4828-ae2c-914ac79e84b7" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_d500a70f-6287-4152-a9a4-aba08e37cbe1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember_dd1ca143-3c3f-4615-8781-9163818d5cb9" xlink:href="sgry-20210930.xsd#sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_d500a70f-6287-4152-a9a4-aba08e37cbe1" xlink:to="loc_sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember_dd1ca143-3c3f-4615-8781-9163818d5cb9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_d9a0a73d-3b50-493a-91bb-daeb39bb9df0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sgry_SaleOfStockTable_2d4bbb6d-2539-4c89-bc51-2562aa3d4df9" xlink:to="loc_us-gaap_StatementClassOfStockAxis_d9a0a73d-3b50-493a-91bb-daeb39bb9df0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d9a0a73d-3b50-493a-91bb-daeb39bb9df0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d9a0a73d-3b50-493a-91bb-daeb39bb9df0" xlink:to="loc_us-gaap_ClassOfStockDomain_d9a0a73d-3b50-493a-91bb-daeb39bb9df0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_66e09b89-788b-4e40-9dd5-31066c12c085" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d9a0a73d-3b50-493a-91bb-daeb39bb9df0" xlink:to="loc_us-gaap_ClassOfStockDomain_66e09b89-788b-4e40-9dd5-31066c12c085" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_320bfdd9-0962-464d-9062-e8841dfb8455" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_66e09b89-788b-4e40-9dd5-31066c12c085" xlink:to="loc_us-gaap_CommonClassAMember_320bfdd9-0962-464d-9062-e8841dfb8455" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_e50b3fbd-9c69-4d53-b55b-2bedf685b57e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_e50b3fbd-9c69-4d53-b55b-2bedf685b57e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_65dc4bda-f334-4a4d-81be-276759efb16b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember_d5292cdf-03fc-412f-8aa5-fbd7c865d1f0" xlink:href="sgry-20210930.xsd#sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_fd5337fd-50cd-4e18-a68a-88eab064d47c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_fd5337fd-50cd-4e18-a68a-88eab064d47c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_da0bcc34-4972-4b96-8ccc-d9bf8b37d74b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_a4413915-a2d4-4960-ba43-c9fc9a8980d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="ib371d45f09204d549558ba8f2b0f14a2_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsLineItems_c7e09e40-c7d1-478d-912d-ee1bb38896aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve_3a436f3e-27b2-4643-a9ad-3b6cc26f1204" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_c7e09e40-c7d1-478d-912d-ee1bb38896aa" xlink:to="loc_us-gaap_SelfInsuranceReserve_3a436f3e-27b2-4643-a9ad-3b6cc26f1204" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimatedInsuranceRecoveries_859e64fc-29d0-4a9b-bf02-27f8b655ca60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimatedInsuranceRecoveries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_c7e09e40-c7d1-478d-912d-ee1bb38896aa" xlink:to="loc_us-gaap_EstimatedInsuranceRecoveries_859e64fc-29d0-4a9b-bf02-27f8b655ca60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_7c7274b4-9461-430d-bbb2-940323c8a040" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_c7e09e40-c7d1-478d-912d-ee1bb38896aa" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_7c7274b4-9461-430d-bbb2-940323c8a040" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_09f864b7-0e42-441d-b06e-18cd9b57e681" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_c7e09e40-c7d1-478d-912d-ee1bb38896aa" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_09f864b7-0e42-441d-b06e-18cd9b57e681" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm_ed67d75e-1a47-41ac-ab01-185470bd29f8" xlink:href="sgry-20210930.xsd#sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_c7e09e40-c7d1-478d-912d-ee1bb38896aa" xlink:to="loc_sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm_ed67d75e-1a47-41ac-ab01-185470bd29f8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_681de85e-5465-4bbf-aa5e-b9977ba8f402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_c7e09e40-c7d1-478d-912d-ee1bb38896aa" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_681de85e-5465-4bbf-aa5e-b9977ba8f402" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate_d4508f7a-78a8-4480-b4bc-31ed6e561d6c" xlink:href="sgry-20210930.xsd#sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_c7e09e40-c7d1-478d-912d-ee1bb38896aa" xlink:to="loc_sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate_d4508f7a-78a8-4480-b4bc-31ed6e561d6c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_342dada3-55cc-467b-96d6-9b4cf145aad6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_c7e09e40-c7d1-478d-912d-ee1bb38896aa" xlink:to="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_342dada3-55cc-467b-96d6-9b4cf145aad6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount_d602c607-4cf5-4b84-8bad-48a2481d186e" xlink:href="sgry-20210930.xsd#sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_c7e09e40-c7d1-478d-912d-ee1bb38896aa" xlink:to="loc_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount_d602c607-4cf5-4b84-8bad-48a2481d186e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent_75b27abf-61ce-4157-b223-f4c473b9faa0" xlink:href="sgry-20210930.xsd#sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_c7e09e40-c7d1-478d-912d-ee1bb38896aa" xlink:to="loc_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent_75b27abf-61ce-4157-b223-f4c473b9faa0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_ae37ed7e-1fee-45b3-ac6a-3eec2e38734e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGuaranteeObligationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_c7e09e40-c7d1-478d-912d-ee1bb38896aa" xlink:to="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_ae37ed7e-1fee-45b3-ac6a-3eec2e38734e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_f069ce35-a8f9-4fae-a7d1-42a4a5c540d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_ae37ed7e-1fee-45b3-ac6a-3eec2e38734e" xlink:to="loc_us-gaap_VariableRateAxis_f069ce35-a8f9-4fae-a7d1-42a4a5c540d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_f069ce35-a8f9-4fae-a7d1-42a4a5c540d4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_f069ce35-a8f9-4fae-a7d1-42a4a5c540d4" xlink:to="loc_us-gaap_VariableRateDomain_f069ce35-a8f9-4fae-a7d1-42a4a5c540d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_9ea6892d-2fcf-4532-bc17-94d64bc826ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_f069ce35-a8f9-4fae-a7d1-42a4a5c540d4" xlink:to="loc_us-gaap_VariableRateDomain_9ea6892d-2fcf-4532-bc17-94d64bc826ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_7d1160ad-aeaa-4527-bea5-a7e806e430a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_9ea6892d-2fcf-4532-bc17-94d64bc826ca" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_7d1160ad-aeaa-4527-bea5-a7e806e430a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_fbfbd1d3-52a0-47e5-8633-2a7e62187ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_9ea6892d-2fcf-4532-bc17-94d64bc826ca" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_fbfbd1d3-52a0-47e5-8633-2a7e62187ea5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualRiskOrUncertaintyByNatureAxis_8b5c50b9-3fcc-4e98-956b-d3bca7a291bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualRiskOrUncertaintyByNatureAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_ae37ed7e-1fee-45b3-ac6a-3eec2e38734e" xlink:to="loc_us-gaap_UnusualRiskOrUncertaintyByNatureAxis_8b5c50b9-3fcc-4e98-956b-d3bca7a291bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualRiskOrUncertaintyNatureDomain_8b5c50b9-3fcc-4e98-956b-d3bca7a291bd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualRiskOrUncertaintyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualRiskOrUncertaintyByNatureAxis_8b5c50b9-3fcc-4e98-956b-d3bca7a291bd" xlink:to="loc_us-gaap_UnusualRiskOrUncertaintyNatureDomain_8b5c50b9-3fcc-4e98-956b-d3bca7a291bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualRiskOrUncertaintyNatureDomain_5f8474ad-0310-4328-aafb-48d2c7a5da2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualRiskOrUncertaintyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualRiskOrUncertaintyByNatureAxis_8b5c50b9-3fcc-4e98-956b-d3bca7a291bd" xlink:to="loc_us-gaap_UnusualRiskOrUncertaintyNatureDomain_5f8474ad-0310-4328-aafb-48d2c7a5da2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_MateriallyMoreRestrictiveMember_94c6abae-0f74-465d-a1bb-26533800811c" xlink:href="sgry-20210930.xsd#sgry_MateriallyMoreRestrictiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualRiskOrUncertaintyNatureDomain_5f8474ad-0310-4328-aafb-48d2c7a5da2e" xlink:to="loc_sgry_MateriallyMoreRestrictiveMember_94c6abae-0f74-465d-a1bb-26533800811c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NotMateriallyMoreRestrictiveMember_0a1393c6-7585-4a70-a327-fd36e92674da" xlink:href="sgry-20210930.xsd#sgry_NotMateriallyMoreRestrictiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualRiskOrUncertaintyNatureDomain_5f8474ad-0310-4328-aafb-48d2c7a5da2e" xlink:to="loc_sgry_NotMateriallyMoreRestrictiveMember_0a1393c6-7585-4a70-a327-fd36e92674da" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails" xlink:type="extended" id="i532212ddcf6b472c8c65dd22b52e7eed_SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_cc75955d-d7cd-4729-8b3c-d97d5d5a7354" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_d9f64b38-c4a7-4e8e-8993-f2ecb6e6b187" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cc75955d-d7cd-4729-8b3c-d97d5d5a7354" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_d9f64b38-c4a7-4e8e-8993-f2ecb6e6b187" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization_94a14dcb-d181-454e-aca4-ecb0b21f1a91" xlink:href="sgry-20210930.xsd#sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cc75955d-d7cd-4729-8b3c-d97d5d5a7354" xlink:to="loc_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization_94a14dcb-d181-454e-aca4-ecb0b21f1a91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cc75955d-d7cd-4729-8b3c-d97d5d5a7354" xlink:to="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_be772b91-40c1-4c20-b952-0be53764b48b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_be772b91-40c1-4c20-b952-0be53764b48b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_eb336b70-183c-471c-a772-c482345acf06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_eb336b70-183c-471c-a772-c482345acf06" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_8106f0eb-4426-47f3-9c81-2a0f1d31930d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_8106f0eb-4426-47f3-9c81-2a0f1d31930d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_a4542e45-97ca-4644-81ed-1f8998edb669" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_a4542e45-97ca-4644-81ed-1f8998edb669" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_002df161-b02e-4760-97e0-d26bdfc29aae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:to="loc_us-gaap_ShareBasedCompensation_002df161-b02e-4760-97e0-d26bdfc29aae" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts_7cdeb66e-565e-4910-8d5b-a04167ef435c" xlink:href="sgry-20210930.xsd#sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:to="loc_sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts_7cdeb66e-565e-4910-8d5b-a04167ef435c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_0e24b996-9edb-46e9-b22d-6f2ef21d2092" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:to="loc_us-gaap_AssetImpairmentCharges_0e24b996-9edb-46e9-b22d-6f2ef21d2092" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation_19e4a720-1946-4c27-9ded-e40d997e5ea0" xlink:href="sgry-20210930.xsd#sgry_GainLossOnDispositionOfAssetsAndDeconsolidation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:to="loc_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation_19e4a720-1946-4c27-9ded-e40d997e5ea0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts_ed9d37c8-0c22-42c2-8865-36eb96208074" xlink:href="sgry-20210930.xsd#sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:to="loc_sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts_ed9d37c8-0c22-42c2-8865-36eb96208074" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_4e80713c-2012-4bbf-b983-de870e89aabf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_4e80713c-2012-4bbf-b983-de870e89aabf" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_BusinessCombinationGainLossOnAcquisitionEscrow_6b8c5148-6aa6-4443-8125-c1abea70b52c" xlink:href="sgry-20210930.xsd#sgry_BusinessCombinationGainLossOnAcquisitionEscrow"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:to="loc_sgry_BusinessCombinationGainLossOnAcquisitionEscrow_6b8c5148-6aa6-4443-8125-c1abea70b52c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemNetGainLoss_f655d4b4-fcc1-4ae4-8422-f2aa18964cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemNetGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:to="loc_us-gaap_UnusualOrInfrequentItemNetGainLoss_f655d4b4-fcc1-4ae4-8422-f2aa18964cd9" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization_18253484-c9b9-4221-b316-97739469b2f3" xlink:href="sgry-20210930.xsd#sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_f3407d96-cdfb-4681-bd2b-0cd82c52e51b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_f3407d96-cdfb-4681-bd2b-0cd82c52e51b" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_926a5ad8-a3e2-465f-8f88-b0d05cffa1d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_926a5ad8-a3e2-465f-8f88-b0d05cffa1d3" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_b96fb076-4efb-45ea-b2ca-e44ec0f3f83c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:to="loc_us-gaap_LitigationSettlementExpense_b96fb076-4efb-45ea-b2ca-e44ec0f3f83c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_7bdf95f0-4904-4d04-8f48-f6a62d931a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_7bdf95f0-4904-4d04-8f48-f6a62d931a4a" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5dcd368f-9c2f-4005-829e-9c4802f6db23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cc75955d-d7cd-4729-8b3c-d97d5d5a7354" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5dcd368f-9c2f-4005-829e-9c4802f6db23" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_ee2c2510-96b6-4b05-a588-897da74b524f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5dcd368f-9c2f-4005-829e-9c4802f6db23" xlink:to="loc_srt_ConsolidationItemsAxis_ee2c2510-96b6-4b05-a588-897da74b524f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_ee2c2510-96b6-4b05-a588-897da74b524f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_ee2c2510-96b6-4b05-a588-897da74b524f" xlink:to="loc_srt_ConsolidationItemsDomain_ee2c2510-96b6-4b05-a588-897da74b524f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_99633eb1-0b42-4dfb-a4e3-9f26124868be" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_ee2c2510-96b6-4b05-a588-897da74b524f" xlink:to="loc_srt_ConsolidationItemsDomain_99633eb1-0b42-4dfb-a4e3-9f26124868be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_22d0ec14-3c7c-410f-aa88-49b4798e3026" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_99633eb1-0b42-4dfb-a4e3-9f26124868be" xlink:to="loc_us-gaap_OperatingSegmentsMember_22d0ec14-3c7c-410f-aa88-49b4798e3026" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_e72f4859-5ef9-47b1-9093-1378753e7537" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_99633eb1-0b42-4dfb-a4e3-9f26124868be" xlink:to="loc_us-gaap_CorporateNonSegmentMember_e72f4859-5ef9-47b1-9093-1378753e7537" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c408cff2-88e5-40d4-8540-9a116914ef75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5dcd368f-9c2f-4005-829e-9c4802f6db23" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c408cff2-88e5-40d4-8540-9a116914ef75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c408cff2-88e5-40d4-8540-9a116914ef75_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c408cff2-88e5-40d4-8540-9a116914ef75" xlink:to="loc_us-gaap_SegmentDomain_c408cff2-88e5-40d4-8540-9a116914ef75_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_119ea4e6-0f9a-4b6b-a2a6-6f1aed0729a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c408cff2-88e5-40d4-8540-9a116914ef75" xlink:to="loc_us-gaap_SegmentDomain_119ea4e6-0f9a-4b6b-a2a6-6f1aed0729a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SurgicalFacilityServicesMember_5f7252f6-b7df-45d3-a1e4-cd2d3fe68a5d" xlink:href="sgry-20210930.xsd#sgry_SurgicalFacilityServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_119ea4e6-0f9a-4b6b-a2a6-6f1aed0729a5" xlink:to="loc_sgry_SurgicalFacilityServicesMember_5f7252f6-b7df-45d3-a1e4-cd2d3fe68a5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_AncillaryServicesMember_a435b72f-717e-4855-a804-21a9a4774ba2" xlink:href="sgry-20210930.xsd#sgry_AncillaryServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_119ea4e6-0f9a-4b6b-a2a6-6f1aed0729a5" xlink:to="loc_sgry_AncillaryServicesMember_a435b72f-717e-4855-a804-21a9a4774ba2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_OpticalServicesMember_c30680ec-7913-4edb-8e30-aedcbe8b3cd2" xlink:href="sgry-20210930.xsd#sgry_OpticalServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_119ea4e6-0f9a-4b6b-a2a6-6f1aed0729a5" xlink:to="loc_sgry_OpticalServicesMember_c30680ec-7913-4edb-8e30-aedcbe8b3cd2" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails" xlink:type="extended" id="ia07bd1a3988a48daa443beec53a18398_SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_9f44a5e9-4135-4548-b16a-8488c4df90bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_f093df91-4968-4000-89e8-3b58d4dd37ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9f44a5e9-4135-4548-b16a-8488c4df90bf" xlink:to="loc_us-gaap_Assets_f093df91-4968-4000-89e8-3b58d4dd37ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_9c4e1364-9626-499f-a13c-ae8b3f19aa89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9f44a5e9-4135-4548-b16a-8488c4df90bf" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_9c4e1364-9626-499f-a13c-ae8b3f19aa89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_754bab23-531b-4bc4-be82-276a80461a55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9f44a5e9-4135-4548-b16a-8488c4df90bf" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_754bab23-531b-4bc4-be82-276a80461a55" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_3fb65a36-db90-4312-a7c4-78beca80cd54" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_754bab23-531b-4bc4-be82-276a80461a55" xlink:to="loc_srt_ConsolidationItemsAxis_3fb65a36-db90-4312-a7c4-78beca80cd54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_3fb65a36-db90-4312-a7c4-78beca80cd54_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_3fb65a36-db90-4312-a7c4-78beca80cd54" xlink:to="loc_srt_ConsolidationItemsDomain_3fb65a36-db90-4312-a7c4-78beca80cd54_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_88c4d88d-8e61-4d92-9033-1f67b8dd5902" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_3fb65a36-db90-4312-a7c4-78beca80cd54" xlink:to="loc_srt_ConsolidationItemsDomain_88c4d88d-8e61-4d92-9033-1f67b8dd5902" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_e032ee9b-73ef-4e79-86ea-789581dc4f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_88c4d88d-8e61-4d92-9033-1f67b8dd5902" xlink:to="loc_us-gaap_OperatingSegmentsMember_e032ee9b-73ef-4e79-86ea-789581dc4f5a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_e21421dc-4719-4455-bc84-f0ad3659beb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_88c4d88d-8e61-4d92-9033-1f67b8dd5902" xlink:to="loc_us-gaap_CorporateNonSegmentMember_e21421dc-4719-4455-bc84-f0ad3659beb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1e5a51c8-543d-4411-81a4-ffa2bf3b09ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_754bab23-531b-4bc4-be82-276a80461a55" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1e5a51c8-543d-4411-81a4-ffa2bf3b09ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1e5a51c8-543d-4411-81a4-ffa2bf3b09ff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1e5a51c8-543d-4411-81a4-ffa2bf3b09ff" xlink:to="loc_us-gaap_SegmentDomain_1e5a51c8-543d-4411-81a4-ffa2bf3b09ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_79578c4f-3bf0-41a2-99b0-331b353db9c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1e5a51c8-543d-4411-81a4-ffa2bf3b09ff" xlink:to="loc_us-gaap_SegmentDomain_79578c4f-3bf0-41a2-99b0-331b353db9c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SurgicalFacilityServicesMember_f2a3f1ea-a9fa-447c-924b-c841001a5a8e" xlink:href="sgry-20210930.xsd#sgry_SurgicalFacilityServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_79578c4f-3bf0-41a2-99b0-331b353db9c0" xlink:to="loc_sgry_SurgicalFacilityServicesMember_f2a3f1ea-a9fa-447c-924b-c841001a5a8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_AncillaryServicesMember_1f21f8ca-9755-489a-845c-def68cc1ca5a" xlink:href="sgry-20210930.xsd#sgry_AncillaryServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_79578c4f-3bf0-41a2-99b0-331b353db9c0" xlink:to="loc_sgry_AncillaryServicesMember_1f21f8ca-9755-489a-845c-def68cc1ca5a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/SubsequentEventsNarrativeDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#SubsequentEventsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/SubsequentEventsNarrativeDetails" xlink:type="extended" id="i1a648b0e137f4adeb56578b1f16e0dea_SubsequentEventsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_de7759d7-f103-4f38-b524-341ced65a9f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_6052605a-99e0-4d58-902a-f57babc93a29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_de7759d7-f103-4f38-b524-341ced65a9f6" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_6052605a-99e0-4d58-902a-f57babc93a29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_8494df2c-ae22-470b-9d29-4db92c511cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_de7759d7-f103-4f38-b524-341ced65a9f6" xlink:to="loc_us-gaap_SubsequentEventTable_8494df2c-ae22-470b-9d29-4db92c511cb8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_7005a322-6739-47d3-80f9-540b8359c312" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_8494df2c-ae22-470b-9d29-4db92c511cb8" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_7005a322-6739-47d3-80f9-540b8359c312" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_7005a322-6739-47d3-80f9-540b8359c312_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_7005a322-6739-47d3-80f9-540b8359c312" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_7005a322-6739-47d3-80f9-540b8359c312_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1f6daa0f-4ea8-464e-91c2-f20b21fe4099" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_7005a322-6739-47d3-80f9-540b8359c312" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1f6daa0f-4ea8-464e-91c2-f20b21fe4099" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_b648497e-73f0-443a-8dff-f1ef773f3c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1f6daa0f-4ea8-464e-91c2-f20b21fe4099" xlink:to="loc_us-gaap_SubsequentEventMember_b648497e-73f0-443a-8dff-f1ef773f3c7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4b996948-dbfd-4315-9687-b7958ad28f58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_8494df2c-ae22-470b-9d29-4db92c511cb8" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4b996948-dbfd-4315-9687-b7958ad28f58" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4b996948-dbfd-4315-9687-b7958ad28f58_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4b996948-dbfd-4315-9687-b7958ad28f58" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4b996948-dbfd-4315-9687-b7958ad28f58_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e66e3ac9-1423-4b30-ba44-f648bc273cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4b996948-dbfd-4315-9687-b7958ad28f58" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e66e3ac9-1423-4b30-ba44-f648bc273cd9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SurgicalFacilitiesExistingMarketsMember_4d410e06-2462-4239-b5bf-1763f825dd49" xlink:href="sgry-20210930.xsd#sgry_SurgicalFacilitiesExistingMarketsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e66e3ac9-1423-4b30-ba44-f648bc273cd9" xlink:to="loc_sgry_SurgicalFacilitiesExistingMarketsMember_4d410e06-2462-4239-b5bf-1763f825dd49" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>sgry-20210930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:4fc50bef-303f-4567-8d1f-fa45eceeed5f,g:878f1ef0-0d6b-4fb6-8cd6-b11c4615e811-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_HedgingDesignationDomain_d15eb8d9-4406-4cf0-9ef7-1f142ebb0fd9_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1ff9b96d-c873-4cbe-afda-eba0aa213536_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal effective tax rate (percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_cb7a9a03-c7f5-4f68-84f0-3aef387bc3a5_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_58dcde82-6b83-429c-ad81-4f3ac596dac0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction and integration costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Integration Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b075e258-e9f0-42b4-89ba-302d9660ef17_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_fdb330f0-87bd-4b1d-a90b-fe9d9dee108d_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to Surgery Partners, Inc.</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_dde066fb-4103-47ba-bc33-c1c4960fb4be_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to Surgery Partners, Inc.</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_04d1e485-d54a-433d-aa48-40e33e01909d_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_caee4f46-ace8-41e0-a94d-05d4e5e2e090_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_88263c13-7a14-445d-b9f2-fb0529d049e9_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_7e7eb5cd-2b3e-4a05-a1e7-1d0b0c5ad26d_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use operating lease assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_9114da48-d88c-49de-9846-34e830dab94b_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_ee121c15-c6e6-4b8b-9d62-482c3038a077_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued payroll and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_a9e558dc-f6a9-4969-bf83-5153cdf4e616_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_6769f54a-fd60-4c7a-926d-595c0a4eb26d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Start-up costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_7c170f5e-dcfa-41d1-8753-31d0936a9c39_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_f541a2b9-e7f2-4d1d-9030-1da405213be0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_SurgicalFacilitiesNewMarketsMember_1122b787-269b-46ee-a6f1-6ecd0333f31a_terseLabel_en-US" xlink:label="lab_sgry_SurgicalFacilitiesNewMarketsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Facilities, New Markets</link:label>
    <link:label id="lab_sgry_SurgicalFacilitiesNewMarketsMember_label_en-US" xlink:label="lab_sgry_SurgicalFacilitiesNewMarketsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Facilities, New Markets [Member]</link:label>
    <link:label id="lab_sgry_SurgicalFacilitiesNewMarketsMember_documentation_en-US" xlink:label="lab_sgry_SurgicalFacilitiesNewMarketsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Facilities, New Markets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SurgicalFacilitiesNewMarketsMember" xlink:href="sgry-20210930.xsd#sgry_SurgicalFacilitiesNewMarketsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_SurgicalFacilitiesNewMarketsMember" xlink:to="lab_sgry_SurgicalFacilitiesNewMarketsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_e1d008b1-c97e-49b4-877e-7b60db5f981e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Adjusted EBITDA:</link:label>
    <link:label id="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Other Significant Reconciling Item, Consolidated [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract" xlink:to="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_2d29dd97-21a6-4eba-a763-91487029a223_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization_ec973ab7-fb49-4b99-8ca2-820d476f60db_terseLabel_en-US" xlink:label="lab_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted EBITDA</link:label>
    <link:label id="lab_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization_label_en-US" xlink:label="lab_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Before Interest Taxes Depreciation And Amortization</link:label>
    <link:label id="lab_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization_documentation_en-US" xlink:label="lab_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Before Interest Taxes Depreciation And Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:href="sgry-20210930.xsd#sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:to="lab_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_f258bdfe-cb44-4ef9-8d58-63d020693c5c_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable preferred stock, shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:to="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_0b656740-ee34-4c58-840d-9701200a225f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_TemporaryEquityThresholdTradingDays_01865a45-4040-4af4-a33b-70a0b78597ff_terseLabel_en-US" xlink:label="lab_sgry_TemporaryEquityThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading days</link:label>
    <link:label id="lab_sgry_TemporaryEquityThresholdTradingDays_label_en-US" xlink:label="lab_sgry_TemporaryEquityThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Threshold Trading Days</link:label>
    <link:label id="lab_sgry_TemporaryEquityThresholdTradingDays_documentation_en-US" xlink:label="lab_sgry_TemporaryEquityThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_TemporaryEquityThresholdTradingDays" xlink:href="sgry-20210930.xsd#sgry_TemporaryEquityThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_TemporaryEquityThresholdTradingDays" xlink:to="lab_sgry_TemporaryEquityThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfBusinessesAcquired_c1c7a648-2d96-4dfb-adc6-be0b2b372a9c_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of facilities acquired</link:label>
    <link:label id="lab_us-gaap_NumberOfBusinessesAcquired_label_en-US" xlink:label="lab_us-gaap_NumberOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Businesses Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfBusinessesAcquired" xlink:to="lab_us-gaap_NumberOfBusinessesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount_c85a8783-0410-4f29-a83d-697a27bcefcc_terseLabel_en-US" xlink:label="lab_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net long-term tax receivable agreement liability</link:label>
    <link:label id="lab_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount_label_en-US" xlink:label="lab_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net Of Discount</link:label>
    <link:label id="lab_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount_documentation_en-US" xlink:label="lab_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net Of Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount" xlink:href="sgry-20210930.xsd#sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount" xlink:to="lab_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_e0f426fa-8c41-41e6-82aa-640b9d5c3682_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_a586991b-d6b5-4495-8e07-65bd92b9ea94_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMinorityShareholders_c2e40cfd-58f8-405a-a16d-956245ddba5b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receipts (payments) related to ownership transactions with non-controlling interest holders</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMinorityShareholders" xlink:to="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonrecurringIncomeExpense_b468ed22-dcaf-4ade-963b-1b1af4406844_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonrecurringIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income</link:label>
    <link:label id="lab_us-gaap_OtherNonrecurringIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonrecurringIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonrecurring (Income) Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonrecurringIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonrecurringIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonrecurringIncomeExpense" xlink:to="lab_us-gaap_OtherNonrecurringIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5f7b3fb0-bb69-4870-9473-0414c98cf161_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_91b1d5f0-1b40-4263-bf6f-9c1128edca91_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_29def06a-a1d6-4571-a019-cdb37967f191_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_53d51eff-de93-4648-9753-f7e6b03cb797_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other litigation costs</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementExpense" xlink:to="lab_us-gaap_LitigationSettlementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_aee05445-6050-4d6b-99e1-c13622c0147a_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_69216d54-b39f-4ccf-b511-8124cf8458e9_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, less current maturities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_52e23c03-f364-46fd-b474-12d1659078ac_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d4122dd6-ff29-4f91-bf4b-df82d697c454_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive (shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests_6ff25109-6a9e-4854-a938-4a119a08c5ea_terseLabel_en-US" xlink:label="lab_sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition (disposal) of shares of non-controlling interests, net&#8212;redeemable</link:label>
    <link:label id="lab_sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests_label_en-US" xlink:label="lab_sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Increase (Decrease) From Redemptions Or Purchase Of Interests</link:label>
    <link:label id="lab_sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests_documentation_en-US" xlink:label="lab_sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Increase (Decrease) from Redemptions or Purchase of Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests" xlink:href="sgry-20210930.xsd#sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests" xlink:to="lab_sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_944c2b8d-3524-4353-add2-e93e245a51fb_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_d2d25071-8031-4db5-b6de-bf49291d3389_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_PayFixedSwapSixMember_63ef415e-7000-4d6c-a413-032620b54951_terseLabel_en-US" xlink:label="lab_sgry_PayFixedSwapSixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed swap</link:label>
    <link:label id="lab_sgry_PayFixedSwapSixMember_label_en-US" xlink:label="lab_sgry_PayFixedSwapSixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed Swap Six [Member]</link:label>
    <link:label id="lab_sgry_PayFixedSwapSixMember_documentation_en-US" xlink:label="lab_sgry_PayFixedSwapSixMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed Swap Six Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapSixMember" xlink:href="sgry-20210930.xsd#sgry_PayFixedSwapSixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_PayFixedSwapSixMember" xlink:to="lab_sgry_PayFixedSwapSixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfStatesInWhichEntityOperates_812935c3-b881-465c-ab32-7b7cb1f064e4_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states in which entity operates</link:label>
    <link:label id="lab_us-gaap_NumberOfStatesInWhichEntityOperates_label_en-US" xlink:label="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of States in which Entity Operates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:to="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_12248e6f-b81b-43f2-aa3c-fc718e630715_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_0b453c22-eebd-430e-903c-ea97e45ab70f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_749bfd0d-ab07-42a3-a255-8ea192fdd8b1_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_PrivateInsuranceMember_9c2cdb24-bd0b-4daf-bbd8-ead230dffb8f_terseLabel_en-US" xlink:label="lab_sgry_PrivateInsuranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private insurance</link:label>
    <link:label id="lab_sgry_PrivateInsuranceMember_label_en-US" xlink:label="lab_sgry_PrivateInsuranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Insurance [Member]</link:label>
    <link:label id="lab_sgry_PrivateInsuranceMember_documentation_en-US" xlink:label="lab_sgry_PrivateInsuranceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Insurance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PrivateInsuranceMember" xlink:href="sgry-20210930.xsd#sgry_PrivateInsuranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_PrivateInsuranceMember" xlink:to="lab_sgry_PrivateInsuranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_NotesPayableAndSecuredLoansMember_d958d5db-2fa1-4677-9c0c-a7b7f18154e6_terseLabel_en-US" xlink:label="lab_sgry_NotesPayableAndSecuredLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable and other secured loans</link:label>
    <link:label id="lab_sgry_NotesPayableAndSecuredLoansMember_label_en-US" xlink:label="lab_sgry_NotesPayableAndSecuredLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable and Secured Loans [Member]</link:label>
    <link:label id="lab_sgry_NotesPayableAndSecuredLoansMember_documentation_en-US" xlink:label="lab_sgry_NotesPayableAndSecuredLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable and Secured Loans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NotesPayableAndSecuredLoansMember" xlink:href="sgry-20210930.xsd#sgry_NotesPayableAndSecuredLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_NotesPayableAndSecuredLoansMember" xlink:to="lab_sgry_NotesPayableAndSecuredLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SuppliesExpense_d2f75126-4f98-4327-9fcc-aca63f888d3a_terseLabel_en-US" xlink:label="lab_us-gaap_SuppliesExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplies</link:label>
    <link:label id="lab_us-gaap_SuppliesExpense_label_en-US" xlink:label="lab_us-gaap_SuppliesExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplies Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SuppliesExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SuppliesExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SuppliesExpense" xlink:to="lab_us-gaap_SuppliesExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_5efc5bdb-5d06-4426-8825-f0723732fd7c_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_24274b05-fedd-4aa8-a560-db445595f59b_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_f301dff0-9745-4f44-99a2-a75047eecce7_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for finance lease obligations</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimatedInsuranceRecoveries_ed7fd928-1a0b-4c99-a816-98f675b007d8_terseLabel_en-US" xlink:label="lab_us-gaap_EstimatedInsuranceRecoveries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected insurance recoveries</link:label>
    <link:label id="lab_us-gaap_EstimatedInsuranceRecoveries_label_en-US" xlink:label="lab_us-gaap_EstimatedInsuranceRecoveries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Insurance Recoveries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimatedInsuranceRecoveries" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimatedInsuranceRecoveries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimatedInsuranceRecoveries" xlink:to="lab_us-gaap_EstimatedInsuranceRecoveries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_6c1d6b8e-ee22-4006-b964-bed2339a2294_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives and Hedging Activities</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AirlineProductsAndServicesTable_2be847c7-fe9e-4dea-9e64-d227b64f5d61_terseLabel_en-US" xlink:label="lab_us-gaap_AirlineProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products and Services [Table]</link:label>
    <link:label id="lab_us-gaap_AirlineProductsAndServicesTable_label_en-US" xlink:label="lab_us-gaap_AirlineProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products and Services [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AirlineProductsAndServicesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AirlineProductsAndServicesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AirlineProductsAndServicesTable" xlink:to="lab_us-gaap_AirlineProductsAndServicesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_f4d6afba-7727-4732-9ea7-a31b09003bbf_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service revenues as a percentage of total revenues</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_e5f3d88f-8b16-4462-9c92-8e12353c18f6_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.01 par value; shares authorized - 20,000,000; shares issued or outstanding - none</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_8bc7a8ef-59ce-41b7-b7aa-e789563a95ca_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to non-controlling interests&#8212;non-redeemable holders</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_b5ce5a26-6d3f-4901-9618-da13c8e29821_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefits related to the sale of partnership interests</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Disposition of Business, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationDispositionOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:to="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_OneMonthLondonInterbankOfferedRateLIBORMember_624ad36c-c725-4bbb-937d-eb0be49bc0a6_terseLabel_en-US" xlink:label="lab_sgry_OneMonthLondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One-month LIBOR</link:label>
    <link:label id="lab_sgry_OneMonthLondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_sgry_OneMonthLondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Month London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:label id="lab_sgry_OneMonthLondonInterbankOfferedRateLIBORMember_documentation_en-US" xlink:label="lab_sgry_OneMonthLondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Month London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_OneMonthLondonInterbankOfferedRateLIBORMember" xlink:href="sgry-20210930.xsd#sgry_OneMonthLondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_OneMonthLondonInterbankOfferedRateLIBORMember" xlink:to="lab_sgry_OneMonthLondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_ebdd3e6b-db7b-49d5-97ed-5896a0d3757f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_d5a34dca-e1c3-400b-b86d-a7afa0ccc513_terseLabel_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price per share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_label_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_us-gaap_SharesIssuedPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_9de1599c-9012-40fc-aac1-14139e56d9af_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_a436ae28-cd43-45f3-8ade-fbb63846c093_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityPreferredRedemptionValue_679a4377-6fd2-41b6-9187-9fda224f59b4_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityPreferredRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable preferred stock, redemption value</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityPreferredRedemptionValue_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityPreferredRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Preferred, Redemption Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityPreferredRedemptionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityPreferredRedemptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityPreferredRedemptionValue" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityPreferredRedemptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest_3d14bc64-76b4-466c-ae76-2bd4bdc232fe_terseLabel_en-US" xlink:label="lab_sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of surgical facilities owned, majority interest</link:label>
    <link:label id="lab_sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest_label_en-US" xlink:label="lab_sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Surgical Facilities Owned, Majority Interest</link:label>
    <link:label id="lab_sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest_documentation_en-US" xlink:label="lab_sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Surgical Facilities Owned, Majority Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest" xlink:href="sgry-20210930.xsd#sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest" xlink:to="lab_sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_0ecdf76c-0816-4313-84ab-54f9638a7955_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityDividendsAdjustment_a269be24-2193-4392-8efe-0ec34127f666_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityDividendsAdjustment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityDividendsAdjustment_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityDividendsAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Dividends, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDividendsAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDividendsAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityDividendsAdjustment" xlink:to="lab_us-gaap_TemporaryEquityDividendsAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_d2a9a0ea-d589-4e88-bc71-ce915f63a288_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred share conversion</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0ce2a98c-8900-460e-b12f-2901375fd6d4_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_900d248b-757a-46a3-9b22-f9a4da6d0d30_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_832162c8-6af1-4e2a-9590-1f9bfc57ef0d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityTableTextBlock_ec0db0fd-0698-4c6c-a3b2-9db562a57162_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Activity Related to Redeemable Preferred Stock</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityTableTextBlock" xlink:to="lab_us-gaap_TemporaryEquityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_bb2b00e6-4d28-4e84-bc0c-e1ccf21397ac_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for operating lease obligations</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_DebtInstrumentBasisSpreadOnVariableRateFloor_05a9b802-6cb7-4dec-985f-7114b8de9e54_terseLabel_en-US" xlink:label="lab_sgry_DebtInstrumentBasisSpreadOnVariableRateFloor" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, basis spread on variable rate, floor (percent)</link:label>
    <link:label id="lab_sgry_DebtInstrumentBasisSpreadOnVariableRateFloor_label_en-US" xlink:label="lab_sgry_DebtInstrumentBasisSpreadOnVariableRateFloor" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread On Variable Rate, Floor</link:label>
    <link:label id="lab_sgry_DebtInstrumentBasisSpreadOnVariableRateFloor_documentation_en-US" xlink:label="lab_sgry_DebtInstrumentBasisSpreadOnVariableRateFloor" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread On Variable Rate, Floor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DebtInstrumentBasisSpreadOnVariableRateFloor" xlink:href="sgry-20210930.xsd#sgry_DebtInstrumentBasisSpreadOnVariableRateFloor"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_DebtInstrumentBasisSpreadOnVariableRateFloor" xlink:to="lab_sgry_DebtInstrumentBasisSpreadOnVariableRateFloor" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation_115879be-53de-4466-a735-645fad030e6b_negatedTerseLabel_en-US" xlink:label="lab_sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestitures and deconsolidations</link:label>
    <link:label id="lab_sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation_label_en-US" xlink:label="lab_sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Written off Related to Sale of Business Unit and Deconsolidation</link:label>
    <link:label id="lab_sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation_documentation_en-US" xlink:label="lab_sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Written off Related to Sale of Business Unit and Deconsolidation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation" xlink:href="sgry-20210930.xsd#sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation" xlink:to="lab_sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_82d5e6e4-d5a7-49e3-918c-51aca72fb992_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxSettlements_a020d186-0f9c-4d8f-8fc3-206194cf3798_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax expense related to settlement payment</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxSettlements_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Settlement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxSettlements" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7513787a-9f20-4a0b-8d08-329828fa6792_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_77a0b8ab-8d7f-4d58-a303-ec0df37f34ba_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4ead9309-cfc4-4fd6-97f7-3a5addff66ac_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_492fae64-f696-4970-804f-2ba35a95c31c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash outflows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_ea842ba9-8282-4d96-bf31-9354017f5912_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_b14275ee-3c0c-447f-8349-8d0ed8dcbcfd_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of interest rate swaps</link:label>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_label_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Interest Rate Derivatives Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:to="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_GrantRevenue_fd2fdbe5-64a8-4b5a-a258-2a059b0e7ac6_negatedTerseLabel_en-US" xlink:label="lab_sgry_GrantRevenue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant funds</link:label>
    <link:label id="lab_sgry_GrantRevenue_053cd766-4859-41f5-b34d-0f03ab74483f_terseLabel_en-US" xlink:label="lab_sgry_GrantRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant funds</link:label>
    <link:label id="lab_sgry_GrantRevenue_label_en-US" xlink:label="lab_sgry_GrantRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant Revenue</link:label>
    <link:label id="lab_sgry_GrantRevenue_documentation_en-US" xlink:label="lab_sgry_GrantRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_GrantRevenue" xlink:href="sgry-20210930.xsd#sgry_GrantRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_GrantRevenue" xlink:to="lab_sgry_GrantRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_79de50ec-7733-47da-b1a5-352eb3263df0_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_0073580d-b28a-43ba-a225-f7944f5f21a0_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Availability on line of credit instrument</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_87d05786-f723-48de-a686-1d1f787d4bdd_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_DebtInstrumentCovenantMaturityMinimumMaturityDateForOtherExistingDebtRemaining_d1168160-55ab-46d2-9760-522a9baf776a_terseLabel_en-US" xlink:label="lab_sgry_DebtInstrumentCovenantMaturityMinimumMaturityDateForOtherExistingDebtRemaining" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity covenant, minimum maturity date for borrowings after August 31, 2026 by no later than April 1, 2025</link:label>
    <link:label id="lab_sgry_DebtInstrumentCovenantMaturityMinimumMaturityDateForOtherExistingDebtRemaining_label_en-US" xlink:label="lab_sgry_DebtInstrumentCovenantMaturityMinimumMaturityDateForOtherExistingDebtRemaining" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Maturity, Minimum Maturity Date For Other Existing Debt Remaining</link:label>
    <link:label id="lab_sgry_DebtInstrumentCovenantMaturityMinimumMaturityDateForOtherExistingDebtRemaining_documentation_en-US" xlink:label="lab_sgry_DebtInstrumentCovenantMaturityMinimumMaturityDateForOtherExistingDebtRemaining" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Maturity, Minimum Maturity Date For Other Existing Debt Remaining</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DebtInstrumentCovenantMaturityMinimumMaturityDateForOtherExistingDebtRemaining" xlink:href="sgry-20210930.xsd#sgry_DebtInstrumentCovenantMaturityMinimumMaturityDateForOtherExistingDebtRemaining"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_DebtInstrumentCovenantMaturityMinimumMaturityDateForOtherExistingDebtRemaining" xlink:to="lab_sgry_DebtInstrumentCovenantMaturityMinimumMaturityDateForOtherExistingDebtRemaining" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_PayFixedSwapEightMember_583dfa4a-d8f3-4d08-a490-c57f226ee11c_terseLabel_en-US" xlink:label="lab_sgry_PayFixedSwapEightMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed swap</link:label>
    <link:label id="lab_sgry_PayFixedSwapEightMember_label_en-US" xlink:label="lab_sgry_PayFixedSwapEightMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed Swap Eight [Member]</link:label>
    <link:label id="lab_sgry_PayFixedSwapEightMember_documentation_en-US" xlink:label="lab_sgry_PayFixedSwapEightMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed Swap Eight</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapEightMember" xlink:href="sgry-20210930.xsd#sgry_PayFixedSwapEightMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_PayFixedSwapEightMember" xlink:to="lab_sgry_PayFixedSwapEightMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_454a45dd-303e-451c-8845-d8ad773c745c_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_ReceiveFixedSwapThreeMember_b68eea05-a08f-41c2-8de7-3dcce42a95b3_terseLabel_en-US" xlink:label="lab_sgry_ReceiveFixedSwapThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receive-fixed swap</link:label>
    <link:label id="lab_sgry_ReceiveFixedSwapThreeMember_label_en-US" xlink:label="lab_sgry_ReceiveFixedSwapThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receive-fixed Swap Three [Member]</link:label>
    <link:label id="lab_sgry_ReceiveFixedSwapThreeMember_documentation_en-US" xlink:label="lab_sgry_ReceiveFixedSwapThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receive-fixed Swap Three Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ReceiveFixedSwapThreeMember" xlink:href="sgry-20210930.xsd#sgry_ReceiveFixedSwapThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_ReceiveFixedSwapThreeMember" xlink:to="lab_sgry_ReceiveFixedSwapThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_6c86721d-3e81-4189-b928-6bf0f1970508_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_bdacae79-2e9e-410d-9abc-4b144a3085b0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_914b0265-f3c1-42a3-a5f5-3f26a0ac0eb4_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_522c93f9-d191-4077-b966-b5d606a644ea_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash outflows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockDividendRatePercentage_8b95a148-b9f4-42cd-9c7a-7107e8a3f2f2_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockDividendRatePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock dividend rate (percent)</link:label>
    <link:label id="lab_us-gaap_PreferredStockDividendRatePercentage_label_en-US" xlink:label="lab_us-gaap_PreferredStockDividendRatePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividend Rate, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockDividendRatePercentage" xlink:to="lab_us-gaap_PreferredStockDividendRatePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_ca029700-0a1a-456a-ae16-8607cbead891_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss recognized in OCI (effective portion)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_A2017SeniorSecuredCreditFacilityMember_a19d82b5-6833-4e83-99b0-246c2d945256_terseLabel_en-US" xlink:label="lab_sgry_A2017SeniorSecuredCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Revolver</link:label>
    <link:label id="lab_sgry_A2017SeniorSecuredCreditFacilityMember_label_en-US" xlink:label="lab_sgry_A2017SeniorSecuredCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Senior Secured Credit Facility [Member]</link:label>
    <link:label id="lab_sgry_A2017SeniorSecuredCreditFacilityMember_documentation_en-US" xlink:label="lab_sgry_A2017SeniorSecuredCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Senior Secured Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_A2017SeniorSecuredCreditFacilityMember" xlink:href="sgry-20210930.xsd#sgry_A2017SeniorSecuredCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_A2017SeniorSecuredCreditFacilityMember" xlink:to="lab_sgry_A2017SeniorSecuredCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_c245ecc3-8a1c-4808-a004-4f766ade55ac_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Combined purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember_8b4c95f2-c7eb-43e1-af2a-4b88cd6959c3_terseLabel_en-US" xlink:label="lab_sgry_A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Term Loans</link:label>
    <link:label id="lab_sgry_A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember_label_en-US" xlink:label="lab_sgry_A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Senior Secured Credit Facility, Sixth Amendment, New Term Loans [Member]</link:label>
    <link:label id="lab_sgry_A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember_documentation_en-US" xlink:label="lab_sgry_A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Senior Secured Credit Facility, Sixth Amendment, New Term Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember" xlink:href="sgry-20210930.xsd#sgry_A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember" xlink:to="lab_sgry_A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_36f3e292-93a9-49ec-9496-6ec8a2bb3b15_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_2fef9465-ddd0-4ca2-bdde-a75c036da267_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_ecfa976f-7735-4f97-ab70-a5f44b84d18f_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current maturities of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_aa1ab09f-cd78-46ad-aa8c-ee1e71661c2b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Current maturities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_FacilitiesSurgicalHospitalsMember_eb072f82-ea10-471e-9700-545dbdf4afba_terseLabel_en-US" xlink:label="lab_sgry_FacilitiesSurgicalHospitalsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facilities, Surgical Hospitals</link:label>
    <link:label id="lab_sgry_FacilitiesSurgicalHospitalsMember_label_en-US" xlink:label="lab_sgry_FacilitiesSurgicalHospitalsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facilities, Surgical Hospitals [Member]</link:label>
    <link:label id="lab_sgry_FacilitiesSurgicalHospitalsMember_documentation_en-US" xlink:label="lab_sgry_FacilitiesSurgicalHospitalsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facilities, Surgical Hospitals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_FacilitiesSurgicalHospitalsMember" xlink:href="sgry-20210930.xsd#sgry_FacilitiesSurgicalHospitalsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_FacilitiesSurgicalHospitalsMember" xlink:to="lab_sgry_FacilitiesSurgicalHospitalsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_6085eedd-11f3-4426-a395-ab98d2dcd089_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts_f4bfb475-2b9d-4839-b226-c5ae8c51ced6_terseLabel_en-US" xlink:label="lab_sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction, integration and acquisition costs</link:label>
    <link:label id="lab_sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts_label_en-US" xlink:label="lab_sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Integration Related Costs, And Merger Costs</link:label>
    <link:label id="lab_sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts_documentation_en-US" xlink:label="lab_sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Integration Related Costs, And Merger Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts" xlink:href="sgry-20210930.xsd#sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts" xlink:to="lab_sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_46c6ee23-1137-42ae-b19f-6c98a11596da_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_TaxReceivableAgreementLiabilityCurrent_a766f05d-cb1a-4710-a666-d007a4eaaae9_terseLabel_en-US" xlink:label="lab_sgry_TaxReceivableAgreementLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax receivable agreement liability</link:label>
    <link:label id="lab_sgry_TaxReceivableAgreementLiabilityCurrent_label_en-US" xlink:label="lab_sgry_TaxReceivableAgreementLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Receivable Agreement Liability, Current</link:label>
    <link:label id="lab_sgry_TaxReceivableAgreementLiabilityCurrent_documentation_en-US" xlink:label="lab_sgry_TaxReceivableAgreementLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Receivable Agreement Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_TaxReceivableAgreementLiabilityCurrent" xlink:href="sgry-20210930.xsd#sgry_TaxReceivableAgreementLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_TaxReceivableAgreementLiabilityCurrent" xlink:to="lab_sgry_TaxReceivableAgreementLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_9bc86ec4-33c1-4cd5-a091-a26fb8dc7ef0_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_15bc7517-366c-4a33-a7c5-90b5105213ea_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_5415bf3d-c5ef-4331-8598-7835517e382b_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_325ded16-5386-4ea3-8758-bc3e1cf12155_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_3dbe690c-3af1-472b-a4ae-3117946df25c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative activity</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_7a5a30b2-7112-43b2-a776-68799b3f07e4_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_d60acc7c-d6b8-4198-ba60-d3d7f5f777c5_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of unrealized losses recorded in OCI</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_d6b48b55-74a5-4b00-9f62-f6d24c21f893_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefits related to vesting of restricted stock awards</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_PayFixedSwapFiveMember_9e7f94f4-e6ea-4e8f-8915-529d46ea8cb3_terseLabel_en-US" xlink:label="lab_sgry_PayFixedSwapFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed swap</link:label>
    <link:label id="lab_sgry_PayFixedSwapFiveMember_label_en-US" xlink:label="lab_sgry_PayFixedSwapFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed Swap Five [Member]</link:label>
    <link:label id="lab_sgry_PayFixedSwapFiveMember_documentation_en-US" xlink:label="lab_sgry_PayFixedSwapFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed Swap Five Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapFiveMember" xlink:href="sgry-20210930.xsd#sgry_PayFixedSwapFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_PayFixedSwapFiveMember" xlink:to="lab_sgry_PayFixedSwapFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_624a7cff-1bc3-4aac-82a5-0f414d5fde92_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_SeniorUnsecuredNotesDue2027Member_50d34dc2-9b4f-4d42-8116-ba6479983017_terseLabel_en-US" xlink:label="lab_sgry_SeniorUnsecuredNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">10.000% senior unsecured notes due 2027</link:label>
    <link:label id="lab_sgry_SeniorUnsecuredNotesDue2027Member_label_en-US" xlink:label="lab_sgry_SeniorUnsecuredNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, Due 2027 [Member]</link:label>
    <link:label id="lab_sgry_SeniorUnsecuredNotesDue2027Member_documentation_en-US" xlink:label="lab_sgry_SeniorUnsecuredNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, Due 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SeniorUnsecuredNotesDue2027Member" xlink:href="sgry-20210930.xsd#sgry_SeniorUnsecuredNotesDue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_SeniorUnsecuredNotesDue2027Member" xlink:to="lab_sgry_SeniorUnsecuredNotesDue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d54eaef9-b60c-49f0-8916-5843f7c923f7_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_62ae10d7-31f8-4034-a746-f2004f4f2e5d_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_LineOfCreditFacilityMaximumBorrowingCapacityIncrease_5341083c-db13-44d5-ba0f-2c93996cd137_terseLabel_en-US" xlink:label="lab_sgry_LineOfCreditFacilityMaximumBorrowingCapacityIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in outstanding commitments</link:label>
    <link:label id="lab_sgry_LineOfCreditFacilityMaximumBorrowingCapacityIncrease_label_en-US" xlink:label="lab_sgry_LineOfCreditFacilityMaximumBorrowingCapacityIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Maximum Borrowing Capacity, Increase</link:label>
    <link:label id="lab_sgry_LineOfCreditFacilityMaximumBorrowingCapacityIncrease_documentation_en-US" xlink:label="lab_sgry_LineOfCreditFacilityMaximumBorrowingCapacityIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Maximum Borrowing Capacity, Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_LineOfCreditFacilityMaximumBorrowingCapacityIncrease" xlink:href="sgry-20210930.xsd#sgry_LineOfCreditFacilityMaximumBorrowingCapacityIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_LineOfCreditFacilityMaximumBorrowingCapacityIncrease" xlink:to="lab_sgry_LineOfCreditFacilityMaximumBorrowingCapacityIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_FinanceLeaseCost1Abstract_8a4115c3-8f8e-4315-9170-d7f7848acad0_terseLabel_en-US" xlink:label="lab_sgry_FinanceLeaseCost1Abstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease costs:</link:label>
    <link:label id="lab_sgry_FinanceLeaseCost1Abstract_label_en-US" xlink:label="lab_sgry_FinanceLeaseCost1Abstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Cost1 [Abstract]</link:label>
    <link:label id="lab_sgry_FinanceLeaseCost1Abstract_documentation_en-US" xlink:label="lab_sgry_FinanceLeaseCost1Abstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Cost1 [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_FinanceLeaseCost1Abstract" xlink:href="sgry-20210930.xsd#sgry_FinanceLeaseCost1Abstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_FinanceLeaseCost1Abstract" xlink:to="lab_sgry_FinanceLeaseCost1Abstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_e2a4e641-0892-4219-b8a4-a6ad661a9dc9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_63c4e74e-9643-4675-8402-222ab1b2889f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_b92f1b5c-1254-493d-ab33-2ddff34aa3b8_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_16a5b5c6-842f-45b6-b30f-6f6604510377_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Assets from Segment to Consolidated</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Assets from Segment to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_269848ab-b5fb-4bce-9b90-7aff08adbe91_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating assets and liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_PayFixedSwapTenMember_190d6728-f079-4ae7-9a4a-df599ba024b0_terseLabel_en-US" xlink:label="lab_sgry_PayFixedSwapTenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed swap</link:label>
    <link:label id="lab_sgry_PayFixedSwapTenMember_label_en-US" xlink:label="lab_sgry_PayFixedSwapTenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed Swap Ten [Member]</link:label>
    <link:label id="lab_sgry_PayFixedSwapTenMember_documentation_en-US" xlink:label="lab_sgry_PayFixedSwapTenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed Swap Ten</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapTenMember" xlink:href="sgry-20210930.xsd#sgry_PayFixedSwapTenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_PayFixedSwapTenMember" xlink:to="lab_sgry_PayFixedSwapTenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_IncreaseDecreaseInSettlementPayments_a8a8e92a-ab8e-4536-953a-df39def8d352_negatedTerseLabel_en-US" xlink:label="lab_sgry_IncreaseDecreaseInSettlementPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DOJ settlement payments</link:label>
    <link:label id="lab_sgry_IncreaseDecreaseInSettlementPayments_label_en-US" xlink:label="lab_sgry_IncreaseDecreaseInSettlementPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Settlement Payments</link:label>
    <link:label id="lab_sgry_IncreaseDecreaseInSettlementPayments_documentation_en-US" xlink:label="lab_sgry_IncreaseDecreaseInSettlementPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Settlement Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_IncreaseDecreaseInSettlementPayments" xlink:href="sgry-20210930.xsd#sgry_IncreaseDecreaseInSettlementPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_IncreaseDecreaseInSettlementPayments" xlink:to="lab_sgry_IncreaseDecreaseInSettlementPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_cf069d9c-3408-4d37-bd92-0ea4f82a2221_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of line of credit outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts_0f933793-a33a-43d7-8cb2-d8da23037a79_negatedTerseLabel_en-US" xlink:label="lab_sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement and other litigation costs</link:label>
    <link:label id="lab_sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts_label_en-US" xlink:label="lab_sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement And Other Litigation Costs</link:label>
    <link:label id="lab_sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts_documentation_en-US" xlink:label="lab_sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement And Other Litigation Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts" xlink:href="sgry-20210930.xsd#sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts" xlink:to="lab_sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_33f03c5b-e42d-4bd0-b9c0-954328357dd8_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_7b38ceac-66bb-4b62-9f5c-1a351dd679a4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Comprehensive income attributable to non-controlling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_43970d8d-837c-4f30-b605-21a5fe877137_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_4b90ac9e-4fdf-494d-b0f9-98965a37e545_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_c2c4b779-5252-4afa-8bb7-dc22a5ede0ec_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfProductiveAssets_2196a7f7-ccf9-4798-bdca-9dd215770465_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from disposals of facilities and other assets</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfProductiveAssets_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:to="lab_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_0a9f1659-ad27-4cc9-8cb5-baa0f676c941_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_f020f539-cd74-4e5a-8d64-b3cd8756fa4f_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_7a334a4d-7c7e-4f80-a294-195677c53a3e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_b3ca0ff8-9789-4299-82c8-3c9c41b36cbd_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_7334051e-f4ae-413b-90a6-9bdc9e1a9886_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity offering</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_81b7e279-10f0-4e45-ac69-622ddf23436c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of preferred shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_f4f318f0-ce4a-40cb-8ccb-b1f2f134cfa7_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative expenses</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_c82b58c0-4222-4abc-aac9-cd371857a793_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_828285b8-8615-4d7d-9c59-96543f80c14d_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_99752c34-9446-43ed-a4df-a5a4b723adb0_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_6131eee9-4b86-4642-905a-b1977f9fe996_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of non-controlling interests</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_d75bb0de-d9d8-4c28-b41c-8dd173bc4a88_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation on property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_0eb4fdab-7911-40d9-91eb-9525d1e25199_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_ecec990f-fd8b-418b-ade4-d37380ac707e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of equity offering costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_ddf14515-744e-47ca-a191-7afc7fc5f80d_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underwriting discounts, commissions and other related costs related to offering</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_c4d29dbe-956f-47f8-ad73-90abc5e5580a_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity offering (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_69c8169f-ef6b-4405-8bc0-7b03f8f1f59d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued during period (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_ff4c53f6-534a-4121-818f-3e8d073abe49_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_98780702-1416-42b5-9969-846c436b7d83_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interests&#8212;redeemable</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_f975d719-197d-42b9-839f-d70e36ad7c88_periodStartLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_d9549b3e-7f66-487c-b65e-736ebd89e864_periodEndLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_6553a5c1-3292-4a63-aa5c-aba625d16500_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_d552288b-ec9e-41f9-a4f4-c2b1e9e2d00b_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_dd775cca-743a-4999-9f06-d99c6db99eb7_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, including post acquisition adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_391358cf-036b-4d64-8833-5cc86591c914_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_64db5bef-46e5-4d3e-a059-d0f703e1e0f2_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_2d098b14-11de-4223-ae10-7359ab03cab3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_fa3fcb7e-722f-46e6-aa3a-86bd2d700af4_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Rollforward of Noncontrolling Interest - Redeemable</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c4f81f53-3aaf-4595-8e60-d4be2331384c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_ee2b7d5c-21d7-45ef-b706-17649e6d2647_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of leased assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_379aa4d2-1bec-4dff-87a4-d34f23bff803_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_74de95a5-1b9c-4d30-bc82-b1cca922ec2d_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted shares</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock_df345255-b5f4-4061-b0a0-48f01b3cacec_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effect of Interest Rate Swaps</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Interest Rate Derivatives [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_d07c9142-43ff-4e99-9764-7eb14ba8c7d9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_0426ce63-d0a8-4d6d-bdf6-98b9fa51e40b_terseLabel_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Source</link:label>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductConcentrationRiskMember" xlink:to="lab_us-gaap_ProductConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_ce9a1ecb-c969-4cec-a92a-59b7396e339b_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_c65937e6-2a3e-40b0-b088-498ab5098c59_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_ReceiveFixedSwapTwoMember_88270cf2-6d62-4e09-9fd4-32f428d66880_terseLabel_en-US" xlink:label="lab_sgry_ReceiveFixedSwapTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receive-fixed swap</link:label>
    <link:label id="lab_sgry_ReceiveFixedSwapTwoMember_label_en-US" xlink:label="lab_sgry_ReceiveFixedSwapTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receive-fixed Swap Two [Member]</link:label>
    <link:label id="lab_sgry_ReceiveFixedSwapTwoMember_documentation_en-US" xlink:label="lab_sgry_ReceiveFixedSwapTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receive-fixed Swap Two Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ReceiveFixedSwapTwoMember" xlink:href="sgry-20210930.xsd#sgry_ReceiveFixedSwapTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_ReceiveFixedSwapTwoMember" xlink:to="lab_sgry_ReceiveFixedSwapTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_42f79e22-aee9-416b-8399-8b7e26b001ff_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_12202370-84aa-4c7d-ac15-ff9b2d36f09d_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_7eab2240-0e71-4ee1-aafb-df63b64d79f6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax expense attributable to impairment of goodwill</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_6a480c04-1ccf-4921-9739-03dd35aaa9b6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityByClassOfStockTable_beb3f38d-9abb-4b7e-a4e9-1071aac970fe_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityByClassOfStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, by Class of Stock [Table]</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityByClassOfStockTable_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityByClassOfStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, by Class of Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="lab_us-gaap_TemporaryEquityByClassOfStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_cea1cf15-d5c8-4206-b72c-c16604398bf2_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from stock offering</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt_271040f3-8b09-4b5b-a8e3-d75b6a4ed89d_negatedTerseLabel_en-US" xlink:label="lab_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt_label_en-US" xlink:label="lab_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long Term Debt</link:label>
    <link:label id="lab_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt_documentation_en-US" xlink:label="lab_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt" xlink:href="sgry-20210930.xsd#sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt" xlink:to="lab_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_3220acd5-3f66-4c90-ac50-8b7938e5f8c7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of accumulated OCI related</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Reclassification for Discontinuance, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingRightOfUseAssets_201feeff-040d-4f81-bb5b-3eee17a86a34_terseLabel_en-US" xlink:label="lab_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use operating lease assets</link:label>
    <link:label id="lab_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingRightOfUseAssets_label_en-US" xlink:label="lab_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Right Of Use Assets</link:label>
    <link:label id="lab_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingRightOfUseAssets_documentation_en-US" xlink:label="lab_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Right Of Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingRightOfUseAssets" xlink:href="sgry-20210930.xsd#sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingRightOfUseAssets" xlink:to="lab_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_6747ec72-5a41-4e7b-b641-d1a6f5e282e9_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable preferred stock - Series A; shares authorized - 310,000; shares issued or outstanding - none and 310,000, respectively; redemption value - $&#8212; and $434.5, respectively</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_5951ca23-2ccb-4b90-ab61-d55cfaec70cc_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_0e6e22d5-ad08-4392-8f94-f346e2ab6e21_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_0dfcfc47-a272-4ed0-956f-6061708c5c40_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_c1badfa0-dd58-4ba7-9a2a-4f4aa3786754_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred dividends</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_2e6b15d4-e941-4562-bc81-076083dc92d2_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_3a0f66cb-667a-43d3-a153-5fa7723a6465_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_efc97e74-b294-4794-9a87-5a345d785eaa_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Amount</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_TemporaryEquityThresholdSharePrice_de8180b0-d7dc-4b54-90b9-d66aa34f5cb2_terseLabel_en-US" xlink:label="lab_sgry_TemporaryEquityThresholdSharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold share price (in USD per share)</link:label>
    <link:label id="lab_sgry_TemporaryEquityThresholdSharePrice_label_en-US" xlink:label="lab_sgry_TemporaryEquityThresholdSharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Threshold Share Price</link:label>
    <link:label id="lab_sgry_TemporaryEquityThresholdSharePrice_documentation_en-US" xlink:label="lab_sgry_TemporaryEquityThresholdSharePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Threshold Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_TemporaryEquityThresholdSharePrice" xlink:href="sgry-20210930.xsd#sgry_TemporaryEquityThresholdSharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_TemporaryEquityThresholdSharePrice" xlink:to="lab_sgry_TemporaryEquityThresholdSharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_DebtInstrumentCovenantMaturityMinimumAmountOfOtherExistingDebtRemaining_5c71cad2-1e36-4020-86a3-60e0855954da_terseLabel_en-US" xlink:label="lab_sgry_DebtInstrumentCovenantMaturityMinimumAmountOfOtherExistingDebtRemaining" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity covenant, minimum amount of Borrower's 6.750% senior unsecured notes due 2025 not repaid, repurchased or redeemed or refinanced</link:label>
    <link:label id="lab_sgry_DebtInstrumentCovenantMaturityMinimumAmountOfOtherExistingDebtRemaining_label_en-US" xlink:label="lab_sgry_DebtInstrumentCovenantMaturityMinimumAmountOfOtherExistingDebtRemaining" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Maturity, Minimum Amount Of Other Existing Debt Remaining</link:label>
    <link:label id="lab_sgry_DebtInstrumentCovenantMaturityMinimumAmountOfOtherExistingDebtRemaining_documentation_en-US" xlink:label="lab_sgry_DebtInstrumentCovenantMaturityMinimumAmountOfOtherExistingDebtRemaining" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Maturity, Minimum Amount Of Other Existing Debt Remaining</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DebtInstrumentCovenantMaturityMinimumAmountOfOtherExistingDebtRemaining" xlink:href="sgry-20210930.xsd#sgry_DebtInstrumentCovenantMaturityMinimumAmountOfOtherExistingDebtRemaining"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_DebtInstrumentCovenantMaturityMinimumAmountOfOtherExistingDebtRemaining" xlink:to="lab_sgry_DebtInstrumentCovenantMaturityMinimumAmountOfOtherExistingDebtRemaining" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualRiskOrUncertaintyNatureDomain_86398eba-1b05-49ee-a1e7-0cd73292620e_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualRiskOrUncertaintyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual Risk or Uncertainty, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_UnusualRiskOrUncertaintyNatureDomain_label_en-US" xlink:label="lab_us-gaap_UnusualRiskOrUncertaintyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual Risk or Uncertainty, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualRiskOrUncertaintyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualRiskOrUncertaintyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualRiskOrUncertaintyNatureDomain" xlink:to="lab_us-gaap_UnusualRiskOrUncertaintyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_3cada7c4-521b-4db1-9239-5317d7f04cf9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_766e26bb-9cea-4bc9-a3ee-ec522797d9e1_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_e2c32dee-5b30-4e34-ade4-223767eea602_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_41a497d4-a495-4388-a244-8a4f2fcce8e2_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfessionalFees_144099f2-5618-4a3f-a223-46870fa305ce_terseLabel_en-US" xlink:label="lab_us-gaap_ProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional and medical fees</link:label>
    <link:label id="lab_us-gaap_ProfessionalFees_label_en-US" xlink:label="lab_us-gaap_ProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfessionalFees" xlink:to="lab_us-gaap_ProfessionalFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_d5933e82-2324-4d73-afb3-5298cd37fb02_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_d38ef082-60f7-4d83-a320-741a9be86562_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Including Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_CoronavirusAidReliefandEconomicSecurityActCARESActGovernmentGrantReceivedAcceleratedPayments_d302af3e-a45a-4e0f-a94c-f34d30beb3b7_terseLabel_en-US" xlink:label="lab_sgry_CoronavirusAidReliefandEconomicSecurityActCARESActGovernmentGrantReceivedAcceleratedPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated payments</link:label>
    <link:label id="lab_sgry_CoronavirusAidReliefandEconomicSecurityActCARESActGovernmentGrantReceivedAcceleratedPayments_label_en-US" xlink:label="lab_sgry_CoronavirusAidReliefandEconomicSecurityActCARESActGovernmentGrantReceivedAcceleratedPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coronavirus Aid, Relief, and Economic Security Act CARES Act, Government Grant Received, Accelerated Payments</link:label>
    <link:label id="lab_sgry_CoronavirusAidReliefandEconomicSecurityActCARESActGovernmentGrantReceivedAcceleratedPayments_documentation_en-US" xlink:label="lab_sgry_CoronavirusAidReliefandEconomicSecurityActCARESActGovernmentGrantReceivedAcceleratedPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coronavirus Aid, Relief, and Economic Security Act CARES Act, Government Grant Received, Accelerated Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_CoronavirusAidReliefandEconomicSecurityActCARESActGovernmentGrantReceivedAcceleratedPayments" xlink:href="sgry-20210930.xsd#sgry_CoronavirusAidReliefandEconomicSecurityActCARESActGovernmentGrantReceivedAcceleratedPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_CoronavirusAidReliefandEconomicSecurityActCARESActGovernmentGrantReceivedAcceleratedPayments" xlink:to="lab_sgry_CoronavirusAidReliefandEconomicSecurityActCARESActGovernmentGrantReceivedAcceleratedPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_fb1a0471-49e0-4854-bc12-4742bb5cf489_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e665cb0d-5f2b-4273-a6e8-b0a42bb2b95b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_0c2da76a-c521-47ea-be12-ac3acd46708f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_c931a65e-19ea-42a1-851b-7420d41fb6a7_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenues</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpenses" xlink:to="lab_us-gaap_OperatingCostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_3dea5c7b-000e-4c14-a122-2411800ad1f5_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_44122f33-7435-44f1-8540-02e7d33dac06_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_3964eace-ff44-48ea-be56-add0f95349cf_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_OperatingAndFinanceLeaseExpense_15c02a5d-98e0-425c-934b-19876968dd29_terseLabel_en-US" xlink:label="lab_sgry_OperatingAndFinanceLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease expense</link:label>
    <link:label id="lab_sgry_OperatingAndFinanceLeaseExpense_label_en-US" xlink:label="lab_sgry_OperatingAndFinanceLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Expense</link:label>
    <link:label id="lab_sgry_OperatingAndFinanceLeaseExpense_documentation_en-US" xlink:label="lab_sgry_OperatingAndFinanceLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_OperatingAndFinanceLeaseExpense" xlink:href="sgry-20210930.xsd#sgry_OperatingAndFinanceLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_OperatingAndFinanceLeaseExpense" xlink:to="lab_sgry_OperatingAndFinanceLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_06a15d60-66ec-419b-8978-dea5c9baaf04_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_43c7cda2-b609-4782-b352-d3eea5fbfeb0_negatedTerseLabel_en-US" xlink:label="lab_sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to non-controlling interest&#8212;redeemable holders</link:label>
    <link:label id="lab_sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Decrease From Distributions To Noncontrolling Interest Holders</link:label>
    <link:label id="lab_sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_documentation_en-US" xlink:label="lab_sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="sgry-20210930.xsd#sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_PayFixedSwapSevenMember_97be1d52-a031-4bf8-9be8-d4619f5a6c15_terseLabel_en-US" xlink:label="lab_sgry_PayFixedSwapSevenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed swap</link:label>
    <link:label id="lab_sgry_PayFixedSwapSevenMember_label_en-US" xlink:label="lab_sgry_PayFixedSwapSevenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed Swap Seven [Member]</link:label>
    <link:label id="lab_sgry_PayFixedSwapSevenMember_documentation_en-US" xlink:label="lab_sgry_PayFixedSwapSevenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed Swap Seven</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapSevenMember" xlink:href="sgry-20210930.xsd#sgry_PayFixedSwapSevenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_PayFixedSwapSevenMember" xlink:to="lab_sgry_PayFixedSwapSevenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_827185b6-93df-4da3-8403-e3eda7d0add5_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_806349f0-cf9b-492e-ac59-a8298960eafb_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_SaleOfStockTable_0ed8cba9-4c60-40e5-a61d-b43d4adc9582_terseLabel_en-US" xlink:label="lab_sgry_SaleOfStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock [Table]</link:label>
    <link:label id="lab_sgry_SaleOfStockTable_label_en-US" xlink:label="lab_sgry_SaleOfStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock [Table]</link:label>
    <link:label id="lab_sgry_SaleOfStockTable_documentation_en-US" xlink:label="lab_sgry_SaleOfStockTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SaleOfStockTable" xlink:href="sgry-20210930.xsd#sgry_SaleOfStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_SaleOfStockTable" xlink:to="lab_sgry_SaleOfStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_d5ed27f2-7966-4581-bffd-d64356e59607_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation_5cea20e4-0bce-4647-970f-ef6c7bdd24e3_negatedLabel_en-US" xlink:label="lab_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on disposals and deconsolidations, net</link:label>
    <link:label id="lab_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation_2e92699f-9f0b-4eee-9940-5017ac0456af_negatedTerseLabel_en-US" xlink:label="lab_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on disposals and deconsolidations, net</link:label>
    <link:label id="lab_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation_label_en-US" xlink:label="lab_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Disposition Of Assets And Deconsolidation</link:label>
    <link:label id="lab_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation_documentation_en-US" xlink:label="lab_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Disposition of Assets And Deconsolidation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation" xlink:href="sgry-20210930.xsd#sgry_GainLossOnDispositionOfAssetsAndDeconsolidation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation" xlink:to="lab_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_b9570ac9-be51-486a-b580-c132c7414200_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investing activities</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_VariableInterestEntityNumberOfFacilities_27ce4664-4037-47ee-8179-585e529db962_terseLabel_en-US" xlink:label="lab_sgry_VariableInterestEntityNumberOfFacilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of facilities included in VIE</link:label>
    <link:label id="lab_sgry_VariableInterestEntityNumberOfFacilities_label_en-US" xlink:label="lab_sgry_VariableInterestEntityNumberOfFacilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Number Of Facilities</link:label>
    <link:label id="lab_sgry_VariableInterestEntityNumberOfFacilities_documentation_en-US" xlink:label="lab_sgry_VariableInterestEntityNumberOfFacilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Number of Facilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_VariableInterestEntityNumberOfFacilities" xlink:href="sgry-20210930.xsd#sgry_VariableInterestEntityNumberOfFacilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_VariableInterestEntityNumberOfFacilities" xlink:to="lab_sgry_VariableInterestEntityNumberOfFacilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5d9b07e8-e9fd-48e8-b3e1-e320b4cb12a4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f80d1dbf-ece6-4a83-a80f-65e316ace7c3_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_4c859bc1-4e8a-4db9-97ea-0d184b83b245_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_bc3f6ab0-fcd8-4c7e-8914-f09bfccfe670_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_1ace968c-0d68-4181-bca4-0cca5e6d5198_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_OtherServicesMember_af991293-14e1-4615-afdc-61403665ccce_verboseLabel_en-US" xlink:label="lab_sgry_OtherServicesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other service revenues</link:label>
    <link:label id="lab_sgry_OtherServicesMember_label_en-US" xlink:label="lab_sgry_OtherServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Services [Member]</link:label>
    <link:label id="lab_sgry_OtherServicesMember_documentation_en-US" xlink:label="lab_sgry_OtherServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_OtherServicesMember" xlink:href="sgry-20210930.xsd#sgry_OtherServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_OtherServicesMember" xlink:to="lab_sgry_OtherServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_RedeemableNoncontrollingInterestRollForward_3d6f43db-2465-4b4e-a642-de7255c122d1_terseLabel_en-US" xlink:label="lab_sgry_RedeemableNoncontrollingInterestRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Controlling Interests - Redeemable [Roll Forward]</link:label>
    <link:label id="lab_sgry_RedeemableNoncontrollingInterestRollForward_label_en-US" xlink:label="lab_sgry_RedeemableNoncontrollingInterestRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Roll Forward]</link:label>
    <link:label id="lab_sgry_RedeemableNoncontrollingInterestRollForward_documentation_en-US" xlink:label="lab_sgry_RedeemableNoncontrollingInterestRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_RedeemableNoncontrollingInterestRollForward" xlink:href="sgry-20210930.xsd#sgry_RedeemableNoncontrollingInterestRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_RedeemableNoncontrollingInterestRollForward" xlink:to="lab_sgry_RedeemableNoncontrollingInterestRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_ThreePayFixedInterestRateSwapsMember_4ea9eae4-d29b-4cc0-8092-fd3042a0cf7a_terseLabel_en-US" xlink:label="lab_sgry_ThreePayFixedInterestRateSwapsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Pay-fixed Interest Rate Swaps</link:label>
    <link:label id="lab_sgry_ThreePayFixedInterestRateSwapsMember_label_en-US" xlink:label="lab_sgry_ThreePayFixedInterestRateSwapsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Pay-fixed Interest Rate Swaps [Member]</link:label>
    <link:label id="lab_sgry_ThreePayFixedInterestRateSwapsMember_documentation_en-US" xlink:label="lab_sgry_ThreePayFixedInterestRateSwapsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Pay-fixed Interest Rate Swaps Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ThreePayFixedInterestRateSwapsMember" xlink:href="sgry-20210930.xsd#sgry_ThreePayFixedInterestRateSwapsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_ThreePayFixedInterestRateSwapsMember" xlink:to="lab_sgry_ThreePayFixedInterestRateSwapsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_ae87aeb3-bb8b-463e-bac1-ca2056be800d_terseLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_ReceiveFixedSwapOneMember_bee3b49c-f0ee-4234-810b-b824474c3278_terseLabel_en-US" xlink:label="lab_sgry_ReceiveFixedSwapOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receive-fixed swap</link:label>
    <link:label id="lab_sgry_ReceiveFixedSwapOneMember_label_en-US" xlink:label="lab_sgry_ReceiveFixedSwapOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receive-fixed Swap One [Member]</link:label>
    <link:label id="lab_sgry_ReceiveFixedSwapOneMember_documentation_en-US" xlink:label="lab_sgry_ReceiveFixedSwapOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receive-fixed Swap One Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ReceiveFixedSwapOneMember" xlink:href="sgry-20210930.xsd#sgry_ReceiveFixedSwapOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_ReceiveFixedSwapOneMember" xlink:to="lab_sgry_ReceiveFixedSwapOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGuaranteeObligationsTable_47d7b5d2-cfa5-4935-a66f-3aa306500f63_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGuaranteeObligationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Guarantor Obligations [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGuaranteeObligationsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGuaranteeObligationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Guarantor Obligations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGuaranteeObligationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGuaranteeObligationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGuaranteeObligationsTable" xlink:to="lab_us-gaap_ScheduleOfGuaranteeObligationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments_a49adede-821e-47c4-85fa-c5b9c4285da0_terseLabel_en-US" xlink:label="lab_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of grants received</link:label>
    <link:label id="lab_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments_label_en-US" xlink:label="lab_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coronavirus Aid, Relief, and Economic Security Act CARES Act, Government Grant Received, Repayments</link:label>
    <link:label id="lab_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments_documentation_en-US" xlink:label="lab_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coronavirus Aid, Relief, and Economic Security Act CARES Act, Government Grant Received, Repayments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments" xlink:href="sgry-20210930.xsd#sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments" xlink:to="lab_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_577c63f8-6384-4808-adf2-b44ed8c67381_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_44a134f8-5e9a-40e3-99c9-49d987a08631_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_9dedc2d6-dfa0-4ac1-942c-d86d564fb207_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Surgery Partners, Inc. stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_f942df85-680e-464d-a4a4-f3d36a95e9b7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_921f1b60-b806-4b12-be89-bb98cc376a48_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants_4e2cc348-8f02-4566-8ced-ec3da97e6b3a_terseLabel_en-US" xlink:label="lab_sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare accelerated payments and deferred governmental grants</link:label>
    <link:label id="lab_sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants_label_en-US" xlink:label="lab_sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Medicare Accelerated Payments And Deferred Governmental Grants</link:label>
    <link:label id="lab_sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants_documentation_en-US" xlink:label="lab_sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Medicare Accelerated Payments And Deferred Governmental Grants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants" xlink:href="sgry-20210930.xsd#sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants" xlink:to="lab_sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_24c76900-6482-4998-8a34-1c81a3a573be_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives in cash flow hedging relationships</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_7b48b7b7-d773-4a6c-9485-6ea5780d1a28_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets acquired:</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_93aa7fff-14e5-498a-9c62-b6243349ae54_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain) loss on debt extinguishment</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrentAndNoncurrent_a2a1c666-3244-4377-8c50-98c4627e6789_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term tax receivable agreement liability</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_141155be-c2f3-4f60-bdbc-e5ab281ca3a3_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Variable Interest Entity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:to="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_947e78b5-986a-4338-8201-a7295efef1c0_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_75c47848-5ef2-48fe-bf6c-c973657e3f10_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_NumberOfSurgicalFacilitiesOwnedConsolidated_1986cba2-b37b-4433-9fbf-4fd7afe1ff3e_terseLabel_en-US" xlink:label="lab_sgry_NumberOfSurgicalFacilitiesOwnedConsolidated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of surgical facilities owned, consolidated</link:label>
    <link:label id="lab_sgry_NumberOfSurgicalFacilitiesOwnedConsolidated_label_en-US" xlink:label="lab_sgry_NumberOfSurgicalFacilitiesOwnedConsolidated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Surgical Facilities Owned, Consolidated</link:label>
    <link:label id="lab_sgry_NumberOfSurgicalFacilitiesOwnedConsolidated_documentation_en-US" xlink:label="lab_sgry_NumberOfSurgicalFacilitiesOwnedConsolidated" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Surgical Facilities Owned, Consolidated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NumberOfSurgicalFacilitiesOwnedConsolidated" xlink:href="sgry-20210930.xsd#sgry_NumberOfSurgicalFacilitiesOwnedConsolidated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_NumberOfSurgicalFacilitiesOwnedConsolidated" xlink:to="lab_sgry_NumberOfSurgicalFacilitiesOwnedConsolidated" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_8fe41174-ce69-4d88-ad47-da22c527d96e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate acquisition date fair value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_135f413b-f664-4f5a-9e43-ede388944479_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate acquisition date fair value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_NotMateriallyMoreRestrictiveMember_c06a559f-9e46-49d4-a64e-eb599b67c6e1_terseLabel_en-US" xlink:label="lab_sgry_NotMateriallyMoreRestrictiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Materially More Restrictive</link:label>
    <link:label id="lab_sgry_NotMateriallyMoreRestrictiveMember_label_en-US" xlink:label="lab_sgry_NotMateriallyMoreRestrictiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Materially More Restrictive [Member]</link:label>
    <link:label id="lab_sgry_NotMateriallyMoreRestrictiveMember_documentation_en-US" xlink:label="lab_sgry_NotMateriallyMoreRestrictiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Materially More Restrictive [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NotMateriallyMoreRestrictiveMember" xlink:href="sgry-20210930.xsd#sgry_NotMateriallyMoreRestrictiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_NotMateriallyMoreRestrictiveMember" xlink:to="lab_sgry_NotMateriallyMoreRestrictiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_9cdc57a1-2372-43ff-bf4b-fd7faa816583_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_TemporaryEquityThresholdConsecutiveTradingDays_7681c5e0-59e0-4609-9e22-495361d47119_terseLabel_en-US" xlink:label="lab_sgry_TemporaryEquityThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consecutive trading days</link:label>
    <link:label id="lab_sgry_TemporaryEquityThresholdConsecutiveTradingDays_label_en-US" xlink:label="lab_sgry_TemporaryEquityThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Threshold Consecutive Trading Days</link:label>
    <link:label id="lab_sgry_TemporaryEquityThresholdConsecutiveTradingDays_documentation_en-US" xlink:label="lab_sgry_TemporaryEquityThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_TemporaryEquityThresholdConsecutiveTradingDays" xlink:href="sgry-20210930.xsd#sgry_TemporaryEquityThresholdConsecutiveTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_TemporaryEquityThresholdConsecutiveTradingDays" xlink:to="lab_sgry_TemporaryEquityThresholdConsecutiveTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_77ba4908-b187-4b1b-b6e8-4c2d87ab39fc_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_807d56ab-52f3-4715-8a4d-0c068dce2a4b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_c13e7c0d-b3e4-4d24-894c-e99aeec79082_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_dda14246-d063-451a-9f38-4c479fcabc1a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_e1693aff-7528-45f8-9a8e-6fa58e1b3cae_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_96776f7d-5f1f-43e8-b7fa-25b10fc07080_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_8d8415ed-3494-4c2b-9aa1-3d162510d940_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_bd3425a7-bd60-4a10-bddb-c98271fb9447_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_a17c2780-d385-464b-b61b-7ae9196734e6_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_72c9fe11-a594-4aca-ac0e-c827aae9655c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_RedeemableNoncontrollingInterestPolicyTextBlock_58d0d474-8b0f-49f1-8cbf-28066cb011ba_terseLabel_en-US" xlink:label="lab_sgry_RedeemableNoncontrollingInterestPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Controlling Interests&#8212;Redeemable</link:label>
    <link:label id="lab_sgry_RedeemableNoncontrollingInterestPolicyTextBlock_label_en-US" xlink:label="lab_sgry_RedeemableNoncontrollingInterestPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Policy Text Block]</link:label>
    <link:label id="lab_sgry_RedeemableNoncontrollingInterestPolicyTextBlock_documentation_en-US" xlink:label="lab_sgry_RedeemableNoncontrollingInterestPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_RedeemableNoncontrollingInterestPolicyTextBlock" xlink:href="sgry-20210930.xsd#sgry_RedeemableNoncontrollingInterestPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_RedeemableNoncontrollingInterestPolicyTextBlock" xlink:to="lab_sgry_RedeemableNoncontrollingInterestPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_e674666c-37ef-494e-9f71-22177d619e96_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization and Summary of Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_dbe46b26-ba54-440f-8fe7-3e764e79d202_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7acc30a8-4dfc-44c5-a287-2b66afb555bc_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3c3b7494-807e-41b2-9a22-d16dda20b2ae_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance, stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5774c943-5f05-4754-b1bb-24903e0fb98a_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance, stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_6a604b57-6646-4162-b44d-f9f856d738d4_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_711756c7-6d99-40d1-ae0f-215e754ebe0e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_0b71aa3f-6039-40f1-b181-6ca760e06c21_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_08c0ef4b-e4d9-4b8c-98e6-6767b34ca989_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_d75c209b-6bdc-4019-a49f-1b48ce7e2937_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockSharesIssued1_bb3d4e9f-a444-431d-9fd9-a05d33f0efaa_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares of common stock issued in conversion (shares)</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockSharesIssued1_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockSharesIssued1" xlink:to="lab_us-gaap_ConversionOfStockSharesIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_ProceedsFromGovernmentAssistance_101676a8-3d19-40d6-93b1-793433b0c406_terseLabel_en-US" xlink:label="lab_sgry_ProceedsFromGovernmentAssistance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from grants received</link:label>
    <link:label id="lab_sgry_ProceedsFromGovernmentAssistance_label_en-US" xlink:label="lab_sgry_ProceedsFromGovernmentAssistance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Government Assistance</link:label>
    <link:label id="lab_sgry_ProceedsFromGovernmentAssistance_documentation_en-US" xlink:label="lab_sgry_ProceedsFromGovernmentAssistance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Government Assistance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ProceedsFromGovernmentAssistance" xlink:href="sgry-20210930.xsd#sgry_ProceedsFromGovernmentAssistance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_ProceedsFromGovernmentAssistance" xlink:to="lab_sgry_ProceedsFromGovernmentAssistance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_9361114d-598d-4d2a-8113-08c554463247_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_941c4bd6-064d-4e43-b40a-ba75b88a1198_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_1229c47a-310c-4fb5-97db-8a57660249de_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_4d0aa5ba-cf92-4391-8102-749c815c7d05_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_888a1360-4c78-4bb5-9466-74cd3b806c88_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_52ed0aee-dd93-48da-833a-b1c88f19b0f4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Financial Information by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_a39f5cc1-763b-4f8e-9c49-d4af23012456_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_a89a78b6-e502-4c68-a4cb-d14a1c5b3d63_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_7e2ff273-e6f5-46d5-903a-557170d7be27_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_435c5d2d-a673-4b3f-8c10-cf9c850478dd_negatedLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Amounts attributable to participating securities</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings (Loss) Allocated to Participating Securities, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:to="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_1b6bd772-6a50-4fd1-a394-6cb9df55512e_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_4268ca09-b0bc-4dcd-8983-7502c64130d0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_0b1508c6-2d25-43c2-9e02-61c56752bd94_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_8946dfa7-b821-4c3c-99c4-40e26f6cfa8f_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_ce9ad743-5713-45a0-809b-45cecef59997_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_SelfPayRevenueMember_9bb7d06f-a52c-4b2a-8b34-0a793e5dc3eb_terseLabel_en-US" xlink:label="lab_sgry_SelfPayRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self-pay</link:label>
    <link:label id="lab_sgry_SelfPayRevenueMember_label_en-US" xlink:label="lab_sgry_SelfPayRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self-Pay Revenue [Member]</link:label>
    <link:label id="lab_sgry_SelfPayRevenueMember_documentation_en-US" xlink:label="lab_sgry_SelfPayRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self-Pay Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SelfPayRevenueMember" xlink:href="sgry-20210930.xsd#sgry_SelfPayRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_SelfPayRevenueMember" xlink:to="lab_sgry_SelfPayRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_OtherPatientServiceRevenueSourcesMember_10463b24-9fd0-4f78-8a0e-f5e63e3ff742_terseLabel_en-US" xlink:label="lab_sgry_OtherPatientServiceRevenueSourcesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_sgry_OtherPatientServiceRevenueSourcesMember_label_en-US" xlink:label="lab_sgry_OtherPatientServiceRevenueSourcesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Patient Service Revenue Sources [Member]</link:label>
    <link:label id="lab_sgry_OtherPatientServiceRevenueSourcesMember_documentation_en-US" xlink:label="lab_sgry_OtherPatientServiceRevenueSourcesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Patient Service Revenue Sources [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_OtherPatientServiceRevenueSourcesMember" xlink:href="sgry-20210930.xsd#sgry_OtherPatientServiceRevenueSourcesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_OtherPatientServiceRevenueSourcesMember" xlink:to="lab_sgry_OtherPatientServiceRevenueSourcesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_0b86c52d-7e6d-46ac-b315-d191bdc60fa8_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_MateriallyMoreRestrictiveMember_2b314440-87e4-4e2f-aaa5-bc721f83b327_terseLabel_en-US" xlink:label="lab_sgry_MateriallyMoreRestrictiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Materially More Restrictive</link:label>
    <link:label id="lab_sgry_MateriallyMoreRestrictiveMember_label_en-US" xlink:label="lab_sgry_MateriallyMoreRestrictiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Materially More Restrictive [Member]</link:label>
    <link:label id="lab_sgry_MateriallyMoreRestrictiveMember_documentation_en-US" xlink:label="lab_sgry_MateriallyMoreRestrictiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Materially More Restrictive [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_MateriallyMoreRestrictiveMember" xlink:href="sgry-20210930.xsd#sgry_MateriallyMoreRestrictiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_MateriallyMoreRestrictiveMember" xlink:to="lab_sgry_MateriallyMoreRestrictiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_PublicStockOfferingMember_6016eb8c-99f6-4a38-b18b-b2d3d9ecdc2f_terseLabel_en-US" xlink:label="lab_sgry_PublicStockOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Offering</link:label>
    <link:label id="lab_sgry_PublicStockOfferingMember_label_en-US" xlink:label="lab_sgry_PublicStockOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Stock Offering [Member]</link:label>
    <link:label id="lab_sgry_PublicStockOfferingMember_documentation_en-US" xlink:label="lab_sgry_PublicStockOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Stock Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PublicStockOfferingMember" xlink:href="sgry-20210930.xsd#sgry_PublicStockOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_PublicStockOfferingMember" xlink:to="lab_sgry_PublicStockOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_6a328c66-0997-4caf-b31e-5ba2c52d891d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_SaleOfStockLineItems_5b42b141-2ca5-4108-af9c-ad8c6fba031b_terseLabel_en-US" xlink:label="lab_sgry_SaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock [Line Items]</link:label>
    <link:label id="lab_sgry_SaleOfStockLineItems_label_en-US" xlink:label="lab_sgry_SaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock [Line Items]</link:label>
    <link:label id="lab_sgry_SaleOfStockLineItems_documentation_en-US" xlink:label="lab_sgry_SaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SaleOfStockLineItems" xlink:href="sgry-20210930.xsd#sgry_SaleOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_SaleOfStockLineItems" xlink:to="lab_sgry_SaleOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_NumberOfSurgicalFacilitiesOwned_882b4fdf-b305-47c4-b567-ba06d397d87c_terseLabel_en-US" xlink:label="lab_sgry_NumberOfSurgicalFacilitiesOwned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of surgical facilities owned</link:label>
    <link:label id="lab_sgry_NumberOfSurgicalFacilitiesOwned_label_en-US" xlink:label="lab_sgry_NumberOfSurgicalFacilitiesOwned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Surgical Facilities Owned</link:label>
    <link:label id="lab_sgry_NumberOfSurgicalFacilitiesOwned_documentation_en-US" xlink:label="lab_sgry_NumberOfSurgicalFacilitiesOwned" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Surgical Facilities Owned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NumberOfSurgicalFacilitiesOwned" xlink:href="sgry-20210930.xsd#sgry_NumberOfSurgicalFacilitiesOwned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_NumberOfSurgicalFacilitiesOwned" xlink:to="lab_sgry_NumberOfSurgicalFacilitiesOwned" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8055f21c-dc00-4de2-a085-9c9d088f3062_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity-based compensation (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_18f5958c-c142-480e-86f3-0b465f23487f_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_962cd198-5cb8-4258-aaf7-0317b9b82ac7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_d73365ef-32d7-4def-95f7-8ea08102cae9_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net of accumulated depreciation of $254.0 and $189.3, respectively</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_02361c90-79fb-4ac2-958b-53641c38389e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_62fcadc0-e89d-4a5f-b294-d9fe1f86e306_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_ea4b3688-7bc9-4c97-9b33-1867dc4aaf14_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment under settlement agreement</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_SurgicalFacilityServicesMember_4e5a6a85-5546-4cc3-919f-fe91daf706dd_terseLabel_en-US" xlink:label="lab_sgry_SurgicalFacilityServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Facility Services</link:label>
    <link:label id="lab_sgry_SurgicalFacilityServicesMember_label_en-US" xlink:label="lab_sgry_SurgicalFacilityServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Facility Services [Member]</link:label>
    <link:label id="lab_sgry_SurgicalFacilityServicesMember_documentation_en-US" xlink:label="lab_sgry_SurgicalFacilityServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Facility Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SurgicalFacilityServicesMember" xlink:href="sgry-20210930.xsd#sgry_SurgicalFacilityServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_SurgicalFacilityServicesMember" xlink:to="lab_sgry_SurgicalFacilityServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_53865006-e801-4495-87bf-c3754403d382_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity-based compensation</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability_b3c63a7d-8b24-46fa-a5ea-0a987d4a916c_negatedTerseLabel_en-US" xlink:label="lab_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use operating lease liabilities</link:label>
    <link:label id="lab_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability_label_en-US" xlink:label="lab_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Liability</link:label>
    <link:label id="lab_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability_documentation_en-US" xlink:label="lab_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability" xlink:href="sgry-20210930.xsd#sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability" xlink:to="lab_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_71a7246d-4a81-4a23-a387-6e53a23f53a3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Amounts and Fair Values of Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockNameDomain_1f4ad57b-bce9-48bc-a3be-7364965a5e30_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Stock, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockNameDomain_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Stock, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockNameDomain" xlink:to="lab_us-gaap_ConversionOfStockNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_3c4c0010-a70e-45ba-9c1b-ac5871d35c22_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_InterestRateCapTwoMember_566ad0bc-6c52-48e7-b76c-dd0d2b709039_terseLabel_en-US" xlink:label="lab_sgry_InterestRateCapTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cap</link:label>
    <link:label id="lab_sgry_InterestRateCapTwoMember_label_en-US" xlink:label="lab_sgry_InterestRateCapTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap Two [Member]</link:label>
    <link:label id="lab_sgry_InterestRateCapTwoMember_documentation_en-US" xlink:label="lab_sgry_InterestRateCapTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_InterestRateCapTwoMember" xlink:href="sgry-20210930.xsd#sgry_InterestRateCapTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_InterestRateCapTwoMember" xlink:to="lab_sgry_InterestRateCapTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_SeniorUnsecuredNotesDue2025Member_72adb9a3-6ea8-4c24-8a5e-3458e48f7f6f_verboseLabel_en-US" xlink:label="lab_sgry_SeniorUnsecuredNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.750% senior unsecured notes due 2025</link:label>
    <link:label id="lab_sgry_SeniorUnsecuredNotesDue2025Member_6b3b1e10-86c3-48d5-9fdd-dbc09c7b1540_terseLabel_en-US" xlink:label="lab_sgry_SeniorUnsecuredNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.750% senior unsecured notes due 2025</link:label>
    <link:label id="lab_sgry_SeniorUnsecuredNotesDue2025Member_label_en-US" xlink:label="lab_sgry_SeniorUnsecuredNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes Due 2025 [Member]</link:label>
    <link:label id="lab_sgry_SeniorUnsecuredNotesDue2025Member_documentation_en-US" xlink:label="lab_sgry_SeniorUnsecuredNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes Due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SeniorUnsecuredNotesDue2025Member" xlink:href="sgry-20210930.xsd#sgry_SeniorUnsecuredNotesDue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_SeniorUnsecuredNotesDue2025Member" xlink:to="lab_sgry_SeniorUnsecuredNotesDue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_7f61b395-5a39-44c5-84b3-ce54f7243c53_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_4acfa3ef-a91a-4577-80c9-a984987bf8db_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeVariableInterestRate_deb9b1fe-e75b-4560-a920-0c5d23ba8c34_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeVariableInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable interest rate of derivative instrument (percent)</link:label>
    <link:label id="lab_us-gaap_DerivativeVariableInterestRate_label_en-US" xlink:label="lab_us-gaap_DerivativeVariableInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Variable Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeVariableInterestRate" xlink:to="lab_us-gaap_DerivativeVariableInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_AncillaryServicesMember_88c60596-edd1-4582-9f8f-7f5e49fc0ced_terseLabel_en-US" xlink:label="lab_sgry_AncillaryServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ancillary Services</link:label>
    <link:label id="lab_sgry_AncillaryServicesMember_label_en-US" xlink:label="lab_sgry_AncillaryServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ancillary Services [Member]</link:label>
    <link:label id="lab_sgry_AncillaryServicesMember_documentation_en-US" xlink:label="lab_sgry_AncillaryServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ancillary Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_AncillaryServicesMember" xlink:href="sgry-20210930.xsd#sgry_AncillaryServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_AncillaryServicesMember" xlink:to="lab_sgry_AncillaryServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_4e575a8b-dad6-495c-8a2d-9b7eaf8875e0_verboseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_e6983fe6-0f63-499e-83d5-37f9e8d6842c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_d1966a10-87e0-4799-a756-6fc41c5a65cd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_f5c7c05a-d847-4be0-844d-95c223c5a5f0_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_f3da9453-93c9-461f-b04a-0eabc49caa24_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_a73b7959-a86a-4972-ad96-c07b39646fe5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_4584b7f7-ed38-41be-90ba-b8d94583b607_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ad0b6a4c-b977-4668-8841-66525fb32d05_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_1b53a57a-5c03-4c0e-a4d4-dcdaa7af18ff_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_4582d675-ddca-425b-a413-7eb49c92e47d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount estimated to be reclassified as a reduction to interest expense over next 12 months</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_14caef6f-abbe-4a88-9efd-7728a9e9473f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_df7f0b24-1f89-4600-abc5-cf9e8e528a1c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from equity offering</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_3d2bd54b-c0c0-4c0a-9bf1-30ab5a845612_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_4d291ee1-8bba-4a1a-8da2-ae809abbb94c_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_Assets_4c341b62-1353-4d50-9031-68c17018b5eb_verboseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_0b7530b1-d049-4ece-b68e-f123aede21dd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_eeb6cce9-2e05-4824-b1e8-78077ded4666_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receipts (payments) related to ownership transactions with non-controlling interest holders</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToMinorityShareholders" xlink:to="lab_us-gaap_PaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_ea4595e5-8dca-458a-b5eb-b325673a9f6e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndInvestmentsNoncurrent_7c3f14cf-dbba-4c1c-9fe4-86646c30f15e_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted invested assets included in other long-term assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndInvestmentsNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Investments, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:to="lab_us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_NoncashInterestIncomeExpenseNet_2c88f85b-b785-4bb1-bf81-60ca837a34a0_negatedTerseLabel_en-US" xlink:label="lab_sgry_NoncashInterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash interest expense, net</link:label>
    <link:label id="lab_sgry_NoncashInterestIncomeExpenseNet_label_en-US" xlink:label="lab_sgry_NoncashInterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Interest Income (Expense), Net</link:label>
    <link:label id="lab_sgry_NoncashInterestIncomeExpenseNet_documentation_en-US" xlink:label="lab_sgry_NoncashInterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NoncashInterestIncomeExpenseNet" xlink:href="sgry-20210930.xsd#sgry_NoncashInterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_NoncashInterestIncomeExpenseNet" xlink:to="lab_sgry_NoncashInterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAbstract_4f231805-484b-4961-8b38-ea413624f9e0_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAbstract" xlink:to="lab_us-gaap_NetIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_FacilitiesAmbulatorySurgeryCentersMember_56da2d34-6c7d-4762-b814-774eed186594_terseLabel_en-US" xlink:label="lab_sgry_FacilitiesAmbulatorySurgeryCentersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facilities, Ambulatory Surgery Centers</link:label>
    <link:label id="lab_sgry_FacilitiesAmbulatorySurgeryCentersMember_label_en-US" xlink:label="lab_sgry_FacilitiesAmbulatorySurgeryCentersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facilities, Ambulatory Surgery Centers [Member]</link:label>
    <link:label id="lab_sgry_FacilitiesAmbulatorySurgeryCentersMember_documentation_en-US" xlink:label="lab_sgry_FacilitiesAmbulatorySurgeryCentersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facilities, Ambulatory Surgery Centers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_FacilitiesAmbulatorySurgeryCentersMember" xlink:href="sgry-20210930.xsd#sgry_FacilitiesAmbulatorySurgeryCentersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_FacilitiesAmbulatorySurgeryCentersMember" xlink:to="lab_sgry_FacilitiesAmbulatorySurgeryCentersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_d5ed8d48-d2fc-45c6-973f-ed053c8c06c0_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_b8a19e6e-d59e-4e73-96b3-6481bd4d408b_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_e44df8f4-a529-448b-a8e4-1c100b0575d5_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_a7528552-f017-4fa1-aaa7-80c3326df4fc_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Controlling Interests&#8212; Non-Redeemable</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsLineItems_df077917-fe47-4469-941a-238c853390f5_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations [Line Items]</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsLineItems_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems" xlink:to="lab_us-gaap_GuaranteeObligationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_4f96a204-19f4-4c82-96cc-31b1fa459e4e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated interest rate (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_61f0a5e7-e997-4344-a9d9-453664b6a659_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_d7040ed5-8607-4844-a541-eb7c4edaf124_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_4a223057-0873-4c08-be3e-f09790f98522_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net income attributable to non-controlling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_a3f2a98d-9ec9-4a5e-b930-dea8cc1b91fa_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to non-controlling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_93c4a2ea-294b-453c-a9eb-c33f123fa6fd_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_DerivativeLiabilityNotionalAmountFinancingComponent_8d83ec5d-8bed-4e78-aea1-e0807c22d98e_terseLabel_en-US" xlink:label="lab_sgry_DerivativeLiabilityNotionalAmountFinancingComponent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability, notional amount, financing component</link:label>
    <link:label id="lab_sgry_DerivativeLiabilityNotionalAmountFinancingComponent_label_en-US" xlink:label="lab_sgry_DerivativeLiabilityNotionalAmountFinancingComponent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Notional Amount, Financing Component</link:label>
    <link:label id="lab_sgry_DerivativeLiabilityNotionalAmountFinancingComponent_documentation_en-US" xlink:label="lab_sgry_DerivativeLiabilityNotionalAmountFinancingComponent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Notional Amount, Financing Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DerivativeLiabilityNotionalAmountFinancingComponent" xlink:href="sgry-20210930.xsd#sgry_DerivativeLiabilityNotionalAmountFinancingComponent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_DerivativeLiabilityNotionalAmountFinancingComponent" xlink:to="lab_sgry_DerivativeLiabilityNotionalAmountFinancingComponent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a96ceb1-ebe6-4a78-a325-67ae1b8102da_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_cb92fe8b-e8fc-484d-a67f-9c73036787e9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_6d3739b0-712e-475f-bd77-423b058645df_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_c30248ae-8e7b-4f46-ae99-ccf202e6ff56_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityNotionalAmount" xlink:to="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_2bab4d61-0e13-40ed-b668-33e7f2c5cba5_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Lease Expense and Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_0dba300e-7142-4212-85a8-ac40a4870181_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_a1d87540-66b2-4a68-be3b-7a1408498c39_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_61891728-0333-4096-b3e0-52582b42f1fb_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis_4721d81f-f85d-466d-802a-8ee54bc09277_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Conversion Description [Axis]</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Conversion Description [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:to="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_78a38017-0c2e-4819-908f-c5777121c174_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_70098e11-dcab-4676-80f5-dc0f6685db4f_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding- basic (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_b20a7121-dabb-4462-9412-92dfa478f23c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_63ad17a1-fd11-4eaa-a611-6ee12dad5f93_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_CostReportLiabilitiesCurrent_65669033-6fb8-4037-8f6c-1f8c6836e7bd_terseLabel_en-US" xlink:label="lab_sgry_CostReportLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost report liabilities</link:label>
    <link:label id="lab_sgry_CostReportLiabilitiesCurrent_label_en-US" xlink:label="lab_sgry_CostReportLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Report Liabilities, Current</link:label>
    <link:label id="lab_sgry_CostReportLiabilitiesCurrent_documentation_en-US" xlink:label="lab_sgry_CostReportLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Report Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_CostReportLiabilitiesCurrent" xlink:href="sgry-20210930.xsd#sgry_CostReportLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_CostReportLiabilitiesCurrent" xlink:to="lab_sgry_CostReportLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemNetGainLoss_124bdae4-b077-4b21-a41e-5df583943b48_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemNetGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hurricane-related operating losses</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemNetGainLoss_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemNetGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both, Net (Gain) Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemNetGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemNetGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemNetGainLoss" xlink:to="lab_us-gaap_UnusualOrInfrequentItemNetGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_9d2b9daf-599a-4b8a-82a9-5bb7f67499da_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale price to public (in USD per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_2d903e80-63a4-4a40-ba7b-4f83344950ae_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_A2017TermLoanMaturing2024Member_782f400b-61e4-46c8-99b8-cf21c6375e33_verboseLabel_en-US" xlink:label="lab_sgry_A2017TermLoanMaturing2024Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior secured term loan</link:label>
    <link:label id="lab_sgry_A2017TermLoanMaturing2024Member_label_en-US" xlink:label="lab_sgry_A2017TermLoanMaturing2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Term Loan, Maturing 2024 [Member]</link:label>
    <link:label id="lab_sgry_A2017TermLoanMaturing2024Member_documentation_en-US" xlink:label="lab_sgry_A2017TermLoanMaturing2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Term Loan, Maturing 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_A2017TermLoanMaturing2024Member" xlink:href="sgry-20210930.xsd#sgry_A2017TermLoanMaturing2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_A2017TermLoanMaturing2024Member" xlink:to="lab_sgry_A2017TermLoanMaturing2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_6aebb757-4af8-4740-b26b-94b3c9eaab39_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to non-controlling interests&#8212;redeemable</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_4d778e9d-c3b7-4d02-bd9f-b4e121da8231_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and advances to affiliates</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_787917d4-6e6a-4e28-9c9b-e0b961bf86b1_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_bf2f9760-8ef2-4b36-ae8e-be7a60c8121f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_ThreeReceiveFixedInterestRateSwapsMember_812256ef-c26f-4c50-a683-97fa6430c144_terseLabel_en-US" xlink:label="lab_sgry_ThreeReceiveFixedInterestRateSwapsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Receive-fixed Interest Rate Swaps</link:label>
    <link:label id="lab_sgry_ThreeReceiveFixedInterestRateSwapsMember_label_en-US" xlink:label="lab_sgry_ThreeReceiveFixedInterestRateSwapsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Receive-fixed Interest Rate Swaps [Member]</link:label>
    <link:label id="lab_sgry_ThreeReceiveFixedInterestRateSwapsMember_documentation_en-US" xlink:label="lab_sgry_ThreeReceiveFixedInterestRateSwapsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Receive-fixed Interest Rate Swaps Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ThreeReceiveFixedInterestRateSwapsMember" xlink:href="sgry-20210930.xsd#sgry_ThreeReceiveFixedInterestRateSwapsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_ThreeReceiveFixedInterestRateSwapsMember" xlink:to="lab_sgry_ThreeReceiveFixedInterestRateSwapsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsMinorityInterest_bfca0669-86b8-40a9-a6da-d97363965a4a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to non-controlling interest holders</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsMinorityInterest_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_5a9ce3cc-c71f-4b51-84f5-6416f3352a9e_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss attributable to Surgery Partners, Inc.</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesAuthorized_e0c8b7b1-8436-4821-939a-391aee8dd807_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable preferred stock, shares authorized (shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesAuthorized_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesAuthorized" xlink:to="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_f8467747-8960-4316-afa1-5948f5e73c12_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_7124ea60-3ec5-4ac0-aa7a-31da5116ccd5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_ab711da5-bddb-423b-895c-5ccd47d8837f_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_ce731001-0006-4489-9f7e-c20645ff6bc1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_e9c1431b-11e1-4284-aa65-8f691fb2113c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from equity investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1429f353-a184-4847-a383-11c9397978f0_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred share conversion (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_f347d507-db08-49b4-a58d-047deb3f2cbc_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_779d4954-da57-4035-9f08-697b23b7cd5c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_EffectiveIncomeTaxRateReconciliationCoronavirusAidReliefAndEconomicSecurityActCARESActAndTaxSettlementAmount_d02bc7ae-8d36-4fd9-9893-1309ad386e22_negatedTerseLabel_en-US" xlink:label="lab_sgry_EffectiveIncomeTaxRateReconciliationCoronavirusAidReliefAndEconomicSecurityActCARESActAndTaxSettlementAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefits related to CARES Act and Settlement Agreement</link:label>
    <link:label id="lab_sgry_EffectiveIncomeTaxRateReconciliationCoronavirusAidReliefAndEconomicSecurityActCARESActAndTaxSettlementAmount_label_en-US" xlink:label="lab_sgry_EffectiveIncomeTaxRateReconciliationCoronavirusAidReliefAndEconomicSecurityActCARESActAndTaxSettlementAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Coronavirus Aid, Relief, and Economic Security Act (CARES Act) And Tax Settlement, Amount</link:label>
    <link:label id="lab_sgry_EffectiveIncomeTaxRateReconciliationCoronavirusAidReliefAndEconomicSecurityActCARESActAndTaxSettlementAmount_documentation_en-US" xlink:label="lab_sgry_EffectiveIncomeTaxRateReconciliationCoronavirusAidReliefAndEconomicSecurityActCARESActAndTaxSettlementAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Coronavirus Aid, Relief, and Economic Security Act (CARES Act) And Tax Settlement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_EffectiveIncomeTaxRateReconciliationCoronavirusAidReliefAndEconomicSecurityActCARESActAndTaxSettlementAmount" xlink:href="sgry-20210930.xsd#sgry_EffectiveIncomeTaxRateReconciliationCoronavirusAidReliefAndEconomicSecurityActCARESActAndTaxSettlementAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_EffectiveIncomeTaxRateReconciliationCoronavirusAidReliefAndEconomicSecurityActCARESActAndTaxSettlementAmount" xlink:to="lab_sgry_EffectiveIncomeTaxRateReconciliationCoronavirusAidReliefAndEconomicSecurityActCARESActAndTaxSettlementAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCostAndExpenseOperating_619c4c50-3477-4427-9d1b-4126b2ee1d1e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCostAndExpenseOperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating expenses</link:label>
    <link:label id="lab_us-gaap_OtherCostAndExpenseOperating_label_en-US" xlink:label="lab_us-gaap_OtherCostAndExpenseOperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Cost and Expense, Operating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCostAndExpenseOperating" xlink:to="lab_us-gaap_OtherCostAndExpenseOperating" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember_6b0b97fa-f0ea-400e-b969-7ea79abb1793_terseLabel_en-US" xlink:label="lab_sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Series A Preferred Stock into Common Stock</link:label>
    <link:label id="lab_sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember_label_en-US" xlink:label="lab_sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion Of Series A Preferred Stock Into Common Stock [Member]</link:label>
    <link:label id="lab_sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember_documentation_en-US" xlink:label="lab_sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion Of Series A Preferred Stock Into Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember" xlink:href="sgry-20210930.xsd#sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember" xlink:to="lab_sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_22f9e452-85a8-487b-ac68-51afbad4d5a4_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_39915233-6b72-4de1-9995-6662d0fec903_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_73382c45-ba15-4f9a-a455-4bdf514dd805_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_32ee9db7-7aa1-4e22-8ddd-f4b7f810e20d_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_644c9c85-a766-462a-ad8e-8c008fdc5b79_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_OpticalServicesMember_423e9251-0f10-4b22-9184-e23cc224574a_terseLabel_en-US" xlink:label="lab_sgry_OpticalServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Optical Services</link:label>
    <link:label id="lab_sgry_OpticalServicesMember_label_en-US" xlink:label="lab_sgry_OpticalServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Optical Services [Member]</link:label>
    <link:label id="lab_sgry_OpticalServicesMember_documentation_en-US" xlink:label="lab_sgry_OpticalServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Optical Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_OpticalServicesMember" xlink:href="sgry-20210930.xsd#sgry_OpticalServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_OpticalServicesMember" xlink:to="lab_sgry_OpticalServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_3ee3ac2a-6b59-480b-b6f7-a4c45d8db440_verboseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued legal settlement</link:label>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveCurrent" xlink:to="lab_us-gaap_LitigationReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0aa42d83-0669-4365-ae5d-a65c15759018_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_PublicStockOfferingFirmSharesMember_0e8fafdc-94c4-413c-a576-99a187d5e984_terseLabel_en-US" xlink:label="lab_sgry_PublicStockOfferingFirmSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Firm Shares</link:label>
    <link:label id="lab_sgry_PublicStockOfferingFirmSharesMember_label_en-US" xlink:label="lab_sgry_PublicStockOfferingFirmSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Stock Offering, Firm Shares [Member]</link:label>
    <link:label id="lab_sgry_PublicStockOfferingFirmSharesMember_documentation_en-US" xlink:label="lab_sgry_PublicStockOfferingFirmSharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Stock Offering, Firm Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PublicStockOfferingFirmSharesMember" xlink:href="sgry-20210930.xsd#sgry_PublicStockOfferingFirmSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_PublicStockOfferingFirmSharesMember" xlink:to="lab_sgry_PublicStockOfferingFirmSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_97dadcc5-3a9c-4664-b8f2-06ba31545252_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_3e577df8-16f9-43ac-913e-524d69c443f0_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance, stockholders' equity (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_686a44e4-e2b0-4dc8-a107-885830ba570a_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance, stockholders' equity (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualRiskOrUncertaintyByNatureAxis_1ee9324f-4838-4a42-995f-c82d2dffcea8_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualRiskOrUncertaintyByNatureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual Risk or Uncertainty, Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_UnusualRiskOrUncertaintyByNatureAxis_label_en-US" xlink:label="lab_us-gaap_UnusualRiskOrUncertaintyByNatureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual Risk or Uncertainty, Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualRiskOrUncertaintyByNatureAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualRiskOrUncertaintyByNatureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualRiskOrUncertaintyByNatureAxis" xlink:to="lab_us-gaap_UnusualRiskOrUncertaintyByNatureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_5b00c9c1-9a23-4591-b1fb-ee320bc913ea_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityDisclosureAbstract_c1cce98d-c6cc-469a-aff9-685b3f906d93_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="lab_us-gaap_TemporaryEquityDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_SurgicalFacilitiesExistingMarketsMember_20a73236-03e1-46db-bf4b-a38156292a17_terseLabel_en-US" xlink:label="lab_sgry_SurgicalFacilitiesExistingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Facilities, Existing Markets</link:label>
    <link:label id="lab_sgry_SurgicalFacilitiesExistingMarketsMember_label_en-US" xlink:label="lab_sgry_SurgicalFacilitiesExistingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Facilities, Existing Markets [Member]</link:label>
    <link:label id="lab_sgry_SurgicalFacilitiesExistingMarketsMember_documentation_en-US" xlink:label="lab_sgry_SurgicalFacilitiesExistingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Facilities, Existing Markets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SurgicalFacilitiesExistingMarketsMember" xlink:href="sgry-20210930.xsd#sgry_SurgicalFacilitiesExistingMarketsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_SurgicalFacilitiesExistingMarketsMember" xlink:to="lab_sgry_SurgicalFacilitiesExistingMarketsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_075731c3-7979-4ffa-973f-09025babaa60_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_CashFlowLesseeAbstract_4f51f659-b497-4820-85fa-4a898b4a440e_terseLabel_en-US" xlink:label="lab_sgry_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurement of lease liabilities:</link:label>
    <link:label id="lab_sgry_CashFlowLesseeAbstract_label_en-US" xlink:label="lab_sgry_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Lessee [Abstract]</link:label>
    <link:label id="lab_sgry_CashFlowLesseeAbstract_documentation_en-US" xlink:label="lab_sgry_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Lessee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_CashFlowLesseeAbstract" xlink:href="sgry-20210930.xsd#sgry_CashFlowLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_CashFlowLesseeAbstract" xlink:to="lab_sgry_CashFlowLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_e4b4beb2-5095-4c80-80c7-33a639847789_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCapMember_3b4bbdd8-777f-4909-85f8-df90801b2201_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap</link:label>
    <link:label id="lab_us-gaap_InterestRateCapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCapMember" xlink:to="lab_us-gaap_InterestRateCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_PayFixedSwapOneMember_ed2639f7-6400-4a4c-a5bc-5672b412ed72_terseLabel_en-US" xlink:label="lab_sgry_PayFixedSwapOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed swap</link:label>
    <link:label id="lab_sgry_PayFixedSwapOneMember_label_en-US" xlink:label="lab_sgry_PayFixedSwapOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed Swap One [Member]</link:label>
    <link:label id="lab_sgry_PayFixedSwapOneMember_documentation_en-US" xlink:label="lab_sgry_PayFixedSwapOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed Swap One Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapOneMember" xlink:href="sgry-20210930.xsd#sgry_PayFixedSwapOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_PayFixedSwapOneMember" xlink:to="lab_sgry_PayFixedSwapOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_9c8a517f-29a0-476d-bb1c-8099956154a9_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_abecc489-a61b-42aa-92ec-2388f7fbcff3_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease costs</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_9e3906ef-751d-4574-859a-39c91a9a56ca_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_43a074be-1c42-4e5a-ba48-132ed3b1da1a_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_32f3ade1-81da-4f83-b868-e19f0212fe93_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable preferred stock conversion to common stock</link:label>
    <link:label id="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_label_en-US" xlink:label="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications of Temporary to Permanent Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:to="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesIssued_bb887d7b-a48a-43a2-85b4-886f4da6f2db_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable preferred stock, shares issued (shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesIssued_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesIssued" xlink:to="lab_us-gaap_TemporaryEquitySharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MajorityShareholderMember_07afcdcd-e735-43f3-9171-cd43d02277ef_terseLabel_en-US" xlink:label="lab_us-gaap_MajorityShareholderMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bain Capital Private Equity, L.P.</link:label>
    <link:label id="lab_us-gaap_MajorityShareholderMember_label_en-US" xlink:label="lab_us-gaap_MajorityShareholderMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Majority Shareholder [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MajorityShareholderMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MajorityShareholderMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MajorityShareholderMember" xlink:to="lab_us-gaap_MajorityShareholderMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_DebtInstrumentQuarterlyAmortizationPercentPerAnnum_6466bdad-3465-4166-8ddb-71b26be69260_terseLabel_en-US" xlink:label="lab_sgry_DebtInstrumentQuarterlyAmortizationPercentPerAnnum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly amortization in aggregate principal amount, percent per annum (percent)</link:label>
    <link:label id="lab_sgry_DebtInstrumentQuarterlyAmortizationPercentPerAnnum_label_en-US" xlink:label="lab_sgry_DebtInstrumentQuarterlyAmortizationPercentPerAnnum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Quarterly Amortization, Percent Per Annum</link:label>
    <link:label id="lab_sgry_DebtInstrumentQuarterlyAmortizationPercentPerAnnum_documentation_en-US" xlink:label="lab_sgry_DebtInstrumentQuarterlyAmortizationPercentPerAnnum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Quarterly Amortization, Percent Per Annum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DebtInstrumentQuarterlyAmortizationPercentPerAnnum" xlink:href="sgry-20210930.xsd#sgry_DebtInstrumentQuarterlyAmortizationPercentPerAnnum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_DebtInstrumentQuarterlyAmortizationPercentPerAnnum" xlink:to="lab_sgry_DebtInstrumentQuarterlyAmortizationPercentPerAnnum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_9b7f3ed7-4aca-4916-b42e-c22512da7875_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_9ba0f0a8-78e8-4237-8b2c-acdb4d67a81b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeMember_d39ba3df-652d-4d2b-b2ad-d2a572fb1650_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income</link:label>
    <link:label id="lab_us-gaap_OtherIncomeMember_label_en-US" xlink:label="lab_us-gaap_OtherIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeMember" xlink:to="lab_us-gaap_OtherIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_PayFixedSwapNineMember_2e1957fd-2034-483d-a18a-ae9fec472d5d_terseLabel_en-US" xlink:label="lab_sgry_PayFixedSwapNineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed swap</link:label>
    <link:label id="lab_sgry_PayFixedSwapNineMember_label_en-US" xlink:label="lab_sgry_PayFixedSwapNineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed Swap Nine [Member]</link:label>
    <link:label id="lab_sgry_PayFixedSwapNineMember_documentation_en-US" xlink:label="lab_sgry_PayFixedSwapNineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed Swap Nine</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapNineMember" xlink:href="sgry-20210930.xsd#sgry_PayFixedSwapNineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_PayFixedSwapNineMember" xlink:to="lab_sgry_PayFixedSwapNineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_5b8cdedd-ecb2-4d68-922c-57a970f0ade4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_c44eed49-7857-4632-8c14-278edc94648d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments on long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_c79f2611-b4e5-4587-ba20-54594cb921e7_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet_3c5ed3bc-4488-432c-af3e-2222fd7c2a70_terseLabel_en-US" xlink:label="lab_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and disposal of shares of non-controlling interests, net</link:label>
    <link:label id="lab_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet_label_en-US" xlink:label="lab_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Controlling Interest, Acquisitions And Disposals Of Interests Held By Non-Controlling Interest Holders, Net</link:label>
    <link:label id="lab_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet_documentation_en-US" xlink:label="lab_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Controlling Interest, Acquisitions And Disposals Of Interests Held By Non-Controlling Interest Holders, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" xlink:href="sgry-20210930.xsd#sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" xlink:to="lab_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_PayFixedSwapTwoMember_f469b620-bae6-41be-a781-603def95bf8c_terseLabel_en-US" xlink:label="lab_sgry_PayFixedSwapTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed swap</link:label>
    <link:label id="lab_sgry_PayFixedSwapTwoMember_label_en-US" xlink:label="lab_sgry_PayFixedSwapTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed Swap Two [Member]</link:label>
    <link:label id="lab_sgry_PayFixedSwapTwoMember_documentation_en-US" xlink:label="lab_sgry_PayFixedSwapTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed Swap Two Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapTwoMember" xlink:href="sgry-20210930.xsd#sgry_PayFixedSwapTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_PayFixedSwapTwoMember" xlink:to="lab_sgry_PayFixedSwapTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_04bdb6d2-1325-45d7-bc27-871bc0b039aa_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent_faff2356-00ed-4f7a-b194-bc49c58ad275_terseLabel_en-US" xlink:label="lab_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of tax liability</link:label>
    <link:label id="lab_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent_label_en-US" xlink:label="lab_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net Of Discount, Current</link:label>
    <link:label id="lab_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent_documentation_en-US" xlink:label="lab_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net Of Discount, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent" xlink:href="sgry-20210930.xsd#sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent" xlink:to="lab_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_be59000f-4896-4527-9cff-a6eca58e8f73_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_cd9754ae-32fd-42a4-863a-fa526ef52b35_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GovernmentContractMember_f67d1431-693f-4b67-ae6d-59756a712179_terseLabel_en-US" xlink:label="lab_us-gaap_GovernmentContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government</link:label>
    <link:label id="lab_us-gaap_GovernmentContractMember_label_en-US" xlink:label="lab_us-gaap_GovernmentContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GovernmentContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GovernmentContractMember" xlink:to="lab_us-gaap_GovernmentContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_PayablesToCustomers_869704c4-ae22-4e63-a420-e678fc4adaef_terseLabel_en-US" xlink:label="lab_srt_PayablesToCustomers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts due to patients and payors</link:label>
    <link:label id="lab_srt_PayablesToCustomers_label_en-US" xlink:label="lab_srt_PayablesToCustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Broker-Dealer, Payable to Customer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_PayablesToCustomers" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_PayablesToCustomers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_PayablesToCustomers" xlink:to="lab_srt_PayablesToCustomers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_4a59924d-fd9b-4533-af3b-01a9412cddec_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Including Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_09da7230-dbdf-42be-b165-973ad6b69828_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:to="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_d9fbc9af-1bd3-4221-af44-01fbf271d889_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share attributable to common stockholders</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_8aa6b9f9-be82-4d4c-a8e2-8fae655725a8_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_42580499-23f2-4009-b1be-7c6349331571_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_575be3e0-e59b-4d01-8298-92e98e771fd8_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate (percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_d6e5e82e-8958-4c3c-ad6b-729c8c6bd9c8_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A Preferred Stock</link:label>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesAPreferredStockMember" xlink:to="lab_us-gaap_SeriesAPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LaborAndRelatedExpense_18e2c3f4-7f64-4aff-b3ec-c5dd22c0dd4f_terseLabel_en-US" xlink:label="lab_us-gaap_LaborAndRelatedExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Salaries and benefits</link:label>
    <link:label id="lab_us-gaap_LaborAndRelatedExpense_label_en-US" xlink:label="lab_us-gaap_LaborAndRelatedExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Labor and Related Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LaborAndRelatedExpense" xlink:to="lab_us-gaap_LaborAndRelatedExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_4ce5a722-851a-40e3-a181-8aa680f708a4_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_3d0f13d7-94e1-4336-bc59-44b1e7750105_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonClassAMember_3705f8ab-4fcc-4082-b337-72cc4b7b0977_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonClassAMember_label_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class A [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassAMember" xlink:to="lab_us-gaap_CommonClassAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_RedeemablePreferredStockTextBlock_7397ae58-ae56-443c-af81-b8aa3c62f68d_terseLabel_en-US" xlink:label="lab_sgry_RedeemablePreferredStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Preferred Stock</link:label>
    <link:label id="lab_sgry_RedeemablePreferredStockTextBlock_label_en-US" xlink:label="lab_sgry_RedeemablePreferredStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Preferred Stock [Text Block]</link:label>
    <link:label id="lab_sgry_RedeemablePreferredStockTextBlock_documentation_en-US" xlink:label="lab_sgry_RedeemablePreferredStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Preferred Stock [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_RedeemablePreferredStockTextBlock" xlink:href="sgry-20210930.xsd#sgry_RedeemablePreferredStockTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_RedeemablePreferredStockTextBlock" xlink:to="lab_sgry_RedeemablePreferredStockTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1f758e81-bbf2-4776-9a28-c7f93499bfbd_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cf42d700-a9ba-4b5e-809a-08b326fe2fc0_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_0db21e0c-039b-403d-b5a4-dedfdeca031d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Interest Rate Swaps and Interest Rate Caps Outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_ee6b3be8-6e29-4d4d-a50b-d8687d47b0f8_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock sold in offering (shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_72ecae70-cc92-461b-85eb-02a0fe574f28_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_92845047-bf6b-4d72-8e65-bfac5a0b2655_terseLabel_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues</link:label>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_label_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedules of Concentration of Risk, by Risk Factor [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:to="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a88c9b0b-1cae-4422-90a3-d84272133740_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_9a8fa28f-09ea-4a13-85f5-7170f5ade4a5_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_23b600b9-5e00-4557-a9a1-abc6ecc5b13b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other financing activities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_HealthcareOrganizationPatientServiceMember_36b3fa28-3661-4525-821b-17d7ead4b5e1_verboseLabel_en-US" xlink:label="lab_sgry_HealthcareOrganizationPatientServiceMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patent service revenues</link:label>
    <link:label id="lab_sgry_HealthcareOrganizationPatientServiceMember_9be5ffe9-d583-43a2-aef5-770b4065e7b2_terseLabel_en-US" xlink:label="lab_sgry_HealthcareOrganizationPatientServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total patient service revenues</link:label>
    <link:label id="lab_sgry_HealthcareOrganizationPatientServiceMember_label_en-US" xlink:label="lab_sgry_HealthcareOrganizationPatientServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Organization, Patient Service [Member]</link:label>
    <link:label id="lab_sgry_HealthcareOrganizationPatientServiceMember_documentation_en-US" xlink:label="lab_sgry_HealthcareOrganizationPatientServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Organization, Patient Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_HealthcareOrganizationPatientServiceMember" xlink:href="sgry-20210930.xsd#sgry_HealthcareOrganizationPatientServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_HealthcareOrganizationPatientServiceMember" xlink:to="lab_sgry_HealthcareOrganizationPatientServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_5cf42d6e-bf84-46ea-a799-66ff5120e2a6_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_adbfea32-747d-4472-ae1a-a9e45901a7dd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Nonoperating, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_13172491-1340-4ae4-b43b-a21598603f62_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_7c3bd649-8924-42a0-b2a7-46be33c6c4cd_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_42aa9937-75ca-4510-a307-e1edb657b166_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_a6f41b96-b372-44b0-aa07-de09e908e305_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_13877f7e-2bff-4a40-8b94-73dbbddc5492_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_4b7bf1e2-de5c-4a20-9bf0-ef5eee8a69a2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_daec034b-7ba4-40b7-9fc0-6a06b7881cac_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5a694b52-22c3-4d44-afc1-0b2be3724606_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding- diluted (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1da56d43-8a61-4816-a2d5-a7abb4abdfe8_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c8881350-5c0a-467d-8caa-e37e76146f20_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_PayFixedSwapThreeMember_6789b2bf-22c5-4ae7-9301-2f7c507c3d09_terseLabel_en-US" xlink:label="lab_sgry_PayFixedSwapThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed swap</link:label>
    <link:label id="lab_sgry_PayFixedSwapThreeMember_label_en-US" xlink:label="lab_sgry_PayFixedSwapThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed Swap Three [Member]</link:label>
    <link:label id="lab_sgry_PayFixedSwapThreeMember_documentation_en-US" xlink:label="lab_sgry_PayFixedSwapThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed Swap Three Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapThreeMember" xlink:href="sgry-20210930.xsd#sgry_PayFixedSwapThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_PayFixedSwapThreeMember" xlink:to="lab_sgry_PayFixedSwapThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_FinanceLeaseCost_755c024c-f978-4f9f-9fb8-f61fda18bdd9_totalLabel_en-US" xlink:label="lab_sgry_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease costs</link:label>
    <link:label id="lab_sgry_FinanceLeaseCost_label_en-US" xlink:label="lab_sgry_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Cost</link:label>
    <link:label id="lab_sgry_FinanceLeaseCost_documentation_en-US" xlink:label="lab_sgry_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_FinanceLeaseCost" xlink:href="sgry-20210930.xsd#sgry_FinanceLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_FinanceLeaseCost" xlink:to="lab_sgry_FinanceLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrent_3b5daf36-8326-4b92-b46d-e3c8591518b1_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest payable</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrent" xlink:to="lab_us-gaap_InterestPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OverAllotmentOptionMember_e8028ff1-211b-4d01-bd17-6f1ac52287e2_terseLabel_en-US" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Shares Granted to Underwriters</link:label>
    <link:label id="lab_us-gaap_OverAllotmentOptionMember_label_en-US" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Over-Allotment Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OverAllotmentOptionMember" xlink:to="lab_us-gaap_OverAllotmentOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_ef11b71a-ba38-4053-9431-4ad79461b34a_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_dfe67275-5765-491a-af22-f852ab4d9b3e_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_45425ff5-0ee7-4359-a09c-3cc7d1a23d30_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_92cd689c-0879-4e73-a82f-1694bbd020c8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, basis spread on variable rate (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_1b7b04b1-57bd-496f-a457-658b83846c08_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_ProductsAndServicesLineItems_91afa31d-a65f-4073-94ef-7772d0535778_terseLabel_en-US" xlink:label="lab_sgry_ProductsAndServicesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products And Services [Line Items]</link:label>
    <link:label id="lab_sgry_ProductsAndServicesLineItems_label_en-US" xlink:label="lab_sgry_ProductsAndServicesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products And Services [Line Items]</link:label>
    <link:label id="lab_sgry_ProductsAndServicesLineItems_documentation_en-US" xlink:label="lab_sgry_ProductsAndServicesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products And Services [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ProductsAndServicesLineItems" xlink:href="sgry-20210930.xsd#sgry_ProductsAndServicesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_ProductsAndServicesLineItems" xlink:to="lab_sgry_ProductsAndServicesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_de94411e-5a2f-46e8-ac50-5bd2c2424cbb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_168add01-edf9-4a86-a75e-1139878c77fc_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_d29583d9-9a98-433b-96a1-6a2a73aa3624_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives not designated as hedging instruments</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_22f1f1c7-0d38-49e9-8e10-70739322e120_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_50f0eccf-1990-4114-8b0d-542f667bc047_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_34128136-1bba-463b-92ff-771fa65d4926_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Revenue and Operating Income</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_9b097dd1-88df-4ec7-b6d3-751db378a41f_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_87ed0dd9-fa44-4c6f-9398-caea1d06c1a3_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, net of acquisitions and divestitures:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_d5fec7a1-cacd-4d88-b045-4b39a4fcd9b1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_598616be-80d0-492a-ac03-e35c676e85fe_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_PayFixedSwapFourMember_a083f391-307c-49e5-aed5-2bc04caa07c9_terseLabel_en-US" xlink:label="lab_sgry_PayFixedSwapFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed swap</link:label>
    <link:label id="lab_sgry_PayFixedSwapFourMember_label_en-US" xlink:label="lab_sgry_PayFixedSwapFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed Swap Four [Member]</link:label>
    <link:label id="lab_sgry_PayFixedSwapFourMember_documentation_en-US" xlink:label="lab_sgry_PayFixedSwapFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed Swap Four Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapFourMember" xlink:href="sgry-20210930.xsd#sgry_PayFixedSwapFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_PayFixedSwapFourMember" xlink:to="lab_sgry_PayFixedSwapFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_87369344-8b6c-4367-81c3-7805f3d68cd0_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_c2b98be3-f713-4a08-a6bb-c3f6ad0b512d_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_7e8cdeb9-bbc5-4b65-82d2-71636d42c5c3_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm_a8c08baf-1d89-40a4-a056-f4a5913608e6_terseLabel_en-US" xlink:label="lab_sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected tax savings period</link:label>
    <link:label id="lab_sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm_label_en-US" xlink:label="lab_sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Tax Agreement, Projected Tax Savings, Term</link:label>
    <link:label id="lab_sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm_documentation_en-US" xlink:label="lab_sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Tax Agreement, Projected Tax Savings, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm" xlink:href="sgry-20210930.xsd#sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm" xlink:to="lab_sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_33fc14ab-6df4-4529-9078-c897c5b8d172_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total consideration</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_6cfe92a1-e8ef-4701-88c2-6411743d1c94_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of preferred dividends</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Preferred Stock and Preference Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:to="lab_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityLineItems_051eed07-ff9d-401b-8b95-58b5ba0da62b_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Line Items]</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityLineItems_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityLineItems" xlink:to="lab_us-gaap_TemporaryEquityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_247b4c0a-5b2c-4f53-8a06-bf6432426889_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_d1ad3cf1-9852-49eb-9250-ab398aee94dd_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash outflows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e8a50f6e-72f5-43ee-b5b8-1a47f41c620b_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_6e1bce68-92cc-4e63-84bb-ac6a746bb2f0_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_955bf623-6445-40a4-bf6a-db369bee32ca_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_74042d19-20fc-43e1-b281-fd36289dac0d_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_17248e60-40cc-40cf-9bb6-fb20885d6c7c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_893418e2-2f99-45e3-afe5-2f74e63c9215_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: unamortized debt issuance costs and discounts</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_096914a9-41a4-41bc-bbc0-859f217b5656_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs and discount, net of issuance premium</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_ef676555-8487-452b-8f03-eaed1fe1e500_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_6b2a786c-6c0f-4474-8ad0-b3660af38dbd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_83dd5458-38ba-43a9-8592-18a74b6d47b2_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalFundsEffectiveSwapRateMember_607e5779-f33f-440a-a4d0-5ec46bc3c597_terseLabel_en-US" xlink:label="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Funds Rate</link:label>
    <link:label id="lab_us-gaap_FederalFundsEffectiveSwapRateMember_label_en-US" xlink:label="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fed Funds Effective Rate Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:to="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_e1f120b3-7311-4955-91d0-21ee4f9086ee_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_b641fd8e-1129-4706-a946-522f717a23b0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_23f4485e-cb5d-4880-aabc-f185ba8708d1_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent_4f20ffb4-0341-484c-9ddc-b4a61d44f836_terseLabel_en-US" xlink:label="lab_sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare accelerated payments and deferred governmental grants</link:label>
    <link:label id="lab_sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent_label_en-US" xlink:label="lab_sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Accelerated Payments And Deferred Governmental Grants, Current</link:label>
    <link:label id="lab_sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent_documentation_en-US" xlink:label="lab_sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Accelerated Payments And Deferred Governmental Grants, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent" xlink:href="sgry-20210930.xsd#sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent" xlink:to="lab_sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_7d42c59e-e60d-448a-8876-e69450f478e2_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_9e064401-73ea-4a7b-8077-940367ea7f77_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized fair value discount (premium)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_3fa3860f-1025-40c0-a733-6cbbec9c7129_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_8d6d42a7-36f2-4586-99f3-087ebae7bf5a_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, beginning of period</link:label>
    <link:label id="lab_us-gaap_Goodwill_8aab212a-102c-429f-b669-61bfc96c7f34_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, end of period</link:label>
    <link:label id="lab_us-gaap_Goodwill_c105590c-cd61-451d-ba69-4fae9273bf20_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_05c6d5f2-2afa-47ce-a096-d53659d60ef4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain recognized in income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_568c75dd-fd06-4502-b45e-cf75bb8fb467_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interests&#8212;non-redeemable</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_VariableAndShortTermLeaseCost_fbf0c0d2-d1c4-4b2b-b51d-23b0b8ca87ee_terseLabel_en-US" xlink:label="lab_sgry_VariableAndShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable and short-term lease costs</link:label>
    <link:label id="lab_sgry_VariableAndShortTermLeaseCost_label_en-US" xlink:label="lab_sgry_VariableAndShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable And Short-Term Lease, Cost</link:label>
    <link:label id="lab_sgry_VariableAndShortTermLeaseCost_documentation_en-US" xlink:label="lab_sgry_VariableAndShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable And Short-Term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_VariableAndShortTermLeaseCost" xlink:href="sgry-20210930.xsd#sgry_VariableAndShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_VariableAndShortTermLeaseCost" xlink:to="lab_sgry_VariableAndShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_InterestRateCapOneMember_767d342f-69fb-4c79-8e3c-d42e98605944_terseLabel_en-US" xlink:label="lab_sgry_InterestRateCapOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cap</link:label>
    <link:label id="lab_sgry_InterestRateCapOneMember_label_en-US" xlink:label="lab_sgry_InterestRateCapOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap One [Member]</link:label>
    <link:label id="lab_sgry_InterestRateCapOneMember_documentation_en-US" xlink:label="lab_sgry_InterestRateCapOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_InterestRateCapOneMember" xlink:href="sgry-20210930.xsd#sgry_InterestRateCapOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_InterestRateCapOneMember" xlink:to="lab_sgry_InterestRateCapOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SelfInsuranceReserve_04db8d10-f9e2-4f35-8682-237970884ce6_terseLabel_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional, general and workers' compensation insurance reserve</link:label>
    <link:label id="lab_us-gaap_SelfInsuranceReserve_label_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self Insurance Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SelfInsuranceReserve" xlink:to="lab_us-gaap_SelfInsuranceReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_c3bf1b12-50ac-48f1-90bd-81fc18569a7d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Rollforward of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_4df149a8-ad04-4b84-838f-6e542c5a97a6_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_70d377ae-515a-4893-82c9-9abcc8879358_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 82,458,385 and 50,461,706, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValueOutstanding" xlink:to="lab_us-gaap_CommonStockValueOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_e4a410d3-b4bc-46f4-9a70-46e93b705896_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_DeferredEmployeeRelatedLiabilitiesCurrent_3e7cbe37-a61c-4d06-99a6-4538fdae0771_terseLabel_en-US" xlink:label="lab_sgry_DeferredEmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred accrued payroll and benefits</link:label>
    <link:label id="lab_sgry_DeferredEmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_sgry_DeferredEmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Employee-related Liabilities, Current</link:label>
    <link:label id="lab_sgry_DeferredEmployeeRelatedLiabilitiesCurrent_documentation_en-US" xlink:label="lab_sgry_DeferredEmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DeferredEmployeeRelatedLiabilitiesCurrent" xlink:href="sgry-20210930.xsd#sgry_DeferredEmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_DeferredEmployeeRelatedLiabilitiesCurrent" xlink:to="lab_sgry_DeferredEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate_92ab6d26-3328-4a8b-9f55-8449184f91a5_terseLabel_en-US" xlink:label="lab_sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative tax agreement, basis spread on variable rate (percent)</link:label>
    <link:label id="lab_sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate_label_en-US" xlink:label="lab_sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Tax Agreement, Interest Rate, Basis Spread on Variable Rate</link:label>
    <link:label id="lab_sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate_documentation_en-US" xlink:label="lab_sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Tax Agreement, Interest Rate, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate" xlink:href="sgry-20210930.xsd#sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate" xlink:to="lab_sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_be2f3974-957f-4919-ab04-9eb94f3a12fc_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease costs</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_c9f5031b-6c77-448f-bc96-46f7b4c9ab0c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from equity investments, net of distributions received</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments, Net of Dividends or Distributions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_caff32df-10ba-4a67-b126-db382ffe87fa_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_BusinessCombinationGainLossOnAcquisitionEscrow_3fcf36c4-5eae-4d74-9ecd-ddfcbd3cabe4_negatedTerseLabel_en-US" xlink:label="lab_sgry_BusinessCombinationGainLossOnAcquisitionEscrow" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on escrow release</link:label>
    <link:label id="lab_sgry_BusinessCombinationGainLossOnAcquisitionEscrow_label_en-US" xlink:label="lab_sgry_BusinessCombinationGainLossOnAcquisitionEscrow" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Gain (Loss) On Acquisition Escrow</link:label>
    <link:label id="lab_sgry_BusinessCombinationGainLossOnAcquisitionEscrow_documentation_en-US" xlink:label="lab_sgry_BusinessCombinationGainLossOnAcquisitionEscrow" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Gain (Loss) On Acquisition Escrow</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_BusinessCombinationGainLossOnAcquisitionEscrow" xlink:href="sgry-20210930.xsd#sgry_BusinessCombinationGainLossOnAcquisitionEscrow"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_BusinessCombinationGainLossOnAcquisitionEscrow" xlink:to="lab_sgry_BusinessCombinationGainLossOnAcquisitionEscrow" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_e70740b5-b35c-4e0a-ae14-e308222c8bb6_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments_a8dbafb9-23ef-4217-8e00-ae9d3e5ba147_terseLabel_en-US" xlink:label="lab_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred accelerated payments</link:label>
    <link:label id="lab_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments_label_en-US" xlink:label="lab_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coronavirus Aid, Relief, and Economic Security Act CARES Act, Government Grants, Deferred Accelerated Payments</link:label>
    <link:label id="lab_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments_documentation_en-US" xlink:label="lab_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coronavirus Aid, Relief, and Economic Security Act CARES Act, Government Grants, Deferred Accelerated Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments" xlink:href="sgry-20210930.xsd#sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments" xlink:to="lab_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_487179b3-bc50-4792-b487-231c9b331110_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_68e5f0d3-703d-4573-a641-19e495af8c87_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income (loss) to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionOfDividends_144f7729-5eea-4577-8b41-ed651b290f67_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionOfDividends" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends accrued</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionOfDividends_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Accretion of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityAccretionOfDividends" xlink:to="lab_us-gaap_TemporaryEquityAccretionOfDividends" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>sgry-20210930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:4fc50bef-303f-4567-8d1f-fa45eceeed5f,g:878f1ef0-0d6b-4fb6-8cd6-b11c4615e811-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.surgerypartners.com/role/CoverPage" xlink:type="simple" xlink:href="sgry-20210930.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_eb19a725-c387-499e-b65b-d25a20676754" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_e52bded1-fabb-42d5-b29c-e3ace5e3fb9a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_eb19a725-c387-499e-b65b-d25a20676754" xlink:to="loc_dei_DocumentType_e52bded1-fabb-42d5-b29c-e3ace5e3fb9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_80fe37f6-d320-498a-bd29-9c9f003d3041" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_eb19a725-c387-499e-b65b-d25a20676754" xlink:to="loc_dei_DocumentQuarterlyReport_80fe37f6-d320-498a-bd29-9c9f003d3041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_82eee3e8-35c1-4865-9d39-06d551572051" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_eb19a725-c387-499e-b65b-d25a20676754" xlink:to="loc_dei_DocumentPeriodEndDate_82eee3e8-35c1-4865-9d39-06d551572051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_92322231-1633-4cca-893b-ee63f99ab389" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_eb19a725-c387-499e-b65b-d25a20676754" xlink:to="loc_dei_DocumentTransitionReport_92322231-1633-4cca-893b-ee63f99ab389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_7a1adcf5-185b-467a-81f8-49f787a382d4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_eb19a725-c387-499e-b65b-d25a20676754" xlink:to="loc_dei_EntityFileNumber_7a1adcf5-185b-467a-81f8-49f787a382d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_26521e02-0e2e-4676-af07-5e85379a1e1a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_eb19a725-c387-499e-b65b-d25a20676754" xlink:to="loc_dei_EntityRegistrantName_26521e02-0e2e-4676-af07-5e85379a1e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_ef5393b5-9936-4807-b0e5-95be355422a5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_eb19a725-c387-499e-b65b-d25a20676754" xlink:to="loc_dei_EntityIncorporationStateCountryCode_ef5393b5-9936-4807-b0e5-95be355422a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_f065c050-a2b6-45f2-882d-e83c8e84de04" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_eb19a725-c387-499e-b65b-d25a20676754" xlink:to="loc_dei_EntityTaxIdentificationNumber_f065c050-a2b6-45f2-882d-e83c8e84de04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_e6ddd3ba-50df-4d70-902e-eb29dbb06637" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_eb19a725-c387-499e-b65b-d25a20676754" xlink:to="loc_dei_EntityAddressAddressLine1_e6ddd3ba-50df-4d70-902e-eb29dbb06637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_9a261b50-f2fe-4910-a602-e5d2165430d6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_eb19a725-c387-499e-b65b-d25a20676754" xlink:to="loc_dei_EntityAddressCityOrTown_9a261b50-f2fe-4910-a602-e5d2165430d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_2c4d71f2-dfb3-4dcf-902a-60505652d5e3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_eb19a725-c387-499e-b65b-d25a20676754" xlink:to="loc_dei_EntityAddressStateOrProvince_2c4d71f2-dfb3-4dcf-902a-60505652d5e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_079bf11c-da6e-4f7c-b26d-f3195c4ea37e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_eb19a725-c387-499e-b65b-d25a20676754" xlink:to="loc_dei_EntityAddressPostalZipCode_079bf11c-da6e-4f7c-b26d-f3195c4ea37e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_2257c08e-205f-4646-b780-a32943691d93" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_eb19a725-c387-499e-b65b-d25a20676754" xlink:to="loc_dei_CityAreaCode_2257c08e-205f-4646-b780-a32943691d93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_e948a390-4afa-441c-9a45-1865114e48f6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_eb19a725-c387-499e-b65b-d25a20676754" xlink:to="loc_dei_LocalPhoneNumber_e948a390-4afa-441c-9a45-1865114e48f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_06a04378-708c-427b-b1ff-3af5c2e09355" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_eb19a725-c387-499e-b65b-d25a20676754" xlink:to="loc_dei_Security12bTitle_06a04378-708c-427b-b1ff-3af5c2e09355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_d2569be6-86f1-4d74-81a0-422b3efa4a14" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_eb19a725-c387-499e-b65b-d25a20676754" xlink:to="loc_dei_TradingSymbol_d2569be6-86f1-4d74-81a0-422b3efa4a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_cb0239a3-8060-4c51-b8f8-ec63c6e94de4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_eb19a725-c387-499e-b65b-d25a20676754" xlink:to="loc_dei_SecurityExchangeName_cb0239a3-8060-4c51-b8f8-ec63c6e94de4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_4f55bbef-40dd-43e2-b37c-0cb4f34f3917" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_eb19a725-c387-499e-b65b-d25a20676754" xlink:to="loc_dei_EntityCurrentReportingStatus_4f55bbef-40dd-43e2-b37c-0cb4f34f3917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_4f27ea64-f0a4-4a04-b180-29f9a60af1ed" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_eb19a725-c387-499e-b65b-d25a20676754" xlink:to="loc_dei_EntityInteractiveDataCurrent_4f27ea64-f0a4-4a04-b180-29f9a60af1ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_38630623-2620-47fa-8a1e-b0aaf9924c4f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_eb19a725-c387-499e-b65b-d25a20676754" xlink:to="loc_dei_EntityFilerCategory_38630623-2620-47fa-8a1e-b0aaf9924c4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_9c206b89-9ed6-4472-ac42-a76f1fed348f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_eb19a725-c387-499e-b65b-d25a20676754" xlink:to="loc_dei_EntitySmallBusiness_9c206b89-9ed6-4472-ac42-a76f1fed348f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_91cf9ab2-308a-4319-b86d-9b760efc7ee5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_eb19a725-c387-499e-b65b-d25a20676754" xlink:to="loc_dei_EntityEmergingGrowthCompany_91cf9ab2-308a-4319-b86d-9b760efc7ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_da002038-2d17-46eb-8ca8-177f4df93fcf" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_eb19a725-c387-499e-b65b-d25a20676754" xlink:to="loc_dei_EntityShellCompany_da002038-2d17-46eb-8ca8-177f4df93fcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_0a98f0a8-b806-4768-b5f9-eb66c71cb472" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_eb19a725-c387-499e-b65b-d25a20676754" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_0a98f0a8-b806-4768-b5f9-eb66c71cb472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_6411a19d-832a-4e0f-a17a-ae64b47b0921" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_eb19a725-c387-499e-b65b-d25a20676754" xlink:to="loc_dei_EntityCentralIndexKey_6411a19d-832a-4e0f-a17a-ae64b47b0921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_23cf4cca-c0f5-47f7-ba1a-b8de9ff367da" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_eb19a725-c387-499e-b65b-d25a20676754" xlink:to="loc_dei_CurrentFiscalYearEndDate_23cf4cca-c0f5-47f7-ba1a-b8de9ff367da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_dbd06d54-44e6-4c0e-bcc9-34147dbe45db" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_eb19a725-c387-499e-b65b-d25a20676754" xlink:to="loc_dei_DocumentFiscalYearFocus_dbd06d54-44e6-4c0e-bcc9-34147dbe45db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_ee41c7a6-3d72-4dcb-b003-b8a662224b5e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_eb19a725-c387-499e-b65b-d25a20676754" xlink:to="loc_dei_DocumentFiscalPeriodFocus_ee41c7a6-3d72-4dcb-b003-b8a662224b5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_f467f430-38cd-4a0e-80e4-44eec0a41473" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_eb19a725-c387-499e-b65b-d25a20676754" xlink:to="loc_dei_AmendmentFlag_f467f430-38cd-4a0e-80e4-44eec0a41473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="sgry-20210930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_4f942bc5-01c1-41f0-8cf7-b7ddda0167d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_2db7eac6-84db-4594-8bf8-6d2bfbc7ef74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4f942bc5-01c1-41f0-8cf7-b7ddda0167d8" xlink:to="loc_us-gaap_AssetsAbstract_2db7eac6-84db-4594-8bf8-6d2bfbc7ef74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_5e8d4b65-3367-4d1a-ac56-98c115f5ac26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2db7eac6-84db-4594-8bf8-6d2bfbc7ef74" xlink:to="loc_us-gaap_AssetsCurrentAbstract_5e8d4b65-3367-4d1a-ac56-98c115f5ac26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3fe00636-25ac-448d-b052-22ffc102bf07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_5e8d4b65-3367-4d1a-ac56-98c115f5ac26" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3fe00636-25ac-448d-b052-22ffc102bf07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_b995d43e-0abf-4c8d-8d6f-8e7fad89ca6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_5e8d4b65-3367-4d1a-ac56-98c115f5ac26" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_b995d43e-0abf-4c8d-8d6f-8e7fad89ca6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_f7131621-4348-417d-9af1-66ee25bb3dab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_5e8d4b65-3367-4d1a-ac56-98c115f5ac26" xlink:to="loc_us-gaap_InventoryNet_f7131621-4348-417d-9af1-66ee25bb3dab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_feac8fa3-64ec-4508-8079-eb664b4a2f95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_5e8d4b65-3367-4d1a-ac56-98c115f5ac26" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_feac8fa3-64ec-4508-8079-eb664b4a2f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_81b16fd5-558c-4e39-916c-71d377b2289b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_5e8d4b65-3367-4d1a-ac56-98c115f5ac26" xlink:to="loc_us-gaap_OtherAssetsCurrent_81b16fd5-558c-4e39-916c-71d377b2289b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_96d6413c-2de1-4a53-b2ac-7508341b96b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_5e8d4b65-3367-4d1a-ac56-98c115f5ac26" xlink:to="loc_us-gaap_AssetsCurrent_96d6413c-2de1-4a53-b2ac-7508341b96b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0079d44e-2035-4340-ab9e-3692656f268b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2db7eac6-84db-4594-8bf8-6d2bfbc7ef74" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0079d44e-2035-4340-ab9e-3692656f268b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_500c7380-b615-4b93-9e6f-1ec61f55a876" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2db7eac6-84db-4594-8bf8-6d2bfbc7ef74" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_500c7380-b615-4b93-9e6f-1ec61f55a876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_a42c288b-3533-40c2-b539-69e5b412ad38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2db7eac6-84db-4594-8bf8-6d2bfbc7ef74" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_a42c288b-3533-40c2-b539-69e5b412ad38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_778d6416-3089-46d6-bfbb-80457ff1cbcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2db7eac6-84db-4594-8bf8-6d2bfbc7ef74" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_778d6416-3089-46d6-bfbb-80457ff1cbcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_b0556227-110b-44f2-90d5-4b930ecc274d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2db7eac6-84db-4594-8bf8-6d2bfbc7ef74" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_b0556227-110b-44f2-90d5-4b930ecc274d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_93220509-19b6-4c6a-81c7-dc7731b5f689" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2db7eac6-84db-4594-8bf8-6d2bfbc7ef74" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_93220509-19b6-4c6a-81c7-dc7731b5f689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_dd726bac-f253-46f3-bed7-52c0a09105b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2db7eac6-84db-4594-8bf8-6d2bfbc7ef74" xlink:to="loc_us-gaap_Assets_dd726bac-f253-46f3-bed7-52c0a09105b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_43720bc7-1853-41d0-b066-42b67d5143f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4f942bc5-01c1-41f0-8cf7-b7ddda0167d8" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_43720bc7-1853-41d0-b066-42b67d5143f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_6cfe2703-091f-4e05-ad2c-349376a6ba0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_43720bc7-1853-41d0-b066-42b67d5143f9" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_6cfe2703-091f-4e05-ad2c-349376a6ba0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_c718b038-6ce7-4f97-bcb6-0a871be831ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6cfe2703-091f-4e05-ad2c-349376a6ba0e" xlink:to="loc_us-gaap_AccountsPayableCurrent_c718b038-6ce7-4f97-bcb6-0a871be831ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_5989ab91-f3ca-4bb5-8601-06af8fc60bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6cfe2703-091f-4e05-ad2c-349376a6ba0e" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_5989ab91-f3ca-4bb5-8601-06af8fc60bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent_16ff4bec-358e-4a4b-a98d-4d144729ba0c" xlink:href="sgry-20210930.xsd#sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6cfe2703-091f-4e05-ad2c-349376a6ba0e" xlink:to="loc_sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent_16ff4bec-358e-4a4b-a98d-4d144729ba0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_31495d39-a7ce-4536-a341-14dede089e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6cfe2703-091f-4e05-ad2c-349376a6ba0e" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_31495d39-a7ce-4536-a341-14dede089e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_0ce12eda-9b3b-4a00-a352-0c231bb5d949" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6cfe2703-091f-4e05-ad2c-349376a6ba0e" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_0ce12eda-9b3b-4a00-a352-0c231bb5d949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_3dfa1539-cbe0-4d98-b0ab-5f7bfc856242" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6cfe2703-091f-4e05-ad2c-349376a6ba0e" xlink:to="loc_us-gaap_LiabilitiesCurrent_3dfa1539-cbe0-4d98-b0ab-5f7bfc856242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_32610a96-8b50-44be-aef9-3b478c93aea4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_43720bc7-1853-41d0-b066-42b67d5143f9" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_32610a96-8b50-44be-aef9-3b478c93aea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_a8c99823-e8ea-49a3-beab-88441298b633" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_43720bc7-1853-41d0-b066-42b67d5143f9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_a8c99823-e8ea-49a3-beab-88441298b633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_aa57561d-0c8a-4e86-8ea2-fc871365b7d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_43720bc7-1853-41d0-b066-42b67d5143f9" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_aa57561d-0c8a-4e86-8ea2-fc871365b7d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_43d4ab64-82ab-4294-82e9-6541af5b2e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_43720bc7-1853-41d0-b066-42b67d5143f9" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_43d4ab64-82ab-4294-82e9-6541af5b2e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_13f08898-9a74-478e-804c-3efc19181f38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_43720bc7-1853-41d0-b066-42b67d5143f9" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_13f08898-9a74-478e-804c-3efc19181f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_35e2229e-8909-4a7c-b5cd-ee1ca8a51cb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_43720bc7-1853-41d0-b066-42b67d5143f9" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_35e2229e-8909-4a7c-b5cd-ee1ca8a51cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_49d9e6b9-8c6e-4fff-b482-e6689e59d6b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_35e2229e-8909-4a7c-b5cd-ee1ca8a51cb4" xlink:to="loc_us-gaap_PreferredStockValue_49d9e6b9-8c6e-4fff-b482-e6689e59d6b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_d604c8f0-2779-4300-b4f5-637050a6ef02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_35e2229e-8909-4a7c-b5cd-ee1ca8a51cb4" xlink:to="loc_us-gaap_CommonStockValueOutstanding_d604c8f0-2779-4300-b4f5-637050a6ef02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_cbe694dd-4e68-4dcf-88f1-8b439013bfd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_35e2229e-8909-4a7c-b5cd-ee1ca8a51cb4" xlink:to="loc_us-gaap_AdditionalPaidInCapital_cbe694dd-4e68-4dcf-88f1-8b439013bfd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_96d6fcdd-7d55-4cea-9825-9a15abbd0b41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_35e2229e-8909-4a7c-b5cd-ee1ca8a51cb4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_96d6fcdd-7d55-4cea-9825-9a15abbd0b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0a0ec0c0-8452-45a4-8902-326a9eaafe68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_35e2229e-8909-4a7c-b5cd-ee1ca8a51cb4" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0a0ec0c0-8452-45a4-8902-326a9eaafe68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e6776918-a467-430d-a8d6-d41c77956f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_35e2229e-8909-4a7c-b5cd-ee1ca8a51cb4" xlink:to="loc_us-gaap_StockholdersEquity_e6776918-a467-430d-a8d6-d41c77956f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_a8c5cb41-2fdb-4bed-941e-08f7cdb50d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_35e2229e-8909-4a7c-b5cd-ee1ca8a51cb4" xlink:to="loc_us-gaap_MinorityInterest_a8c5cb41-2fdb-4bed-941e-08f7cdb50d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b570f584-6d24-429b-b3de-4a31a315c5ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_35e2229e-8909-4a7c-b5cd-ee1ca8a51cb4" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b570f584-6d24-429b-b3de-4a31a315c5ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_f64025ef-608e-48ea-ae0e-ab1e8c87cad6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_43720bc7-1853-41d0-b066-42b67d5143f9" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_f64025ef-608e-48ea-ae0e-ab1e8c87cad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="sgry-20210930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_58cd2fba-ca65-471b-94f5-c4aec96a5eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_914c41b1-8d5e-47a5-b3c5-add066a9b3c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_58cd2fba-ca65-471b-94f5-c4aec96a5eaa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_914c41b1-8d5e-47a5-b3c5-add066a9b3c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_31a34224-e531-4059-b8ae-3b8f41360e41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_58cd2fba-ca65-471b-94f5-c4aec96a5eaa" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_31a34224-e531-4059-b8ae-3b8f41360e41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_ade5cb65-bb0f-4f5e-acf1-0dafab54d44b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_58cd2fba-ca65-471b-94f5-c4aec96a5eaa" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_ade5cb65-bb0f-4f5e-acf1-0dafab54d44b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_f7f510ca-5215-45cc-a688-f3330296baff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_58cd2fba-ca65-471b-94f5-c4aec96a5eaa" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_f7f510ca-5215-45cc-a688-f3330296baff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityPreferredRedemptionValue_1307a62f-f214-4ec0-beaa-050f0688e54b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityPreferredRedemptionValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_58cd2fba-ca65-471b-94f5-c4aec96a5eaa" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityPreferredRedemptionValue_1307a62f-f214-4ec0-beaa-050f0688e54b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_bcdb0d14-b5cd-4955-8d72-28795c480b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_58cd2fba-ca65-471b-94f5-c4aec96a5eaa" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_bcdb0d14-b5cd-4955-8d72-28795c480b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_9bf68877-0ece-4af3-ae2c-b5f388e651e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_58cd2fba-ca65-471b-94f5-c4aec96a5eaa" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_9bf68877-0ece-4af3-ae2c-b5f388e651e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_155c4271-4e3d-4fb1-abb1-2bd69d51e1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_58cd2fba-ca65-471b-94f5-c4aec96a5eaa" xlink:to="loc_us-gaap_PreferredStockSharesIssued_155c4271-4e3d-4fb1-abb1-2bd69d51e1c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_1fca4828-9aa6-4cb0-aada-fb4d66f88dd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_58cd2fba-ca65-471b-94f5-c4aec96a5eaa" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_1fca4828-9aa6-4cb0-aada-fb4d66f88dd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_f443bf43-3e40-47b4-832c-df0905db55e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_58cd2fba-ca65-471b-94f5-c4aec96a5eaa" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_f443bf43-3e40-47b4-832c-df0905db55e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_b0cb2e35-0415-4ab5-8fd1-692e2bb8b590" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_58cd2fba-ca65-471b-94f5-c4aec96a5eaa" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_b0cb2e35-0415-4ab5-8fd1-692e2bb8b590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_12e9c5e5-c49c-4285-a3ba-420f547c5235" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_58cd2fba-ca65-471b-94f5-c4aec96a5eaa" xlink:to="loc_us-gaap_CommonStockSharesIssued_12e9c5e5-c49c-4285-a3ba-420f547c5235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_e9c8eed1-bac2-449b-a37e-8251a70b36f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_58cd2fba-ca65-471b-94f5-c4aec96a5eaa" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_e9c8eed1-bac2-449b-a37e-8251a70b36f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="sgry-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_7426a503-3064-4fa6-84b6-75473e0bf8c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_0baeab7d-d4a7-4b66-9ae9-6915f3821999" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7426a503-3064-4fa6-84b6-75473e0bf8c6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_0baeab7d-d4a7-4b66-9ae9-6915f3821999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_abd89b92-e1d2-45ac-8ccb-e105c96eaf46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7426a503-3064-4fa6-84b6-75473e0bf8c6" xlink:to="loc_us-gaap_OperatingExpensesAbstract_abd89b92-e1d2-45ac-8ccb-e105c96eaf46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_87d52efe-b2bb-4a55-9a55-139637f37695" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_abd89b92-e1d2-45ac-8ccb-e105c96eaf46" xlink:to="loc_us-gaap_LaborAndRelatedExpense_87d52efe-b2bb-4a55-9a55-139637f37695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SuppliesExpense_25e2736f-31bd-4a74-9ddc-21cf765eda9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SuppliesExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_abd89b92-e1d2-45ac-8ccb-e105c96eaf46" xlink:to="loc_us-gaap_SuppliesExpense_25e2736f-31bd-4a74-9ddc-21cf765eda9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees_6e37da72-9302-42a0-ac5e-cc82da3acd6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalFees"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_abd89b92-e1d2-45ac-8ccb-e105c96eaf46" xlink:to="loc_us-gaap_ProfessionalFees_6e37da72-9302-42a0-ac5e-cc82da3acd6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_OperatingAndFinanceLeaseExpense_d94a3fba-e867-4b5b-86c8-3202af37c7d4" xlink:href="sgry-20210930.xsd#sgry_OperatingAndFinanceLeaseExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_abd89b92-e1d2-45ac-8ccb-e105c96eaf46" xlink:to="loc_sgry_OperatingAndFinanceLeaseExpense_d94a3fba-e867-4b5b-86c8-3202af37c7d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_c6ff81c4-322e-424d-836a-bd1534c41c52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_abd89b92-e1d2-45ac-8ccb-e105c96eaf46" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating_c6ff81c4-322e-424d-836a-bd1534c41c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_0424fc1f-e973-4389-990f-5d15e0a0feda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_abd89b92-e1d2-45ac-8ccb-e105c96eaf46" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_0424fc1f-e973-4389-990f-5d15e0a0feda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_98cbe304-8532-4d4a-9be7-d4b3f6fefaad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_abd89b92-e1d2-45ac-8ccb-e105c96eaf46" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_98cbe304-8532-4d4a-9be7-d4b3f6fefaad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_6b8be8aa-a080-4ebf-856f-85801e34e0f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_abd89b92-e1d2-45ac-8ccb-e105c96eaf46" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_6b8be8aa-a080-4ebf-856f-85801e34e0f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_671d0315-de4c-4257-94ff-4e63c9bc481c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_abd89b92-e1d2-45ac-8ccb-e105c96eaf46" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_671d0315-de4c-4257-94ff-4e63c9bc481c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation_7394b0b5-ed07-484b-bfde-1c3f7a020fc5" xlink:href="sgry-20210930.xsd#sgry_GainLossOnDispositionOfAssetsAndDeconsolidation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_abd89b92-e1d2-45ac-8ccb-e105c96eaf46" xlink:to="loc_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation_7394b0b5-ed07-484b-bfde-1c3f7a020fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_e0c6c231-95d3-4294-9ff0-51e36c5ad8c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_abd89b92-e1d2-45ac-8ccb-e105c96eaf46" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_e0c6c231-95d3-4294-9ff0-51e36c5ad8c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_1aa27482-f1be-4019-af3f-3907b4afb379" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_abd89b92-e1d2-45ac-8ccb-e105c96eaf46" xlink:to="loc_us-gaap_AssetImpairmentCharges_1aa27482-f1be-4019-af3f-3907b4afb379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_GrantRevenue_73418ff4-5bac-46fc-9813-4b5cd0443dde" xlink:href="sgry-20210930.xsd#sgry_GrantRevenue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_abd89b92-e1d2-45ac-8ccb-e105c96eaf46" xlink:to="loc_sgry_GrantRevenue_73418ff4-5bac-46fc-9813-4b5cd0443dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3749e3fd-a058-4a7a-a9eb-73dba56ad5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_abd89b92-e1d2-45ac-8ccb-e105c96eaf46" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3749e3fd-a058-4a7a-a9eb-73dba56ad5a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_63281c82-0ce9-4ac5-8abc-34d548a8f918" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_abd89b92-e1d2-45ac-8ccb-e105c96eaf46" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_63281c82-0ce9-4ac5-8abc-34d548a8f918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonrecurringIncomeExpense_de8dab2c-9aac-43f8-9c2a-4f7e561e03f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonrecurringIncomeExpense"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_abd89b92-e1d2-45ac-8ccb-e105c96eaf46" xlink:to="loc_us-gaap_OtherNonrecurringIncomeExpense_de8dab2c-9aac-43f8-9c2a-4f7e561e03f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_4b032cd0-7b1e-4256-9a5b-f2fbe2dda4f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_abd89b92-e1d2-45ac-8ccb-e105c96eaf46" xlink:to="loc_us-gaap_OperatingExpenses_4b032cd0-7b1e-4256-9a5b-f2fbe2dda4f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9c8a7578-5669-4ab0-a7ea-1a7025447a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7426a503-3064-4fa6-84b6-75473e0bf8c6" xlink:to="loc_us-gaap_OperatingIncomeLoss_9c8a7578-5669-4ab0-a7ea-1a7025447a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_219df8c1-61e2-4666-a098-a753b3d7fd6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7426a503-3064-4fa6-84b6-75473e0bf8c6" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_219df8c1-61e2-4666-a098-a753b3d7fd6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_5209146e-099f-491c-bd49-28a4719b5d81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7426a503-3064-4fa6-84b6-75473e0bf8c6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_5209146e-099f-491c-bd49-28a4719b5d81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_204e017f-e320-4742-b7bf-cf99206f3c29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7426a503-3064-4fa6-84b6-75473e0bf8c6" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_204e017f-e320-4742-b7bf-cf99206f3c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_70005722-d773-4495-a03a-1a7673d70827" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7426a503-3064-4fa6-84b6-75473e0bf8c6" xlink:to="loc_us-gaap_ProfitLoss_70005722-d773-4495-a03a-1a7673d70827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7850fe72-97a4-46f5-9150-58f1d8919471" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7426a503-3064-4fa6-84b6-75473e0bf8c6" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7850fe72-97a4-46f5-9150-58f1d8919471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_173d5961-d5dc-41dd-8016-7093f7a75d89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7426a503-3064-4fa6-84b6-75473e0bf8c6" xlink:to="loc_us-gaap_NetIncomeLoss_173d5961-d5dc-41dd-8016-7093f7a75d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_dde09d57-5fa3-4465-9a8f-f3adf3d72b54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7426a503-3064-4fa6-84b6-75473e0bf8c6" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_dde09d57-5fa3-4465-9a8f-f3adf3d72b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_7d405853-07a8-4ac6-a2fa-05347195de59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7426a503-3064-4fa6-84b6-75473e0bf8c6" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_7d405853-07a8-4ac6-a2fa-05347195de59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_d21ccafb-d90b-4364-ad6e-8d2e1cc72847" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7426a503-3064-4fa6-84b6-75473e0bf8c6" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_d21ccafb-d90b-4364-ad6e-8d2e1cc72847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_2c8a9228-01be-4586-a40e-9d3f711157d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_d21ccafb-d90b-4364-ad6e-8d2e1cc72847" xlink:to="loc_us-gaap_EarningsPerShareBasic_2c8a9228-01be-4586-a40e-9d3f711157d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_c284ffce-2d19-43ba-aa34-5c1f83863c82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_d21ccafb-d90b-4364-ad6e-8d2e1cc72847" xlink:to="loc_us-gaap_EarningsPerShareDiluted_c284ffce-2d19-43ba-aa34-5c1f83863c82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_0c1cfa3d-251b-4eec-9375-3c64a7a17178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7426a503-3064-4fa6-84b6-75473e0bf8c6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_0c1cfa3d-251b-4eec-9375-3c64a7a17178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_175bb5bc-bfdc-4b36-ab71-95b94790329a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_0c1cfa3d-251b-4eec-9375-3c64a7a17178" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_175bb5bc-bfdc-4b36-ab71-95b94790329a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d506412e-f95a-48ac-8762-1044caf43e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_0c1cfa3d-251b-4eec-9375-3c64a7a17178" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d506412e-f95a-48ac-8762-1044caf43e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="sgry-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5b236f86-a99f-4ca8-a639-af19ed42cfc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_19b5474c-3037-48d1-8f77-df0ec1d692ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5b236f86-a99f-4ca8-a639-af19ed42cfc4" xlink:to="loc_us-gaap_ProfitLoss_19b5474c-3037-48d1-8f77-df0ec1d692ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_be4ab5c1-27ce-492d-acc3-ec63c0d988e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5b236f86-a99f-4ca8-a639-af19ed42cfc4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_be4ab5c1-27ce-492d-acc3-ec63c0d988e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1b726d09-b3dd-4686-89c8-af3a53a7f574" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_be4ab5c1-27ce-492d-acc3-ec63c0d988e7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1b726d09-b3dd-4686-89c8-af3a53a7f574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_f5eec3a6-9d68-488e-8151-507bb217f490" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5b236f86-a99f-4ca8-a639-af19ed42cfc4" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_f5eec3a6-9d68-488e-8151-507bb217f490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_ca0e9acb-e4da-4ab9-b57d-92c0eec52531" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5b236f86-a99f-4ca8-a639-af19ed42cfc4" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_ca0e9acb-e4da-4ab9-b57d-92c0eec52531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_88f7d8d9-0b80-48c8-b694-a5fde5d57cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5b236f86-a99f-4ca8-a639-af19ed42cfc4" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_88f7d8d9-0b80-48c8-b694-a5fde5d57cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="sgry-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_48280c7d-d229-4ae4-a89d-0a47666fda1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f197ab62-be17-41fd-b0df-034e3887d0f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_48280c7d-d229-4ae4-a89d-0a47666fda1b" xlink:to="loc_us-gaap_StatementTable_f197ab62-be17-41fd-b0df-034e3887d0f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a49a9b16-bf1c-4022-910f-9b1d4391d9ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f197ab62-be17-41fd-b0df-034e3887d0f9" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a49a9b16-bf1c-4022-910f-9b1d4391d9ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ea9ebae6-9f63-4f4b-81b8-72bddd789271" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a49a9b16-bf1c-4022-910f-9b1d4391d9ef" xlink:to="loc_us-gaap_EquityComponentDomain_ea9ebae6-9f63-4f4b-81b8-72bddd789271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_47038b5d-8f8b-457e-8d16-6c391c627ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ea9ebae6-9f63-4f4b-81b8-72bddd789271" xlink:to="loc_us-gaap_CommonStockMember_47038b5d-8f8b-457e-8d16-6c391c627ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_01009fe2-5798-4cf3-b38e-70a78770b9ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ea9ebae6-9f63-4f4b-81b8-72bddd789271" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_01009fe2-5798-4cf3-b38e-70a78770b9ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_88bd6740-2d26-4aea-95ac-c08b52719ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ea9ebae6-9f63-4f4b-81b8-72bddd789271" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_88bd6740-2d26-4aea-95ac-c08b52719ea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_cb2051d3-0dd3-4813-867e-52380d55bd8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ea9ebae6-9f63-4f4b-81b8-72bddd789271" xlink:to="loc_us-gaap_RetainedEarningsMember_cb2051d3-0dd3-4813-867e-52380d55bd8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_f9159629-627e-41bb-ad05-8fdfea189f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ea9ebae6-9f63-4f4b-81b8-72bddd789271" xlink:to="loc_us-gaap_NoncontrollingInterestMember_f9159629-627e-41bb-ad05-8fdfea189f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_59b0599c-41f9-45b7-a717-5359c2d2bc25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f197ab62-be17-41fd-b0df-034e3887d0f9" xlink:to="loc_us-gaap_StatementLineItems_59b0599c-41f9-45b7-a717-5359c2d2bc25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3511347a-77f2-435b-9760-db7e0bcc1318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_59b0599c-41f9-45b7-a717-5359c2d2bc25" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3511347a-77f2-435b-9760-db7e0bcc1318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_e96da1d5-cd70-4320-979c-466a9c52e6e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3511347a-77f2-435b-9760-db7e0bcc1318" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_e96da1d5-cd70-4320-979c-466a9c52e6e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0d2ea42c-ebc7-4c95-b5bb-8150b5ab30c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3511347a-77f2-435b-9760-db7e0bcc1318" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0d2ea42c-ebc7-4c95-b5bb-8150b5ab30c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_9200eb12-b0d3-4cd1-93ea-8248c6d650f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3511347a-77f2-435b-9760-db7e0bcc1318" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_9200eb12-b0d3-4cd1-93ea-8248c6d650f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_7198e261-a78f-497c-9267-c81872cec03e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3511347a-77f2-435b-9760-db7e0bcc1318" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_7198e261-a78f-497c-9267-c81872cec03e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_d895b278-0076-4904-a725-6f63d5f8a209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3511347a-77f2-435b-9760-db7e0bcc1318" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_d895b278-0076-4904-a725-6f63d5f8a209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_629f9cad-9f34-4781-adba-602b4d0c535e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3511347a-77f2-435b-9760-db7e0bcc1318" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_629f9cad-9f34-4781-adba-602b4d0c535e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_2f88ccf8-a70a-40de-867a-8319a881a3a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3511347a-77f2-435b-9760-db7e0bcc1318" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_2f88ccf8-a70a-40de-867a-8319a881a3a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_c96e8456-9c5e-4ca3-8f83-d4874b67d6b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3511347a-77f2-435b-9760-db7e0bcc1318" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_c96e8456-9c5e-4ca3-8f83-d4874b67d6b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_df6aa87c-515f-4506-abcf-824815be0f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3511347a-77f2-435b-9760-db7e0bcc1318" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_df6aa87c-515f-4506-abcf-824815be0f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_8faddab2-da3b-49f2-adf2-0d419d69a1ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3511347a-77f2-435b-9760-db7e0bcc1318" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_8faddab2-da3b-49f2-adf2-0d419d69a1ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_c3977ccd-3f07-425a-8e47-e5b02748bd03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3511347a-77f2-435b-9760-db7e0bcc1318" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_c3977ccd-3f07-425a-8e47-e5b02748bd03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet_f7bfd6ab-6d08-424b-8faf-5c5fa2c35998" xlink:href="sgry-20210930.xsd#sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3511347a-77f2-435b-9760-db7e0bcc1318" xlink:to="loc_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet_f7bfd6ab-6d08-424b-8faf-5c5fa2c35998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_d2b2fb82-32ea-4a3b-be9d-b4325357d36a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3511347a-77f2-435b-9760-db7e0bcc1318" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_d2b2fb82-32ea-4a3b-be9d-b4325357d36a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_b7cccf99-38ea-4f0d-a644-1d4790e0296f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3511347a-77f2-435b-9760-db7e0bcc1318" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_b7cccf99-38ea-4f0d-a644-1d4790e0296f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6cde8613-ce31-4ff3-8729-b134f6830d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3511347a-77f2-435b-9760-db7e0bcc1318" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6cde8613-ce31-4ff3-8729-b134f6830d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="sgry-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_0688648c-a09e-4758-8a5c-736427cac8a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dd5ca47c-7a20-4cd7-b710-8fdbdefb2ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0688648c-a09e-4758-8a5c-736427cac8a5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dd5ca47c-7a20-4cd7-b710-8fdbdefb2ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f7e6176e-cef9-46a6-a439-c3cbadb76992" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dd5ca47c-7a20-4cd7-b710-8fdbdefb2ce9" xlink:to="loc_us-gaap_ProfitLoss_f7e6176e-cef9-46a6-a439-c3cbadb76992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e10ec615-d899-4d26-b4a3-f48e82bf6f52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dd5ca47c-7a20-4cd7-b710-8fdbdefb2ce9" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e10ec615-d899-4d26-b4a3-f48e82bf6f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_6d4ff509-7055-42a3-85e9-e202d8c526c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e10ec615-d899-4d26-b4a3-f48e82bf6f52" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_6d4ff509-7055-42a3-85e9-e202d8c526c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NoncashInterestIncomeExpenseNet_2c0f87d4-8f8d-4fd0-9721-3f88f22097a3" xlink:href="sgry-20210930.xsd#sgry_NoncashInterestIncomeExpenseNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e10ec615-d899-4d26-b4a3-f48e82bf6f52" xlink:to="loc_sgry_NoncashInterestIncomeExpenseNet_2c0f87d4-8f8d-4fd0-9721-3f88f22097a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_af74dbf6-8194-49e6-b78b-08ca96c3e355" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e10ec615-d899-4d26-b4a3-f48e82bf6f52" xlink:to="loc_us-gaap_ShareBasedCompensation_af74dbf6-8194-49e6-b78b-08ca96c3e355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation_b4c7fbc3-0556-48d9-8568-a87d192b62ed" xlink:href="sgry-20210930.xsd#sgry_GainLossOnDispositionOfAssetsAndDeconsolidation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e10ec615-d899-4d26-b4a3-f48e82bf6f52" xlink:to="loc_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation_b4c7fbc3-0556-48d9-8568-a87d192b62ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_698a6ce5-625a-476b-a018-bdf955112f64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e10ec615-d899-4d26-b4a3-f48e82bf6f52" xlink:to="loc_us-gaap_AssetImpairmentCharges_698a6ce5-625a-476b-a018-bdf955112f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_fd713f70-249a-4a6f-8b9f-35ffd00dd724" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e10ec615-d899-4d26-b4a3-f48e82bf6f52" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_fd713f70-249a-4a6f-8b9f-35ffd00dd724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_53fffbec-7483-4fd3-9b40-2ada004b87c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e10ec615-d899-4d26-b4a3-f48e82bf6f52" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_53fffbec-7483-4fd3-9b40-2ada004b87c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_d8341df8-4b59-469f-a9f3-80a40a566a72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e10ec615-d899-4d26-b4a3-f48e82bf6f52" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_d8341df8-4b59-469f-a9f3-80a40a566a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_c6884b5e-8407-48bf-998d-2898b14f9fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e10ec615-d899-4d26-b4a3-f48e82bf6f52" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_c6884b5e-8407-48bf-998d-2898b14f9fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ba1544e8-3a96-4de5-81e7-a8d743854036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e10ec615-d899-4d26-b4a3-f48e82bf6f52" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ba1544e8-3a96-4de5-81e7-a8d743854036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_240b234c-5ffa-4ee0-8903-c759451067ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ba1544e8-3a96-4de5-81e7-a8d743854036" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_240b234c-5ffa-4ee0-8903-c759451067ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants_c6c38023-929d-42b9-b13c-e8e90030cd81" xlink:href="sgry-20210930.xsd#sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ba1544e8-3a96-4de5-81e7-a8d743854036" xlink:to="loc_sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants_c6c38023-929d-42b9-b13c-e8e90030cd81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_IncreaseDecreaseInSettlementPayments_da6b0bc8-95b7-4837-b35d-e85581fab902" xlink:href="sgry-20210930.xsd#sgry_IncreaseDecreaseInSettlementPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ba1544e8-3a96-4de5-81e7-a8d743854036" xlink:to="loc_sgry_IncreaseDecreaseInSettlementPayments_da6b0bc8-95b7-4837-b35d-e85581fab902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_5e7c3d24-9eba-43e7-a62e-a9aa2f4cb3cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ba1544e8-3a96-4de5-81e7-a8d743854036" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_5e7c3d24-9eba-43e7-a62e-a9aa2f4cb3cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_238de1d9-52e7-4fc9-984a-d370541d04b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dd5ca47c-7a20-4cd7-b710-8fdbdefb2ce9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_238de1d9-52e7-4fc9-984a-d370541d04b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_176ad7e1-4bf1-49b2-bc71-3f45716601e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0688648c-a09e-4758-8a5c-736427cac8a5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_176ad7e1-4bf1-49b2-bc71-3f45716601e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ca033418-facb-424c-83d7-3cc90ab34fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_176ad7e1-4bf1-49b2-bc71-3f45716601e2" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ca033418-facb-424c-83d7-3cc90ab34fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_cb0494c4-2a03-461d-8edc-57715a69d350" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_176ad7e1-4bf1-49b2-bc71-3f45716601e2" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_cb0494c4-2a03-461d-8edc-57715a69d350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_b9c9f011-fd34-4d7d-9251-d9ef988eb503" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_176ad7e1-4bf1-49b2-bc71-3f45716601e2" xlink:to="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_b9c9f011-fd34-4d7d-9251-d9ef988eb503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_8d0aaa67-d426-4a65-9b4d-e27ebe7f7347" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_176ad7e1-4bf1-49b2-bc71-3f45716601e2" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_8d0aaa67-d426-4a65-9b4d-e27ebe7f7347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b12d307b-bb6d-4b78-b69a-c12a36c34507" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_176ad7e1-4bf1-49b2-bc71-3f45716601e2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b12d307b-bb6d-4b78-b69a-c12a36c34507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_57a41ea7-91f0-4f03-8dec-c17104750b21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0688648c-a09e-4758-8a5c-736427cac8a5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_57a41ea7-91f0-4f03-8dec-c17104750b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_ef2579bc-9644-4a0c-a45b-e8be2bb3acdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_57a41ea7-91f0-4f03-8dec-c17104750b21" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_ef2579bc-9644-4a0c-a45b-e8be2bb3acdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_4ba97600-39bb-4390-b527-2638b610d2ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_57a41ea7-91f0-4f03-8dec-c17104750b21" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_4ba97600-39bb-4390-b527-2638b610d2ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_5f7d3845-3180-4d50-b574-2530345ac1ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_57a41ea7-91f0-4f03-8dec-c17104750b21" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_5f7d3845-3180-4d50-b574-2530345ac1ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_50296318-7169-4d02-8902-bdceda862006" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_57a41ea7-91f0-4f03-8dec-c17104750b21" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_50296318-7169-4d02-8902-bdceda862006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_f21bfb57-86a4-4819-8d67-101be7dd8dab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_57a41ea7-91f0-4f03-8dec-c17104750b21" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_f21bfb57-86a4-4819-8d67-101be7dd8dab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_6ab96de4-5310-4c36-bfe4-3a4fb2e21c13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_57a41ea7-91f0-4f03-8dec-c17104750b21" xlink:to="loc_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_6ab96de4-5310-4c36-bfe4-3a4fb2e21c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest_5f3c08c0-6034-443c-b874-1a988b08a16d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_57a41ea7-91f0-4f03-8dec-c17104750b21" xlink:to="loc_us-gaap_PaymentsOfDividendsMinorityInterest_5f3c08c0-6034-443c-b874-1a988b08a16d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_49b68242-7fc3-43fe-9446-c993c5a82130" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_57a41ea7-91f0-4f03-8dec-c17104750b21" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_49b68242-7fc3-43fe-9446-c993c5a82130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_8770790b-ad66-47de-96e2-d7666e224292" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_57a41ea7-91f0-4f03-8dec-c17104750b21" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_8770790b-ad66-47de-96e2-d7666e224292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_88a6ca92-a992-45bd-89fc-39db4c9b08d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_57a41ea7-91f0-4f03-8dec-c17104750b21" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_88a6ca92-a992-45bd-89fc-39db4c9b08d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_22c27786-ce66-457e-a1b6-afe6ccc59a49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_57a41ea7-91f0-4f03-8dec-c17104750b21" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_22c27786-ce66-457e-a1b6-afe6ccc59a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e48a79e0-93ff-4a28-9362-8420161249d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0688648c-a09e-4758-8a5c-736427cac8a5" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e48a79e0-93ff-4a28-9362-8420161249d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_072b3d34-2e01-47e0-a260-5abc3422a849" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0688648c-a09e-4758-8a5c-736427cac8a5" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_072b3d34-2e01-47e0-a260-5abc3422a849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_13c4239f-f183-479e-a84f-95c54eaa47c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0688648c-a09e-4758-8a5c-736427cac8a5" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_13c4239f-f183-479e-a84f-95c54eaa47c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPolicies" xlink:type="simple" xlink:href="sgry-20210930.xsd#OrganizationandSummaryofAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_44fa1436-9e62-42d7-8037-0cbc73d4f5e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_357ecd7a-9dee-4a12-b4b2-e3daeb33e31d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_44fa1436-9e62-42d7-8037-0cbc73d4f5e4" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_357ecd7a-9dee-4a12-b4b2-e3daeb33e31d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies" xlink:type="simple" xlink:href="sgry-20210930.xsd#OrganizationandSummaryofAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7d8b8660-4499-4655-b27e-ace4ea4ce710" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1b25a62a-7498-4d59-8c08-913d3f86c97b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7d8b8660-4499-4655-b27e-ace4ea4ce710" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1b25a62a-7498-4d59-8c08-913d3f86c97b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_5a6566d0-4dfe-48ea-8813-7b69381c4922" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7d8b8660-4499-4655-b27e-ace4ea4ce710" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_5a6566d0-4dfe-48ea-8813-7b69381c4922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_7d90ea26-ed36-4562-8f22-5662539c68c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7d8b8660-4499-4655-b27e-ace4ea4ce710" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_7d90ea26-ed36-4562-8f22-5662539c68c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_53ceb4f5-57fb-45fc-b08e-e496df1a9579" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7d8b8660-4499-4655-b27e-ace4ea4ce710" xlink:to="loc_us-gaap_UseOfEstimates_53ceb4f5-57fb-45fc-b08e-e496df1a9579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_bd9effe6-aeea-4fbe-8b32-540088523e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7d8b8660-4499-4655-b27e-ace4ea4ce710" xlink:to="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_bd9effe6-aeea-4fbe-8b32-540088523e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_660129cc-6b4c-421c-a06f-08eca56280ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7d8b8660-4499-4655-b27e-ace4ea4ce710" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_660129cc-6b4c-421c-a06f-08eca56280ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_a5c8982b-2de6-43c6-b286-19e31e035983" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7d8b8660-4499-4655-b27e-ace4ea4ce710" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_a5c8982b-2de6-43c6-b286-19e31e035983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_140ad8f6-d9c4-4d2d-b197-155cfc5d3599" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7d8b8660-4499-4655-b27e-ace4ea4ce710" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_140ad8f6-d9c4-4d2d-b197-155cfc5d3599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_a327e1dd-cb70-45ff-8533-42fd42f666ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7d8b8660-4499-4655-b27e-ace4ea4ce710" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_a327e1dd-cb70-45ff-8533-42fd42f666ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_2a279d84-6014-48cc-87a3-28caf99f7ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7d8b8660-4499-4655-b27e-ace4ea4ce710" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_2a279d84-6014-48cc-87a3-28caf99f7ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_925cb5d4-d093-4ee8-a857-42c21a101c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7d8b8660-4499-4655-b27e-ace4ea4ce710" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_925cb5d4-d093-4ee8-a857-42c21a101c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_RedeemableNoncontrollingInterestPolicyTextBlock_d84580f7-7b12-4356-bbef-8f5d7eff3097" xlink:href="sgry-20210930.xsd#sgry_RedeemableNoncontrollingInterestPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7d8b8660-4499-4655-b27e-ace4ea4ce710" xlink:to="loc_sgry_RedeemableNoncontrollingInterestPolicyTextBlock_d84580f7-7b12-4356-bbef-8f5d7eff3097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_b1ffb300-82fc-4d1a-9e4d-8a6d2e4e5260" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7d8b8660-4499-4655-b27e-ace4ea4ce710" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_b1ffb300-82fc-4d1a-9e4d-8a6d2e4e5260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_e59865d0-6790-4184-bc0b-a84ca70df025" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7d8b8660-4499-4655-b27e-ace4ea4ce710" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_e59865d0-6790-4184-bc0b-a84ca70df025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesTables" xlink:type="simple" xlink:href="sgry-20210930.xsd#OrganizationandSummaryofAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f7f4a525-a54c-4a20-a10a-1cc39b24cd82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_170324de-7e43-4a2b-89f6-b6a4a335d820" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f7f4a525-a54c-4a20-a10a-1cc39b24cd82" xlink:to="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_170324de-7e43-4a2b-89f6-b6a4a335d820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_f4633778-d119-454e-91d9-4335fc60e13a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f7f4a525-a54c-4a20-a10a-1cc39b24cd82" xlink:to="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_f4633778-d119-454e-91d9-4335fc60e13a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_c8582d3c-a929-4edb-a1d8-206f0301c9dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f7f4a525-a54c-4a20-a10a-1cc39b24cd82" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_c8582d3c-a929-4edb-a1d8-206f0301c9dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_d1ea0d24-42e6-4b4d-8bc5-09b14fc8f2fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f7f4a525-a54c-4a20-a10a-1cc39b24cd82" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_d1ea0d24-42e6-4b4d-8bc5-09b14fc8f2fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesOrganizationDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#OrganizationandSummaryofAccountingPoliciesOrganizationDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesOrganizationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9414f72f-6710-41c2-8249-ff2775a3af6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AirlineProductsAndServicesTable_92e2e558-dbe9-43f6-bda4-bc463f09a93f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AirlineProductsAndServicesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9414f72f-6710-41c2-8249-ff2775a3af6b" xlink:to="loc_us-gaap_AirlineProductsAndServicesTable_92e2e558-dbe9-43f6-bda4-bc463f09a93f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b045dc52-b55a-4e5f-9a68-7e5419529e72" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AirlineProductsAndServicesTable_92e2e558-dbe9-43f6-bda4-bc463f09a93f" xlink:to="loc_srt_ProductOrServiceAxis_b045dc52-b55a-4e5f-9a68-7e5419529e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d8c4af9d-cbc3-407b-9426-36a7e6f45b78" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_b045dc52-b55a-4e5f-9a68-7e5419529e72" xlink:to="loc_srt_ProductsAndServicesDomain_d8c4af9d-cbc3-407b-9426-36a7e6f45b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_FacilitiesAmbulatorySurgeryCentersMember_33ac05d0-79b1-4c1b-85db-fe1094eb670b" xlink:href="sgry-20210930.xsd#sgry_FacilitiesAmbulatorySurgeryCentersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d8c4af9d-cbc3-407b-9426-36a7e6f45b78" xlink:to="loc_sgry_FacilitiesAmbulatorySurgeryCentersMember_33ac05d0-79b1-4c1b-85db-fe1094eb670b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_FacilitiesSurgicalHospitalsMember_4234cac8-b607-43f0-8c2b-8475fe9e6806" xlink:href="sgry-20210930.xsd#sgry_FacilitiesSurgicalHospitalsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d8c4af9d-cbc3-407b-9426-36a7e6f45b78" xlink:to="loc_sgry_FacilitiesSurgicalHospitalsMember_4234cac8-b607-43f0-8c2b-8475fe9e6806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ProductsAndServicesLineItems_8f6a585d-771c-4e04-a7c7-150d18517d3a" xlink:href="sgry-20210930.xsd#sgry_ProductsAndServicesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AirlineProductsAndServicesTable_92e2e558-dbe9-43f6-bda4-bc463f09a93f" xlink:to="loc_sgry_ProductsAndServicesLineItems_8f6a585d-771c-4e04-a7c7-150d18517d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NumberOfSurgicalFacilitiesOwned_ba8f0595-20a0-44c0-9b5e-d7f7180fbcef" xlink:href="sgry-20210930.xsd#sgry_NumberOfSurgicalFacilitiesOwned"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_ProductsAndServicesLineItems_8f6a585d-771c-4e04-a7c7-150d18517d3a" xlink:to="loc_sgry_NumberOfSurgicalFacilitiesOwned_ba8f0595-20a0-44c0-9b5e-d7f7180fbcef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates_118bb147-3c04-4416-9776-fb7106176429" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_ProductsAndServicesLineItems_8f6a585d-771c-4e04-a7c7-150d18517d3a" xlink:to="loc_us-gaap_NumberOfStatesInWhichEntityOperates_118bb147-3c04-4416-9776-fb7106176429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest_1dce8fe6-85e1-4249-950b-aafcb6dc44d3" xlink:href="sgry-20210930.xsd#sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_ProductsAndServicesLineItems_8f6a585d-771c-4e04-a7c7-150d18517d3a" xlink:to="loc_sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest_1dce8fe6-85e1-4249-950b-aafcb6dc44d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NumberOfSurgicalFacilitiesOwnedConsolidated_61a12b27-c822-4c96-9e28-4b65823b8fd4" xlink:href="sgry-20210930.xsd#sgry_NumberOfSurgicalFacilitiesOwnedConsolidated"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_ProductsAndServicesLineItems_8f6a585d-771c-4e04-a7c7-150d18517d3a" xlink:to="loc_sgry_NumberOfSurgicalFacilitiesOwnedConsolidated_61a12b27-c822-4c96-9e28-4b65823b8fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCARESACTDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#OrganizationandSummaryofAccountingPoliciesCARESACTDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCARESACTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e72e2317-45a6-4784-afc6-624a2a2f6741" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ProceedsFromGovernmentAssistance_f4f9a909-087d-4027-b253-15db0f99d22f" xlink:href="sgry-20210930.xsd#sgry_ProceedsFromGovernmentAssistance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e72e2317-45a6-4784-afc6-624a2a2f6741" xlink:to="loc_sgry_ProceedsFromGovernmentAssistance_f4f9a909-087d-4027-b253-15db0f99d22f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_GrantRevenue_eb991260-752a-436d-a763-1556b920334a" xlink:href="sgry-20210930.xsd#sgry_GrantRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e72e2317-45a6-4784-afc6-624a2a2f6741" xlink:to="loc_sgry_GrantRevenue_eb991260-752a-436d-a763-1556b920334a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_CoronavirusAidReliefandEconomicSecurityActCARESActGovernmentGrantReceivedAcceleratedPayments_add701ed-1304-4da8-aafb-a4fb57ed9857" xlink:href="sgry-20210930.xsd#sgry_CoronavirusAidReliefandEconomicSecurityActCARESActGovernmentGrantReceivedAcceleratedPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e72e2317-45a6-4784-afc6-624a2a2f6741" xlink:to="loc_sgry_CoronavirusAidReliefandEconomicSecurityActCARESActGovernmentGrantReceivedAcceleratedPayments_add701ed-1304-4da8-aafb-a4fb57ed9857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments_4efccf8f-a497-429e-9126-c01803a869c2" xlink:href="sgry-20210930.xsd#sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e72e2317-45a6-4784-afc6-624a2a2f6741" xlink:to="loc_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments_4efccf8f-a497-429e-9126-c01803a869c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments_15fffd09-d7ca-4b75-bcc2-0eb0e2aed927" xlink:href="sgry-20210930.xsd#sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e72e2317-45a6-4784-afc6-624a2a2f6741" xlink:to="loc_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments_15fffd09-d7ca-4b75-bcc2-0eb0e2aed927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DeferredEmployeeRelatedLiabilitiesCurrent_9a94d935-056d-4045-81cc-2321ba99c947" xlink:href="sgry-20210930.xsd#sgry_DeferredEmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e72e2317-45a6-4784-afc6-624a2a2f6741" xlink:to="loc_sgry_DeferredEmployeeRelatedLiabilitiesCurrent_9a94d935-056d-4045-81cc-2321ba99c947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fb9f6fef-1d3c-4165-a795-bd129ddd8485" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_182f6d90-1eef-4af2-87f0-376d02a9f21d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fb9f6fef-1d3c-4165-a795-bd129ddd8485" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_182f6d90-1eef-4af2-87f0-376d02a9f21d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_2e11e6e1-63c3-4e93-8d81-24748e08e225" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_182f6d90-1eef-4af2-87f0-376d02a9f21d" xlink:to="loc_srt_ConsolidatedEntitiesAxis_2e11e6e1-63c3-4e93-8d81-24748e08e225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_2974eb6c-3665-4c56-ac75-f447c91c3968" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_2e11e6e1-63c3-4e93-8d81-24748e08e225" xlink:to="loc_srt_ConsolidatedEntitiesDomain_2974eb6c-3665-4c56-ac75-f447c91c3968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_d47124b7-5ff3-4c9c-b4a3-1a03f602e7bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_2974eb6c-3665-4c56-ac75-f447c91c3968" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_d47124b7-5ff3-4c9c-b4a3-1a03f602e7bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_5ca74159-9aa9-4b9f-8f03-7d4ed5734d31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_182f6d90-1eef-4af2-87f0-376d02a9f21d" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_5ca74159-9aa9-4b9f-8f03-7d4ed5734d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_VariableInterestEntityNumberOfFacilities_44594fc3-acf5-466f-9a83-432f514f76e8" xlink:href="sgry-20210930.xsd#sgry_VariableInterestEntityNumberOfFacilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_5ca74159-9aa9-4b9f-8f03-7d4ed5734d31" xlink:to="loc_sgry_VariableInterestEntityNumberOfFacilities_44594fc3-acf5-466f-9a83-432f514f76e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_739f89a8-96aa-4e87-bea3-4bbefe62b5ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_5ca74159-9aa9-4b9f-8f03-7d4ed5734d31" xlink:to="loc_us-gaap_Assets_739f89a8-96aa-4e87-bea3-4bbefe62b5ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_ca7977c6-c3ab-4ad7-af43-9db16f412dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_5ca74159-9aa9-4b9f-8f03-7d4ed5734d31" xlink:to="loc_us-gaap_Liabilities_ca7977c6-c3ab-4ad7-af43-9db16f412dcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e045edf9-cc36-4a4d-951b-a400278ad232" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_6e770c1d-ce7f-4b1a-99a4-81f7c9eb9c31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e045edf9-cc36-4a4d-951b-a400278ad232" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_6e770c1d-ce7f-4b1a-99a4-81f7c9eb9c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c5415087-26fd-48c1-b6ea-6aad2d928943" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_6e770c1d-ce7f-4b1a-99a4-81f7c9eb9c31" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c5415087-26fd-48c1-b6ea-6aad2d928943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_bfe100d8-b242-4216-87a3-cc65bf71f9cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c5415087-26fd-48c1-b6ea-6aad2d928943" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_bfe100d8-b242-4216-87a3-cc65bf71f9cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_c0601f08-4190-4bbb-801a-4485ee2e1af9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_bfe100d8-b242-4216-87a3-cc65bf71f9cf" xlink:to="loc_us-gaap_SecuredDebtMember_c0601f08-4190-4bbb-801a-4485ee2e1af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_53862c66-a6b5-42ff-8bb8-15c886c4147c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_bfe100d8-b242-4216-87a3-cc65bf71f9cf" xlink:to="loc_us-gaap_SeniorNotesMember_53862c66-a6b5-42ff-8bb8-15c886c4147c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_dced37c1-d2c1-40fc-bcb1-914ac89dc8b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_6e770c1d-ce7f-4b1a-99a4-81f7c9eb9c31" xlink:to="loc_us-gaap_DebtInstrumentAxis_dced37c1-d2c1-40fc-bcb1-914ac89dc8b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8cea8921-e35d-42ff-9dd0-969c10ed7d12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_dced37c1-d2c1-40fc-bcb1-914ac89dc8b8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8cea8921-e35d-42ff-9dd0-969c10ed7d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_A2017TermLoanMaturing2024Member_e222a3ae-9727-43ec-9f92-74aa8931ba94" xlink:href="sgry-20210930.xsd#sgry_A2017TermLoanMaturing2024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8cea8921-e35d-42ff-9dd0-969c10ed7d12" xlink:to="loc_sgry_A2017TermLoanMaturing2024Member_e222a3ae-9727-43ec-9f92-74aa8931ba94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SeniorUnsecuredNotesDue2025Member_687f41e9-34ee-4b1a-a81e-c10721b7ba07" xlink:href="sgry-20210930.xsd#sgry_SeniorUnsecuredNotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8cea8921-e35d-42ff-9dd0-969c10ed7d12" xlink:to="loc_sgry_SeniorUnsecuredNotesDue2025Member_687f41e9-34ee-4b1a-a81e-c10721b7ba07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SeniorUnsecuredNotesDue2027Member_e902476b-6356-446e-b074-e3c7fe90fa2e" xlink:href="sgry-20210930.xsd#sgry_SeniorUnsecuredNotesDue2027Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8cea8921-e35d-42ff-9dd0-969c10ed7d12" xlink:to="loc_sgry_SeniorUnsecuredNotesDue2027Member_e902476b-6356-446e-b074-e3c7fe90fa2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_d4bddab4-958c-4107-a26c-27ce6d3881af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_6e770c1d-ce7f-4b1a-99a4-81f7c9eb9c31" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_d4bddab4-958c-4107-a26c-27ce6d3881af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_1136f1cb-2b82-4670-913f-35e9305cebd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_d4bddab4-958c-4107-a26c-27ce6d3881af" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_1136f1cb-2b82-4670-913f-35e9305cebd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8133943f-37c8-4653-9de8-e6bd61bd3827" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_1136f1cb-2b82-4670-913f-35e9305cebd9" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8133943f-37c8-4653-9de8-e6bd61bd3827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_dcbe2476-3358-41d5-90b8-30cdbca160ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_1136f1cb-2b82-4670-913f-35e9305cebd9" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_dcbe2476-3358-41d5-90b8-30cdbca160ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_4b72ef77-10f1-43a4-a477-38be275a0568" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_1136f1cb-2b82-4670-913f-35e9305cebd9" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_4b72ef77-10f1-43a4-a477-38be275a0568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bd4997b1-31b4-4cdc-86e4-5950346e56a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_6e770c1d-ce7f-4b1a-99a4-81f7c9eb9c31" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bd4997b1-31b4-4cdc-86e4-5950346e56a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_84f84939-06f7-487d-810a-420e2dff9b78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bd4997b1-31b4-4cdc-86e4-5950346e56a7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_84f84939-06f7-487d-810a-420e2dff9b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_f37eff34-ada8-4793-a0c5-e570ce8979c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_84f84939-06f7-487d-810a-420e2dff9b78" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_f37eff34-ada8-4793-a0c5-e570ce8979c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_73071f82-a181-46c2-a666-73fb9e6b60ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_6e770c1d-ce7f-4b1a-99a4-81f7c9eb9c31" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_73071f82-a181-46c2-a666-73fb9e6b60ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_56fd4ffa-6428-424c-be87-b8a5e8338bec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_73071f82-a181-46c2-a666-73fb9e6b60ef" xlink:to="loc_us-gaap_LongTermDebt_56fd4ffa-6428-424c-be87-b8a5e8338bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_7575e590-b38c-4f9c-889d-826054755e11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_73071f82-a181-46c2-a666-73fb9e6b60ef" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_7575e590-b38c-4f9c-889d-826054755e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_224f860e-73db-42b5-8788-8ad487a90c91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_7a410a55-5b7c-42d7-974d-d6abc68a8ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_224f860e-73db-42b5-8788-8ad487a90c91" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_7a410a55-5b7c-42d7-974d-d6abc68a8ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_964abef4-0a50-4f78-b841-8a45cab24626" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_7a410a55-5b7c-42d7-974d-d6abc68a8ee5" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_964abef4-0a50-4f78-b841-8a45cab24626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_5632d618-e5c3-41fb-a48d-6c47d835eb5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_964abef4-0a50-4f78-b841-8a45cab24626" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_5632d618-e5c3-41fb-a48d-6c47d835eb5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_423e0678-453a-4f4a-9a39-ea93bda82bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_5632d618-e5c3-41fb-a48d-6c47d835eb5f" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_423e0678-453a-4f4a-9a39-ea93bda82bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_acb78d08-6379-4b94-a7f6-1db0ddef24f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_7a410a55-5b7c-42d7-974d-d6abc68a8ee5" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_acb78d08-6379-4b94-a7f6-1db0ddef24f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_572f8f27-0757-4f58-a495-c52af53e209d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_acb78d08-6379-4b94-a7f6-1db0ddef24f2" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_572f8f27-0757-4f58-a495-c52af53e209d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_629a7c1e-e584-48b1-b197-be79d1ebac58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_572f8f27-0757-4f58-a495-c52af53e209d" xlink:to="loc_us-gaap_SalesRevenueNetMember_629a7c1e-e584-48b1-b197-be79d1ebac58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_18370c23-1855-4768-869b-c8f42631c7fd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_7a410a55-5b7c-42d7-974d-d6abc68a8ee5" xlink:to="loc_srt_ProductOrServiceAxis_18370c23-1855-4768-869b-c8f42631c7fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2d668b59-4a81-433a-85e4-0c6e6f7dd60d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_18370c23-1855-4768-869b-c8f42631c7fd" xlink:to="loc_srt_ProductsAndServicesDomain_2d668b59-4a81-433a-85e4-0c6e6f7dd60d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_HealthcareOrganizationPatientServiceMember_38c20205-0a69-4389-a717-84ae9d04c452" xlink:href="sgry-20210930.xsd#sgry_HealthcareOrganizationPatientServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2d668b59-4a81-433a-85e4-0c6e6f7dd60d" xlink:to="loc_sgry_HealthcareOrganizationPatientServiceMember_38c20205-0a69-4389-a717-84ae9d04c452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SurgicalFacilityServicesMember_3a18259c-380d-47c9-8380-ff91e89b7a2a" xlink:href="sgry-20210930.xsd#sgry_SurgicalFacilityServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_HealthcareOrganizationPatientServiceMember_38c20205-0a69-4389-a717-84ae9d04c452" xlink:to="loc_sgry_SurgicalFacilityServicesMember_3a18259c-380d-47c9-8380-ff91e89b7a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_AncillaryServicesMember_e6657e55-0376-464b-986a-ed383b856abf" xlink:href="sgry-20210930.xsd#sgry_AncillaryServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_HealthcareOrganizationPatientServiceMember_38c20205-0a69-4389-a717-84ae9d04c452" xlink:to="loc_sgry_AncillaryServicesMember_e6657e55-0376-464b-986a-ed383b856abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_OtherServicesMember_11438caf-f74a-47ab-9188-56d16ddd0dea" xlink:href="sgry-20210930.xsd#sgry_OtherServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2d668b59-4a81-433a-85e4-0c6e6f7dd60d" xlink:to="loc_sgry_OtherServicesMember_11438caf-f74a-47ab-9188-56d16ddd0dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_3595624d-7b20-469d-869e-9f2fe191ce81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_7a410a55-5b7c-42d7-974d-d6abc68a8ee5" xlink:to="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_3595624d-7b20-469d-869e-9f2fe191ce81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_1e300284-d55e-4da5-9605-ef4bdc5964a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_3595624d-7b20-469d-869e-9f2fe191ce81" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_1e300284-d55e-4da5-9605-ef4bdc5964a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e83ef9ac-4d39-4ad9-a18e-d6c8386e293d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_58614a3a-e597-4cfe-831c-472db270ff2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e83ef9ac-4d39-4ad9-a18e-d6c8386e293d" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_58614a3a-e597-4cfe-831c-472db270ff2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_360d6425-6b59-4193-9267-c3698d08d8e6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_58614a3a-e597-4cfe-831c-472db270ff2c" xlink:to="loc_srt_ProductOrServiceAxis_360d6425-6b59-4193-9267-c3698d08d8e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0d16651a-0b21-445d-8b45-cb99fe8f7bda" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_360d6425-6b59-4193-9267-c3698d08d8e6" xlink:to="loc_srt_ProductsAndServicesDomain_0d16651a-0b21-445d-8b45-cb99fe8f7bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_HealthcareOrganizationPatientServiceMember_8efa0768-6b88-4f6a-96fe-8f782f1a3511" xlink:href="sgry-20210930.xsd#sgry_HealthcareOrganizationPatientServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0d16651a-0b21-445d-8b45-cb99fe8f7bda" xlink:to="loc_sgry_HealthcareOrganizationPatientServiceMember_8efa0768-6b88-4f6a-96fe-8f782f1a3511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PrivateInsuranceMember_f0f7e804-334f-4993-9220-7b4f9b22d6f0" xlink:href="sgry-20210930.xsd#sgry_PrivateInsuranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_HealthcareOrganizationPatientServiceMember_8efa0768-6b88-4f6a-96fe-8f782f1a3511" xlink:to="loc_sgry_PrivateInsuranceMember_f0f7e804-334f-4993-9220-7b4f9b22d6f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentContractMember_4c48418a-e6ae-4096-b3ac-540a58a6883d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GovernmentContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_HealthcareOrganizationPatientServiceMember_8efa0768-6b88-4f6a-96fe-8f782f1a3511" xlink:to="loc_us-gaap_GovernmentContractMember_4c48418a-e6ae-4096-b3ac-540a58a6883d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SelfPayRevenueMember_ee474379-30ec-4fee-a84c-dbfc18f7982d" xlink:href="sgry-20210930.xsd#sgry_SelfPayRevenueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_HealthcareOrganizationPatientServiceMember_8efa0768-6b88-4f6a-96fe-8f782f1a3511" xlink:to="loc_sgry_SelfPayRevenueMember_ee474379-30ec-4fee-a84c-dbfc18f7982d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_OtherPatientServiceRevenueSourcesMember_e4c3d32f-b605-43d4-8b61-8e2463496864" xlink:href="sgry-20210930.xsd#sgry_OtherPatientServiceRevenueSourcesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_HealthcareOrganizationPatientServiceMember_8efa0768-6b88-4f6a-96fe-8f782f1a3511" xlink:to="loc_sgry_OtherPatientServiceRevenueSourcesMember_e4c3d32f-b605-43d4-8b61-8e2463496864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_OtherServicesMember_7d64e3b8-9eb3-4417-91a2-9852ff8585b6" xlink:href="sgry-20210930.xsd#sgry_OtherServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0d16651a-0b21-445d-8b45-cb99fe8f7bda" xlink:to="loc_sgry_OtherServicesMember_7d64e3b8-9eb3-4417-91a2-9852ff8585b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_ca56bb75-1dd9-4883-9445-e12c13c09e54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_58614a3a-e597-4cfe-831c-472db270ff2c" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_ca56bb75-1dd9-4883-9445-e12c13c09e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_55b7f792-aa6b-4f44-bc02-9503607965f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ca56bb75-1dd9-4883-9445-e12c13c09e54" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_55b7f792-aa6b-4f44-bc02-9503607965f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_30831abe-ad5f-42e7-a0fd-256c5c8e74ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_55b7f792-aa6b-4f44-bc02-9503607965f3" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_30831abe-ad5f-42e7-a0fd-256c5c8e74ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0267a68d-8aa3-423f-abf0-7d765de3fc4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_58614a3a-e597-4cfe-831c-472db270ff2c" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0267a68d-8aa3-423f-abf0-7d765de3fc4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_56691ec0-6760-4948-9b37-9a281074367d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0267a68d-8aa3-423f-abf0-7d765de3fc4f" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_56691ec0-6760-4948-9b37-9a281074367d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_d84d2408-2be4-4b38-a57f-8145943b019e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_56691ec0-6760-4948-9b37-9a281074367d" xlink:to="loc_us-gaap_SalesRevenueNetMember_d84d2408-2be4-4b38-a57f-8145943b019e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_a4e08ff0-e2ef-4768-86b6-fc2b0f155d93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_58614a3a-e597-4cfe-831c-472db270ff2c" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_a4e08ff0-e2ef-4768-86b6-fc2b0f155d93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_324665a3-3f82-44e6-90b6-d8ba39c023f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4e08ff0-e2ef-4768-86b6-fc2b0f155d93" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_324665a3-3f82-44e6-90b6-d8ba39c023f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_aba39dfb-7f6b-43d6-b54e-4f3ac064ef5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4e08ff0-e2ef-4768-86b6-fc2b0f155d93" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_aba39dfb-7f6b-43d6-b54e-4f3ac064ef5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#OrganizationandSummaryofAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f6fcbfdf-bcdc-4463-b961-f107e29d2eca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_7622ac9b-0a52-4445-ad73-739504863a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f6fcbfdf-bcdc-4463-b961-f107e29d2eca" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_7622ac9b-0a52-4445-ad73-739504863a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesRollforwardofGoodwillDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#OrganizationandSummaryofAccountingPoliciesRollforwardofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesRollforwardofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a0fa0524-f458-4c28-8543-a795060caf67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_f9c96167-de5c-4a67-a9e1-b1c5de78569f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a0fa0524-f458-4c28-8543-a795060caf67" xlink:to="loc_us-gaap_GoodwillRollForward_f9c96167-de5c-4a67-a9e1-b1c5de78569f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d6027ae6-cbc4-4310-9317-eea42e4b197c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_f9c96167-de5c-4a67-a9e1-b1c5de78569f" xlink:to="loc_us-gaap_Goodwill_d6027ae6-cbc4-4310-9317-eea42e4b197c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_b4397dc2-aeb0-431a-b430-074a35e6b40d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_f9c96167-de5c-4a67-a9e1-b1c5de78569f" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_b4397dc2-aeb0-431a-b430-074a35e6b40d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation_2291e246-0aca-41be-ac0e-eaefe21bc18c" xlink:href="sgry-20210930.xsd#sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_f9c96167-de5c-4a67-a9e1-b1c5de78569f" xlink:to="loc_sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation_2291e246-0aca-41be-ac0e-eaefe21bc18c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_fe06b82f-2750-47cb-8808-a3b9a55a7241" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_f9c96167-de5c-4a67-a9e1-b1c5de78569f" xlink:to="loc_us-gaap_Goodwill_fe06b82f-2750-47cb-8808-a3b9a55a7241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofNonControllingInterestsRedeemableDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#OrganizationandSummaryofAccountingPoliciesScheduleofNonControllingInterestsRedeemableDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofNonControllingInterestsRedeemableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_de75aacf-b894-41b3-8f04-1ba32030aa62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_RedeemableNoncontrollingInterestRollForward_85b21673-4d15-4e4e-8a0f-014596cfd3d1" xlink:href="sgry-20210930.xsd#sgry_RedeemableNoncontrollingInterestRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_de75aacf-b894-41b3-8f04-1ba32030aa62" xlink:to="loc_sgry_RedeemableNoncontrollingInterestRollForward_85b21673-4d15-4e4e-8a0f-014596cfd3d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_7505b89d-2f1e-4621-ba2a-843f56732d53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_RedeemableNoncontrollingInterestRollForward_85b21673-4d15-4e4e-8a0f-014596cfd3d1" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_7505b89d-2f1e-4621-ba2a-843f56732d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_def881f9-6a6f-429c-883e-b8033a620872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_RedeemableNoncontrollingInterestRollForward_85b21673-4d15-4e4e-8a0f-014596cfd3d1" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_def881f9-6a6f-429c-883e-b8033a620872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests_5b2d849f-301e-414e-be97-14f8dc90819c" xlink:href="sgry-20210930.xsd#sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_RedeemableNoncontrollingInterestRollForward_85b21673-4d15-4e4e-8a0f-014596cfd3d1" xlink:to="loc_sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests_5b2d849f-301e-414e-be97-14f8dc90819c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_0de7420e-79bf-4042-a514-5a7f66469feb" xlink:href="sgry-20210930.xsd#sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_RedeemableNoncontrollingInterestRollForward_85b21673-4d15-4e4e-8a0f-014596cfd3d1" xlink:to="loc_sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_0de7420e-79bf-4042-a514-5a7f66469feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_ad265dd2-c753-4ad8-b8c9-cc8a3c6047fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_RedeemableNoncontrollingInterestRollForward_85b21673-4d15-4e4e-8a0f-014596cfd3d1" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_ad265dd2-c753-4ad8-b8c9-cc8a3c6047fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesIncomeTaxesDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#OrganizationandSummaryofAccountingPoliciesIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_daeee9e1-d85f-4c4d-a500-0b19cffef0dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b5708432-2273-4048-bb13-a62fbae9f17a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_daeee9e1-d85f-4c4d-a500-0b19cffef0dc" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b5708432-2273-4048-bb13-a62fbae9f17a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_de37b858-e654-42cd-9d4c-fbbcb5283d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_daeee9e1-d85f-4c4d-a500-0b19cffef0dc" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_de37b858-e654-42cd-9d4c-fbbcb5283d4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_b1af4a79-3e36-4fad-a236-f26c25d1a066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationDispositionOfBusiness"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_daeee9e1-d85f-4c4d-a500-0b19cffef0dc" xlink:to="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_b1af4a79-3e36-4fad-a236-f26c25d1a066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_EffectiveIncomeTaxRateReconciliationCoronavirusAidReliefAndEconomicSecurityActCARESActAndTaxSettlementAmount_796cc707-c03f-4fe0-bf56-ee9484437813" xlink:href="sgry-20210930.xsd#sgry_EffectiveIncomeTaxRateReconciliationCoronavirusAidReliefAndEconomicSecurityActCARESActAndTaxSettlementAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_daeee9e1-d85f-4c4d-a500-0b19cffef0dc" xlink:to="loc_sgry_EffectiveIncomeTaxRateReconciliationCoronavirusAidReliefAndEconomicSecurityActCARESActAndTaxSettlementAmount_796cc707-c03f-4fe0-bf56-ee9484437813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxSettlements_5bfe095c-6f7c-44ce-9770-83fbdb8ff17a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxSettlements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_daeee9e1-d85f-4c4d-a500-0b19cffef0dc" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxSettlements_5bfe095c-6f7c-44ce-9770-83fbdb8ff17a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_b8bbc9f0-4046-4018-96db-d8b00db353bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_daeee9e1-d85f-4c4d-a500-0b19cffef0dc" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_b8bbc9f0-4046-4018-96db-d8b00db353bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/Acquisitions" xlink:type="simple" xlink:href="sgry-20210930.xsd#Acquisitions"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/Acquisitions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_0ebfe16d-ea3b-47ea-98a9-a22093835a67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_1fffb86b-82ca-400f-8e54-aab3f2b910fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_0ebfe16d-ea3b-47ea-98a9-a22093835a67" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_1fffb86b-82ca-400f-8e54-aab3f2b910fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/AcquisitionsTables" xlink:type="simple" xlink:href="sgry-20210930.xsd#AcquisitionsTables"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/AcquisitionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ad9ecd54-5db7-4b67-95ba-0c7d471ab0ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_6d146163-d175-43e1-b9f2-3ed52f82ffea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ad9ecd54-5db7-4b67-95ba-0c7d471ab0ca" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_6d146163-d175-43e1-b9f2-3ed52f82ffea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/AcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#AcquisitionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/AcquisitionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_6508e14f-4a4e-4f99-8eef-405c444f4ced" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_15f201c9-d774-4741-afc9-fad3ea2701e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_6508e14f-4a4e-4f99-8eef-405c444f4ced" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_15f201c9-d774-4741-afc9-fad3ea2701e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_733283eb-7213-4536-879d-42c12d8dd3f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_15f201c9-d774-4741-afc9-fad3ea2701e8" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_733283eb-7213-4536-879d-42c12d8dd3f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fd4bff1e-4e6d-4f03-bae8-c202a7b9ce2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_733283eb-7213-4536-879d-42c12d8dd3f6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fd4bff1e-4e6d-4f03-bae8-c202a7b9ce2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SurgicalFacilitiesNewMarketsMember_6ae2c861-ea75-452d-997f-ec18cf7e8046" xlink:href="sgry-20210930.xsd#sgry_SurgicalFacilitiesNewMarketsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fd4bff1e-4e6d-4f03-bae8-c202a7b9ce2c" xlink:to="loc_sgry_SurgicalFacilitiesNewMarketsMember_6ae2c861-ea75-452d-997f-ec18cf7e8046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SurgicalFacilitiesExistingMarketsMember_d99581f3-912b-4919-b880-fee73a973752" xlink:href="sgry-20210930.xsd#sgry_SurgicalFacilitiesExistingMarketsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fd4bff1e-4e6d-4f03-bae8-c202a7b9ce2c" xlink:to="loc_sgry_SurgicalFacilitiesExistingMarketsMember_d99581f3-912b-4919-b880-fee73a973752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_7eab7de3-5dfc-4055-9eb9-ad7a39515e19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_15f201c9-d774-4741-afc9-fad3ea2701e8" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_7eab7de3-5dfc-4055-9eb9-ad7a39515e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_6239af42-52d1-437a-be26-5d4d6a8c3252" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7eab7de3-5dfc-4055-9eb9-ad7a39515e19" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_6239af42-52d1-437a-be26-5d4d6a8c3252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_edb2aadc-8bb8-455b-8f7f-f6518402cb50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7eab7de3-5dfc-4055-9eb9-ad7a39515e19" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_edb2aadc-8bb8-455b-8f7f-f6518402cb50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/AcquisitionsSummaryDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#AcquisitionsSummaryDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/AcquisitionsSummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_cecff7a1-1b58-439b-a649-d68eefea3568" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_273258a7-af94-4a5c-aa83-11550fe038e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_cecff7a1-1b58-439b-a649-d68eefea3568" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_273258a7-af94-4a5c-aa83-11550fe038e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5034efc0-fb47-4178-a5a7-654bf785c578" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_273258a7-af94-4a5c-aa83-11550fe038e9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5034efc0-fb47-4178-a5a7-654bf785c578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_06c2a69f-565b-4904-90a5-fc4c423a7843" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5034efc0-fb47-4178-a5a7-654bf785c578" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_06c2a69f-565b-4904-90a5-fc4c423a7843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SurgicalFacilitiesExistingMarketsMember_3eeca084-e506-4ff8-8a2c-16cd497bfc4d" xlink:href="sgry-20210930.xsd#sgry_SurgicalFacilitiesExistingMarketsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_06c2a69f-565b-4904-90a5-fc4c423a7843" xlink:to="loc_sgry_SurgicalFacilitiesExistingMarketsMember_3eeca084-e506-4ff8-8a2c-16cd497bfc4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_f3825a2c-a8d3-4b2c-bbd7-5eee4c38aec5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_273258a7-af94-4a5c-aa83-11550fe038e9" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_f3825a2c-a8d3-4b2c-bbd7-5eee4c38aec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_d19c7148-b82a-4a78-a249-5f1aa6e894a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3825a2c-a8d3-4b2c-bbd7-5eee4c38aec5" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_d19c7148-b82a-4a78-a249-5f1aa6e894a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_0968a95f-0341-4198-87ed-a8c8ccc84f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3825a2c-a8d3-4b2c-bbd7-5eee4c38aec5" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_0968a95f-0341-4198-87ed-a8c8ccc84f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_706da4b0-cdbd-47f1-adeb-72ddd97a9ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3825a2c-a8d3-4b2c-bbd7-5eee4c38aec5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_706da4b0-cdbd-47f1-adeb-72ddd97a9ed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_b0240f86-6a63-41ea-9b1e-4ff8a8eabc7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3825a2c-a8d3-4b2c-bbd7-5eee4c38aec5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_b0240f86-6a63-41ea-9b1e-4ff8a8eabc7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_bc0d357e-8e71-427a-a6ea-4e89ec4e6463" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_b0240f86-6a63-41ea-9b1e-4ff8a8eabc7f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_bc0d357e-8e71-427a-a6ea-4e89ec4e6463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_24e1413d-91f5-4196-9340-cced3f40fe83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_b0240f86-6a63-41ea-9b1e-4ff8a8eabc7f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_24e1413d-91f5-4196-9340-cced3f40fe83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_eae7f238-63f8-4a1c-80a6-47c3223da8b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_b0240f86-6a63-41ea-9b1e-4ff8a8eabc7f" xlink:to="loc_us-gaap_Goodwill_eae7f238-63f8-4a1c-80a6-47c3223da8b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingRightOfUseAssets_848e2197-9d33-40df-9cdc-cf551a4395d0" xlink:href="sgry-20210930.xsd#sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingRightOfUseAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_b0240f86-6a63-41ea-9b1e-4ff8a8eabc7f" xlink:to="loc_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingRightOfUseAssets_848e2197-9d33-40df-9cdc-cf551a4395d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_e70fe001-493d-4e11-b0f2-9463853f147a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_b0240f86-6a63-41ea-9b1e-4ff8a8eabc7f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_e70fe001-493d-4e11-b0f2-9463853f147a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_5fd3286d-a16a-4a56-aa7c-3b3494c062ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_b0240f86-6a63-41ea-9b1e-4ff8a8eabc7f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_5fd3286d-a16a-4a56-aa7c-3b3494c062ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt_d38f364c-da58-4a34-905a-55667969e083" xlink:href="sgry-20210930.xsd#sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_b0240f86-6a63-41ea-9b1e-4ff8a8eabc7f" xlink:to="loc_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt_d38f364c-da58-4a34-905a-55667969e083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability_5b0f9b1f-440c-4db4-81ec-d5b5013d6cb5" xlink:href="sgry-20210930.xsd#sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_b0240f86-6a63-41ea-9b1e-4ff8a8eabc7f" xlink:to="loc_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability_5b0f9b1f-440c-4db4-81ec-d5b5013d6cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_815b0d96-2025-47dd-9f87-3d6b11623e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_b0240f86-6a63-41ea-9b1e-4ff8a8eabc7f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_815b0d96-2025-47dd-9f87-3d6b11623e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/LongTermDebt" xlink:type="simple" xlink:href="sgry-20210930.xsd#LongTermDebt"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2560cfe3-1916-403b-bd68-173af7b96f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_375e8c5b-1641-44cb-98ef-32d0d81bd57a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2560cfe3-1916-403b-bd68-173af7b96f5d" xlink:to="loc_us-gaap_LongTermDebtTextBlock_375e8c5b-1641-44cb-98ef-32d0d81bd57a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="sgry-20210930.xsd#LongTermDebtTables"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/LongTermDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_3c7b8b9f-e2fd-4c3e-ac52-26ddbba1a0dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_e1bbe568-f377-456e-b2fa-4a28bba4a0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3c7b8b9f-e2fd-4c3e-ac52-26ddbba1a0dd" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_e1bbe568-f377-456e-b2fa-4a28bba4a0b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/LongTermDebtSummaryDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#LongTermDebtSummaryDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/LongTermDebtSummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_14305f68-0277-429a-a82a-861500f512e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_27d3a536-907b-4015-acce-dc7959d7adef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_14305f68-0277-429a-a82a-861500f512e0" xlink:to="loc_us-gaap_DebtInstrumentTable_27d3a536-907b-4015-acce-dc7959d7adef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b8900527-791c-4437-8d2e-cd145163d78b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_27d3a536-907b-4015-acce-dc7959d7adef" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b8900527-791c-4437-8d2e-cd145163d78b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6b02ab2d-61a8-47f7-a1be-13b8f86a19cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b8900527-791c-4437-8d2e-cd145163d78b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6b02ab2d-61a8-47f7-a1be-13b8f86a19cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_f8b7a2ab-1742-4918-be26-bd19b7bd4846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6b02ab2d-61a8-47f7-a1be-13b8f86a19cc" xlink:to="loc_us-gaap_SecuredDebtMember_f8b7a2ab-1742-4918-be26-bd19b7bd4846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_98956455-2184-498b-8b79-70c6ae620624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6b02ab2d-61a8-47f7-a1be-13b8f86a19cc" xlink:to="loc_us-gaap_SeniorNotesMember_98956455-2184-498b-8b79-70c6ae620624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NotesPayableAndSecuredLoansMember_887d6fa6-03b4-4518-ac05-60ca6599a1d5" xlink:href="sgry-20210930.xsd#sgry_NotesPayableAndSecuredLoansMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6b02ab2d-61a8-47f7-a1be-13b8f86a19cc" xlink:to="loc_sgry_NotesPayableAndSecuredLoansMember_887d6fa6-03b4-4518-ac05-60ca6599a1d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_eeecef8c-f733-406d-94c9-f1542ee742ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_27d3a536-907b-4015-acce-dc7959d7adef" xlink:to="loc_us-gaap_DebtInstrumentAxis_eeecef8c-f733-406d-94c9-f1542ee742ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3acbc753-b50e-4beb-bb17-bcd8eee16fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_eeecef8c-f733-406d-94c9-f1542ee742ac" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3acbc753-b50e-4beb-bb17-bcd8eee16fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_A2017TermLoanMaturing2024Member_f405b4ab-70af-457c-b9ab-19341b87e0ee" xlink:href="sgry-20210930.xsd#sgry_A2017TermLoanMaturing2024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3acbc753-b50e-4beb-bb17-bcd8eee16fc4" xlink:to="loc_sgry_A2017TermLoanMaturing2024Member_f405b4ab-70af-457c-b9ab-19341b87e0ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SeniorUnsecuredNotesDue2025Member_1fb3632d-371f-4371-a147-13c301958cb0" xlink:href="sgry-20210930.xsd#sgry_SeniorUnsecuredNotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3acbc753-b50e-4beb-bb17-bcd8eee16fc4" xlink:to="loc_sgry_SeniorUnsecuredNotesDue2025Member_1fb3632d-371f-4371-a147-13c301958cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SeniorUnsecuredNotesDue2027Member_d168798b-8f14-4727-84db-7b36e3819cad" xlink:href="sgry-20210930.xsd#sgry_SeniorUnsecuredNotesDue2027Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3acbc753-b50e-4beb-bb17-bcd8eee16fc4" xlink:to="loc_sgry_SeniorUnsecuredNotesDue2027Member_d168798b-8f14-4727-84db-7b36e3819cad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2cc05c55-5d32-41d5-9219-2765ebdedacc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_27d3a536-907b-4015-acce-dc7959d7adef" xlink:to="loc_us-gaap_DebtInstrumentLineItems_2cc05c55-5d32-41d5-9219-2765ebdedacc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_ad5468f4-8083-4840-94e8-0c6192e601db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cc05c55-5d32-41d5-9219-2765ebdedacc" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_ad5468f4-8083-4840-94e8-0c6192e601db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_a93e3b22-d7c2-4e14-9d98-7f89e88f22f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cc05c55-5d32-41d5-9219-2765ebdedacc" xlink:to="loc_us-gaap_FinanceLeaseLiability_a93e3b22-d7c2-4e14-9d98-7f89e88f22f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_c2452554-ec71-4709-b669-134f401a681b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cc05c55-5d32-41d5-9219-2765ebdedacc" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_c2452554-ec71-4709-b669-134f401a681b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_53b062e3-c2d2-471e-b6b6-683df7a8aa8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cc05c55-5d32-41d5-9219-2765ebdedacc" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_53b062e3-c2d2-471e-b6b6-683df7a8aa8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_f620fc60-f776-47d2-a37f-6ea8acc6ed45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cc05c55-5d32-41d5-9219-2765ebdedacc" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_f620fc60-f776-47d2-a37f-6ea8acc6ed45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_736f4f88-0509-4c2e-87db-74eaa954b4e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cc05c55-5d32-41d5-9219-2765ebdedacc" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_736f4f88-0509-4c2e-87db-74eaa954b4e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_30ae6f05-cca3-43cf-8f4b-a35ff9124c59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cc05c55-5d32-41d5-9219-2765ebdedacc" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_30ae6f05-cca3-43cf-8f4b-a35ff9124c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_c04d1972-0c01-4e97-8d34-1d809ac97f58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cc05c55-5d32-41d5-9219-2765ebdedacc" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_c04d1972-0c01-4e97-8d34-1d809ac97f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/LongTermDebtSummaryDetails_1" xlink:type="simple" xlink:href="sgry-20210930.xsd#LongTermDebtSummaryDetails_1"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/LongTermDebtSummaryDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#LongTermDebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e0617f9c-fd16-449d-937d-9cf66beb02a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_19321f02-f1c9-4685-b7a8-440e95c28658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e0617f9c-fd16-449d-937d-9cf66beb02a0" xlink:to="loc_us-gaap_DebtInstrumentTable_19321f02-f1c9-4685-b7a8-440e95c28658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_d1f32f95-b2fc-4c76-9796-83b7c1b5e688" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_19321f02-f1c9-4685-b7a8-440e95c28658" xlink:to="loc_us-gaap_CreditFacilityAxis_d1f32f95-b2fc-4c76-9796-83b7c1b5e688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_96659b30-13aa-4bf4-a041-30ff089b5de5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_d1f32f95-b2fc-4c76-9796-83b7c1b5e688" xlink:to="loc_us-gaap_CreditFacilityDomain_96659b30-13aa-4bf4-a041-30ff089b5de5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_965f3693-5d5c-47ae-88fc-c186618d0e63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_96659b30-13aa-4bf4-a041-30ff089b5de5" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_965f3693-5d5c-47ae-88fc-c186618d0e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_673c58d6-c953-4a13-a380-93858ca81f31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_96659b30-13aa-4bf4-a041-30ff089b5de5" xlink:to="loc_us-gaap_LetterOfCreditMember_673c58d6-c953-4a13-a380-93858ca81f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_50484e52-9057-4d81-ae69-566ac2d6ac81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_19321f02-f1c9-4685-b7a8-440e95c28658" xlink:to="loc_us-gaap_DebtInstrumentAxis_50484e52-9057-4d81-ae69-566ac2d6ac81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a9923f57-1f0b-4686-aedb-3e0a33a17d30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_50484e52-9057-4d81-ae69-566ac2d6ac81" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a9923f57-1f0b-4686-aedb-3e0a33a17d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_A2017SeniorSecuredCreditFacilityMember_fa68ef2c-774c-4e49-bc75-ebafaab19ab8" xlink:href="sgry-20210930.xsd#sgry_A2017SeniorSecuredCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9923f57-1f0b-4686-aedb-3e0a33a17d30" xlink:to="loc_sgry_A2017SeniorSecuredCreditFacilityMember_fa68ef2c-774c-4e49-bc75-ebafaab19ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember_91ccc2d0-d1b2-41a2-b059-590272943b15" xlink:href="sgry-20210930.xsd#sgry_A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9923f57-1f0b-4686-aedb-3e0a33a17d30" xlink:to="loc_sgry_A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember_91ccc2d0-d1b2-41a2-b059-590272943b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SeniorUnsecuredNotesDue2025Member_ab92ef38-c0a0-4d60-9fe4-11f2f950da18" xlink:href="sgry-20210930.xsd#sgry_SeniorUnsecuredNotesDue2025Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9923f57-1f0b-4686-aedb-3e0a33a17d30" xlink:to="loc_sgry_SeniorUnsecuredNotesDue2025Member_ab92ef38-c0a0-4d60-9fe4-11f2f950da18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_131b9b85-565d-4bd0-84f8-085e1b574646" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_19321f02-f1c9-4685-b7a8-440e95c28658" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_131b9b85-565d-4bd0-84f8-085e1b574646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9a417d78-2790-4c76-9d60-9604ba9d636b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_131b9b85-565d-4bd0-84f8-085e1b574646" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9a417d78-2790-4c76-9d60-9604ba9d636b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_ebfd7d56-fdad-441d-885a-b52246b86884" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9a417d78-2790-4c76-9d60-9604ba9d636b" xlink:to="loc_us-gaap_SecuredDebtMember_ebfd7d56-fdad-441d-885a-b52246b86884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_ce0d174d-1dcc-4d33-9c70-8e3bb9b3b671" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9a417d78-2790-4c76-9d60-9604ba9d636b" xlink:to="loc_us-gaap_SeniorNotesMember_ce0d174d-1dcc-4d33-9c70-8e3bb9b3b671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_9fd2a0da-f446-4c9d-889d-9d7abdd74fba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_19321f02-f1c9-4685-b7a8-440e95c28658" xlink:to="loc_us-gaap_VariableRateAxis_9fd2a0da-f446-4c9d-889d-9d7abdd74fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_21df4002-27de-483d-a1b1-97930cf942af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_9fd2a0da-f446-4c9d-889d-9d7abdd74fba" xlink:to="loc_us-gaap_VariableRateDomain_21df4002-27de-483d-a1b1-97930cf942af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_da4bea5c-3f83-43e5-860a-59d09388eb79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_21df4002-27de-483d-a1b1-97930cf942af" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_da4bea5c-3f83-43e5-860a-59d09388eb79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_34eb4a77-1860-436d-8f9b-9e2e1d5c17b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_21df4002-27de-483d-a1b1-97930cf942af" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_34eb4a77-1860-436d-8f9b-9e2e1d5c17b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_OneMonthLondonInterbankOfferedRateLIBORMember_d01ba07e-a2c3-4a14-8a93-e098232264da" xlink:href="sgry-20210930.xsd#sgry_OneMonthLondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_21df4002-27de-483d-a1b1-97930cf942af" xlink:to="loc_sgry_OneMonthLondonInterbankOfferedRateLIBORMember_d01ba07e-a2c3-4a14-8a93-e098232264da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_365a6146-6d72-4b8e-9712-7e3c7f968db6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_21df4002-27de-483d-a1b1-97930cf942af" xlink:to="loc_us-gaap_BaseRateMember_365a6146-6d72-4b8e-9712-7e3c7f968db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ed67b7a6-828f-47e6-b7f4-1fd07b3f6bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_19321f02-f1c9-4685-b7a8-440e95c28658" xlink:to="loc_us-gaap_DebtInstrumentLineItems_ed67b7a6-828f-47e6-b7f4-1fd07b3f6bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_LineOfCreditFacilityMaximumBorrowingCapacityIncrease_e8359e2a-8a42-431e-aba9-5f41497c2979" xlink:href="sgry-20210930.xsd#sgry_LineOfCreditFacilityMaximumBorrowingCapacityIncrease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed67b7a6-828f-47e6-b7f4-1fd07b3f6bdc" xlink:to="loc_sgry_LineOfCreditFacilityMaximumBorrowingCapacityIncrease_e8359e2a-8a42-431e-aba9-5f41497c2979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_39057f61-ea9f-46a5-89a9-b47c4a38d05a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed67b7a6-828f-47e6-b7f4-1fd07b3f6bdc" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_39057f61-ea9f-46a5-89a9-b47c4a38d05a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_ba2133df-16a0-40c3-b9fa-663724330e72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed67b7a6-828f-47e6-b7f4-1fd07b3f6bdc" xlink:to="loc_us-gaap_LineOfCredit_ba2133df-16a0-40c3-b9fa-663724330e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_41ac3518-128a-4d03-966f-70b7a30918ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed67b7a6-828f-47e6-b7f4-1fd07b3f6bdc" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_41ac3518-128a-4d03-966f-70b7a30918ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DebtInstrumentCovenantMaturityMinimumAmountOfOtherExistingDebtRemaining_87d2e11b-fede-45e8-924d-299244ee44a1" xlink:href="sgry-20210930.xsd#sgry_DebtInstrumentCovenantMaturityMinimumAmountOfOtherExistingDebtRemaining"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed67b7a6-828f-47e6-b7f4-1fd07b3f6bdc" xlink:to="loc_sgry_DebtInstrumentCovenantMaturityMinimumAmountOfOtherExistingDebtRemaining_87d2e11b-fede-45e8-924d-299244ee44a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e5db7e3d-2bb4-42b0-8a8a-242210e9915f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed67b7a6-828f-47e6-b7f4-1fd07b3f6bdc" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e5db7e3d-2bb4-42b0-8a8a-242210e9915f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DebtInstrumentCovenantMaturityMinimumMaturityDateForOtherExistingDebtRemaining_c82b057e-9722-415a-b6af-0ca60f560472" xlink:href="sgry-20210930.xsd#sgry_DebtInstrumentCovenantMaturityMinimumMaturityDateForOtherExistingDebtRemaining"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed67b7a6-828f-47e6-b7f4-1fd07b3f6bdc" xlink:to="loc_sgry_DebtInstrumentCovenantMaturityMinimumMaturityDateForOtherExistingDebtRemaining_c82b057e-9722-415a-b6af-0ca60f560472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_b5dd612d-7ace-4579-956d-492b0f50ab3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed67b7a6-828f-47e6-b7f4-1fd07b3f6bdc" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_b5dd612d-7ace-4579-956d-492b0f50ab3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DebtInstrumentBasisSpreadOnVariableRateFloor_81b38f64-680a-4d9d-ac0b-49ca73fc95c7" xlink:href="sgry-20210930.xsd#sgry_DebtInstrumentBasisSpreadOnVariableRateFloor"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed67b7a6-828f-47e6-b7f4-1fd07b3f6bdc" xlink:to="loc_sgry_DebtInstrumentBasisSpreadOnVariableRateFloor_81b38f64-680a-4d9d-ac0b-49ca73fc95c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DebtInstrumentQuarterlyAmortizationPercentPerAnnum_8f6e36de-6026-407e-aa75-f55ad1bb0652" xlink:href="sgry-20210930.xsd#sgry_DebtInstrumentQuarterlyAmortizationPercentPerAnnum"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed67b7a6-828f-47e6-b7f4-1fd07b3f6bdc" xlink:to="loc_sgry_DebtInstrumentQuarterlyAmortizationPercentPerAnnum_8f6e36de-6026-407e-aa75-f55ad1bb0652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_e6e63990-25ea-4186-85ac-c2d361062a82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed67b7a6-828f-47e6-b7f4-1fd07b3f6bdc" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_e6e63990-25ea-4186-85ac-c2d361062a82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_479cdc79-3ef2-4f76-864b-e787b5563480" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed67b7a6-828f-47e6-b7f4-1fd07b3f6bdc" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_479cdc79-3ef2-4f76-864b-e787b5563480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/Leases" xlink:type="simple" xlink:href="sgry-20210930.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_f6dbde18-e7e8-4943-8dfd-20abe448b596" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_a30a6cb1-37de-4fb4-a8ed-ee5b5b6698c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f6dbde18-e7e8-4943-8dfd-20abe448b596" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_a30a6cb1-37de-4fb4-a8ed-ee5b5b6698c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_9d6eee10-fdca-4bff-bfb4-eebef26f35db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f6dbde18-e7e8-4943-8dfd-20abe448b596" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_9d6eee10-fdca-4bff-bfb4-eebef26f35db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/LeasesTables" xlink:type="simple" xlink:href="sgry-20210930.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_6300b610-587a-41d4-a22e-b3295318e7de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_47abae5f-1977-4650-8524-7da78a6959d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6300b610-587a-41d4-a22e-b3295318e7de" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_47abae5f-1977-4650-8524-7da78a6959d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#LeasesLeaseExpenseandCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_669ad489-a44f-44ac-88f4-43831788879d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_350563b9-9bb2-49d6-ba71-bbc88b1063b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_669ad489-a44f-44ac-88f4-43831788879d" xlink:to="loc_us-gaap_OperatingLeaseCost_350563b9-9bb2-49d6-ba71-bbc88b1063b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_FinanceLeaseCost1Abstract_7171c1f6-eb3c-4007-b8c3-67adae9170a6" xlink:href="sgry-20210930.xsd#sgry_FinanceLeaseCost1Abstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_669ad489-a44f-44ac-88f4-43831788879d" xlink:to="loc_sgry_FinanceLeaseCost1Abstract_7171c1f6-eb3c-4007-b8c3-67adae9170a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_03f653ba-edd0-48e9-95d4-bdb7dcbe1497" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_FinanceLeaseCost1Abstract_7171c1f6-eb3c-4007-b8c3-67adae9170a6" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_03f653ba-edd0-48e9-95d4-bdb7dcbe1497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_de2dad4b-345b-44de-ba55-ec587f0b1ae3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_FinanceLeaseCost1Abstract_7171c1f6-eb3c-4007-b8c3-67adae9170a6" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_de2dad4b-345b-44de-ba55-ec587f0b1ae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_FinanceLeaseCost_b6c35a85-5c93-4a7d-ac37-73ee83324ee7" xlink:href="sgry-20210930.xsd#sgry_FinanceLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_FinanceLeaseCost1Abstract_7171c1f6-eb3c-4007-b8c3-67adae9170a6" xlink:to="loc_sgry_FinanceLeaseCost_b6c35a85-5c93-4a7d-ac37-73ee83324ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_VariableAndShortTermLeaseCost_c3fb6d6c-bde5-484f-91b8-a590813405cc" xlink:href="sgry-20210930.xsd#sgry_VariableAndShortTermLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_669ad489-a44f-44ac-88f4-43831788879d" xlink:to="loc_sgry_VariableAndShortTermLeaseCost_c3fb6d6c-bde5-484f-91b8-a590813405cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_13c64f30-3519-44e3-9e18-17e7bee32f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_669ad489-a44f-44ac-88f4-43831788879d" xlink:to="loc_us-gaap_LeaseCost_13c64f30-3519-44e3-9e18-17e7bee32f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_CashFlowLesseeAbstract_ed6554b2-4df6-4f4c-a809-482f4195639f" xlink:href="sgry-20210930.xsd#sgry_CashFlowLesseeAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_669ad489-a44f-44ac-88f4-43831788879d" xlink:to="loc_sgry_CashFlowLesseeAbstract_ed6554b2-4df6-4f4c-a809-482f4195639f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_977d1f00-a5a6-4595-b1e3-b45ee89ef57d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_CashFlowLesseeAbstract_ed6554b2-4df6-4f4c-a809-482f4195639f" xlink:to="loc_us-gaap_OperatingLeasePayments_977d1f00-a5a6-4595-b1e3-b45ee89ef57d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_0f0cd679-6908-42b6-8fe4-da2561ad3f23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_CashFlowLesseeAbstract_ed6554b2-4df6-4f4c-a809-482f4195639f" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_0f0cd679-6908-42b6-8fe4-da2561ad3f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_fe269085-658b-428e-91d0-20c56183e26d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_CashFlowLesseeAbstract_ed6554b2-4df6-4f4c-a809-482f4195639f" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_fe269085-658b-428e-91d0-20c56183e26d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_ca202f1c-0b62-4826-9a9e-9fcad8609822" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_669ad489-a44f-44ac-88f4-43831788879d" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_ca202f1c-0b62-4826-9a9e-9fcad8609822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_5ee0e70e-6b05-4772-bc3d-dbcd10fa1a79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_669ad489-a44f-44ac-88f4-43831788879d" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_5ee0e70e-6b05-4772-bc3d-dbcd10fa1a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/RedeemablePreferredStock" xlink:type="simple" xlink:href="sgry-20210930.xsd#RedeemablePreferredStock"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/RedeemablePreferredStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_6e7e6852-782b-4771-afb5-4cddef80d2fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_RedeemablePreferredStockTextBlock_2eee6092-84b3-4e57-8751-5fec67fb081f" xlink:href="sgry-20210930.xsd#sgry_RedeemablePreferredStockTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_6e7e6852-782b-4771-afb5-4cddef80d2fe" xlink:to="loc_sgry_RedeemablePreferredStockTextBlock_2eee6092-84b3-4e57-8751-5fec67fb081f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/RedeemablePreferredStockTables" xlink:type="simple" xlink:href="sgry-20210930.xsd#RedeemablePreferredStockTables"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/RedeemablePreferredStockTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_b61744ed-63f0-42dd-9a63-f271fbda45f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityTableTextBlock_437b4847-bc0e-4a7e-8762-77175c0431e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_b61744ed-63f0-42dd-9a63-f271fbda45f8" xlink:to="loc_us-gaap_TemporaryEquityTableTextBlock_437b4847-bc0e-4a7e-8762-77175c0431e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/RedeemablePreferredStockNarrativeDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#RedeemablePreferredStockNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/RedeemablePreferredStockNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_2ed97753-21ad-4e96-8450-b585cb19b848" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_fa26a78c-d4a8-47e2-8272-ee91c1c4ec39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_2ed97753-21ad-4e96-8450-b585cb19b848" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_fa26a78c-d4a8-47e2-8272-ee91c1c4ec39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_58fc9286-448c-4724-b03d-df494441b274" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_fa26a78c-d4a8-47e2-8272-ee91c1c4ec39" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_58fc9286-448c-4724-b03d-df494441b274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_844ece92-a6b5-4d4c-81e1-76c342475a84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_58fc9286-448c-4724-b03d-df494441b274" xlink:to="loc_us-gaap_RelatedPartyDomain_844ece92-a6b5-4d4c-81e1-76c342475a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MajorityShareholderMember_9d264421-1cf8-4cf2-a02b-b94eecb7b061" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MajorityShareholderMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_844ece92-a6b5-4d4c-81e1-76c342475a84" xlink:to="loc_us-gaap_MajorityShareholderMember_9d264421-1cf8-4cf2-a02b-b94eecb7b061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_9c1d9906-d545-4ceb-a33b-2e60a24e46e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_fa26a78c-d4a8-47e2-8272-ee91c1c4ec39" xlink:to="loc_us-gaap_StatementClassOfStockAxis_9c1d9906-d545-4ceb-a33b-2e60a24e46e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_819b213c-8e22-467e-81be-57ad36a10da9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_9c1d9906-d545-4ceb-a33b-2e60a24e46e5" xlink:to="loc_us-gaap_ClassOfStockDomain_819b213c-8e22-467e-81be-57ad36a10da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_c7e9ee5a-ff05-4f9d-b21c-cf080c594ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_819b213c-8e22-467e-81be-57ad36a10da9" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_c7e9ee5a-ff05-4f9d-b21c-cf080c594ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_fb51aede-f730-4c1b-8495-b8008f17b10b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_819b213c-8e22-467e-81be-57ad36a10da9" xlink:to="loc_us-gaap_CommonClassAMember_fb51aede-f730-4c1b-8495-b8008f17b10b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_f7772f74-fa57-4d44-92bf-898809053082" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_fa26a78c-d4a8-47e2-8272-ee91c1c4ec39" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_f7772f74-fa57-4d44-92bf-898809053082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_6d710b63-ba01-4665-af26-6282e56b5021" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_f7772f74-fa57-4d44-92bf-898809053082" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_6d710b63-ba01-4665-af26-6282e56b5021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember_9a3d265f-f4f3-4845-9701-61d70af96dc4" xlink:href="sgry-20210930.xsd#sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_6d710b63-ba01-4665-af26-6282e56b5021" xlink:to="loc_sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember_9a3d265f-f4f3-4845-9701-61d70af96dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_19ebaf9b-54bb-41b7-9f07-f25bfbebcac4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_fa26a78c-d4a8-47e2-8272-ee91c1c4ec39" xlink:to="loc_us-gaap_TemporaryEquityLineItems_19ebaf9b-54bb-41b7-9f07-f25bfbebcac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_cc87c0a6-61ed-47c4-b8f7-b86d2231c61c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_19ebaf9b-54bb-41b7-9f07-f25bfbebcac4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_cc87c0a6-61ed-47c4-b8f7-b86d2231c61c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_b8245fd3-7fd9-42de-b64e-c7f1d8db32a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_19ebaf9b-54bb-41b7-9f07-f25bfbebcac4" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_b8245fd3-7fd9-42de-b64e-c7f1d8db32a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_ecb80ec6-a8fb-42f3-aafe-82f4d337da3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_19ebaf9b-54bb-41b7-9f07-f25bfbebcac4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_ecb80ec6-a8fb-42f3-aafe-82f4d337da3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_985d2735-4ebd-4cd6-88be-c43ffc202ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_19ebaf9b-54bb-41b7-9f07-f25bfbebcac4" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_985d2735-4ebd-4cd6-88be-c43ffc202ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_TemporaryEquityThresholdTradingDays_d27dbfa2-9e16-438f-b49b-fa7cdddf37e0" xlink:href="sgry-20210930.xsd#sgry_TemporaryEquityThresholdTradingDays"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_19ebaf9b-54bb-41b7-9f07-f25bfbebcac4" xlink:to="loc_sgry_TemporaryEquityThresholdTradingDays_d27dbfa2-9e16-438f-b49b-fa7cdddf37e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_TemporaryEquityThresholdConsecutiveTradingDays_0e28749b-e8be-472c-adcf-eb4175741d57" xlink:href="sgry-20210930.xsd#sgry_TemporaryEquityThresholdConsecutiveTradingDays"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_19ebaf9b-54bb-41b7-9f07-f25bfbebcac4" xlink:to="loc_sgry_TemporaryEquityThresholdConsecutiveTradingDays_0e28749b-e8be-472c-adcf-eb4175741d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_TemporaryEquityThresholdSharePrice_9ce8ba3e-b6bd-4f32-acae-8e1588155649" xlink:href="sgry-20210930.xsd#sgry_TemporaryEquityThresholdSharePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_19ebaf9b-54bb-41b7-9f07-f25bfbebcac4" xlink:to="loc_sgry_TemporaryEquityThresholdSharePrice_9ce8ba3e-b6bd-4f32-acae-8e1588155649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1_30dacdf7-566e-47bf-8054-3b8aaac2d679" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_19ebaf9b-54bb-41b7-9f07-f25bfbebcac4" xlink:to="loc_us-gaap_ConversionOfStockSharesIssued1_30dacdf7-566e-47bf-8054-3b8aaac2d679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_cccfd50c-5cc6-4ab5-b734-b57a28522787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_19ebaf9b-54bb-41b7-9f07-f25bfbebcac4" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_cccfd50c-5cc6-4ab5-b734-b57a28522787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_4675a0a9-fdd0-4dd6-a0fe-c74a92daa87c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_19ebaf9b-54bb-41b7-9f07-f25bfbebcac4" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_4675a0a9-fdd0-4dd6-a0fe-c74a92daa87c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/RedeemablePreferredStockSummaryDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#RedeemablePreferredStockSummaryDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/RedeemablePreferredStockSummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_5ed30429-7c2d-4d37-b741-8724afbad56e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_fbea4ff2-68e4-47f0-9d71-b0c2d1afe49f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_5ed30429-7c2d-4d37-b741-8724afbad56e" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_fbea4ff2-68e4-47f0-9d71-b0c2d1afe49f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_de75f39d-10e2-44b6-9cfc-0f06323904fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_fbea4ff2-68e4-47f0-9d71-b0c2d1afe49f" xlink:to="loc_us-gaap_StatementClassOfStockAxis_de75f39d-10e2-44b6-9cfc-0f06323904fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_88c21e65-ce71-47f0-b764-042fac133f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_de75f39d-10e2-44b6-9cfc-0f06323904fc" xlink:to="loc_us-gaap_ClassOfStockDomain_88c21e65-ce71-47f0-b764-042fac133f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_5f703b1b-f758-46da-a1ce-3a798918c710" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_88c21e65-ce71-47f0-b764-042fac133f1b" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_5f703b1b-f758-46da-a1ce-3a798918c710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_ed172468-c2b8-4f13-b9dd-b87d42fb43f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_fbea4ff2-68e4-47f0-9d71-b0c2d1afe49f" xlink:to="loc_us-gaap_TemporaryEquityLineItems_ed172468-c2b8-4f13-b9dd-b87d42fb43f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_13ed5db2-6449-43e7-8936-2b2da7bd520a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_ed172468-c2b8-4f13-b9dd-b87d42fb43f9" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_13ed5db2-6449-43e7-8936-2b2da7bd520a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_7e1fd268-c1f9-44fb-91cc-f9bb215d031c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_13ed5db2-6449-43e7-8936-2b2da7bd520a" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_7e1fd268-c1f9-44fb-91cc-f9bb215d031c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionOfDividends_ab052ad0-2626-4b37-85dc-be119ef80f00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionOfDividends"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_13ed5db2-6449-43e7-8936-2b2da7bd520a" xlink:to="loc_us-gaap_TemporaryEquityAccretionOfDividends_ab052ad0-2626-4b37-85dc-be119ef80f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDividendsAdjustment_394024a9-bc4b-436c-a648-c501962030b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDividendsAdjustment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_13ed5db2-6449-43e7-8936-2b2da7bd520a" xlink:to="loc_us-gaap_TemporaryEquityDividendsAdjustment_394024a9-bc4b-436c-a648-c501962030b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_fabd8edb-39af-4c4c-95dc-36e5b4c9b6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_13ed5db2-6449-43e7-8936-2b2da7bd520a" xlink:to="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_fabd8edb-39af-4c4c-95dc-36e5b4c9b6b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_da0d394c-3061-4e23-b178-22ebbe9bcb25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_13ed5db2-6449-43e7-8936-2b2da7bd520a" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_da0d394c-3061-4e23-b178-22ebbe9bcb25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/DerivativesandHedgingActivities" xlink:type="simple" xlink:href="sgry-20210930.xsd#DerivativesandHedgingActivities"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/DerivativesandHedgingActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2b8f99b4-756d-4af7-a8ac-b1f54d1d50e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_0eb84f0e-ec65-4760-8f66-be0bb3c57b98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2b8f99b4-756d-4af7-a8ac-b1f54d1d50e4" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_0eb84f0e-ec65-4760-8f66-be0bb3c57b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesTables" xlink:type="simple" xlink:href="sgry-20210930.xsd#DerivativesandHedgingActivitiesTables"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9c6dc500-bbd1-4fa6-baa1-070e7e1d7164" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_f7405c8d-3fc9-4402-8ddd-0858eda2cd28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9c6dc500-bbd1-4fa6-baa1-070e7e1d7164" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_f7405c8d-3fc9-4402-8ddd-0858eda2cd28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_2365e375-9841-40c4-9022-e30a2a2bdd84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9c6dc500-bbd1-4fa6-baa1-070e7e1d7164" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_2365e375-9841-40c4-9022-e30a2a2bdd84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock_5929f6e6-bb91-496e-9327-057896224583" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9c6dc500-bbd1-4fa6-baa1-070e7e1d7164" xlink:to="loc_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock_5929f6e6-bb91-496e-9327-057896224583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#DerivativesandHedgingActivitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_17658c3b-cc89-44c5-be22-e1493d8ef8f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b8853ecc-007b-4417-b4ee-30a7cf70cc31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_17658c3b-cc89-44c5-be22-e1493d8ef8f3" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b8853ecc-007b-4417-b4ee-30a7cf70cc31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3b8b7cd8-5957-4eea-b168-138cdffafc5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b8853ecc-007b-4417-b4ee-30a7cf70cc31" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3b8b7cd8-5957-4eea-b168-138cdffafc5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_dcf9eff7-0cd2-42a1-bfb9-ff5f176e9e11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3b8b7cd8-5957-4eea-b168-138cdffafc5f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_dcf9eff7-0cd2-42a1-bfb9-ff5f176e9e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_732879c8-a5de-461a-8798-80ab1222afcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_dcf9eff7-0cd2-42a1-bfb9-ff5f176e9e11" xlink:to="loc_us-gaap_InterestRateSwapMember_732879c8-a5de-461a-8798-80ab1222afcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ThreePayFixedInterestRateSwapsMember_b68faa5e-7eae-4e65-82f1-2a95b634fa78" xlink:href="sgry-20210930.xsd#sgry_ThreePayFixedInterestRateSwapsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_dcf9eff7-0cd2-42a1-bfb9-ff5f176e9e11" xlink:to="loc_sgry_ThreePayFixedInterestRateSwapsMember_b68faa5e-7eae-4e65-82f1-2a95b634fa78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ThreeReceiveFixedInterestRateSwapsMember_7af76a4d-ed01-4618-bfe2-9519e821b824" xlink:href="sgry-20210930.xsd#sgry_ThreeReceiveFixedInterestRateSwapsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_dcf9eff7-0cd2-42a1-bfb9-ff5f176e9e11" xlink:to="loc_sgry_ThreeReceiveFixedInterestRateSwapsMember_7af76a4d-ed01-4618-bfe2-9519e821b824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_42cc1680-0a23-479c-ac06-d2aead625345" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_dcf9eff7-0cd2-42a1-bfb9-ff5f176e9e11" xlink:to="loc_us-gaap_InterestRateCapMember_42cc1680-0a23-479c-ac06-d2aead625345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_5d53f483-8fb6-447e-bdb3-ad36822d44d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b8853ecc-007b-4417-b4ee-30a7cf70cc31" xlink:to="loc_us-gaap_HedgingDesignationAxis_5d53f483-8fb6-447e-bdb3-ad36822d44d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_6caaf833-9c3a-4c26-83b2-38049ce38eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_5d53f483-8fb6-447e-bdb3-ad36822d44d5" xlink:to="loc_us-gaap_HedgingDesignationDomain_6caaf833-9c3a-4c26-83b2-38049ce38eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_a33aa44e-78d7-4619-8109-2b6e479a1914" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_6caaf833-9c3a-4c26-83b2-38049ce38eb8" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_a33aa44e-78d7-4619-8109-2b6e479a1914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_acfa6052-a794-4ba0-afb3-e2eb7704884e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_6caaf833-9c3a-4c26-83b2-38049ce38eb8" xlink:to="loc_us-gaap_NondesignatedMember_acfa6052-a794-4ba0-afb3-e2eb7704884e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_f1dd60b1-c49e-4438-bb21-dff88420b8d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b8853ecc-007b-4417-b4ee-30a7cf70cc31" xlink:to="loc_us-gaap_VariableRateAxis_f1dd60b1-c49e-4438-bb21-dff88420b8d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_4b1431c6-6267-45fb-9b04-b3b53ca85214" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_f1dd60b1-c49e-4438-bb21-dff88420b8d3" xlink:to="loc_us-gaap_VariableRateDomain_4b1431c6-6267-45fb-9b04-b3b53ca85214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_71bcf92f-155f-4f1a-94e7-7addd44f5037" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_4b1431c6-6267-45fb-9b04-b3b53ca85214" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_71bcf92f-155f-4f1a-94e7-7addd44f5037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dff39e48-e04c-4e95-a59d-46457c37e39e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b8853ecc-007b-4417-b4ee-30a7cf70cc31" xlink:to="loc_srt_RangeAxis_dff39e48-e04c-4e95-a59d-46457c37e39e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0bd9629c-0067-4b64-abfb-b99dc026c161" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_dff39e48-e04c-4e95-a59d-46457c37e39e" xlink:to="loc_srt_RangeMember_0bd9629c-0067-4b64-abfb-b99dc026c161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f716f381-464b-443d-8ced-3a1794346615" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0bd9629c-0067-4b64-abfb-b99dc026c161" xlink:to="loc_srt_MinimumMember_f716f381-464b-443d-8ced-3a1794346615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6fcd9aa7-d230-49ae-ac27-b46df5783e32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b8853ecc-007b-4417-b4ee-30a7cf70cc31" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6fcd9aa7-d230-49ae-ac27-b46df5783e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_d0c23119-a59a-4733-9714-135f81e7a5da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6fcd9aa7-d230-49ae-ac27-b46df5783e32" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_d0c23119-a59a-4733-9714-135f81e7a5da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_6f808d8d-1489-4937-8dd8-7b357f9dfb8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6fcd9aa7-d230-49ae-ac27-b46df5783e32" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_6f808d8d-1489-4937-8dd8-7b357f9dfb8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_4f88d8c8-f04f-4942-a8ee-db16127bd5c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6fcd9aa7-d230-49ae-ac27-b46df5783e32" xlink:to="loc_us-gaap_DerivativeNotionalAmount_4f88d8c8-f04f-4942-a8ee-db16127bd5c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate_c9017855-7d21-43b4-9cd8-6686f571400d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6fcd9aa7-d230-49ae-ac27-b46df5783e32" xlink:to="loc_us-gaap_DerivativeVariableInterestRate_c9017855-7d21-43b4-9cd8-6686f571400d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_8d4f32ce-79e5-4d07-924e-c658d0de255f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6fcd9aa7-d230-49ae-ac27-b46df5783e32" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_8d4f32ce-79e5-4d07-924e-c658d0de255f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0410f707-165d-47e3-84f2-1e9e4c926dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_88ac633c-01ac-4f29-847c-361201ea5d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0410f707-165d-47e3-84f2-1e9e4c926dd4" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_88ac633c-01ac-4f29-847c-361201ea5d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6e4df3d3-f532-4973-95ad-23ee714f3fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_88ac633c-01ac-4f29-847c-361201ea5d0c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6e4df3d3-f532-4973-95ad-23ee714f3fb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4157557d-46c2-450b-8993-a68a99fb1c77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6e4df3d3-f532-4973-95ad-23ee714f3fb4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4157557d-46c2-450b-8993-a68a99fb1c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapOneMember_76e644d4-5d3b-455c-8548-3b18c5151f3d" xlink:href="sgry-20210930.xsd#sgry_PayFixedSwapOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4157557d-46c2-450b-8993-a68a99fb1c77" xlink:to="loc_sgry_PayFixedSwapOneMember_76e644d4-5d3b-455c-8548-3b18c5151f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapTwoMember_9d296e1d-6f49-4da1-8760-44607e5bd38c" xlink:href="sgry-20210930.xsd#sgry_PayFixedSwapTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4157557d-46c2-450b-8993-a68a99fb1c77" xlink:to="loc_sgry_PayFixedSwapTwoMember_9d296e1d-6f49-4da1-8760-44607e5bd38c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapThreeMember_a114d95a-2173-41e3-a2b4-a2cd87dc793e" xlink:href="sgry-20210930.xsd#sgry_PayFixedSwapThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4157557d-46c2-450b-8993-a68a99fb1c77" xlink:to="loc_sgry_PayFixedSwapThreeMember_a114d95a-2173-41e3-a2b4-a2cd87dc793e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_InterestRateCapOneMember_ff8c4b9c-ce76-4aff-888c-d5b690e9e362" xlink:href="sgry-20210930.xsd#sgry_InterestRateCapOneMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4157557d-46c2-450b-8993-a68a99fb1c77" xlink:to="loc_sgry_InterestRateCapOneMember_ff8c4b9c-ce76-4aff-888c-d5b690e9e362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_InterestRateCapTwoMember_00ad0805-5a67-4e67-a92e-9ec604c18f07" xlink:href="sgry-20210930.xsd#sgry_InterestRateCapTwoMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4157557d-46c2-450b-8993-a68a99fb1c77" xlink:to="loc_sgry_InterestRateCapTwoMember_00ad0805-5a67-4e67-a92e-9ec604c18f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapFourMember_fac80c51-87c0-4ac0-90d1-30d5ba4c9c16" xlink:href="sgry-20210930.xsd#sgry_PayFixedSwapFourMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4157557d-46c2-450b-8993-a68a99fb1c77" xlink:to="loc_sgry_PayFixedSwapFourMember_fac80c51-87c0-4ac0-90d1-30d5ba4c9c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapFiveMember_b7fba556-6748-4f71-93e8-da64101d5c9e" xlink:href="sgry-20210930.xsd#sgry_PayFixedSwapFiveMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4157557d-46c2-450b-8993-a68a99fb1c77" xlink:to="loc_sgry_PayFixedSwapFiveMember_b7fba556-6748-4f71-93e8-da64101d5c9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapSixMember_5fab6149-456c-4bf7-a6ef-595aa5180d28" xlink:href="sgry-20210930.xsd#sgry_PayFixedSwapSixMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4157557d-46c2-450b-8993-a68a99fb1c77" xlink:to="loc_sgry_PayFixedSwapSixMember_5fab6149-456c-4bf7-a6ef-595aa5180d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ReceiveFixedSwapOneMember_8daae23c-8004-41ff-9de9-269256ccfae1" xlink:href="sgry-20210930.xsd#sgry_ReceiveFixedSwapOneMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4157557d-46c2-450b-8993-a68a99fb1c77" xlink:to="loc_sgry_ReceiveFixedSwapOneMember_8daae23c-8004-41ff-9de9-269256ccfae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ReceiveFixedSwapTwoMember_19b0de84-5956-430c-9262-c3f143a340ad" xlink:href="sgry-20210930.xsd#sgry_ReceiveFixedSwapTwoMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4157557d-46c2-450b-8993-a68a99fb1c77" xlink:to="loc_sgry_ReceiveFixedSwapTwoMember_19b0de84-5956-430c-9262-c3f143a340ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ReceiveFixedSwapThreeMember_f2065cef-2de2-4947-ae17-a10e63f196d6" xlink:href="sgry-20210930.xsd#sgry_ReceiveFixedSwapThreeMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4157557d-46c2-450b-8993-a68a99fb1c77" xlink:to="loc_sgry_ReceiveFixedSwapThreeMember_f2065cef-2de2-4947-ae17-a10e63f196d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapSevenMember_fb9b0051-5c6c-4bce-b198-76a92f215093" xlink:href="sgry-20210930.xsd#sgry_PayFixedSwapSevenMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4157557d-46c2-450b-8993-a68a99fb1c77" xlink:to="loc_sgry_PayFixedSwapSevenMember_fb9b0051-5c6c-4bce-b198-76a92f215093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapEightMember_b4f3ba12-4eb4-49dd-8f4a-0ea991c7b1b0" xlink:href="sgry-20210930.xsd#sgry_PayFixedSwapEightMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4157557d-46c2-450b-8993-a68a99fb1c77" xlink:to="loc_sgry_PayFixedSwapEightMember_b4f3ba12-4eb4-49dd-8f4a-0ea991c7b1b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapNineMember_6ba22721-4450-4643-adce-15eb81db1cb2" xlink:href="sgry-20210930.xsd#sgry_PayFixedSwapNineMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4157557d-46c2-450b-8993-a68a99fb1c77" xlink:to="loc_sgry_PayFixedSwapNineMember_6ba22721-4450-4643-adce-15eb81db1cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapTenMember_3ce78b4d-6744-4934-9603-270a7098926c" xlink:href="sgry-20210930.xsd#sgry_PayFixedSwapTenMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4157557d-46c2-450b-8993-a68a99fb1c77" xlink:to="loc_sgry_PayFixedSwapTenMember_3ce78b4d-6744-4934-9603-270a7098926c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_e1447b66-fd60-4e6d-8a1d-2c46dd70bb8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_88ac633c-01ac-4f29-847c-361201ea5d0c" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_e1447b66-fd60-4e6d-8a1d-2c46dd70bb8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_ab0ecff9-5ba7-4f8a-9c2a-101e9bc3c6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_e1447b66-fd60-4e6d-8a1d-2c46dd70bb8f" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_ab0ecff9-5ba7-4f8a-9c2a-101e9bc3c6d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_7a2c88fa-692a-4d7d-b237-81f54faa0cea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_e1447b66-fd60-4e6d-8a1d-2c46dd70bb8f" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_7a2c88fa-692a-4d7d-b237-81f54faa0cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_8eab7b32-4324-4ad3-903c-06f2ddd0ece0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_e1447b66-fd60-4e6d-8a1d-2c46dd70bb8f" xlink:to="loc_us-gaap_DerivativeNotionalAmount_8eab7b32-4324-4ad3-903c-06f2ddd0ece0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesandtheirlocationonthecondensedconsolidatedbalancesheetsDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#DerivativesandHedgingActivitiesDerivativesandtheirlocationonthecondensedconsolidatedbalancesheetsDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesandtheirlocationonthecondensedconsolidatedbalancesheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_12992362-ae36-4875-98f0-993f27b5410f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_adc94c73-5f18-4b0d-8bfa-44a3a21a845f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_12992362-ae36-4875-98f0-993f27b5410f" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_adc94c73-5f18-4b0d-8bfa-44a3a21a845f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_1bc4777e-dfa7-4aae-8e4b-2a1587e22e23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_adc94c73-5f18-4b0d-8bfa-44a3a21a845f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_1bc4777e-dfa7-4aae-8e4b-2a1587e22e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7f39da99-984e-4333-9e5e-7bb49ec340c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1bc4777e-dfa7-4aae-8e4b-2a1587e22e23" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7f39da99-984e-4333-9e5e-7bb49ec340c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_ce8cb295-0e39-4f01-b848-83b35bba7351" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7f39da99-984e-4333-9e5e-7bb49ec340c3" xlink:to="loc_us-gaap_InterestRateSwapMember_ce8cb295-0e39-4f01-b848-83b35bba7351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_9d9ec1aa-156b-46a5-96b6-6cb19a6220cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7f39da99-984e-4333-9e5e-7bb49ec340c3" xlink:to="loc_us-gaap_InterestRateCapMember_9d9ec1aa-156b-46a5-96b6-6cb19a6220cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_c420a9e0-edd8-452e-baaf-3607edf6f89c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_adc94c73-5f18-4b0d-8bfa-44a3a21a845f" xlink:to="loc_us-gaap_HedgingDesignationAxis_c420a9e0-edd8-452e-baaf-3607edf6f89c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_48d7ae84-189a-402c-91da-dc6ee1a94170" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_c420a9e0-edd8-452e-baaf-3607edf6f89c" xlink:to="loc_us-gaap_HedgingDesignationDomain_48d7ae84-189a-402c-91da-dc6ee1a94170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_c29a70e7-faa6-4acc-ada1-e5e0ed609379" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_48d7ae84-189a-402c-91da-dc6ee1a94170" xlink:to="loc_us-gaap_NondesignatedMember_c29a70e7-faa6-4acc-ada1-e5e0ed609379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_d137d2f2-a5d6-4b88-86b9-48cff32c7526" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_48d7ae84-189a-402c-91da-dc6ee1a94170" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_d137d2f2-a5d6-4b88-86b9-48cff32c7526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_18ffe66e-c802-409d-b7d7-8dff8327c21c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_adc94c73-5f18-4b0d-8bfa-44a3a21a845f" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_18ffe66e-c802-409d-b7d7-8dff8327c21c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_821e06ee-8f58-4334-be44-714df43869f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_18ffe66e-c802-409d-b7d7-8dff8327c21c" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_821e06ee-8f58-4334-be44-714df43869f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_b4633a1f-8a7d-4197-b663-9c4dad9dca71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_821e06ee-8f58-4334-be44-714df43869f3" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_b4633a1f-8a7d-4197-b663-9c4dad9dca71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_da17e793-d43a-4ec6-a67a-29cdd792c037" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_821e06ee-8f58-4334-be44-714df43869f3" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_da17e793-d43a-4ec6-a67a-29cdd792c037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_0405fcdd-8b1a-4f30-a5c0-e08e39e8d2ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_adc94c73-5f18-4b0d-8bfa-44a3a21a845f" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_0405fcdd-8b1a-4f30-a5c0-e08e39e8d2ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_c9af1a88-9c0b-4143-9a32-9b196dcce7eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_0405fcdd-8b1a-4f30-a5c0-e08e39e8d2ad" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_c9af1a88-9c0b-4143-9a32-9b196dcce7eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_290a7c9e-f9da-4758-ba80-d42bae14b48e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_0405fcdd-8b1a-4f30-a5c0-e08e39e8d2ad" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_290a7c9e-f9da-4758-ba80-d42bae14b48e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DerivativeLiabilityNotionalAmountFinancingComponent_88065988-162b-4179-82a8-46912a25b350" xlink:href="sgry-20210930.xsd#sgry_DerivativeLiabilityNotionalAmountFinancingComponent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_0405fcdd-8b1a-4f30-a5c0-e08e39e8d2ad" xlink:to="loc_sgry_DerivativeLiabilityNotionalAmountFinancingComponent_88065988-162b-4179-82a8-46912a25b350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1c2e2d88-9205-4ec7-916f-19c00b022d29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_aae4421f-70da-47f1-a0cc-5f6f77d1c4d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1c2e2d88-9205-4ec7-916f-19c00b022d29" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_aae4421f-70da-47f1-a0cc-5f6f77d1c4d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_735b6c20-bdff-4e47-9299-1f2a14708502" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_aae4421f-70da-47f1-a0cc-5f6f77d1c4d7" xlink:to="loc_us-gaap_HedgingDesignationAxis_735b6c20-bdff-4e47-9299-1f2a14708502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_8ca64242-2f7a-441d-bc81-cf85dd85595f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_735b6c20-bdff-4e47-9299-1f2a14708502" xlink:to="loc_us-gaap_HedgingDesignationDomain_8ca64242-2f7a-441d-bc81-cf85dd85595f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_38dae39e-fa77-4d9a-a67e-5de70d33b414" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_8ca64242-2f7a-441d-bc81-cf85dd85595f" xlink:to="loc_us-gaap_NondesignatedMember_38dae39e-fa77-4d9a-a67e-5de70d33b414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_bc0ea1fe-10f4-4e13-a6eb-fcf2c4cf0c09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_8ca64242-2f7a-441d-bc81-cf85dd85595f" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_bc0ea1fe-10f4-4e13-a6eb-fcf2c4cf0c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_0c5c5e17-9f05-4e0b-ac43-19b6a53d62bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_aae4421f-70da-47f1-a0cc-5f6f77d1c4d7" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_0c5c5e17-9f05-4e0b-ac43-19b6a53d62bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_793379a1-8fe9-4c31-9505-2e54b4221c10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0c5c5e17-9f05-4e0b-ac43-19b6a53d62bd" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_793379a1-8fe9-4c31-9505-2e54b4221c10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_5215fe29-049a-479c-8d69-094a0a80d58b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_793379a1-8fe9-4c31-9505-2e54b4221c10" xlink:to="loc_us-gaap_OtherIncomeMember_5215fe29-049a-479c-8d69-094a0a80d58b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_dec7f5f1-78a5-47be-8ce5-9e79ad8d1bca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_793379a1-8fe9-4c31-9505-2e54b4221c10" xlink:to="loc_us-gaap_InterestExpenseMember_dec7f5f1-78a5-47be-8ce5-9e79ad8d1bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6a41299e-5ea2-4a52-9a47-c21549e3e593" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_aae4421f-70da-47f1-a0cc-5f6f77d1c4d7" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6a41299e-5ea2-4a52-9a47-c21549e3e593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_9450c216-4090-4457-8e81-cc6f661622cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6a41299e-5ea2-4a52-9a47-c21549e3e593" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_9450c216-4090-4457-8e81-cc6f661622cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_7948b863-c321-4ff1-bcd3-64c7a6ae6785" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6a41299e-5ea2-4a52-9a47-c21549e3e593" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_7948b863-c321-4ff1-bcd3-64c7a6ae6785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_418b7a44-cf50-416c-b39b-f084eb5f5b0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6a41299e-5ea2-4a52-9a47-c21549e3e593" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_418b7a44-cf50-416c-b39b-f084eb5f5b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/EarningsPerShare" xlink:type="simple" xlink:href="sgry-20210930.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b3c69cd0-48c2-4c50-902e-8098d971a600" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_e8624624-daea-46dd-9453-294059b93c94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b3c69cd0-48c2-4c50-902e-8098d971a600" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_e8624624-daea-46dd-9453-294059b93c94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="sgry-20210930.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5ff0d64d-096a-411d-a790-2b7b8524835b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_10101f30-ccde-4bcd-84e9-d0278ac0ca7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5ff0d64d-096a-411d-a790-2b7b8524835b" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_10101f30-ccde-4bcd-84e9-d0278ac0ca7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#EarningsPerShareSummaryDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8f882d56-34b8-4de5-ace5-4986d31d3f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_265d99f1-380e-4e7d-852b-981ef0fd581d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8f882d56-34b8-4de5-ace5-4986d31d3f9c" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_265d99f1-380e-4e7d-852b-981ef0fd581d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3c46acb9-0b4c-4ec2-b3a7-0af13f87e496" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_265d99f1-380e-4e7d-852b-981ef0fd581d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3c46acb9-0b4c-4ec2-b3a7-0af13f87e496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b49433b8-8687-486f-950a-257177ff8bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3c46acb9-0b4c-4ec2-b3a7-0af13f87e496" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b49433b8-8687-486f-950a-257177ff8bc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_27321d67-2198-4ecd-bd92-3ad67146d9cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b49433b8-8687-486f-950a-257177ff8bc5" xlink:to="loc_us-gaap_EmployeeStockOptionMember_27321d67-2198-4ecd-bd92-3ad67146d9cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_2121948e-7dfd-4030-9a09-e04bd426af96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b49433b8-8687-486f-950a-257177ff8bc5" xlink:to="loc_us-gaap_RestrictedStockMember_2121948e-7dfd-4030-9a09-e04bd426af96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_d5c18272-4f24-416e-8c98-b9463b43c7ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_265d99f1-380e-4e7d-852b-981ef0fd581d" xlink:to="loc_us-gaap_EarningsPerShareBasicLineItems_d5c18272-4f24-416e-8c98-b9463b43c7ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract_2ae328f5-23ef-445e-b1f3-47da04561e54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_d5c18272-4f24-416e-8c98-b9463b43c7ac" xlink:to="loc_us-gaap_NetIncomeLossAbstract_2ae328f5-23ef-445e-b1f3-47da04561e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2a77d0da-d205-4f63-b946-2c48ebe82b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_2ae328f5-23ef-445e-b1f3-47da04561e54" xlink:to="loc_us-gaap_NetIncomeLoss_2a77d0da-d205-4f63-b946-2c48ebe82b5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_07f8c627-17a1-42af-96fe-535f365570bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_2ae328f5-23ef-445e-b1f3-47da04561e54" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_07f8c627-17a1-42af-96fe-535f365570bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_4c318c6d-63fc-4be6-8802-494ae02fb273" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_2ae328f5-23ef-445e-b1f3-47da04561e54" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_4c318c6d-63fc-4be6-8802-494ae02fb273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8d2bfe35-75a0-4d64-a056-98142ec7bd3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_d5c18272-4f24-416e-8c98-b9463b43c7ac" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8d2bfe35-75a0-4d64-a056-98142ec7bd3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_420afc78-a57b-4338-80db-bb3881bdd598" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8d2bfe35-75a0-4d64-a056-98142ec7bd3c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_420afc78-a57b-4338-80db-bb3881bdd598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0d4fd7f6-c181-49ba-beb5-a49bf63cfd53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8d2bfe35-75a0-4d64-a056-98142ec7bd3c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0d4fd7f6-c181-49ba-beb5-a49bf63cfd53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_d6dc6792-6ef0-4163-ad04-8b990e979502" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_d5c18272-4f24-416e-8c98-b9463b43c7ac" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_d6dc6792-6ef0-4163-ad04-8b990e979502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_54d66930-216c-4c75-990d-133b54ef7852" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_d6dc6792-6ef0-4163-ad04-8b990e979502" xlink:to="loc_us-gaap_EarningsPerShareBasic_54d66930-216c-4c75-990d-133b54ef7852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_08e7a91e-f9b7-466d-9b33-2adedca32ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_d6dc6792-6ef0-4163-ad04-8b990e979502" xlink:to="loc_us-gaap_EarningsPerShareDiluted_08e7a91e-f9b7-466d-9b33-2adedca32ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ced3996f-a175-4a89-9296-c3ce5fcbe74d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_d5c18272-4f24-416e-8c98-b9463b43c7ac" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ced3996f-a175-4a89-9296-c3ce5fcbe74d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/EarningsPerShareNarrativeDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#EarningsPerShareNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/EarningsPerShareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b8f4c4d4-5e37-4c1d-867c-05543d66ed7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SaleOfStockTable_2d4bbb6d-2539-4c89-bc51-2562aa3d4df9" xlink:href="sgry-20210930.xsd#sgry_SaleOfStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b8f4c4d4-5e37-4c1d-867c-05543d66ed7f" xlink:to="loc_sgry_SaleOfStockTable_2d4bbb6d-2539-4c89-bc51-2562aa3d4df9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_9f9b821a-3d80-4fde-9303-d36470aac80d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_SaleOfStockTable_2d4bbb6d-2539-4c89-bc51-2562aa3d4df9" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_9f9b821a-3d80-4fde-9303-d36470aac80d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c9d5eb48-b02b-4301-b60a-2aec8d8ea3cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_9f9b821a-3d80-4fde-9303-d36470aac80d" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c9d5eb48-b02b-4301-b60a-2aec8d8ea3cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PublicStockOfferingMember_b1552b6c-b2b4-42fb-96a7-2dc8109ad280" xlink:href="sgry-20210930.xsd#sgry_PublicStockOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c9d5eb48-b02b-4301-b60a-2aec8d8ea3cf" xlink:to="loc_sgry_PublicStockOfferingMember_b1552b6c-b2b4-42fb-96a7-2dc8109ad280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PublicStockOfferingFirmSharesMember_a15dd971-e46b-4cb7-b36d-5d7e07f6f117" xlink:href="sgry-20210930.xsd#sgry_PublicStockOfferingFirmSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_PublicStockOfferingMember_b1552b6c-b2b4-42fb-96a7-2dc8109ad280" xlink:to="loc_sgry_PublicStockOfferingFirmSharesMember_a15dd971-e46b-4cb7-b36d-5d7e07f6f117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_5d3e367e-3196-4ec8-b36f-b7bd247743cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_PublicStockOfferingMember_b1552b6c-b2b4-42fb-96a7-2dc8109ad280" xlink:to="loc_us-gaap_OverAllotmentOptionMember_5d3e367e-3196-4ec8-b36f-b7bd247743cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_5966a485-ecfc-4828-ae2c-914ac79e84b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_SaleOfStockTable_2d4bbb6d-2539-4c89-bc51-2562aa3d4df9" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_5966a485-ecfc-4828-ae2c-914ac79e84b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_d500a70f-6287-4152-a9a4-aba08e37cbe1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_5966a485-ecfc-4828-ae2c-914ac79e84b7" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_d500a70f-6287-4152-a9a4-aba08e37cbe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember_dd1ca143-3c3f-4615-8781-9163818d5cb9" xlink:href="sgry-20210930.xsd#sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_d500a70f-6287-4152-a9a4-aba08e37cbe1" xlink:to="loc_sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember_dd1ca143-3c3f-4615-8781-9163818d5cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_d9a0a73d-3b50-493a-91bb-daeb39bb9df0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_SaleOfStockTable_2d4bbb6d-2539-4c89-bc51-2562aa3d4df9" xlink:to="loc_us-gaap_StatementClassOfStockAxis_d9a0a73d-3b50-493a-91bb-daeb39bb9df0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_66e09b89-788b-4e40-9dd5-31066c12c085" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d9a0a73d-3b50-493a-91bb-daeb39bb9df0" xlink:to="loc_us-gaap_ClassOfStockDomain_66e09b89-788b-4e40-9dd5-31066c12c085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_320bfdd9-0962-464d-9062-e8841dfb8455" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_66e09b89-788b-4e40-9dd5-31066c12c085" xlink:to="loc_us-gaap_CommonClassAMember_320bfdd9-0962-464d-9062-e8841dfb8455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_e50b3fbd-9c69-4d53-b55b-2bedf685b57e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_65dc4bda-f334-4a4d-81be-276759efb16b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember_d5292cdf-03fc-412f-8aa5-fbd7c865d1f0" xlink:href="sgry-20210930.xsd#sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_fd5337fd-50cd-4e18-a68a-88eab064d47c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_da0bcc34-4972-4b96-8ccc-d9bf8b37d74b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_a4413915-a2d4-4960-ba43-c9fc9a8980d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SaleOfStockLineItems_5f91f719-82e0-4316-bd5a-7b883b37d7ea" xlink:href="sgry-20210930.xsd#sgry_SaleOfStockLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_SaleOfStockTable_2d4bbb6d-2539-4c89-bc51-2562aa3d4df9" xlink:to="loc_sgry_SaleOfStockLineItems_5f91f719-82e0-4316-bd5a-7b883b37d7ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_1eb6b911-f167-4c6a-93a8-16d095128cf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_SaleOfStockLineItems_5f91f719-82e0-4316-bd5a-7b883b37d7ea" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_1eb6b911-f167-4c6a-93a8-16d095128cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_2f52c296-359a-4664-80c3-3e179dfff911" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_SaleOfStockLineItems_5f91f719-82e0-4316-bd5a-7b883b37d7ea" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_2f52c296-359a-4664-80c3-3e179dfff911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_bac726a5-6709-450e-a5d7-ce553fd7e87e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_SaleOfStockLineItems_5f91f719-82e0-4316-bd5a-7b883b37d7ea" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_bac726a5-6709-450e-a5d7-ce553fd7e87e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_eeb0ee72-5ce7-4c16-8da3-80a277547f62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_SaleOfStockLineItems_5f91f719-82e0-4316-bd5a-7b883b37d7ea" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_eeb0ee72-5ce7-4c16-8da3-80a277547f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_cf3b680a-5d98-4fca-a3ad-187d65f5de3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_SaleOfStockLineItems_5f91f719-82e0-4316-bd5a-7b883b37d7ea" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_cf3b680a-5d98-4fca-a3ad-187d65f5de3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1_e2ea1c0a-5b09-4e3c-8f38-5ab4c3e5261e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_SaleOfStockLineItems_5f91f719-82e0-4316-bd5a-7b883b37d7ea" xlink:to="loc_us-gaap_ConversionOfStockSharesIssued1_e2ea1c0a-5b09-4e3c-8f38-5ab4c3e5261e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1_708d3c98-1d04-4c4a-8497-a2dc7f443745" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OtherCurrentLiabilities" xlink:type="simple" xlink:href="sgry-20210930.xsd#OtherCurrentLiabilities"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/OtherCurrentLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_523d48b0-a921-4e6d-9511-a20ed30537ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_c9835a89-00bf-4215-a645-4c7ec1a0497e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_523d48b0-a921-4e6d-9511-a20ed30537ed" xlink:to="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_c9835a89-00bf-4215-a645-4c7ec1a0497e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OtherCurrentLiabilitiesTables" xlink:type="simple" xlink:href="sgry-20210930.xsd#OtherCurrentLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/OtherCurrentLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_9829e261-06f6-4213-b6c1-b8dc7af832b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_39e56217-9ee3-4b9e-b406-624d08fdf279" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_9829e261-06f6-4213-b6c1-b8dc7af832b4" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_39e56217-9ee3-4b9e-b406-624d08fdf279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#OtherCurrentLiabilitiesSummaryDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_97a3a0b0-604a-4a75-944d-3b873c897276" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_827f9155-09b1-4cc9-a017-29d9999816ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_97a3a0b0-604a-4a75-944d-3b873c897276" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_827f9155-09b1-4cc9-a017-29d9999816ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_a68a8cd1-53f3-4b09-887a-57a16ef85e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_97a3a0b0-604a-4a75-944d-3b873c897276" xlink:to="loc_us-gaap_InterestPayableCurrent_a68a8cd1-53f3-4b09-887a-57a16ef85e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_CostReportLiabilitiesCurrent_5a2a2344-781d-4210-aeaa-651fa342ac58" xlink:href="sgry-20210930.xsd#sgry_CostReportLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_97a3a0b0-604a-4a75-944d-3b873c897276" xlink:to="loc_sgry_CostReportLiabilitiesCurrent_5a2a2344-781d-4210-aeaa-651fa342ac58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_PayablesToCustomers_f83361fc-7d08-4b69-aa4d-524708180749" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_PayablesToCustomers"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_97a3a0b0-604a-4a75-944d-3b873c897276" xlink:to="loc_srt_PayablesToCustomers_f83361fc-7d08-4b69-aa4d-524708180749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_TaxReceivableAgreementLiabilityCurrent_ac23e56f-d3b4-451a-83a6-ee560c05921d" xlink:href="sgry-20210930.xsd#sgry_TaxReceivableAgreementLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_97a3a0b0-604a-4a75-944d-3b873c897276" xlink:to="loc_sgry_TaxReceivableAgreementLiabilityCurrent_ac23e56f-d3b4-451a-83a6-ee560c05921d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_f054d5dc-3f68-447f-bce0-e68e40757b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_97a3a0b0-604a-4a75-944d-3b873c897276" xlink:to="loc_us-gaap_LitigationReserveCurrent_f054d5dc-3f68-447f-bce0-e68e40757b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_c415e050-7284-43e5-98fe-9ac34d37a1e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_97a3a0b0-604a-4a75-944d-3b873c897276" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_c415e050-7284-43e5-98fe-9ac34d37a1e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_d28334c3-7a4f-41ac-a100-6b400b973d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_97a3a0b0-604a-4a75-944d-3b873c897276" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_d28334c3-7a4f-41ac-a100-6b400b973d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="sgry-20210930.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_381e9fbe-9424-46bc-84b3-97f57dd9ff20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_7676c5d8-3f73-49f0-93d0-c0f36d499dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_381e9fbe-9424-46bc-84b3-97f57dd9ff20" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_7676c5d8-3f73-49f0-93d0-c0f36d499dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_db980ad6-d800-4f41-b021-473eff7a3a18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_ae37ed7e-1fee-45b3-ac6a-3eec2e38734e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGuaranteeObligationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_db980ad6-d800-4f41-b021-473eff7a3a18" xlink:to="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_ae37ed7e-1fee-45b3-ac6a-3eec2e38734e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_f069ce35-a8f9-4fae-a7d1-42a4a5c540d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_ae37ed7e-1fee-45b3-ac6a-3eec2e38734e" xlink:to="loc_us-gaap_VariableRateAxis_f069ce35-a8f9-4fae-a7d1-42a4a5c540d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_9ea6892d-2fcf-4532-bc17-94d64bc826ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_f069ce35-a8f9-4fae-a7d1-42a4a5c540d4" xlink:to="loc_us-gaap_VariableRateDomain_9ea6892d-2fcf-4532-bc17-94d64bc826ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_7d1160ad-aeaa-4527-bea5-a7e806e430a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_9ea6892d-2fcf-4532-bc17-94d64bc826ca" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_7d1160ad-aeaa-4527-bea5-a7e806e430a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_fbfbd1d3-52a0-47e5-8633-2a7e62187ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_9ea6892d-2fcf-4532-bc17-94d64bc826ca" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_fbfbd1d3-52a0-47e5-8633-2a7e62187ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualRiskOrUncertaintyByNatureAxis_8b5c50b9-3fcc-4e98-956b-d3bca7a291bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualRiskOrUncertaintyByNatureAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_ae37ed7e-1fee-45b3-ac6a-3eec2e38734e" xlink:to="loc_us-gaap_UnusualRiskOrUncertaintyByNatureAxis_8b5c50b9-3fcc-4e98-956b-d3bca7a291bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualRiskOrUncertaintyNatureDomain_5f8474ad-0310-4328-aafb-48d2c7a5da2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualRiskOrUncertaintyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualRiskOrUncertaintyByNatureAxis_8b5c50b9-3fcc-4e98-956b-d3bca7a291bd" xlink:to="loc_us-gaap_UnusualRiskOrUncertaintyNatureDomain_5f8474ad-0310-4328-aafb-48d2c7a5da2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_MateriallyMoreRestrictiveMember_94c6abae-0f74-465d-a1bb-26533800811c" xlink:href="sgry-20210930.xsd#sgry_MateriallyMoreRestrictiveMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualRiskOrUncertaintyNatureDomain_5f8474ad-0310-4328-aafb-48d2c7a5da2e" xlink:to="loc_sgry_MateriallyMoreRestrictiveMember_94c6abae-0f74-465d-a1bb-26533800811c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NotMateriallyMoreRestrictiveMember_0a1393c6-7585-4a70-a327-fd36e92674da" xlink:href="sgry-20210930.xsd#sgry_NotMateriallyMoreRestrictiveMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualRiskOrUncertaintyNatureDomain_5f8474ad-0310-4328-aafb-48d2c7a5da2e" xlink:to="loc_sgry_NotMateriallyMoreRestrictiveMember_0a1393c6-7585-4a70-a327-fd36e92674da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsLineItems_c7e09e40-c7d1-478d-912d-ee1bb38896aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_ae37ed7e-1fee-45b3-ac6a-3eec2e38734e" xlink:to="loc_us-gaap_GuaranteeObligationsLineItems_c7e09e40-c7d1-478d-912d-ee1bb38896aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve_3a436f3e-27b2-4643-a9ad-3b6cc26f1204" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_c7e09e40-c7d1-478d-912d-ee1bb38896aa" xlink:to="loc_us-gaap_SelfInsuranceReserve_3a436f3e-27b2-4643-a9ad-3b6cc26f1204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimatedInsuranceRecoveries_859e64fc-29d0-4a9b-bf02-27f8b655ca60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimatedInsuranceRecoveries"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_c7e09e40-c7d1-478d-912d-ee1bb38896aa" xlink:to="loc_us-gaap_EstimatedInsuranceRecoveries_859e64fc-29d0-4a9b-bf02-27f8b655ca60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_7c7274b4-9461-430d-bbb2-940323c8a040" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_c7e09e40-c7d1-478d-912d-ee1bb38896aa" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_7c7274b4-9461-430d-bbb2-940323c8a040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_09f864b7-0e42-441d-b06e-18cd9b57e681" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_c7e09e40-c7d1-478d-912d-ee1bb38896aa" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_09f864b7-0e42-441d-b06e-18cd9b57e681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm_ed67d75e-1a47-41ac-ab01-185470bd29f8" xlink:href="sgry-20210930.xsd#sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_c7e09e40-c7d1-478d-912d-ee1bb38896aa" xlink:to="loc_sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm_ed67d75e-1a47-41ac-ab01-185470bd29f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_681de85e-5465-4bbf-aa5e-b9977ba8f402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_c7e09e40-c7d1-478d-912d-ee1bb38896aa" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_681de85e-5465-4bbf-aa5e-b9977ba8f402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate_d4508f7a-78a8-4480-b4bc-31ed6e561d6c" xlink:href="sgry-20210930.xsd#sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_c7e09e40-c7d1-478d-912d-ee1bb38896aa" xlink:to="loc_sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate_d4508f7a-78a8-4480-b4bc-31ed6e561d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_342dada3-55cc-467b-96d6-9b4cf145aad6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_c7e09e40-c7d1-478d-912d-ee1bb38896aa" xlink:to="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_342dada3-55cc-467b-96d6-9b4cf145aad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount_d602c607-4cf5-4b84-8bad-48a2481d186e" xlink:href="sgry-20210930.xsd#sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_c7e09e40-c7d1-478d-912d-ee1bb38896aa" xlink:to="loc_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount_d602c607-4cf5-4b84-8bad-48a2481d186e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent_75b27abf-61ce-4157-b223-f4c473b9faa0" xlink:href="sgry-20210930.xsd#sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_c7e09e40-c7d1-478d-912d-ee1bb38896aa" xlink:to="loc_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent_75b27abf-61ce-4157-b223-f4c473b9faa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/SegmentReporting" xlink:type="simple" xlink:href="sgry-20210930.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a2bbb1be-343f-4424-a50f-aebbdaaf4828" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_3e574f94-4b1b-4abf-9cb0-69fbd3f019fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a2bbb1be-343f-4424-a50f-aebbdaaf4828" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_3e574f94-4b1b-4abf-9cb0-69fbd3f019fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="sgry-20210930.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_1edff962-fdf9-4a63-9cd5-d326b555bc8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_dcd3d85a-ee07-41bf-8f08-57cfce70a547" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_1edff962-fdf9-4a63-9cd5-d326b555bc8e" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_dcd3d85a-ee07-41bf-8f08-57cfce70a547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_5af1ca92-29d6-4603-92b2-866d642f39e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_1edff962-fdf9-4a63-9cd5-d326b555bc8e" xlink:to="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_5af1ca92-29d6-4603-92b2-866d642f39e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_acf12084-40f2-4322-b45a-0fb55239509f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_1edff962-fdf9-4a63-9cd5-d326b555bc8e" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_acf12084-40f2-4322-b45a-0fb55239509f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_e51a322d-537b-40df-9e28-156d23d8f7d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_42caff03-68b0-40f7-9659-c9d89d76cda8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_e51a322d-537b-40df-9e28-156d23d8f7d4" xlink:to="loc_us-gaap_NumberOfOperatingSegments_42caff03-68b0-40f7-9659-c9d89d76cda8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5dcd368f-9c2f-4005-829e-9c4802f6db23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_e51a322d-537b-40df-9e28-156d23d8f7d4" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5dcd368f-9c2f-4005-829e-9c4802f6db23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_ee2c2510-96b6-4b05-a588-897da74b524f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5dcd368f-9c2f-4005-829e-9c4802f6db23" xlink:to="loc_srt_ConsolidationItemsAxis_ee2c2510-96b6-4b05-a588-897da74b524f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_99633eb1-0b42-4dfb-a4e3-9f26124868be" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_ee2c2510-96b6-4b05-a588-897da74b524f" xlink:to="loc_srt_ConsolidationItemsDomain_99633eb1-0b42-4dfb-a4e3-9f26124868be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_22d0ec14-3c7c-410f-aa88-49b4798e3026" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_99633eb1-0b42-4dfb-a4e3-9f26124868be" xlink:to="loc_us-gaap_OperatingSegmentsMember_22d0ec14-3c7c-410f-aa88-49b4798e3026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_e72f4859-5ef9-47b1-9093-1378753e7537" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_99633eb1-0b42-4dfb-a4e3-9f26124868be" xlink:to="loc_us-gaap_CorporateNonSegmentMember_e72f4859-5ef9-47b1-9093-1378753e7537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c408cff2-88e5-40d4-8540-9a116914ef75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5dcd368f-9c2f-4005-829e-9c4802f6db23" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c408cff2-88e5-40d4-8540-9a116914ef75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_119ea4e6-0f9a-4b6b-a2a6-6f1aed0729a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c408cff2-88e5-40d4-8540-9a116914ef75" xlink:to="loc_us-gaap_SegmentDomain_119ea4e6-0f9a-4b6b-a2a6-6f1aed0729a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SurgicalFacilityServicesMember_5f7252f6-b7df-45d3-a1e4-cd2d3fe68a5d" xlink:href="sgry-20210930.xsd#sgry_SurgicalFacilityServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_119ea4e6-0f9a-4b6b-a2a6-6f1aed0729a5" xlink:to="loc_sgry_SurgicalFacilityServicesMember_5f7252f6-b7df-45d3-a1e4-cd2d3fe68a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_AncillaryServicesMember_a435b72f-717e-4855-a804-21a9a4774ba2" xlink:href="sgry-20210930.xsd#sgry_AncillaryServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_119ea4e6-0f9a-4b6b-a2a6-6f1aed0729a5" xlink:to="loc_sgry_AncillaryServicesMember_a435b72f-717e-4855-a804-21a9a4774ba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_OpticalServicesMember_c30680ec-7913-4edb-8e30-aedcbe8b3cd2" xlink:href="sgry-20210930.xsd#sgry_OpticalServicesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_119ea4e6-0f9a-4b6b-a2a6-6f1aed0729a5" xlink:to="loc_sgry_OpticalServicesMember_c30680ec-7913-4edb-8e30-aedcbe8b3cd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_cc75955d-d7cd-4729-8b3c-d97d5d5a7354" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5dcd368f-9c2f-4005-829e-9c4802f6db23" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_cc75955d-d7cd-4729-8b3c-d97d5d5a7354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_d9f64b38-c4a7-4e8e-8993-f2ecb6e6b187" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cc75955d-d7cd-4729-8b3c-d97d5d5a7354" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_d9f64b38-c4a7-4e8e-8993-f2ecb6e6b187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization_94a14dcb-d181-454e-aca4-ecb0b21f1a91" xlink:href="sgry-20210930.xsd#sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cc75955d-d7cd-4729-8b3c-d97d5d5a7354" xlink:to="loc_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization_94a14dcb-d181-454e-aca4-ecb0b21f1a91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cc75955d-d7cd-4729-8b3c-d97d5d5a7354" xlink:to="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_be772b91-40c1-4c20-b952-0be53764b48b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_be772b91-40c1-4c20-b952-0be53764b48b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_eb336b70-183c-471c-a772-c482345acf06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_eb336b70-183c-471c-a772-c482345acf06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_8106f0eb-4426-47f3-9c81-2a0f1d31930d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_8106f0eb-4426-47f3-9c81-2a0f1d31930d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_a4542e45-97ca-4644-81ed-1f8998edb669" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_a4542e45-97ca-4644-81ed-1f8998edb669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_002df161-b02e-4760-97e0-d26bdfc29aae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:to="loc_us-gaap_ShareBasedCompensation_002df161-b02e-4760-97e0-d26bdfc29aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts_7cdeb66e-565e-4910-8d5b-a04167ef435c" xlink:href="sgry-20210930.xsd#sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:to="loc_sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts_7cdeb66e-565e-4910-8d5b-a04167ef435c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_0e24b996-9edb-46e9-b22d-6f2ef21d2092" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:to="loc_us-gaap_AssetImpairmentCharges_0e24b996-9edb-46e9-b22d-6f2ef21d2092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation_19e4a720-1946-4c27-9ded-e40d997e5ea0" xlink:href="sgry-20210930.xsd#sgry_GainLossOnDispositionOfAssetsAndDeconsolidation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:to="loc_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation_19e4a720-1946-4c27-9ded-e40d997e5ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts_ed9d37c8-0c22-42c2-8865-36eb96208074" xlink:href="sgry-20210930.xsd#sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:to="loc_sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts_ed9d37c8-0c22-42c2-8865-36eb96208074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_4e80713c-2012-4bbf-b983-de870e89aabf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_4e80713c-2012-4bbf-b983-de870e89aabf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_BusinessCombinationGainLossOnAcquisitionEscrow_6b8c5148-6aa6-4443-8125-c1abea70b52c" xlink:href="sgry-20210930.xsd#sgry_BusinessCombinationGainLossOnAcquisitionEscrow"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:to="loc_sgry_BusinessCombinationGainLossOnAcquisitionEscrow_6b8c5148-6aa6-4443-8125-c1abea70b52c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemNetGainLoss_f655d4b4-fcc1-4ae4-8422-f2aa18964cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemNetGainLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:to="loc_us-gaap_UnusualOrInfrequentItemNetGainLoss_f655d4b4-fcc1-4ae4-8422-f2aa18964cd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization_18253484-c9b9-4221-b316-97739469b2f3" xlink:href="sgry-20210930.xsd#sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:to="loc_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization_18253484-c9b9-4221-b316-97739469b2f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_f3407d96-cdfb-4681-bd2b-0cd82c52e51b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_f3407d96-cdfb-4681-bd2b-0cd82c52e51b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_926a5ad8-a3e2-465f-8f88-b0d05cffa1d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_926a5ad8-a3e2-465f-8f88-b0d05cffa1d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_b96fb076-4efb-45ea-b2ca-e44ec0f3f83c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:to="loc_us-gaap_LitigationSettlementExpense_b96fb076-4efb-45ea-b2ca-e44ec0f3f83c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_7bdf95f0-4904-4d04-8f48-f6a62d931a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_0433fad1-24cf-4c5f-9aa3-ab752dc67c3e" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_7bdf95f0-4904-4d04-8f48-f6a62d931a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_6e4e05d2-9b78-4753-8bdd-20a6a76af431" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_754bab23-531b-4bc4-be82-276a80461a55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_6e4e05d2-9b78-4753-8bdd-20a6a76af431" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_754bab23-531b-4bc4-be82-276a80461a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_3fb65a36-db90-4312-a7c4-78beca80cd54" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_754bab23-531b-4bc4-be82-276a80461a55" xlink:to="loc_srt_ConsolidationItemsAxis_3fb65a36-db90-4312-a7c4-78beca80cd54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_88c4d88d-8e61-4d92-9033-1f67b8dd5902" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_3fb65a36-db90-4312-a7c4-78beca80cd54" xlink:to="loc_srt_ConsolidationItemsDomain_88c4d88d-8e61-4d92-9033-1f67b8dd5902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_e032ee9b-73ef-4e79-86ea-789581dc4f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_88c4d88d-8e61-4d92-9033-1f67b8dd5902" xlink:to="loc_us-gaap_OperatingSegmentsMember_e032ee9b-73ef-4e79-86ea-789581dc4f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_e21421dc-4719-4455-bc84-f0ad3659beb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_88c4d88d-8e61-4d92-9033-1f67b8dd5902" xlink:to="loc_us-gaap_CorporateNonSegmentMember_e21421dc-4719-4455-bc84-f0ad3659beb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1e5a51c8-543d-4411-81a4-ffa2bf3b09ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_754bab23-531b-4bc4-be82-276a80461a55" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1e5a51c8-543d-4411-81a4-ffa2bf3b09ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_79578c4f-3bf0-41a2-99b0-331b353db9c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1e5a51c8-543d-4411-81a4-ffa2bf3b09ff" xlink:to="loc_us-gaap_SegmentDomain_79578c4f-3bf0-41a2-99b0-331b353db9c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SurgicalFacilityServicesMember_f2a3f1ea-a9fa-447c-924b-c841001a5a8e" xlink:href="sgry-20210930.xsd#sgry_SurgicalFacilityServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_79578c4f-3bf0-41a2-99b0-331b353db9c0" xlink:to="loc_sgry_SurgicalFacilityServicesMember_f2a3f1ea-a9fa-447c-924b-c841001a5a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_AncillaryServicesMember_1f21f8ca-9755-489a-845c-def68cc1ca5a" xlink:href="sgry-20210930.xsd#sgry_AncillaryServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_79578c4f-3bf0-41a2-99b0-331b353db9c0" xlink:to="loc_sgry_AncillaryServicesMember_1f21f8ca-9755-489a-845c-def68cc1ca5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_9f44a5e9-4135-4548-b16a-8488c4df90bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_754bab23-531b-4bc4-be82-276a80461a55" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_9f44a5e9-4135-4548-b16a-8488c4df90bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_f093df91-4968-4000-89e8-3b58d4dd37ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9f44a5e9-4135-4548-b16a-8488c4df90bf" xlink:to="loc_us-gaap_Assets_f093df91-4968-4000-89e8-3b58d4dd37ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_9c4e1364-9626-499f-a13c-ae8b3f19aa89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9f44a5e9-4135-4548-b16a-8488c4df90bf" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_9c4e1364-9626-499f-a13c-ae8b3f19aa89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/SubsequentEvents" xlink:type="simple" xlink:href="sgry-20210930.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_9f8e1fce-13a7-4cab-a5e9-9abf8123d731" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_b9bb4a75-07e9-427c-8391-16003763215b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_9f8e1fce-13a7-4cab-a5e9-9abf8123d731" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_b9bb4a75-07e9-427c-8391-16003763215b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/SubsequentEventsNarrativeDetails" xlink:type="simple" xlink:href="sgry-20210930.xsd#SubsequentEventsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/SubsequentEventsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_fcc18dd1-d886-4519-9cae-b71b38148c08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_8494df2c-ae22-470b-9d29-4db92c511cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_fcc18dd1-d886-4519-9cae-b71b38148c08" xlink:to="loc_us-gaap_SubsequentEventTable_8494df2c-ae22-470b-9d29-4db92c511cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_7005a322-6739-47d3-80f9-540b8359c312" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_8494df2c-ae22-470b-9d29-4db92c511cb8" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_7005a322-6739-47d3-80f9-540b8359c312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1f6daa0f-4ea8-464e-91c2-f20b21fe4099" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_7005a322-6739-47d3-80f9-540b8359c312" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1f6daa0f-4ea8-464e-91c2-f20b21fe4099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_b648497e-73f0-443a-8dff-f1ef773f3c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1f6daa0f-4ea8-464e-91c2-f20b21fe4099" xlink:to="loc_us-gaap_SubsequentEventMember_b648497e-73f0-443a-8dff-f1ef773f3c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4b996948-dbfd-4315-9687-b7958ad28f58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_8494df2c-ae22-470b-9d29-4db92c511cb8" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4b996948-dbfd-4315-9687-b7958ad28f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e66e3ac9-1423-4b30-ba44-f648bc273cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4b996948-dbfd-4315-9687-b7958ad28f58" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e66e3ac9-1423-4b30-ba44-f648bc273cd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SurgicalFacilitiesExistingMarketsMember_4d410e06-2462-4239-b5bf-1763f825dd49" xlink:href="sgry-20210930.xsd#sgry_SurgicalFacilitiesExistingMarketsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e66e3ac9-1423-4b30-ba44-f648bc273cd9" xlink:to="loc_sgry_SurgicalFacilitiesExistingMarketsMember_4d410e06-2462-4239-b5bf-1763f825dd49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_de7759d7-f103-4f38-b524-341ced65a9f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_8494df2c-ae22-470b-9d29-4db92c511cb8" xlink:to="loc_us-gaap_SubsequentEventLineItems_de7759d7-f103-4f38-b524-341ced65a9f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_6052605a-99e0-4d58-902a-f57babc93a29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_de7759d7-f103-4f38-b524-341ced65a9f6" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_6052605a-99e0-4d58-902a-f57babc93a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>sgry-20210930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:sgry="http://www.surgerypartners.com/20210930"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="sgry-20210930.xsd" xlink:type="simple"/>
    <context id="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2b2125d4d75646e88ad9f2ad3127cbad_I20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <instant>2021-10-29</instant>
        </period>
    </context>
    <context id="i882aa7da35e6452cbe7ffa904416e6cd_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia9055b0c653648f0919c1c9b458ca340_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if7ea101365284e93a6ac503e7e44170b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9c05ce754df645d98f80d7ffa09f927e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if9aa0d95886f432db9278aadacd55da4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i40304b7c460b45958fb265491cf6bb14_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie7bf9f7034fb4595a4b18217e2ceaeb0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib5484a5886424dc6b347b2b8ba32b919_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iac8c4f727e89495faa49068c7628988d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib3af38d809db4b7a8d26a05b63fa42b5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5a44af99afa44f24bc727649252223dc_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6453064d41354fd1bc9110d0cd3c3e4c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id9d3034dcc144fa3a6b470e98cc8e6c7_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib36db35e625047569233e786bdc89d3a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8e786c45dae04a89a45c7c72c011e04a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="icde2fc5b1e01435d98af7a6ea3c9d3ee_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if7bc8516124c4fafb914be3b2c9936ba_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7a8fd0aa6b7a4d549e90dc2fb6ab3ff3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie80e658267b44f07b2ddd4012b02d206_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4ab7dd37d1e7404696a9549accda39b9_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iee943e15508949c2baaacaa9fdc9724c_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i30ed8caf27dd4768b110022f3860e021_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5827f320e258406b952e1a452a006818_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie856a8782f374508af805ab30b4d7f1a_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i25643604ef6c4d269d4585afa6c3ba1b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i53a6a629d2c54847bafd53081201b921_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6cddba9fa8504c48ac5dd4b5006afdd6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i99bd0353d66749c5b88fe887803a2f51_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5379e81f3c3549b4ab8058d34662a9dc_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6936b3e1ceae47a881d3535da654ef72_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib382c78377b74941b68729e139319e6b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="idbf85fe5fc0e4c159aecfae0b8c53435_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8af1e4e9ef8b4538abb29b36d015c7ae_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia7899289c9f0473bb1689d5ee1c73d47_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i694eeba75abb4a6e87f66ac345a9c219_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i73f4af3ea9df4ed2b218df3257e2721c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9016d0b2b49e436eb7581ad09f123943_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i53ed285db0384407b947ec9264dbbe9e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id0ba3f14ca9b4ad5bc0acd92524c74d0_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia878eeebac2e40afa6724b929ac0040e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7c4b9a7850e5426e85fd9a49ad79c29f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i5e1addbe96484bc7b75825f9c8dc7a58_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3bada32aacf64a1ead6b4b370e83e526_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i34d67e0b428b44e281d788187793a269_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if4a87dd7e0b445fca10ae39b0ed707d3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i87973734c6ee4a99945e9948dbf8e70c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i723b8483c8a44fa3831eba25ac4e8771_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if614186fb0024af2a131eccab2af782d_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i04307c27f0e44baa8e6d7ba57acdb88e_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ie870b4adc63f46feb66eb8a8c8e4d011_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iae6e1dc8f3104428a423e41e99d59cf9_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iec6e709cf8ff41aaa43ed32125aaa1ad_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i73a098cbb4e54750892085bb826f7c51_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i65bbc1666baf4ab58e1d5def95db43cd_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i0302db6bf7784a859b41b1557a29eada_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i02e8e2f7aa5d4308af89bd5d9eaa7cab_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8b951a38115c49a0a25b0d9d1a4a8894_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i28fe5537d2e64becaa3ad572da05ec1b_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i19264b0de7ab4eb8b0352aece77637f2_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="idfdd711a02e74ca889726084c6b89bb3_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i645577772ef04b6580b69faed65e927c_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i46f6e83b5d4c4d579db2515cc00632b1_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5d60bb0e88bd464082a32b07117af980_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i81ab0a7efcd546818b950401c349d061_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3eb05b01366a444c95e4e82842f9a25b_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib021d0c212de49bca1b78b3cc314c610_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i04dd444ed05f4a46a5ab9054213d6ca2_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="if2409f81f8b64985bad5ef07e2f6ea31_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ic66bbcb9058847ae98f2300c873039bd_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ia5e06688327645e0bf1b08b54c9f4601_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ife84e5119b9d41d2997dd2e6bc21006f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="iae7a31bb630448b9a2fada4b9475deaa_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9544c9d9dc744b44bb14b59cccb2d54b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iddbb89f01a7d4e139ba298e541047140_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2ef302e3ae1f4cd8bde62e0c447620d0_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i394e252b2ffa4fd0b8c8e8d0f831e656_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i95271104483f4cd2a13aa0fd11c4c9c4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i42f848f9a2a94d5e9604c62328ab388a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2c4b6f5d56814c14aba12fdc98258eea_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i219bd4659c5a4f2ba0b0d28c6bdde0d5_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i711cc27756dd4866a36dee4b75131f1d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id38661458bd24a6c81732c5d5160d949_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0b8f04298f2f4487880978d9ac283c40_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:FacilitiesAmbulatorySurgeryCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ifac1f29acb89455b90f5cd970447f0a9_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:FacilitiesSurgicalHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i40f463b41ec94ef59b20aaf801aebf70_D20200327-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <startDate>2020-03-27</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifbd2503cfbf74ec8aa4c1f9de99fff89_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i32be3c0b3a7f46518fcdfa2dab23569e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i894cda222d3d4b14afb4128bc02678fd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i962fa35551cd479c8e9aed5680bfb517_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017TermLoanMaturing2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7c9c6ffb79ae4ec5815bfd1526797134_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017TermLoanMaturing2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icaca869429314f97a2375ca94953fd78_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017TermLoanMaturing2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i42b70d9ee17d4631895533f028803e8b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017TermLoanMaturing2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2bacc8e8772841cdbb2620ef10c4ca4f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i667f3ee4fc3f4e098746acef1144296f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id2b7f57e6dc049148da6841ad22d457f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icbfc05d48fc543a19f054a1cc19d7fe1_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iaffb336a9a3b4525984047c9cd6a707e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic8eddef2cc304b9c98cff9dfa3b5279d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i95aa1f95aa154cc1b14c588d17ea7543_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie7fe14d003214347b2cc288cb20c5df6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6c4016e7689e4c859eccdeea6ca19ac5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i5d8af47260764ab4a3254e17e605316e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5a36782fa2bc4df19287a1556d0bf2c4_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if728a9865da84a0380fd1550912931a8_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i54e5084300b248e6920827b61dce0943_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1f1c728ff4fa4a09ab6c46f289cf0c49_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i843b1778208d4e50b16f7c11bdf1e6fb_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5c8ee242dc044d2c9036d788a9a56762_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4af18ac975044d50a2ea274814e3f36d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i882ea7583a5546c7a0376ce43d387ecf_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i63770fd818324501b078a13e278a2991_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i85aeab70f1b346e3b6010265e0f54c1b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8f0e94193ec74331b69bee876be7394b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i32c65d19973748b8abb14d3b08023423_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if0fb8315dd704b23a2452d16f9d4169f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1699c2a292e44cc0ba2155cd47ae8171_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i11b91707b010413287ffa0b97b9edd79_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7cab1a6fb67e44eb9f664045e38c77fb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic18ae544123642ddbc9fb91be061be82_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i201f9b152e43400da5c39192eee73807_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0962a819986d4646b1b65ccf8a64364a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i72f9be049f1c4e16b1369f54ef365688_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3c428e120f3b4e7b8ec14607857cd6c0_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:PrivateInsuranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ife562b2a0b4b43f7a740f883ebb3f9b2_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:PrivateInsuranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6a422701acfb4654890456c3f48a79f6_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:PrivateInsuranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0b1711cca24e4b1bab0201cd8a60b43d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:PrivateInsuranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie849beb4c21f4b39aabfc1121489da56_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GovernmentContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i02b93a2c47cf40a48adee19c7d6fa0d4_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GovernmentContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9e24a27c70c5488b809dc406c7f2b718_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GovernmentContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibc799fec3e51413a9fc7c55e26f13cb5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GovernmentContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib90d2af58a99466c8a29503e4f921426_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SelfPayRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if9f0bd05efdd438c8ab2afdf0d745752_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SelfPayRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8d82a46716de4518ac0b5840519715d5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SelfPayRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic7663ed8a8ac40619a7d5b3ba42a13f6_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SelfPayRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1b7a80a48aef4f70976ee8453ca6ce93_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherPatientServiceRevenueSourcesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id9d4994c80754a68880bfc13a642ede4_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherPatientServiceRevenueSourcesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i234d99c99d2f4f739eae5fea2587ff52_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherPatientServiceRevenueSourcesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i55e1271c0167429bb3d4328fcd101340_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherPatientServiceRevenueSourcesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i69813463e96b4ad5ad2215be2f949b59_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id7bc8fed1453459e9f611c96dc337763_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibd4def59018047f1a3fb46e36d9c173d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id87e71179efc435cbf5d5497ee13da93_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i01a782bdc9ca4f1981073ae5a91b46ed_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4692edb42bed4c66adc2020e302cbcf8_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2b478a448f1d417c80797c7716cbfd28_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:PrivateInsuranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8180fc2d8a6249dd8811a378d0ecb43e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:PrivateInsuranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3eb8b684a6d444be9b221c39b9fae635_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:PrivateInsuranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i45a407f7ad6e40059d9b211fc5bb9365_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:PrivateInsuranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3cab09bbdad14d0b965a11a034a5990c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GovernmentContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ica4a944ad4a44a4aa65601825760e1cb_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GovernmentContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i260cb7274b4b4e4c94ee4d68c91b5dbd_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GovernmentContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifc0ac37030af4e318d33ccfd2ab4e424_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GovernmentContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1004335253334a8c93031def1519e24f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SelfPayRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i50ffceccf0314f6a82061db05cc97ce3_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SelfPayRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i33d0674cc1fd4188a31803833a52a9c8_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SelfPayRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i77d5c398e437417096ffee0b774a3695_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SelfPayRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id8665a6cd8314ab9a760fa0b0a9f8993_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherPatientServiceRevenueSourcesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id077ce6df7bb4afaa072fd999ff742a6_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherPatientServiceRevenueSourcesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iebfa8b8fa273451ba8ff90cbb6df3b55_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherPatientServiceRevenueSourcesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9a43941cb1cc4a9a9cc87de4189023a4_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherPatientServiceRevenueSourcesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5c0a49e90fc4404c8e52a743f9dac439_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if78e1d4ca8e44e09afc12dd31cc9f3f1_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i39f55b837d7e4a3ba4f01efb13d89635_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia1f02fe0e7044c94a65bd438e74a232f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i83f6dd0a92d3471a856b0a9062de35ee_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i31b97175fcb54075b8a9d18788bcd4e8_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i18304528b10e4cf5ad801229a9076ceb_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">sgry:SurgicalFacilitiesNewMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i28bb531c0e434976827266bc64ff25c5_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">sgry:SurgicalFacilitiesExistingMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7e305bdf3ff54b04a60b6fe6642b9f6a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">sgry:SurgicalFacilitiesExistingMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0a13579da2b047bbaec50c1bfea80ffd_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017TermLoanMaturing2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4fc897253a9442a9a2188353b29a9de9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017TermLoanMaturing2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6be5a05e68144411af66ad15197c0602_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic05baa9bdba04592bd63550510944a35_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idf48234a181c4a79a5fb7a98c7b58186_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">sgry:NotesPayableAndSecuredLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id74f0993fe00448b8bee613cc4480b55_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">sgry:NotesPayableAndSecuredLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i36f0d89975a14bafb53bb8f74a75d68d_I20210127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017SeniorSecuredCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-27</instant>
        </period>
    </context>
    <context id="i4a3f44c7bfb64dcc8cb79cb5bf1acee6_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i297477a2c42e4f71ac25067c3ed77ad7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i131b465568af4c979a7999024ec537d2_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017SeniorSecuredCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if8cd6f59f10b43cba5e2609681a2b8ed_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017SeniorSecuredCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia69846ae143244c7b534d9be52a586b8_I20210503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-03</instant>
        </period>
    </context>
    <context id="ic2198de7087442b19f4693243784c6b6_I20210503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-03</instant>
        </period>
    </context>
    <context id="i959e09a7ea984f0da5610e0124ec6404_D20210503-20210503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-03</startDate>
            <endDate>2021-05-03</endDate>
        </period>
    </context>
    <context id="iebb24a566b9144d8b8d7fdb1d5cc3aad_D20210503-20210503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-03</startDate>
            <endDate>2021-05-03</endDate>
        </period>
    </context>
    <context id="i216348724a3a425d96f16ce750304715_D20210503-20210503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:FederalFundsEffectiveSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-03</startDate>
            <endDate>2021-05-03</endDate>
        </period>
    </context>
    <context id="ie83b774759cc472b85d1d0d1561fafb6_D20210503-20210503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">sgry:OneMonthLondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-03</startDate>
            <endDate>2021-05-03</endDate>
        </period>
    </context>
    <context id="icb8c8ccf05034972b3907a963deb3f26_D20210503-20210503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-03</startDate>
            <endDate>2021-05-03</endDate>
        </period>
    </context>
    <context id="iea9e184d11334ae0bf911f88c3c9df84_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i47cc30be5f9646198974e49f2c9e62ac_D20170831-20170831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:MajorityShareholderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-08-31</startDate>
            <endDate>2017-08-31</endDate>
        </period>
    </context>
    <context id="i3b26b76efac540d991bd9159654d84be_I20170831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:MajorityShareholderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-08-31</instant>
        </period>
    </context>
    <context id="if6b9767d8d5b496f900fae3b3d1d446a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id264cc07d6a44dcc9fd4169a79dd9ff8_D20210517-20210517">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">sgry:ConversionOfSeriesAPreferredStockIntoCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-17</startDate>
            <endDate>2021-05-17</endDate>
        </period>
    </context>
    <context id="i518a3c2c62754078a7891bd9741853b1_I20210517">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">sgry:ConversionOfSeriesAPreferredStockIntoCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-17</instant>
        </period>
    </context>
    <context id="i909487bf12ef47639fb9b75fbee5e586_I20210517">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-17</instant>
        </period>
    </context>
    <context id="i57cb9c1772694302ba3eea3dd06765c8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2547d9c927b94663bfad99cb87818db1_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i00ee4c8851df48caa969c447c0623250_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4346577dec794239931317575c5f8e9c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie4f417c62ec54180ac8803b4615fe4f2_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ThreePayFixedInterestRateSwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ifb9ae4c2db2641b79a0f5be58b08a21c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ThreePayFixedInterestRateSwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i794be503a719415da656f24f25e586f6_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ThreeReceiveFixedInterestRateSwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id89e28dd0e71485f834aa4d7bf9df97f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ibe696861f1c44c73a063d43906a9e50e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie418b260d34a48179bdbb66a998bcef5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if2a4a57522444f5a9676cde41ceac59b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if49ae29f929f42ada509df5619f333a8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie1fca4d2f481407caeb5d56d7e7b7136_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6ddeec416d7940a3b12a296f74c3903a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3536b9c7d5144d1da0598b1b21687583_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9e920f1f29fa4053be880fffd25a4918_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7495d32d52cd4da7bc6c8619c45a887b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2fa37eb2bae649c99d96bc2572e45115_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:InterestRateCapOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i58ed36c033be416a89ff87077161fdf4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:InterestRateCapOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4c4ccb8fa70f4bc2a4428f508fe28abf_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:InterestRateCapTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ibb17c059c9044d64a267e4e97184de8e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:InterestRateCapTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7ed85bf6cfba4944b0e52d8ec460f7ae_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i868a7c854f3f4197b6fb56be16cb8ff6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8fb04a4c58d74fb494b82609189a5eb9_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i71181849cd1a430e8336d8791688e295_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie9c29b53a6e548b8889f9b102d76603f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2c36d93181114c73a3df7489d3e1fcee_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i720356769cb94b1ab627aaf16068270d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ReceiveFixedSwapOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i1f56d30ff3394bbaad99a11dd5142150_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ReceiveFixedSwapOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic24c1d36e32e4b2e9a6ee11412475f2f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ReceiveFixedSwapTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie7bfba01da58476bbd4fc84970535d16_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ReceiveFixedSwapTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8f8bf0021814474c81ca8bbbc00fa691_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ReceiveFixedSwapThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2640e344b23640b5b12ef1711c6f7c00_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ReceiveFixedSwapThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i07615d50aa95456b8dd258c5dcc40329_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapSevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3059028e583a4104804a186f6de5c099_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapSevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i85fde8cb3f9949af8bacf04f0259be1c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0873884b62114aea86cd9f3b89d0b590_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i48af39d8cccf4a5691cd76b4715ca6a3_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapNineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i37cfcc38e9e146619f3cc3c95a7adf45_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapNineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i00125affeb654327acf6e06c632b8f66_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapTenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i1c6267b72cab412abdf10d903fe10285_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapTenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idf8a876d526646558f40ab931121afc0_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib62a37350e4a421d8bc7b5bcf8967a8e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib7b61f220e42445f91138f5f8e598c8e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7662430cb53043369eb6d812bbbc2d36_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i454dcfeb7551452b9a0a7e150c838cfb_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i06a53c3ba45b4d8cbbe78361c63c0b54_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i808ef80af90c47f68c7968b13ae34c7e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9032094a43424c8ea3085296aae5d36c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia6c750f147ed4f38954df76797436ad8_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6c6a16294f3e464bbdbc6cc59d2922fb_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6af2f02ead9e4c9f87a0e450cf3f134f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id7109ce10eb84b6b9880cfb4246c23ef_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i54804f8602fa4a35a8b9674c532d6b4b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic2c4350be42c47498a9bab682e3c418b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i78eea1b8023b40d48343347521f72035_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7791d5655eb846eb8e57e1bf970fb10f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia3173a5d521c49e1a9e897a1d64450e8_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib68ac7c0981b4940a6352b394b343b73_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie2a1bea4a7df41318981b1d3405801df_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0c7a094bccf049e5a50369c2dc0775bf_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1dfc84c1f55d48fdbe932272d2d40dc1_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic30bbc4807ee4a90b1e5e73a917f7981_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iec7a2ccc58c14483aefa7eef623648ff_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i21ccc0b58d41465bb76c786bd6c59944_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2e6bf043d8e543ca9a60ab545728b68d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id809a0ee79f9462cbd0b84dc0a1f8ba6_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i27cea47c34d24be486efd529a214dfe3_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i37ed33a1a2e84bac96ea96cc638d09be_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7d1f48dd9e4b49d78df2715069875ead_D20210127-20210127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgry:PublicStockOfferingFirmSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-27</startDate>
            <endDate>2021-01-27</endDate>
        </period>
    </context>
    <context id="if7415e8f12eb4b0f857512e10ff2b1df_I20210127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <instant>2021-01-27</instant>
        </period>
    </context>
    <context id="ia81e7b3e0bbf4ed8817112cf8a395a4d_D20210127-20210127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-27</startDate>
            <endDate>2021-01-27</endDate>
        </period>
    </context>
    <context id="i606fa788b0c34beca685e0fe3cef5cca_D20210201-20210201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgry:PublicStockOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-01</endDate>
        </period>
    </context>
    <context id="i3967e790bb894cf8acd4602519023b78_D20210401-20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-01</endDate>
        </period>
    </context>
    <context id="if703c13f85f14316b033116a88b9d2f6_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:FederalFundsEffectiveSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3adc24f120064bdb80d18207eba230d9_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualRiskOrUncertaintyByNatureAxis">sgry:MateriallyMoreRestrictiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i403f136aa2eb4d108d1df4f2b90ccdd5_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualRiskOrUncertaintyByNatureAxis">sgry:NotMateriallyMoreRestrictiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic1b634056ada477481858c03f1bb914f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if166aaf3eb59483bb7262ede561423c7_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i02f0df4797ab4a1e9bacd76ffdc57ab6_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icfbed4bef98e44fea406cc92949cdb3d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie4894cd8d6cd44708c0cbc6ef5c7418f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i086a33999d294178ad7e9154bb2b9765_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic567b93a1ce84e17ad9837f0055b163b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifb2d426435c8450cafd7728d9d2dc8f3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib98011fc87b240309c26b764d426abd9_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:OpticalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i18afa682ccf34322b6bcdd13fdbfa4af_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:OpticalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i24645f34e6a44361a5fbad3eb0ddf170_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:OpticalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idff1d62b1cb640b687f9fb96f5b4bb00_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:OpticalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i22e6f85fd88d44d89f23a959137fd882_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i11790ef5309b4773a0839312e45271b1_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3cd422f84ed747328d3a0d61c7f136fa_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i69c8d97578e54edc825c05346d77f05a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i07b5831fa25c4593977edb314caf0810_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9f0d8a6647ac43d3acecd87aa3917e60_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6cebdc44291f4ef09e8f91e82d5fb5b1_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i98faa269bef74b28b6fbd87fbc70f99e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if61366db2c44498391f1d66e8a6f3a10_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic360167dd83a4d318b00e5cd3eb72bd0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0613206f307d4141bf872d310477a2cb_D20211001-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">sgry:SurgicalFacilitiesExistingMarketsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="surgical_facility">
        <measure>sgry:surgical_facility</measure>
    </unit>
    <unit id="state">
        <measure>sgry:state</measure>
    </unit>
    <unit id="physician_practice">
        <measure>sgry:physician_practice</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="lease_renewal_option">
        <measure>sgry:lease_renewal_option</measure>
    </unit>
    <unit id="interest_rate_cap">
        <measure>sgry:interest_rate_cap</measure>
    </unit>
    <unit id="segment">
        <measure>sgry:segment</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80L2ZyYWc6YjkzZGVjOWVmMDJlNGIxZjgxYzIxMzIzOGViZDI5OTYvdGFibGU6ODg1MTUyZjZhNDQ1NDQ1YzkwZWVlOWNhNzY0Y2ZkMmIvdGFibGVyYW5nZTo4ODUxNTJmNmE0NDU0NDVjOTBlZWU5Y2E3NjRjZmQyYl80LTEtMS0xLTEyNzEy_4c1dddcb-0259-4aeb-bdf5-e8a656739f46">0001638833</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80L2ZyYWc6YjkzZGVjOWVmMDJlNGIxZjgxYzIxMzIzOGViZDI5OTYvdGFibGU6ODg1MTUyZjZhNDQ1NDQ1YzkwZWVlOWNhNzY0Y2ZkMmIvdGFibGVyYW5nZTo4ODUxNTJmNmE0NDU0NDVjOTBlZWU5Y2E3NjRjZmQyYl81LTEtMS0xLTEyNzEy_df5bd1a5-578c-41a8-bfe6-2a7a0791fa18">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80L2ZyYWc6YjkzZGVjOWVmMDJlNGIxZjgxYzIxMzIzOGViZDI5OTYvdGFibGU6ODg1MTUyZjZhNDQ1NDQ1YzkwZWVlOWNhNzY0Y2ZkMmIvdGFibGVyYW5nZTo4ODUxNTJmNmE0NDU0NDVjOTBlZWU5Y2E3NjRjZmQyYl85LTEtMS0xLTEyNzEy_9f3fc2fe-03ab-4dea-bcd7-fb682aad53b2">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80L2ZyYWc6YjkzZGVjOWVmMDJlNGIxZjgxYzIxMzIzOGViZDI5OTYvdGFibGU6ODg1MTUyZjZhNDQ1NDQ1YzkwZWVlOWNhNzY0Y2ZkMmIvdGFibGVyYW5nZTo4ODUxNTJmNmE0NDU0NDVjOTBlZWU5Y2E3NjRjZmQyYl8xMC0xLTEtMS0xMjcxMg_e7bd594e-a186-46b1-8828-c0c50908fd32">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80L2ZyYWc6YjkzZGVjOWVmMDJlNGIxZjgxYzIxMzIzOGViZDI5OTYvdGFibGU6ODg1MTUyZjZhNDQ1NDQ1YzkwZWVlOWNhNzY0Y2ZkMmIvdGFibGVyYW5nZTo4ODUxNTJmNmE0NDU0NDVjOTBlZWU5Y2E3NjRjZmQyYl8xMS0xLTEtMS0xMjcxMg_e6c8e8bb-db6a-4b75-9b79-124e1a4bd0d3">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGV4dHJlZ2lvbjo5NzAxYjc1ZWM1MzI0MTVmOGM5NWM0MjcyNmEzNDNiNl8yMzQ3_2652b8f6-a674-4dd3-a84c-5e38c9865676">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGV4dHJlZ2lvbjo5NzAxYjc1ZWM1MzI0MTVmOGM5NWM0MjcyNmEzNDNiNl8yMzM4_bf43f8f2-7a78-44ef-b488-2c5c219aba89">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGV4dHJlZ2lvbjo5NzAxYjc1ZWM1MzI0MTVmOGM5NWM0MjcyNmEzNDNiNl8yOTg_38fc45fc-5141-4906-958a-d19d0ff1fef3">2021-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGV4dHJlZ2lvbjo5NzAxYjc1ZWM1MzI0MTVmOGM5NWM0MjcyNmEzNDNiNl8yMzQ5_32eacc9a-74bb-4ff8-b65e-2b7438a876ba">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGV4dHJlZ2lvbjo5NzAxYjc1ZWM1MzI0MTVmOGM5NWM0MjcyNmEzNDNiNl8yMzUy_d444c225-b898-4ae5-ad6e-f93b9b401c6f">001-37576</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGV4dHJlZ2lvbjo5NzAxYjc1ZWM1MzI0MTVmOGM5NWM0MjcyNmEzNDNiNl8yMzUz_39a5e540-5bc4-433f-9eb8-a0358ce50eba">Surgery Partners, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGFibGU6NjYzM2FhZGM5NmVkNGNjYTkwMGI4OTljMDVmMWU2MTcvdGFibGVyYW5nZTo2NjMzYWFkYzk2ZWQ0Y2NhOTAwYjg5OWMwNWYxZTYxN18wLTAtMS0xLTEyNzEy_4da4e01e-28e4-4abf-9350-e9b5c292169b">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGFibGU6NjYzM2FhZGM5NmVkNGNjYTkwMGI4OTljMDVmMWU2MTcvdGFibGVyYW5nZTo2NjMzYWFkYzk2ZWQ0Y2NhOTAwYjg5OWMwNWYxZTYxN18wLTItMS0xLTEyNzEy_5efe7b96-9fbc-4df5-bb1e-a506477bdae9">47-3620923</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGV4dHJlZ2lvbjo5NzAxYjc1ZWM1MzI0MTVmOGM5NWM0MjcyNmEzNDNiNl8yMzM5_836534cb-1a0a-4cda-b4b6-f606f6891901">310 Seven Springs Way, Suite&#160;500</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGV4dHJlZ2lvbjo5NzAxYjc1ZWM1MzI0MTVmOGM5NWM0MjcyNmEzNDNiNl8yMzQ0_f5f8346c-fc87-4501-aa3c-4879a54270c4">Brentwood</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGV4dHJlZ2lvbjo5NzAxYjc1ZWM1MzI0MTVmOGM5NWM0MjcyNmEzNDNiNl8yMzQw_37fdfd3b-3f8f-4832-a7e2-b9a2014988fd">TN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGV4dHJlZ2lvbjo5NzAxYjc1ZWM1MzI0MTVmOGM5NWM0MjcyNmEzNDNiNl8yMzQ1_d379cc99-b4d8-4449-8863-e430210ddc03">37027</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGV4dHJlZ2lvbjo5NzAxYjc1ZWM1MzI0MTVmOGM5NWM0MjcyNmEzNDNiNl8yMzU0_fce232b2-6706-4731-9374-50197513f144">615</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGV4dHJlZ2lvbjo5NzAxYjc1ZWM1MzI0MTVmOGM5NWM0MjcyNmEzNDNiNl8yMzQ2_16b860d1-29cb-4ec0-a08f-0ebb3b8faddd">234-5900</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGFibGU6MGJlYzliYTgyNDc1NDA1YzkwMWU0ZGMxNGVhNGZiZmQvdGFibGVyYW5nZTowYmVjOWJhODI0NzU0MDVjOTAxZTRkYzE0ZWE0ZmJmZF8xLTAtMS0xLTEyNzEy_b74dbc41-162c-4b3d-9073-6a05d49f3039">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGFibGU6MGJlYzliYTgyNDc1NDA1YzkwMWU0ZGMxNGVhNGZiZmQvdGFibGVyYW5nZTowYmVjOWJhODI0NzU0MDVjOTAxZTRkYzE0ZWE0ZmJmZF8xLTItMS0xLTEyNzEy_6d315e76-5e9e-4cbb-a587-bc2a0dbb315b">SGRY</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGFibGU6MGJlYzliYTgyNDc1NDA1YzkwMWU0ZGMxNGVhNGZiZmQvdGFibGVyYW5nZTowYmVjOWJhODI0NzU0MDVjOTAxZTRkYzE0ZWE0ZmJmZF8xLTQtMS0xLTEyNzEy_2d0ce03e-acea-4982-a6bd-58a229e1fbed">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGV4dHJlZ2lvbjo5NzAxYjc1ZWM1MzI0MTVmOGM5NWM0MjcyNmEzNDNiNl8yMzM3_43aaf038-3bcc-408b-9fe0-5d3411f97e71">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGV4dHJlZ2lvbjo5NzAxYjc1ZWM1MzI0MTVmOGM5NWM0MjcyNmEzNDNiNl8yMzUw_eac8ab86-4073-47d8-911c-93f341803b97">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGFibGU6Yjc1NjQxYzMxZTAzNDExOWI4YmNjN2VkNjg1OTNhMWEvdGFibGVyYW5nZTpiNzU2NDFjMzFlMDM0MTE5YjhiY2M3ZWQ2ODU5M2ExYV8wLTItMS0xLTEyNzEyL3RleHRyZWdpb246ZmJjOTFiN2NkMDQ0NGRmN2E2OWM3NjA4NTE5YWE5ZTFfNA_0fc0a868-7b2b-4bfe-b03e-744a6ace4812">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGFibGU6Yjc1NjQxYzMxZTAzNDExOWI4YmNjN2VkNjg1OTNhMWEvdGFibGVyYW5nZTpiNzU2NDFjMzFlMDM0MTE5YjhiY2M3ZWQ2ODU5M2ExYV8xLTItMS0xLTEyNzEyL3RleHRyZWdpb246ZmJmN2QxZGYxZGI5NDk1ZWFjZmIyN2UwZjk2MmU1Y2NfMzA_65fdf92e-fb09-4415-96ec-042aae9c728b">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGFibGU6Yjc1NjQxYzMxZTAzNDExOWI4YmNjN2VkNjg1OTNhMWEvdGFibGVyYW5nZTpiNzU2NDFjMzFlMDM0MTE5YjhiY2M3ZWQ2ODU5M2ExYV8yLTItMS0xLTEyNzEyL3RleHRyZWdpb246ZGFhZGM1MWQxYWRkNDg3ZTllNjcxZDI2MTczZDJiZTFfMjg_defeac8d-11b6-4fe2-8cb0-3e5f11050368">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGV4dHJlZ2lvbjo5NzAxYjc1ZWM1MzI0MTVmOGM5NWM0MjcyNmEzNDNiNl8yMzUx_6d2a51fb-8698-4721-bbd4-4d491ac20d9b">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i2b2125d4d75646e88ad9f2ad3127cbad_I20211029"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xL2ZyYWc6OTcwMWI3NWVjNTMyNDE1ZjhjOTVjNDI3MjZhMzQzYjYvdGV4dHJlZ2lvbjo5NzAxYjc1ZWM1MzI0MTVmOGM5NWM0MjcyNmEzNDNiNl8yMjgx_248ff61b-d1e1-4cd1-81f5-4871573d62a3"
      unitRef="shares">82436720</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfNC0yLTEtMS0xMjcxMg_a6f30eb6-3a3b-4426-adc4-9fbea9bfc9db"
      unitRef="usd">330400000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfNC00LTEtMS0xMjcxMg_f475c554-713a-4cc0-ba16-8c9e5ef63f7d"
      unitRef="usd">317900000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfNS0yLTEtMS0xMjcxMg_cb482968-8b7d-4547-9066-f44df07d2d48"
      unitRef="usd">393400000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfNS00LTEtMS0xMjcxMg_e0999b99-ae1a-446d-b716-8f565672ccca"
      unitRef="usd">382200000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfNi0yLTEtMS0xMjcxMg_52a02887-ec8b-4388-b26c-8dcdfb8d62ba"
      unitRef="usd">59300000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfNi00LTEtMS0xMjcxMg_cf9d0b47-ee95-44af-98fd-eb9263b0087d"
      unitRef="usd">56400000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfNy0yLTEtMS0xMjcxMg_c5476082-643d-43fe-b846-56748fb45536"
      unitRef="usd">29800000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfNy00LTEtMS0xMjcxMg_398704f4-6c73-4e21-90e3-d7e9a8a878a7"
      unitRef="usd">17600000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfOC0yLTEtMS0xMjcxMg_9c0d7b3b-c4c3-44c8-bdd6-18011386c3a8"
      unitRef="usd">28800000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfOC00LTEtMS0xMjcxMg_5fe5967c-f00a-4be6-867b-d53965cedf7e"
      unitRef="usd">27400000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfOS0yLTEtMS0xMjcxMg_67a62398-847d-4924-afbf-1a902f4e27ba"
      unitRef="usd">841700000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfOS00LTEtMS0xMjcxMg_2dd974e2-063d-4309-9123-4a9eb694fd08"
      unitRef="usd">801500000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMTAtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo2YzEyMjJjMzQ5ZTY0ODgwOTZlNGJlYjc3NjYzN2NkNV82Mw_803685eb-1d40-45f1-88f2-4698a5629c41"
      unitRef="usd">254000000.0</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMTAtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo2YzEyMjJjMzQ5ZTY0ODgwOTZlNGJlYjc3NjYzN2NkNV83MA_3d79c90c-9465-49fe-926c-632681d5addf"
      unitRef="usd">189300000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMTAtMi0xLTEtMTI3MTI_e9ecc2f0-4e54-499d-b3fc-10eb6948e0c0"
      unitRef="usd">542100000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMTAtNC0xLTEtMTI3MTI_836d81e5-0adf-4ec4-9ea5-b4287b989efa"
      unitRef="usd">544600000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMTEtMi0xLTEtMTI3MTI_4cc7b11e-3f53-45bb-aa35-4d45797c9980"
      unitRef="usd">3659300000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMTEtNC0xLTEtMTI3MTI_c35a57ec-3a29-4034-af4f-85220fcb23fa"
      unitRef="usd">3514900000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMTItMi0xLTEtMTI3MTI_af2714be-e808-4665-87c9-137c0276049c"
      unitRef="usd">89600000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMTItNC0xLTEtMTI3MTI_29d6535a-4d83-4e49-b641-ad4f80e1f0ca"
      unitRef="usd">90300000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMTMtMi0xLTEtMTI3MTI_e6fd8b2c-ef7d-454a-bdda-a8b3ae1410a7"
      unitRef="usd">320500000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMTMtNC0xLTEtMTI3MTI_bf6acb9a-3ffc-4159-9d2e-86f33c1ae513"
      unitRef="usd">310100000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMTQtMi0xLTEtMTI3MTI_dd1299cd-1b72-46a9-958d-4e0fed0be54e"
      unitRef="usd">128100000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMTQtNC0xLTEtMTI3MTI_3bc687f3-0e67-404e-8f55-21e49248a453"
      unitRef="usd">124800000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMTUtMi0xLTEtMTI3MTI_146595a3-dcaf-44ab-96bf-adbba9990c7d"
      unitRef="usd">50300000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMTUtNC0xLTEtMTI3MTI_906f7e8d-fbb8-4143-9872-1a11571f2484"
      unitRef="usd">27000000.0</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMTYtMi0xLTEtMTI3MTI_6f449f33-1296-4d90-adbb-1e5159b9965f"
      unitRef="usd">5631600000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMTYtNC0xLTEtMTI3MTI_52cf2c5e-40b1-45f4-9871-903f6daf3646"
      unitRef="usd">5413200000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjAtMi0xLTEtMTI3MTI_08c02d11-a49a-4ab0-8ecc-af51dacd4a85"
      unitRef="usd">116500000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjAtNC0xLTEtMTI3MTI_bf5abe1b-0d91-4759-9ac9-c338f7ca716e"
      unitRef="usd">100200000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjEtMi0xLTEtMTI3MTI_509f4fdc-aa5a-4c3a-bf42-b158f7d06c4f"
      unitRef="usd">73100000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjEtNC0xLTEtMTI3MTI_c4bcde61-09e4-4791-9244-8d266f15d141"
      unitRef="usd">65400000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <sgry:MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjItMi0xLTEtMTI3MTI_e2f8636a-f46c-43fa-a098-cd0b0ae67653"
      unitRef="usd">81800000</sgry:MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent>
    <sgry:MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjItNC0xLTEtMTI3MTI_7a444372-2f0b-4966-a017-3ce85328a5b7"
      unitRef="usd">109800000</sgry:MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjMtMi0xLTEtMTI3MTI_19f093fd-7d41-49a4-ad6c-ea06d4a14fae"
      unitRef="usd">208300000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjMtNC0xLTEtMTI3MTI_08be4c76-e2af-4c79-b9b0-8d5f1dea64d3"
      unitRef="usd">217000000.0</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjQtMi0xLTEtMTI3MTI_f6d20049-8d6b-4507-bf46-3fb0f654a691"
      unitRef="usd">60800000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjQtNC0xLTEtMTI3MTI_3419960c-0a83-4751-b795-51c03f573a36"
      unitRef="usd">64400000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjUtMi0xLTEtMTI3MTI_38c4f67b-ef86-4a38-a209-061ae91aab82"
      unitRef="usd">540500000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjUtNC0xLTEtMTI3MTI_f75dbb5e-9aae-4765-981f-590039326790"
      unitRef="usd">556800000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjYtMi0xLTEtMTI3MTI_83cd88b5-ee76-4804-9762-5f6afce1af50"
      unitRef="usd">2791900000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjYtNC0xLTEtMTI3MTI_2581e6e1-d869-439f-a87a-d4836c6bfa19"
      unitRef="usd">2792400000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjctMi0xLTEtMTI3MTI_9b34eb7b-9087-4ce8-8091-9663fc5d2253"
      unitRef="usd">312400000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjctNC0xLTEtMTI3MTI_5ec1bcd3-0f6d-44e9-97f8-ff25cb90d823"
      unitRef="usd">300900000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjgtMi0xLTEtMTI3MTI_56ab25e7-40a5-4f06-a8e7-304684eebea2"
      unitRef="usd">124400000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMjgtNC0xLTEtMTI3MTI_c8f34808-5ee0-4975-a914-c82f01fc0b67"
      unitRef="usd">139700000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzAtMi0xLTEtMTI3MTI_7fa969a7-ee7c-4126-bcfe-377c8efe24cd"
      unitRef="usd">310400000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzAtNC0xLTEtMTI3MTI_87111d3d-4983-463b-8cde-1a60bd0ae4c9"
      unitRef="usd">306800000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzEtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo3Y2QzNjg3MzI1NTY0NDhjODI1ZTRiNzc2ZmRmM2EwOF82Mw_0d38a78e-9722-4b2c-82a5-25c11ed04b35"
      unitRef="shares">310000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzEtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo3Y2QzNjg3MzI1NTY0NDhjODI1ZTRiNzc2ZmRmM2EwOF82Mw_f5bdc294-1765-47f2-879c-ca596c6e618b"
      unitRef="shares">310000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzEtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo3Y2QzNjg3MzI1NTY0NDhjODI1ZTRiNzc2ZmRmM2EwOF85OA_4f7d6699-11f7-430a-9b3a-63da3e692daf"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzEtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo3Y2QzNjg3MzI1NTY0NDhjODI1ZTRiNzc2ZmRmM2EwOF85OA_a4028762-efef-4602-a22a-43747a2e0682"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzEtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo3Y2QzNjg3MzI1NTY0NDhjODI1ZTRiNzc2ZmRmM2EwOF8xMDU_094aeadd-7895-4d1b-b84d-3957da5feb4e"
      unitRef="shares">310000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzEtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo3Y2QzNjg3MzI1NTY0NDhjODI1ZTRiNzc2ZmRmM2EwOF8xMDU_939dd8ac-b539-4ebf-aaec-c30695ae543b"
      unitRef="shares">310000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:RedeemableNoncontrollingInterestEquityPreferredRedemptionValue
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzEtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo3Y2QzNjg3MzI1NTY0NDhjODI1ZTRiNzc2ZmRmM2EwOF8xNDI_773499ae-378c-4e8d-a0b8-a711fc72dfca"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityPreferredRedemptionValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityPreferredRedemptionValue
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzEtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo3Y2QzNjg3MzI1NTY0NDhjODI1ZTRiNzc2ZmRmM2EwOF8xNDk_3a2e4863-4e0c-4c11-bbde-5777b019870a"
      unitRef="usd">434500000</us-gaap:RedeemableNoncontrollingInterestEquityPreferredRedemptionValue>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzEtMi0xLTEtMTI3MTI_80cad896-6064-49bb-b0e7-1de361268599"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzEtNC0xLTEtMTI3MTI_2c0a6159-d8b1-414a-8f31-91183840f977"
      unitRef="usd">434500000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzQtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjoyYzY3MDdmNDRhNmU0NzJhYjhiMzI1NmYwNjBiOGIzZV8yMQ_2d0151c8-95fd-4128-a374-9e7d8f209c97"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzQtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjoyYzY3MDdmNDRhNmU0NzJhYjhiMzI1NmYwNjBiOGIzZV8yMQ_e6eea99a-6c50-4bdf-989a-79e430ee591a"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzQtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjoyYzY3MDdmNDRhNmU0NzJhYjhiMzI1NmYwNjBiOGIzZV81NQ_8d99257d-46b3-4bcc-83e9-cdec817139be"
      unitRef="shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzQtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjoyYzY3MDdmNDRhNmU0NzJhYjhiMzI1NmYwNjBiOGIzZV81NQ_d379f60c-e5af-49b2-9dbf-584cae015423"
      unitRef="shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzQtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjoyYzY3MDdmNDRhNmU0NzJhYjhiMzI1NmYwNjBiOGIzZV85MA_1010415c-97c1-4ca4-9711-2ef5857575a4"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzQtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjoyYzY3MDdmNDRhNmU0NzJhYjhiMzI1NmYwNjBiOGIzZV85MA_71c2a624-a36d-44ec-879f-3e394f883c02"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzQtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjoyYzY3MDdmNDRhNmU0NzJhYjhiMzI1NmYwNjBiOGIzZV85MA_80be2081-857f-4ac3-8339-e85cd98049b9"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzQtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjoyYzY3MDdmNDRhNmU0NzJhYjhiMzI1NmYwNjBiOGIzZV85MA_dfe3f2bf-007f-4ef5-b0f8-34ae5e9f5eb6"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzQtMi0xLTEtMTI3MTI_5c68fb06-6166-4ddb-bc31-7bf343266821"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzQtNC0xLTEtMTI3MTI_8d3950e8-7ca2-44f4-9048-0166a085bf46"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzUtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo0YzhmMjg4OTY4NmI0OTA2YWEyNmY2Y2NmNDJhOTdkOF8xOA_00c39c81-0092-4f34-8b57-97a04111c3ee"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzUtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo0YzhmMjg4OTY4NmI0OTA2YWEyNmY2Y2NmNDJhOTdkOF8xOA_99953a10-a4bd-41d1-ba70-dc77533f1139"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzUtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo0YzhmMjg4OTY4NmI0OTA2YWEyNmY2Y2NmNDJhOTdkOF81Mg_057f4f82-fd06-4c5f-9a90-94ed734a2808"
      unitRef="shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzUtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo0YzhmMjg4OTY4NmI0OTA2YWEyNmY2Y2NmNDJhOTdkOF81Mg_38c943fd-3432-413e-b321-8aa4f7ffaf93"
      unitRef="shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzUtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo0YzhmMjg4OTY4NmI0OTA2YWEyNmY2Y2NmNDJhOTdkOF84OA_16809d8a-409f-4e1f-b390-49bbd691df25"
      unitRef="shares">82458385</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzUtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo0YzhmMjg4OTY4NmI0OTA2YWEyNmY2Y2NmNDJhOTdkOF84OA_716ad421-0ccf-473a-b56b-6fb43326e225"
      unitRef="shares">82458385</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzUtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo0YzhmMjg4OTY4NmI0OTA2YWEyNmY2Y2NmNDJhOTdkOF85NQ_0bd5c636-5948-4f4a-b4c2-4fa37c0e530d"
      unitRef="shares">50461706</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzUtMC0xLTEtMTI3MTIvdGV4dHJlZ2lvbjo0YzhmMjg4OTY4NmI0OTA2YWEyNmY2Y2NmNDJhOTdkOF85NQ_8f92704d-53cc-4638-8a24-90b1a7c7f36b"
      unitRef="shares">50461706</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValueOutstanding
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzUtMi0xLTEtMTI3MTI_d63faebf-a4db-4744-9c0e-44d8f9923d4d"
      unitRef="usd">800000</us-gaap:CommonStockValueOutstanding>
    <us-gaap:CommonStockValueOutstanding
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzUtNC0xLTEtMTI3MTI_e3efb40f-ce33-46f9-afc7-7aa30531d4f7"
      unitRef="usd">500000</us-gaap:CommonStockValueOutstanding>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzYtMi0xLTEtMTI3MTI_51e9655e-d7d7-4b40-a523-8814a00485de"
      unitRef="usd">1306000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzYtNC0xLTEtMTI3MTI_36d2626d-db29-4c23-8cab-88ddcbb65e7b"
      unitRef="usd">607900000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzctMi0xLTEtMTI3MTI_3af8053f-ff1c-4e21-a76a-8ff8575f897c"
      unitRef="usd">-47900000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzctNC0xLTEtMTI3MTI_d609cd2b-c92e-4efd-87ae-8fbaed1af4f3"
      unitRef="usd">-61000000.0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzgtMi0xLTEtMTI3MTI_bda693ff-0f09-4386-b13b-46b6d3f42664"
      unitRef="usd">-502600000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzgtNC0xLTEtMTI3MTI_5ea9b4ed-21d9-4ea3-a8a3-6ee6eb6a7a2a"
      unitRef="usd">-431800000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzktMi0xLTEtMTI3MTI_85c5ce38-79ee-4d37-ae19-2166c10c70e2"
      unitRef="usd">756300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfMzktNC0xLTEtMTI3MTI_c7b3c6fc-bcbb-439e-a7fb-4d476f2a23cc"
      unitRef="usd">115600000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfNDAtMi0xLTEtMTI3MTI_2e518cc3-4be0-4a8b-9639-37e076b11eb6"
      unitRef="usd">795700000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfNDAtNC0xLTEtMTI3MTI_601fd415-7234-4360-ba57-8e3862686921"
      unitRef="usd">766500000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfNDEtMi0xLTEtMTI3MTI_793e7087-621f-4068-8665-e8f36fcc01d3"
      unitRef="usd">1552000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfNDEtNC0xLTEtMTI3MTI_f748ed6b-30c2-4c31-a1f0-587604b01ed7"
      unitRef="usd">882100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfNDItMi0xLTEtMTI3MTI_622ba33f-c9cf-4d77-9534-0c631c68879f"
      unitRef="usd">5631600000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xMy9mcmFnOjBmYWNkNWQyMDE5ZDRjMTJhZDIxMmI1Y2E1ZWQ5MDM1L3RhYmxlOjQwZTQ1MzdhMDg3OTQ2MmU4NmJjMDkxMTAwODI0MDM0L3RhYmxlcmFuZ2U6NDBlNDUzN2EwODc5NDYyZTg2YmMwOTExMDA4MjQwMzRfNDItNC0xLTEtMTI3MTI_f5976f33-22b8-4e43-bdd0-2f71dcf9a1d6"
      unitRef="usd">5413200000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMy0yLTEtMS0xMjcxMg_923f17f1-0594-4b21-81d4-3d60df6fafc7"
      unitRef="usd">559200000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMy00LTEtMS0xMjcxMg_13fa2a76-52e0-41b7-82e3-69bb5136f8af"
      unitRef="usd">496100000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMy02LTEtMS0xMjcxMg_f8afb80b-3586-435e-ac7c-77df724d1ab7"
      unitRef="usd">1614900000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMy04LTEtMS0xMjcxMg_b9b9c57c-336b-407f-95e9-5a4dfa244ed6"
      unitRef="usd">1311800000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:LaborAndRelatedExpense
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfNS0yLTEtMS0xMjcxMg_803c8061-df35-4f70-b9b4-c7d2a184b4bb"
      unitRef="usd">162300000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfNS00LTEtMS0xMjcxMg_520c8f92-ba8b-4968-a4a9-5a71d59e2f91"
      unitRef="usd">141700000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfNS02LTEtMS0xMjcxMg_87739226-2e8c-4561-a83d-e837d63fd388"
      unitRef="usd">468700000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfNS04LTEtMS0xMjcxMg_f2c52207-4c84-4eb4-90f3-4e1e82eaccca"
      unitRef="usd">398200000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:SuppliesExpense
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfNi0yLTEtMS0xMjcxMg_18a7daf6-eb4a-46f7-b89c-0118bca494bb"
      unitRef="usd">160100000</us-gaap:SuppliesExpense>
    <us-gaap:SuppliesExpense
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfNi00LTEtMS0xMjcxMg_b00db77a-efdd-454e-b56c-c03dbbdb4bf1"
      unitRef="usd">142800000</us-gaap:SuppliesExpense>
    <us-gaap:SuppliesExpense
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfNi02LTEtMS0xMjcxMg_4e1cda6d-5477-47cb-a6ab-cb19102498be"
      unitRef="usd">464900000</us-gaap:SuppliesExpense>
    <us-gaap:SuppliesExpense
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfNi04LTEtMS0xMjcxMg_253e1428-b970-4850-ad84-0d3017cb5081"
      unitRef="usd">382200000</us-gaap:SuppliesExpense>
    <us-gaap:ProfessionalFees
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfNy0yLTEtMS0xMjcxMg_0f6ed289-9d5a-4e59-8fda-7337577d9974"
      unitRef="usd">56800000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfNy00LTEtMS0xMjcxMg_7bb56835-fbe4-40cb-b8d6-7103a26afc7a"
      unitRef="usd">46300000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfNy02LTEtMS0xMjcxMg_c0281d64-3a8f-46f1-902d-96cfd902f468"
      unitRef="usd">169700000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfNy04LTEtMS0xMjcxMg_fe262fd1-6097-4b41-8c13-3202b6c11ead"
      unitRef="usd">138400000</us-gaap:ProfessionalFees>
    <sgry:OperatingAndFinanceLeaseExpense
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfOC0yLTEtMS0xMjcxMg_b602f995-f020-4624-b39c-a40e0ad6450f"
      unitRef="usd">23400000</sgry:OperatingAndFinanceLeaseExpense>
    <sgry:OperatingAndFinanceLeaseExpense
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfOC00LTEtMS0xMjcxMg_daf68f81-a1e6-4ef7-be85-3f2c95be3029"
      unitRef="usd">21900000</sgry:OperatingAndFinanceLeaseExpense>
    <sgry:OperatingAndFinanceLeaseExpense
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfOC02LTEtMS0xMjcxMg_12b68522-afb3-44a5-bdb6-6f8690c3951d"
      unitRef="usd">68800000</sgry:OperatingAndFinanceLeaseExpense>
    <sgry:OperatingAndFinanceLeaseExpense
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfOC04LTEtMS0xMjcxMg_b6ad6c3c-3201-4dc5-91e2-80153834fcdc"
      unitRef="usd">64700000</sgry:OperatingAndFinanceLeaseExpense>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfOS0yLTEtMS0xMjcxMg_c23f56a7-0249-436e-8208-256fda2bfa93"
      unitRef="usd">34100000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfOS00LTEtMS0xMjcxMg_7190ea23-e71a-4340-b57c-e5ef3ced5cec"
      unitRef="usd">29200000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfOS02LTEtMS0xMjcxMg_3d65bbb4-4fc6-443c-a5ae-5af30a568eda"
      unitRef="usd">98500000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfOS04LTEtMS0xMjcxMg_08a1912c-d1a4-4dd2-8e8d-e2d17220ee9d"
      unitRef="usd">83900000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTAtMi0xLTEtMTI3MTI_c089830a-569e-4d75-9eec-7825b6362034"
      unitRef="usd">436700000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTAtNC0xLTEtMTI3MTI_e8cc4ec3-6238-4ea8-8b01-2b451f79b1fe"
      unitRef="usd">381900000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTAtNi0xLTEtMTI3MTI_68f93426-ec60-45ed-ab98-82abc7a24a54"
      unitRef="usd">1270600000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTAtOC0xLTEtMTI3MTI_b2c80fd3-7508-4548-9205-2bf17338a72a"
      unitRef="usd">1067400000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTEtMi0xLTEtMTI3MTI_88208a6e-fc8b-4f56-ae49-c3f3a2601645"
      unitRef="usd">25500000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTEtNC0xLTEtMTI3MTI_4f652a06-c513-41d3-8b2d-89b901f49454"
      unitRef="usd">25200000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTEtNi0xLTEtMTI3MTI_eedd423d-1e77-44f2-93b3-3cf8c2accad6"
      unitRef="usd">76800000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTEtOC0xLTEtMTI3MTI_efdeb28b-a2b6-44b5-a2d3-c058f51f658a"
      unitRef="usd">73300000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTItMi0xLTEtMTI3MTI_b798d976-e342-41ed-af9f-798744943b2c"
      unitRef="usd">25200000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTItNC0xLTEtMTI3MTI_52693c4c-c908-4f64-8aa0-8b35fbf81bbb"
      unitRef="usd">24100000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTItNi0xLTEtMTI3MTI_7f963b62-5799-4826-9f72-95f6f137030d"
      unitRef="usd">76100000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTItOC0xLTEtMTI3MTI_f8e6c16d-853c-4fb5-81e2-14682b23b0f5"
      unitRef="usd">69300000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTMtMi0xLTEtMTI3MTI_f81d17c0-cd38-4abf-a6f4-5a475717b9dd"
      unitRef="usd">2900000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTMtNC0xLTEtMTI3MTI_407200fd-8585-4e67-ae29-252efb099000"
      unitRef="usd">3100000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTMtNi0xLTEtMTI3MTI_83eeb351-41c5-4708-bd53-a57bd7a0a9c4"
      unitRef="usd">8500000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTMtOC0xLTEtMTI3MTI_f7acc92e-3d07-4c19-86ea-9088abda3294"
      unitRef="usd">7600000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <sgry:GainLossOnDispositionOfAssetsAndDeconsolidation
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTQtMi0xLTEtMTI3MTI_cf2684c5-6f85-4f6e-b1b6-3fefd9fb0c38"
      unitRef="usd">-1900000</sgry:GainLossOnDispositionOfAssetsAndDeconsolidation>
    <sgry:GainLossOnDispositionOfAssetsAndDeconsolidation
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTQtNC0xLTEtMTI3MTI_b9d821f1-63b0-4b1f-a2e9-78de1cee06f2"
      unitRef="usd">-700000</sgry:GainLossOnDispositionOfAssetsAndDeconsolidation>
    <sgry:GainLossOnDispositionOfAssetsAndDeconsolidation
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTQtNi0xLTEtMTI3MTI_44f40701-2a55-49ef-b74c-3ed8d1bcb5bb"
      unitRef="usd">-2000000.0</sgry:GainLossOnDispositionOfAssetsAndDeconsolidation>
    <sgry:GainLossOnDispositionOfAssetsAndDeconsolidation
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTQtOC0xLTEtMTI3MTI_9a351211-9672-4410-ac1f-e3f57c285afb"
      unitRef="usd">-7100000</sgry:GainLossOnDispositionOfAssetsAndDeconsolidation>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTUtMi0xLTEtMTI3MTI_6a5f7e23-27c1-4148-9edc-c0efabaf9f11"
      unitRef="usd">10200000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTUtNC0xLTEtMTI3MTI_d0c089d9-412e-48d0-b8a7-5dc0049a8c2e"
      unitRef="usd">5400000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTUtNi0xLTEtMTI3MTI_92a4e7fc-7894-4eae-941e-85c9b8099db5"
      unitRef="usd">24700000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTUtOC0xLTEtMTI3MTI_0dcd233b-880d-43b1-9f7f-84d534333bc8"
      unitRef="usd">15800000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:AssetImpairmentCharges
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTYtMi0xLTEtMTY5OTU_9b2326c7-1f82-4251-81cb-e38ab61f4bc1"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTYtNC0xLTEtMTcwMDQ_15664651-1fa9-46c0-a211-abc8ea405629"
      unitRef="usd">33500000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTYtNi0xLTEtMTcwMTI_9f7aca16-83fe-42a2-9acf-633c2f2c9d97"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTYtOC0xLTEtMTcwMjA_c59ca081-18c8-45bf-b1ce-073483076f8d"
      unitRef="usd">33500000</us-gaap:AssetImpairmentCharges>
    <sgry:GrantRevenue
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTYtMi0xLTEtMTI3MTI_afd09345-87b0-4d81-b9ea-176106e17ddd"
      unitRef="usd">0</sgry:GrantRevenue>
    <sgry:GrantRevenue
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTYtNC0xLTEtMTI3MTI_a33b8406-e4fc-4ea8-8f12-dfa0c0e6e849"
      unitRef="usd">-9900000</sgry:GrantRevenue>
    <sgry:GrantRevenue
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTYtNi0xLTEtMTI3MTI_21fb4bf2-d0b4-46b0-b087-15436edf7375"
      unitRef="usd">20000000.0</sgry:GrantRevenue>
    <sgry:GrantRevenue
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTYtOC0xLTEtMTI3MTI_7ca6618a-ee28-499c-92d4-4d7759adf84c"
      unitRef="usd">33200000</sgry:GrantRevenue>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTctMi0xLTEtMTI3MTI_b4fb98e3-a591-46f4-83a9-c4bd6caf6d6c"
      unitRef="usd">500000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTctNC0xLTEtMTI3MTI_35c318e6-1acf-4ae1-b326-835709f8c534"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTctNi0xLTEtMTI3MTI_4052c5fd-b59c-4c9d-bd70-04387cb4e744"
      unitRef="usd">-9100000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTctOC0xLTEtMTI3MTI_7be0f9eb-9065-4220-9cd7-f74ae4e17e6d"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTgtMi0xLTEtMTI3MTI_1b4fb7a9-c464-4287-8804-652efc63ac3e"
      unitRef="usd">0</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTgtNC0xLTEtMTI3MTI_998e8c41-5222-482c-a39c-67cf1cc9a6d4"
      unitRef="usd">0</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTgtNi0xLTEtMTI3MTI_466498c1-c08a-41ec-93ac-a677995382c5"
      unitRef="usd">0</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTgtOC0xLTEtMTI3MTI_f995d071-cc0d-454d-9b50-554f899c1ec2"
      unitRef="usd">-1200000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:OtherNonrecurringIncomeExpense
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTktMi0xLTEtMTI3MTI_617395ba-de60-4ba9-943f-3a37fd9a11d6"
      unitRef="usd">-500000</us-gaap:OtherNonrecurringIncomeExpense>
    <us-gaap:OtherNonrecurringIncomeExpense
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTktNC0xLTEtMTI3MTI_9953bcc9-f3e7-4e01-8992-5f4255883c87"
      unitRef="usd">0</us-gaap:OtherNonrecurringIncomeExpense>
    <us-gaap:OtherNonrecurringIncomeExpense
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTktNi0xLTEtMTI3MTI_b830e054-f4f8-4e29-876c-f0ed866f9246"
      unitRef="usd">-3300000</us-gaap:OtherNonrecurringIncomeExpense>
    <us-gaap:OtherNonrecurringIncomeExpense
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMTktOC0xLTEtMTI3MTI_e6795b18-d4fc-43bc-84a4-149f76374f25"
      unitRef="usd">-1700000</us-gaap:OtherNonrecurringIncomeExpense>
    <us-gaap:OperatingExpenses
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjAtMi0xLTEtMTI3MTI_d5f0ae9e-5a2a-4f6c-a60c-cde07450fb2f"
      unitRef="usd">495600000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjAtNC0xLTEtMTI3MTI_f46eafd1-b948-4863-b4aa-22a5fa0447fd"
      unitRef="usd">477600000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjAtNi0xLTEtMTI3MTI_755d3c69-1b97-4d50-b25a-21b40a43531d"
      unitRef="usd">1427500000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjAtOC0xLTEtMTI3MTI_944c5d27-d82d-4604-9cb5-87c6b6eb6b3e"
      unitRef="usd">1225100000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjEtMi0xLTEtMTI3MTI_063088a5-0e10-44ad-adf0-94a8e301f29a"
      unitRef="usd">63600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjEtNC0xLTEtMTI3MTI_6182a64b-fe3d-4bfa-b55f-e17df9e2978b"
      unitRef="usd">18500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjEtNi0xLTEtMTI3MTI_f5692a52-f7b4-4591-9756-2094e359d491"
      unitRef="usd">187400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjEtOC0xLTEtMTI3MTI_d63604e0-c474-4eb6-8a16-6d5430c5bde4"
      unitRef="usd">86700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjItMi0xLTEtMTI3MTI_87199e04-1976-46fe-945a-c67c8bc3a6cc"
      unitRef="usd">-54200000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjItNC0xLTEtMTI3MTI_36c871ac-2ba6-413b-945d-2cd76167dc4f"
      unitRef="usd">-51500000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjItNi0xLTEtMTI3MTI_5f569a29-b23a-4150-8854-b74980a5f27e"
      unitRef="usd">-160900000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjItOC0xLTEtMTI3MTI_b014ca9b-2b68-419a-a3fd-1bf46d4431ed"
      unitRef="usd">-147800000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjMtMi0xLTEtMTI3MTI_034c4fea-694e-48af-bdd3-8805e6784f33"
      unitRef="usd">9400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjMtNC0xLTEtMTI3MTI_13e41418-de19-4c92-9bdb-2f95e5b882f0"
      unitRef="usd">-33000000.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjMtNi0xLTEtMTI3MTI_92814818-118c-47ab-a797-aef127bb6e04"
      unitRef="usd">26500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjMtOC0xLTEtMTI3MTI_8802fa4c-90d2-4daf-be11-29d4fb3d9172"
      unitRef="usd">-61100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjQtMi0xLTEtMTI3MTI_0a8159fc-bcec-4cbd-974c-9e756c59a6da"
      unitRef="usd">1200000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjQtNC0xLTEtMTI3MTI_7c7502a8-361a-4b3a-9e03-9e94498ac06e"
      unitRef="usd">1300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjQtNi0xLTEtMTI3MTI_4c6e16eb-e472-43dd-a963-e6e19af300b9"
      unitRef="usd">-1300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjQtOC0xLTEtMTI3MTI_d2baa323-2740-4633-97d1-aa430baa2594"
      unitRef="usd">-14500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjUtMi0xLTEtMTI3MTI_52ac0e62-cd10-4e29-a4c1-c4c2ac3799b6"
      unitRef="usd">8200000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjUtNC0xLTEtMTI3MTI_a74b984a-4216-4caf-abf0-ce070f23c7fc"
      unitRef="usd">-34300000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjUtNi0xLTEtMTI3MTI_b2168d8e-d1db-41db-a0d4-5517c790866b"
      unitRef="usd">27800000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjUtOC0xLTEtMTI3MTI_ebf4c4b7-1b78-4b19-82a1-077e647b671a"
      unitRef="usd">-46600000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjYtMi0xLTEtMTI3MTI_5c144b3a-2617-47c5-b37f-0d9f59b94977"
      unitRef="usd">31100000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjYtNC0xLTEtMTI3MTI_951aecb5-369f-4b7a-bfcf-dc23b3f77e5b"
      unitRef="usd">27300000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjYtNi0xLTEtMTI3MTI_b1fb2fde-3f6e-4f2f-8d89-ea066d3bb5c2"
      unitRef="usd">98600000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjYtOC0xLTEtMTI3MTI_1cc5e4e5-1d88-48ae-8b7c-4880b9db89aa"
      unitRef="usd">75000000.0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjctMi0xLTEtMTI3MTI_6e544045-c907-43cf-8098-ff4e66fc7a9f"
      unitRef="usd">-22900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjctNC0xLTEtMTI3MTI_efab8ef4-0170-4770-b6bb-a99816e563fe"
      unitRef="usd">-61600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjctNi0xLTEtMTI3MTI_72d6ccde-9df8-48a6-95ba-305be7fad3e6"
      unitRef="usd">-70800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjctOC0xLTEtMTI3MTI_3c96f6be-ac9d-4a89-88ec-695c816da8c7"
      unitRef="usd">-121600000</us-gaap:NetIncomeLoss>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjgtMi0xLTEtMTI3MTI_f25396e8-45c3-4ec7-bd8b-dbf127c9d6cf"
      unitRef="usd">0</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjgtNC0xLTEtMTI3MTI_cfdc8745-7774-4438-8642-4283ceaec163"
      unitRef="usd">10000000.0</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjgtNi0xLTEtMTI3MTI_2d71a8b2-0372-4ca0-b269-3f026b17c88b"
      unitRef="usd">10300000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjgtOC0xLTEtMTI3MTI_3c4d847c-b8ea-4d8f-8951-878656483cc9"
      unitRef="usd">29200000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjktMi0xLTEtMTI3MTI_c715c1de-ec05-4944-81e0-66c83b6a693d"
      unitRef="usd">-22900000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjktNC0xLTEtMTI3MTI_ed238a85-a17d-4e4e-afc5-1878f1ced894"
      unitRef="usd">-71600000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjktNi0xLTEtMTI3MTI_f57c07f6-a466-4721-9cd1-2d0b1b7824a4"
      unitRef="usd">-81100000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMjktOC0xLTEtMTI3MTI_7db769f7-bc01-48b9-9381-a3a41226986f"
      unitRef="usd">-150800000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzItMi0xLTEtMTI3MTI_0cbde892-b9da-4f3a-b671-edb30dcdd9bd"
      unitRef="usdPerShare">-0.28</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzItNC0xLTEtMTI3MTI_cac5d8a2-65d7-4b05-8a66-a5e8be116871"
      unitRef="usdPerShare">-1.46</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzItNi0xLTEtMTI3MTI_5c68fb1b-5804-44ab-a8db-5a7d1d3ac08f"
      unitRef="usdPerShare">-1.19</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzItOC0xLTEtMTI3MTI_22ef134a-712e-4886-82f2-97b5023cc78b"
      unitRef="usdPerShare">-3.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzMtMi0xLTEtMTI3MTI_ad685e45-a25b-4ec6-9a56-2b2a3487e7bf"
      unitRef="usdPerShare">-0.28</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzMtNC0xLTEtMTI3MTI_968f5681-1769-41d6-a061-1929f8ad5a8f"
      unitRef="usdPerShare">-1.46</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzMtNi0xLTEtMTI3MTI_4f0eb82c-7974-4547-a439-39ca1842fe73"
      unitRef="usdPerShare">-1.19</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzMtOC0xLTEtMTI3MTI_273a7f14-a739-4182-a3d3-05f17b106441"
      unitRef="usdPerShare">-3.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzUtMi0xLTEtMTI3MTI_73635dc4-f3a4-49ca-8761-5975522fc6b3"
      unitRef="shares">80726000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzUtNC0xLTEtMTI3MTI_2a511397-13dd-4b63-aef8-a62a7c79d6d7"
      unitRef="shares">48883000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzUtNi0xLTEtMTI3MTI_33cd84d6-e33a-4643-b7cf-74ab021c2bb7"
      unitRef="shares">68350000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzUtOC0xLTEtMTI3MTI_97c5c9be-6133-405d-b7eb-a7561fa14f13"
      unitRef="shares">48736000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzYtMi0xLTEtMTI3MTI_cc9caa97-f852-4b67-8131-f88f3d64052d"
      unitRef="shares">80726000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzYtNC0xLTEtMTI3MTI_be5b1b69-bfc0-452c-9d3f-d7450ecfab16"
      unitRef="shares">48883000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzYtNi0xLTEtMTI3MTI_9855857c-965c-4348-adf6-292a3c982615"
      unitRef="shares">68350000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzYtOC0xLTEtMTI3MTI_3f297b3b-19ae-4564-a4f4-e76d87e5c80f"
      unitRef="shares">48736000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfMy0yLTEtMS0xMjcxMg_52ac0e62-cd10-4e29-a4c1-c4c2ac3799b6"
      unitRef="usd">8200000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfMy00LTEtMS0xMjcxMg_a74b984a-4216-4caf-abf0-ce070f23c7fc"
      unitRef="usd">-34300000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfMy02LTEtMS0xMjcxMg_b2168d8e-d1db-41db-a0d4-5517c790866b"
      unitRef="usd">27800000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfMy04LTEtMS0xMjcxMg_ebf4c4b7-1b78-4b19-82a1-077e647b671a"
      unitRef="usd">-46600000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfNS0yLTEtMS0xMjcxMg_4d24f276-a959-4f4c-a1ec-23e8af91d421"
      unitRef="usd">6500000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfNS00LTEtMS0xMjcxMg_815c68cf-356d-4150-8cc9-a23c47328c71"
      unitRef="usd">3300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfNS02LTEtMS0xMjcxMg_7bbe628e-1f6e-4ca1-94de-2625648c658e"
      unitRef="usd">13100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfNS04LTEtMS0xMjcxMg_09f4bcdd-abba-46eb-9c72-af38cce7bcf7"
      unitRef="usd">-14600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfNi0yLTEtMS0xMjcxMg_e79109dd-a86a-48f4-b60f-2d68d9c1c584"
      unitRef="usd">14700000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfNi00LTEtMS0xMjcxMg_c1daa70a-b211-4a4d-8fde-26e02d7a5dce"
      unitRef="usd">-31000000.0</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfNi02LTEtMS0xMjcxMg_c0eed380-2b67-4743-a373-d5b67a7c6744"
      unitRef="usd">40900000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfNi04LTEtMS0xMjcxMg_4ef4de39-9b1b-41bf-8cb5-e9ddc28b0ed9"
      unitRef="usd">-61200000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfNy0yLTEtMS0xMjcxMg_bc6230f4-3895-4326-84c2-5312c1b0745c"
      unitRef="usd">31100000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfNy00LTEtMS0xMjcxMg_871d5026-4d6e-4eaf-a17f-a39534088658"
      unitRef="usd">27300000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfNy02LTEtMS0xMjcxMg_87bded83-03e2-4914-ada0-df8a298dd551"
      unitRef="usd">98600000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfNy04LTEtMS0xMjcxMg_78fd731d-3d3d-4cd6-99c6-5959d76092d2"
      unitRef="usd">75000000.0</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfOC0yLTEtMS0xMjcxMg_0d294bc3-9559-4763-bb50-1866f2bf2044"
      unitRef="usd">-16400000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfOC00LTEtMS0xMjcxMg_4e2e6fab-6781-4012-a891-51722dca55f2"
      unitRef="usd">-58300000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfOC02LTEtMS0xMjcxMg_43f26ffd-d271-4c1f-9257-53111b84be69"
      unitRef="usd">-57700000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xOS9mcmFnOmEwYjNjNmMzYjA0NzRkOTg4YzhhYTJhNWZiMDI2MGJmL3RhYmxlOmU4NDM5MTdjN2IzOTRjZTliYzFjNTFmZGY5ZWYwZmY5L3RhYmxlcmFuZ2U6ZTg0MzkxN2M3YjM5NGNlOWJjMWM1MWZkZjllZjBmZjlfOC04LTEtMS0xMjcxMg_a00f9811-2ac2-4623-add2-d6b9c6ca0d50"
      unitRef="usd">-136200000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="if7ea101365284e93a6ac503e7e44170b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMS0xLTEtMS0xMjcxMg_77b20a60-019f-4676-8348-f6faa1b9a11a"
      unitRef="shares">50462000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if7ea101365284e93a6ac503e7e44170b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMS0zLTEtMS0xMjcxMg_0b86ecd1-bf46-4834-a88c-ab897ce76d23"
      unitRef="usd">500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9c05ce754df645d98f80d7ffa09f927e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMS01LTEtMS0xMjcxMg_720e6527-e5fe-477d-88c2-719895833565"
      unitRef="usd">607900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if9aa0d95886f432db9278aadacd55da4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMS03LTEtMS0xMjcxMg_08e1824c-dedc-4926-88ac-4b3dad5b2645"
      unitRef="usd">-61000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i40304b7c460b45958fb265491cf6bb14_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMS05LTEtMS0xMjcxMg_bf4b01e9-9713-406d-8692-92341fd070f6"
      unitRef="usd">-431800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie7bf9f7034fb4595a4b18217e2ceaeb0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMS0xMS0xLTEtMTI3MTI_8bde8e2c-40a1-43a0-b4e5-48a50bc7799a"
      unitRef="usd">766500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMS0xMy0xLTEtMTI3MTI_b5862a96-80bc-4e40-b419-affce737ec4a"
      unitRef="usd">882100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="ib5484a5886424dc6b347b2b8ba32b919_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMi05LTEtMS0xMjcxMg_b905ef59-c0bf-4c05-84f8-e84670757e5f"
      unitRef="usd">-21000000.0</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="iac8c4f727e89495faa49068c7628988d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMi0xMS0xLTEtMTI3MTI_39b4280b-d55b-4f7d-8729-162c70ec2457"
      unitRef="usd">21100000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="ib3af38d809db4b7a8d26a05b63fa42b5_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMi0xMy0xLTEtMTI3MTI_9bbbcc6d-5b9e-4a6c-a3c3-ca2b3576f388"
      unitRef="usd">100000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i5a44af99afa44f24bc727649252223dc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMy0xLTEtMS0xMjcxMg_c75bc749-28f2-4163-8295-a06d06f70af5"
      unitRef="shares">812000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i6453064d41354fd1bc9110d0cd3c3e4c_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMy01LTEtMS0xMjcxMg_413bae54-f983-490f-9da2-e00a4219bbf1"
      unitRef="usd">-2800000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ib3af38d809db4b7a8d26a05b63fa42b5_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMy0xMy0xLTEtMTI3MTI_b4b79088-87f1-438e-b8dd-dc587564e5ee"
      unitRef="usd">-2800000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
      contextRef="i6453064d41354fd1bc9110d0cd3c3e4c_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfNC01LTEtMS0xMjcxMg_854999d9-fa70-491f-8821-24ae3086085b"
      unitRef="usd">10300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
      contextRef="ib3af38d809db4b7a8d26a05b63fa42b5_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfNC0xMy0xLTEtMTI3MTI_2cace298-6c4d-4e3a-9dfc-1e60fd4e8bf0"
      unitRef="usd">10300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i5a44af99afa44f24bc727649252223dc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfNS0xLTEtMS0xMjcxMg_c161f3e6-1102-41b2-bd3a-f341e408639d"
      unitRef="shares">8625000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i5a44af99afa44f24bc727649252223dc_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfNS0zLTEtMS0xMjcxMg_14d50bbf-6964-40bf-ac76-f96eb61c69be"
      unitRef="usd">100000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i6453064d41354fd1bc9110d0cd3c3e4c_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfNS01LTEtMS0xMjcxMg_4d5d2cda-1ebc-48c3-9438-3fef016b39a3"
      unitRef="usd">248200000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ib3af38d809db4b7a8d26a05b63fa42b5_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfNS0xMy0xLTEtMTI3MTI_3451a64b-d968-48d1-8844-c4d97b22487b"
      unitRef="usd">248300000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="id9d3034dcc144fa3a6b470e98cc8e6c7_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfNi03LTEtMS0xMjcxMg_0c6e7b59-a251-4871-a1c7-6305300eb006"
      unitRef="usd">6400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ib3af38d809db4b7a8d26a05b63fa42b5_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfNi0xMy0xLTEtMTI3MTI_679cf7a4-9942-4c06-9688-73df95644447"
      unitRef="usd">6400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
      contextRef="i6453064d41354fd1bc9110d0cd3c3e4c_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfNy01LTEtMS0xMjcxMg_3a1292d8-96ac-4bd0-91a4-8a0711b3895c"
      unitRef="usd">300000</sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet>
    <sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
      contextRef="iac8c4f727e89495faa49068c7628988d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfNy0xMS0xLTEtMTI3MTI_d52573c9-bfb7-44c7-b5af-81cf4e008067"
      unitRef="usd">2000000.0</sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet>
    <sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
      contextRef="ib3af38d809db4b7a8d26a05b63fa42b5_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfNy0xMy0xLTEtMTI3MTI_ff8c662d-2ece-4667-96a5-2d063a71ae74"
      unitRef="usd">2300000</sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="iac8c4f727e89495faa49068c7628988d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfOC0xMS0xLTEtMTI3MTI_56c6578c-51e8-4aa6-a631-96649f488171"
      unitRef="usd">20800000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ib3af38d809db4b7a8d26a05b63fa42b5_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfOC0xMy0xLTEtMTI3MTI_d71d89b6-3d80-49d1-8bdd-988d0c9ef309"
      unitRef="usd">20800000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib36db35e625047569233e786bdc89d3a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfOS0xLTEtMS0xMjcxMg_a0cffa87-f2fa-403d-b490-b1bdabf5ba57"
      unitRef="shares">59899000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib36db35e625047569233e786bdc89d3a_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfOS0zLTEtMS0xMjcxMg_757c78d7-3e70-4a74-b802-7a83ec618d53"
      unitRef="usd">600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8e786c45dae04a89a45c7c72c011e04a_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfOS01LTEtMS0xMjcxMg_465a12de-766d-4f94-bd7a-893331c3d3a0"
      unitRef="usd">843300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icde2fc5b1e01435d98af7a6ea3c9d3ee_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfOS03LTEtMS0xMjcxMg_3318c4c5-64a7-4493-a716-ad7b4a81b622"
      unitRef="usd">-54600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if7bc8516124c4fafb914be3b2c9936ba_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfOS05LTEtMS0xMjcxMg_41b5f0a6-1c5b-4583-bce4-06384aa325ee"
      unitRef="usd">-452800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7a8fd0aa6b7a4d549e90dc2fb6ab3ff3_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfOS0xMS0xLTEtMTI3MTI_78d0af70-d9d7-4f0b-8d7e-ac649bd8362a"
      unitRef="usd">768800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie80e658267b44f07b2ddd4012b02d206_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfOS0xMy0xLTEtMTI3MTI_d599d83a-58eb-4303-9fe2-64ecd06a4745"
      unitRef="usd">1105300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i4ab7dd37d1e7404696a9549accda39b9_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTAtOS0xLTEtMTI3MTI_5cf43282-00d1-461a-b4f0-80586b5c5de3"
      unitRef="usd">-26900000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="iee943e15508949c2baaacaa9fdc9724c_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTAtMTEtMS0xLTEyNzEy_e2eecc5c-81ab-49f3-8fbe-dabe9857a6e4"
      unitRef="usd">22000000.0</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i30ed8caf27dd4768b110022f3860e021_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTAtMTMtMS0xLTEyNzEy_20bc210e-8276-44ec-bac9-0959b8183aad"
      unitRef="usd">-4900000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i5827f320e258406b952e1a452a006818_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTEtMS0xLTEtMTI3MTI_a8b62a89-3524-4394-a052-203a15a2ed31"
      unitRef="shares">-29000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ie856a8782f374508af805ab30b4d7f1a_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTEtNS0xLTEtMTI3MTI_874c1ad0-9479-492b-9688-074144b5c1d4"
      unitRef="usd">3700000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i30ed8caf27dd4768b110022f3860e021_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTEtMTMtMS0xLTEyNzEy_c4919841-9b3b-4065-ae61-db8bc55a1fc7"
      unitRef="usd">3700000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i5827f320e258406b952e1a452a006818_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTItMS0xLTEtMTI3MTI_fc4669ee-f903-4639-9ada-0f3cc104bde8"
      unitRef="shares">22609000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i5827f320e258406b952e1a452a006818_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTItMy0xLTEtMTI3MTI_941c4aef-88a7-4653-9c1c-29490726b8f0"
      unitRef="usd">200000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="ie856a8782f374508af805ab30b4d7f1a_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTItNS0xLTEtMTI3MTI_39edf9cd-6669-40ed-97d1-266e74f704a5"
      unitRef="usd">439500000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i30ed8caf27dd4768b110022f3860e021_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTItMTMtMS0xLTEyNzEy_ced44369-002f-4be2-aecc-493615d84280"
      unitRef="usd">439700000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i25643604ef6c4d269d4585afa6c3ba1b_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTMtNy0xLTEtMTI3MTI_04e179ba-091d-4a6f-88c2-6baa49978490"
      unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i30ed8caf27dd4768b110022f3860e021_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTMtMTMtMS0xLTEyNzEy_46e71a46-18ad-4002-b47c-df29c89d83cb"
      unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
      contextRef="ie856a8782f374508af805ab30b4d7f1a_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTQtNS0xLTEtMTI3MTI_2a5782bc-e534-4713-a623-cd6410cd3b88"
      unitRef="usd">11900000</sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet>
    <sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
      contextRef="iee943e15508949c2baaacaa9fdc9724c_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTQtMTEtMS0xLTEyNzEy_369cd299-673c-4370-8c7b-03f3da62d85a"
      unitRef="usd">-6300000</sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet>
    <sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
      contextRef="i30ed8caf27dd4768b110022f3860e021_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTQtMTMtMS0xLTEyNzEy_a7dea6cc-482b-4d11-b462-cdd67e283423"
      unitRef="usd">5600000</sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="iee943e15508949c2baaacaa9fdc9724c_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTUtMTEtMS0xLTEyNzEy_debb4605-cbee-4221-9acb-813fab652654"
      unitRef="usd">22300000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i30ed8caf27dd4768b110022f3860e021_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTUtMTMtMS0xLTEyNzEy_9aef913b-b6e2-41fc-ad83-7734a5027701"
      unitRef="usd">22300000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i53a6a629d2c54847bafd53081201b921_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTYtMS0xLTEtMTI3MTI_1510a955-faa3-43fa-a621-e53594685142"
      unitRef="shares">82479000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i53a6a629d2c54847bafd53081201b921_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTYtMy0xLTEtMTI3MTI_81954441-ef91-41be-82a4-6707ade8e4b5"
      unitRef="usd">800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6cddba9fa8504c48ac5dd4b5006afdd6_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTYtNS0xLTEtMTI3MTI_939bc7e1-0e72-4cc9-aa08-8c1e9a568a73"
      unitRef="usd">1298400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i99bd0353d66749c5b88fe887803a2f51_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTYtNy0xLTEtMTI3MTI_31053033-85af-4fc5-acbb-e0d862d9f301"
      unitRef="usd">-54400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5379e81f3c3549b4ab8058d34662a9dc_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTYtOS0xLTEtMTI3MTI_18905a7b-e485-4656-9da6-142a0edd6ea6"
      unitRef="usd">-479700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6936b3e1ceae47a881d3535da654ef72_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTYtMTEtMS0xLTEyNzEy_fa4da3d5-4290-4c90-82c9-39f28c0fec01"
      unitRef="usd">762200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib382c78377b74941b68729e139319e6b_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTYtMTMtMS0xLTEyNzEy_5f27f287-0d0a-4d2b-96d5-cc7865d23cc9"
      unitRef="usd">1527300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="idbf85fe5fc0e4c159aecfae0b8c53435_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTktOS0xLTEtMTMxNTU_58c08e10-5bce-4e27-9d10-987c2e3ba865"
      unitRef="usd">-22900000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i8af1e4e9ef8b4538abb29b36d015c7ae_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTktMTEtMS0xLTEzMTY1_8cb8064c-30da-424f-9ae4-f9b8b39225bd"
      unitRef="usd">21700000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMTktMTMtMS0xLTE3NjUy_fda159fd-d901-4af4-aae3-da2f9b723322"
      unitRef="usd">-1200000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ia7899289c9f0473bb1689d5ee1c73d47_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMjAtMS0xLTEtMTMwOTU_5567594f-0ebc-4215-9f20-58270791411f"
      unitRef="shares">-21000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i694eeba75abb4a6e87f66ac345a9c219_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMjAtNS0xLTEtMTMxMTg_d1289671-eb36-442a-be90-8234c6043395"
      unitRef="usd">4100000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMjAtMTMtMS0xLTE3NjUy_322322e0-25b3-470b-b571-0682cc877b22"
      unitRef="usd">4100000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i73f4af3ea9df4ed2b218df3257e2721c_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMjItNy0xLTEtMTMxMzc_0b829693-a83d-4cbd-aec2-14e01fe9934d"
      unitRef="usd">6500000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMjItMTMtMS0xLTE3NjUy_56dd8b9b-c65b-452a-a5d1-a72dadd094d5"
      unitRef="usd">6500000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
      contextRef="i694eeba75abb4a6e87f66ac345a9c219_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMjMtNS0xLTEtMTMxMTg_5d7c7660-4e5a-4905-9ded-f7d139bd9fd9"
      unitRef="usd">3500000</sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet>
    <sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
      contextRef="i8af1e4e9ef8b4538abb29b36d015c7ae_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMjMtMTEtMS0xLTEzMTY1_d950aba8-a224-4151-a580-24a4baa11fc5"
      unitRef="usd">33600000</sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet>
    <sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMjMtMTMtMS0xLTE3NjUy_ede2cbaa-56b8-4f8a-84b8-c42357bf0db3"
      unitRef="usd">37100000</sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i8af1e4e9ef8b4538abb29b36d015c7ae_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMjQtMTEtMS0xLTEzMTY1_57d618e8-3617-437d-8b03-2b6170d30937"
      unitRef="usd">21800000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMjQtMTMtMS0xLTE3NjUy_43783f72-c477-456f-b1c4-6096d7193afc"
      unitRef="usd">21800000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i9016d0b2b49e436eb7581ad09f123943_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMjUtMS0xLTEtMTczMDM_f6ec02e6-de4c-4dcb-b701-fe8215520521"
      unitRef="shares">82458000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9016d0b2b49e436eb7581ad09f123943_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMjUtMy0xLTEtMTczMDY_dd7bd5f6-8899-4487-ad26-e414451aea82"
      unitRef="usd">800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i53ed285db0384407b947ec9264dbbe9e_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMjUtNS0xLTEtMTczMDY_fa93c408-64da-4dae-9463-a8766409466d"
      unitRef="usd">1306000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id0ba3f14ca9b4ad5bc0acd92524c74d0_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMjUtNy0xLTEtMTczMDY_50634665-4d23-4dca-8154-bb696cbbb275"
      unitRef="usd">-47900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia878eeebac2e40afa6724b929ac0040e_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMjUtOS0xLTEtMTczMDY_d2096a11-e711-4bd3-9e2d-8e33d4178e95"
      unitRef="usd">-502600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7c4b9a7850e5426e85fd9a49ad79c29f_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMjUtMTEtMS0xLTE3MzA2_25cf9b89-ee17-4427-9086-b42a154fbc67"
      unitRef="usd">795700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOmYwMGJiNWM5YmFjYTRhNTM5YWNiYzM5OGFkZjljMjI5L3RhYmxlcmFuZ2U6ZjAwYmI1YzliYWNhNGE1MzlhY2JjMzk4YWRmOWMyMjlfMjUtMTMtMS0xLTE3MzA2_c69da91b-80ad-4558-be47-476a960a44d3"
      unitRef="usd">1552000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i5e1addbe96484bc7b75825f9c8dc7a58_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMy0xLTEtMS0xMjg5OA_12285b9f-edfa-4b8f-a763-d0a51825a4a3"
      unitRef="shares">49299000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5e1addbe96484bc7b75825f9c8dc7a58_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMy0zLTEtMS0xMjg5OA_f7086e38-48c5-433f-80a0-b16eaaa7db22"
      unitRef="usd">500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3bada32aacf64a1ead6b4b370e83e526_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMy01LTEtMS0xMjg5OA_2c40c138-e839-444b-9b49-e3f7f77c6109"
      unitRef="usd">662700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i34d67e0b428b44e281d788187793a269_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMy03LTEtMS0xMjg5OA_d66289de-d955-4c86-a4f2-b02114eef459"
      unitRef="usd">-50700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if4a87dd7e0b445fca10ae39b0ed707d3_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMy05LTEtMS0xMjg5OA_4af77536-71ba-4539-9ca2-cf648b793ef1"
      unitRef="usd">-315700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i87973734c6ee4a99945e9948dbf8e70c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMy0xMS0xLTEtMTI4OTg_60056665-caca-4ec0-986c-a661a5d9e9b2"
      unitRef="usd">686600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i723b8483c8a44fa3831eba25ac4e8771_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMy0xMy0xLTEtMTczMTg_2de5ae27-e2d1-4815-af96-58c8ce3f88b5"
      unitRef="usd">983400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="if614186fb0024af2a131eccab2af782d_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfNC05LTEtMS0xMjg5OA_59ce5f97-d170-4dae-bb77-32b1b5f18951"
      unitRef="usd">-27500000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i04307c27f0e44baa8e6d7ba57acdb88e_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfNC0xMS0xLTEtMTI4OTg_ffda7fe7-c027-4637-b07d-b26da278883a"
      unitRef="usd">13600000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="ie870b4adc63f46feb66eb8a8c8e4d011_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfNC0xMy0xLTEtMTczMjE_413eed7a-ecd6-47c3-9580-c0127574d6f4"
      unitRef="usd">-13900000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="iae6e1dc8f3104428a423e41e99d59cf9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfNS0xLTEtMS0xMjg5OA_ad3f9e05-c5bc-46b1-9359-c81989e9fe3e"
      unitRef="shares">1219000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="iec6e709cf8ff41aaa43ed32125aaa1ad_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfNS01LTEtMS0xMjg5OA_b7dc8ba7-0832-4ff0-851b-538c7da404de"
      unitRef="usd">2800000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ie870b4adc63f46feb66eb8a8c8e4d011_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfNS0xMy0xLTEtMTczMjM_4060b8a1-2a09-4aa7-9d94-971ccf7d911e"
      unitRef="usd">2800000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
      contextRef="iec6e709cf8ff41aaa43ed32125aaa1ad_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfNi01LTEtMS0xMjg5OA_9730c584-2cb8-4060-b1cf-a6447c5bcd5f"
      unitRef="usd">9500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
      contextRef="ie870b4adc63f46feb66eb8a8c8e4d011_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfNi0xMy0xLTEtMTczMjU_e1af7278-f708-45f6-b488-ddc4b9075a0f"
      unitRef="usd">9500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i73a098cbb4e54750892085bb826f7c51_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfNy03LTEtMS0xMjg5OA_09a33005-4f40-4215-905e-ad52364623d3"
      unitRef="usd">-25200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ie870b4adc63f46feb66eb8a8c8e4d011_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfNy0xMy0xLTEtMTczMjc_d2d3655b-75e3-4829-bc2a-c388562ffd95"
      unitRef="usd">-25200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
      contextRef="iec6e709cf8ff41aaa43ed32125aaa1ad_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfOC01LTEtMS0xMjg5OA_e03af7a4-3381-4af1-ab81-e5199b766ad5"
      unitRef="usd">-700000</sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet>
    <sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
      contextRef="i04307c27f0e44baa8e6d7ba57acdb88e_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfOC0xMS0xLTEtMTI4OTg_3f491faf-dd99-47e1-964a-7fb3e612a98f"
      unitRef="usd">1400000</sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet>
    <sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
      contextRef="ie870b4adc63f46feb66eb8a8c8e4d011_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfOC0xMy0xLTEtMTczMjk_49db42ba-edf9-4274-bcc5-1754dda16543"
      unitRef="usd">700000</sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i04307c27f0e44baa8e6d7ba57acdb88e_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfOS0xMS0xLTEtMTI4OTg_441588e7-5421-4e1d-89ec-196ab306a7fd"
      unitRef="usd">14900000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ie870b4adc63f46feb66eb8a8c8e4d011_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfOS0xMy0xLTEtMTczMzE_e9857fb4-f623-45bd-87e0-51e14fc7038a"
      unitRef="usd">14900000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i65bbc1666baf4ab58e1d5def95db43cd_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTAtMS0xLTEtMTczMzM_e2ff6a20-69ee-4f9e-9e24-e9e7155ab032"
      unitRef="shares">50518000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i65bbc1666baf4ab58e1d5def95db43cd_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTAtMy0xLTEtMTczMzU_60586ec8-d008-4f3a-bcad-bac43046933d"
      unitRef="usd">500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0302db6bf7784a859b41b1557a29eada_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTAtNS0xLTEtMTczMzU_5103ecff-cf61-4a26-b7db-ff35e44356e4"
      unitRef="usd">655300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i02e8e2f7aa5d4308af89bd5d9eaa7cab_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTAtNy0xLTEtMTczMzU_d3ce52b2-3ac0-4658-bb1c-550973296176"
      unitRef="usd">-75900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8b951a38115c49a0a25b0d9d1a4a8894_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTAtOS0xLTEtMTczMzU_6c5011ea-d0ea-4a20-a4ef-d5cf4370f9f3"
      unitRef="usd">-343200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i28fe5537d2e64becaa3ad572da05ec1b_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTAtMTEtMS0xLTE3MzM1_0dbc2c6b-43d9-4788-b9ed-64571a68a669"
      unitRef="usd">686700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i19264b0de7ab4eb8b0352aece77637f2_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTAtMTMtMS0xLTE3MzM1_32fe007b-d3a2-41e1-867b-60bc38e2e5c5"
      unitRef="usd">923400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="idfdd711a02e74ca889726084c6b89bb3_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTEtOS0xLTEtMTI4OTg_eab270d4-f810-44a3-b92e-48e0123f453d"
      unitRef="usd">-32500000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i645577772ef04b6580b69faed65e927c_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTEtMTEtMS0xLTEyODk4_24ec75ba-26a3-4c4e-805e-ea63f86403e0"
      unitRef="usd">22800000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i46f6e83b5d4c4d579db2515cc00632b1_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTEtMTMtMS0xLTE3MzQy_0b05ed3e-23a6-4c8c-805a-500aade4b461"
      unitRef="usd">-9700000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i5d60bb0e88bd464082a32b07117af980_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTItMS0xLTEtMTI4OTg_33da8cf0-8cda-45e0-aee4-10354887ab8c"
      unitRef="shares">33000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i81ab0a7efcd546818b950401c349d061_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTItNS0xLTEtMTI4OTg_3fbe78a8-9539-406f-a293-0ea7491a2e5b"
      unitRef="usd">3800000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i46f6e83b5d4c4d579db2515cc00632b1_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTItMTMtMS0xLTE3MzQ0_bf0356dc-3833-4afe-9c46-367d6e487085"
      unitRef="usd">3800000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
      contextRef="i81ab0a7efcd546818b950401c349d061_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTMtNS0xLTEtMTI4OTg_1adca598-ef4b-4ba3-9bc9-f545734cbc45"
      unitRef="usd">9700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
      contextRef="i46f6e83b5d4c4d579db2515cc00632b1_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTMtMTMtMS0xLTE3MzQ2_4491942e-821f-4b1f-9801-de9d21307c84"
      unitRef="usd">9700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i3eb05b01366a444c95e4e82842f9a25b_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTQtNy0xLTEtMTI4OTg_e4de5d4e-cfcb-460a-8daf-8a6116c9269b"
      unitRef="usd">7300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i46f6e83b5d4c4d579db2515cc00632b1_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTQtMTMtMS0xLTE3MzQ4_2d755ec4-8080-44de-ad44-b16ec8538abe"
      unitRef="usd">7300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
      contextRef="i81ab0a7efcd546818b950401c349d061_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTUtNS0xLTEtMTI4OTg_112caad3-657c-4b75-bc4b-518f129d28e5"
      unitRef="usd">-1200000</sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet>
    <sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
      contextRef="i645577772ef04b6580b69faed65e927c_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTUtMTEtMS0xLTEyODk4_5330893a-3bde-4bc4-9b81-7c95ee74961f"
      unitRef="usd">2900000</sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet>
    <sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
      contextRef="i46f6e83b5d4c4d579db2515cc00632b1_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTUtMTMtMS0xLTE3MzUw_62ba47b7-f0c0-43f3-b216-cecd6568db30"
      unitRef="usd">1700000</sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i645577772ef04b6580b69faed65e927c_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTYtMTEtMS0xLTEyODk4_ebb23b78-7cad-4204-9276-4d161ee71cd6"
      unitRef="usd">20900000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i46f6e83b5d4c4d579db2515cc00632b1_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTYtMTMtMS0xLTE3MzUy_5c335c46-f354-48de-be8f-078a80778d37"
      unitRef="usd">20900000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib021d0c212de49bca1b78b3cc314c610_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTctMS0xLTEtMTczNTQ_fa6067e7-b07d-44b8-baf9-20da1221815b"
      unitRef="shares">50551000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib021d0c212de49bca1b78b3cc314c610_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTctMy0xLTEtMTczNTQ_0991c43a-40e7-4573-9161-466430b093b8"
      unitRef="usd">500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i04dd444ed05f4a46a5ab9054213d6ca2_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTctNS0xLTEtMTczNTQ_f8f0e093-2c5e-4a92-ab1b-5a1defd95d6e"
      unitRef="usd">648200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if2409f81f8b64985bad5ef07e2f6ea31_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTctNy0xLTEtMTczNTQ_52083e62-e111-4521-8669-fd05f343d3c4"
      unitRef="usd">-68600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic66bbcb9058847ae98f2300c873039bd_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTctOS0xLTEtMTczNTQ_64c2dbdd-cf82-48a7-9666-b6b6a896914f"
      unitRef="usd">-375700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia5e06688327645e0bf1b08b54c9f4601_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTctMTEtMS0xLTE3MzU0_21b27b31-46b9-456f-8c6d-616c1641b2dc"
      unitRef="usd">691500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ife84e5119b9d41d2997dd2e6bc21006f_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTctMTMtMS0xLTE3MzU0_60ba6e9e-f98f-4bfd-a0cf-18f76097f913"
      unitRef="usd">895900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="iae7a31bb630448b9a2fada4b9475deaa_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTgtOS0xLTEtMTM0NDY_6c9538fc-e7f0-4ac5-b0d7-76d3e48f19a6"
      unitRef="usd">-61600000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i9544c9d9dc744b44bb14b59cccb2d54b_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTgtMTEtMS0xLTEzNDU1_e688f8ef-2502-4170-a034-af68844fdf2f"
      unitRef="usd">19300000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTgtMTMtMS0xLTE3MzYw_f443e041-73b6-4a50-826c-8fd853c7973c"
      unitRef="usd">-42300000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="iddbb89f01a7d4e139ba298e541047140_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTktMS0xLTEtMTMzNzI_8dfc6178-0f99-4a18-93e2-7e9811e4ea90"
      unitRef="shares">-56000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i2ef302e3ae1f4cd8bde62e0c447620d0_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTktNS0xLTEtMTM0MDg_0e5899a4-42ed-4561-9411-162d03d02193"
      unitRef="usd">3000000.0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMTktMTMtMS0xLTE3MzYz_bcf67a25-2a9c-4bf1-9c02-4df3aeb598e1"
      unitRef="usd">3000000.0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
      contextRef="i2ef302e3ae1f4cd8bde62e0c447620d0_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMjAtNS0xLTEtMTM0MDg_9aaa16d7-8794-4463-860e-a7b1f9917791"
      unitRef="usd">10000000.0</us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMjAtMTMtMS0xLTE3MzY2_8b9b0a82-e0b5-47d4-bc06-e1803b8ab45e"
      unitRef="usd">10000000.0</us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i394e252b2ffa4fd0b8c8e8d0f831e656_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMjEtNy0xLTEtMTM0MzA_94d0aaea-1b3f-4d84-9277-93f3f8545737"
      unitRef="usd">3300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMjEtMTMtMS0xLTE3MzY5_a2a4fc5c-fab0-46ce-9c94-45627652a2f9"
      unitRef="usd">3300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
      contextRef="i2ef302e3ae1f4cd8bde62e0c447620d0_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMjItNS0xLTEtMTM0MDg_d356cce4-07f7-42a3-a26b-9e5396dc6042"
      unitRef="usd">-37900000</sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet>
    <sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
      contextRef="i9544c9d9dc744b44bb14b59cccb2d54b_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMjItMTEtMS0xLTEzNDU1_3a05b309-71c1-481b-b574-ae25256d0cec"
      unitRef="usd">7600000</sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet>
    <sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMjItMTMtMS0xLTE3Mzcy_f7546349-0c37-4efe-9c3f-c4b00ac39e5b"
      unitRef="usd">-30300000</sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i9544c9d9dc744b44bb14b59cccb2d54b_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMjMtMTEtMS0xLTEzNDU1_f1d5eb4b-9b37-440c-a96a-bdd01121818c"
      unitRef="usd">18800000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMjMtMTMtMS0xLTE3Mzc1_d2e831a2-10d6-4bc9-80b5-b6db80a14a39"
      unitRef="usd">18800000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i95271104483f4cd2a13aa0fd11c4c9c4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMjQtMS0xLTEtMTczNTY_d45dea1c-e0a4-436d-b1bd-7f668687fc66"
      unitRef="shares">50495000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i95271104483f4cd2a13aa0fd11c4c9c4_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMjQtMy0xLTEtMTczNTg_bb4a39c8-e9c8-494e-9b9f-fdd74ebac700"
      unitRef="usd">500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i42f848f9a2a94d5e9604c62328ab388a_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMjQtNS0xLTEtMTczNTg_faf002aa-94ba-47c8-9075-3246a6a3031c"
      unitRef="usd">603300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2c4b6f5d56814c14aba12fdc98258eea_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMjQtNy0xLTEtMTczNTg_589804c7-2631-4e87-8137-e88b53296e2e"
      unitRef="usd">-65300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i219bd4659c5a4f2ba0b0d28c6bdde0d5_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMjQtOS0xLTEtMTczNTg_919cb33e-56bd-463c-bc47-6cfb5665b33a"
      unitRef="usd">-437300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i711cc27756dd4866a36dee4b75131f1d_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMjQtMTEtMS0xLTE3MzU4_93b45a1c-5de0-44b9-a239-d5887d230179"
      unitRef="usd">699600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id38661458bd24a6c81732c5d5160d949_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yMi9mcmFnOjg4YzEwOGYyNTI0NTRmZWViOTc1YjM2NjY3NmFmNTA1L3RhYmxlOjQyMzhlNDkyYmZhYzRmOWI4NzQ4MmQzMTA3MjVkYTVkL3RhYmxlcmFuZ2U6NDIzOGU0OTJiZmFjNGY5Yjg3NDgyZDMxMDcyNWRhNWRfMjQtMTMtMS0xLTE3MzU4_6a6870da-8db1-4120-ace4-081a850acca5"
      unitRef="usd">800800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMy0yLTEtMS0xMjcxMg_b2168d8e-d1db-41db-a0d4-5517c790866b"
      unitRef="usd">27800000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMy00LTEtMS0xMjcxMg_ebf4c4b7-1b78-4b19-82a1-077e647b671a"
      unitRef="usd">-46600000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfNS0yLTEtMS0xMjcxMg_54fdefc8-77dd-4422-a6ca-465fbfa260e8"
      unitRef="usd">76100000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfNS00LTEtMS0xMjcxMg_b7509724-6c83-44a1-b48b-988edea19353"
      unitRef="usd">69300000</us-gaap:DepreciationDepletionAndAmortization>
    <sgry:NoncashInterestIncomeExpenseNet
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfNi0yLTEtMS0xMjcxMg_51e7fda5-f0c5-4da9-8f5b-fbc7da5f5689"
      unitRef="usd">-12000000.0</sgry:NoncashInterestIncomeExpenseNet>
    <sgry:NoncashInterestIncomeExpenseNet
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfNi00LTEtMS0xMjcxMg_50908dd6-8426-43cd-81ae-dd04a73cc4a9"
      unitRef="usd">-3100000</sgry:NoncashInterestIncomeExpenseNet>
    <us-gaap:ShareBasedCompensation
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfNy0yLTEtMS0xMjcxMg_b7506d86-b441-4bee-ab01-d7f8e17929c2"
      unitRef="usd">13400000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfNy00LTEtMS0xMjcxMg_e57c28b1-5989-488f-a449-1be3d16a8d7b"
      unitRef="usd">9900000</us-gaap:ShareBasedCompensation>
    <sgry:GainLossOnDispositionOfAssetsAndDeconsolidation
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfOC0yLTEtMS0xMjcxMg_4634cd15-f1ea-4c50-88d5-ed40e3c270a7"
      unitRef="usd">-2000000.0</sgry:GainLossOnDispositionOfAssetsAndDeconsolidation>
    <sgry:GainLossOnDispositionOfAssetsAndDeconsolidation
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfOC00LTEtMS0xMjcxMg_c53e6dd4-91e6-486e-bd55-f67f56f0fdab"
      unitRef="usd">-7100000</sgry:GainLossOnDispositionOfAssetsAndDeconsolidation>
    <us-gaap:AssetImpairmentCharges
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfOS0yLTEtMS0xMzUxNQ_9e1e6309-77bc-4eab-883e-42ae78c697e4"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfOS00LTEtMS0xMzUwMQ_cc35bcfc-6a86-46be-b7f8-4327ad3ec715"
      unitRef="usd">33500000</us-gaap:AssetImpairmentCharges>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfOS0yLTEtMS0xMjcxMg_fa7a788a-b836-4e4b-b235-554beab406d8"
      unitRef="usd">-9100000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfOS00LTEtMS0xMjcxMg_7e186f84-5eea-48f1-876b-2cd873d0a66e"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMTAtMi0xLTEtMTI3MTI_2306a02d-ef6b-458c-a45b-5f1e3de26ef4"
      unitRef="usd">-2300000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMTAtNC0xLTEtMTI3MTI_c9013359-141f-47ed-8408-8e3f5079a39c"
      unitRef="usd">-15300000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMTEtMi0xLTEtMTI3MTI_c4fa1ebd-8624-4fda-b7b5-7c6959531733"
      unitRef="usd">-200000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMTEtNC0xLTEtMTI3MTI_6216a2ee-f67f-4ac5-9de3-f3d11e0eea8f"
      unitRef="usd">1000000.0</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMTItMi0xLTEtMTI3MTI_14d6c15a-d079-4803-ac16-2e753f85a246"
      unitRef="usd">30300000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMTItNC0xLTEtMTI3MTI_2c762cff-8371-47e9-88c1-1bcb07889da9"
      unitRef="usd">29400000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMTQtMi0xLTEtMTI3MTI_e0fbd85a-ca4c-4241-92fd-9771cb5132fb"
      unitRef="usd">18400000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMTQtNC0xLTEtMTI3MTI_29637577-6eb2-40bb-a624-900e84eca1f6"
      unitRef="usd">11900000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <sgry:IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMTUtMi0xLTEtMTI3MTI_ab78b834-9a39-4ff0-b577-e8d587ae6df0"
      unitRef="usd">-48500000</sgry:IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants>
    <sgry:IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMTUtNC0xLTEtMTI3MTI_235d3ed6-8b73-4045-bd6a-b8385a3b44aa"
      unitRef="usd">141000000.0</sgry:IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants>
    <sgry:IncreaseDecreaseInSettlementPayments
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMTYtMi0xLTEtMTI3MTI_cf85a980-6960-431f-a262-04cd83f8c530"
      unitRef="usd">32200000</sgry:IncreaseDecreaseInSettlementPayments>
    <sgry:IncreaseDecreaseInSettlementPayments
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMTYtNC0xLTEtMTI3MTI_ee70319b-5dc0-4b4f-b7b6-78317f2140a9"
      unitRef="usd">0</sgry:IncreaseDecreaseInSettlementPayments>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMTctMi0xLTEtMTI3MTI_eed1bf03-f0e0-4358-8552-a4fb2049b9b3"
      unitRef="usd">2100000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMTctNC0xLTEtMTI3MTI_59cf80c3-1983-45a8-84e4-c793d2154e77"
      unitRef="usd">-19500000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMTgtMi0xLTEtMTI3MTI_cff36ccd-c086-425a-824e-e52fee0e100a"
      unitRef="usd">67400000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMTgtNC0xLTEtMTI3MTI_ff4017bd-0828-4108-b35b-de43fc3bd74f"
      unitRef="usd">238000000.0</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMjEtMi0xLTEtMTI3MTI_c2d23bb9-1a5e-4239-9824-34488c0774e1"
      unitRef="usd">43500000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMjEtNC0xLTEtMTI3MTI_c429a8c1-9f61-4c88-a458-46fd4b4b747c"
      unitRef="usd">27800000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMjItMi0xLTEtMTI3MTI_7bfe2294-c9c2-44c7-97e7-4d637d11aae4"
      unitRef="usd">101000000.0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMjItNC0xLTEtMTI3MTI_1d95bcf7-1733-4663-8328-b2fda9ef2cb2"
      unitRef="usd">14200000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMjMtMi0xLTEtMTI3MTI_190e00be-6331-478d-8049-94eea64abce0"
      unitRef="usd">2500000</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMjMtNC0xLTEtMTI3MTI_e0daf8c8-2986-4a3a-9a48-cb6c90484dfd"
      unitRef="usd">48300000</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMjQtMi0xLTEtMTI3MTI_57fb167c-c870-4bde-9148-540ac2f14413"
      unitRef="usd">-300000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMjQtNC0xLTEtMTI3MTI_3bd114d8-ae4c-43f9-859d-3c0281a567c9"
      unitRef="usd">-500000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMjUtMi0xLTEtMTI3MTI_ba8faab5-c687-4db5-a8e7-f9b58c619bf1"
      unitRef="usd">-141700000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMjUtNC0xLTEtMTI3MTI_03d63dc9-16bf-4422-a534-fed3185b8935"
      unitRef="usd">6800000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMjgtMi0xLTEtMTI3MTI_4296db0c-a6bc-4eaf-940e-931124c9c745"
      unitRef="usd">328400000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMjgtNC0xLTEtMTI3MTI_062e1220-d017-4947-889c-9f189a7c9fd4"
      unitRef="usd">197300000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMjktMi0xLTEtMTI3MTI_1e7c3bf0-f65c-47b9-9ff1-84fcac89210f"
      unitRef="usd">293000000.0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMjktNC0xLTEtMTI3MTI_2c3324fd-a9da-43f2-b9e9-7d0635a66da5"
      unitRef="usd">428000000.0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzAtMi0xLTEtMTI3MTI_680038d6-f6da-4f6c-875b-facc76152250"
      unitRef="usd">11700000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzAtNC0xLTEtMTI3MTI_72a609a2-4551-4c44-8c42-c3e91f9aee0e"
      unitRef="usd">8300000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzItMi0xLTEtMTI3MTI_7db28c25-1fda-4426-84d3-b4b5935a0443"
      unitRef="usd">260900000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzItNC0xLTEtMTI3MTI_087cda11-f860-4e80-84ed-c68ed7b04306"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzMtMi0xLTEtMTI3MTI_2736205c-36ed-4d85-a06f-31d41a8acdde"
      unitRef="usd">12700000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzMtNC0xLTEtMTI3MTI_aef3a03e-32f3-49e8-972c-07aa030d32e6"
      unitRef="usd">0</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzQtMi0xLTEtMTI3MTI_c78ece95-db8f-410b-a192-b9652e49d82b"
      unitRef="usd">5100000</us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock>
    <us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzQtNC0xLTEtMTI3MTI_881ea479-4f62-41ff-981b-ec8fde873307"
      unitRef="usd">0</us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzUtMi0xLTEtMTI3MTI_23ec4f2a-8049-44f4-9204-3dd91099742b"
      unitRef="usd">97500000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzUtNC0xLTEtMTI3MTI_89e70c83-9575-4e36-a683-65e757d10561"
      unitRef="usd">82300000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzYtMi0xLTEtMTI3MTI_90c9e762-f30e-42e9-8e0d-4219937f8a5a"
      unitRef="usd">2400000</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzYtNC0xLTEtMTI3MTI_17d0328e-2ac2-418f-8191-86af90f5b625"
      unitRef="usd">27300000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzctMi0xLTEtMTI3MTI_ac5bdd37-4e49-49da-8020-c49ce6ce362d"
      unitRef="usd">-14400000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzctNC0xLTEtMTI3MTI_8db82329-0344-423c-b1a6-ce5ca3bc857b"
      unitRef="usd">-300000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzgtMi0xLTEtMTI3MTI_f5923ebf-7413-4cfe-acbf-f10493386ad3"
      unitRef="usd">86500000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzgtNC0xLTEtMTI3MTI_2df64786-8702-4e74-994e-f5219fd1bfd0"
      unitRef="usd">112500000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzktMi0xLTEtMTI3MTI_0c8d7286-ca1e-42f7-9a4f-68c7a7f68b8e"
      unitRef="usd">12200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfMzktNC0xLTEtMTI3MTI_f804921c-8740-431d-bdfc-f5f3a2d6aa02"
      unitRef="usd">357300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfNDAtMi0xLTEtMTI3MTI_8dbdaafa-ca1c-4d84-abd0-923ee33e15b8"
      unitRef="usd">318200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i723b8483c8a44fa3831eba25ac4e8771_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfNDAtNC0xLTEtMTI3MTI_951e5fc4-a327-4ffc-891e-cc4ef6f0ef12"
      unitRef="usd">93000000.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfNDEtMi0xLTEtMTI3MTI_3514ff68-0e4e-40b8-9a4c-95dcc935faaa"
      unitRef="usd">330400000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id38661458bd24a6c81732c5d5160d949_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8yNS9mcmFnOmJiNWRkMmE1MGQ5MTQyNDNhNzUxMGVlYmU2OTY1OGE2L3RhYmxlOmE3YTQzZmRjZmMyNzQ4N2E5ZDU1OGVmMmZkZDdjYzZjL3RhYmxlcmFuZ2U6YTdhNDNmZGNmYzI3NDg3YTlkNTU4ZWYyZmRkN2NjNmNfNDEtNC0xLTEtMTI3MTI_516f2cea-573b-4a0f-871c-d4ff46a88629"
      unitRef="usd">450300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjc5NzY_fdbf38c1-7c38-436b-b43f-9396839b677b">Organization and Summary of Accounting Policies&lt;div style="margin-bottom:6pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Organization&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Surgery Partners, Inc., a Delaware corporation, acting through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The surgical facilities, which include ambulatory surgery centers ("ASCs") and surgical hospitals, primarily provide non-emergency surgical procedures across many specialties, including, among others, gastroenterology, general surgery, ophthalmology, orthopedics and pain management. The Company's surgical hospitals also provide services such as diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy and wound care. Ancillary services are comprised of multi-specialty physician practices, urgent care facilities and anesthesia services. Unless the context otherwise indicates, Surgery Partners, Inc. and its subsidiaries are referred to herein as "Surgery Partners," "we," "us," "our" or the "Company."&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2021, the Company owned or operated a portfolio of 127 surgical facilities, comprised of 110 ASCs and 17 surgical hospitals in 31 states. The Company owns these facilities in partnership with physicians and, in some cases, health care systems in the markets and communities it serves.&#160;The Company owned a majority interest in 90 of the surgical facilities and consolidated 110 of the facilities for financial reporting purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation of the Company's financial position and results of operations have been included. The Company&#x2019;s fiscal year ends on December&#160;31 and interim results are not necessarily indicative of results for a full year or any other interim period. The information contained in these condensed consolidated financial statements should be read in conjunction with the Company&#x2019;s consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2020 (the "2020 Annual Report on Form 10-K").&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, as well as interests in partnerships and limited liability companies controlled by the Company through its ownership of a majority voting interest or other rights granted to the Company by contract to manage and control the affiliate's business. All significant intercompany balances and transactions are eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Certain reclassifications have been made to the comparative periods' financial statements to conform to the current year presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;COVID-19 Pandemic&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The COVID-19 global pandemic has significantly affected the Company's facilities, employees, patients, communities, business operations and financial performance, as well as the United States economy and financial markets. The impact of COVID-19 on the Company's surgical facilities varies based on the market in which the facility operates, the type of surgical facility and the procedures that are typically performed. Although the Company cannot provide any certainty regarding the length and severity of the impact of the COVID-19 pandemic, surgical case volumes continue to improve in 2021 as government restrictions ease and public sentiment changes.  The Company has implemented new clinical safety measures to provide a safe environment for its patients, surgeons and employees. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;CARES Act &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;On March 27, 2020, the Coronavirus Aid, Relief and Economic Security Act (the &#x201c;CARES Act&#x201d;) was signed into law to provide stimulus funding for the United States economy. As part of the CARES Act, the United States government announced that it would offer relief to eligible health care providers, including distribution of direct grants to hospitals, ASCs and other health care providers based on how much they bill Medicare. Payments received from these grants are not required to be repaid provided the recipients attest to and comply with certain terms and conditions, including limitations on balance billing and not using funds received from the grants to reimburse expenses or losses that other sources are obligated to reimburse. The Company has received approximately $67&#160;million of the grant funds distributed under the CARES Act and other governmental assistance programs, including approximately $8&#160;million during the nine months ended September&#160;30, 2021. The Company did not receive any grant funds during the three months ended September&#160;30, 2021. The recognition of amounts received is conditioned upon attestation with terms and conditions that funds will be used for COVID-19 related healthcare expenses or lost revenues.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;The Company&#x2019;s assessment of whether the terms and conditions for amounts received are reasonably assured of having been met considers, among other things, the CARES Act, the COVID-19 Economic Relief Bill, enacted on December 27, 2020, and all frequently asked questions and other interpretive guidance issued by the United States Department of Health and Human Services ("HHS"), including in the Provider Relief Fund Reporting Portal and associated user guides. This guidance sets forth the allowable methods for quantifying eligible healthcare related expenses and lost revenues. Only healthcare related expenses attributable to COVID-19 that another source has not reimbursed and is not obligated to reimburse are eligible to be claimed. Based on guidance, the Company estimates approximately $20.0&#160;million of grant funds received qualified for recognition as a reduction in operating expenses for the nine months ended September 30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Amounts received, but not recognized as a reduction to operating expenses, are reflected as a component of Medicare accelerated payments and deferred governmental grants in the condensed consolidated balance sheets as of both September&#160;30, 2021 and December 31, 2020. Any unrecognized amounts may be recognized as a reduction in operating expenses in subsequent periods if the underlying conditions for recognition are met. HHS&#x2019; interpretation of the underlying terms and conditions of grant funds received through the CARES Act and other governmental assistance programs, including auditing and reporting requirements, may evolve. Additional guidance or new and amended interpretations of existing guidance on the terms and conditions of such payments may result in the Company&#x2019;s inability to recognize certain payments, changes in the estimate of amounts recognized, or the derecognition of amounts previously recognized, which may be material.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;As a way to increase cash flow to Medicare providers impacted by the COVID-19 pandemic, the CARES Act expanded the Medicare Accelerated and Advance Payment Program, which allowed for most providers and suppliers, including the Company&#x2019;s surgical hospitals and ASCs to request an advance payment of anticipated Medicare revenues. The Company received approximately $120&#160;million of accelerated payments during the year ended December 31, 2020. The payments received were deferred and included in the condensed consolidated balance sheets. During the three and nine months ended September 30, 2021, approximately $18&#160;million and $38&#160;million, respectively, has been repaid in accordance with the terms of the program. These repayments are included as a component of the change in Medicare accelerated payments and deferred government grants in the condensed consolidated statements of cash flows. Under these terms, repayment started one year after the initial funding by offsetting 25% of new claims paid by CMS.  After 11 months of repayment at this level, the repayments will increase to 50% of new claims paid by CMS for a period of six months. Any outstanding amounts due at the end of the repayment period are subject to interest at a rate of 4%. As of September 30, 2021 and December 31, 2020, the current portion of deferred accelerated payments was approximately $80&#160;million and $95&#160;million, respectively, and is included as a component of Medicare accelerated payments and deferred governmental grants in the condensed consolidated balance sheets. The long-term portion is included as a component of other long-term liabilities in the condensed consolidated balance sheets. The Company does not expect to receive additional Medicare accelerated payments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The CARES Act also provided for the deferral of the Company's portion of social security payroll taxes during 2020. Under the CARES Act, half of the deferred amount will be paid in each of December 2021 and December 2022. As of both September&#160;30, 2021 and December 31, 2020, the Company had deferred approximately $16.9&#160;million. The current portion is included as a component of accrued payroll and benefits and the long term portion is included as a component of other long-term liabilities in the condensed consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company is closely monitoring legislative actions and regulatory guidance at the federal, state and local levels with respect to the CARES Act as other governmental assistance might become available to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Variable Interest Entities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements include the accounts of variable interest entities ("VIE") in which the Company is the primary beneficiary under the provisions of the Financial Accounting Standards Board's ("FASB") Accounting Standards Codification 810, "&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consolidation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;". The Company has the power to direct the activities that most significantly impact a VIE's economic performance. Additionally, the Company would absorb the majority of the expected losses from any of these entities should such expected losses occur. As of September&#160;30, 2021, the Company's consolidated VIEs include four surgical facilities and three physician practices. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The total assets (excluding goodwill and intangible assets, net) of the consolidated VIEs included in the accompanying condensed consolidated balance sheets as of September&#160;30, 2021 and December&#160;31, 2020 were $26.7 million and $27.7 million, respectively, and the total liabilities of the consolidated VIEs were $19.1 million and $21.1 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair value of a financial instrument is the amount at which the instrument could be exchanged in an orderly transaction between market participants to sell the asset or transfer the liability. The Company uses fair value measurements based on inputs classified into the following hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt"&gt;Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt"&gt;Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These may include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt"&gt;Level 3: Unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, depending on the nature of the item being valued.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The carrying amounts reported in the condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, restricted invested assets and accounts payable approximate their fair values under Level 3 calculations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A summary of the carrying amounts and estimated fair values of the Company's long-term debt follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.787%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.787%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.787%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior secured term loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,534.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,539.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,523.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,533.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.750% senior unsecured notes due 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;370.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;370.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;376.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;376.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.000% senior unsecured notes due 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;545.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;545.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;589.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;596.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair values in the table above were based on Level 2 inputs using quoted prices for identical liabilities in inactive markets. The carrying amounts related to the Company's other long-term debt obligations, including finance lease obligations, approximate their fair values based on Level 3 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company's revenues generally relate to contracts with patients in which the performance obligations are to provide health care services. The Company recognizes revenues in the period in which its obligations to provide health care services are satisfied and reports the amount that reflects the consideration the Company expects to be entitled to receive. The contractual relationships with patients, in most cases, also involve a third-party payor (e.g., Medicare, Medicaid and private insurance organizations, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by or negotiated with the third-party payors. The payment arrangements with third-party payors for the services provided to the related patients typically specify payments at amounts less than the Company's standard charges. The Company continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A summary of revenues by service type as a percentage of total revenues follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Surgical facilities revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Ancillary services revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total patient service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Patient service revenues.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;This revenue is related to charging facility fees in exchange for providing patient care. The fee charged for health care procedures performed in surgical facilities varies depending on the type of service provided, but usually includes all charges for usage of an operating room, a recovery room, special equipment, medical supplies, nursing staff and medications. The fee does not normally include professional fees charged by the patient&#x2019;s surgeon, anesthesiologist or other attending physician, which are billed directly by such physicians to the patient or third-party payor. However, in several surgical facilities, the Company charges for anesthesia services. Ancillary service revenues include fees for patient visits to the Company's physician practices, pharmacy services and diagnostic tests ordered by physicians.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Patient service revenues are recognized as performance obligations are satisfied. Performance obligations are based on the nature of services provided. Typically, the Company recognizes revenue at a point in time in which services are rendered and the Company has no obligation to provide further patient services. As the Company primarily performs outpatient procedures, performance obligations are generally satisfied same day and revenue is recognized on the date of service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company determines the transaction price based on gross charges for services provided, net of estimated contractual adjustments and discounts from third-party payors. The Company estimates its contractual adjustments and discounts based on contractual agreements, its discount policies and historical experience. Changes in estimated contractual adjustments and discounts are recorded in the period of change. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other service revenues.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Other service revenues include management and administrative service fees derived from the non-consolidated facilities that the Company accounts for under the equity method, management of surgical facilities in which it does not own an interest, and management services provided to physician practices for which the Company is not required to provide capital or additional &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;assets. These agreements typically require the Company to provide recurring management services over a multi-year period, which are billed and collected on a monthly basis. The fees derived from these management arrangements are based on a predetermined percentage of the revenues of each facility or practice and are recognized in the period in which management services are rendered and billed. For the three and nine months ended September 30, 2020, other service revenues also includes optical service revenues, which consisted of handling charges billed to the members of the Company's optical products purchasing organization. The Company sold its optical products purchasing organization on December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table sets forth patient service revenues by type of payor and as a percentage of total patient service revenues for the Company's consolidated surgical facilities (dollars in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:6pt;text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.238%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.815%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.815%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Private insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;271.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;257.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;248.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;188.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Self-pay&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total patient service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;551.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;489.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 20.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;559.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;496.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:6pt;text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.238%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.815%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.815%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Private insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;790.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;682.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;700.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;505.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Self-pay&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total patient service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,593.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,293.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 20.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,614.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,311.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"&gt;Other is comprised of anesthesia service agreements, automobile liability, letters of protection and other payor types. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents and Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. The Company maintains its cash and cash equivalent balances at high credit quality financial institutions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;At December 31, 2020, cash, cash equivalents and restricted cash reported within the condensed consolidated statement of cash flows includes $0.3 million of restricted investments, which are reflected in other long-term assets in the condensed consolidated balance sheets. These restricted investments represented restricted cash held in accordance with the provisions of a long-term operating lease agreement held as security for performance under the Company's covenants and obligations within the agreement. The restrictions were released during the nine months ended September 30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts receivable from third-party payors are recorded net of estimated implicit price concessions, which are estimated based on the historical trend of the Company's surgical hospitals&#x2019; cash collections and contractual write-offs, and for the Company's surgical facilities in general, established fee schedules, relationships with payors and procedure statistics. While changes in estimated reimbursement from third-party payors remain a possibility, the Company expects that any such changes would be minimal and, therefore, would not have a material effect on its financial condition or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts receivable consists of receivables from federal and state agencies (under the Medicare and Medicaid programs), private insurance organizations, employers and patients. Management recognizes that revenues and receivables from government agencies are significant to the Company's operations, but it does not believe that there is significant credit risk associated with these government agencies. Concentration of credit risk with respect to other payors is limited because of the large number of such payors. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company recognizes that final reimbursement of accounts receivable is subject to final approval by each third-party payor. However, because the Company has contracts with its third-party payors and also verifies insurance coverage of the patient before medical services are rendered, the amounts that are pending approval from third-party payors are not considered significant. Amounts are classified outside of self-pay if the Company has an agreement with the third-party payor or has verified a patient&#x2019;s coverage prior to services rendered. The Company's policy is to collect co-payments and deductibles prior to providing medical services. Patient services of the Company are primarily non-emergency, which allows the surgical facilities to control the procedures for which third-party reimbursement is sought and obtained. The Company does not require collateral from self-pay patients.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company's collection policies and procedures are based on the type of payor, size of claim and estimated collection percentage for each patient account. The Company analyzes accounts receivable at each of its surgical facilities to ensure the proper collection and aged category. Collection efforts include direct contact with third-party payors or patients, written correspondence and the use of legal or collection agency assistance, as required. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Goodwill represents the fair value of the consideration provided in an acquisition over the fair value of net assets acquired and is not amortized. Additions to goodwill include amounts resulting from new business combinations and incremental ownership purchases in the Company's subsidiaries. A summary of the Company's acquisitions and dispositions for the nine months ended September&#160;30, 2021 is included in Note 2. "Acquisitions."&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A summary of activity related to goodwill for the nine months ended September&#160;30, 2021 is as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.167%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,468.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisitions, including post acquisition adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;145.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Divestitures and deconsolidations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,613.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A detailed evaluation of potential impairment indicators was performed as of September 30, 2021, which specifically considered the ongoing impact of the COVID-19 pandemic. On the basis of available evidence as of September 30, 2021, no indicators of impairment were identified. Future estimates of fair value could be adversely affected if the actual outcome of one or more of the Company's assumptions changes materially in the future, including a material decline in the Company&#x2019;s stock price and the fair value of its long-term debt, lower than expected surgical case volumes, higher market interest rates or increased operating costs. Such changes impacting the calculation of fair value, the risks of which are amplified by the COVID-19 pandemic, could result in a material impairment charge in the future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Derivative Instruments and Hedging Activities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company records all derivatives on the balance sheet at fair value and any financing elements treated as debt instruments are recorded at amortized cost. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Non-Controlling Interests&#x2014;Redeemable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Each partnership and limited liability company through which the Company owns and operates its surgical facilities is governed by a partnership or operating agreement, respectively.&#160;In certain circumstances, the applicable partnership or operating agreements for the Company's surgical facilities provide that the facilities will purchase all of the physician limited partners&#x2019; or physician minority members&#x2019;, as applicable, ownership if certain adverse regulatory events occur, such as it becoming illegal for the physician(s) to own an interest in a surgical facility, refer patients to a surgical facility or receive cash distributions from a surgical facility.&#160;The non-controlling interests&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;redeemable are reported outside of stockholders' equity in the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A summary of activity related to non-controlling interests&#x2014;redeemable for the nine months ended September&#160;30, 2021 and 2020 is as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at&#160;beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;306.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;321.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to non-controlling interests&#x2014;redeemable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisition (disposal) of shares of non-controlling interests, net&#x2014;redeemable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Distributions to non-controlling interest&#x2014;redeemable holders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(27.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at&#160;end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;310.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;304.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Income Taxes &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company uses the asset and liability method to account for income taxes. Under this method, deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. If a carryforward exists, the Company makes a determination as to whether the carryforward will be utilized in the future. A valuation allowance is established for certain carryforwards when their recoverability is deemed to be uncertain. The carrying value of the net deferred tax assets assumes that the Company will be able to generate sufficient future taxable income in certain tax jurisdictions, based on estimates and assumptions. If our expectations for future operating results on a consolidated basis or at the state jurisdiction level vary from actual results due to changes in health care regulations, general economic conditions, or other factors, we may need to adjust the valuation allowance, for all or a portion of our deferred tax assets. Our income tax expense in future periods will be reduced or increased to the extent of offsetting decreases or increases, respectively, in our valuation allowance in the period when the change in circumstances occurs. These changes could have a significant impact on our future earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company and certain of its subsidiaries file a consolidated federal income tax return. The partnerships, limited liability companies, and certain non-consolidated physician practice corporations also file separate income tax returns. The Company's allocable portion of each partnership's and limited liability company's income or loss is included in taxable income of the Company. The remaining income or loss of each partnership and limited liability company is allocated to the other owners.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company's effective tax rate was (4.9)% for the nine months ended September&#160;30, 2021 compared to 23.7% for the nine months ended September&#160;30, 2020. For the nine months ended September&#160;30, 2021, the effective tax rate differed from 21% primarily due to discrete tax benefits of (a) $4.4&#160;million related to the vesting of restricted stock awards, and (b) $3.0&#160;million related to entity divestitures. For the nine months ended September&#160;30, 2020, the effective tax rate differed from 21% primarily due to (a) discrete tax benefits of $6.9 million attributable to the release of federal and state valuation allowances on the Company&#x2019;s Internal Revenue Code Section 163(j) interest carryforwards as a result of the increase in deductible interest expense allowed under the CARES Act, and $5.0&#160;million attributable to a portion of the payments under the Settlement Agreement, as defined in Note 9. "Commitments and Contingencies," being classified as "restitution" for income tax purposes, and (b) a discrete tax expense of $5.0&#160;million attributable to the impairment of goodwill. Based upon the application of interim accounting guidance, the tax rate as a percentage of net income after income attributable to non-controlling interests will vary based upon the relative net income from period to period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued Accounting Standard Update ("ASU") 2020-04,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt; Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. The ASU provides optional guidance for a limited period of time to ease the potential burden in accounting for or recognizing the effects of reference rate reform on financial reporting and applies only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The ASU is effective as of March 12, 2020 through December 31, 2022. Entities may adopt ASU 2020-04 as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020 or prospectively from a date within an interim period that includes or is subsequent to March 12, 2020, up to the date that the financial statements are available to be issued. The Company is evaluating the impact of this ASU on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <sgry:NumberOfSurgicalFacilitiesOwned
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMTAyMQ_4a3ea481-4da2-431e-bf21-a1fff8e2ef45"
      unitRef="surgical_facility">127</sgry:NumberOfSurgicalFacilitiesOwned>
    <sgry:NumberOfSurgicalFacilitiesOwned
      contextRef="i0b8f04298f2f4487880978d9ac283c40_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMTA1OA_24d6163e-8256-496f-90d1-af648b677de2"
      unitRef="surgical_facility">110</sgry:NumberOfSurgicalFacilitiesOwned>
    <sgry:NumberOfSurgicalFacilitiesOwned
      contextRef="ifac1f29acb89455b90f5cd970447f0a9_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMTA3MA_160931c3-f106-468a-936a-2671cbe9f625"
      unitRef="surgical_facility">17</sgry:NumberOfSurgicalFacilitiesOwned>
    <us-gaap:NumberOfStatesInWhichEntityOperates
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMTA5NQ_54ce3d84-279d-462a-ac00-85a2295fb50b"
      unitRef="state">31</us-gaap:NumberOfStatesInWhichEntityOperates>
    <sgry:NumberOfSurgicalFacilitiesOwnedMajorityInterest
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMTI5NA_19cfd159-1751-4121-94ba-a7cba7aab273"
      unitRef="surgical_facility">90</sgry:NumberOfSurgicalFacilitiesOwnedMajorityInterest>
    <sgry:NumberOfSurgicalFacilitiesOwnedConsolidated
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMTM0MQ_927d5789-cfbb-4a84-996c-9c302d882268"
      unitRef="surgical_facility">110</sgry:NumberOfSurgicalFacilitiesOwnedConsolidated>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjc4OTk_6f8f5bc4-5fc2-4e9c-b7db-f460f45ecb85">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation of the Company's financial position and results of operations have been included. The Company&#x2019;s fiscal year ends on December&#160;31 and interim results are not necessarily indicative of results for a full year or any other interim period. The information contained in these condensed consolidated financial statements should be read in conjunction with the Company&#x2019;s consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2020 (the "2020 Annual Report on Form 10-K").&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjgwMTA_fd600d45-9f6e-4745-bbb2-c6d606f666b3">The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, as well as interests in partnerships and limited liability companies controlled by the Company through its ownership of a majority voting interest or other rights granted to the Company by contract to manage and control the affiliate's business. All significant intercompany balances and transactions are eliminated in consolidation.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjc4OTE_ae09fedb-8ccc-4c70-af48-b9d00be8dd8b">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Certain reclassifications have been made to the comparative periods' financial statements to conform to the current year presentation.&lt;/span&gt;&lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:UseOfEstimates
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjc5NDE_0af3dda6-2869-411f-8354-3e845a54b3b1">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <sgry:ProceedsFromGovernmentAssistance
      contextRef="i40f463b41ec94ef59b20aaf801aebf70_D20200327-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfNDk4NA_41a995dc-ef26-4fff-8d4b-42aa927a1b32"
      unitRef="usd">67000000</sgry:ProceedsFromGovernmentAssistance>
    <sgry:ProceedsFromGovernmentAssistance
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfNTExMw_0c5459c4-2e01-4a66-9fbe-2ce3e7b8c9fe"
      unitRef="usd">8000000</sgry:ProceedsFromGovernmentAssistance>
    <sgry:ProceedsFromGovernmentAssistance
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjc0ODc3OTEwNjU2Mg_a5e68178-9e68-44de-88b0-b2b8c07f44b6"
      unitRef="usd">0</sgry:ProceedsFromGovernmentAssistance>
    <sgry:GrantRevenue
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfNjE2Mg_58863437-ddc5-4885-9786-1d2dc254889a"
      unitRef="usd">20000000</sgry:GrantRevenue>
    <sgry:CoronavirusAidReliefandEconomicSecurityActCARESActGovernmentGrantReceivedAcceleratedPayments
      contextRef="ifbd2503cfbf74ec8aa4c1f9de99fff89_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfODE2MQ_18eed761-2fe5-4268-b88c-6dcf653ccdcd"
      unitRef="usd">120000000</sgry:CoronavirusAidReliefandEconomicSecurityActCARESActGovernmentGrantReceivedAcceleratedPayments>
    <sgry:CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMTA5OTUxMTY2NDYxNQ_eb96eedb-96c4-43ad-8db8-7c0823e2fbb3"
      unitRef="usd">18000000</sgry:CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments>
    <sgry:CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMTA5OTUxMTY1ODg2Mg_86c5cabc-d7a5-4ab9-b7e9-d63550ba31bb"
      unitRef="usd">38000000</sgry:CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments>
    <sgry:CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMTA5OTUxMTY1ODgzNw_abf39d7f-73a3-4ba8-a996-3d71a1e8a3b0"
      unitRef="usd">80000000</sgry:CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments>
    <sgry:CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfODU1Nw_7cbc9db1-842c-41b5-b9d1-db6d7c4f2ee9"
      unitRef="usd">95000000</sgry:CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments>
    <sgry:DeferredEmployeeRelatedLiabilitiesCurrent
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfOTIyMQ_1462ca5b-fa4f-47a8-89d8-8362d35ff41b"
      unitRef="usd">16900000</sgry:DeferredEmployeeRelatedLiabilitiesCurrent>
    <sgry:DeferredEmployeeRelatedLiabilitiesCurrent
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfOTIyMQ_f03eba5b-b457-4a98-8f1b-772578e6c436"
      unitRef="usd">16900000</sgry:DeferredEmployeeRelatedLiabilitiesCurrent>
    <us-gaap:ConsolidationVariableInterestEntityPolicy
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjc5MDI_05aa557c-62bf-40aa-a079-c18a97bebafd">Variable Interest Entities&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements include the accounts of variable interest entities ("VIE") in which the Company is the primary beneficiary under the provisions of the Financial Accounting Standards Board's ("FASB") Accounting Standards Codification 810, "&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consolidation&lt;/span&gt;". The Company has the power to direct the activities that most significantly impact a VIE's economic performance. Additionally, the Company would absorb the majority of the expected losses from any of these entities should such expected losses occur.</us-gaap:ConsolidationVariableInterestEntityPolicy>
    <sgry:VariableInterestEntityNumberOfFacilities
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMTAzOTk_b9e01055-9be7-4750-b6d9-8e322885fcc3"
      unitRef="surgical_facility">4</sgry:VariableInterestEntityNumberOfFacilities>
    <sgry:VariableInterestEntityNumberOfFacilities
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMTA0MjY_c33ba645-9467-418b-bda0-ef86faf346a3"
      unitRef="physician_practice">3</sgry:VariableInterestEntityNumberOfFacilities>
    <us-gaap:Assets
      contextRef="i32be3c0b3a7f46518fcdfa2dab23569e_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMTA2Mjk_b23adc03-9df4-42b0-a1d3-6744e3d1b60e"
      unitRef="usd">26700000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i894cda222d3d4b14afb4128bc02678fd_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMTA2MzY_ad982901-4986-404e-a323-01255dab9163"
      unitRef="usd">27700000</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="i32be3c0b3a7f46518fcdfa2dab23569e_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMTA3MTA_c1fe13fc-4edc-42c8-98f1-25b7193c43a7"
      unitRef="usd">19100000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i894cda222d3d4b14afb4128bc02678fd_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMTA3MTc_96ca5d22-e49f-4be2-87ac-fb3910ff1325"
      unitRef="usd">21100000</us-gaap:Liabilities>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjgwMTU_711c72c3-4a5e-4894-a0da-200763b99842">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair value of a financial instrument is the amount at which the instrument could be exchanged in an orderly transaction between market participants to sell the asset or transfer the liability. The Company uses fair value measurements based on inputs classified into the following hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt"&gt;Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt"&gt;Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These may include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt"&gt;Level 3: Unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, depending on the nature of the item being valued.&lt;/span&gt;&lt;/div&gt;The carrying amounts reported in the condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, restricted invested assets and accounts payable approximate their fair values under Level 3 calculations.The fair values in the table above were based on Level 2 inputs using quoted prices for identical liabilities in inactive markets. The carrying amounts related to the Company's other long-term debt obligations, including finance lease obligations, approximate their fair values based on Level 3 inputs.</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjc5MzY_3c1962d2-4b8e-4a5e-85fc-9c2dba196180">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A summary of the carrying amounts and estimated fair values of the Company's long-term debt follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.787%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.787%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.787%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior secured term loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,534.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,539.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,523.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,533.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.750% senior unsecured notes due 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;370.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;370.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;376.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;376.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.000% senior unsecured notes due 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;545.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;545.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;589.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;596.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i962fa35551cd479c8e9aed5680bfb517_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjk0NjBkNTY0ZjRlMDQ2YjM4MzkyNmU1ODVhYWUzZWFhL3RhYmxlcmFuZ2U6OTQ2MGQ1NjRmNGUwNDZiMzgzOTI2ZTU4NWFhZTNlYWFfMy0yLTEtMS0xMjcxMg_a2058325-0db5-4b82-bf14-2f2318687a84"
      unitRef="usd">1534500000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i7c9c6ffb79ae4ec5815bfd1526797134_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjk0NjBkNTY0ZjRlMDQ2YjM4MzkyNmU1ODVhYWUzZWFhL3RhYmxlcmFuZ2U6OTQ2MGQ1NjRmNGUwNDZiMzgzOTI2ZTU4NWFhZTNlYWFfMy00LTEtMS0xMjcxMg_f6bc7fb9-6c34-4c15-8891-3296e6c0179f"
      unitRef="usd">1539400000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="icaca869429314f97a2375ca94953fd78_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjk0NjBkNTY0ZjRlMDQ2YjM4MzkyNmU1ODVhYWUzZWFhL3RhYmxlcmFuZ2U6OTQ2MGQ1NjRmNGUwNDZiMzgzOTI2ZTU4NWFhZTNlYWFfMy02LTEtMS0xMjcxMg_d14fc880-542d-442e-9a24-3ed4e9de2cd8"
      unitRef="usd">1523000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i42b70d9ee17d4631895533f028803e8b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjk0NjBkNTY0ZjRlMDQ2YjM4MzkyNmU1ODVhYWUzZWFhL3RhYmxlcmFuZ2U6OTQ2MGQ1NjRmNGUwNDZiMzgzOTI2ZTU4NWFhZTNlYWFfMy04LTEtMS0xMjcxMg_933b30e7-e11f-4686-a84b-683e30d9ab26"
      unitRef="usd">1533400000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2bacc8e8772841cdbb2620ef10c4ca4f_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjk0NjBkNTY0ZjRlMDQ2YjM4MzkyNmU1ODVhYWUzZWFhL3RhYmxlcmFuZ2U6OTQ2MGQ1NjRmNGUwNDZiMzgzOTI2ZTU4NWFhZTNlYWFfNC0wLTEtMS0xMjcxMi90ZXh0cmVnaW9uOjc5ODY5NjA4NDU1YTRlYTI4OTJiZDdiZDA0OGJmNDYwXzQ_f0c6d9e6-2846-442a-b8d8-c284cfbfcc32"
      unitRef="number">0.06750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i667f3ee4fc3f4e098746acef1144296f_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjk0NjBkNTY0ZjRlMDQ2YjM4MzkyNmU1ODVhYWUzZWFhL3RhYmxlcmFuZ2U6OTQ2MGQ1NjRmNGUwNDZiMzgzOTI2ZTU4NWFhZTNlYWFfNC0yLTEtMS0xMjcxMg_9558abaa-0dec-4215-9d0c-43de9e341797"
      unitRef="usd">370000000.0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="id2b7f57e6dc049148da6841ad22d457f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjk0NjBkNTY0ZjRlMDQ2YjM4MzkyNmU1ODVhYWUzZWFhL3RhYmxlcmFuZ2U6OTQ2MGQ1NjRmNGUwNDZiMzgzOTI2ZTU4NWFhZTNlYWFfNC00LTEtMS0xMjcxMg_0485e223-4ef5-40f9-80e7-61e4395ed6f0"
      unitRef="usd">370000000.0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="icbfc05d48fc543a19f054a1cc19d7fe1_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjk0NjBkNTY0ZjRlMDQ2YjM4MzkyNmU1ODVhYWUzZWFhL3RhYmxlcmFuZ2U6OTQ2MGQ1NjRmNGUwNDZiMzgzOTI2ZTU4NWFhZTNlYWFfNC02LTEtMS0xMjcxMg_0cffab92-992e-4f39-ade5-2665ada50428"
      unitRef="usd">376000000.0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iaffb336a9a3b4525984047c9cd6a707e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjk0NjBkNTY0ZjRlMDQ2YjM4MzkyNmU1ODVhYWUzZWFhL3RhYmxlcmFuZ2U6OTQ2MGQ1NjRmNGUwNDZiMzgzOTI2ZTU4NWFhZTNlYWFfNC04LTEtMS0xMjcxMg_8dad8da5-e6f8-4d70-8614-daf638532517"
      unitRef="usd">376000000.0</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic8eddef2cc304b9c98cff9dfa3b5279d_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjk0NjBkNTY0ZjRlMDQ2YjM4MzkyNmU1ODVhYWUzZWFhL3RhYmxlcmFuZ2U6OTQ2MGQ1NjRmNGUwNDZiMzgzOTI2ZTU4NWFhZTNlYWFfNS0wLTEtMS0xMjcxMi90ZXh0cmVnaW9uOjA3NDEzODA2YWRjOTQyZmViMDM5Y2Q5NWI5ZDA5MDYxXzQ_d6d418ae-2acc-4fef-b739-0bdd367cc2a5"
      unitRef="number">0.10000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i95aa1f95aa154cc1b14c588d17ea7543_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjk0NjBkNTY0ZjRlMDQ2YjM4MzkyNmU1ODVhYWUzZWFhL3RhYmxlcmFuZ2U6OTQ2MGQ1NjRmNGUwNDZiMzgzOTI2ZTU4NWFhZTNlYWFfNS0yLTEtMS0xMjcxMg_08e443be-b55b-449b-859c-b53ffba8a3b1"
      unitRef="usd">545000000.0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ie7fe14d003214347b2cc288cb20c5df6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjk0NjBkNTY0ZjRlMDQ2YjM4MzkyNmU1ODVhYWUzZWFhL3RhYmxlcmFuZ2U6OTQ2MGQ1NjRmNGUwNDZiMzgzOTI2ZTU4NWFhZTNlYWFfNS00LTEtMS0xMjcxMg_c258d77a-770b-4f59-b24b-3da3eb255635"
      unitRef="usd">545000000.0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i6c4016e7689e4c859eccdeea6ca19ac5_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjk0NjBkNTY0ZjRlMDQ2YjM4MzkyNmU1ODVhYWUzZWFhL3RhYmxlcmFuZ2U6OTQ2MGQ1NjRmNGUwNDZiMzgzOTI2ZTU4NWFhZTNlYWFfNS02LTEtMS0xMjcxMg_2bbd5135-7daf-4967-b88e-118f5cbb1041"
      unitRef="usd">589300000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i5d8af47260764ab4a3254e17e605316e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjk0NjBkNTY0ZjRlMDQ2YjM4MzkyNmU1ODVhYWUzZWFhL3RhYmxlcmFuZ2U6OTQ2MGQ1NjRmNGUwNDZiMzgzOTI2ZTU4NWFhZTNlYWFfNS04LTEtMS0xMjcxMg_da7d6111-e636-40c6-8449-3efae94f2623"
      unitRef="usd">596800000</us-gaap:LongTermDebt>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjc5ODQ_bfa62db0-ec0f-41d5-a7e2-07155b7fae3b">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company's revenues generally relate to contracts with patients in which the performance obligations are to provide health care services. The Company recognizes revenues in the period in which its obligations to provide health care services are satisfied and reports the amount that reflects the consideration the Company expects to be entitled to receive. The contractual relationships with patients, in most cases, also involve a third-party payor (e.g., Medicare, Medicaid and private insurance organizations, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by or negotiated with the third-party payors. The payment arrangements with third-party payors for the services provided to the related patients typically specify payments at amounts less than the Company's standard charges. The Company continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Patient service revenues.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;This revenue is related to charging facility fees in exchange for providing patient care. The fee charged for health care procedures performed in surgical facilities varies depending on the type of service provided, but usually includes all charges for usage of an operating room, a recovery room, special equipment, medical supplies, nursing staff and medications. The fee does not normally include professional fees charged by the patient&#x2019;s surgeon, anesthesiologist or other attending physician, which are billed directly by such physicians to the patient or third-party payor. However, in several surgical facilities, the Company charges for anesthesia services. Ancillary service revenues include fees for patient visits to the Company's physician practices, pharmacy services and diagnostic tests ordered by physicians.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Patient service revenues are recognized as performance obligations are satisfied. Performance obligations are based on the nature of services provided. Typically, the Company recognizes revenue at a point in time in which services are rendered and the Company has no obligation to provide further patient services. As the Company primarily performs outpatient procedures, performance obligations are generally satisfied same day and revenue is recognized on the date of service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company determines the transaction price based on gross charges for services provided, net of estimated contractual adjustments and discounts from third-party payors. The Company estimates its contractual adjustments and discounts based on contractual agreements, its discount policies and historical experience. Changes in estimated contractual adjustments and discounts are recorded in the period of change. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other service revenues.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Other service revenues include management and administrative service fees derived from the non-consolidated facilities that the Company accounts for under the equity method, management of surgical facilities in which it does not own an interest, and management services provided to physician practices for which the Company is not required to provide capital or additional &lt;/span&gt;&lt;/div&gt;assets. These agreements typically require the Company to provide recurring management services over a multi-year period, which are billed and collected on a monthly basis. The fees derived from these management arrangements are based on a predetermined percentage of the revenues of each facility or practice and are recognized in the period in which management services are rendered and billed. For the three and nine months ended September 30, 2020, other service revenues also includes optical service revenues, which consisted of handling charges billed to the members of the Company's optical products purchasing organization. The Company sold its optical products purchasing organization on December 31, 2020.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjc5NDM_4992e91c-53bd-4675-98f1-827b2fbf4369">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A summary of revenues by service type as a percentage of total revenues follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Surgical facilities revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Ancillary services revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total patient service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table sets forth patient service revenues by type of payor and as a percentage of total patient service revenues for the Company's consolidated surgical facilities (dollars in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:6pt;text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.238%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.815%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.815%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Private insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;271.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;257.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;248.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;188.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Self-pay&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total patient service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;551.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;489.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 20.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;559.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;496.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:6pt;text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.238%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.815%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.815%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Private insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;790.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;682.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;700.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;505.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Self-pay&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total patient service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,593.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,293.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 20.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,614.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,311.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1)Other is comprised of anesthesia service agreements, automobile liability, letters of protection and other payor types.</us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i5a36782fa2bc4df19287a1556d0bf2c4_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfMy0yLTEtMS0xMjcxMg_fcb24031-9bb7-49bd-9ba6-e9b51053d740"
      unitRef="number">0.956</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if728a9865da84a0380fd1550912931a8_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfMy00LTEtMS0xMjcxMg_69524143-6e99-4647-af7d-fb113d3875db"
      unitRef="number">0.954</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i54e5084300b248e6920827b61dce0943_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfMy02LTEtMS0xMjcxMg_c8b433f3-7577-482f-88ac-65c05eb8edaf"
      unitRef="number">0.955</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i1f1c728ff4fa4a09ab6c46f289cf0c49_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfMy04LTEtMS0xMjcxMg_2149b0e0-8585-4c6a-bbbb-2e8bd2ccf733"
      unitRef="number">0.950</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i843b1778208d4e50b16f7c11bdf1e6fb_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfNC0yLTEtMS0xMjcxMg_01daebb3-1a65-4259-a08d-dfb6ae6b7916"
      unitRef="number">0.030</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i5c8ee242dc044d2c9036d788a9a56762_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfNC00LTEtMS0xMjcxMg_0cbe5044-3df0-4c74-b173-ae60f77fea4b"
      unitRef="number">0.034</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i4af18ac975044d50a2ea274814e3f36d_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfNC02LTEtMS0xMjcxMg_bd50a4ea-299a-4450-9f27-8856aa3093c1"
      unitRef="number">0.031</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i882ea7583a5546c7a0376ce43d387ecf_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfNC04LTEtMS0xMjcxMg_0275439b-cccd-4aa1-ad05-9c519828dd23"
      unitRef="number">0.036</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i63770fd818324501b078a13e278a2991_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfNS0yLTEtMS0xMjcxMg_55cd6d91-7c36-471a-9918-14a404ed5a47"
      unitRef="number">0.986</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i85aeab70f1b346e3b6010265e0f54c1b_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfNS00LTEtMS0xMjcxMg_68517e8c-8788-4cf8-a243-4784d887201b"
      unitRef="number">0.988</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i8f0e94193ec74331b69bee876be7394b_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfNS02LTEtMS0xMjcxMg_e0063a1d-de20-47b5-883c-da56dbc57c17"
      unitRef="number">0.986</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i32c65d19973748b8abb14d3b08023423_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfNS04LTEtMS0xMjcxMg_0ceb32b0-a2ad-4881-89db-e5c4a4f5eaf9"
      unitRef="number">0.986</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if0fb8315dd704b23a2452d16f9d4169f_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfNi0yLTEtMS0xMjcxMg_ab17d337-b6fd-47e5-92ad-0089b1a86ad2"
      unitRef="number">0.014</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i1699c2a292e44cc0ba2155cd47ae8171_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfNi00LTEtMS0xMjcxMg_d5ce42a3-8caf-4fa0-9ad0-d3345be911d4"
      unitRef="number">0.012</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i11b91707b010413287ffa0b97b9edd79_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfNi02LTEtMS0xMjcxMg_601c682e-49fb-4ff9-8216-c17aff69f4e4"
      unitRef="number">0.014</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i7cab1a6fb67e44eb9f664045e38c77fb_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfNi04LTEtMS0xMjcxMg_df565f03-b7ae-409d-9337-117a532704bd"
      unitRef="number">0.014</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic18ae544123642ddbc9fb91be061be82_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfNy0yLTEtMS0xMjcxMg_801cc903-ae62-4719-b595-51ab8cee2c72"
      unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i201f9b152e43400da5c39192eee73807_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfNy00LTEtMS0xMjcxMg_c1f38e1b-8988-4818-b908-c0a43dbdbdf9"
      unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i0962a819986d4646b1b65ccf8a64364a_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfNy02LTEtMS0xMjcxMg_16ad5433-649a-47e5-9cbe-dc47bc8d0d3d"
      unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i72f9be049f1c4e16b1369f54ef365688_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjhiZThlY2UwNjYxMzQ0M2ZhNTJkY2VhYjgxZjU5ZmIyL3RhYmxlcmFuZ2U6OGJlOGVjZTA2NjEzNDQzZmE1MmRjZWFiODFmNTlmYjJfNy04LTEtMS0xMjcxMg_8af22b4d-8fb3-41c7-99e9-2c668ab967cd"
      unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3c428e120f3b4e7b8ec14607857cd6c0_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfNC0yLTEtMS0xMjcxMg_db7a4d3e-45e6-49b6-952f-d8f9b50696d4"
      unitRef="usd">271400000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ife562b2a0b4b43f7a740f883ebb3f9b2_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfNC00LTEtMS0xMjcxMg_898f5610-7ff4-4dda-88d6-23a76b5baf63"
      unitRef="number">0.492</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6a422701acfb4654890456c3f48a79f6_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfNC02LTEtMS0xMjcxMg_d9338fb9-aa39-4a03-bbfa-f221e4d97513"
      unitRef="usd">257400000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i0b1711cca24e4b1bab0201cd8a60b43d_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfNC04LTEtMS0xMjcxMg_bb6d858f-9ce6-4a6d-a689-1ada69ae0dc0"
      unitRef="number">0.526</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ie849beb4c21f4b39aabfc1121489da56_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfNS0yLTEtMS0xMjcxMg_af072f62-bd10-4115-9a83-f3111a011f1a"
      unitRef="usd">248000000.0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i02b93a2c47cf40a48adee19c7d6fa0d4_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfNS00LTEtMS0xMjcxMg_5b135d7b-07f4-4389-93cc-25ca4968cc5a"
      unitRef="number">0.450</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i9e24a27c70c5488b809dc406c7f2b718_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfNS02LTEtMS0xMjcxMg_67715473-6b00-49d9-9bea-0ee334485bbe"
      unitRef="usd">188800000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ibc799fec3e51413a9fc7c55e26f13cb5_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfNS04LTEtMS0xMjcxMg_bd78cc8a-a53f-4ed9-9802-5ee34be32c88"
      unitRef="number">0.385</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ib90d2af58a99466c8a29503e4f921426_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfNi0yLTEtMS0xMjcxMg_09b127e7-4b8e-48e0-8557-7f626f039d23"
      unitRef="usd">15900000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if9f0bd05efdd438c8ab2afdf0d745752_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfNi00LTEtMS0xMjcxMg_85fe40a0-e939-406e-9188-f526875d2ece"
      unitRef="number">0.029</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i8d82a46716de4518ac0b5840519715d5_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfNi02LTEtMS0xMjcxMg_40904fe1-8111-44c5-a8f0-9bf7f9a7a11f"
      unitRef="usd">19400000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic7663ed8a8ac40619a7d5b3ba42a13f6_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfNi04LTEtMS0xMjcxMg_94f6c668-b3e6-4946-a9ae-275388f07a84"
      unitRef="number">0.040</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i1b7a80a48aef4f70976ee8453ca6ce93_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfNy0yLTEtMS0xMjcxMg_bd51971a-c08e-47d8-ad2c-72cd01c98ade"
      unitRef="usd">16100000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id9d4994c80754a68880bfc13a642ede4_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfNy00LTEtMS0xMjcxMg_3c746732-759d-4a12-bd3c-05a96b95e417"
      unitRef="number">0.029</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i234d99c99d2f4f739eae5fea2587ff52_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfNy02LTEtMS0xMjcxMg_93101bf4-85f2-4b92-8933-a83480b4a90d"
      unitRef="usd">24200000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i55e1271c0167429bb3d4328fcd101340_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfNy04LTEtMS0xMjcxMg_a753aebb-1e0c-4bdd-a1a6-52830f163dc7"
      unitRef="number">0.049</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i69813463e96b4ad5ad2215be2f949b59_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfOC0yLTEtMS0xMjcxMg_a9f1eaed-9442-4ebf-8563-7a0cd76019bb"
      unitRef="usd">551400000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id7bc8fed1453459e9f611c96dc337763_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfOC00LTEtMS0xMjcxMg_bba8a493-2a3f-4193-aa17-48220ee9ecb2"
      unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ibd4def59018047f1a3fb46e36d9c173d_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfOC02LTEtMS0xMjcxMg_146b8fd8-fdff-4811-9397-10f465392142"
      unitRef="usd">489800000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id87e71179efc435cbf5d5497ee13da93_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfOC04LTEtMS0xMjcxMg_45c1fb32-1d45-446e-ad74-648bd2cfb99a"
      unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i01a782bdc9ca4f1981073ae5a91b46ed_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfOS0yLTEtMS0xMjcxMg_56460c95-ab2d-4098-8183-6cdcf4c03b23"
      unitRef="usd">7800000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i4692edb42bed4c66adc2020e302cbcf8_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfOS02LTEtMS0xMjcxMg_8998d8bc-4ae9-4286-935b-83985721d837"
      unitRef="usd">6300000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfMTAtMi0xLTEtMTI3MTI_d61b842c-919b-4382-ab3d-61794b150044"
      unitRef="usd">559200000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjgyOWU3YmRkOGRjZTQ3YWNhMWY4YTUwZDVhZDVlZjQ3L3RhYmxlcmFuZ2U6ODI5ZTdiZGQ4ZGNlNDdhY2ExZjhhNTBkNWFkNWVmNDdfMTAtNi0xLTEtMTI3MTI_202b4ed7-15ea-4472-b130-aabe092d9f28"
      unitRef="usd">496100000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i2b478a448f1d417c80797c7716cbfd28_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfNC0yLTEtMS0xMjcxMg_8fa0acae-c133-4885-90ca-4ad84c043c09"
      unitRef="usd">790500000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i8180fc2d8a6249dd8811a378d0ecb43e_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfNC00LTEtMS0xMjcxMg_76b666ef-a8c8-4e58-89a4-826af3307d26"
      unitRef="number">0.496</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3eb8b684a6d444be9b221c39b9fae635_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfNC02LTEtMS0xMjcxMg_bc575323-b657-4743-adaa-92b967e76419"
      unitRef="usd">682600000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i45a407f7ad6e40059d9b211fc5bb9365_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfNC04LTEtMS0xMjcxMg_5e233b35-e190-4f66-a2bf-70de7f343600"
      unitRef="number">0.528</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3cab09bbdad14d0b965a11a034a5990c_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfNS0yLTEtMS0xMjcxMg_a083c5a0-f508-4d13-bdcc-4127c61bd54f"
      unitRef="usd">700600000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ica4a944ad4a44a4aa65601825760e1cb_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfNS00LTEtMS0xMjcxMg_710da7d4-c235-43b1-82ee-9dcb93e22e27"
      unitRef="number">0.440</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i260cb7274b4b4e4c94ee4d68c91b5dbd_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfNS02LTEtMS0xMjcxMg_28956d63-f181-4a89-8a33-74f42af244b9"
      unitRef="usd">505400000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ifc0ac37030af4e318d33ccfd2ab4e424_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfNS04LTEtMS0xMjcxMg_b89e5418-b3f8-4a18-af85-96b7e809e1c5"
      unitRef="number">0.391</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i1004335253334a8c93031def1519e24f_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfNi0yLTEtMS0xMjcxMg_fd83307c-91c0-44a1-91e8-554675452a3c"
      unitRef="usd">46900000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i50ffceccf0314f6a82061db05cc97ce3_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfNi00LTEtMS0xMjcxMg_a0b52bcb-0100-43be-aefb-23ae62a4c185"
      unitRef="number">0.029</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i33d0674cc1fd4188a31803833a52a9c8_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfNi02LTEtMS0xMjcxMg_60f7c702-3b05-4cf3-883d-55232e47f405"
      unitRef="usd">43400000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i77d5c398e437417096ffee0b774a3695_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfNi04LTEtMS0xMjcxMg_4c6fbd73-a147-4668-a3e0-3f1d5583b058"
      unitRef="number">0.034</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="id8665a6cd8314ab9a760fa0b0a9f8993_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfNy0yLTEtMS0xMjcxMg_acce34a0-900a-4b54-aabf-d42b238a3095"
      unitRef="usd">55000000.0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id077ce6df7bb4afaa072fd999ff742a6_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfNy00LTEtMS0xMjcxMg_0a5dc1b9-d8e0-4849-abb1-b24903c11f0f"
      unitRef="number">0.035</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iebfa8b8fa273451ba8ff90cbb6df3b55_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfNy02LTEtMS0xMjcxMg_1d6ae83b-a55e-4a80-9fa8-0f329df6b69d"
      unitRef="usd">62100000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i9a43941cb1cc4a9a9cc87de4189023a4_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfNy04LTEtMS0xMjcxMg_4e870c47-bab4-4946-8928-d8040095d722"
      unitRef="number">0.047</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i5c0a49e90fc4404c8e52a743f9dac439_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfOC0yLTEtMS0xMjcxMg_6e954beb-3d48-467a-a31c-1ae9c5d54889"
      unitRef="usd">1593000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if78e1d4ca8e44e09afc12dd31cc9f3f1_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfOC00LTEtMS0xMjcxMg_ce7bb12a-c145-4d1f-9a06-783ed936ba40"
      unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i39f55b837d7e4a3ba4f01efb13d89635_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfOC02LTEtMS0xMjcxMg_a9538476-6480-4f60-ae6e-fb185288142b"
      unitRef="usd">1293500000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia1f02fe0e7044c94a65bd438e74a232f_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfOC04LTEtMS0xMjcxMg_13ab9eb9-082f-4848-81a2-1a217afb2da2"
      unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i83f6dd0a92d3471a856b0a9062de35ee_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfOS0yLTEtMS0xMjcxMg_c985af1a-43f4-41b0-88e7-4f01e8811db5"
      unitRef="usd">21900000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i31b97175fcb54075b8a9d18788bcd4e8_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfOS02LTEtMS0xMjcxMg_21c9500a-780e-430e-a354-4d9723988486"
      unitRef="usd">18300000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfMTAtMi0xLTEtMTI3MTI_2ff08688-8e26-455c-8af5-5ab76800e3dd"
      unitRef="usd">1614900000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmJhMmI5YzRjZmZkOTRhNjg4NTM4OWUxZTUxNjg0Y2FiL3RhYmxlcmFuZ2U6YmEyYjljNGNmZmQ5NGE2ODg1Mzg5ZTFlNTE2ODRjYWJfMTAtNi0xLTEtMTI3MTI_73540f50-9a3b-4a21-9b3b-f74e046ef8f3"
      unitRef="usd">1311800000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjc5NzQ_ee697aff-5d8c-444e-bbbd-2756480ea842">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents and Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. The Company maintains its cash and cash equivalent balances at high credit quality financial institutions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;At December 31, 2020, cash, cash equivalents and restricted cash reported within the condensed consolidated statement of cash flows includes $0.3 million of restricted investments, which are reflected in other long-term assets in the condensed consolidated balance sheets. These restricted investments represented restricted cash held in accordance with the provisions of a long-term operating lease agreement held as security for performance under the Company's covenants and obligations within the agreement. The restrictions were released during the nine months ended September 30, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMTcxMTc_da8ea5af-c984-4297-b608-d3b81bac25a1"
      unitRef="usd">300000</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjc5MzI_d4c345a2-8750-4bf2-a515-d38813b74072">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts receivable from third-party payors are recorded net of estimated implicit price concessions, which are estimated based on the historical trend of the Company's surgical hospitals&#x2019; cash collections and contractual write-offs, and for the Company's surgical facilities in general, established fee schedules, relationships with payors and procedure statistics. While changes in estimated reimbursement from third-party payors remain a possibility, the Company expects that any such changes would be minimal and, therefore, would not have a material effect on its financial condition or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts receivable consists of receivables from federal and state agencies (under the Medicare and Medicaid programs), private insurance organizations, employers and patients. Management recognizes that revenues and receivables from government agencies are significant to the Company's operations, but it does not believe that there is significant credit risk associated with these government agencies. Concentration of credit risk with respect to other payors is limited because of the large number of such payors. &lt;/span&gt;&lt;/div&gt;The Company recognizes that final reimbursement of accounts receivable is subject to final approval by each third-party payor. However, because the Company has contracts with its third-party payors and also verifies insurance coverage of the patient before medical services are rendered, the amounts that are pending approval from third-party payors are not considered significant. Amounts are classified outside of self-pay if the Company has an agreement with the third-party payor or has verified a patient&#x2019;s coverage prior to services rendered. The Company's policy is to collect co-payments and deductibles prior to providing medical services. Patient services of the Company are primarily non-emergency, which allows the surgical facilities to control the procedures for which third-party reimbursement is sought and obtained. The Company does not require collateral from self-pay patients.The Company's collection policies and procedures are based on the type of payor, size of claim and estimated collection percentage for each patient account. The Company analyzes accounts receivable at each of its surgical facilities to ensure the proper collection and aged category. Collection efforts include direct contact with third-party payors or patients, written correspondence and the use of legal or collection agency assistance, as required.</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjgwMzA_a4aaf693-f753-4d77-a783-59792dd260ab">GoodwillGoodwill represents the fair value of the consideration provided in an acquisition over the fair value of net assets acquired and is not amortized. Additions to goodwill include amounts resulting from new business combinations and incremental ownership purchases in the Company's subsidiaries.</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjc5OTk_b219ed38-8320-4d50-bf8a-c5cac0e6f46d">&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A summary of activity related to goodwill for the nine months ended September&#160;30, 2021 is as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.167%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,468.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisitions, including post acquisition adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;145.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Divestitures and deconsolidations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,613.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjYyMzdlYmZlZDI1NjQ1YTFiNTE0MTI5OTEyOTZkM2ExL3RhYmxlcmFuZ2U6NjIzN2ViZmVkMjU2NDVhMWI1MTQxMjk5MTI5NmQzYTFfMC0yLTEtMS0xMjcxMg_2fbf1e3a-1111-4bb7-b451-a87c9508f157"
      unitRef="usd">3468000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjYyMzdlYmZlZDI1NjQ1YTFiNTE0MTI5OTEyOTZkM2ExL3RhYmxlcmFuZ2U6NjIzN2ViZmVkMjU2NDVhMWI1MTQxMjk5MTI5NmQzYTFfMS0yLTEtMS0xMjcxMg_6ea8ec2e-88f6-4c6e-9a15-05c0351555d2"
      unitRef="usd">145700000</us-gaap:GoodwillAcquiredDuringPeriod>
    <sgry:GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjYyMzdlYmZlZDI1NjQ1YTFiNTE0MTI5OTEyOTZkM2ExL3RhYmxlcmFuZ2U6NjIzN2ViZmVkMjU2NDVhMWI1MTQxMjk5MTI5NmQzYTFfMi0yLTEtMS0xMjcxMg_49f69dec-48c3-4ea7-8990-6f2e21885f67"
      unitRef="usd">100000</sgry:GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation>
    <us-gaap:Goodwill
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOjYyMzdlYmZlZDI1NjQ1YTFiNTE0MTI5OTEyOTZkM2ExL3RhYmxlcmFuZ2U6NjIzN2ViZmVkMjU2NDVhMWI1MTQxMjk5MTI5NmQzYTFfMy0yLTEtMS0xMjcxMg_04150163-8b6c-4a90-9f85-28207b15d304"
      unitRef="usd">3613600000</us-gaap:Goodwill>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjc4OTM_b33770fd-db83-47cb-ac16-9dd11d966c09">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Derivative Instruments and Hedging Activities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company records all derivatives on the balance sheet at fair value and any financing elements treated as debt instruments are recorded at amortized cost. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.&lt;/span&gt;&lt;/div&gt;For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in accumulated other comprehensive income ("OCI") and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings, as documented at hedge inception in accordance with the Company&#x2019;s accounting policy election. Amounts reported in accumulated OCI related to derivatives will be reclassified to interest expense as interest payments are made on the Company&#x2019;s variable-rate debt.</us-gaap:DerivativesPolicyTextBlock>
    <sgry:RedeemableNoncontrollingInterestPolicyTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjc5NDA_a87ce89f-3c88-4468-bbb6-486b2cdcef51">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Non-Controlling Interests&#x2014;Redeemable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Each partnership and limited liability company through which the Company owns and operates its surgical facilities is governed by a partnership or operating agreement, respectively.&#160;In certain circumstances, the applicable partnership or operating agreements for the Company's surgical facilities provide that the facilities will purchase all of the physician limited partners&#x2019; or physician minority members&#x2019;, as applicable, ownership if certain adverse regulatory events occur, such as it becoming illegal for the physician(s) to own an interest in a surgical facility, refer patients to a surgical facility or receive cash distributions from a surgical facility.&#160;The non-controlling interests&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;redeemable are reported outside of stockholders' equity in the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</sgry:RedeemableNoncontrollingInterestPolicyTextBlock>
    <us-gaap:RedeemableNoncontrollingInterestTableTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjc5MDQ_0a06a1d7-0c91-47e8-8ee1-d21088baa9d4">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A summary of activity related to non-controlling interests&#x2014;redeemable for the nine months ended September&#160;30, 2021 and 2020 is as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at&#160;beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;306.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;321.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to non-controlling interests&#x2014;redeemable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisition (disposal) of shares of non-controlling interests, net&#x2014;redeemable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Distributions to non-controlling interest&#x2014;redeemable holders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(27.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at&#160;end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;310.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;304.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RedeemableNoncontrollingInterestTableTextBlock>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmFhMjE0MDg0ZTMwMDRkYTBiODdiZWRiNWQ3MGQ0M2NlL3RhYmxlcmFuZ2U6YWEyMTQwODRlMzAwNGRhMGI4N2JlZGI1ZDcwZDQzY2VfMi0yLTEtMS0xMjcxMg_1c3d886b-a44f-47c5-8cf6-854543aeb4d6"
      unitRef="usd">306800000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i723b8483c8a44fa3831eba25ac4e8771_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmFhMjE0MDg0ZTMwMDRkYTBiODdiZWRiNWQ3MGQ0M2NlL3RhYmxlcmFuZ2U6YWEyMTQwODRlMzAwNGRhMGI4N2JlZGI1ZDcwZDQzY2VfMi00LTEtMS0xMjcxMg_f0b938ab-fd36-4def-a5b9-f27a9a66bdce"
      unitRef="usd">321000000.0</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmFhMjE0MDg0ZTMwMDRkYTBiODdiZWRiNWQ3MGQ0M2NlL3RhYmxlcmFuZ2U6YWEyMTQwODRlMzAwNGRhMGI4N2JlZGI1ZDcwZDQzY2VfMy0yLTEtMS0xMjcxMg_b781b9d3-f1a2-408c-be3a-6893dd6cc77a"
      unitRef="usd">33800000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmFhMjE0MDg0ZTMwMDRkYTBiODdiZWRiNWQ3MGQ0M2NlL3RhYmxlcmFuZ2U6YWEyMTQwODRlMzAwNGRhMGI4N2JlZGI1ZDcwZDQzY2VfMy00LTEtMS0xMjcxMg_a1b8ce6a-6259-41b7-9b8c-78ea6484d9c2"
      unitRef="usd">19300000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <sgry:RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmFhMjE0MDg0ZTMwMDRkYTBiODdiZWRiNWQ3MGQ0M2NlL3RhYmxlcmFuZ2U6YWEyMTQwODRlMzAwNGRhMGI4N2JlZGI1ZDcwZDQzY2VfNC0yLTEtMS0xMjcxMg_b4f225f2-ba0b-4263-bfef-b3ce6ad8d147"
      unitRef="usd">2400000</sgry:RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests>
    <sgry:RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmFhMjE0MDg0ZTMwMDRkYTBiODdiZWRiNWQ3MGQ0M2NlL3RhYmxlcmFuZ2U6YWEyMTQwODRlMzAwNGRhMGI4N2JlZGI1ZDcwZDQzY2VfNC00LTEtMS0xMjcxMg_148bc8f6-e4d3-4a41-a3a6-f0f61081e3f4"
      unitRef="usd">-7900000</sgry:RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests>
    <sgry:RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmFhMjE0MDg0ZTMwMDRkYTBiODdiZWRiNWQ3MGQ0M2NlL3RhYmxlcmFuZ2U6YWEyMTQwODRlMzAwNGRhMGI4N2JlZGI1ZDcwZDQzY2VfNS0yLTEtMS0xMjcxMg_9fe4afa9-7033-41e5-977b-afa050e9f2af"
      unitRef="usd">32600000</sgry:RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <sgry:RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmFhMjE0MDg0ZTMwMDRkYTBiODdiZWRiNWQ3MGQ0M2NlL3RhYmxlcmFuZ2U6YWEyMTQwODRlMzAwNGRhMGI4N2JlZGI1ZDcwZDQzY2VfNS00LTEtMS0xMjcxMg_83cb0feb-bc23-454e-aff7-383b48c70476"
      unitRef="usd">27700000</sgry:RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmFhMjE0MDg0ZTMwMDRkYTBiODdiZWRiNWQ3MGQ0M2NlL3RhYmxlcmFuZ2U6YWEyMTQwODRlMzAwNGRhMGI4N2JlZGI1ZDcwZDQzY2VfNi0yLTEtMS0xMjcxMg_a7782aa1-e3c6-472a-9262-bca93951c1a3"
      unitRef="usd">310400000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="id38661458bd24a6c81732c5d5160d949_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RhYmxlOmFhMjE0MDg0ZTMwMDRkYTBiODdiZWRiNWQ3MGQ0M2NlL3RhYmxlcmFuZ2U6YWEyMTQwODRlMzAwNGRhMGI4N2JlZGI1ZDcwZDQzY2VfNi00LTEtMS0xMjcxMg_b676cf6d-7bb5-4a9d-86c7-01b9790e438b"
      unitRef="usd">304700000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjc4OTg_8e7afdd0-68ea-4f49-a126-06036b8edb5b">&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Income Taxes &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company uses the asset and liability method to account for income taxes. Under this method, deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. If a carryforward exists, the Company makes a determination as to whether the carryforward will be utilized in the future. A valuation allowance is established for certain carryforwards when their recoverability is deemed to be uncertain. The carrying value of the net deferred tax assets assumes that the Company will be able to generate sufficient future taxable income in certain tax jurisdictions, based on estimates and assumptions. If our expectations for future operating results on a consolidated basis or at the state jurisdiction level vary from actual results due to changes in health care regulations, general economic conditions, or other factors, we may need to adjust the valuation allowance, for all or a portion of our deferred tax assets. Our income tax expense in future periods will be reduced or increased to the extent of offsetting decreases or increases, respectively, in our valuation allowance in the period when the change in circumstances occurs. These changes could have a significant impact on our future earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company and certain of its subsidiaries file a consolidated federal income tax return. The partnerships, limited liability companies, and certain non-consolidated physician practice corporations also file separate income tax returns. The Company's allocable portion of each partnership's and limited liability company's income or loss is included in taxable income of the Company. The remaining income or loss of each partnership and limited liability company is allocated to the other owners.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjU4OTk_bfd40b54-0ca7-411b-84c3-c296317e2043"
      unitRef="number">-0.049</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjU5NDE_35fe6f20-5584-44a5-bb12-504e935c7105"
      unitRef="number">0.237</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMTA5OTUxMTY2NDg2OQ_da8c6504-139b-4a9c-955c-2bcd96dfebe8"
      unitRef="usd">-4400000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:IncomeTaxReconciliationDispositionOfBusiness
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjYxMzE_329c782f-e035-4a37-b744-e6e66230c9e5"
      unitRef="usd">-3000000</us-gaap:IncomeTaxReconciliationDispositionOfBusiness>
    <sgry:EffectiveIncomeTaxRateReconciliationCoronavirusAidReliefAndEconomicSecurityActCARESActAndTaxSettlementAmount
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjYyNzA_9633bee8-3f96-4f81-8afe-2aa429e17819"
      unitRef="usd">-6900000</sgry:EffectiveIncomeTaxRateReconciliationCoronavirusAidReliefAndEconomicSecurityActCARESActAndTaxSettlementAmount>
    <us-gaap:IncomeTaxReconciliationTaxSettlements
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjE5OTAyMzI5Mjg0OQ_ef9caae5-7ff8-4021-9a1c-5028271f1068"
      unitRef="usd">5000000</us-gaap:IncomeTaxReconciliationTaxSettlements>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjE5OTAyMzI5MzAzMA_5b3c245e-6e9e-40e1-b3f6-4ccc205ca5e4"
      unitRef="usd">5000000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zMS9mcmFnOmY0YjkyNWY3MmU5YjRmZWY5NmZiNmU2YWE0M2M4MDBmL3RleHRyZWdpb246ZjRiOTI1ZjcyZTliNGZlZjk2ZmI2ZTZhYTQzYzgwMGZfMjc5NjM_c42742f4-821b-40aa-b84c-73d6188f4b8d">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued Accounting Standard Update ("ASU") 2020-04,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt; Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. The ASU provides optional guidance for a limited period of time to ease the potential burden in accounting for or recognizing the effects of reference rate reform on financial reporting and applies only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The ASU is effective as of March 12, 2020 through December 31, 2022. Entities may adopt ASU 2020-04 as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020 or prospectively from a date within an interim period that includes or is subsequent to March 12, 2020, up to the date that the financial statements are available to be issued. The Company is evaluating the impact of this ASU on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNC9mcmFnOjE4YjM5Y2RmN2RlZjQ0MTI5MzVmYmM3MjJhM2Y1ODNlL3RleHRyZWdpb246MThiMzljZGY3ZGVmNDQxMjkzNWZiYzcyMmEzZjU4M2VfMTQxOQ_bbbdaeab-42fe-44db-b958-1e5a6ea47ef1">Acquisitions&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;During the nine months ended September&#160;30, 2021, the Company acquired controlling interests in four surgical facilities in new markets and two surgical facilities in existing markets that were merged into existing facilities for aggregate cash consideration of $101.0&#160;million, net of cash acquired. The cash consideration was funded through available resources. The total consideration was allocated to the assets acquired and liabilities assumed based upon the respective acquisition date fair values. The aggregate amounts preliminarily recognized for each major class of assets acquired and liabilities assumed for the acquisitions are as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.804%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consideration&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Aggregate acquisition date fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;149.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net assets acquired:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;145.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right-of-use operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right-of-use operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Aggregate acquisition date fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;149.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair values assigned to certain assets acquired and liabilities assumed by the Company have been estimated on a preliminary basis and are subject to change as new facts and circumstances emerge that were present at the date of acquisition. During the nine months ended September&#160;30, 2021, no significant changes were made to the purchase price allocation of assets and liabilities, existing at the date of acquisition, related to individual acquisitions completed in 2020. The goodwill acquired was allocated to the Company's Surgical Facility services reportable segment. The results of operations of the acquisitions were included in the Company&#x2019;s results of operations beginning on the dates of acquisition and were not considered significant for the nine months ended September&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="i18304528b10e4cf5ad801229a9076ceb_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNC9mcmFnOjE4YjM5Y2RmN2RlZjQ0MTI5MzVmYmM3MjJhM2Y1ODNlL3RleHRyZWdpb246MThiMzljZGY3ZGVmNDQxMjkzNWZiYzcyMmEzZjU4M2VfMTA5OTUxMTYyOTQ4OQ_de3ab0fb-2af3-42b2-93d4-e627f6359050"
      unitRef="surgical_facility">4</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="i28bb531c0e434976827266bc64ff25c5_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNC9mcmFnOjE4YjM5Y2RmN2RlZjQ0MTI5MzVmYmM3MjJhM2Y1ODNlL3RleHRyZWdpb246MThiMzljZGY3ZGVmNDQxMjkzNWZiYzcyMmEzZjU4M2VfMTQw_787bbb3e-e4e2-4521-8c9c-9b621cc78c16"
      unitRef="surgical_facility">2</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i28bb531c0e434976827266bc64ff25c5_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNC9mcmFnOjE4YjM5Y2RmN2RlZjQ0MTI5MzVmYmM3MjJhM2Y1ODNlL3RleHRyZWdpb246MThiMzljZGY3ZGVmNDQxMjkzNWZiYzcyMmEzZjU4M2VfMjYx_23b4988b-4857-4fec-95d2-181528354c44"
      unitRef="usd">101000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNC9mcmFnOjE4YjM5Y2RmN2RlZjQ0MTI5MzVmYmM3MjJhM2Y1ODNlL3RleHRyZWdpb246MThiMzljZGY3ZGVmNDQxMjkzNWZiYzcyMmEzZjU4M2VfMTQyNw_40368756-2686-4061-9078-8d776f83486b">The aggregate amounts preliminarily recognized for each major class of assets acquired and liabilities assumed for the acquisitions are as follows (in millions):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.804%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consideration&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Aggregate acquisition date fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;149.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net assets acquired:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;145.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right-of-use operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right-of-use operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Aggregate acquisition date fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;149.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i28bb531c0e434976827266bc64ff25c5_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNC9mcmFnOjE4YjM5Y2RmN2RlZjQ0MTI5MzVmYmM3MjJhM2Y1ODNlL3RhYmxlOjg4MDQwOTQ2NDBjYzRhYjI5ZTMxMTNiODhjZjRmMjhkL3RhYmxlcmFuZ2U6ODgwNDA5NDY0MGNjNGFiMjllMzExM2I4OGNmNGYyOGRfMS0yLTEtMS0xMjcxMg_7618914f-a8e7-4a95-8cc1-024fed182c04"
      unitRef="usd">103000000.0</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
      contextRef="i7e305bdf3ff54b04a60b6fe6642b9f6a_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNC9mcmFnOjE4YjM5Y2RmN2RlZjQ0MTI5MzVmYmM3MjJhM2Y1ODNlL3RhYmxlOjg4MDQwOTQ2NDBjYzRhYjI5ZTMxMTNiODhjZjRmMjhkL3RhYmxlcmFuZ2U6ODgwNDA5NDY0MGNjNGFiMjllMzExM2I4OGNmNGYyOGRfMi0yLTEtMS0xMjcxMg_089fb67b-ff44-43bf-b2a0-e533b8fe4a0e"
      unitRef="usd">46400000</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i7e305bdf3ff54b04a60b6fe6642b9f6a_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNC9mcmFnOjE4YjM5Y2RmN2RlZjQ0MTI5MzVmYmM3MjJhM2Y1ODNlL3RhYmxlOjg4MDQwOTQ2NDBjYzRhYjI5ZTMxMTNiODhjZjRmMjhkL3RhYmxlcmFuZ2U6ODgwNDA5NDY0MGNjNGFiMjllMzExM2I4OGNmNGYyOGRfMy0yLTEtMS0xMjcxMg_56107f80-d846-47f3-88aa-4ccd2969ff79"
      unitRef="usd">149400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
      contextRef="i7e305bdf3ff54b04a60b6fe6642b9f6a_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNC9mcmFnOjE4YjM5Y2RmN2RlZjQ0MTI5MzVmYmM3MjJhM2Y1ODNlL3RhYmxlOjg4MDQwOTQ2NDBjYzRhYjI5ZTMxMTNiODhjZjRmMjhkL3RhYmxlcmFuZ2U6ODgwNDA5NDY0MGNjNGFiMjllMzExM2I4OGNmNGYyOGRfNS0yLTEtMS0xMjcxMg_b0b7d8c8-a599-4cf9-b600-59fb728a0b90"
      unitRef="usd">6900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i7e305bdf3ff54b04a60b6fe6642b9f6a_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNC9mcmFnOjE4YjM5Y2RmN2RlZjQ0MTI5MzVmYmM3MjJhM2Y1ODNlL3RhYmxlOjg4MDQwOTQ2NDBjYzRhYjI5ZTMxMTNiODhjZjRmMjhkL3RhYmxlcmFuZ2U6ODgwNDA5NDY0MGNjNGFiMjllMzExM2I4OGNmNGYyOGRfNi0yLTEtMS0xMjcxMg_da367f36-b8d8-46b4-92b0-17da44d96f37"
      unitRef="usd">3800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:Goodwill
      contextRef="i7e305bdf3ff54b04a60b6fe6642b9f6a_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNC9mcmFnOjE4YjM5Y2RmN2RlZjQ0MTI5MzVmYmM3MjJhM2Y1ODNlL3RhYmxlOjg4MDQwOTQ2NDBjYzRhYjI5ZTMxMTNiODhjZjRmMjhkL3RhYmxlcmFuZ2U6ODgwNDA5NDY0MGNjNGFiMjllMzExM2I4OGNmNGYyOGRfNy0yLTEtMS0xMjcxMg_56fd3a24-87ab-465d-b90f-a7d37c93ea76"
      unitRef="usd">145800000</us-gaap:Goodwill>
    <sgry:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingRightOfUseAssets
      contextRef="i7e305bdf3ff54b04a60b6fe6642b9f6a_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNC9mcmFnOjE4YjM5Y2RmN2RlZjQ0MTI5MzVmYmM3MjJhM2Y1ODNlL3RhYmxlOjg4MDQwOTQ2NDBjYzRhYjI5ZTMxMTNiODhjZjRmMjhkL3RhYmxlcmFuZ2U6ODgwNDA5NDY0MGNjNGFiMjllMzExM2I4OGNmNGYyOGRfOC0yLTEtMS0xMjcxMg_f1cdeff2-3b93-4c1f-81cd-5df151e32d59"
      unitRef="usd">8200000</sgry:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingRightOfUseAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i7e305bdf3ff54b04a60b6fe6642b9f6a_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNC9mcmFnOjE4YjM5Y2RmN2RlZjQ0MTI5MzVmYmM3MjJhM2Y1ODNlL3RhYmxlOjg4MDQwOTQ2NDBjYzRhYjI5ZTMxMTNiODhjZjRmMjhkL3RhYmxlcmFuZ2U6ODgwNDA5NDY0MGNjNGFiMjllMzExM2I4OGNmNGYyOGRfOS0yLTEtMS0xODI0OQ_48142c42-a2f2-4b7e-ad8b-ff720338191b"
      unitRef="usd">100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="i7e305bdf3ff54b04a60b6fe6642b9f6a_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNC9mcmFnOjE4YjM5Y2RmN2RlZjQ0MTI5MzVmYmM3MjJhM2Y1ODNlL3RhYmxlOjg4MDQwOTQ2NDBjYzRhYjI5ZTMxMTNiODhjZjRmMjhkL3RhYmxlcmFuZ2U6ODgwNDA5NDY0MGNjNGFiMjllMzExM2I4OGNmNGYyOGRfOS0yLTEtMS0xMjcxMg_75c14d35-54f1-43f7-a87f-96b4f8fc8159"
      unitRef="usd">8200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <sgry:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt
      contextRef="i7e305bdf3ff54b04a60b6fe6642b9f6a_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNC9mcmFnOjE4YjM5Y2RmN2RlZjQ0MTI5MzVmYmM3MjJhM2Y1ODNlL3RhYmxlOjg4MDQwOTQ2NDBjYzRhYjI5ZTMxMTNiODhjZjRmMjhkL3RhYmxlcmFuZ2U6ODgwNDA5NDY0MGNjNGFiMjllMzExM2I4OGNmNGYyOGRfMTAtMi0xLTEtMTI3MTI_550021d0-c488-4f4d-a240-de4e73a8bb90"
      unitRef="usd">100000</sgry:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt>
    <sgry:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability
      contextRef="i7e305bdf3ff54b04a60b6fe6642b9f6a_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNC9mcmFnOjE4YjM5Y2RmN2RlZjQ0MTI5MzVmYmM3MjJhM2Y1ODNlL3RhYmxlOjg4MDQwOTQ2NDBjYzRhYjI5ZTMxMTNiODhjZjRmMjhkL3RhYmxlcmFuZ2U6ODgwNDA5NDY0MGNjNGFiMjllMzExM2I4OGNmNGYyOGRfMTEtMi0xLTEtMTI3MTI_69cc16b7-18ad-4365-8b9d-5ecf947364c4"
      unitRef="usd">7100000</sgry:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i7e305bdf3ff54b04a60b6fe6642b9f6a_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNC9mcmFnOjE4YjM5Y2RmN2RlZjQ0MTI5MzVmYmM3MjJhM2Y1ODNlL3RhYmxlOjg4MDQwOTQ2NDBjYzRhYjI5ZTMxMTNiODhjZjRmMjhkL3RhYmxlcmFuZ2U6ODgwNDA5NDY0MGNjNGFiMjllMzExM2I4OGNmNGYyOGRfMTItMi0xLTEtMTI3MTI_e2e3d99f-2cc0-4f62-afc2-a54274d709f1"
      unitRef="usd">149400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:LongTermDebtTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfMzE5OA_53c7e382-7283-4d31-bc83-00fa4d6cdd1c">Long-Term Debt&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A summary of long-term debt follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.953%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior secured term loan &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,534.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,539.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.750% senior unsecured notes due 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;370.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;370.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.000% senior unsecured notes due 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;545.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;545.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Notes payable and other secured loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;140.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;137.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;279.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;281.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt issuance costs and discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,852.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,856.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Current maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,791.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,792.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:4pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"&gt;Includes unamortized fair value discount of $3.1 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;and $3.7 million as of September&#160;30, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revolving Credit Facility&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On January 27, 2021, the Company entered into an amendment to the credit agreement governing its revolving credit facility (the "Revolver"), which amended and supplemented the credit agreement, dated as of August 31, 2017 (the "Credit Agreement"), to provide for an extension of the maturity date of the Revolver to February 1, 2026 and a $50.0&#160;million increase in the outstanding commitments under the Revolver. The maturity extension and the additional commitments became effective on February 1, 2021. As of September 30, 2021, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;the Company's availability on the Revolver was $163.0 million (including outstanding letters of credit of $7.0 million). There were no outstanding borrowings under the Revolver as of both September 30, 2021 and December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sixth Amendment to Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On May 3, 2021, the Company entered into a sixth amendment to the Credit Agreement. The sixth amendment provides for, among other things, a new tranche of term loans under the Credit Agreement in an aggregate original principal amount of approximately $1.545&#160;billion (the &#x201c;New Term Loans&#x201d;), which New Term Loans replace or refinance in full all of the existing term loans outstanding under the Credit Agreement. The New Term Loans mature on August 31, 2026 (or, if at least $185&#160;million of the Borrower&#x2019;s 6.750% senior unsecured notes due 2025 shall have not either been repaid, repurchased or redeemed or refinanced with indebtedness having a maturity date not earlier than 91 days after August 31, 2026 by no later than April 1, 2025, then April 1, 2025). The New Term Loans bear interest at a rate per annum equal to (x) LIBOR plus a margin of 3.75% per annum (LIBOR with respect to the New Term Loans shall be subject to a floor of 0.75%) or (y) an alternate base rate (which will be the highest of (i) the prime rate, (ii) 0.5% per annum above the federal funds effective rate and (iii) one-month LIBOR plus 1.00% per annum (the alternate base rate with respect to the New Term Loans shall be subject to a floor of 1.75%)) plus a margin of 2.75% per annum. The New Term Loans are subject to quarterly amortization in an aggregate original principal amount of approximately 1.00% per annum. Voluntary prepayments of the New Term Loans are permitted, in whole or in part, with prior notice, without premium or penalty (except LIBOR breakage costs and a call premium in the case of certain repricing events within a specified period of time after May 3, 2021, as further set forth in the sixth amendment).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In connection with the sixth amendment, the Company recorded debt issuance costs and discount of $11.9&#160;million, and a debt extinguishment loss of $9.1&#160;million, included in loss on debt extinguishment in the accompanying condensed consolidated statement of operations for the nine months ended September 30, 2021. The loss includes the partial write-off of unamortized debt issuance costs and discounts related to the prior existing term loans, and a portion of debt issuance costs incurred with the New Term Loans.&lt;/span&gt;&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfMzIxMQ_3d9c2cc5-5c06-45fd-aa2d-d815563f76b8">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A summary of long-term debt follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.953%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior secured term loan &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,534.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,539.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.750% senior unsecured notes due 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;370.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;370.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.000% senior unsecured notes due 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;545.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;545.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Notes payable and other secured loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;140.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;137.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;279.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;281.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt issuance costs and discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,852.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,856.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Current maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,791.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,792.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"&gt;Includes unamortized fair value discount of $3.1 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;and $3.7 million as of September&#160;30, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;December&#160;31, 2020, respectively.</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i0a13579da2b047bbaec50c1bfea80ffd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfMi0yLTEtMS0xMjcxMg_548465d1-7b36-4c35-a085-6cf7ebe42900"
      unitRef="usd">1534500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i4fc897253a9442a9a2188353b29a9de9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfMi00LTEtMS0xMjcxMg_b9287b32-3607-42c8-9a77-60d48bc259e4"
      unitRef="usd">1539400000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2bacc8e8772841cdbb2620ef10c4ca4f_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfMy0wLTEtMS0xMjcxMi90ZXh0cmVnaW9uOjgwMzY4NzZlMDczYTRiMDY5NzZkMjYxODdhYjhhY2EwXzQ_f0c6d9e6-2846-442a-b8d8-c284cfbfcc32"
      unitRef="number">0.06750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2bacc8e8772841cdbb2620ef10c4ca4f_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfMy0yLTEtMS0xMjcxMg_cfda8ba5-d14e-4b7e-8904-7e97562723ae"
      unitRef="usd">370000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6be5a05e68144411af66ad15197c0602_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfMy00LTEtMS0xMjcxMg_d472eb1c-d421-4f18-9971-282360060e5e"
      unitRef="usd">370000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic8eddef2cc304b9c98cff9dfa3b5279d_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfNC0wLTEtMS0xMjcxMi90ZXh0cmVnaW9uOjg2ZTBiOTJhMWYzYjQ1NDI4NWFhMTAyYmQwYjI3MWRmXzQ_d6d418ae-2acc-4fef-b739-0bdd367cc2a5"
      unitRef="number">0.10000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic8eddef2cc304b9c98cff9dfa3b5279d_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfNC0yLTEtMS0xMjcxMg_16d7c374-c74f-4288-b1dc-76f3234a8238"
      unitRef="usd">545000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic05baa9bdba04592bd63550510944a35_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfNC00LTEtMS0xMjcxMg_b6d0ed3d-aff3-4a10-be20-e8649fd58df9"
      unitRef="usd">545000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="idf48234a181c4a79a5fb7a98c7b58186_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfNS0yLTEtMS0xMjcxMg_1e2fa849-567a-414e-8c4d-caf6de6190b3"
      unitRef="usd">140500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id74f0993fe00448b8bee613cc4480b55_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfNS00LTEtMS0xMjcxMg_8ee7d042-b1ba-425d-9a7d-f7e3db0fab2b"
      unitRef="usd">137500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:FinanceLeaseLiability
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfNi0yLTEtMS0xMjcxMg_6c930d7f-379d-4351-a2ec-70db0abcca16"
      unitRef="usd">279900000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfNi00LTEtMS0xMjcxMg_1393b0a8-e4fa-44fe-9753-175e3c11aacc"
      unitRef="usd">281200000</us-gaap:FinanceLeaseLiability>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfNy0yLTEtMS0xMjcxMg_ea8514c6-4fd2-49df-b4c4-2a3e62f7bbaa"
      unitRef="usd">17200000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfNy00LTEtMS0xMjcxMg_bee23882-6da8-4335-adb2-cb231ba92cea"
      unitRef="usd">16300000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfOC0yLTEtMS0xMjcxMg_291503ac-bc91-443a-9159-9d3adaf8df98"
      unitRef="usd">2852700000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfOC00LTEtMS0xMjcxMg_db3160cc-067e-41ff-86c5-a48d2fcd61ca"
      unitRef="usd">2856800000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfOS0yLTEtMS0xMjcxMg_f6d20049-8d6b-4507-bf46-3fb0f654a691"
      unitRef="usd">60800000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfOS00LTEtMS0xMjcxMg_3419960c-0a83-4751-b795-51c03f573a36"
      unitRef="usd">64400000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfMTAtMi0xLTEtMTI3MTI_b8073610-3b0e-4cef-8f46-112ae3ae21af"
      unitRef="usd">2791900000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RhYmxlOjNiOTRlZGEyZmI1ZTRkZDViY2YzMjQzNzM4MTM2MGFkL3RhYmxlcmFuZ2U6M2I5NGVkYTJmYjVlNGRkNWJjZjMyNDM3MzgxMzYwYWRfMTAtNC0xLTEtMTI3MTI_8270fd72-29e6-40cf-891a-9baf9fa8b587"
      unitRef="usd">2792400000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="i0a13579da2b047bbaec50c1bfea80ffd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfMTIz_690c3332-96bf-4d12-a5b7-efbc711d2b4a"
      unitRef="usd">3100000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="i4fc897253a9442a9a2188353b29a9de9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfMTMw_2c4b1061-bd00-4290-8a1f-e69cb355dfd1"
      unitRef="usd">3700000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <sgry:LineOfCreditFacilityMaximumBorrowingCapacityIncrease
      contextRef="i36f0d89975a14bafb53bb8f74a75d68d_I20210127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfNTA1_4cd15cdf-669c-45f7-aed0-0702c01d8af2"
      unitRef="usd">50000000</sgry:LineOfCreditFacilityMaximumBorrowingCapacityIncrease>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i4a3f44c7bfb64dcc8cb79cb5bf1acee6_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfNzI4_9edc86f8-4b86-45d4-8339-76e957f76752"
      unitRef="usd">163000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i297477a2c42e4f71ac25067c3ed77ad7_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfNzc1_f03dfa30-a5ae-4915-8032-b24de9c09d2f"
      unitRef="usd">7000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCredit
      contextRef="i131b465568af4c979a7999024ec537d2_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfNzkx_c076a459-318a-4527-825b-d3c66f87985f"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="if8cd6f59f10b43cba5e2609681a2b8ed_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfNzkx_c1b41368-04c5-4185-b462-2c53e5fb9f7a"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ia69846ae143244c7b534d9be52a586b8_I20210503"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfMTI3Mg_8c74fe31-ee85-4cc0-b958-bf74ac7e4e61"
      unitRef="usd">1545000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <sgry:DebtInstrumentCovenantMaturityMinimumAmountOfOtherExistingDebtRemaining
      contextRef="ia69846ae143244c7b534d9be52a586b8_I20210503"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfMTQ4Mg_ee4c8c1d-ede7-48b4-87f2-9b21282d3b3a"
      unitRef="usd">185000000</sgry:DebtInstrumentCovenantMaturityMinimumAmountOfOtherExistingDebtRemaining>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic2198de7087442b19f4693243784c6b6_I20210503"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfMTUwMw_893ecef7-fd41-4f08-abab-2f81c7c3aaff"
      unitRef="number">0.06750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <sgry:DebtInstrumentCovenantMaturityMinimumMaturityDateForOtherExistingDebtRemaining
      contextRef="i959e09a7ea984f0da5610e0124ec6404_D20210503-20210503"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfMTY2OQ_dbf010c0-8dc1-454a-8fb8-86059356b86c">P91D</sgry:DebtInstrumentCovenantMaturityMinimumMaturityDateForOtherExistingDebtRemaining>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="iebb24a566b9144d8b8d7fdb1d5cc3aad_D20210503-20210503"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfMTgzNg_a70911eb-b8d1-4042-aaa5-fd9c8bbf7259"
      unitRef="number">0.0375</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <sgry:DebtInstrumentBasisSpreadOnVariableRateFloor
      contextRef="iebb24a566b9144d8b8d7fdb1d5cc3aad_D20210503-20210503"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfMTkyMg_66c067c3-3a5c-472e-aa88-983358f155e9"
      unitRef="number">0.0075</sgry:DebtInstrumentBasisSpreadOnVariableRateFloor>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i216348724a3a425d96f16ce750304715_D20210503-20210503"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfMjAxMQ_7cdd9677-a22c-4dca-a9ee-2c481948fab4"
      unitRef="number">0.005</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ie83b774759cc472b85d1d0d1561fafb6_D20210503-20210503"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfMjA5NA_91897f0c-14c2-419e-9df1-1a4249731717"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <sgry:DebtInstrumentBasisSpreadOnVariableRateFloor
      contextRef="icb8c8ccf05034972b3907a963deb3f26_D20210503-20210503"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfMjE5OA_0d73c2bf-ca4b-4ca8-ad9b-52d31b693424"
      unitRef="number">0.0175</sgry:DebtInstrumentBasisSpreadOnVariableRateFloor>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="icb8c8ccf05034972b3907a963deb3f26_D20210503-20210503"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfMjIyMA_d5b6f0b1-0095-4362-83ab-7b2bccb579e9"
      unitRef="number">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <sgry:DebtInstrumentQuarterlyAmortizationPercentPerAnnum
      contextRef="i959e09a7ea984f0da5610e0124ec6404_D20210503-20210503"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfMjM1MA_1b3d3cb4-7a5b-4881-8729-3a06f4a7a2e7"
      unitRef="number">0.0100</sgry:DebtInstrumentQuarterlyAmortizationPercentPerAnnum>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="iea9e184d11334ae0bf911f88c3c9df84_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfMTY0OTI2NzQ0NTAxNg_c970c832-a3d5-435f-bf04-405b9db703b8"
      unitRef="usd">11900000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8zNy9mcmFnOjEzY2M4MzZiYzFmZjQ3ZTlhZGQzZThkMTI4MTJjZjA4L3RleHRyZWdpb246MTNjYzgzNmJjMWZmNDdlOWFkZDNlOGQxMjgxMmNmMDhfMTY0OTI2NzQ0NDk2MQ_03e9fa42-2e44-424a-a7f9-ed0eb98e2db8"
      unitRef="usd">-9100000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RleHRyZWdpb246NjQxZjg2MWMxMjU1NDJhMjkyOGQ0ZjQzOGFmZTNhZGNfNTQz_91aaf87f-6532-4a0c-8792-84a74757c3de">Leases&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company's operating leases are primarily for real estate, including medical office buildings, and corporate and other administrative offices. The Company's finance leases are primarily for medical equipment and information technology and telecommunications assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table presents the components of the Company's lease expense and their classification in the condensed consolidated statement of operations (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of leased assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total finance lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Variable and short-term lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:1pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table presents supplemental cash flow information (dollars in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash outflows from operating leases &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash outflows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Financing cash outflows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RleHRyZWdpb246NjQxZjg2MWMxMjU1NDJhMjkyOGQ0ZjQzOGFmZTNhZGNfNTQz_e61f3199-e77d-4cdf-9d74-ff3c0944e572">Leases&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company's operating leases are primarily for real estate, including medical office buildings, and corporate and other administrative offices. The Company's finance leases are primarily for medical equipment and information technology and telecommunications assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table presents the components of the Company's lease expense and their classification in the condensed consolidated statement of operations (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of leased assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total finance lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Variable and short-term lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:1pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table presents supplemental cash flow information (dollars in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash outflows from operating leases &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash outflows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Financing cash outflows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RleHRyZWdpb246NjQxZjg2MWMxMjU1NDJhMjkyOGQ0ZjQzOGFmZTNhZGNfNTU2_6f275cbc-29cd-4c7e-9818-81dced5b5509">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table presents the components of the Company's lease expense and their classification in the condensed consolidated statement of operations (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of leased assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total finance lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Variable and short-term lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:1pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table presents supplemental cash flow information (dollars in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash outflows from operating leases &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash outflows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Financing cash outflows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOjMyNjEzN2Q0NWI2YzQ2MzlhNDUwYTg2NWY1ZWYwN2Q4L3RhYmxlcmFuZ2U6MzI2MTM3ZDQ1YjZjNDYzOWE0NTBhODY1ZjVlZjA3ZDhfMi0yLTEtMS0xMjcxMg_3f0013f6-3282-46b2-a40e-c6ec72738af3"
      unitRef="usd">56600000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOjMyNjEzN2Q0NWI2YzQ2MzlhNDUwYTg2NWY1ZWYwN2Q4L3RhYmxlcmFuZ2U6MzI2MTM3ZDQ1YjZjNDYzOWE0NTBhODY1ZjVlZjA3ZDhfMi00LTEtMS0xMjcxMg_6ee4daa5-63d7-4a3a-8e1b-750bfbe33374"
      unitRef="usd">54900000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOjMyNjEzN2Q0NWI2YzQ2MzlhNDUwYTg2NWY1ZWYwN2Q4L3RhYmxlcmFuZ2U6MzI2MTM3ZDQ1YjZjNDYzOWE0NTBhODY1ZjVlZjA3ZDhfNC0yLTEtMS0xMjcxMg_22c31635-77a5-4ada-97ff-528fb842199d"
      unitRef="usd">20400000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOjMyNjEzN2Q0NWI2YzQ2MzlhNDUwYTg2NWY1ZWYwN2Q4L3RhYmxlcmFuZ2U6MzI2MTM3ZDQ1YjZjNDYzOWE0NTBhODY1ZjVlZjA3ZDhfNC00LTEtMS0xMjcxMg_87cfbf42-92c7-42dc-9fb6-ac2c5b48ce98"
      unitRef="usd">19000000.0</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOjMyNjEzN2Q0NWI2YzQ2MzlhNDUwYTg2NWY1ZWYwN2Q4L3RhYmxlcmFuZ2U6MzI2MTM3ZDQ1YjZjNDYzOWE0NTBhODY1ZjVlZjA3ZDhfNS0yLTEtMS0xMjcxMg_f909f215-c164-459a-9fad-925911507e71"
      unitRef="usd">18900000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOjMyNjEzN2Q0NWI2YzQ2MzlhNDUwYTg2NWY1ZWYwN2Q4L3RhYmxlcmFuZ2U6MzI2MTM3ZDQ1YjZjNDYzOWE0NTBhODY1ZjVlZjA3ZDhfNS00LTEtMS0xMjcxMg_8067ca61-e05a-4ab4-92f8-d3e1fae0a9a7"
      unitRef="usd">15700000</us-gaap:FinanceLeaseInterestExpense>
    <sgry:FinanceLeaseCost
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOjMyNjEzN2Q0NWI2YzQ2MzlhNDUwYTg2NWY1ZWYwN2Q4L3RhYmxlcmFuZ2U6MzI2MTM3ZDQ1YjZjNDYzOWE0NTBhODY1ZjVlZjA3ZDhfNi0yLTEtMS0xMjcxMg_3584ddfd-5202-4bed-b9bb-2503ddeaf358"
      unitRef="usd">39300000</sgry:FinanceLeaseCost>
    <sgry:FinanceLeaseCost
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOjMyNjEzN2Q0NWI2YzQ2MzlhNDUwYTg2NWY1ZWYwN2Q4L3RhYmxlcmFuZ2U6MzI2MTM3ZDQ1YjZjNDYzOWE0NTBhODY1ZjVlZjA3ZDhfNi00LTEtMS0xMjcxMg_5c9101ef-b0db-4275-bc53-af0b274b01ef"
      unitRef="usd">34700000</sgry:FinanceLeaseCost>
    <sgry:VariableAndShortTermLeaseCost
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOjMyNjEzN2Q0NWI2YzQ2MzlhNDUwYTg2NWY1ZWYwN2Q4L3RhYmxlcmFuZ2U6MzI2MTM3ZDQ1YjZjNDYzOWE0NTBhODY1ZjVlZjA3ZDhfNy0yLTEtMS0xMjcxMg_b16e3f48-aa64-4c87-9420-317bd1087701"
      unitRef="usd">15000000.0</sgry:VariableAndShortTermLeaseCost>
    <sgry:VariableAndShortTermLeaseCost
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOjMyNjEzN2Q0NWI2YzQ2MzlhNDUwYTg2NWY1ZWYwN2Q4L3RhYmxlcmFuZ2U6MzI2MTM3ZDQ1YjZjNDYzOWE0NTBhODY1ZjVlZjA3ZDhfNy00LTEtMS0xMjcxMg_4f1e02d3-a22d-47ac-a9bb-5141935876fd"
      unitRef="usd">12600000</sgry:VariableAndShortTermLeaseCost>
    <us-gaap:LeaseCost
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOjMyNjEzN2Q0NWI2YzQ2MzlhNDUwYTg2NWY1ZWYwN2Q4L3RhYmxlcmFuZ2U6MzI2MTM3ZDQ1YjZjNDYzOWE0NTBhODY1ZjVlZjA3ZDhfOC0yLTEtMS0xMjcxMg_c3975373-86b9-45bc-bfcc-6781ae3ee2d9"
      unitRef="usd">110900000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOjMyNjEzN2Q0NWI2YzQ2MzlhNDUwYTg2NWY1ZWYwN2Q4L3RhYmxlcmFuZ2U6MzI2MTM3ZDQ1YjZjNDYzOWE0NTBhODY1ZjVlZjA3ZDhfOC00LTEtMS0xMjcxMg_b2db5fbd-fc1e-4123-a9ad-2c8b21770833"
      unitRef="usd">102200000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOmJjNjAzNWNmYzMyNzQ2NWU5NTM2ZDE5YWU0YTgyM2JhL3RhYmxlcmFuZ2U6YmM2MDM1Y2ZjMzI3NDY1ZTk1MzZkMTlhZTRhODIzYmFfMy0xLTEtMS0xMjcxMg_60254ecb-e0fd-4a46-be5e-982565fa6ea2"
      unitRef="usd">55200000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOmJjNjAzNWNmYzMyNzQ2NWU5NTM2ZDE5YWU0YTgyM2JhL3RhYmxlcmFuZ2U6YmM2MDM1Y2ZjMzI3NDY1ZTk1MzZkMTlhZTRhODIzYmFfMy0zLTEtMS0xMjcxMg_6117550e-947a-44cd-880d-c4f7f18528fe"
      unitRef="usd">49800000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOmJjNjAzNWNmYzMyNzQ2NWU5NTM2ZDE5YWU0YTgyM2JhL3RhYmxlcmFuZ2U6YmM2MDM1Y2ZjMzI3NDY1ZTk1MzZkMTlhZTRhODIzYmFfNC0xLTEtMS0xMjcxMg_d204edc0-ca57-4ff1-86ba-5083164da590"
      unitRef="usd">18000000.0</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOmJjNjAzNWNmYzMyNzQ2NWU5NTM2ZDE5YWU0YTgyM2JhL3RhYmxlcmFuZ2U6YmM2MDM1Y2ZjMzI3NDY1ZTk1MzZkMTlhZTRhODIzYmFfNC0zLTEtMS0xMjcxMg_8690769d-498a-41a1-accd-880d08a647e3"
      unitRef="usd">15700000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOmJjNjAzNWNmYzMyNzQ2NWU5NTM2ZDE5YWU0YTgyM2JhL3RhYmxlcmFuZ2U6YmM2MDM1Y2ZjMzI3NDY1ZTk1MzZkMTlhZTRhODIzYmFfNS0xLTEtMS0xMjcxMg_b033d822-ba23-42d4-b296-e6565b94f258"
      unitRef="usd">15800000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOmJjNjAzNWNmYzMyNzQ2NWU5NTM2ZDE5YWU0YTgyM2JhL3RhYmxlcmFuZ2U6YmM2MDM1Y2ZjMzI3NDY1ZTk1MzZkMTlhZTRhODIzYmFfNS0zLTEtMS0xMjcxMg_d86e2c78-5943-4d97-afd8-af6735614d22"
      unitRef="usd">12900000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOmJjNjAzNWNmYzMyNzQ2NWU5NTM2ZDE5YWU0YTgyM2JhL3RhYmxlcmFuZ2U6YmM2MDM1Y2ZjMzI3NDY1ZTk1MzZkMTlhZTRhODIzYmFfOC0xLTEtMS0xMjcxMg_6dfeafcc-d71a-442b-848c-dd0bcf9da9f1"
      unitRef="usd">44900000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOmJjNjAzNWNmYzMyNzQ2NWU5NTM2ZDE5YWU0YTgyM2JhL3RhYmxlcmFuZ2U6YmM2MDM1Y2ZjMzI3NDY1ZTk1MzZkMTlhZTRhODIzYmFfOC0zLTEtMS0xMjcxMg_b771e85e-7fa7-4446-9134-996b9310fc69"
      unitRef="usd">53900000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOmJjNjAzNWNmYzMyNzQ2NWU5NTM2ZDE5YWU0YTgyM2JhL3RhYmxlcmFuZ2U6YmM2MDM1Y2ZjMzI3NDY1ZTk1MzZkMTlhZTRhODIzYmFfOS0xLTEtMS0xMjcxMg_f8d07cd7-b64c-4c12-9cae-9577cd385e6f"
      unitRef="usd">10100000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80MC9mcmFnOjY0MWY4NjFjMTI1NTQyYTI5MjhkNGY0MzhhZmUzYWRjL3RhYmxlOmJjNjAzNWNmYzMyNzQ2NWU5NTM2ZDE5YWU0YTgyM2JhL3RhYmxlcmFuZ2U6YmM2MDM1Y2ZjMzI3NDY1ZTk1MzZkMTlhZTRhODIzYmFfOS0zLTEtMS0xMjcxMg_462bfaa3-8d76-4a2b-ba68-bd2e082391a9"
      unitRef="usd">11500000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <sgry:RedeemablePreferredStockTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80My9mcmFnOjliNjVlODVhZjQ0YjRiMTFiOGMzZjJiMTkxY2I3Y2MyL3RleHRyZWdpb246OWI2NWU4NWFmNDRiNGIxMWI4YzNmMmIxOTFjYjdjYzJfMTM4OA_95d98e08-e2ca-45d6-91d0-af869858e3c3">Redeemable Preferred Stock&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On August 31, 2017, the Company issued 310,000 shares of Series A Preferred Stock to Bain Capital Private Equity, L.P. ("Bain Capital") at a purchase price of $1,000 per share for an aggregate purchase price of $310.0 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Pursuant to the Certificate of Designations, Preferences, Rights and Limitations of 10.00% Series A Convertible Perpetual Participating Preferred Stock of Surgery Partners, Inc. (the &#x201c;Certificate of Designation&#x201d;), the Company was permitted to require the conversion of all, but not less than all, of the Series A Preferred Stock pursuant to the terms and conditions of the Certificate of Designation, after the second anniversary of the date of issuance, if the volume weighted average closing price of the Common Stock for any twenty out of thirty consecutive trading days prior to such date, equals or exceeds $42.00 per share. In accordance with such provision, on May 17, 2021, the Company converted all outstanding shares of Series A Preferred Stock into approximately 22.609&#160;million shares of common stock, $0.01 par value per share. Following the conversion, no shares of Series A Preferred Stock remain outstanding. The conversion of the Series A Preferred Stock into common stock was a non-cash transaction, and therefore had no impact on the condensed consolidated statements of cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A summary of activity related to the Series A Preferred Stock follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.442%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;434.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividends accrued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividends declared&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Redeemable preferred stock conversion to common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(439.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sgry:RedeemablePreferredStockTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i47cc30be5f9646198974e49f2c9e62ac_D20170831-20170831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80My9mcmFnOjliNjVlODVhZjQ0YjRiMTFiOGMzZjJiMTkxY2I3Y2MyL3RleHRyZWdpb246OWI2NWU4NWFmNDRiNGIxMWI4YzNmMmIxOTFjYjdjYzJfNzU_bf8bc1e0-46bb-4beb-beeb-22c8afc90845"
      unitRef="shares">310000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="i3b26b76efac540d991bd9159654d84be_I20170831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80My9mcmFnOjliNjVlODVhZjQ0YjRiMTFiOGMzZjJiMTkxY2I3Y2MyL3RleHRyZWdpb246OWI2NWU4NWFmNDRiNGIxMWI4YzNmMmIxOTFjYjdjYzJfMTkw_cfad6cf1-34a2-4366-8aa2-4be1fa09ceb8"
      unitRef="usdPerShare">1000</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i47cc30be5f9646198974e49f2c9e62ac_D20170831-20170831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80My9mcmFnOjliNjVlODVhZjQ0YjRiMTFiOGMzZjJiMTkxY2I3Y2MyL3RleHRyZWdpb246OWI2NWU4NWFmNDRiNGIxMWI4YzNmMmIxOTFjYjdjYzJfMjM4_aba68f67-ec34-44b3-a4d5-8870eead94f0"
      unitRef="usd">310000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="if6b9767d8d5b496f900fae3b3d1d446a_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80My9mcmFnOjliNjVlODVhZjQ0YjRiMTFiOGMzZjJiMTkxY2I3Y2MyL3RleHRyZWdpb246OWI2NWU4NWFmNDRiNGIxMWI4YzNmMmIxOTFjYjdjYzJfMzI2_befe6cdc-4122-4fa5-b31e-989c373c6888"
      unitRef="number">0.1000</us-gaap:PreferredStockDividendRatePercentage>
    <sgry:TemporaryEquityThresholdTradingDays
      contextRef="if6b9767d8d5b496f900fae3b3d1d446a_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80My9mcmFnOjliNjVlODVhZjQ0YjRiMTFiOGMzZjJiMTkxY2I3Y2MyL3RleHRyZWdpb246OWI2NWU4NWFmNDRiNGIxMWI4YzNmMmIxOTFjYjdjYzJfNzUz_a1ee2172-9f06-414b-8c8f-2297479bc816"
      unitRef="lease_renewal_option">20</sgry:TemporaryEquityThresholdTradingDays>
    <sgry:TemporaryEquityThresholdConsecutiveTradingDays
      contextRef="if6b9767d8d5b496f900fae3b3d1d446a_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80My9mcmFnOjliNjVlODVhZjQ0YjRiMTFiOGMzZjJiMTkxY2I3Y2MyL3RleHRyZWdpb246OWI2NWU4NWFmNDRiNGIxMWI4YzNmMmIxOTFjYjdjYzJfNzYz_2125482d-95cd-4ac4-9a15-85c4a9803bbf"
      unitRef="lease_renewal_option">30</sgry:TemporaryEquityThresholdConsecutiveTradingDays>
    <sgry:TemporaryEquityThresholdSharePrice
      contextRef="if6b9767d8d5b496f900fae3b3d1d446a_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80My9mcmFnOjliNjVlODVhZjQ0YjRiMTFiOGMzZjJiMTkxY2I3Y2MyL3RleHRyZWdpb246OWI2NWU4NWFmNDRiNGIxMWI4YzNmMmIxOTFjYjdjYzJfODI5_6cedf1c9-dd41-4c4e-a3a6-1da2d7d148ff"
      unitRef="usdPerShare">42.00</sgry:TemporaryEquityThresholdSharePrice>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="id264cc07d6a44dcc9fd4169a79dd9ff8_D20210517-20210517"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80My9mcmFnOjliNjVlODVhZjQ0YjRiMTFiOGMzZjJiMTkxY2I3Y2MyL3RleHRyZWdpb246OWI2NWU4NWFmNDRiNGIxMWI4YzNmMmIxOTFjYjdjYzJfOTg3_577f7cd0-aabf-4111-85db-066aad282cf6"
      unitRef="shares">22609000</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i518a3c2c62754078a7891bd9741853b1_I20210517"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80My9mcmFnOjliNjVlODVhZjQ0YjRiMTFiOGMzZjJiMTkxY2I3Y2MyL3RleHRyZWdpb246OWI2NWU4NWFmNDRiNGIxMWI4YzNmMmIxOTFjYjdjYzJfMTAxNA_ed6cc676-5784-4e56-bdb4-05c9cf6af0f7"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i909487bf12ef47639fb9b75fbee5e586_I20210517"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80My9mcmFnOjliNjVlODVhZjQ0YjRiMTFiOGMzZjJiMTkxY2I3Y2MyL3RleHRyZWdpb246OWI2NWU4NWFmNDRiNGIxMWI4YzNmMmIxOTFjYjdjYzJfMTA2NA_4fb382cb-d54f-4067-af09-81f547a1f640"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:TemporaryEquityTableTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80My9mcmFnOjliNjVlODVhZjQ0YjRiMTFiOGMzZjJiMTkxY2I3Y2MyL3RleHRyZWdpb246OWI2NWU4NWFmNDRiNGIxMWI4YzNmMmIxOTFjYjdjYzJfMTM5MA_8be98624-3a41-483d-8317-4ae2f489801d">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A summary of activity related to the Series A Preferred Stock follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.442%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;434.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividends accrued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividends declared&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Redeemable preferred stock conversion to common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(439.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:TemporaryEquityTableTextBlock>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i57cb9c1772694302ba3eea3dd06765c8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80My9mcmFnOjliNjVlODVhZjQ0YjRiMTFiOGMzZjJiMTkxY2I3Y2MyL3RhYmxlOjdlODc1MDRmM2M3ODQ1YzU5ZTA4MTI0MjI1YWFlODRjL3RhYmxlcmFuZ2U6N2U4NzUwNGYzYzc4NDVjNTllMDgxMjQyMjVhYWU4NGNfMC0yLTEtMS0xMjcxMg_6f6fcd42-64e4-446e-a734-74a71422bab8"
      unitRef="usd">434500000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityAccretionOfDividends
      contextRef="if6b9767d8d5b496f900fae3b3d1d446a_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80My9mcmFnOjliNjVlODVhZjQ0YjRiMTFiOGMzZjJiMTkxY2I3Y2MyL3RhYmxlOjdlODc1MDRmM2M3ODQ1YzU5ZTA4MTI0MjI1YWFlODRjL3RhYmxlcmFuZ2U6N2U4NzUwNGYzYzc4NDVjNTllMDgxMjQyMjVhYWU4NGNfMS0yLTEtMS0xMjcxMg_2d1e4db8-f470-4063-86c4-973e7445cb55"
      unitRef="usd">10300000</us-gaap:TemporaryEquityAccretionOfDividends>
    <us-gaap:TemporaryEquityDividendsAdjustment
      contextRef="if6b9767d8d5b496f900fae3b3d1d446a_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80My9mcmFnOjliNjVlODVhZjQ0YjRiMTFiOGMzZjJiMTkxY2I3Y2MyL3RhYmxlOjdlODc1MDRmM2M3ODQ1YzU5ZTA4MTI0MjI1YWFlODRjL3RhYmxlcmFuZ2U6N2U4NzUwNGYzYzc4NDVjNTllMDgxMjQyMjVhYWU4NGNfMi0yLTEtMS0xMjcxMg_8284fa80-b77b-4cfa-9d43-3d9e51457ea7"
      unitRef="usd">5100000</us-gaap:TemporaryEquityDividendsAdjustment>
    <us-gaap:ReclassificationsOfTemporaryToPermanentEquity
      contextRef="if6b9767d8d5b496f900fae3b3d1d446a_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80My9mcmFnOjliNjVlODVhZjQ0YjRiMTFiOGMzZjJiMTkxY2I3Y2MyL3RhYmxlOjdlODc1MDRmM2M3ODQ1YzU5ZTA4MTI0MjI1YWFlODRjL3RhYmxlcmFuZ2U6N2U4NzUwNGYzYzc4NDVjNTllMDgxMjQyMjVhYWU4NGNfMy0yLTEtMS0xMjcxMg_54d5ef1b-7595-429a-bf16-2de2ecd35885"
      unitRef="usd">439700000</us-gaap:ReclassificationsOfTemporaryToPermanentEquity>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i2547d9c927b94663bfad99cb87818db1_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80My9mcmFnOjliNjVlODVhZjQ0YjRiMTFiOGMzZjJiMTkxY2I3Y2MyL3RhYmxlOjdlODc1MDRmM2M3ODQ1YzU5ZTA4MTI0MjI1YWFlODRjL3RhYmxlcmFuZ2U6N2U4NzUwNGYzYzc4NDVjNTllMDgxMjQyMjVhYWU4NGNfNC0yLTEtMS0xMjcxMg_19f5c817-e3eb-45ea-a107-2eb0f55ae0ff"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfNTE2OA_bb316a30-bba3-4b94-9c3c-6aa948fab2d9">Derivatives and Hedging Activities&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps and interest rate caps as part of its interest rate risk management strategy. During 2021 and 2020, such derivatives have been used to hedge the variable cash flows associated with existing variable-rate debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in accumulated other comprehensive income ("OCI") and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings, as documented at hedge inception in accordance with the Company&#x2019;s accounting policy election. Amounts reported in accumulated OCI related to derivatives will be reclassified to interest expense as interest payments are made on the Company&#x2019;s variable-rate debt. Over the next 12 months, the Company estimates that an additional $26.3 million will be reclassified as an increase to interest expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In May 2021, the Company entered into additional interest rate swap agreements to match the terms of the New Term Loan and effectively extend the termination date to March 31, 2025. As of September&#160;30, 2021, the Company had nine interest rate swaps with a total net hedged notional amount of $1.2&#160;billion. Of the nine interest rate swaps, three are pay-fixed, receive 1-Month LIBOR (subject to a minimum of 0.75%) interest rate swaps designated in cash flow hedging relationships with a total notional amount of $1.2&#160;billion and a termination date of March 31, 2025. The remaining six interest rate swaps are undesignated and consist of three pay-fixed, receive 1-Month LIBOR (subject to a minimum of 1.00%) interest rate swaps and three pay 1-Month LIBOR (subject to a minimum of 1.00%), receive-fixed interest rate swaps with a termination date of November 30, 2023. The pay-floating, receive-fixed swaps are designed to economically offset the undesignated pay-fixed, receive-floating swaps. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Concurrently with the May 2021 transactions, the four previously existing interest rate swap positions were amended, de-designated or terminated and replaced with the new interest rate swaps discussed above. The Company voluntarily de-designated an aggregate notional amount of $435&#160;million (the effects of which are offset by the pay-floating, receive-fixed interest rate swaps) and terminated an aggregate notional amount of $435&#160;million. No cash was exchanged between the Company and the counterparties due to the transactions described above, therefore the non-cash transactions had no impact on the condensed consolidated statements of cash flows. The amount of unrealized losses recorded in OCI related to the de-designated and terminated notional amounts at the time of the de-designation and termination was $55.0&#160;million. This amount will be amortized to interest expense over the remaining term of the original interest rate swaps. The liability of the de-designated and terminated notional amounts was blended into the fixed rate of the new pay-fixed interest rate swaps.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The pay-fixed, receive floating interest rate swaps entered into in May 2021 did not meet the requirements to be considered derivatives in their entirety as a result of the financing component. Accordingly, the swaps are considered hybrid instruments, consisting of a financing element treated as a debt instrument and an embedded at-market derivative that was designated as a cash flow hedge. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Within the Company&#x2019;s condensed consolidated balance sheets, the financing elements treated as debt instruments described above are carried at amortized cost and the embedded at-market derivatives and the undesignated swaps are recorded at fair value. The cash flows related to the portion treated as debt are classified as financing activities in the condensed consolidated statements of cash flows while the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;portion treated as an at-market derivative are classified as operating activities. Cash settlements related to the undesignated swaps will offset and are classified as operating activities in the condensed consolidated cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In September 2021, the Company entered into interest rate cap agreements to more effectively hedge the interest rate risk. As of September&#160;30, 2021, the Company had two interest rate caps with a total hedged notional amount of $337.5&#160;million, and each has a termination date of March 31, 2025. Within the Company&#x2019;s condensed consolidated balance sheets, the interest rate caps are recorded at fair value. The cash flows related to the interest rate caps are classified as operating activities in the condensed consolidated statements of cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The key terms of interest rate swaps and interest rate caps outstanding are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.144%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.144%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.743%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount (in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Status&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount (in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Status&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;May 7, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;435.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;May 7, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;330.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;May 7, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;435.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest rate cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;168.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest rate cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;168.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;165.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;120.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;June 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;150.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Receive-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;April 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(165.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Receive-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;April 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(120.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Receive-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;April 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(150.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Terminated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;330.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Terminated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;330.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Terminated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;240.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;June 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Terminated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;300.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,537.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,200.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our interest rate swap agreements, excluding the portion treated as debt, are recognized at fair value in the condensed consolidated balance sheets and are valued using pricing models that rely on market observable inputs such as yield curve data, which are classified as Level 2 inputs within the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair value of the interest rate caps are determined using the market standard methodology of discounting the future expected cash receipts that would occur if variable interest rates rise above the strike rate of the caps. The variable interest rates used in the calculation of projected receipts on the caps are based on an expectation of future interest rates derived from observable market interest rate curves and volatilities. The interest rate caps are classified using Level 2 inputs within the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table presents the fair values of our derivatives and their location on the condensed consolidated balance sheets (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.995%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives in cash flow hedging relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;61.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest rate caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;66.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;61.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"&gt;The balance as of September&#160;30, 2021 includes $49.4 million related to the financing component of the pay-fixed, receive floating interest rate swaps.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table presents the pre-tax effect of the interest rate swaps and caps on the Company's accumulated OCI and condensed consolidated statement of operations (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.253%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives in cash flow hedging relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Loss recognized in OCI (effective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;29.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Loss reclassified from accumulated OCI into income (effective portion) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"&gt;Includes amortization of accumulated OCI related to de-designated and terminated interest rate swaps of $5.4 million and $8.6 million for the three and nine months ended September&#160;30, 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfMTEwMw_edea3f07-d554-4973-bf7a-b691a562659a"
      unitRef="usd">-26300000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="i00ee4c8851df48caa969c447c0623250_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfNTE3Ng_4be4923c-09df-4745-aad0-3ed34869f171"
      unitRef="lease_renewal_option">9</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4346577dec794239931317575c5f8e9c_I20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfMTQyNw_5ff338ad-94a2-43fb-9f87-4d88ff35656d"
      unitRef="usd">1200000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="i00ee4c8851df48caa969c447c0623250_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfNTE3MQ_bb48121a-2e76-4653-9878-e5392d5f7b3d"
      unitRef="lease_renewal_option">9</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:DerivativeVariableInterestRate
      contextRef="ie4f417c62ec54180ac8803b4615fe4f2_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfMTUzMA_fc44a9c7-85dc-43e0-a59b-124671844c29"
      unitRef="number">0.0075</us-gaap:DerivativeVariableInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4346577dec794239931317575c5f8e9c_I20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfMTYzMg_f8846b9d-5a58-4d67-b467-710d39d68aec"
      unitRef="usd">1200000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeVariableInterestRate
      contextRef="ifb9ae4c2db2641b79a0f5be58b08a21c_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfMTc5Nw_92ecf8d2-5bbd-4368-b392-5a1fa66d304a"
      unitRef="number">0.0100</us-gaap:DerivativeVariableInterestRate>
    <us-gaap:DerivativeVariableInterestRate
      contextRef="i794be503a719415da656f24f25e586f6_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfMTg3Mg_d05108fd-db44-4057-ad3a-b00a861c02a6"
      unitRef="number">0.0100</us-gaap:DerivativeVariableInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id89e28dd0e71485f834aa4d7bf9df97f_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfMjM0Nw_ae796054-d5f8-4f18-82f8-33401b8062bd"
      unitRef="usd">435000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i00ee4c8851df48caa969c447c0623250_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfMjQ4Ng_acc00b4d-7763-46de-acdc-7065daa47a40"
      unitRef="usd">435000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ibe696861f1c44c73a063d43906a9e50e_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfMjg2NQ_06bc0ee5-47a9-42c3-ad41-421488d6e78d"
      unitRef="usd">-55000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="ie418b260d34a48179bdbb66a998bcef5_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfMTA5OTUxMTYzMzQwMg_b8bbe6e4-d474-4e1f-a06b-cf322cd7d65b"
      unitRef="interest_rate_cap">2</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if2a4a57522444f5a9676cde41ceac59b_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfMTA5OTUxMTYzMzM4Nw_7449aa7b-d571-4a8f-a344-8b9988c0ac82"
      unitRef="usd">337500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfNTE4MA_f378927d-6fb6-41a6-89f0-00a6277aa8c3">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The key terms of interest rate swaps and interest rate caps outstanding are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.144%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.144%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.743%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount (in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Status&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount (in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Status&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;May 7, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;435.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;May 7, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;330.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;May 7, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;435.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest rate cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;168.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest rate cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;168.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;165.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;120.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;June 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;150.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Receive-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;April 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(165.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Receive-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;April 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(120.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Receive-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;April 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(150.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Terminated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;330.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Terminated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;330.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Terminated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;240.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;June 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Terminated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;300.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,537.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,200.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="if49ae29f929f42ada509df5619f333a8_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfMi00LTEtMS0xMjcxMg_edfd1bbd-9fc0-44e5-b79e-b2d1279b074d"
      unitRef="usd">435000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ie1fca4d2f481407caeb5d56d7e7b7136_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfMi04LTEtMS0xMjcxMg_354669f8-92ad-469e-8239-cfee18d87d86"
      unitRef="usd">0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i6ddeec416d7940a3b12a296f74c3903a_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfMy00LTEtMS0xMjcxMg_277d2fc7-6021-4752-99b7-6d998a7b689b"
      unitRef="usd">330000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i3536b9c7d5144d1da0598b1b21687583_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfMy04LTEtMS0xMjcxMg_d1bb1899-9516-4bdf-b13d-99dd2fb5ccdc"
      unitRef="usd">0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i9e920f1f29fa4053be880fffd25a4918_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfNC00LTEtMS0xMjcxMg_b9c99cca-404c-45ea-9f2b-d76e7cd10138"
      unitRef="usd">435000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i7495d32d52cd4da7bc6c8619c45a887b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfNC04LTEtMS0xMjcxMg_e548cc4a-e9d8-4ee5-9bf6-a797a476f7ed"
      unitRef="usd">0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i2fa37eb2bae649c99d96bc2572e45115_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfNS00LTEtMS0xODQzNw_28e89fa6-0a6b-455e-a827-27b30cfe6e47"
      unitRef="usd">168800000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i58ed36c033be416a89ff87077161fdf4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfNS04LTEtMS0xODQ0Mw_eb48801e-f578-49a4-bf31-8d2f7d5561c3"
      unitRef="usd">0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i4c4ccb8fa70f4bc2a4428f508fe28abf_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfNi00LTEtMS0xODQzNw_abf46cde-1d72-4405-a7f6-f6b0804e6145"
      unitRef="usd">168700000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ibb17c059c9044d64a267e4e97184de8e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfNi04LTEtMS0xODQ0Mw_3654bf6c-f17e-41ac-be49-b943a3713f64"
      unitRef="usd">0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i7ed85bf6cfba4944b0e52d8ec460f7ae_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfNS00LTEtMS0xMjcxMg_87082501-56cc-4196-8892-76d6d2c8d8a8"
      unitRef="usd">165000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i868a7c854f3f4197b6fb56be16cb8ff6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfNS04LTEtMS0xMjcxMg_6c4a0524-72c3-4761-b426-66c424c86d6c"
      unitRef="usd">0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i8fb04a4c58d74fb494b82609189a5eb9_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfNi00LTEtMS0xMjcxMg_f76ed8c0-ba83-4668-a7a6-9a0f95949956"
      unitRef="usd">120000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i71181849cd1a430e8336d8791688e295_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfNi04LTEtMS0xMjcxMg_e4b8e557-5e96-4eae-bf2e-c567523c667a"
      unitRef="usd">0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ie9c29b53a6e548b8889f9b102d76603f_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfNy00LTEtMS0xMjcxMg_7f9b1ed0-a4ea-4806-9e80-44f98a436fc6"
      unitRef="usd">150000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i2c36d93181114c73a3df7489d3e1fcee_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfNy04LTEtMS0xMjcxMg_81dd540a-b419-434e-8f02-51633e485ea1"
      unitRef="usd">0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i720356769cb94b1ab627aaf16068270d_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfOC00LTEtMS0xMjcxMg_d2ebe0a7-531c-480b-9eda-dcb77087cb2d"
      unitRef="usd">165000000.0</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i1f56d30ff3394bbaad99a11dd5142150_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfOC04LTEtMS0xMjcxMg_496b2e7a-b36e-4d7a-864c-41f77337c80f"
      unitRef="usd">0</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="ic24c1d36e32e4b2e9a6ee11412475f2f_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfOS00LTEtMS0xMjcxMg_7851f75c-6ed8-4def-9ca5-f7f82b62218b"
      unitRef="usd">120000000.0</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="ie7bfba01da58476bbd4fc84970535d16_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfOS04LTEtMS0xMjcxMg_878be688-ac9f-4b32-bb4d-dc618e703aac"
      unitRef="usd">0</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i8f8bf0021814474c81ca8bbbc00fa691_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfMTAtNC0xLTEtMTI3MTI_223690b6-f8d2-4788-91f4-759a6415c42f"
      unitRef="usd">150000000.0</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i2640e344b23640b5b12ef1711c6f7c00_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfMTAtOC0xLTEtMTI3MTI_e9141f9a-4f6f-4c6e-87d7-81d2a1947734"
      unitRef="usd">0</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i07615d50aa95456b8dd258c5dcc40329_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfMTEtNC0xLTEtMTI3MTI_c21acf7a-86c3-42c7-b46f-7d07911af0a9"
      unitRef="usd">0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i3059028e583a4104804a186f6de5c099_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfMTEtOC0xLTEtMTI3MTI_9d567955-2ae6-4486-adc3-6ff80cbb3907"
      unitRef="usd">330000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i85fde8cb3f9949af8bacf04f0259be1c_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfMTItNC0xLTEtMTI3MTI_40bab659-b8dc-49ca-b926-bad71b872463"
      unitRef="usd">0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i0873884b62114aea86cd9f3b89d0b590_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfMTItOC0xLTEtMTI3MTI_1c0134d7-529d-497d-b9e9-0f9e705cdef5"
      unitRef="usd">330000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i48af39d8cccf4a5691cd76b4715ca6a3_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfMTMtNC0xLTEtMTI3MTI_f63460ea-eced-49e1-88b8-b84e660e467a"
      unitRef="usd">0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i37cfcc38e9e146619f3cc3c95a7adf45_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfMTMtOC0xLTEtMTI3MTI_da31525d-763f-408d-aa09-b94bf119aabd"
      unitRef="usd">240000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i00125affeb654327acf6e06c632b8f66_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfMTQtNC0xLTEtMTI3MTI_a05b30f6-28ad-4522-bc6e-9c66104f3245"
      unitRef="usd">0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i1c6267b72cab412abdf10d903fe10285_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfMTQtOC0xLTEtMTI3MTI_6fbf307d-1bab-4381-860d-4e939875d327"
      unitRef="usd">300000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfMTUtNC0xLTEtMTI3MTI_d304cf4f-5f77-4afc-a977-c9b3b30fe095"
      unitRef="usd">1537500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjYxNWE5ODVmNTQ1NzQ2ZjNiMzhmNjRkODgzNmUzMTgxL3RhYmxlcmFuZ2U6NjE1YTk4NWY1NDU3NDZmM2IzOGY2NGQ4ODM2ZTMxODFfMTUtOC0xLTEtMTI3MTI_bb3e200f-eaf3-4f35-9d8e-6890826a4512"
      unitRef="usd">1200000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfNTE3Nw_9cd594b5-5f9b-472c-abef-0360e34ac6e9">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table presents the fair values of our derivatives and their location on the condensed consolidated balance sheets (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.995%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives in cash flow hedging relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;61.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest rate caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;66.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;61.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"&gt;The balance as of September&#160;30, 2021 includes $49.4 million related to the financing component of the pay-fixed, receive floating interest rate swaps.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="idf8a876d526646558f40ab931121afc0_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfMy00LTEtMS0xMjcxMg_124d7094-90c4-42fd-a980-18167f1c4c9b"
      unitRef="usd">15800000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="idf8a876d526646558f40ab931121afc0_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfMy02LTEtMS0xMjcxMg_3193677c-791c-48cb-8a36-979c976268fe"
      unitRef="usd">0</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ib62a37350e4a421d8bc7b5bcf8967a8e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfMy04LTEtMS0xMjcxMg_33bd5413-38e8-4ad5-be85-d1c4ebd16adc"
      unitRef="usd">0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="ib62a37350e4a421d8bc7b5bcf8967a8e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfMy0xMC0xLTEtMTI3MTI_f5a51985-7359-4ae3-b916-265faa312e8a"
      unitRef="usd">0</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ib7b61f220e42445f91138f5f8e598c8e_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfNC00LTEtMS0xMjcxMg_6f2c3763-2eae-4a1e-b4ce-3e36fc7f992c"
      unitRef="usd">0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="ib7b61f220e42445f91138f5f8e598c8e_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfNC02LTEtMS0xMjcxMg_820e9368-7375-4d77-bdad-7b1e241caeb8"
      unitRef="usd">15600000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i7662430cb53043369eb6d812bbbc2d36_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfNC04LTEtMS0xMjcxMg_3b2f92ae-518d-4080-9b03-539646477b5b"
      unitRef="usd">0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i7662430cb53043369eb6d812bbbc2d36_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfNC0xMC0xLTEtMTI3MTI_722ac99a-5963-4089-8dfa-ea961aae3487"
      unitRef="usd">0</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i454dcfeb7551452b9a0a7e150c838cfb_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfNy00LTEtMS0xMjcxMg_e8d1ae48-3a37-496f-aa6e-1b58a6af5543"
      unitRef="usd">0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i454dcfeb7551452b9a0a7e150c838cfb_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfNy02LTEtMS0xMjcxMg_96d75a8c-2155-497f-b04b-d28c6e506a09"
      unitRef="usd">51000000.0</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i06a53c3ba45b4d8cbbe78361c63c0b54_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfNy04LTEtMS0xMjcxMg_080c1c8c-70e8-4879-b0e7-8ced1a4a6123"
      unitRef="usd">0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i06a53c3ba45b4d8cbbe78361c63c0b54_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfNy0xMC0xLTEtMTI3MTI_2f0cb1f9-a3b9-43aa-b007-617c104e29f6"
      unitRef="usd">61000000.0</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i808ef80af90c47f68c7968b13ae34c7e_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfOC00LTEtMS0xODUwMg_b02eb53c-212d-496e-af35-76015cb1cc7c"
      unitRef="usd">1800000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i808ef80af90c47f68c7968b13ae34c7e_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfOC02LTEtMS0xODUxNA_41e8fbbf-63e6-4e08-bd7f-4037c6f1b7c1"
      unitRef="usd">0</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i9032094a43424c8ea3085296aae5d36c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfOC04LTEtMS0xODUxNA_9f8733e4-c098-4fd3-babb-92414feefd92"
      unitRef="usd">0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i9032094a43424c8ea3085296aae5d36c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfOC0xMC0xLTEtMTg1MTQ_20b00ddc-bd42-4168-bdb5-b597be021453"
      unitRef="usd">0</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfOC00LTEtMS0xMjcxMg_77a08169-9e4b-4355-b86e-b8708e27cd16"
      unitRef="usd">17600000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfOC02LTEtMS0xMjcxMg_62db887f-f01a-4796-bc8b-cd56d52d8f03"
      unitRef="usd">66600000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfOC04LTEtMS0xMjcxMg_3f678f93-1a36-4569-8ab0-82942980276b"
      unitRef="usd">0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOmZjODFlMGE3MDIyODQ0NzJhMmUwZmM5N2RiODVlNWE0L3RhYmxlcmFuZ2U6ZmM4MWUwYTcwMjI4NDQ3MmEyZTBmYzk3ZGI4NWU1YTRfOC0xMC0xLTEtMTI3MTI_8d0e3b34-8370-4136-a1f0-54569089c416"
      unitRef="usd">61000000.0</us-gaap:DerivativeLiabilityNotionalAmount>
    <sgry:DerivativeLiabilityNotionalAmountFinancingComponent
      contextRef="i00ee4c8851df48caa969c447c0623250_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfNDczOQ_be420321-5be3-43b6-873d-c8adb4ae26c9"
      unitRef="usd">49400000</sgry:DerivativeLiabilityNotionalAmountFinancingComponent>
    <us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfNTE3MA_425c481d-8a61-4dcd-8420-1f03dae00885">&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table presents the pre-tax effect of the interest rate swaps and caps on the Company's accumulated OCI and condensed consolidated statement of operations (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.253%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives in cash flow hedging relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Loss recognized in OCI (effective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;29.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Loss reclassified from accumulated OCI into income (effective portion) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"&gt;Includes amortization of accumulated OCI related to de-designated and terminated interest rate swaps of $5.4 million and $8.6 million for the three and nine months ended September&#160;30, 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ia6c750f147ed4f38954df76797436ad8_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjEzMTMyMzI0OTA1NTRhMjJhMmJiZmEwMmRkMTFlZjA4L3RhYmxlcmFuZ2U6MTMxMzIzMjQ5MDU1NGEyMmEyYmJmYTAyZGQxMWVmMDhfMy0zLTEtMS0xMjcxMg_8d871e3b-23a5-4a24-bb2d-a85eea0f8299"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i6c6a16294f3e464bbdbc6cc59d2922fb_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjEzMTMyMzI0OTA1NTRhMjJhMmJiZmEwMmRkMTFlZjA4L3RhYmxlcmFuZ2U6MTMxMzIzMjQ5MDU1NGEyMmEyYmJmYTAyZGQxMWVmMDhfMy01LTEtMS0xMjcxMg_a3116c9a-b468-47a3-9e83-fcc291d6b6da"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i6af2f02ead9e4c9f87a0e450cf3f134f_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjEzMTMyMzI0OTA1NTRhMjJhMmJiZmEwMmRkMTFlZjA4L3RhYmxlcmFuZ2U6MTMxMzIzMjQ5MDU1NGEyMmEyYmJmYTAyZGQxMWVmMDhfMy03LTEtMS0xMjcxMg_c7d5a3c6-c084-4e81-b362-2d7b16559d2a"
      unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="id7109ce10eb84b6b9880cfb4246c23ef_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjEzMTMyMzI0OTA1NTRhMjJhMmJiZmEwMmRkMTFlZjA4L3RhYmxlcmFuZ2U6MTMxMzIzMjQ5MDU1NGEyMmEyYmJmYTAyZGQxMWVmMDhfMy05LTEtMS0xMjcxMg_9c9dfba4-5638-472f-a6dc-969cac441294"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i54804f8602fa4a35a8b9674c532d6b4b_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjEzMTMyMzI0OTA1NTRhMjJhMmJiZmEwMmRkMTFlZjA4L3RhYmxlcmFuZ2U6MTMxMzIzMjQ5MDU1NGEyMmEyYmJmYTAyZGQxMWVmMDhfNi0zLTEtMS0xMjcxMg_54c04522-6b8a-4a81-9a18-7b3c7debd3b7"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ic2c4350be42c47498a9bab682e3c418b_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjEzMTMyMzI0OTA1NTRhMjJhMmJiZmEwMmRkMTFlZjA4L3RhYmxlcmFuZ2U6MTMxMzIzMjQ5MDU1NGEyMmEyYmJmYTAyZGQxMWVmMDhfNi01LTEtMS0xMjcxMg_85c14ac2-9217-464e-afd6-8847b5e3c2fb"
      unitRef="usd">2300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i78eea1b8023b40d48343347521f72035_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjEzMTMyMzI0OTA1NTRhMjJhMmJiZmEwMmRkMTFlZjA4L3RhYmxlcmFuZ2U6MTMxMzIzMjQ5MDU1NGEyMmEyYmJmYTAyZGQxMWVmMDhfNi03LTEtMS0xMjcxMg_48fb764f-c0c0-4786-8310-54efaf6793f4"
      unitRef="usd">5000000.0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i7791d5655eb846eb8e57e1bf970fb10f_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjEzMTMyMzI0OTA1NTRhMjJhMmJiZmEwMmRkMTFlZjA4L3RhYmxlcmFuZ2U6MTMxMzIzMjQ5MDU1NGEyMmEyYmJmYTAyZGQxMWVmMDhfNi05LTEtMS0xMjcxMg_41d68d58-193a-4347-8045-4ca92570feaa"
      unitRef="usd">29200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ia3173a5d521c49e1a9e897a1d64450e8_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjEzMTMyMzI0OTA1NTRhMjJhMmJiZmEwMmRkMTFlZjA4L3RhYmxlcmFuZ2U6MTMxMzIzMjQ5MDU1NGEyMmEyYmJmYTAyZGQxMWVmMDhfNy0zLTEtMS0xMjcxMg_bb7fd536-dc49-4ef8-a98b-17edd35efd21"
      unitRef="usd">6600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ib68ac7c0981b4940a6352b394b343b73_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjEzMTMyMzI0OTA1NTRhMjJhMmJiZmEwMmRkMTFlZjA4L3RhYmxlcmFuZ2U6MTMxMzIzMjQ5MDU1NGEyMmEyYmJmYTAyZGQxMWVmMDhfNy01LTEtMS0xMjcxMg_719ca020-9269-448f-b9d7-8d5f598ae83e"
      unitRef="usd">5600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ie2a1bea4a7df41318981b1d3405801df_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjEzMTMyMzI0OTA1NTRhMjJhMmJiZmEwMmRkMTFlZjA4L3RhYmxlcmFuZ2U6MTMxMzIzMjQ5MDU1NGEyMmEyYmJmYTAyZGQxMWVmMDhfNy03LTEtMS0xMjcxMg_00085593-6ae1-4da4-8caf-d9cd51d17876"
      unitRef="usd">18100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i0c7a094bccf049e5a50369c2dc0775bf_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RhYmxlOjEzMTMyMzI0OTA1NTRhMjJhMmJiZmEwMmRkMTFlZjA4L3RhYmxlcmFuZ2U6MTMxMzIzMjQ5MDU1NGEyMmEyYmJmYTAyZGQxMWVmMDhfNy05LTEtMS0xMjcxMg_3b9fce1f-20d1-48cb-8405-dc59ea38efac"
      unitRef="usd">14600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfNTExNA_55d1f93d-9822-4c6d-81ed-1d1f0a2b22d8"
      unitRef="usd">5400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80Ni9mcmFnOjM3OGQ5NDA5MWJkMzQ1YjI5MGUwNjQ3YjIzNTU4MjdjL3RleHRyZWdpb246Mzc4ZDk0MDkxYmQzNDViMjkwZTA2NDdiMjM1NTgyN2NfMTA5OTUxMTYzMzk2OQ_dd7b72fb-8267-456b-8774-0874d2177776"
      unitRef="usd">8600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RleHRyZWdpb246NzQ2YWUxOGUwNjRkNGZmMzk1YWRlMzg5N2NiNDk5YjNfMTkwOA_3d77d1c0-306b-4bff-9546-99e2178b4090">Earnings Per Share&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Basic and diluted earnings per share are calculated based on the weighted-average number of shares outstanding in each period and dilutive stock options, unvested shares and warrants, to the extent such securities exist and have a dilutive effect on earnings per share. The Company computes basic and diluted earnings per share using the two-class method. The two-class method of computing earnings per share is an earnings allocation method that determines earnings per share for common shares and participating securities according to their participation rights in dividends and undistributed earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (dollars in millions, except per share amounts; shares in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.411%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.253%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss attributable to Surgery Partners, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(61.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(70.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(121.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: amounts allocated to participating securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(29.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss attributable to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(71.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(81.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(150.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding- basic and diluted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;80,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Loss per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic and diluted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.09)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"&gt;Includes dividends accrued for the Series A Preferred Stock. The Series A Preferred Stock does not participate in undistributed losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"&gt;The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in each period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On January 27, 2021, the Company entered into an underwriting agreement relating to a public offering of 7,500,000 shares (the &#x201c;Firm Shares&#x201d;) of the Company&#x2019;s common stock, $0.01 par value per share, at a price to the public of $30.25 per share. In addition, the Company granted the underwriters an option to purchase up to an additional 1,125,000 shares of common stock at the same price per share as the Firm Shares. On February 1, 2021, the Company completed the public offering pursuant to which the Company sold 8,625,000 shares of common stock (including the Firm Shares and the option shares), resulting in gross proceeds of $260.9&#160;million. In connection with the offering, the Company incurred underwriting discounts, commissions and other related costs of $12.7&#160;million, which were recognized as a direct reduction of proceeds received.&lt;/span&gt;&lt;/div&gt;On May 17, 2021, the Company converted all outstanding shares of Series A Preferred Stock into approximately 22.609&#160;million shares of common stock. See Note 5. "Redeemable Preferred Stock" for further discussion.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RleHRyZWdpb246NzQ2YWUxOGUwNjRkNGZmMzk1YWRlMzg5N2NiNDk5YjNfMTkwNQ_4ac57ac2-f2ec-4d98-9714-65e99adb5808">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (dollars in millions, except per share amounts; shares in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.411%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.253%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss attributable to Surgery Partners, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(61.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(70.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(121.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: amounts allocated to participating securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(29.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss attributable to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(71.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(81.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(150.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding- basic and diluted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;80,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Loss per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic and diluted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.09)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"&gt;Includes dividends accrued for the Series A Preferred Stock. The Series A Preferred Stock does not participate in undistributed losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"&gt;The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in each period.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMy0xLTEtMS0xMjcxMg_6e544045-c907-43cf-8098-ff4e66fc7a9f"
      unitRef="usd">-22900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMy0zLTEtMS0xMjcxMg_efab8ef4-0170-4770-b6bb-a99816e563fe"
      unitRef="usd">-61600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMy01LTEtMS0xMjcxMg_72d6ccde-9df8-48a6-95ba-305be7fad3e6"
      unitRef="usd">-70800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMy03LTEtMS0xMjcxMg_3c96f6be-ac9d-4a89-88ec-695c816da8c7"
      unitRef="usd">-121600000</us-gaap:NetIncomeLoss>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfNC0xLTEtMS0xMjcxMg_b47643af-cd0a-4b34-9d77-76d791270079"
      unitRef="usd">0</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfNC0zLTEtMS0xMjcxMg_2bc45596-c434-490f-80eb-473e983647b0"
      unitRef="usd">10000000.0</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfNC01LTEtMS0xMjcxMg_d9fa3455-0087-40fc-8f47-dd297d5b031c"
      unitRef="usd">10300000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfNC03LTEtMS0xMjcxMg_a151e27a-ae02-4063-bc52-a151fd98b084"
      unitRef="usd">29200000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfNS0xLTEtMS0xMjcxMg_82a0a716-8e6f-4209-bba1-7772e9628c73"
      unitRef="usd">-22900000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfNS0zLTEtMS0xMjcxMg_bf5ba131-bcbf-470d-a9a1-2ce79cff5eff"
      unitRef="usd">-71600000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfNS01LTEtMS0xMjcxMg_0c0aa7da-fa2f-4b69-8f5c-795551662a1d"
      unitRef="usd">-81100000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfNS03LTEtMS0xMjcxMg_240253ec-b5bd-4545-8484-a4eccd43218d"
      unitRef="usd">-150800000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfOC0xLTEtMS0xMjcxMg_4f044aee-9189-444a-9e4d-21d5f67f1423"
      unitRef="shares">80726000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfOC0xLTEtMS0xMjcxMg_fd7e5903-26a8-4350-b997-17dbda7ff6c8"
      unitRef="shares">80726000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfOC0zLTEtMS0xMjcxMg_b200075e-2890-441c-a09d-82c69b6bde31"
      unitRef="shares">48883000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfOC0zLTEtMS0xMjcxMg_ec0a039a-c111-4595-bc00-4132aef4aa76"
      unitRef="shares">48883000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfOC01LTEtMS0xMjcxMg_42a0d0f5-c0eb-413e-ba48-1b3679e8829d"
      unitRef="shares">68350000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfOC01LTEtMS0xMjcxMg_c2b225ab-9965-43b8-b6f1-8365537b5d7f"
      unitRef="shares">68350000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfOC03LTEtMS0xMjcxMg_26141137-ca14-4628-ab72-d2e1c2e9a9b7"
      unitRef="shares">48736000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfOC03LTEtMS0xMjcxMg_b8815c8a-60fd-4776-8f83-35bbb63e466b"
      unitRef="shares">48736000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMTEtMS0xLTEtMTI3MTI_8336c9a8-7529-46eb-8a61-0085c1b9fad5"
      unitRef="usdPerShare">-0.28</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMTEtMS0xLTEtMTI3MTI_95fa4b91-948a-4a0d-ab3e-a247b1927f30"
      unitRef="usdPerShare">-0.28</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMTEtMy0xLTEtMTI3MTI_f8559cf1-5a15-4354-9ed8-0cca6b857bff"
      unitRef="usdPerShare">-1.46</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMTEtMy0xLTEtMTI3MTI_ff4d4114-fb01-407f-9544-4b5b1ffad941"
      unitRef="usdPerShare">-1.46</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMTEtNS0xLTEtMTI3MTI_04883c53-d3f9-4dc5-b856-b9b2f476a091"
      unitRef="usdPerShare">-1.19</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMTEtNS0xLTEtMTI3MTI_b9732faf-160d-41f3-ad8a-93edcf40a35d"
      unitRef="usdPerShare">-1.19</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMTEtNy0xLTEtMTI3MTI_03387df3-c25a-4fc3-8ece-a5e98eb6b8d1"
      unitRef="usdPerShare">-3.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMTEtNy0xLTEtMTI3MTI_e44fcf20-f4c1-4b80-a994-acbd27ab1593"
      unitRef="usdPerShare">-3.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1dfc84c1f55d48fdbe932272d2d40dc1_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMTQtMS0xLTEtMTI3MTI_2be42dbd-0903-4c29-9257-c456dbaf1fea"
      unitRef="shares">1974000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic30bbc4807ee4a90b1e5e73a917f7981_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMTQtMy0xLTEtMTI3MTI_a6d44346-3721-4fdc-8d42-2e2e35e44131"
      unitRef="shares">810000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iec7a2ccc58c14483aefa7eef623648ff_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMTQtNS0xLTEtMTI3MTI_fc0cbd7c-072d-4a1d-902b-2493b17852b7"
      unitRef="shares">1927000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i21ccc0b58d41465bb76c786bd6c59944_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMTQtNy0xLTEtMTI3MTI_50540804-da53-4c2b-af35-dfa506fd06c7"
      unitRef="shares">285000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i2e6bf043d8e543ca9a60ab545728b68d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMTUtMS0xLTEtMTI3MTI_75fc1ce3-baac-4f38-bc80-d3179282f9f2"
      unitRef="shares">1461000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id809a0ee79f9462cbd0b84dc0a1f8ba6_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMTUtMy0xLTEtMTI3MTI_b034ff91-bccc-47a3-b581-875f1a5c6d6e"
      unitRef="shares">986000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i27cea47c34d24be486efd529a214dfe3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMTUtNS0xLTEtMTI3MTI_44002281-a151-43cf-8b4b-c878f068cd9f"
      unitRef="shares">1444000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i37ed33a1a2e84bac96ea96cc638d09be_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RhYmxlOjYxYjE4ZTdmOGZhZjQ5ZmJhYWEwYWEyZjdjYWFjMThhL3RhYmxlcmFuZ2U6NjFiMThlN2Y4ZmFmNDlmYmFhYTBhYTJmN2NhYWMxOGFfMTUtNy0xLTEtMTI3MTI_2c9a8f16-a2a5-44cc-ab78-7124239ee07a"
      unitRef="shares">848000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i7d1f48dd9e4b49d78df2715069875ead_D20210127-20210127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RleHRyZWdpb246NzQ2YWUxOGUwNjRkNGZmMzk1YWRlMzg5N2NiNDk5YjNfMTIxNQ_04f0fe8e-a856-4f53-a7d8-e3971b95c0af"
      unitRef="shares">7500000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="if7415e8f12eb4b0f857512e10ff2b1df_I20210127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RleHRyZWdpb246NzQ2YWUxOGUwNjRkNGZmMzk1YWRlMzg5N2NiNDk5YjNfMTI3Ng_1dbacdbf-1970-4319-bad0-e3751e3b6c97"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="if7415e8f12eb4b0f857512e10ff2b1df_I20210127"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RleHRyZWdpb246NzQ2YWUxOGUwNjRkNGZmMzk1YWRlMzg5N2NiNDk5YjNfMTMyOA_e8245556-2912-482b-b4d0-c5e0b8549c94"
      unitRef="usdPerShare">30.25</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="ia81e7b3e0bbf4ed8817112cf8a395a4d_D20210127-20210127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RleHRyZWdpb246NzQ2YWUxOGUwNjRkNGZmMzk1YWRlMzg5N2NiNDk5YjNfMTQzNA_9f368627-cf71-4b59-bdf3-da9405773967"
      unitRef="shares">1125000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i606fa788b0c34beca685e0fe3cef5cca_D20210201-20210201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RleHRyZWdpb246NzQ2YWUxOGUwNjRkNGZmMzk1YWRlMzg5N2NiNDk5YjNfMTYwNg_4a890151-a75b-4069-b7b4-20284903f048"
      unitRef="shares">8625000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="i606fa788b0c34beca685e0fe3cef5cca_D20210201-20210201"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RleHRyZWdpb246NzQ2YWUxOGUwNjRkNGZmMzk1YWRlMzg5N2NiNDk5YjNfMTcxNA_1960b5a3-c555-4015-a182-31e7b737c0b9"
      unitRef="usd">260900000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i606fa788b0c34beca685e0fe3cef5cca_D20210201-20210201"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RleHRyZWdpb246NzQ2YWUxOGUwNjRkNGZmMzk1YWRlMzg5N2NiNDk5YjNfMTgzNQ_b588f814-2274-4926-89f6-f3c0e6199ddf"
      unitRef="usd">12700000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="id264cc07d6a44dcc9fd4169a79dd9ff8_D20210517-20210517"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF80OS9mcmFnOjc0NmFlMThlMDY0ZDRmZjM5NWFkZTM4OTdjYjQ5OWIzL3RleHRyZWdpb246NzQ2YWUxOGUwNjRkNGZmMzk1YWRlMzg5N2NiNDk5YjNfMTA5OTUxMTYyOTkyOA_577f7cd0-aabf-4111-85db-066aad282cf6"
      unitRef="shares">22609000</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:OtherLiabilitiesDisclosureTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RleHRyZWdpb246OTEyMTNmODY5ODUxNGIwZDk0ODYzNTZkMWI0MWY0ZjRfMTc1_ea933ab5-e595-4c3f-a18f-54dbe5d371f6">Other Current Liabilities&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A summary of other current liabilities is as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.953%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right-of-use operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost report liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts due to patients and payors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tax receivable agreement liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued legal settlement &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;208.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:1pt;padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"&gt;See Note 9. "Commitments and Contingencies" for further discussion.&lt;/span&gt;&lt;/div&gt;</us-gaap:OtherLiabilitiesDisclosureTextBlock>
    <us-gaap:OtherCurrentLiabilitiesTableTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RleHRyZWdpb246OTEyMTNmODY5ODUxNGIwZDk0ODYzNTZkMWI0MWY0ZjRfMTcy_daf3ab84-0653-4634-a5e4-68ea36535208">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A summary of other current liabilities is as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.953%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right-of-use operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost report liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts due to patients and payors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tax receivable agreement liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued legal settlement &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;208.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:1pt;padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"&gt;See Note 9. "Commitments and Contingencies" for further discussion.&lt;/span&gt;&lt;/div&gt;</us-gaap:OtherCurrentLiabilitiesTableTextBlock>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RhYmxlOjAxM2ZjZjAwYjdhMDRmNTRhNTg4NzM4ZWEzMDAyOWNiL3RhYmxlcmFuZ2U6MDEzZmNmMDBiN2EwNGY1NGE1ODg3MzhlYTMwMDI5Y2JfMi0yLTEtMS0xMjcxMg_ff8dbbcc-ceb1-4301-8a21-14b46a4b185d"
      unitRef="usd">40500000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RhYmxlOjAxM2ZjZjAwYjdhMDRmNTRhNTg4NzM4ZWEzMDAyOWNiL3RhYmxlcmFuZ2U6MDEzZmNmMDBiN2EwNGY1NGE1ODg3MzhlYTMwMDI5Y2JfMi00LTEtMS0xMjcxMg_ae2d8c60-6da1-41bc-b4fc-a44df62ace13"
      unitRef="usd">39200000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RhYmxlOjAxM2ZjZjAwYjdhMDRmNTRhNTg4NzM4ZWEzMDAyOWNiL3RhYmxlcmFuZ2U6MDEzZmNmMDBiN2EwNGY1NGE1ODg3MzhlYTMwMDI5Y2JfNC0yLTEtMS0xMjcxMg_62665806-e2d3-4f47-be78-393702c8661e"
      unitRef="usd">37000000.0</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RhYmxlOjAxM2ZjZjAwYjdhMDRmNTRhNTg4NzM4ZWEzMDAyOWNiL3RhYmxlcmFuZ2U6MDEzZmNmMDBiN2EwNGY1NGE1ODg3MzhlYTMwMDI5Y2JfNC00LTEtMS0xMjcxMg_0aa5eca0-ea0d-44c5-9779-c1921e880235"
      unitRef="usd">24500000</us-gaap:InterestPayableCurrent>
    <sgry:CostReportLiabilitiesCurrent
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RhYmxlOjAxM2ZjZjAwYjdhMDRmNTRhNTg4NzM4ZWEzMDAyOWNiL3RhYmxlcmFuZ2U6MDEzZmNmMDBiN2EwNGY1NGE1ODg3MzhlYTMwMDI5Y2JfNS0yLTEtMS0xOTc1NA_f9cf445c-60be-45ec-89f7-574a8dad4cee"
      unitRef="usd">28500000</sgry:CostReportLiabilitiesCurrent>
    <sgry:CostReportLiabilitiesCurrent
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RhYmxlOjAxM2ZjZjAwYjdhMDRmNTRhNTg4NzM4ZWEzMDAyOWNiL3RhYmxlcmFuZ2U6MDEzZmNmMDBiN2EwNGY1NGE1ODg3MzhlYTMwMDI5Y2JfNS00LTEtMS0xOTc1NA_1d7583a6-329f-4803-abc1-65af2b78749b"
      unitRef="usd">16900000</sgry:CostReportLiabilitiesCurrent>
    <srt:PayablesToCustomers
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RhYmxlOjAxM2ZjZjAwYjdhMDRmNTRhNTg4NzM4ZWEzMDAyOWNiL3RhYmxlcmFuZ2U6MDEzZmNmMDBiN2EwNGY1NGE1ODg3MzhlYTMwMDI5Y2JfNi0yLTEtMS0xMjcxMg_dc438090-f1ec-4a9c-9a1f-b68e731fb094"
      unitRef="usd">28000000.0</srt:PayablesToCustomers>
    <srt:PayablesToCustomers
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RhYmxlOjAxM2ZjZjAwYjdhMDRmNTRhNTg4NzM4ZWEzMDAyOWNiL3RhYmxlcmFuZ2U6MDEzZmNmMDBiN2EwNGY1NGE1ODg3MzhlYTMwMDI5Y2JfNi00LTEtMS0xMjcxMg_74f97e9c-b916-40fa-b584-8a7b60a431ef"
      unitRef="usd">20900000</srt:PayablesToCustomers>
    <sgry:TaxReceivableAgreementLiabilityCurrent
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RhYmxlOjAxM2ZjZjAwYjdhMDRmNTRhNTg4NzM4ZWEzMDAyOWNiL3RhYmxlcmFuZ2U6MDEzZmNmMDBiN2EwNGY1NGE1ODg3MzhlYTMwMDI5Y2JfNy0yLTEtMS0xMjcxMg_e579e329-504e-4fde-b92e-47030e5a68b5"
      unitRef="usd">21200000</sgry:TaxReceivableAgreementLiabilityCurrent>
    <sgry:TaxReceivableAgreementLiabilityCurrent
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RhYmxlOjAxM2ZjZjAwYjdhMDRmNTRhNTg4NzM4ZWEzMDAyOWNiL3RhYmxlcmFuZ2U6MDEzZmNmMDBiN2EwNGY1NGE1ODg3MzhlYTMwMDI5Y2JfNy00LTEtMS0xMjcxMg_321efb3a-a81a-48b5-a80f-81bfa15b5f33"
      unitRef="usd">21200000</sgry:TaxReceivableAgreementLiabilityCurrent>
    <us-gaap:LitigationReserveCurrent
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RhYmxlOjAxM2ZjZjAwYjdhMDRmNTRhNTg4NzM4ZWEzMDAyOWNiL3RhYmxlcmFuZ2U6MDEzZmNmMDBiN2EwNGY1NGE1ODg3MzhlYTMwMDI5Y2JfOC0yLTEtMS0xOTc3NQ_9ff9c79a-6391-4bab-9735-a8df6abecce7"
      unitRef="usd">0</us-gaap:LitigationReserveCurrent>
    <us-gaap:LitigationReserveCurrent
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RhYmxlOjAxM2ZjZjAwYjdhMDRmNTRhNTg4NzM4ZWEzMDAyOWNiL3RhYmxlcmFuZ2U6MDEzZmNmMDBiN2EwNGY1NGE1ODg3MzhlYTMwMDI5Y2JfOC00LTEtMS0xOTc3NQ_72c48fe8-7841-4e74-93df-60ff444f89d3"
      unitRef="usd">32200000</us-gaap:LitigationReserveCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RhYmxlOjAxM2ZjZjAwYjdhMDRmNTRhNTg4NzM4ZWEzMDAyOWNiL3RhYmxlcmFuZ2U6MDEzZmNmMDBiN2EwNGY1NGE1ODg3MzhlYTMwMDI5Y2JfOC0yLTEtMS0xMjcxMg_f132c6ab-6128-4b6a-882b-e503a2d2e090"
      unitRef="usd">53100000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RhYmxlOjAxM2ZjZjAwYjdhMDRmNTRhNTg4NzM4ZWEzMDAyOWNiL3RhYmxlcmFuZ2U6MDEzZmNmMDBiN2EwNGY1NGE1ODg3MzhlYTMwMDI5Y2JfOC00LTEtMS0xMjcxMg_b4ae9115-6573-4b51-baca-04373a53b74c"
      unitRef="usd">62100000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RhYmxlOjAxM2ZjZjAwYjdhMDRmNTRhNTg4NzM4ZWEzMDAyOWNiL3RhYmxlcmFuZ2U6MDEzZmNmMDBiN2EwNGY1NGE1ODg3MzhlYTMwMDI5Y2JfOS0yLTEtMS0xMjcxMg_e8f4f651-ad37-4846-a83f-49be78ff9032"
      unitRef="usd">208300000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81Mi9mcmFnOjkxMjEzZjg2OTg1MTRiMGQ5NDg2MzU2ZDFiNDFmNGY0L3RhYmxlOjAxM2ZjZjAwYjdhMDRmNTRhNTg4NzM4ZWEzMDAyOWNiL3RhYmxlcmFuZ2U6MDEzZmNmMDBiN2EwNGY1NGE1ODg3MzhlYTMwMDI5Y2JfOS00LTEtMS0xMjcxMg_355c346a-b572-40c3-8107-96f4c01e81ac"
      unitRef="usd">217000000.0</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfOTIwNA_04ec6fed-2367-4788-b76a-dd5e95b1a011">Commitments and Contingencies&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Professional, General and Workers' Compensation Liability Risks&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company is subject to claims and legal actions in the ordinary course of business, including claims relating to patient treatment, employment practices and personal injuries. The Company maintains professional, general and workers' compensation liability insurance in excess of self-insured retentions, through third party commercial insurance carriers. Although management believes the coverage is sufficient for the Company's operations, some claims may potentially exceed the scope of coverage in effect. Plaintiffs in these matters may request punitive or other damages that may not be covered by insurance. The Company is not aware of any such proceedings that are reasonably possible to have a material adverse effect on the Company's business, financial position, results of operations or liquidity. Total professional, general and workers' compensation claim liabilities as of September&#160;30, 2021 and December&#160;31, 2020 were $22.9 million and $21.4 million, respectively. Expected insurance recoveries of $10.5 million as of both September&#160;30, 2021 and December&#160;31, 2020, are included as a component of other current assets and other long-term assets in the condensed consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Laws and Regulations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Laws and regulations governing the Company's business, including those relating to the Medicare and Medicaid programs, are complex and subject to interpretation. These laws and regulations govern every aspect of how the Company's surgical facilities conduct their operations, from licensing requirements to how and whether the Company's facilities may receive payments pursuant to the Medicare and Medicaid programs. Compliance with such laws and regulations can be subject to future government agency review and interpretation as well as legislative changes to such laws. Noncompliance with such laws and regulations may subject the Company to significant regulatory sanctions including fines, penalties, and exclusion from the Medicare, Medicaid and other federal health care programs. From time to time, governmental regulatory agencies will conduct inquiries of the Company's practices, including, but not limited to, the Company's compliance with federal and state fraud and abuse laws, billing practices and relationships with physicians.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Government Settlement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On April 14, 2020, Logan Laboratories, LLC ("Logan Labs"), a toxicology laboratory based in Tampa, Florida, that provides urine testing services and Tampa Pain Relief Centers, Inc. ("Tampa Pain" and, together with Logan Labs, the "Companies"), a pain management medical practice based in Tampa, Florida, both indirect wholly-owned subsidiaries of the Company, entered into a settlement agreement (the "Settlement Agreement") with the United States of America, acting through the United States Department of Justice (&#x201c;DOJ&#x201d;) and on behalf of the Office of Inspector General of the Department of Health and Human Services ("OIG"), the Defense Health Agency, acting on behalf of the TRICARE Program, the Office of Personnel Management, as the administrator of the Federal Employees Health Benefits Program, the Office of Workers Compensation Programs of the United States Department of Labor, which administers federal workers compensation claims for federal employees, including the United States Postal Service, and the United States Department of Veterans Affairs and certain other parties to resolve the pending DOJ investigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Under the terms of the Settlement Agreement, the Companies paid $30.7&#160;million plus accrued interest on April 1, 2021, representing the final payment related to the resolution of the DOJ Investigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stockholder Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On December 4, 2017, a purported Company stockholder filed an action in the Delaware Court of Chancery (the "Delaware Action"). That action is captioned Witmer v. H.I.G. Capital, L.L.C., et al., C.A. No. 2017-0862. The plaintiff in the Delaware Action asserted claims against (i) certain current and former members of the Company&#x2019;s Board of Directors (together, the "Directors"); (ii) H.I.G. Capital, LLC and certain of its affiliates (collectively, "H.I.G."); and (iii) Bain Capital Private Equity, L.P. and certain of its affiliates (collectively, "Bain Capital" and, together with the Directors and H.I.G., the "Defendants"). The plaintiff asserted derivative claims on behalf of the Company, which is a nominal defendant in the Delaware Action, as well as putatively direct claims on behalf of a purported class of Company stockholders. The plaintiff in the Delaware Action asserted that the Defendants breached their fiduciary duties in connection with the transactions in which (i) the Company acquired National Surgical Healthcare; (ii) Bain Capital acquired preferred equity in the Company; and (iii) Bain Capital acquired H.I.G.'s equity stake in the Company, and that, in the alternative, Bain Capital aided and abetted those purported breaches. The plaintiff also asserted an unjust enrichment claim against Bain Capital.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On January 2, 2018, the Defendants moved to dismiss the plaintiff&#x2019;s complaint. On December 19, 2018, the Court of Chancery issued a decision on that motion. Following that decision, all of the Directors have been dismissed from the Delaware Action. The Court did not dismiss the plaintiff&#x2019;s breach of fiduciary duty claim against H.I.G. or the aiding and abetting claim asserted against Bain Capital. However, the Court dismissed the plaintiff&#x2019;s breach of fiduciary duty and unjust enrichment claims against Bain Capital. In addition, the Court dismissed all of the plaintiff&#x2019;s claims that were asserted on behalf of a putative class of Company stockholders. Accordingly, all of the plaintiff&#x2019;s remaining claims in the Delaware Action are asserted derivatively on the Company&#x2019;s behalf. Discovery in the Delaware Action principally concluded on July 30, 2021, and the Defendants moved for summary judgment with respect to the remaining claims asserted against them. While those motions were pending, the parties to the Delaware Action reached an agreement-in-principle to settle the Delaware Action. The parties are currently negotiating the final terms of that settlement, which will be subject to approval by the Court of Chancery. Because the plaintiff in the Delaware Action asserts only derivative claims on the Company&#x2019;s behalf, the Company will be the beneficiary of any settlement that is ultimately approved by the Court of Chancery.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Acquired Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company, through its wholly-owned subsidiaries or controlled partnerships and limited liability companies, has acquired and will continue to acquire surgical facilities with prior operating histories. Such facilities may have unknown or contingent liabilities, including liabilities for failure to comply with health care laws and regulations, such as billing and reimbursement laws and regulations, the Stark Law, the Anti-Kickback Statute, the FCA, and similar fraud and abuse laws. Although the Company attempts to assure that no such liabilities exist, obtain indemnification from prospective sellers covering such matters and institute policies designed to conform centers to its standards following completion of acquisitions, there can be no assurance that the Company will not become liable for past activities that may later be asserted to be improper by private plaintiffs or government agencies. There can be no assurance that any such matter will be covered by indemnification or, if covered, that the liability sustained will not exceed contractual limits or the financial capacity of the indemnifying party.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company cannot predict whether federal or state statutory or regulatory provisions will be enacted that would prohibit or otherwise regulate relationships which the Company has established or may establish with other health care providers or have materially adverse effects on its business or revenues arising from such future actions. Management believes, however, that it will be able to adjust the Company's operations so as to be in compliance with any statutory or regulatory provision as may be applicable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Potential Physician Investor Liability&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A majority of the physician investors in the partnerships and limited liability companies which operate the Company's surgical facilities carry general and professional liability insurance on a claims-made basis. Each partnership or limited liability company may, however, be liable for damages to persons or property arising from occurrences at the surgical facilities. Although the various physician investors and other surgeons generally are required to obtain general and professional liability insurance with tail coverage that extends beyond the period of any claims-made policies, such individuals may not be able to obtain coverage in amounts sufficient to cover all potential liability. Since most insurance policies contain exclusions, the physician investors will not be insured against all possible occurrences. In the event of an uninsured or underinsured loss, the value of an investment in the partnership interests or limited liability company membership units and the amount of distributions could be adversely affected.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Tax Receivable Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On May 9, 2017, the Company entered into an agreement to amend that certain Income Tax Receivable Agreement, dated September 30, 2015 (as amended, the "TRA"), by and between the Company, and the other parties referred to therein, which amendment became effective on August 31, 2017. Pursuant to the amendment to the TRA, the Company agreed to make payments to H.I.G., the Company's former controlling shareholder, in its capacity as the stockholders representative pursuant to a fixed payment schedule. The amounts payable under the TRA are calculated as the product of (i) an annual base amount and (ii) the maximum corporate federal income tax rate for the applicable year plus three percent. The amounts payable under the TRA are related to the Company&#x2019;s projected realized tax savings over the next five years and are not dependent on the Company&#x2019;s actual tax savings over such period. The calculation of amounts payable pursuant to the TRA is thus dependent on the maximum corporate federal income tax rate. To the extent that the Company is unable to make payments under the TRA, such payments will be deferred and will accrue interest at a rate of the LIBOR plus 500 basis points until paid. If the terms of credit agreements and other debt documents cause the Company to be unable to make payments under the TRA and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;such terms are not materially more restrictive than those existing as of September 30, 2015, such payments will be deferred and will accrue interest at a rate of LIBOR plus 300 basis points until paid.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Assuming the Company's tax rate is 24%, calculated as the maximum corporate federal tax rate plus three percent, throughout the remaining term of the TRA, the Company estimates the total remaining amounts payable under the TRA was approximately $43.2 million as of both September&#160;30, 2021 and December&#160;31, 2020. As a result of the amendment to the TRA, the Company was required to value the liability under the TRA by discounting the fixed payment schedule using the Company&#x2019;s incremental borrowing rate. The carrying value of the liability under the TRA, reflecting the discount, was $39.9 million and $37.0 million as of September&#160;30, 2021 and December&#160;31, 2020, respectively. The current portion of the liability was $21.2 million as of both September&#160;30, 2021 and December&#160;31, 2020, and is included as a component of other current liabilities in the condensed consolidated balance sheets. The long-term portion is included as a component of other long-term liabilities in the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:SelfInsuranceReserve
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfMTAwNw_1d6418fa-07b3-4b94-bdf1-7634297d860f"
      unitRef="usd">22900000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfMTAxNA_3d615818-aa65-4af0-a07e-ecf9c3435449"
      unitRef="usd">21400000</us-gaap:SelfInsuranceReserve>
    <us-gaap:EstimatedInsuranceRecoveries
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfMTA2NQ_250e9503-cf71-41d6-a852-a5927f722b17"
      unitRef="usd">10500000</us-gaap:EstimatedInsuranceRecoveries>
    <us-gaap:EstimatedInsuranceRecoveries
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfMTA2NQ_e1df788b-d6f3-4071-9d47-4639e7c9340c"
      unitRef="usd">10500000</us-gaap:EstimatedInsuranceRecoveries>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i3967e790bb894cf8acd4602519023b78_D20210401-20210401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfMzUzNA_cdaa8185-ed8c-45a4-b284-ab1310ff14cd"
      unitRef="usd">30700000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="if703c13f85f14316b033116a88b9d2f6_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfNzQ4OQ_ff0961eb-e568-41dc-87f6-bc3d20c59a00"
      unitRef="number">0.03</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <sgry:CollaborativeTaxAgreementProjectedTaxSavingsTerm
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfNzYwOQ_5f101fd2-4f74-49c5-93e4-02a4f644bc08">P5Y</sgry:CollaborativeTaxAgreementProjectedTaxSavingsTerm>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i3adc24f120064bdb80d18207eba230d9_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfNzk2OA_cc0e8492-f3da-447d-b77f-accadfde6dc3"
      unitRef="number">0.0500</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i403f136aa2eb4d108d1df4f2b90ccdd5_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfODI5NA_22d8fddf-02ba-4023-bc71-5fb29e74a732"
      unitRef="number">0.0300</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfODM1Nw_f52c1326-fa7a-477b-a0be-f12bb0c3e980"
      unitRef="number">0.24</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <sgry:CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate
      contextRef="if703c13f85f14316b033116a88b9d2f6_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfODQxOQ_5a77f997-5be6-4c2d-8762-8f79b5b54e7d"
      unitRef="number">0.03</sgry:CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate>
    <us-gaap:TaxesPayableCurrentAndNoncurrent
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfODU2Mw_169921a9-6970-4f0e-ab65-c13043c88751"
      unitRef="usd">43200000</us-gaap:TaxesPayableCurrentAndNoncurrent>
    <us-gaap:TaxesPayableCurrentAndNoncurrent
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfODU2Mw_1df1b7a7-81be-4026-9314-16559d6c5a3e"
      unitRef="usd">43200000</us-gaap:TaxesPayableCurrentAndNoncurrent>
    <sgry:DeferredIncomeTaxLiabilitiesNetOfDiscount
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfODg2MQ_114d8917-4712-41e1-8c48-419f99473752"
      unitRef="usd">39900000</sgry:DeferredIncomeTaxLiabilitiesNetOfDiscount>
    <sgry:DeferredIncomeTaxLiabilitiesNetOfDiscount
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfODg2OA_ebb66492-3a95-4c6f-b6fa-9ca0278f5758"
      unitRef="usd">37000000</sgry:DeferredIncomeTaxLiabilitiesNetOfDiscount>
    <sgry:DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfODk0Mw_8395beb3-359a-447b-956a-d88eabe1108f"
      unitRef="usd">21200000</sgry:DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent>
    <sgry:DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81NS9mcmFnOjU3ZmIwZmNlMDUwMjQzNjM4MTM0MmY5ZjBjZDdiNzQ3L3RleHRyZWdpb246NTdmYjBmY2UwNTAyNDM2MzgxMzQyZjlmMGNkN2I3NDdfODk0Mw_c87613ed-c23d-440a-8171-39571891f7d3"
      unitRef="usd">21200000</sgry:DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfMTkyMA_2b4742b2-54c5-47db-86b8-81ab8ce687c5">Segment Reporting&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company currently operates in&#160;two&#160;major lines of business that are also the Company's reportable operating segments - the operation of surgical facilities and the operation of ancillary services. The Surgical Facility Services segment consists of the operation of ASCs and surgical hospitals and includes anesthesia services. The Ancillary Services segment consists of multi-specialty physician practices and a diagnostic laboratory, which was closed during the third quarter of 2020. The Optical Services segment for the three and nine months ended September 30, 2020 reflected in the table below consisted of an optical products group purchasing organization, which was sold on December 31, 2020. "All other" primarily consists of the Company's corporate general and administrative functions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following tables present financial information for each reportable segment (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Surgical Facility Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;542.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;478.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,563.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,262.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ancillary Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Optical Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;559.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;496.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,614.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,311.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted EBITDA:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Surgical Facility Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;96.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;287.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;229.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ancillary Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Optical Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(61.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(61.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;225.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;165.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Reconciliation of Adjusted EBITDA:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(33.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(61.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(27.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(98.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(75.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;147.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transaction, integration and acquisition costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss on disposals and deconsolidations, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Litigation settlement and other litigation costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(Gain) loss on debt extinguishment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gain on escrow release &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Hurricane-related operating losses &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;225.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;165.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"&gt;This amount includes transaction and integration costs of $10.2 million and $5.4 million for the three months ended September&#160;30, 2021 and 2020, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $2.1 million for the three months ended September 30, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;This amount includes transaction and integration costs of $24.7 million and $15.8 million for the nine months ended September&#160;30, 2021 and 2020, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $6.3 million and $14.4 million for the nine months ended September&#160;30, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"&gt;This amount includes other litigation costs of $2.5 million and $1.1 million for the three months ended September&#160;30, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;This amount includes other litigation costs of $4.3 million and $3.7 million for the nine months ended September&#160;30, 2021 and 2020, respectively. This amount further includes litigation settlement costs of $1.2 million for the nine months ended September&#160;30, 2020, with no comparable costs for the nine months ended September&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"&gt;Included in other income in the condensed consolidated statement of operations for the nine months ended September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"&gt;Reflects losses incurred in the month of September 2021 at a surgical facility that was closed following Hurricane Ida.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.953%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Surgical Facility Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,124.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,962.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ancillary Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;474.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;415.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,631.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,413.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.953%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash purchases of property and equipment:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Surgical Facility Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ancillary Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total cash purchases of property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfNjI_9c117fc6-f373-451f-a720-7c3ed3f2896c"
      unitRef="segment">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfMTkwMw_2fd01142-a6b0-43f6-96c6-5b7474605d6d">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following tables present financial information for each reportable segment (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Surgical Facility Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;542.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;478.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,563.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,262.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ancillary Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Optical Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;559.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;496.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,614.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,311.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted EBITDA:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Surgical Facility Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;96.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;287.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;229.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ancillary Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Optical Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(61.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(61.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;225.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;165.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Reconciliation of Adjusted EBITDA:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(33.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(61.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(27.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(98.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(75.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;147.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transaction, integration and acquisition costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss on disposals and deconsolidations, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Litigation settlement and other litigation costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(Gain) loss on debt extinguishment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gain on escrow release &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Hurricane-related operating losses &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;225.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;165.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"&gt;This amount includes transaction and integration costs of $10.2 million and $5.4 million for the three months ended September&#160;30, 2021 and 2020, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $2.1 million for the three months ended September 30, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;This amount includes transaction and integration costs of $24.7 million and $15.8 million for the nine months ended September&#160;30, 2021 and 2020, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $6.3 million and $14.4 million for the nine months ended September&#160;30, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"&gt;This amount includes other litigation costs of $2.5 million and $1.1 million for the three months ended September&#160;30, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;This amount includes other litigation costs of $4.3 million and $3.7 million for the nine months ended September&#160;30, 2021 and 2020, respectively. This amount further includes litigation settlement costs of $1.2 million for the nine months ended September&#160;30, 2020, with no comparable costs for the nine months ended September&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"&gt;Included in other income in the condensed consolidated statement of operations for the nine months ended September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"&gt;Reflects losses incurred in the month of September 2021 at a surgical facility that was closed following Hurricane Ida.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ic1b634056ada477481858c03f1bb914f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMy0yLTEtMS0xMjcxMg_d79e9a8a-54cf-4852-af5b-bf962bb04605"
      unitRef="usd">542100000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="if166aaf3eb59483bb7262ede561423c7_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMy00LTEtMS0xMjcxMg_ca9cba7d-6681-444c-98fa-fbb4680f52b6"
      unitRef="usd">478600000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i02f0df4797ab4a1e9bacd76ffdc57ab6_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMy02LTEtMS0xMjcxMg_e297b635-3243-49ba-86be-ec78a9225eca"
      unitRef="usd">1563700000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="icfbed4bef98e44fea406cc92949cdb3d_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMy04LTEtMS0xMjcxMg_1c526fdf-f703-4ebc-91ab-6c490fa46eff"
      unitRef="usd">1262800000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ie4894cd8d6cd44708c0cbc6ef5c7418f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfNC0yLTEtMS0xMjcxMg_cc70cea8-0dfb-48da-9f62-39d93a4aaf50"
      unitRef="usd">17100000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i086a33999d294178ad7e9154bb2b9765_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfNC00LTEtMS0xMjcxMg_2142d557-5d48-4478-8ad8-72f3c14ce8c3"
      unitRef="usd">16700000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ic567b93a1ce84e17ad9837f0055b163b_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfNC02LTEtMS0xMjcxMg_11067ea2-2f60-45f1-a14f-092916e48443"
      unitRef="usd">51200000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ifb2d426435c8450cafd7728d9d2dc8f3_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfNC04LTEtMS0xMjcxMg_63cf9aab-ecac-40c8-9282-5f1da58451d6"
      unitRef="usd">46900000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ib98011fc87b240309c26b764d426abd9_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfNS0yLTEtMS0xMjcxMg_a2c485ee-8f50-477a-9b3c-db94acc1c7b9"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i18afa682ccf34322b6bcdd13fdbfa4af_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfNS00LTEtMS0xMjcxMg_c4062734-edcd-4f7d-92c1-bd28c18d361c"
      unitRef="usd">800000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i24645f34e6a44361a5fbad3eb0ddf170_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfNS02LTEtMS0xMjcxMg_b6e4cdf8-62aa-45d7-9a2d-1412a649be03"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="idff1d62b1cb640b687f9fb96f5b4bb00_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfNS04LTEtMS0xMjcxMg_4c3d5869-a849-49f8-a94e-c65f2d1b03d3"
      unitRef="usd">2100000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfNi0yLTEtMS0xMjcxMg_c5c8b3ff-a6da-41c7-bc9a-3591e26a9858"
      unitRef="usd">559200000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfNi00LTEtMS0xMjcxMg_52984abc-5b3a-493d-9b54-0ccd42428868"
      unitRef="usd">496100000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfNi02LTEtMS0xMjcxMg_a3c21aa8-f654-4004-bf68-4122969cfca2"
      unitRef="usd">1614900000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfNi04LTEtMS0xMjcxMg_867b128e-73b4-49c7-b3c4-f282046c7451"
      unitRef="usd">1311800000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="ic1b634056ada477481858c03f1bb914f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfOS0yLTEtMS0xMjcxMg_7abb6f02-f1a0-410e-b146-2fa1dff4c3f7"
      unitRef="usd">96900000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="if166aaf3eb59483bb7262ede561423c7_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfOS00LTEtMS0xMjcxMg_28a035ed-0bae-4289-b647-7db806181e99"
      unitRef="usd">82500000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i02f0df4797ab4a1e9bacd76ffdc57ab6_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfOS02LTEtMS0xMjcxMg_027a1252-5e22-4cf4-9314-6cb3717f92ff"
      unitRef="usd">287500000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="icfbed4bef98e44fea406cc92949cdb3d_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfOS04LTEtMS0xMjcxMg_a073556f-02c0-4d61-9828-37b4a90f28f3"
      unitRef="usd">229700000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="ie4894cd8d6cd44708c0cbc6ef5c7418f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTAtMi0xLTEtMTI3MTI_85a2ebc9-0a18-4ef3-9386-5f76f30589cc"
      unitRef="usd">0</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i086a33999d294178ad7e9154bb2b9765_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTAtNC0xLTEtMTI3MTI_1252d29c-380e-470e-9dd1-d1b82c2e0f04"
      unitRef="usd">-600000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="ic567b93a1ce84e17ad9837f0055b163b_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTAtNi0xLTEtMTI3MTI_7df4a351-57a8-4b1b-a30d-077e76332e9d"
      unitRef="usd">-1000000.0</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="ifb2d426435c8450cafd7728d9d2dc8f3_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTAtOC0xLTEtMTI3MTI_c7952324-7c4d-4cf2-82bf-6935601711e4"
      unitRef="usd">-3900000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="ib98011fc87b240309c26b764d426abd9_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTEtMi0xLTEtMTI3MTI_cdb072f2-7195-480b-911e-095d05f6cffe"
      unitRef="usd">0</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i18afa682ccf34322b6bcdd13fdbfa4af_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTEtNC0xLTEtMTI3MTI_bb9467b9-c31d-49df-9c93-8f26ca009b51"
      unitRef="usd">400000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i24645f34e6a44361a5fbad3eb0ddf170_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTEtNi0xLTEtMTI3MTI_95b1a2d4-2a52-4f60-988c-8a02502647b3"
      unitRef="usd">0</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="idff1d62b1cb640b687f9fb96f5b4bb00_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTEtOC0xLTEtMTI3MTI_0c36829f-c93d-4b30-b65b-039b69260a36"
      unitRef="usd">1000000.0</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i22e6f85fd88d44d89f23a959137fd882_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTItMi0xLTEtMTI3MTI_df1b71c9-b16e-4c1a-97e9-966a1bc7b8df"
      unitRef="usd">-20500000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i11790ef5309b4773a0839312e45271b1_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTItNC0xLTEtMTI3MTI_415f1c3a-fde8-4e6e-af10-6fa5b64e7faf"
      unitRef="usd">-21200000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i3cd422f84ed747328d3a0d61c7f136fa_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTItNi0xLTEtMTI3MTI_907e491e-8b0c-450f-ad87-34500a05494d"
      unitRef="usd">-61300000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i69c8d97578e54edc825c05346d77f05a_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTItOC0xLTEtMTI3MTI_06d313ac-0ee0-4633-b795-851d45a3aa24"
      unitRef="usd">-61000000.0</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTMtMi0xLTEtMTI3MTI_7929a0fa-dc30-41df-804a-b1814b640ea6"
      unitRef="usd">76400000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTMtNC0xLTEtMTI3MTI_93c4c363-f77a-4890-91c3-fd56befa0e3f"
      unitRef="usd">61100000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTMtNi0xLTEtMTI3MTI_a3bf6f13-930c-4798-95eb-eb343f91092d"
      unitRef="usd">225200000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTMtOC0xLTEtMTI3MTI_37a85b94-c9f7-478f-8e65-3d1e48ac25ae"
      unitRef="usd">165800000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTYtMi0xLTEtMTI3MTI_ea73942b-1fb8-4051-919e-affe3c5131fd"
      unitRef="usd">9400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTYtNC0xLTEtMTI3MTI_63b78bfa-26f9-4386-8775-56174991d362"
      unitRef="usd">-33000000.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTYtNi0xLTEtMTI3MTI_07c31c86-d860-461e-9652-b9cd488d500b"
      unitRef="usd">26500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTYtOC0xLTEtMTI3MTI_22320998-bf21-4f81-8a29-7cac24374aba"
      unitRef="usd">-61100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTgtMi0xLTEtMTI3MTI_364fdc28-b4bb-4f1a-a4e5-99c460ebc799"
      unitRef="usd">31100000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTgtNC0xLTEtMTI3MTI_3c44bdc8-cce7-451c-bfa3-b60aeac18d03"
      unitRef="usd">27300000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTgtNi0xLTEtMTI3MTI_a13fcfd2-cff9-453c-b109-18ea175af2d4"
      unitRef="usd">98600000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTgtOC0xLTEtMTI3MTI_6e178dd6-3c7a-4fd3-8f98-44b0a89ad6c7"
      unitRef="usd">75000000.0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTktMi0xLTEtMTI3MTI_ade47da1-e518-4ab9-8f5b-4b13ce4d2924"
      unitRef="usd">25200000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTktNC0xLTEtMTI3MTI_b9ea6f20-1e9f-40cf-ba6d-d616d59742ec"
      unitRef="usd">24100000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTktNi0xLTEtMTI3MTI_3ea7f7aa-e3ed-4df5-b576-5ea9400217f9"
      unitRef="usd">76100000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMTktOC0xLTEtMTI3MTI_475faa68-315d-416f-8fb3-a67f544b0ce1"
      unitRef="usd">69300000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjAtMi0xLTEtMTI3MTI_9206c103-6787-4e59-b51d-3d158cbba7de"
      unitRef="usd">-54200000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjAtNC0xLTEtMTI3MTI_8729cc78-0a7c-434a-aaa0-5fc51919a3c7"
      unitRef="usd">-51500000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjAtNi0xLTEtMTI3MTI_936825e2-127c-4d8e-9e5c-dda4e615760b"
      unitRef="usd">-160900000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjAtOC0xLTEtMTI3MTI_ffceb7fb-4a83-46ff-84d2-0f05450e647b"
      unitRef="usd">-147800000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:ShareBasedCompensation
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjEtMi0xLTEtMTI3MTI_5bfb7ba2-5884-4489-9417-e81ed6b69d2f"
      unitRef="usd">4100000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjEtNC0xLTEtMTI3MTI_06b5ac50-54a1-4e1c-ad85-a8570a7e6663"
      unitRef="usd">3000000.0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjEtNi0xLTEtMTI3MTI_57556161-07c5-4d8a-9245-adae455f7cfb"
      unitRef="usd">13400000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjEtOC0xLTEtMTI3MTI_fc9ab289-51c1-4735-b381-d2033702f30a"
      unitRef="usd">9900000</us-gaap:ShareBasedCompensation>
    <sgry:BusinessCombinationIntegrationRelatedCostsAndMergerCosts
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjItMi0xLTEtMTI3MTI_b39621f0-7f9b-44ba-ad59-4ccfedff9226"
      unitRef="usd">10200000</sgry:BusinessCombinationIntegrationRelatedCostsAndMergerCosts>
    <sgry:BusinessCombinationIntegrationRelatedCostsAndMergerCosts
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjItNC0xLTEtMTI3MTI_9ac9aa04-5fb9-4d0d-92dd-29cb37f1a6e4"
      unitRef="usd">7500000</sgry:BusinessCombinationIntegrationRelatedCostsAndMergerCosts>
    <sgry:BusinessCombinationIntegrationRelatedCostsAndMergerCosts
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjItNi0xLTEtMTI3MTI_fd3274a8-e833-4df0-8a2e-857fd2605999"
      unitRef="usd">31000000.0</sgry:BusinessCombinationIntegrationRelatedCostsAndMergerCosts>
    <sgry:BusinessCombinationIntegrationRelatedCostsAndMergerCosts
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjItOC0xLTEtMTI3MTI_3d43715d-0d02-492d-9535-73e71a5290c4"
      unitRef="usd">30200000</sgry:BusinessCombinationIntegrationRelatedCostsAndMergerCosts>
    <us-gaap:AssetImpairmentCharges
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjMtMi0xLTEtMTcyNjk_f59be8fd-567c-4157-8ac7-fedb060c15b9"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjMtNC0xLTEtMTcyNzU_0a958c36-0fff-4b1f-a5fe-a0717ea7cb16"
      unitRef="usd">33500000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjMtNi0xLTEtMTcyODE_7abbfcfa-3230-4554-87b2-07a7c448085d"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjMtOC0xLTEtMTcyODc_c53a3a69-570a-469d-9e04-ff2295fb3877"
      unitRef="usd">33500000</us-gaap:AssetImpairmentCharges>
    <sgry:GainLossOnDispositionOfAssetsAndDeconsolidation
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjMtMi0xLTEtMTI3MTI_278cf1ef-435a-4ed1-8a0a-d8c7a12f5fc5"
      unitRef="usd">-1900000</sgry:GainLossOnDispositionOfAssetsAndDeconsolidation>
    <sgry:GainLossOnDispositionOfAssetsAndDeconsolidation
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjMtNC0xLTEtMTI3MTI_65ed2414-fd0d-48a4-89d0-06d900dc3cbc"
      unitRef="usd">-700000</sgry:GainLossOnDispositionOfAssetsAndDeconsolidation>
    <sgry:GainLossOnDispositionOfAssetsAndDeconsolidation
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjMtNi0xLTEtMTI3MTI_091abf0b-56fd-41b7-b6e7-d9123a33b532"
      unitRef="usd">-2000000.0</sgry:GainLossOnDispositionOfAssetsAndDeconsolidation>
    <sgry:GainLossOnDispositionOfAssetsAndDeconsolidation
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjMtOC0xLTEtMTI3MTI_278ef910-6c6b-4574-b888-bc0f283b6571"
      unitRef="usd">-7100000</sgry:GainLossOnDispositionOfAssetsAndDeconsolidation>
    <sgry:GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjQtMi0xLTEtMTI3MTI_0bcf86a1-74df-48e9-b4d0-fca6b25ec353"
      unitRef="usd">-2500000</sgry:GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts>
    <sgry:GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjQtNC0xLTEtMTI3MTI_d24920f7-5f99-4485-9411-2220cc7cc523"
      unitRef="usd">-1100000</sgry:GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts>
    <sgry:GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjQtNi0xLTEtMTI3MTI_c8c7d125-5b32-4cb1-9e36-6e4602026712"
      unitRef="usd">-4300000</sgry:GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts>
    <sgry:GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjQtOC0xLTEtMTI3MTI_3390ab97-5b67-4f7f-acc8-0117f9346b5a"
      unitRef="usd">-4900000</sgry:GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjUtMi0xLTEtMTI3MTI_00316ded-3d7d-490e-bbda-c554b72be746"
      unitRef="usd">500000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjUtNC0xLTEtMTI3MTI_116fc734-8b77-4abe-9796-5098434d7d9e"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjUtNi0xLTEtMTI3MTI_d0c02bd0-481b-42db-a00f-76d474a90b0e"
      unitRef="usd">-9100000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjUtOC0xLTEtMTI3MTI_582d3c86-94db-4396-93a2-e4f9d324860d"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <sgry:BusinessCombinationGainLossOnAcquisitionEscrow
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjYtMi0xLTEtMTI3MTI_3c97355a-2403-4db8-a96a-b8afe33b720b"
      unitRef="usd">0</sgry:BusinessCombinationGainLossOnAcquisitionEscrow>
    <sgry:BusinessCombinationGainLossOnAcquisitionEscrow
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjYtNC0xLTEtMTI3MTI_cb6f576b-0e3a-42e4-be42-488c610ed16d"
      unitRef="usd">0</sgry:BusinessCombinationGainLossOnAcquisitionEscrow>
    <sgry:BusinessCombinationGainLossOnAcquisitionEscrow
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjYtNi0xLTEtMTI3MTI_cd8bc50a-9960-40d5-8cef-5bad46c43f24"
      unitRef="usd">0</sgry:BusinessCombinationGainLossOnAcquisitionEscrow>
    <sgry:BusinessCombinationGainLossOnAcquisitionEscrow
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjYtOC0xLTEtMTI3MTI_43d2ed96-da49-4c19-9e2c-e4fae2c587df"
      unitRef="usd">800000</sgry:BusinessCombinationGainLossOnAcquisitionEscrow>
    <us-gaap:UnusualOrInfrequentItemNetGainLoss
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjgtMi0xLTEtMTg4Mjg_84840592-4c87-4963-820e-0364e6b5d73f"
      unitRef="usd">500000</us-gaap:UnusualOrInfrequentItemNetGainLoss>
    <us-gaap:UnusualOrInfrequentItemNetGainLoss
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjgtNC0xLTEtMTg4Mjg_3dedddae-567c-4670-b2ec-b5e26ff6929e"
      unitRef="usd">0</us-gaap:UnusualOrInfrequentItemNetGainLoss>
    <us-gaap:UnusualOrInfrequentItemNetGainLoss
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjgtNi0xLTEtMTg4Mjg_4f96a77f-8794-44a4-a05d-e56812efd77c"
      unitRef="usd">500000</us-gaap:UnusualOrInfrequentItemNetGainLoss>
    <us-gaap:UnusualOrInfrequentItemNetGainLoss
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjgtOC0xLTEtMTg4Mjg_5d9ded59-a12b-48a4-b7ba-c242ddab4023"
      unitRef="usd">0</us-gaap:UnusualOrInfrequentItemNetGainLoss>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjctMi0xLTEtMTI3MTI_712cf07e-c097-4011-b32d-49415e62e162"
      unitRef="usd">76400000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjctNC0xLTEtMTI3MTI_7e8673e8-e0db-42ce-8b15-59e9fe2ca8d0"
      unitRef="usd">61100000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjctNi0xLTEtMTI3MTI_eaaf9578-2bd2-400a-bf2c-f71b9402985f"
      unitRef="usd">225200000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjM4ZjFiOWYyZDU5NzQ1OWM4OTFiYWYzZjQwZGRkN2FiL3RhYmxlcmFuZ2U6MzhmMWI5ZjJkNTk3NDU5Yzg5MWJhZjNmNDBkZGQ3YWJfMjctOC0xLTEtMTI3MTI_0f6efa1b-518d-448f-bff1-115c539d42c9"
      unitRef="usd">165800000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfOTc1_2dedcc8e-3230-47fd-92ee-91ee0217a559"
      unitRef="usd">10200000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfOTgy_88f94287-37f0-4cc5-a412-d07c381b19c8"
      unitRef="usd">5400000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfMTEyNw_9c482296-0cc9-4524-a0ef-a70f27878fc1"
      unitRef="usd">2100000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfMTIzOA_3ba2086c-3ad8-4b6a-9976-f802c72183b4"
      unitRef="usd">24700000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfMTI0NQ_78acc6f2-b711-44bc-b83c-6208c1a493fe"
      unitRef="usd">15800000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfMTM4Mw_9f7ee5e5-60dc-4af0-bae3-6d34ae3671cd"
      unitRef="usd">6300000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfMTM5MA_f4f8dad6-2909-4e1e-8ece-1b61bf0c5e6c"
      unitRef="usd">14400000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:LitigationSettlementExpense
      contextRef="i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfMTQ5MA_2624d6b7-e156-47c0-8785-00bd0be321c4"
      unitRef="usd">2500000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i310105e45f7d4232aa7ac001f38a2e69_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfMTQ5Nw_77e3dfe4-558e-4c9b-98c0-d68244ff2366"
      unitRef="usd">1100000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfMTU5Nw_572e738d-2d41-4cf0-b244-8c6066d14ba7"
      unitRef="usd">4300000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfMTYwNA_24a4eb60-6317-4dae-88e2-e17cafc47bc8"
      unitRef="usd">3700000</us-gaap:LitigationSettlementExpense>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfMTcwOA_95e5f95f-047e-498d-896a-0deba9f930df"
      unitRef="usd">-1200000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfNDk0NzgwMjMyNjk0Ng_cd32b844-f16e-4255-93ea-6e216cfd4fc9"
      unitRef="usd">0</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfMTkxMw_6431b71c-5c28-4c24-89ae-7e47e484aeca">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.953%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Surgical Facility Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,124.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,962.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ancillary Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;474.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;415.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,631.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,413.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock>
    <us-gaap:Assets
      contextRef="i07b5831fa25c4593977edb314caf0810_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjE0MzU4MjAwOGUyZTQyNWQ4OWU2MDMxZGFhNDMwNzA5L3RhYmxlcmFuZ2U6MTQzNTgyMDA4ZTJlNDI1ZDg5ZTYwMzFkYWE0MzA3MDlfMi0yLTEtMS0xMjcxMg_4c36664b-60b2-4cf6-8789-5295511ea090"
      unitRef="usd">5124400000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i9f0d8a6647ac43d3acecd87aa3917e60_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjE0MzU4MjAwOGUyZTQyNWQ4OWU2MDMxZGFhNDMwNzA5L3RhYmxlcmFuZ2U6MTQzNTgyMDA4ZTJlNDI1ZDg5ZTYwMzFkYWE0MzA3MDlfMi00LTEtMS0xMjcxMg_164eecfc-c6bf-47b7-973f-0b7660816554"
      unitRef="usd">4962400000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i6cebdc44291f4ef09e8f91e82d5fb5b1_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjE0MzU4MjAwOGUyZTQyNWQ4OWU2MDMxZGFhNDMwNzA5L3RhYmxlcmFuZ2U6MTQzNTgyMDA4ZTJlNDI1ZDg5ZTYwMzFkYWE0MzA3MDlfMy0yLTEtMS0xMjcxMg_c7c537da-f8e4-47f5-b1c4-a378be9d5b38"
      unitRef="usd">32500000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i98faa269bef74b28b6fbd87fbc70f99e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjE0MzU4MjAwOGUyZTQyNWQ4OWU2MDMxZGFhNDMwNzA5L3RhYmxlcmFuZ2U6MTQzNTgyMDA4ZTJlNDI1ZDg5ZTYwMzFkYWE0MzA3MDlfMy00LTEtMS0xMjcxMg_e1f83db6-391c-473e-afa6-57dfd3ea797c"
      unitRef="usd">35000000.0</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="if61366db2c44498391f1d66e8a6f3a10_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjE0MzU4MjAwOGUyZTQyNWQ4OWU2MDMxZGFhNDMwNzA5L3RhYmxlcmFuZ2U6MTQzNTgyMDA4ZTJlNDI1ZDg5ZTYwMzFkYWE0MzA3MDlfNC0yLTEtMS0xMjcxMg_3be6260c-0725-43c4-9cc9-0ca41b04d0af"
      unitRef="usd">474700000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ic360167dd83a4d318b00e5cd3eb72bd0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjE0MzU4MjAwOGUyZTQyNWQ4OWU2MDMxZGFhNDMwNzA5L3RhYmxlcmFuZ2U6MTQzNTgyMDA4ZTJlNDI1ZDg5ZTYwMzFkYWE0MzA3MDlfNC00LTEtMS0xMjcxMg_2dcb9225-ea1b-484f-998b-9c659a68e7f8"
      unitRef="usd">415800000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i882aa7da35e6452cbe7ffa904416e6cd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjE0MzU4MjAwOGUyZTQyNWQ4OWU2MDMxZGFhNDMwNzA5L3RhYmxlcmFuZ2U6MTQzNTgyMDA4ZTJlNDI1ZDg5ZTYwMzFkYWE0MzA3MDlfNS0yLTEtMS0xMjcxMg_d5ab3200-a6a8-4e28-907c-756fd54f014e"
      unitRef="usd">5631600000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia9055b0c653648f0919c1c9b458ca340_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjE0MzU4MjAwOGUyZTQyNWQ4OWU2MDMxZGFhNDMwNzA5L3RhYmxlcmFuZ2U6MTQzNTgyMDA4ZTJlNDI1ZDg5ZTYwMzFkYWE0MzA3MDlfNS00LTEtMS0xMjcxMg_a45b8d92-6e2d-4baf-8cb1-fc33b1889109"
      unitRef="usd">5413200000</us-gaap:Assets>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RleHRyZWdpb246Y2Q2ZDFlMmMyYWUwNDIxMzk0MjRjMDE1NDBlNDA4MTRfMTkyMw_e13098a1-816e-4124-87bb-16264fc9ba51">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.953%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash purchases of property and equipment:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Surgical Facility Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ancillary Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total cash purchases of property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i02f0df4797ab4a1e9bacd76ffdc57ab6_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjJhNjgzMDlmNDFkNDQwNWQ5MGRhNzQ2ZWU4ODdmYWUzL3RhYmxlcmFuZ2U6MmE2ODMwOWY0MWQ0NDA1ZDkwZGE3NDZlZTg4N2ZhZTNfMy0yLTEtMS0xMjcxMg_becf9c35-2e31-400c-9667-52ff2b4b509f"
      unitRef="usd">42000000.0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="icfbed4bef98e44fea406cc92949cdb3d_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjJhNjgzMDlmNDFkNDQwNWQ5MGRhNzQ2ZWU4ODdmYWUzL3RhYmxlcmFuZ2U6MmE2ODMwOWY0MWQ0NDA1ZDkwZGE3NDZlZTg4N2ZhZTNfMy00LTEtMS0xMjcxMg_d82ca97d-2ef6-43c8-aeb4-592f84081f76"
      unitRef="usd">24100000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ic567b93a1ce84e17ad9837f0055b163b_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjJhNjgzMDlmNDFkNDQwNWQ5MGRhNzQ2ZWU4ODdmYWUzL3RhYmxlcmFuZ2U6MmE2ODMwOWY0MWQ0NDA1ZDkwZGE3NDZlZTg4N2ZhZTNfNC0yLTEtMS0xMjcxMg_45452b23-5aea-43f0-93ab-6ac2e4103487"
      unitRef="usd">400000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ifb2d426435c8450cafd7728d9d2dc8f3_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjJhNjgzMDlmNDFkNDQwNWQ5MGRhNzQ2ZWU4ODdmYWUzL3RhYmxlcmFuZ2U6MmE2ODMwOWY0MWQ0NDA1ZDkwZGE3NDZlZTg4N2ZhZTNfNC00LTEtMS0xMjcxMg_93881e6c-24f0-4a75-b7ed-b4ceb3da4eb2"
      unitRef="usd">300000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i3cd422f84ed747328d3a0d61c7f136fa_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjJhNjgzMDlmNDFkNDQwNWQ5MGRhNzQ2ZWU4ODdmYWUzL3RhYmxlcmFuZ2U6MmE2ODMwOWY0MWQ0NDA1ZDkwZGE3NDZlZTg4N2ZhZTNfNi0yLTEtMS0xMjcxMg_2ac45b66-9338-4adf-a087-d8b9ee125abc"
      unitRef="usd">1100000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i69c8d97578e54edc825c05346d77f05a_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjJhNjgzMDlmNDFkNDQwNWQ5MGRhNzQ2ZWU4ODdmYWUzL3RhYmxlcmFuZ2U6MmE2ODMwOWY0MWQ0NDA1ZDkwZGE3NDZlZTg4N2ZhZTNfNi00LTEtMS0xMjcxMg_d92519f6-38f6-4cda-a52f-b8cca22496c4"
      unitRef="usd">3400000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjJhNjgzMDlmNDFkNDQwNWQ5MGRhNzQ2ZWU4ODdmYWUzL3RhYmxlcmFuZ2U6MmE2ODMwOWY0MWQ0NDA1ZDkwZGE3NDZlZTg4N2ZhZTNfNy0yLTEtMS0xMjcxMg_032f7460-5ec7-4414-b289-c5ab8458cb73"
      unitRef="usd">43500000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i611af28a78a34270b4959bb98e1eda0b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF81OC9mcmFnOmNkNmQxZTJjMmFlMDQyMTM5NDI0YzAxNTQwZTQwODE0L3RhYmxlOjJhNjgzMDlmNDFkNDQwNWQ5MGRhNzQ2ZWU4ODdmYWUzL3RhYmxlcmFuZ2U6MmE2ODMwOWY0MWQ0NDA1ZDkwZGE3NDZlZTg4N2ZhZTNfNy00LTEtMS0xMjcxMg_5c0c5c79-4202-4f04-af9d-d2d6672627c7"
      unitRef="usd">27800000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i6aa17db36ba04903893d4cddc5066609_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF82MS9mcmFnOmI4ODcxNGM1ZDlmYTQyNGY4MzQ5NjZjMjhiMDVlYzk0L3RleHRyZWdpb246Yjg4NzE0YzVkOWZhNDI0ZjgzNDk2NmMyOGIwNWVjOTRfMzg2_1954f42f-3a15-4037-97e4-d47d684331d2">Subsequent EventsIn October 2021, the Company completed the acquisition of additional interest in one of its consolidated Surgical Facilities for a market-based acquisition price of $31.8&#160;million.</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i0613206f307d4141bf872d310477a2cb_D20211001-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF82MS9mcmFnOmI4ODcxNGM1ZDlmYTQyNGY4MzQ5NjZjMjhiMDVlYzk0L3RleHRyZWdpb246Yjg4NzE0YzVkOWZhNDI0ZjgzNDk2NmMyOGIwNWVjOTRfMjE5OTAyMzI1NjcyNg_3d0044ed-caec-4d86-a35f-6b04ad389814"
      unitRef="usd">31800000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzMtNi0xLTEtMTI3MTI_4f0eb82c-7974-4547-a439-39ca1842fe73"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzMtNi0xLTEtMTI3MTI_4f0eb82c-7974-4547-a439-39ca1842fe73"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzYtNC0xLTEtMTI3MTI_be5b1b69-bfc0-452c-9d3f-d7450ecfab16"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzYtNC0xLTEtMTI3MTI_be5b1b69-bfc0-452c-9d3f-d7450ecfab16"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzMtMi0xLTEtMTI3MTI_ad685e45-a25b-4ec6-9a56-2b2a3487e7bf"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzMtMi0xLTEtMTI3MTI_ad685e45-a25b-4ec6-9a56-2b2a3487e7bf"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzYtMi0xLTEtMTI3MTI_cc9caa97-f852-4b67-8131-f88f3d64052d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzYtMi0xLTEtMTI3MTI_cc9caa97-f852-4b67-8131-f88f3d64052d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzMtOC0xLTEtMTI3MTI_273a7f14-a739-4182-a3d3-05f17b106441"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzMtOC0xLTEtMTI3MTI_273a7f14-a739-4182-a3d3-05f17b106441"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzYtNi0xLTEtMTI3MTI_9855857c-965c-4348-adf6-292a3c982615"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzYtNi0xLTEtMTI3MTI_9855857c-965c-4348-adf6-292a3c982615"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzYtOC0xLTEtMTI3MTI_3f297b3b-19ae-4564-a4f4-e76d87e5c80f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzYtOC0xLTEtMTI3MTI_3f297b3b-19ae-4564-a4f4-e76d87e5c80f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzMtNC0xLTEtMTI3MTI_968f5681-1769-41d6-a061-1929f8ad5a8f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzMtNC0xLTEtMTI3MTI_968f5681-1769-41d6-a061-1929f8ad5a8f"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RleHRyZWdpb246MmEzZmUxMGU0YzU4NDk4MTk4MjBmZmYyMjBmMmU5OWZfMzg3_4763b7d7-48c3-4c3b-a9bc-dbbdb07c3ab4" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RleHRyZWdpb246MmEzZmUxMGU0YzU4NDk4MTk4MjBmZmYyMjBmMmU5OWZfMzg3_4763b7d7-48c3-4c3b-a9bc-dbbdb07c3ab4" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in those periods.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzMtNi0xLTEtMTI3MTI_4f0eb82c-7974-4547-a439-39ca1842fe73"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RleHRyZWdpb246MmEzZmUxMGU0YzU4NDk4MTk4MjBmZmYyMjBmMmU5OWZfMzg3_4763b7d7-48c3-4c3b-a9bc-dbbdb07c3ab4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzYtNC0xLTEtMTI3MTI_be5b1b69-bfc0-452c-9d3f-d7450ecfab16"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RleHRyZWdpb246MmEzZmUxMGU0YzU4NDk4MTk4MjBmZmYyMjBmMmU5OWZfMzg3_4763b7d7-48c3-4c3b-a9bc-dbbdb07c3ab4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzMtMi0xLTEtMTI3MTI_ad685e45-a25b-4ec6-9a56-2b2a3487e7bf"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RleHRyZWdpb246MmEzZmUxMGU0YzU4NDk4MTk4MjBmZmYyMjBmMmU5OWZfMzg3_4763b7d7-48c3-4c3b-a9bc-dbbdb07c3ab4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzYtMi0xLTEtMTI3MTI_cc9caa97-f852-4b67-8131-f88f3d64052d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RleHRyZWdpb246MmEzZmUxMGU0YzU4NDk4MTk4MjBmZmYyMjBmMmU5OWZfMzg3_4763b7d7-48c3-4c3b-a9bc-dbbdb07c3ab4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzMtOC0xLTEtMTI3MTI_273a7f14-a739-4182-a3d3-05f17b106441"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RleHRyZWdpb246MmEzZmUxMGU0YzU4NDk4MTk4MjBmZmYyMjBmMmU5OWZfMzg3_4763b7d7-48c3-4c3b-a9bc-dbbdb07c3ab4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzYtNi0xLTEtMTI3MTI_9855857c-965c-4348-adf6-292a3c982615"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RleHRyZWdpb246MmEzZmUxMGU0YzU4NDk4MTk4MjBmZmYyMjBmMmU5OWZfMzg3_4763b7d7-48c3-4c3b-a9bc-dbbdb07c3ab4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzYtOC0xLTEtMTI3MTI_3f297b3b-19ae-4564-a4f4-e76d87e5c80f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RleHRyZWdpb246MmEzZmUxMGU0YzU4NDk4MTk4MjBmZmYyMjBmMmU5OWZfMzg3_4763b7d7-48c3-4c3b-a9bc-dbbdb07c3ab4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RhYmxlOjEwNTRkNDQ4NDcyNTQwNDlhNjU0MTVjOGZiOGQ1ZjU4L3RhYmxlcmFuZ2U6MTA1NGQ0NDg0NzI1NDA0OWE2NTQxNWM4ZmI4ZDVmNThfMzMtNC0xLTEtMTI3MTI_968f5681-1769-41d6-a061-1929f8ad5a8f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRjYWM5M2FlODU1MDQzNzliNDA0OWYzZjRkNmVmZGI4L3NlYzpkY2FjOTNhZTg1NTA0Mzc5YjQwNDlmM2Y0ZDZlZmRiOF8xNi9mcmFnOjJhM2ZlMTBlNGM1ODQ5ODE5ODIwZmZmMjIwZjJlOTlmL3RleHRyZWdpb246MmEzZmUxMGU0YzU4NDk4MTk4MjBmZmYyMjBmMmU5OWZfMzg3_4763b7d7-48c3-4c3b-a9bc-dbbdb07c3ab4"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763306584504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Surgery Partners, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">47-3620923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">310 Seven Springs Way, Suite&#160;500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Brentwood<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">37027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">234-5900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SGRY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,436,720<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001638833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763211053128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 330.4<span></span>
</td>
<td class="nump">$ 317.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">393.4<span></span>
</td>
<td class="nump">382.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">59.3<span></span>
</td>
<td class="nump">56.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">29.8<span></span>
</td>
<td class="nump">17.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">28.8<span></span>
</td>
<td class="nump">27.4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">841.7<span></span>
</td>
<td class="nump">801.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net of accumulated depreciation of $254.0 and $189.3, respectively</a></td>
<td class="nump">542.1<span></span>
</td>
<td class="nump">544.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Goodwill and other intangible assets, net</a></td>
<td class="nump">3,659.3<span></span>
</td>
<td class="nump">3,514.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investments in and advances to affiliates</a></td>
<td class="nump">89.6<span></span>
</td>
<td class="nump">90.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use operating lease assets</a></td>
<td class="nump">320.5<span></span>
</td>
<td class="nump">310.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Long-term deferred tax assets</a></td>
<td class="nump">128.1<span></span>
</td>
<td class="nump">124.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">50.3<span></span>
</td>
<td class="nump">27.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">5,631.6<span></span>
</td>
<td class="nump">5,413.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">116.5<span></span>
</td>
<td class="nump">100.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued payroll and benefits</a></td>
<td class="nump">73.1<span></span>
</td>
<td class="nump">65.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent', window );">Medicare accelerated payments and deferred governmental grants</a></td>
<td class="nump">81.8<span></span>
</td>
<td class="nump">109.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">208.3<span></span>
</td>
<td class="nump">217.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current maturities of long-term debt</a></td>
<td class="nump">60.8<span></span>
</td>
<td class="nump">64.4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">540.5<span></span>
</td>
<td class="nump">556.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt, less current maturities</a></td>
<td class="nump">2,791.9<span></span>
</td>
<td class="nump">2,792.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Right-of-use operating lease liabilities</a></td>
<td class="nump">312.4<span></span>
</td>
<td class="nump">300.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">124.4<span></span>
</td>
<td class="nump">139.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Non-controlling interests&#8212;redeemable</a></td>
<td class="nump">310.4<span></span>
</td>
<td class="nump">306.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Redeemable preferred stock - Series A; shares authorized - 310,000; shares issued or outstanding - none and 310,000, respectively; redemption value - $&#8212; and $434.5, respectively</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">434.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01 par value; shares authorized - 20,000,000; shares issued or outstanding - none</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValueOutstanding', window );">Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 82,458,385 and 50,461,706, respectively</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">1,306.0<span></span>
</td>
<td class="nump">607.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(47.9)<span></span>
</td>
<td class="num">(61.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained deficit</a></td>
<td class="num">(502.6)<span></span>
</td>
<td class="num">(431.8)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Surgery Partners, Inc. stockholders' equity</a></td>
<td class="nump">756.3<span></span>
</td>
<td class="nump">115.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interests&#8212;non-redeemable</a></td>
<td class="nump">795.7<span></span>
</td>
<td class="nump">766.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity</a></td>
<td class="nump">1,552.0<span></span>
</td>
<td class="nump">882.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 5,631.6<span></span>
</td>
<td class="nump">$ 5,413.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Medicare Accelerated Payments And Deferred Governmental Grants, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763215744776">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization', window );">Accumulated depreciation on property and equipment</a></td>
<td class="nump">$ 254.0<span></span>
</td>
<td class="nump">$ 189.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Redeemable preferred stock, shares authorized (shares)</a></td>
<td class="nump">310,000<span></span>
</td>
<td class="nump">310,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Redeemable preferred stock, shares issued (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">310,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Redeemable preferred stock, shares outstanding (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">310,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityPreferredRedemptionValue', window );">Redeemable preferred stock, redemption value</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 434.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (shares)</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (shares)</a></td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (shares)</a></td>
<td class="nump">82,458,385<span></span>
</td>
<td class="nump">50,461,706<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (shares)</a></td>
<td class="nump">82,458,385<span></span>
</td>
<td class="nump">50,461,706<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityPreferredRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redemption value, as if currently redeemable, of redeemable noncontrolling interest for preferred shares, units or ownership interests classified as temporary equity and the election has been made to accrete changes in redemption value to the earliest redemption date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 24(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityPreferredRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763216512776">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 559.2<span></span>
</td>
<td class="nump">$ 496.1<span></span>
</td>
<td class="nump">$ 1,614.9<span></span>
</td>
<td class="nump">$ 1,311.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LaborAndRelatedExpense', window );">Salaries and benefits</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">162.3<span></span>
</td>
<td class="nump">141.7<span></span>
</td>
<td class="nump">468.7<span></span>
</td>
<td class="nump">398.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SuppliesExpense', window );">Supplies</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">160.1<span></span>
</td>
<td class="nump">142.8<span></span>
</td>
<td class="nump">464.9<span></span>
</td>
<td class="nump">382.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional and medical fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">56.8<span></span>
</td>
<td class="nump">46.3<span></span>
</td>
<td class="nump">169.7<span></span>
</td>
<td class="nump">138.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_OperatingAndFinanceLeaseExpense', window );">Lease expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">23.4<span></span>
</td>
<td class="nump">21.9<span></span>
</td>
<td class="nump">68.8<span></span>
</td>
<td class="nump">64.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCostAndExpenseOperating', window );">Other operating expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">34.1<span></span>
</td>
<td class="nump">29.2<span></span>
</td>
<td class="nump">98.5<span></span>
</td>
<td class="nump">83.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Cost of revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">436.7<span></span>
</td>
<td class="nump">381.9<span></span>
</td>
<td class="nump">1,270.6<span></span>
</td>
<td class="nump">1,067.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">25.5<span></span>
</td>
<td class="nump">25.2<span></span>
</td>
<td class="nump">76.8<span></span>
</td>
<td class="nump">73.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">25.2<span></span>
</td>
<td class="nump">24.1<span></span>
</td>
<td class="nump">76.1<span></span>
</td>
<td class="nump">69.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Income from equity investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2.9)<span></span>
</td>
<td class="num">(3.1)<span></span>
</td>
<td class="num">(8.5)<span></span>
</td>
<td class="num">(7.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation', window );">Loss on disposals and deconsolidations, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">7.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Transaction and integration costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10.2<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
<td class="nump">24.7<span></span>
</td>
<td class="nump">15.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">33.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">33.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_GrantRevenue', window );">Grant funds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">9.9<span></span>
</td>
<td class="num">(20.0)<span></span>
</td>
<td class="num">(33.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">(Gain) loss on debt extinguishment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(0.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">9.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Litigation settlement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonrecurringIncomeExpense', window );">Other income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(0.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(3.3)<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">495.6<span></span>
</td>
<td class="nump">477.6<span></span>
</td>
<td class="nump">1,427.5<span></span>
</td>
<td class="nump">1,225.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">63.6<span></span>
</td>
<td class="nump">18.5<span></span>
</td>
<td class="nump">187.4<span></span>
</td>
<td class="nump">86.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(54.2)<span></span>
</td>
<td class="num">(51.5)<span></span>
</td>
<td class="num">(160.9)<span></span>
</td>
<td class="num">(147.8)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Income (loss) before income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9.4<span></span>
</td>
<td class="num">(33.0)<span></span>
</td>
<td class="nump">26.5<span></span>
</td>
<td class="num">(61.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
<td class="num">(14.5)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8.2<span></span>
</td>
<td class="num">(34.3)<span></span>
</td>
<td class="nump">27.8<span></span>
</td>
<td class="num">(46.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net income attributable to non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(31.1)<span></span>
</td>
<td class="num">(27.3)<span></span>
</td>
<td class="num">(98.6)<span></span>
</td>
<td class="num">(75.0)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to Surgery Partners, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(22.9)<span></span>
</td>
<td class="num">(61.6)<span></span>
</td>
<td class="num">(70.8)<span></span>
</td>
<td class="num">(121.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic', window );">Less: Amounts attributable to participating securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(10.0)<span></span>
</td>
<td class="num">(10.3)<span></span>
</td>
<td class="num">(29.2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to common stockholders</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (22.9)<span></span>
</td>
<td class="num">$ (71.6)<span></span>
</td>
<td class="num">$ (81.1)<span></span>
</td>
<td class="num">$ (150.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Net loss per share attributable to common stockholders</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in USD per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (0.28)<span></span>
</td>
<td class="num">$ (1.46)<span></span>
</td>
<td class="num">$ (1.19)<span></span>
</td>
<td class="num">$ (3.09)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in USD per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (0.28)<span></span>
</td>
<td class="num">$ (1.46)<span></span>
</td>
<td class="num">$ (1.19)<span></span>
</td>
<td class="num">$ (3.09)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Weighted average common shares outstanding</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">80,726<span></span>
</td>
<td class="nump">48,883<span></span>
</td>
<td class="nump">68,350<span></span>
</td>
<td class="nump">48,736<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">80,726<span></span>
</td>
<td class="nump">48,883<span></span>
</td>
<td class="nump">68,350<span></span>
</td>
<td class="nump">48,736<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in those periods.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Disposition of Assets And Deconsolidation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_GainLossOnDispositionOfAssetsAndDeconsolidation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_GrantRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Grant Revenue</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_GrantRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_OperatingAndFinanceLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_OperatingAndFinanceLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LaborAndRelatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LaborAndRelatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostAndExpenseOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostAndExpenseOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonrecurringIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense (income) that is infrequent in occurrence or unusual in nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=114868883&amp;loc=SL114871943-224233<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonrecurringIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.2(a),(b),(c),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433917&amp;loc=SL114874205-224268<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SuppliesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense associated with supplies that were used during the current accounting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SuppliesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 65<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2793-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 66<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2814-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763215307336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 8.2<span></span>
</td>
<td class="num">$ (34.3)<span></span>
</td>
<td class="nump">$ 27.8<span></span>
</td>
<td class="num">$ (46.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Derivative activity</a></td>
<td class="nump">6.5<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
<td class="nump">13.1<span></span>
</td>
<td class="num">(14.6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income (loss)</a></td>
<td class="nump">14.7<span></span>
</td>
<td class="num">(31.0)<span></span>
</td>
<td class="nump">40.9<span></span>
</td>
<td class="num">(61.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: Comprehensive income attributable to non-controlling interests</a></td>
<td class="num">(31.1)<span></span>
</td>
<td class="num">(27.3)<span></span>
</td>
<td class="num">(98.6)<span></span>
</td>
<td class="num">(75.0)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss attributable to Surgery Partners, Inc.</a></td>
<td class="num">$ (16.4)<span></span>
</td>
<td class="num">$ (58.3)<span></span>
</td>
<td class="num">$ (57.7)<span></span>
</td>
<td class="num">$ (136.2)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763206482360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Retained Deficit</div></th>
<th class="th"><div>Non-Controlling Interests&#8212; Non-Redeemable</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning Balance, stockholders' equity (shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,299,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance, stockholders' equity at Dec. 31, 2019</a></td>
<td class="nump">$ 983.4<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 662.7<span></span>
</td>
<td class="num">$ (50.7)<span></span>
</td>
<td class="num">$ (315.7)<span></span>
</td>
<td class="nump">$ 686.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net (loss) income</a></td>
<td class="num">(13.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27.5)<span></span>
</td>
<td class="nump">13.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Equity-based compensation (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,219,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Equity-based compensation</a></td>
<td class="nump">2.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings', window );">Preferred dividends</a></td>
<td class="num">(9.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(25.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet', window );">Acquisition and disposal of shares of non-controlling interests, net</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to non-controlling interests&#8212;non-redeemable holders</a></td>
<td class="num">(14.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14.9)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance, stockholders' equity (shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,518,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance, stockholders' equity at Mar. 31, 2020</a></td>
<td class="nump">923.4<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">655.3<span></span>
</td>
<td class="num">(75.9)<span></span>
</td>
<td class="num">(343.2)<span></span>
</td>
<td class="nump">686.7<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning Balance, stockholders' equity (shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,299,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance, stockholders' equity at Dec. 31, 2019</a></td>
<td class="nump">983.4<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">662.7<span></span>
</td>
<td class="num">(50.7)<span></span>
</td>
<td class="num">(315.7)<span></span>
</td>
<td class="nump">686.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(14.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance, stockholders' equity (shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,495,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance, stockholders' equity at Sep. 30, 2020</a></td>
<td class="nump">800.8<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">603.3<span></span>
</td>
<td class="num">(65.3)<span></span>
</td>
<td class="num">(437.3)<span></span>
</td>
<td class="nump">699.6<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning Balance, stockholders' equity (shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,518,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance, stockholders' equity at Mar. 31, 2020</a></td>
<td class="nump">923.4<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">655.3<span></span>
</td>
<td class="num">(75.9)<span></span>
</td>
<td class="num">(343.2)<span></span>
</td>
<td class="nump">686.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net (loss) income</a></td>
<td class="num">(9.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32.5)<span></span>
</td>
<td class="nump">22.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Equity-based compensation (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Equity-based compensation</a></td>
<td class="nump">3.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings', window );">Preferred dividends</a></td>
<td class="num">(9.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">7.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet', window );">Acquisition and disposal of shares of non-controlling interests, net</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to non-controlling interests&#8212;non-redeemable holders</a></td>
<td class="num">(20.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20.9)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance, stockholders' equity (shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,551,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance, stockholders' equity at Jun. 30, 2020</a></td>
<td class="nump">895.9<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">648.2<span></span>
</td>
<td class="num">(68.6)<span></span>
</td>
<td class="num">(375.7)<span></span>
</td>
<td class="nump">691.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net (loss) income</a></td>
<td class="num">(42.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(61.6)<span></span>
</td>
<td class="nump">19.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Equity-based compensation (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(56,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Equity-based compensation</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings', window );">Preferred dividends</a></td>
<td class="num">(10.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">3.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet', window );">Acquisition and disposal of shares of non-controlling interests, net</a></td>
<td class="num">(30.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(37.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to non-controlling interests&#8212;non-redeemable holders</a></td>
<td class="num">(18.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18.8)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance, stockholders' equity (shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,495,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance, stockholders' equity at Sep. 30, 2020</a></td>
<td class="nump">$ 800.8<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">603.3<span></span>
</td>
<td class="num">(65.3)<span></span>
</td>
<td class="num">(437.3)<span></span>
</td>
<td class="nump">699.6<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning Balance, stockholders' equity (shares) at Dec. 31, 2020</a></td>
<td class="nump">50,461,706<span></span>
</td>
<td class="nump">50,462,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance, stockholders' equity at Dec. 31, 2020</a></td>
<td class="nump">$ 882.1<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">607.9<span></span>
</td>
<td class="num">(61.0)<span></span>
</td>
<td class="num">(431.8)<span></span>
</td>
<td class="nump">766.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net (loss) income</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21.0)<span></span>
</td>
<td class="nump">21.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Equity-based compensation (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">812,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Equity-based compensation</a></td>
<td class="num">(2.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings', window );">Preferred dividends</a></td>
<td class="num">(10.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Equity offering (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Equity offering</a></td>
<td class="nump">248.3<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">248.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">6.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet', window );">Acquisition and disposal of shares of non-controlling interests, net</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to non-controlling interests&#8212;non-redeemable holders</a></td>
<td class="num">(20.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20.8)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance, stockholders' equity (shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,899,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance, stockholders' equity at Mar. 31, 2021</a></td>
<td class="nump">$ 1,105.3<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="nump">843.3<span></span>
</td>
<td class="num">(54.6)<span></span>
</td>
<td class="num">(452.8)<span></span>
</td>
<td class="nump">768.8<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning Balance, stockholders' equity (shares) at Dec. 31, 2020</a></td>
<td class="nump">50,461,706<span></span>
</td>
<td class="nump">50,462,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance, stockholders' equity at Dec. 31, 2020</a></td>
<td class="nump">$ 882.1<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">607.9<span></span>
</td>
<td class="num">(61.0)<span></span>
</td>
<td class="num">(431.8)<span></span>
</td>
<td class="nump">766.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">$ 13.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance, stockholders' equity (shares) at Sep. 30, 2021</a></td>
<td class="nump">82,458,385<span></span>
</td>
<td class="nump">82,458,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance, stockholders' equity at Sep. 30, 2021</a></td>
<td class="nump">$ 1,552.0<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="nump">1,306.0<span></span>
</td>
<td class="num">(47.9)<span></span>
</td>
<td class="num">(502.6)<span></span>
</td>
<td class="nump">795.7<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning Balance, stockholders' equity (shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,899,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance, stockholders' equity at Mar. 31, 2021</a></td>
<td class="nump">1,105.3<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="nump">843.3<span></span>
</td>
<td class="num">(54.6)<span></span>
</td>
<td class="num">(452.8)<span></span>
</td>
<td class="nump">768.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net (loss) income</a></td>
<td class="num">(4.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26.9)<span></span>
</td>
<td class="nump">22.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Equity-based compensation (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Equity-based compensation</a></td>
<td class="nump">3.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Preferred share conversion (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,609,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Preferred share conversion</a></td>
<td class="nump">439.7<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="nump">439.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet', window );">Acquisition and disposal of shares of non-controlling interests, net</a></td>
<td class="nump">5.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to non-controlling interests&#8212;non-redeemable holders</a></td>
<td class="num">(22.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22.3)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance, stockholders' equity (shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,479,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance, stockholders' equity at Jun. 30, 2021</a></td>
<td class="nump">1,527.3<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="nump">1,298.4<span></span>
</td>
<td class="num">(54.4)<span></span>
</td>
<td class="num">(479.7)<span></span>
</td>
<td class="nump">762.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net (loss) income</a></td>
<td class="num">(1.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22.9)<span></span>
</td>
<td class="nump">21.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Equity-based compensation (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Equity-based compensation</a></td>
<td class="nump">4.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">6.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet', window );">Acquisition and disposal of shares of non-controlling interests, net</a></td>
<td class="nump">37.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to non-controlling interests&#8212;non-redeemable holders</a></td>
<td class="num">$ (21.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21.8)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance, stockholders' equity (shares) at Sep. 30, 2021</a></td>
<td class="nump">82,458,385<span></span>
</td>
<td class="nump">82,458,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance, stockholders' equity at Sep. 30, 2021</a></td>
<td class="nump">$ 1,552.0<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="nump">$ 1,306.0<span></span>
</td>
<td class="num">$ (47.9)<span></span>
</td>
<td class="num">$ (502.6)<span></span>
</td>
<td class="nump">$ 795.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-Controlling Interest, Acquisitions And Disposals Of Interests Held By Non-Controlling Interest Holders, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from dividends legally declared (or paid) in excess of retained earnings balance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763294419864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 27.8<span></span>
</td>
<td class="num">$ (46.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">76.1<span></span>
</td>
<td class="nump">69.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_NoncashInterestIncomeExpenseNet', window );">Non-cash interest expense, net</a></td>
<td class="nump">12.0<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Equity-based compensation expense</a></td>
<td class="nump">13.4<span></span>
</td>
<td class="nump">9.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation', window );">Loss on disposals and deconsolidations, net</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">7.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">33.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">(Gain) loss on debt extinguishment</a></td>
<td class="nump">9.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(2.3)<span></span>
</td>
<td class="num">(15.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions', window );">Income from equity investments, net of distributions received</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Non-cash lease expense</a></td>
<td class="nump">30.3<span></span>
</td>
<td class="nump">29.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, net of acquisitions and divestitures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(18.4)<span></span>
</td>
<td class="num">(11.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants', window );">Medicare accelerated payments and deferred governmental grants</a></td>
<td class="num">(48.5)<span></span>
</td>
<td class="nump">141.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_IncreaseDecreaseInSettlementPayments', window );">DOJ settlement payments</a></td>
<td class="num">(32.2)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other operating assets and liabilities</a></td>
<td class="num">(2.1)<span></span>
</td>
<td class="nump">19.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">67.4<span></span>
</td>
<td class="nump">238.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(43.5)<span></span>
</td>
<td class="num">(27.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments for acquisitions, net of cash acquired</a></td>
<td class="num">(101.0)<span></span>
</td>
<td class="num">(14.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfProductiveAssets', window );">Proceeds from disposals of facilities and other assets</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">48.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other investing activities</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) provided by investing activities</a></td>
<td class="num">(141.7)<span></span>
</td>
<td class="nump">6.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Principal payments on long-term debt</a></td>
<td class="num">(328.4)<span></span>
</td>
<td class="num">(197.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Borrowings of long-term debt</a></td>
<td class="nump">293.0<span></span>
</td>
<td class="nump">428.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payments of debt issuance costs</a></td>
<td class="num">(11.7)<span></span>
</td>
<td class="num">(8.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from equity offering</a></td>
<td class="nump">260.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of equity offering costs</a></td>
<td class="num">(12.7)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock', window );">Payment of preferred dividends</a></td>
<td class="num">(5.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsMinorityInterest', window );">Distributions to non-controlling interest holders</a></td>
<td class="num">(97.5)<span></span>
</td>
<td class="num">(82.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMinorityShareholders', window );">Receipts (payments) related to ownership transactions with non-controlling interest holders</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Receipts (payments) related to ownership transactions with non-controlling interest holders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other financing activities</a></td>
<td class="num">(14.4)<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">86.5<span></span>
</td>
<td class="nump">112.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash, cash equivalents and restricted cash</a></td>
<td class="nump">12.2<span></span>
</td>
<td class="nump">357.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">318.2<span></span>
</td>
<td class="nump">93.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">$ 330.4<span></span>
</td>
<td class="nump">$ 450.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Disposition of Assets And Deconsolidation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_GainLossOnDispositionOfAssetsAndDeconsolidation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Medicare Accelerated Payments And Deferred Governmental Grants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_IncreaseDecreaseInSettlementPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Settlement Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_IncreaseDecreaseInSettlementPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_NoncashInterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncash Interest Income (Expense), Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_NoncashInterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763209924584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Organization and Summary of Accounting Policies</a></td>
<td class="text">Organization and Summary of Accounting Policies<div style="margin-bottom:6pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Organization</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Surgery Partners, Inc., a Delaware corporation, acting through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The surgical facilities, which include ambulatory surgery centers ("ASCs") and surgical hospitals, primarily provide non-emergency surgical procedures across many specialties, including, among others, gastroenterology, general surgery, ophthalmology, orthopedics and pain management. The Company's surgical hospitals also provide services such as diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy and wound care. Ancillary services are comprised of multi-specialty physician practices, urgent care facilities and anesthesia services. Unless the context otherwise indicates, Surgery Partners, Inc. and its subsidiaries are referred to herein as "Surgery Partners," "we," "us," "our" or the "Company."</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, the Company owned or operated a portfolio of 127 surgical facilities, comprised of 110 ASCs and 17 surgical hospitals in 31 states. The Company owns these facilities in partnership with physicians and, in some cases, health care systems in the markets and communities it serves.&#160;The Company owned a majority interest in 90 of the surgical facilities and consolidated 110 of the facilities for financial reporting purposes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation of the Company's financial position and results of operations have been included. The Company&#8217;s fiscal year ends on December&#160;31 and interim results are not necessarily indicative of results for a full year or any other interim period. The information contained in these condensed consolidated financial statements should be read in conjunction with the Company&#8217;s consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2020 (the "2020 Annual Report on Form 10-K").</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, as well as interests in partnerships and limited liability companies controlled by the Company through its ownership of a majority voting interest or other rights granted to the Company by contract to manage and control the affiliate's business. All significant intercompany balances and transactions are eliminated in consolidation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Reclassifications</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain reclassifications have been made to the comparative periods' financial statements to conform to the current year presentation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. Actual results could differ from those estimates.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">COVID-19 Pandemic</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The COVID-19 global pandemic has significantly affected the Company's facilities, employees, patients, communities, business operations and financial performance, as well as the United States economy and financial markets. The impact of COVID-19 on the Company's surgical facilities varies based on the market in which the facility operates, the type of surgical facility and the procedures that are typically performed. Although the Company cannot provide any certainty regarding the length and severity of the impact of the COVID-19 pandemic, surgical case volumes continue to improve in 2021 as government restrictions ease and public sentiment changes.  The Company has implemented new clinical safety measures to provide a safe environment for its patients, surgeons and employees. </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CARES Act </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">On March 27, 2020, the Coronavirus Aid, Relief and Economic Security Act (the &#8220;CARES Act&#8221;) was signed into law to provide stimulus funding for the United States economy. As part of the CARES Act, the United States government announced that it would offer relief to eligible health care providers, including distribution of direct grants to hospitals, ASCs and other health care providers based on how much they bill Medicare. Payments received from these grants are not required to be repaid provided the recipients attest to and comply with certain terms and conditions, including limitations on balance billing and not using funds received from the grants to reimburse expenses or losses that other sources are obligated to reimburse. The Company has received approximately $67&#160;million of the grant funds distributed under the CARES Act and other governmental assistance programs, including approximately $8&#160;million during the nine months ended September&#160;30, 2021. The Company did not receive any grant funds during the three months ended September&#160;30, 2021. The recognition of amounts received is conditioned upon attestation with terms and conditions that funds will be used for COVID-19 related healthcare expenses or lost revenues.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The Company&#8217;s assessment of whether the terms and conditions for amounts received are reasonably assured of having been met considers, among other things, the CARES Act, the COVID-19 Economic Relief Bill, enacted on December 27, 2020, and all frequently asked questions and other interpretive guidance issued by the United States Department of Health and Human Services ("HHS"), including in the Provider Relief Fund Reporting Portal and associated user guides. This guidance sets forth the allowable methods for quantifying eligible healthcare related expenses and lost revenues. Only healthcare related expenses attributable to COVID-19 that another source has not reimbursed and is not obligated to reimburse are eligible to be claimed. Based on guidance, the Company estimates approximately $20.0&#160;million of grant funds received qualified for recognition as a reduction in operating expenses for the nine months ended September 30, 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Amounts received, but not recognized as a reduction to operating expenses, are reflected as a component of Medicare accelerated payments and deferred governmental grants in the condensed consolidated balance sheets as of both September&#160;30, 2021 and December 31, 2020. Any unrecognized amounts may be recognized as a reduction in operating expenses in subsequent periods if the underlying conditions for recognition are met. HHS&#8217; interpretation of the underlying terms and conditions of grant funds received through the CARES Act and other governmental assistance programs, including auditing and reporting requirements, may evolve. Additional guidance or new and amended interpretations of existing guidance on the terms and conditions of such payments may result in the Company&#8217;s inability to recognize certain payments, changes in the estimate of amounts recognized, or the derecognition of amounts previously recognized, which may be material.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">As a way to increase cash flow to Medicare providers impacted by the COVID-19 pandemic, the CARES Act expanded the Medicare Accelerated and Advance Payment Program, which allowed for most providers and suppliers, including the Company&#8217;s surgical hospitals and ASCs to request an advance payment of anticipated Medicare revenues. The Company received approximately $120&#160;million of accelerated payments during the year ended December 31, 2020. The payments received were deferred and included in the condensed consolidated balance sheets. During the three and nine months ended September 30, 2021, approximately $18&#160;million and $38&#160;million, respectively, has been repaid in accordance with the terms of the program. These repayments are included as a component of the change in Medicare accelerated payments and deferred government grants in the condensed consolidated statements of cash flows. Under these terms, repayment started one year after the initial funding by offsetting 25% of new claims paid by CMS.  After 11 months of repayment at this level, the repayments will increase to 50% of new claims paid by CMS for a period of six months. Any outstanding amounts due at the end of the repayment period are subject to interest at a rate of 4%. As of September 30, 2021 and December 31, 2020, the current portion of deferred accelerated payments was approximately $80&#160;million and $95&#160;million, respectively, and is included as a component of Medicare accelerated payments and deferred governmental grants in the condensed consolidated balance sheets. The long-term portion is included as a component of other long-term liabilities in the condensed consolidated balance sheets. The Company does not expect to receive additional Medicare accelerated payments. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The CARES Act also provided for the deferral of the Company's portion of social security payroll taxes during 2020. Under the CARES Act, half of the deferred amount will be paid in each of December 2021 and December 2022. As of both September&#160;30, 2021 and December 31, 2020, the Company had deferred approximately $16.9&#160;million. The current portion is included as a component of accrued payroll and benefits and the long term portion is included as a component of other long-term liabilities in the condensed consolidated balance sheets. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is closely monitoring legislative actions and regulatory guidance at the federal, state and local levels with respect to the CARES Act as other governmental assistance might become available to the Company.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Variable Interest Entities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the accounts of variable interest entities ("VIE") in which the Company is the primary beneficiary under the provisions of the Financial Accounting Standards Board's ("FASB") Accounting Standards Codification 810, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Consolidation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">". The Company has the power to direct the activities that most significantly impact a VIE's economic performance. Additionally, the Company would absorb the majority of the expected losses from any of these entities should such expected losses occur. As of September&#160;30, 2021, the Company's consolidated VIEs include four surgical facilities and three physician practices. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The total assets (excluding goodwill and intangible assets, net) of the consolidated VIEs included in the accompanying condensed consolidated balance sheets as of September&#160;30, 2021 and December&#160;31, 2020 were $26.7 million and $27.7 million, respectively, and the total liabilities of the consolidated VIEs were $19.1 million and $21.1 million, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value of a financial instrument is the amount at which the instrument could be exchanged in an orderly transaction between market participants to sell the asset or transfer the liability. The Company uses fair value measurements based on inputs classified into the following hierarchy:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These may include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Level 3: Unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, depending on the nature of the item being valued.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amounts reported in the condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, restricted invested assets and accounts payable approximate their fair values under Level 3 calculations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of the carrying amounts and estimated fair values of the Company's long-term debt follows (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.191%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.787%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.787%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.787%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.788%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior secured term loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,534.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,539.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,523.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,533.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.750% senior unsecured notes due 2025</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">376.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">376.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.000% senior unsecured notes due 2027</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">545.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">545.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">589.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">596.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values in the table above were based on Level 2 inputs using quoted prices for identical liabilities in inactive markets. The carrying amounts related to the Company's other long-term debt obligations, including finance lease obligations, approximate their fair values based on Level 3 inputs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Revenues</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's revenues generally relate to contracts with patients in which the performance obligations are to provide health care services. The Company recognizes revenues in the period in which its obligations to provide health care services are satisfied and reports the amount that reflects the consideration the Company expects to be entitled to receive. The contractual relationships with patients, in most cases, also involve a third-party payor (e.g., Medicare, Medicaid and private insurance organizations, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by or negotiated with the third-party payors. The payment arrangements with third-party payors for the services provided to the related patients typically specify payments at amounts less than the Company's standard charges. The Company continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of revenues by service type as a percentage of total revenues follows:</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Surgical facilities revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Ancillary services revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total patient service revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other service revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Patient service revenues.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">This revenue is related to charging facility fees in exchange for providing patient care. The fee charged for health care procedures performed in surgical facilities varies depending on the type of service provided, but usually includes all charges for usage of an operating room, a recovery room, special equipment, medical supplies, nursing staff and medications. The fee does not normally include professional fees charged by the patient&#8217;s surgeon, anesthesiologist or other attending physician, which are billed directly by such physicians to the patient or third-party payor. However, in several surgical facilities, the Company charges for anesthesia services. Ancillary service revenues include fees for patient visits to the Company's physician practices, pharmacy services and diagnostic tests ordered by physicians.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Patient service revenues are recognized as performance obligations are satisfied. Performance obligations are based on the nature of services provided. Typically, the Company recognizes revenue at a point in time in which services are rendered and the Company has no obligation to provide further patient services. As the Company primarily performs outpatient procedures, performance obligations are generally satisfied same day and revenue is recognized on the date of service.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company determines the transaction price based on gross charges for services provided, net of estimated contractual adjustments and discounts from third-party payors. The Company estimates its contractual adjustments and discounts based on contractual agreements, its discount policies and historical experience. Changes in estimated contractual adjustments and discounts are recorded in the period of change. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other service revenues.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Other service revenues include management and administrative service fees derived from the non-consolidated facilities that the Company accounts for under the equity method, management of surgical facilities in which it does not own an interest, and management services provided to physician practices for which the Company is not required to provide capital or additional </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">assets. These agreements typically require the Company to provide recurring management services over a multi-year period, which are billed and collected on a monthly basis. The fees derived from these management arrangements are based on a predetermined percentage of the revenues of each facility or practice and are recognized in the period in which management services are rendered and billed. For the three and nine months ended September 30, 2020, other service revenues also includes optical service revenues, which consisted of handling charges billed to the members of the Company's optical products purchasing organization. The Company sold its optical products purchasing organization on December 31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth patient service revenues by type of payor and as a percentage of total patient service revenues for the Company's consolidated surgical facilities (dollars in millions):</span></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.238%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.815%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.815%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.887%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Private insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">271.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">248.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Self-pay</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total patient service revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">551.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">489.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other service revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 20.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">559.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">496.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.238%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.815%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.815%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.887%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Private insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">790.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">682.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">505.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Self-pay</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total patient service revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,593.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,293.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other service revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 20.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,614.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,311.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:9pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Other is comprised of anesthesia service agreements, automobile liability, letters of protection and other payor types. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cash, Cash Equivalents and Restricted Cash</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. The Company maintains its cash and cash equivalent balances at high credit quality financial institutions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December 31, 2020, cash, cash equivalents and restricted cash reported within the condensed consolidated statement of cash flows includes $0.3 million of restricted investments, which are reflected in other long-term assets in the condensed consolidated balance sheets. These restricted investments represented restricted cash held in accordance with the provisions of a long-term operating lease agreement held as security for performance under the Company's covenants and obligations within the agreement. The restrictions were released during the nine months ended September 30, 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Accounts Receivable</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable from third-party payors are recorded net of estimated implicit price concessions, which are estimated based on the historical trend of the Company's surgical hospitals&#8217; cash collections and contractual write-offs, and for the Company's surgical facilities in general, established fee schedules, relationships with payors and procedure statistics. While changes in estimated reimbursement from third-party payors remain a possibility, the Company expects that any such changes would be minimal and, therefore, would not have a material effect on its financial condition or results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable consists of receivables from federal and state agencies (under the Medicare and Medicaid programs), private insurance organizations, employers and patients. Management recognizes that revenues and receivables from government agencies are significant to the Company's operations, but it does not believe that there is significant credit risk associated with these government agencies. Concentration of credit risk with respect to other payors is limited because of the large number of such payors. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company recognizes that final reimbursement of accounts receivable is subject to final approval by each third-party payor. However, because the Company has contracts with its third-party payors and also verifies insurance coverage of the patient before medical services are rendered, the amounts that are pending approval from third-party payors are not considered significant. Amounts are classified outside of self-pay if the Company has an agreement with the third-party payor or has verified a patient&#8217;s coverage prior to services rendered. The Company's policy is to collect co-payments and deductibles prior to providing medical services. Patient services of the Company are primarily non-emergency, which allows the surgical facilities to control the procedures for which third-party reimbursement is sought and obtained. The Company does not require collateral from self-pay patients.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's collection policies and procedures are based on the type of payor, size of claim and estimated collection percentage for each patient account. The Company analyzes accounts receivable at each of its surgical facilities to ensure the proper collection and aged category. Collection efforts include direct contact with third-party payors or patients, written correspondence and the use of legal or collection agency assistance, as required. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Goodwill represents the fair value of the consideration provided in an acquisition over the fair value of net assets acquired and is not amortized. Additions to goodwill include amounts resulting from new business combinations and incremental ownership purchases in the Company's subsidiaries. A summary of the Company's acquisitions and dispositions for the nine months ended September&#160;30, 2021 is included in Note 2. "Acquisitions."</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of activity related to goodwill for the nine months ended September&#160;30, 2021 is as follows (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.592%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,468.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions, including post acquisition adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">145.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Divestitures and deconsolidations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,613.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A detailed evaluation of potential impairment indicators was performed as of September 30, 2021, which specifically considered the ongoing impact of the COVID-19 pandemic. On the basis of available evidence as of September 30, 2021, no indicators of impairment were identified. Future estimates of fair value could be adversely affected if the actual outcome of one or more of the Company's assumptions changes materially in the future, including a material decline in the Company&#8217;s stock price and the fair value of its long-term debt, lower than expected surgical case volumes, higher market interest rates or increased operating costs. Such changes impacting the calculation of fair value, the risks of which are amplified by the COVID-19 pandemic, could result in a material impairment charge in the future.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Derivative Instruments and Hedging Activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company records all derivatives on the balance sheet at fair value and any financing elements treated as debt instruments are recorded at amortized cost. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Non-Controlling Interests&#8212;Redeemable</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Each partnership and limited liability company through which the Company owns and operates its surgical facilities is governed by a partnership or operating agreement, respectively.&#160;In certain circumstances, the applicable partnership or operating agreements for the Company's surgical facilities provide that the facilities will purchase all of the physician limited partners&#8217; or physician minority members&#8217;, as applicable, ownership if certain adverse regulatory events occur, such as it becoming illegal for the physician(s) to own an interest in a surgical facility, refer patients to a surgical facility or receive cash distributions from a surgical facility.&#160;The non-controlling interests</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">redeemable are reported outside of stockholders' equity in the condensed consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of activity related to non-controlling interests&#8212;redeemable for the nine months ended September&#160;30, 2021 and 2020 is as follows (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.590%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.443%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at&#160;beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">306.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">321.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests&#8212;redeemable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition (disposal) of shares of non-controlling interests, net&#8212;redeemable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distributions to non-controlling interest&#8212;redeemable holders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at&#160;end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">310.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">304.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Income Taxes </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company uses the asset and liability method to account for income taxes. Under this method, deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. If a carryforward exists, the Company makes a determination as to whether the carryforward will be utilized in the future. A valuation allowance is established for certain carryforwards when their recoverability is deemed to be uncertain. The carrying value of the net deferred tax assets assumes that the Company will be able to generate sufficient future taxable income in certain tax jurisdictions, based on estimates and assumptions. If our expectations for future operating results on a consolidated basis or at the state jurisdiction level vary from actual results due to changes in health care regulations, general economic conditions, or other factors, we may need to adjust the valuation allowance, for all or a portion of our deferred tax assets. Our income tax expense in future periods will be reduced or increased to the extent of offsetting decreases or increases, respectively, in our valuation allowance in the period when the change in circumstances occurs. These changes could have a significant impact on our future earnings.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company and certain of its subsidiaries file a consolidated federal income tax return. The partnerships, limited liability companies, and certain non-consolidated physician practice corporations also file separate income tax returns. The Company's allocable portion of each partnership's and limited liability company's income or loss is included in taxable income of the Company. The remaining income or loss of each partnership and limited liability company is allocated to the other owners.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's effective tax rate was (4.9)% for the nine months ended September&#160;30, 2021 compared to 23.7% for the nine months ended September&#160;30, 2020. For the nine months ended September&#160;30, 2021, the effective tax rate differed from 21% primarily due to discrete tax benefits of (a) $4.4&#160;million related to the vesting of restricted stock awards, and (b) $3.0&#160;million related to entity divestitures. For the nine months ended September&#160;30, 2020, the effective tax rate differed from 21% primarily due to (a) discrete tax benefits of $6.9 million attributable to the release of federal and state valuation allowances on the Company&#8217;s Internal Revenue Code Section 163(j) interest carryforwards as a result of the increase in deductible interest expense allowed under the CARES Act, and $5.0&#160;million attributable to a portion of the payments under the Settlement Agreement, as defined in Note 9. "Commitments and Contingencies," being classified as "restitution" for income tax purposes, and (b) a discrete tax expense of $5.0&#160;million attributable to the impairment of goodwill. Based upon the application of interim accounting guidance, the tax rate as a percentage of net income after income attributable to non-controlling interests will vary based upon the relative net income from period to period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In March 2020, the FASB issued Accounting Standard Update ("ASU") 2020-04,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The ASU provides optional guidance for a limited period of time to ease the potential burden in accounting for or recognizing the effects of reference rate reform on financial reporting and applies only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The ASU is effective as of March 12, 2020 through December 31, 2022. Entities may adopt ASU 2020-04 as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020 or prospectively from a date within an interim period that includes or is subsequent to March 12, 2020, up to the date that the financial statements are available to be issued. The Company is evaluating the impact of this ASU on its consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763208561976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions</a></td>
<td class="text">Acquisitions<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021, the Company acquired controlling interests in four surgical facilities in new markets and two surgical facilities in existing markets that were merged into existing facilities for aggregate cash consideration of $101.0&#160;million, net of cash acquired. The cash consideration was funded through available resources. The total consideration was allocated to the assets acquired and liabilities assumed based upon the respective acquisition date fair values. The aggregate amounts preliminarily recognized for each major class of assets acquired and liabilities assumed for the acquisitions are as follows (in millions):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.804%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.955%"/><td style="width:0.1%"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consideration</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of non-controlling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aggregate acquisition date fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net assets acquired:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">145.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use operating lease assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aggregate acquisition date fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values assigned to certain assets acquired and liabilities assumed by the Company have been estimated on a preliminary basis and are subject to change as new facts and circumstances emerge that were present at the date of acquisition. During the nine months ended September&#160;30, 2021, no significant changes were made to the purchase price allocation of assets and liabilities, existing at the date of acquisition, related to individual acquisitions completed in 2020. The goodwill acquired was allocated to the Company's Surgical Facility services reportable segment. The results of operations of the acquisitions were included in the Company&#8217;s results of operations beginning on the dates of acquisition and were not considered significant for the nine months ended September&#160;30, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763208394232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Long-Term Debt</a></td>
<td class="text">Long-Term Debt<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of long-term debt follows (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.953%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior secured term loan </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,534.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,539.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.750% senior unsecured notes due 2025</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.000% senior unsecured notes due 2027</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">545.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">545.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Notes payable and other secured loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">140.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">279.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">281.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: unamortized debt issuance costs and discounts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,852.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,856.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Current maturities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,791.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,792.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:4pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Includes unamortized fair value discount of $3.1 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">and $3.7 million as of September&#160;30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">December&#160;31, 2020, respectively. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facility</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On January 27, 2021, the Company entered into an amendment to the credit agreement governing its revolving credit facility (the "Revolver"), which amended and supplemented the credit agreement, dated as of August 31, 2017 (the "Credit Agreement"), to provide for an extension of the maturity date of the Revolver to February 1, 2026 and a $50.0&#160;million increase in the outstanding commitments under the Revolver. The maturity extension and the additional commitments became effective on February 1, 2021. As of September 30, 2021, </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">the Company's availability on the Revolver was $163.0 million (including outstanding letters of credit of $7.0 million). There were no outstanding borrowings under the Revolver as of both September 30, 2021 and December 31, 2020.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Sixth Amendment to Credit Agreement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On May 3, 2021, the Company entered into a sixth amendment to the Credit Agreement. The sixth amendment provides for, among other things, a new tranche of term loans under the Credit Agreement in an aggregate original principal amount of approximately $1.545&#160;billion (the &#8220;New Term Loans&#8221;), which New Term Loans replace or refinance in full all of the existing term loans outstanding under the Credit Agreement. The New Term Loans mature on August 31, 2026 (or, if at least $185&#160;million of the Borrower&#8217;s 6.750% senior unsecured notes due 2025 shall have not either been repaid, repurchased or redeemed or refinanced with indebtedness having a maturity date not earlier than 91 days after August 31, 2026 by no later than April 1, 2025, then April 1, 2025). The New Term Loans bear interest at a rate per annum equal to (x) LIBOR plus a margin of 3.75% per annum (LIBOR with respect to the New Term Loans shall be subject to a floor of 0.75%) or (y) an alternate base rate (which will be the highest of (i) the prime rate, (ii) 0.5% per annum above the federal funds effective rate and (iii) one-month LIBOR plus 1.00% per annum (the alternate base rate with respect to the New Term Loans shall be subject to a floor of 1.75%)) plus a margin of 2.75% per annum. The New Term Loans are subject to quarterly amortization in an aggregate original principal amount of approximately 1.00% per annum. Voluntary prepayments of the New Term Loans are permitted, in whole or in part, with prior notice, without premium or penalty (except LIBOR breakage costs and a call premium in the case of certain repricing events within a specified period of time after May 3, 2021, as further set forth in the sixth amendment).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In connection with the sixth amendment, the Company recorded debt issuance costs and discount of $11.9&#160;million, and a debt extinguishment loss of $9.1&#160;million, included in loss on debt extinguishment in the accompanying condensed consolidated statement of operations for the nine months ended September 30, 2021. The loss includes the partial write-off of unamortized debt issuance costs and discounts related to the prior existing term loans, and a portion of debt issuance costs incurred with the New Term Loans.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763210496616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's operating leases are primarily for real estate, including medical office buildings, and corporate and other administrative offices. The Company's finance leases are primarily for medical equipment and information technology and telecommunications assets. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents the components of the Company's lease expense and their classification in the condensed consolidated statement of operations (in millions):</span></div><div style="margin-bottom:12pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.633%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of leased assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Variable and short-term lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents supplemental cash flow information (dollars in millions):</span></div><div style="margin-bottom:12pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.633%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities: </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash outflows from operating leases </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash outflows from finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing cash outflows from finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's operating leases are primarily for real estate, including medical office buildings, and corporate and other administrative offices. The Company's finance leases are primarily for medical equipment and information technology and telecommunications assets. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents the components of the Company's lease expense and their classification in the condensed consolidated statement of operations (in millions):</span></div><div style="margin-bottom:12pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.633%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of leased assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Variable and short-term lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents supplemental cash flow information (dollars in millions):</span></div><div style="margin-bottom:12pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.633%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities: </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash outflows from operating leases </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash outflows from finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing cash outflows from finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763208542280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_RedeemablePreferredStockTextBlock', window );">Redeemable Preferred Stock</a></td>
<td class="text">Redeemable Preferred Stock<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On August 31, 2017, the Company issued 310,000 shares of Series A Preferred Stock to Bain Capital Private Equity, L.P. ("Bain Capital") at a purchase price of $1,000 per share for an aggregate purchase price of $310.0 million.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pursuant to the Certificate of Designations, Preferences, Rights and Limitations of 10.00% Series A Convertible Perpetual Participating Preferred Stock of Surgery Partners, Inc. (the &#8220;Certificate of Designation&#8221;), the Company was permitted to require the conversion of all, but not less than all, of the Series A Preferred Stock pursuant to the terms and conditions of the Certificate of Designation, after the second anniversary of the date of issuance, if the volume weighted average closing price of the Common Stock for any twenty out of thirty consecutive trading days prior to such date, equals or exceeds $42.00 per share. In accordance with such provision, on May 17, 2021, the Company converted all outstanding shares of Series A Preferred Stock into approximately 22.609&#160;million shares of common stock, $0.01 par value per share. Following the conversion, no shares of Series A Preferred Stock remain outstanding. The conversion of the Series A Preferred Stock into common stock was a non-cash transaction, and therefore had no impact on the condensed consolidated statements of cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of activity related to the Series A Preferred Stock follows (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.614%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.442%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">434.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends accrued</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Redeemable preferred stock conversion to common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(439.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_RedeemablePreferredStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redeemable Preferred Stock [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_RedeemablePreferredStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763208623752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives and Hedging Activities<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivatives and Hedging Activities</a></td>
<td class="text">Derivatives and Hedging Activities<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps and interest rate caps as part of its interest rate risk management strategy. During 2021 and 2020, such derivatives have been used to hedge the variable cash flows associated with existing variable-rate debt.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in accumulated other comprehensive income ("OCI") and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings, as documented at hedge inception in accordance with the Company&#8217;s accounting policy election. Amounts reported in accumulated OCI related to derivatives will be reclassified to interest expense as interest payments are made on the Company&#8217;s variable-rate debt. Over the next 12 months, the Company estimates that an additional $26.3 million will be reclassified as an increase to interest expense.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In May 2021, the Company entered into additional interest rate swap agreements to match the terms of the New Term Loan and effectively extend the termination date to March 31, 2025. As of September&#160;30, 2021, the Company had nine interest rate swaps with a total net hedged notional amount of $1.2&#160;billion. Of the nine interest rate swaps, three are pay-fixed, receive 1-Month LIBOR (subject to a minimum of 0.75%) interest rate swaps designated in cash flow hedging relationships with a total notional amount of $1.2&#160;billion and a termination date of March 31, 2025. The remaining six interest rate swaps are undesignated and consist of three pay-fixed, receive 1-Month LIBOR (subject to a minimum of 1.00%) interest rate swaps and three pay 1-Month LIBOR (subject to a minimum of 1.00%), receive-fixed interest rate swaps with a termination date of November 30, 2023. The pay-floating, receive-fixed swaps are designed to economically offset the undesignated pay-fixed, receive-floating swaps. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Concurrently with the May 2021 transactions, the four previously existing interest rate swap positions were amended, de-designated or terminated and replaced with the new interest rate swaps discussed above. The Company voluntarily de-designated an aggregate notional amount of $435&#160;million (the effects of which are offset by the pay-floating, receive-fixed interest rate swaps) and terminated an aggregate notional amount of $435&#160;million. No cash was exchanged between the Company and the counterparties due to the transactions described above, therefore the non-cash transactions had no impact on the condensed consolidated statements of cash flows. The amount of unrealized losses recorded in OCI related to the de-designated and terminated notional amounts at the time of the de-designation and termination was $55.0&#160;million. This amount will be amortized to interest expense over the remaining term of the original interest rate swaps. The liability of the de-designated and terminated notional amounts was blended into the fixed rate of the new pay-fixed interest rate swaps.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The pay-fixed, receive floating interest rate swaps entered into in May 2021 did not meet the requirements to be considered derivatives in their entirety as a result of the financing component. Accordingly, the swaps are considered hybrid instruments, consisting of a financing element treated as a debt instrument and an embedded at-market derivative that was designated as a cash flow hedge. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Within the Company&#8217;s condensed consolidated balance sheets, the financing elements treated as debt instruments described above are carried at amortized cost and the embedded at-market derivatives and the undesignated swaps are recorded at fair value. The cash flows related to the portion treated as debt are classified as financing activities in the condensed consolidated statements of cash flows while the </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">portion treated as an at-market derivative are classified as operating activities. Cash settlements related to the undesignated swaps will offset and are classified as operating activities in the condensed consolidated cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In September 2021, the Company entered into interest rate cap agreements to more effectively hedge the interest rate risk. As of September&#160;30, 2021, the Company had two interest rate caps with a total hedged notional amount of $337.5&#160;million, and each has a termination date of March 31, 2025. Within the Company&#8217;s condensed consolidated balance sheets, the interest rate caps are recorded at fair value. The cash flows related to the interest rate caps are classified as operating activities in the condensed consolidated statements of cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The key terms of interest rate swaps and interest rate caps outstanding are presented below:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:17.352%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.144%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.209%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.144%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.209%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.743%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount (in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Status</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount (in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Status</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 7, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">435.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 7, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">330.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 7, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">435.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate cap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">168.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate cap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">168.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">165.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">120.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 28, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Receive-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">April 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(165.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Receive-fixed swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">April 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(120.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Receive-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">April 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(150.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Terminated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">330.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Terminated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">330.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Terminated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">240.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 28, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Terminated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">300.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,537.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,200.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our interest rate swap agreements, excluding the portion treated as debt, are recognized at fair value in the condensed consolidated balance sheets and are valued using pricing models that rely on market observable inputs such as yield curve data, which are classified as Level 2 inputs within the fair value hierarchy.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value of the interest rate caps are determined using the market standard methodology of discounting the future expected cash receipts that would occur if variable interest rates rise above the strike rate of the caps. The variable interest rates used in the calculation of projected receipts on the caps are based on an expectation of future interest rates derived from observable market interest rate curves and volatilities. The interest rate caps are classified using Level 2 inputs within the fair value hierarchy.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents the fair values of our derivatives and their location on the condensed consolidated balance sheets (in millions):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.995%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives in cash flow hedging relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate caps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">The balance as of September&#160;30, 2021 includes $49.4 million related to the financing component of the pay-fixed, receive floating interest rate swaps.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents the pre-tax effect of the interest rate swaps and caps on the Company's accumulated OCI and condensed consolidated statement of operations (in millions):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.334%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.253%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain recognized in income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:5pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives in cash flow hedging relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss recognized in OCI (effective portion)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss reclassified from accumulated OCI into income (effective portion) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Includes amortization of accumulated OCI related to de-designated and terminated interest rate swaps of $5.4 million and $8.6 million for the three and nine months ended September&#160;30, 2021, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763211146744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">Earnings Per Share<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic and diluted earnings per share are calculated based on the weighted-average number of shares outstanding in each period and dilutive stock options, unvested shares and warrants, to the extent such securities exist and have a dilutive effect on earnings per share. The Company computes basic and diluted earnings per share using the two-class method. The two-class method of computing earnings per share is an earnings allocation method that determines earnings per share for common shares and participating securities according to their participation rights in dividends and undistributed earnings.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (dollars in millions, except per share amounts; shares in thousands): </span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.253%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss attributable to Surgery Partners, Inc.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(61.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(121.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: amounts allocated to participating securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss attributable to common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(71.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(81.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(150.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding- basic and diluted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,726&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Loss per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic and diluted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.09)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,927&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Includes dividends accrued for the Series A Preferred Stock. The Series A Preferred Stock does not participate in undistributed losses.</span></div><div style="margin-bottom:9pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in each period.</span></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On January 27, 2021, the Company entered into an underwriting agreement relating to a public offering of 7,500,000 shares (the &#8220;Firm Shares&#8221;) of the Company&#8217;s common stock, $0.01 par value per share, at a price to the public of $30.25 per share. In addition, the Company granted the underwriters an option to purchase up to an additional 1,125,000 shares of common stock at the same price per share as the Firm Shares. On February 1, 2021, the Company completed the public offering pursuant to which the Company sold 8,625,000 shares of common stock (including the Firm Shares and the option shares), resulting in gross proceeds of $260.9&#160;million. In connection with the offering, the Company incurred underwriting discounts, commissions and other related costs of $12.7&#160;million, which were recognized as a direct reduction of proceeds received.</span></div>On May 17, 2021, the Company converted all outstanding shares of Series A Preferred Stock into approximately 22.609&#160;million shares of common stock. See Note 5. "Redeemable Preferred Stock" for further discussion.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763210129048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Current Liabilities<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureTextBlock', window );">Other Current Liabilities</a></td>
<td class="text">Other Current Liabilities<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of other current liabilities is as follows (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.953%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost report liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts due to patients and payors</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax receivable agreement liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued legal settlement </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">208.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:1pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">See Note 9. "Commitments and Contingencies" for further discussion.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763214704696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Professional, General and Workers' Compensation Liability Risks</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is subject to claims and legal actions in the ordinary course of business, including claims relating to patient treatment, employment practices and personal injuries. The Company maintains professional, general and workers' compensation liability insurance in excess of self-insured retentions, through third party commercial insurance carriers. Although management believes the coverage is sufficient for the Company's operations, some claims may potentially exceed the scope of coverage in effect. Plaintiffs in these matters may request punitive or other damages that may not be covered by insurance. The Company is not aware of any such proceedings that are reasonably possible to have a material adverse effect on the Company's business, financial position, results of operations or liquidity. Total professional, general and workers' compensation claim liabilities as of September&#160;30, 2021 and December&#160;31, 2020 were $22.9 million and $21.4 million, respectively. Expected insurance recoveries of $10.5 million as of both September&#160;30, 2021 and December&#160;31, 2020, are included as a component of other current assets and other long-term assets in the condensed consolidated balance sheets. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Laws and Regulations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Laws and regulations governing the Company's business, including those relating to the Medicare and Medicaid programs, are complex and subject to interpretation. These laws and regulations govern every aspect of how the Company's surgical facilities conduct their operations, from licensing requirements to how and whether the Company's facilities may receive payments pursuant to the Medicare and Medicaid programs. Compliance with such laws and regulations can be subject to future government agency review and interpretation as well as legislative changes to such laws. Noncompliance with such laws and regulations may subject the Company to significant regulatory sanctions including fines, penalties, and exclusion from the Medicare, Medicaid and other federal health care programs. From time to time, governmental regulatory agencies will conduct inquiries of the Company's practices, including, but not limited to, the Company's compliance with federal and state fraud and abuse laws, billing practices and relationships with physicians.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Government Settlement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 14, 2020, Logan Laboratories, LLC ("Logan Labs"), a toxicology laboratory based in Tampa, Florida, that provides urine testing services and Tampa Pain Relief Centers, Inc. ("Tampa Pain" and, together with Logan Labs, the "Companies"), a pain management medical practice based in Tampa, Florida, both indirect wholly-owned subsidiaries of the Company, entered into a settlement agreement (the "Settlement Agreement") with the United States of America, acting through the United States Department of Justice (&#8220;DOJ&#8221;) and on behalf of the Office of Inspector General of the Department of Health and Human Services ("OIG"), the Defense Health Agency, acting on behalf of the TRICARE Program, the Office of Personnel Management, as the administrator of the Federal Employees Health Benefits Program, the Office of Workers Compensation Programs of the United States Department of Labor, which administers federal workers compensation claims for federal employees, including the United States Postal Service, and the United States Department of Veterans Affairs and certain other parties to resolve the pending DOJ investigation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Under the terms of the Settlement Agreement, the Companies paid $30.7&#160;million plus accrued interest on April 1, 2021, representing the final payment related to the resolution of the DOJ Investigation.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Stockholder Litigation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December 4, 2017, a purported Company stockholder filed an action in the Delaware Court of Chancery (the "Delaware Action"). That action is captioned Witmer v. H.I.G. Capital, L.L.C., et al., C.A. No. 2017-0862. The plaintiff in the Delaware Action asserted claims against (i) certain current and former members of the Company&#8217;s Board of Directors (together, the "Directors"); (ii) H.I.G. Capital, LLC and certain of its affiliates (collectively, "H.I.G."); and (iii) Bain Capital Private Equity, L.P. and certain of its affiliates (collectively, "Bain Capital" and, together with the Directors and H.I.G., the "Defendants"). The plaintiff asserted derivative claims on behalf of the Company, which is a nominal defendant in the Delaware Action, as well as putatively direct claims on behalf of a purported class of Company stockholders. The plaintiff in the Delaware Action asserted that the Defendants breached their fiduciary duties in connection with the transactions in which (i) the Company acquired National Surgical Healthcare; (ii) Bain Capital acquired preferred equity in the Company; and (iii) Bain Capital acquired H.I.G.'s equity stake in the Company, and that, in the alternative, Bain Capital aided and abetted those purported breaches. The plaintiff also asserted an unjust enrichment claim against Bain Capital.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On January 2, 2018, the Defendants moved to dismiss the plaintiff&#8217;s complaint. On December 19, 2018, the Court of Chancery issued a decision on that motion. Following that decision, all of the Directors have been dismissed from the Delaware Action. The Court did not dismiss the plaintiff&#8217;s breach of fiduciary duty claim against H.I.G. or the aiding and abetting claim asserted against Bain Capital. However, the Court dismissed the plaintiff&#8217;s breach of fiduciary duty and unjust enrichment claims against Bain Capital. In addition, the Court dismissed all of the plaintiff&#8217;s claims that were asserted on behalf of a putative class of Company stockholders. Accordingly, all of the plaintiff&#8217;s remaining claims in the Delaware Action are asserted derivatively on the Company&#8217;s behalf. Discovery in the Delaware Action principally concluded on July 30, 2021, and the Defendants moved for summary judgment with respect to the remaining claims asserted against them. While those motions were pending, the parties to the Delaware Action reached an agreement-in-principle to settle the Delaware Action. The parties are currently negotiating the final terms of that settlement, which will be subject to approval by the Court of Chancery. Because the plaintiff in the Delaware Action asserts only derivative claims on the Company&#8217;s behalf, the Company will be the beneficiary of any settlement that is ultimately approved by the Court of Chancery.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Acquired Facilities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company, through its wholly-owned subsidiaries or controlled partnerships and limited liability companies, has acquired and will continue to acquire surgical facilities with prior operating histories. Such facilities may have unknown or contingent liabilities, including liabilities for failure to comply with health care laws and regulations, such as billing and reimbursement laws and regulations, the Stark Law, the Anti-Kickback Statute, the FCA, and similar fraud and abuse laws. Although the Company attempts to assure that no such liabilities exist, obtain indemnification from prospective sellers covering such matters and institute policies designed to conform centers to its standards following completion of acquisitions, there can be no assurance that the Company will not become liable for past activities that may later be asserted to be improper by private plaintiffs or government agencies. There can be no assurance that any such matter will be covered by indemnification or, if covered, that the liability sustained will not exceed contractual limits or the financial capacity of the indemnifying party.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company cannot predict whether federal or state statutory or regulatory provisions will be enacted that would prohibit or otherwise regulate relationships which the Company has established or may establish with other health care providers or have materially adverse effects on its business or revenues arising from such future actions. Management believes, however, that it will be able to adjust the Company's operations so as to be in compliance with any statutory or regulatory provision as may be applicable.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Potential Physician Investor Liability</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A majority of the physician investors in the partnerships and limited liability companies which operate the Company's surgical facilities carry general and professional liability insurance on a claims-made basis. Each partnership or limited liability company may, however, be liable for damages to persons or property arising from occurrences at the surgical facilities. Although the various physician investors and other surgeons generally are required to obtain general and professional liability insurance with tail coverage that extends beyond the period of any claims-made policies, such individuals may not be able to obtain coverage in amounts sufficient to cover all potential liability. Since most insurance policies contain exclusions, the physician investors will not be insured against all possible occurrences. In the event of an uninsured or underinsured loss, the value of an investment in the partnership interests or limited liability company membership units and the amount of distributions could be adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Tax Receivable Agreement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On May 9, 2017, the Company entered into an agreement to amend that certain Income Tax Receivable Agreement, dated September 30, 2015 (as amended, the "TRA"), by and between the Company, and the other parties referred to therein, which amendment became effective on August 31, 2017. Pursuant to the amendment to the TRA, the Company agreed to make payments to H.I.G., the Company's former controlling shareholder, in its capacity as the stockholders representative pursuant to a fixed payment schedule. The amounts payable under the TRA are calculated as the product of (i) an annual base amount and (ii) the maximum corporate federal income tax rate for the applicable year plus three percent. The amounts payable under the TRA are related to the Company&#8217;s projected realized tax savings over the next five years and are not dependent on the Company&#8217;s actual tax savings over such period. The calculation of amounts payable pursuant to the TRA is thus dependent on the maximum corporate federal income tax rate. To the extent that the Company is unable to make payments under the TRA, such payments will be deferred and will accrue interest at a rate of the LIBOR plus 500 basis points until paid. If the terms of credit agreements and other debt documents cause the Company to be unable to make payments under the TRA and </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">such terms are not materially more restrictive than those existing as of September 30, 2015, such payments will be deferred and will accrue interest at a rate of LIBOR plus 300 basis points until paid.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Assuming the Company's tax rate is 24%, calculated as the maximum corporate federal tax rate plus three percent, throughout the remaining term of the TRA, the Company estimates the total remaining amounts payable under the TRA was approximately $43.2 million as of both September&#160;30, 2021 and December&#160;31, 2020. As a result of the amendment to the TRA, the Company was required to value the liability under the TRA by discounting the fixed payment schedule using the Company&#8217;s incremental borrowing rate. The carrying value of the liability under the TRA, reflecting the discount, was $39.9 million and $37.0 million as of September&#160;30, 2021 and December&#160;31, 2020, respectively. The current portion of the liability was $21.2 million as of both September&#160;30, 2021 and December&#160;31, 2020, and is included as a component of other current liabilities in the condensed consolidated balance sheets. The long-term portion is included as a component of other long-term liabilities in the condensed consolidated balance sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763210122408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text">Segment Reporting<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company currently operates in&#160;two&#160;major lines of business that are also the Company's reportable operating segments - the operation of surgical facilities and the operation of ancillary services. The Surgical Facility Services segment consists of the operation of ASCs and surgical hospitals and includes anesthesia services. The Ancillary Services segment consists of multi-specialty physician practices and a diagnostic laboratory, which was closed during the third quarter of 2020. The Optical Services segment for the three and nine months ended September 30, 2020 reflected in the table below consisted of an optical products group purchasing organization, which was sold on December 31, 2020. "All other" primarily consists of the Company's corporate general and administrative functions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following tables present financial information for each reportable segment (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.252%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Surgical Facility Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">542.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">478.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,563.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,262.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ancillary Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Optical Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">559.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">496.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,614.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,311.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted EBITDA:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Surgical Facility Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">287.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ancillary Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Optical Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(61.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(61.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reconciliation of Adjusted EBITDA:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(61.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(98.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(75.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">147.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction, integration and acquisition costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on disposals and deconsolidations, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Litigation settlement and other litigation costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Gain) loss on debt extinguishment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on escrow release </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hurricane-related operating losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">This amount includes transaction and integration costs of $10.2 million and $5.4 million for the three months ended September&#160;30, 2021 and 2020, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $2.1 million for the three months ended September 30, 2020. </span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">This amount includes transaction and integration costs of $24.7 million and $15.8 million for the nine months ended September&#160;30, 2021 and 2020, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $6.3 million and $14.4 million for the nine months ended September&#160;30, 2021 and 2020, respectively. </span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">This amount includes other litigation costs of $2.5 million and $1.1 million for the three months ended September&#160;30, 2021 and 2020, respectively. </span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">This amount includes other litigation costs of $4.3 million and $3.7 million for the nine months ended September&#160;30, 2021 and 2020, respectively. This amount further includes litigation settlement costs of $1.2 million for the nine months ended September&#160;30, 2020, with no comparable costs for the nine months ended September&#160;30, 2021.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Included in other income in the condensed consolidated statement of operations for the nine months ended September&#160;30, 2020.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Reflects losses incurred in the month of September 2021 at a surgical facility that was closed following Hurricane Ida.</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.953%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Surgical Facility Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,124.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,962.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ancillary Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">474.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">415.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,631.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,413.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.953%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash purchases of property and equipment:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Surgical Facility Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ancillary Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cash purchases of property and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763208406168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent EventsIn October 2021, the Company completed the acquisition of additional interest in one of its consolidated Surgical Facilities for a market-based acquisition price of $31.8&#160;million.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763216577288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation of the Company's financial position and results of operations have been included. The Company&#8217;s fiscal year ends on December&#160;31 and interim results are not necessarily indicative of results for a full year or any other interim period. The information contained in these condensed consolidated financial statements should be read in conjunction with the Company&#8217;s consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2020 (the "2020 Annual Report on Form 10-K").</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text">The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, as well as interests in partnerships and limited liability companies controlled by the Company through its ownership of a majority voting interest or other rights granted to the Company by contract to manage and control the affiliate's business. All significant intercompany balances and transactions are eliminated in consolidation.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Reclassifications</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain reclassifications have been made to the comparative periods' financial statements to conform to the current year presentation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. Actual results could differ from those estimates.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationVariableInterestEntityPolicy', window );">Variable Interest Entities</a></td>
<td class="text">Variable Interest Entities<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the accounts of variable interest entities ("VIE") in which the Company is the primary beneficiary under the provisions of the Financial Accounting Standards Board's ("FASB") Accounting Standards Codification 810, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Consolidation</span>". The Company has the power to direct the activities that most significantly impact a VIE's economic performance. Additionally, the Company would absorb the majority of the expected losses from any of these entities should such expected losses occur.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value of a financial instrument is the amount at which the instrument could be exchanged in an orderly transaction between market participants to sell the asset or transfer the liability. The Company uses fair value measurements based on inputs classified into the following hierarchy:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These may include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Level 3: Unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, depending on the nature of the item being valued.</span></div>The carrying amounts reported in the condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, restricted invested assets and accounts payable approximate their fair values under Level 3 calculations.The fair values in the table above were based on Level 2 inputs using quoted prices for identical liabilities in inactive markets. The carrying amounts related to the Company's other long-term debt obligations, including finance lease obligations, approximate their fair values based on Level 3 inputs.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenues</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Revenues</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's revenues generally relate to contracts with patients in which the performance obligations are to provide health care services. The Company recognizes revenues in the period in which its obligations to provide health care services are satisfied and reports the amount that reflects the consideration the Company expects to be entitled to receive. The contractual relationships with patients, in most cases, also involve a third-party payor (e.g., Medicare, Medicaid and private insurance organizations, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by or negotiated with the third-party payors. The payment arrangements with third-party payors for the services provided to the related patients typically specify payments at amounts less than the Company's standard charges. The Company continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</span></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Patient service revenues.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">This revenue is related to charging facility fees in exchange for providing patient care. The fee charged for health care procedures performed in surgical facilities varies depending on the type of service provided, but usually includes all charges for usage of an operating room, a recovery room, special equipment, medical supplies, nursing staff and medications. The fee does not normally include professional fees charged by the patient&#8217;s surgeon, anesthesiologist or other attending physician, which are billed directly by such physicians to the patient or third-party payor. However, in several surgical facilities, the Company charges for anesthesia services. Ancillary service revenues include fees for patient visits to the Company's physician practices, pharmacy services and diagnostic tests ordered by physicians.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Patient service revenues are recognized as performance obligations are satisfied. Performance obligations are based on the nature of services provided. Typically, the Company recognizes revenue at a point in time in which services are rendered and the Company has no obligation to provide further patient services. As the Company primarily performs outpatient procedures, performance obligations are generally satisfied same day and revenue is recognized on the date of service.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company determines the transaction price based on gross charges for services provided, net of estimated contractual adjustments and discounts from third-party payors. The Company estimates its contractual adjustments and discounts based on contractual agreements, its discount policies and historical experience. Changes in estimated contractual adjustments and discounts are recorded in the period of change. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other service revenues.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Other service revenues include management and administrative service fees derived from the non-consolidated facilities that the Company accounts for under the equity method, management of surgical facilities in which it does not own an interest, and management services provided to physician practices for which the Company is not required to provide capital or additional </span></div>assets. These agreements typically require the Company to provide recurring management services over a multi-year period, which are billed and collected on a monthly basis. The fees derived from these management arrangements are based on a predetermined percentage of the revenues of each facility or practice and are recognized in the period in which management services are rendered and billed. For the three and nine months ended September 30, 2020, other service revenues also includes optical service revenues, which consisted of handling charges billed to the members of the Company's optical products purchasing organization. The Company sold its optical products purchasing organization on December 31, 2020.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash, Cash Equivalents and Restricted Cash</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cash, Cash Equivalents and Restricted Cash</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. The Company maintains its cash and cash equivalent balances at high credit quality financial institutions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December 31, 2020, cash, cash equivalents and restricted cash reported within the condensed consolidated statement of cash flows includes $0.3 million of restricted investments, which are reflected in other long-term assets in the condensed consolidated balance sheets. These restricted investments represented restricted cash held in accordance with the provisions of a long-term operating lease agreement held as security for performance under the Company's covenants and obligations within the agreement. The restrictions were released during the nine months ended September 30, 2021.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Accounts Receivable</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable from third-party payors are recorded net of estimated implicit price concessions, which are estimated based on the historical trend of the Company's surgical hospitals&#8217; cash collections and contractual write-offs, and for the Company's surgical facilities in general, established fee schedules, relationships with payors and procedure statistics. While changes in estimated reimbursement from third-party payors remain a possibility, the Company expects that any such changes would be minimal and, therefore, would not have a material effect on its financial condition or results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable consists of receivables from federal and state agencies (under the Medicare and Medicaid programs), private insurance organizations, employers and patients. Management recognizes that revenues and receivables from government agencies are significant to the Company's operations, but it does not believe that there is significant credit risk associated with these government agencies. Concentration of credit risk with respect to other payors is limited because of the large number of such payors. </span></div>The Company recognizes that final reimbursement of accounts receivable is subject to final approval by each third-party payor. However, because the Company has contracts with its third-party payors and also verifies insurance coverage of the patient before medical services are rendered, the amounts that are pending approval from third-party payors are not considered significant. Amounts are classified outside of self-pay if the Company has an agreement with the third-party payor or has verified a patient&#8217;s coverage prior to services rendered. The Company's policy is to collect co-payments and deductibles prior to providing medical services. Patient services of the Company are primarily non-emergency, which allows the surgical facilities to control the procedures for which third-party reimbursement is sought and obtained. The Company does not require collateral from self-pay patients.The Company's collection policies and procedures are based on the type of payor, size of claim and estimated collection percentage for each patient account. The Company analyzes accounts receivable at each of its surgical facilities to ensure the proper collection and aged category. Collection efforts include direct contact with third-party payors or patients, written correspondence and the use of legal or collection agency assistance, as required.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text">GoodwillGoodwill represents the fair value of the consideration provided in an acquisition over the fair value of net assets acquired and is not amortized. Additions to goodwill include amounts resulting from new business combinations and incremental ownership purchases in the Company's subsidiaries.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Instruments and Hedging Activities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Derivative Instruments and Hedging Activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company records all derivatives on the balance sheet at fair value and any financing elements treated as debt instruments are recorded at amortized cost. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.</span></div>For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in accumulated other comprehensive income ("OCI") and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings, as documented at hedge inception in accordance with the Company&#8217;s accounting policy election. Amounts reported in accumulated OCI related to derivatives will be reclassified to interest expense as interest payments are made on the Company&#8217;s variable-rate debt.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_RedeemableNoncontrollingInterestPolicyTextBlock', window );">Non-Controlling Interests&#8212;Redeemable</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Non-Controlling Interests&#8212;Redeemable</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Each partnership and limited liability company through which the Company owns and operates its surgical facilities is governed by a partnership or operating agreement, respectively.&#160;In certain circumstances, the applicable partnership or operating agreements for the Company's surgical facilities provide that the facilities will purchase all of the physician limited partners&#8217; or physician minority members&#8217;, as applicable, ownership if certain adverse regulatory events occur, such as it becoming illegal for the physician(s) to own an interest in a surgical facility, refer patients to a surgical facility or receive cash distributions from a surgical facility.&#160;The non-controlling interests</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">redeemable are reported outside of stockholders' equity in the condensed consolidated balance sheets.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Income Taxes </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company uses the asset and liability method to account for income taxes. Under this method, deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. If a carryforward exists, the Company makes a determination as to whether the carryforward will be utilized in the future. A valuation allowance is established for certain carryforwards when their recoverability is deemed to be uncertain. The carrying value of the net deferred tax assets assumes that the Company will be able to generate sufficient future taxable income in certain tax jurisdictions, based on estimates and assumptions. If our expectations for future operating results on a consolidated basis or at the state jurisdiction level vary from actual results due to changes in health care regulations, general economic conditions, or other factors, we may need to adjust the valuation allowance, for all or a portion of our deferred tax assets. Our income tax expense in future periods will be reduced or increased to the extent of offsetting decreases or increases, respectively, in our valuation allowance in the period when the change in circumstances occurs. These changes could have a significant impact on our future earnings.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company and certain of its subsidiaries file a consolidated federal income tax return. The partnerships, limited liability companies, and certain non-consolidated physician practice corporations also file separate income tax returns. The Company's allocable portion of each partnership's and limited liability company's income or loss is included in taxable income of the Company. The remaining income or loss of each partnership and limited liability company is allocated to the other owners.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In March 2020, the FASB issued Accounting Standard Update ("ASU") 2020-04,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The ASU provides optional guidance for a limited period of time to ease the potential burden in accounting for or recognizing the effects of reference rate reform on financial reporting and applies only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The ASU is effective as of March 12, 2020 through December 31, 2022. Entities may adopt ASU 2020-04 as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020 or prospectively from a date within an interim period that includes or is subsequent to March 12, 2020, up to the date that the financial statements are available to be issued. The Company is evaluating the impact of this ASU on its consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_RedeemableNoncontrollingInterestPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redeemable Noncontrolling Interest [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_RedeemableNoncontrollingInterestPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationVariableInterestEntityPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5728-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759159-111685<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2AA<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759068-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationVariableInterestEntityPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763208307320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Schedule of Carrying Amounts and Fair Values of Long-Term Debt</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of the carrying amounts and estimated fair values of the Company's long-term debt follows (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.191%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.787%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.787%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.787%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.788%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior secured term loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,534.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,539.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,523.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,533.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.750% senior unsecured notes due 2025</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">376.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">376.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.000% senior unsecured notes due 2027</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">545.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">545.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">589.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">596.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">Schedule of Revenues</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of revenues by service type as a percentage of total revenues follows:</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Surgical facilities revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Ancillary services revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total patient service revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other service revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth patient service revenues by type of payor and as a percentage of total patient service revenues for the Company's consolidated surgical facilities (dollars in millions):</span></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.238%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.815%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.815%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.887%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Private insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">271.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">248.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Self-pay</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total patient service revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">551.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">489.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other service revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 20.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">559.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">496.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.238%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.815%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.815%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.887%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Private insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">790.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">682.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">505.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Self-pay</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total patient service revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,593.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,293.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other service revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 20.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,614.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,311.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div>(1)Other is comprised of anesthesia service agreements, automobile liability, letters of protection and other payor types.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Rollforward of Goodwill</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of activity related to goodwill for the nine months ended September&#160;30, 2021 is as follows (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.592%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,468.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions, including post acquisition adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">145.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Divestitures and deconsolidations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,613.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock', window );">Schedule of Rollforward of Noncontrolling Interest - Redeemable</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of activity related to non-controlling interests&#8212;redeemable for the nine months ended September&#160;30, 2021 and 2020 is as follows (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.590%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.443%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at&#160;beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">306.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">321.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests&#8212;redeemable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition (disposal) of shares of non-controlling interests, net&#8212;redeemable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distributions to non-controlling interest&#8212;redeemable holders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at&#160;end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">310.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">304.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6327-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6442-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763208522280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Assets Acquired and Liabilities Assumed</a></td>
<td class="text">The aggregate amounts preliminarily recognized for each major class of assets acquired and liabilities assumed for the acquisitions are as follows (in millions):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.804%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.955%"/><td style="width:0.1%"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consideration</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of non-controlling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aggregate acquisition date fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net assets acquired:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">145.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use operating lease assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aggregate acquisition date fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763208338072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Summary of Long-term Debt</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of long-term debt follows (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.953%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior secured term loan </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,534.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,539.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.750% senior unsecured notes due 2025</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.000% senior unsecured notes due 2027</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">545.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">545.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Notes payable and other secured loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">140.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">279.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">281.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: unamortized debt issuance costs and discounts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,852.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,856.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Current maturities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,791.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,792.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Includes unamortized fair value discount of $3.1 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">and $3.7 million as of September&#160;30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span>December&#160;31, 2020, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763210070824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease Expense and Cash Flow Information</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents the components of the Company's lease expense and their classification in the condensed consolidated statement of operations (in millions):</span></div><div style="margin-bottom:12pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.633%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of leased assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Variable and short-term lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents supplemental cash flow information (dollars in millions):</span></div><div style="margin-bottom:12pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.633%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities: </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash outflows from operating leases </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash outflows from finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing cash outflows from finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763308818952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Preferred Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityTableTextBlock', window );">Schedule of Activity Related to Redeemable Preferred Stock</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of activity related to the Series A Preferred Stock follows (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.614%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.442%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">434.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends accrued</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Redeemable preferred stock conversion to common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(439.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763216040872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives and Hedging Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Schedule of Interest Rate Swaps and Interest Rate Caps Outstanding</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The key terms of interest rate swaps and interest rate caps outstanding are presented below:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:17.352%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.144%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.209%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.144%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.209%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.743%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount (in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Status</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount (in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Status</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 7, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">435.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 7, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">330.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 7, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">435.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate cap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">168.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate cap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">168.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">165.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">120.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 28, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Receive-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">April 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(165.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Receive-fixed swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">April 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(120.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Receive-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">April 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(150.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Terminated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">330.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Terminated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">330.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Terminated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">240.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 28, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Terminated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">300.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,537.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,200.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents the fair values of our derivatives and their location on the condensed consolidated balance sheets (in millions):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.995%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives in cash flow hedging relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate caps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">The balance as of September&#160;30, 2021 includes $49.4 million related to the financing component of the pay-fixed, receive floating interest rate swaps.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock', window );">Schedule of Effect of Interest Rate Swaps</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents the pre-tax effect of the interest rate swaps and caps on the Company's accumulated OCI and condensed consolidated statement of operations (in millions):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.334%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.253%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain recognized in income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:5pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives in cash flow hedging relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss recognized in OCI (effective portion)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss reclassified from accumulated OCI into income (effective portion) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Includes amortization of accumulated OCI related to de-designated and terminated interest rate swaps of $5.4 million and $8.6 million for the three and nine months ended September&#160;30, 2021, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41678-113959<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41641-113959<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of interest rate derivatives, including, but not limited to, the fair value of the derivatives, statement of financial position location, and statement of financial performance location of these instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763210104888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (dollars in millions, except per share amounts; shares in thousands): </span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.253%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss attributable to Surgery Partners, Inc.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(61.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(121.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: amounts allocated to participating securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss attributable to common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(71.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(81.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(150.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding- basic and diluted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,726&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Loss per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic and diluted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.09)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,927&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Includes dividends accrued for the Series A Preferred Stock. The Series A Preferred Stock does not participate in undistributed losses.</span></div><div style="margin-bottom:9pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in each period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763208529992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Current Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock', window );">Summary of Other Current Liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of other current liabilities is as follows (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.953%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost report liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts due to patients and payors</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax receivable agreement liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued legal settlement </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">208.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:1pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">See Note 9. "Commitments and Contingencies" for further discussion.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763215490376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Schedule of Segment Revenue and Operating Income</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following tables present financial information for each reportable segment (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.252%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Surgical Facility Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">542.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">478.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,563.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,262.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ancillary Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Optical Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">559.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">496.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,614.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,311.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted EBITDA:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Surgical Facility Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">287.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ancillary Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Optical Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(61.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(61.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reconciliation of Adjusted EBITDA:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(61.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(98.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(75.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">147.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction, integration and acquisition costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on disposals and deconsolidations, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Litigation settlement and other litigation costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Gain) loss on debt extinguishment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on escrow release </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hurricane-related operating losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">This amount includes transaction and integration costs of $10.2 million and $5.4 million for the three months ended September&#160;30, 2021 and 2020, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $2.1 million for the three months ended September 30, 2020. </span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">This amount includes transaction and integration costs of $24.7 million and $15.8 million for the nine months ended September&#160;30, 2021 and 2020, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $6.3 million and $14.4 million for the nine months ended September&#160;30, 2021 and 2020, respectively. </span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">This amount includes other litigation costs of $2.5 million and $1.1 million for the three months ended September&#160;30, 2021 and 2020, respectively. </span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">This amount includes other litigation costs of $4.3 million and $3.7 million for the nine months ended September&#160;30, 2021 and 2020, respectively. This amount further includes litigation settlement costs of $1.2 million for the nine months ended September&#160;30, 2020, with no comparable costs for the nine months ended September&#160;30, 2021.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Included in other income in the condensed consolidated statement of operations for the nine months ended September&#160;30, 2020.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Reflects losses incurred in the month of September 2021 at a surgical facility that was closed following Hurricane Ida.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock', window );">Schedule of Reconciliation of Assets from Segment to Consolidated</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.953%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Surgical Facility Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,124.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,962.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ancillary Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">474.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">415.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,631.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,413.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Financial Information by Reportable Segment</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.953%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash purchases of property and equipment:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Surgical Facility Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ancillary Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cash purchases of property and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763216612600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Organization and Summary of Accounting Policies - Organization (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>surgical_facility </div>
<div>state</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_ProductsAndServicesLineItems', window );"><strong>Products And Services [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_NumberOfSurgicalFacilitiesOwned', window );">Number of surgical facilities owned</a></td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStatesInWhichEntityOperates', window );">Number of states in which entity operates | state</a></td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest', window );">Number of surgical facilities owned, majority interest</a></td>
<td class="nump">90<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_NumberOfSurgicalFacilitiesOwnedConsolidated', window );">Number of surgical facilities owned, consolidated</a></td>
<td class="nump">110<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sgry_FacilitiesAmbulatorySurgeryCentersMember', window );">Facilities, Ambulatory Surgery Centers</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_ProductsAndServicesLineItems', window );"><strong>Products And Services [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_NumberOfSurgicalFacilitiesOwned', window );">Number of surgical facilities owned</a></td>
<td class="nump">110<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sgry_FacilitiesSurgicalHospitalsMember', window );">Facilities, Surgical Hospitals</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_ProductsAndServicesLineItems', window );"><strong>Products And Services [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_NumberOfSurgicalFacilitiesOwned', window );">Number of surgical facilities owned</a></td>
<td class="nump">17<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_NumberOfSurgicalFacilitiesOwned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Surgical Facilities Owned</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_NumberOfSurgicalFacilitiesOwned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_NumberOfSurgicalFacilitiesOwnedConsolidated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Surgical Facilities Owned, Consolidated</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_NumberOfSurgicalFacilitiesOwnedConsolidated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Surgical Facilities Owned, Majority Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_ProductsAndServicesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Products And Services [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_ProductsAndServicesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStatesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of states the entity operates in as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStatesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sgry_FacilitiesAmbulatorySurgeryCentersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sgry_FacilitiesAmbulatorySurgeryCentersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sgry_FacilitiesSurgicalHospitalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sgry_FacilitiesSurgicalHospitalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763216984648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Accounting Policies - CARES ACT (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1">18 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_ProceedsFromGovernmentAssistance', window );">Proceeds from grants received</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_GrantRevenue', window );">Grant funds</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">$ (9.9)<span></span>
</td>
<td class="nump">20.0<span></span>
</td>
<td class="nump">$ 33.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_CoronavirusAidReliefandEconomicSecurityActCARESActGovernmentGrantReceivedAcceleratedPayments', window );">Accelerated payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments', window );">Repayments of grants received</a></td>
<td class="nump">18.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments', window );">Deferred accelerated payments</a></td>
<td class="nump">80.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95.0<span></span>
</td>
<td class="nump">80.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_DeferredEmployeeRelatedLiabilitiesCurrent', window );">Deferred accrued payroll and benefits</a></td>
<td class="nump">$ 16.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.9<span></span>
</td>
<td class="nump">$ 16.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Coronavirus Aid, Relief, and Economic Security Act CARES Act, Government Grant Received, Repayments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Coronavirus Aid, Relief, and Economic Security Act CARES Act, Government Grants, Deferred Accelerated Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_CoronavirusAidReliefandEconomicSecurityActCARESActGovernmentGrantReceivedAcceleratedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Coronavirus Aid, Relief, and Economic Security Act CARES Act, Government Grant Received, Accelerated Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_CoronavirusAidReliefandEconomicSecurityActCARESActGovernmentGrantReceivedAcceleratedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_DeferredEmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Employee-related Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_DeferredEmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_GrantRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Grant Revenue</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_GrantRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_ProceedsFromGovernmentAssistance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Government Assistance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_ProceedsFromGovernmentAssistance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763216698920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Organization and Summary of Accounting Policies - Variable Interest Entities (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>surgical_facility</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>physician_practice</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_VariableInterestEntityNumberOfFacilities', window );">Number of facilities included in VIE</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,631.6<span></span>
</td>
<td class="nump">$ 5,413.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26.7<span></span>
</td>
<td class="nump">27.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.1<span></span>
</td>
<td class="nump">$ 21.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_VariableInterestEntityNumberOfFacilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Variable Interest Entity, Number of Facilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_VariableInterestEntityNumberOfFacilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763216538056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Organization and Summary of Accounting Policies - Carrying Amount and Fair Value of Long-Term Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>May 03, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt | Senior secured term loan | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 1,534.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,539.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt | Senior secured term loan | Fair Value | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 1,523.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,533.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.750% senior unsecured notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">6.75%<span></span>
</td>
<td class="nump">6.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.750% senior unsecured notes due 2025 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 370.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">370.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.750% senior unsecured notes due 2025 | Fair Value | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 376.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">376.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 10.000% senior unsecured notes due 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 10.000% senior unsecured notes due 2027 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 545.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">545.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 10.000% senior unsecured notes due 2027 | Fair Value | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 589.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 596.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=sgry_A2017TermLoanMaturing2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=sgry_A2017TermLoanMaturing2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=sgry_SeniorUnsecuredNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=sgry_SeniorUnsecuredNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=sgry_SeniorUnsecuredNotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=sgry_SeniorUnsecuredNotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763216889016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Accounting Policies - Schedule of Revenues by Service Type (Details) - Revenue Source - Revenue<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Service revenues as a percentage of total revenues</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember', window );">Patent service revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Service revenues as a percentage of total revenues</a></td>
<td class="nump">98.60%<span></span>
</td>
<td class="nump">98.80%<span></span>
</td>
<td class="nump">98.60%<span></span>
</td>
<td class="nump">98.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember', window );">Surgical Facility Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Service revenues as a percentage of total revenues</a></td>
<td class="nump">95.60%<span></span>
</td>
<td class="nump">95.40%<span></span>
</td>
<td class="nump">95.50%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember', window );">Ancillary Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Service revenues as a percentage of total revenues</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
<td class="nump">3.10%<span></span>
</td>
<td class="nump">3.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember', window );">Other service revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Service revenues as a percentage of total revenues</a></td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sgry_HealthcareOrganizationPatientServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sgry_HealthcareOrganizationPatientServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sgry_SurgicalFacilityServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sgry_SurgicalFacilityServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sgry_AncillaryServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sgry_AncillaryServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sgry_OtherServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sgry_OtherServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763317224232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Accounting Policies - Schedule of Revenues by Sources (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 559.2<span></span>
</td>
<td class="nump">$ 496.1<span></span>
</td>
<td class="nump">$ 1,614.9<span></span>
</td>
<td class="nump">$ 1,311.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sgry_HealthcareOrganizationPatientServiceMember', window );">Total patient service revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 551.4<span></span>
</td>
<td class="nump">$ 489.8<span></span>
</td>
<td class="nump">$ 1,593.0<span></span>
</td>
<td class="nump">$ 1,293.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sgry_HealthcareOrganizationPatientServiceMember', window );">Total patient service revenues | Customer | Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Service revenues as a percentage of total revenues</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sgry_PrivateInsuranceMember', window );">Private insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 271.4<span></span>
</td>
<td class="nump">$ 257.4<span></span>
</td>
<td class="nump">$ 790.5<span></span>
</td>
<td class="nump">$ 682.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sgry_PrivateInsuranceMember', window );">Private insurance | Customer | Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Service revenues as a percentage of total revenues</a></td>
<td class="nump">49.20%<span></span>
</td>
<td class="nump">52.60%<span></span>
</td>
<td class="nump">49.60%<span></span>
</td>
<td class="nump">52.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_GovernmentContractMember', window );">Government</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 248.0<span></span>
</td>
<td class="nump">$ 188.8<span></span>
</td>
<td class="nump">$ 700.6<span></span>
</td>
<td class="nump">$ 505.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_GovernmentContractMember', window );">Government | Customer | Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Service revenues as a percentage of total revenues</a></td>
<td class="nump">45.00%<span></span>
</td>
<td class="nump">38.50%<span></span>
</td>
<td class="nump">44.00%<span></span>
</td>
<td class="nump">39.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sgry_SelfPayRevenueMember', window );">Self-pay</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 15.9<span></span>
</td>
<td class="nump">$ 19.4<span></span>
</td>
<td class="nump">$ 46.9<span></span>
</td>
<td class="nump">$ 43.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sgry_SelfPayRevenueMember', window );">Self-pay | Customer | Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Service revenues as a percentage of total revenues</a></td>
<td class="nump">2.90%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">2.90%<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sgry_OtherPatientServiceRevenueSourcesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 16.1<span></span>
</td>
<td class="nump">$ 24.2<span></span>
</td>
<td class="nump">$ 55.0<span></span>
</td>
<td class="nump">$ 62.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sgry_OtherPatientServiceRevenueSourcesMember', window );">Other | Customer | Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Service revenues as a percentage of total revenues</a></td>
<td class="nump">2.90%<span></span>
</td>
<td class="nump">4.90%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="nump">4.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sgry_OtherServicesMember', window );">Other service revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 7.8<span></span>
</td>
<td class="nump">$ 6.3<span></span>
</td>
<td class="nump">$ 21.9<span></span>
</td>
<td class="nump">$ 18.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sgry_HealthcareOrganizationPatientServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sgry_HealthcareOrganizationPatientServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sgry_PrivateInsuranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sgry_PrivateInsuranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_GovernmentContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_GovernmentContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sgry_SelfPayRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sgry_SelfPayRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sgry_OtherPatientServiceRevenueSourcesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sgry_OtherPatientServiceRevenueSourcesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sgry_OtherServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sgry_OtherServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763208398600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Organization and Summary of Accounting Policies - Cash, Cash Equivalents and Restricted Cash (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsNoncurrent', window );">Restricted invested assets included in other long-term assets</a></td>
<td class="nump">$ 0.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndInvestmentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The noncurrent cash, cash equivalents and investments that is restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits classified as long-term; that is not expected to be released from such existing restrictions within one year of the balance sheet date or operating cycle, whichever is longer. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes noncurrent cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120413209&amp;loc=SL6242269-115581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndInvestmentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763294499992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Accounting Policies - Rollforward of Goodwill (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning of period</a></td>
<td class="nump">$ 3,468.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions, including post acquisition adjustments</a></td>
<td class="nump">145.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation', window );">Divestitures and deconsolidations</a></td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, end of period</a></td>
<td class="nump">$ 3,613.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill, Written off Related to Sale of Business Unit and Deconsolidation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763294508040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Accounting Policies - Schedule of Non-Controlling Interests - Redeemable (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_RedeemableNoncontrollingInterestRollForward', window );"><strong>Non-Controlling Interests - Redeemable [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Balance at beginning of period</a></td>
<td class="nump">$ 306.8<span></span>
</td>
<td class="nump">$ 321.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net income attributable to non-controlling interests&#8212;redeemable</a></td>
<td class="nump">33.8<span></span>
</td>
<td class="nump">19.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests', window );">Acquisition (disposal) of shares of non-controlling interests, net&#8212;redeemable</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="num">(7.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to non-controlling interest&#8212;redeemable holders</a></td>
<td class="num">(32.6)<span></span>
</td>
<td class="num">(27.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Balance at end of period</a></td>
<td class="nump">$ 310.4<span></span>
</td>
<td class="nump">$ 304.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redeemable Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redeemable Noncontrolling Interest, Increase (Decrease) from Redemptions or Purchase of Interests</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_RedeemableNoncontrollingInterestRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redeemable Noncontrolling Interest [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_RedeemableNoncontrollingInterestRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763209803560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Accounting Policies - Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate (percent)</a></td>
<td class="num">(4.90%)<span></span>
</td>
<td class="nump">23.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Tax benefits related to vesting of restricted stock awards</a></td>
<td class="nump">$ 4.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationDispositionOfBusiness', window );">Tax benefits related to the sale of partnership interests</a></td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_EffectiveIncomeTaxRateReconciliationCoronavirusAidReliefAndEconomicSecurityActCARESActAndTaxSettlementAmount', window );">Tax benefits related to CARES Act and Settlement Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxSettlements', window );">Tax expense related to settlement payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses', window );">Tax expense attributable to impairment of goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_EffectiveIncomeTaxRateReconciliationCoronavirusAidReliefAndEconomicSecurityActCARESActAndTaxSettlementAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Coronavirus Aid, Relief, and Economic Security Act (CARES Act) And Tax Settlement, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_EffectiveIncomeTaxRateReconciliationCoronavirusAidReliefAndEconomicSecurityActCARESActAndTaxSettlementAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120384911&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationDispositionOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the disposition of a business not qualifying as a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationDispositionOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible impairment loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax settlements. Including, but not limited to, domestic tax settlement, foreign tax settlement, state and local tax settlement, and other tax settlements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763217049032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>surgical_facility</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments for acquisitions, net of cash acquired | $</a></td>
<td class="nump">$ 101.0<span></span>
</td>
<td class="nump">$ 14.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=sgry_SurgicalFacilitiesNewMarketsMember', window );">Surgical Facilities, New Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of facilities acquired | surgical_facility</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=sgry_SurgicalFacilitiesExistingMarketsMember', window );">Surgical Facilities, Existing Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of facilities acquired | surgical_facility</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments for acquisitions, net of cash acquired | $</a></td>
<td class="nump">$ 101.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of businesses acquired by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=sgry_SurgicalFacilitiesNewMarketsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=sgry_SurgicalFacilitiesNewMarketsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=sgry_SurgicalFacilitiesExistingMarketsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=sgry_SurgicalFacilitiesExistingMarketsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763294355640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Summary (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract', window );"><strong>Net assets acquired:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 3,613.6<span></span>
</td>
<td class="nump">$ 3,468.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=sgry_SurgicalFacilitiesExistingMarketsMember', window );">Surgical Facilities, Existing Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Total consideration</a></td>
<td class="nump">103.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue', window );">Fair value of non-controlling interests</a></td>
<td class="nump">46.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Aggregate acquisition date fair value</a></td>
<td class="nump">149.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract', window );"><strong>Net assets acquired:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Current assets</a></td>
<td class="nump">6.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="nump">3.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">145.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingRightOfUseAssets', window );">Right-of-use operating lease assets</a></td>
<td class="nump">8.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other long-term assets</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Current liabilities</a></td>
<td class="num">(8.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt', window );">Long-term debt</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability', window );">Right-of-use operating lease liabilities</a></td>
<td class="num">(7.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Aggregate acquisition date fair value</a></td>
<td class="nump">$ 149.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long Term Debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Right Of Use Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=sgry_SurgicalFacilitiesExistingMarketsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=sgry_SurgicalFacilitiesExistingMarketsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763216538136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt - Summary (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>May 03, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance lease obligations</a></td>
<td class="nump">$ 279.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 281.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Less: unamortized debt issuance costs and discounts</a></td>
<td class="num">(17.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16.3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities', window );">Total debt</a></td>
<td class="nump">2,852.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,856.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Less: Current maturities</a></td>
<td class="nump">60.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Total long-term debt</a></td>
<td class="nump">2,791.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,792.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt | Senior secured term loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">1,534.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,539.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Unamortized fair value discount (premium)</a></td>
<td class="nump">3.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.750% senior unsecured notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 370.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">370.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">6.75%<span></span>
</td>
<td class="nump">6.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 10.000% senior unsecured notes due 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 545.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">545.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=sgry_NotesPayableAndSecuredLoansMember', window );">Notes payable and other secured loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 140.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 137.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount (premium).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28567-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, including portion classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=sgry_A2017TermLoanMaturing2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=sgry_A2017TermLoanMaturing2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=sgry_SeniorUnsecuredNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=sgry_SeniorUnsecuredNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=sgry_SeniorUnsecuredNotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=sgry_SeniorUnsecuredNotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=sgry_NotesPayableAndSecuredLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=sgry_NotesPayableAndSecuredLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763295315576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 03, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jan. 27, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Debt issuance costs and discount, net of issuance premium</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">(Gain) loss on debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(500,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 9,100,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_FederalFundsEffectiveSwapRateMember', window );">Federal Funds Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=sgry_A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember', window );">New Term Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 1,545,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_DebtInstrumentCovenantMaturityMinimumAmountOfOtherExistingDebtRemaining', window );">Maturity covenant, minimum amount of Borrower's 6.750% senior unsecured notes due 2025 not repaid, repurchased or redeemed or refinanced</a></td>
<td class="nump">$ 185,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_DebtInstrumentCovenantMaturityMinimumMaturityDateForOtherExistingDebtRemaining', window );">Maturity covenant, minimum maturity date for borrowings after August 31, 2026 by no later than April 1, 2025</a></td>
<td class="text">91 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_DebtInstrumentQuarterlyAmortizationPercentPerAnnum', window );">Quarterly amortization in aggregate principal amount, percent per annum (percent)</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Debt issuance costs and discount, net of issuance premium</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=sgry_A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember', window );">New Term Loans | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate (percent)</a></td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_DebtInstrumentBasisSpreadOnVariableRateFloor', window );">Debt instrument, basis spread on variable rate, floor (percent)</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=sgry_A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember', window );">New Term Loans | Federal Funds Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate (percent)</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=sgry_A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember', window );">New Term Loans | One-month LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate (percent)</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=sgry_A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember', window );">New Term Loans | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate (percent)</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_DebtInstrumentBasisSpreadOnVariableRateFloor', window );">Debt instrument, basis spread on variable rate, floor (percent)</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=sgry_SeniorUnsecuredNotesDue2025Member', window );">6.750% senior unsecured notes due 2025 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">6.75%<span></span>
</td>
<td class="nump">6.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Availability on line of credit instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 163,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 163,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | The Revolver | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_LineOfCreditFacilityMaximumBorrowingCapacityIncrease', window );">Increase in outstanding commitments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Amount of line of credit outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Availability on line of credit instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_DebtInstrumentBasisSpreadOnVariableRateFloor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Basis Spread On Variable Rate, Floor</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_DebtInstrumentBasisSpreadOnVariableRateFloor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_DebtInstrumentCovenantMaturityMinimumAmountOfOtherExistingDebtRemaining">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Maturity, Minimum Amount Of Other Existing Debt Remaining</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_DebtInstrumentCovenantMaturityMinimumAmountOfOtherExistingDebtRemaining</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_DebtInstrumentCovenantMaturityMinimumMaturityDateForOtherExistingDebtRemaining">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Maturity, Minimum Maturity Date For Other Existing Debt Remaining</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_DebtInstrumentCovenantMaturityMinimumMaturityDateForOtherExistingDebtRemaining</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_DebtInstrumentQuarterlyAmortizationPercentPerAnnum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Quarterly Amortization, Percent Per Annum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_DebtInstrumentQuarterlyAmortizationPercentPerAnnum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_LineOfCreditFacilityMaximumBorrowingCapacityIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Maximum Borrowing Capacity, Increase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_LineOfCreditFacilityMaximumBorrowingCapacityIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_FederalFundsEffectiveSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_FederalFundsEffectiveSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=sgry_A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=sgry_A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=sgry_OneMonthLondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=sgry_OneMonthLondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=sgry_SeniorUnsecuredNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=sgry_SeniorUnsecuredNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=sgry_A2017SeniorSecuredCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=sgry_A2017SeniorSecuredCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763308110936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Lease Expense and Cash Flow Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease costs</a></td>
<td class="nump">$ 56.6<span></span>
</td>
<td class="nump">$ 54.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_FinanceLeaseCost1Abstract', window );"><strong>Finance lease costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of leased assets</a></td>
<td class="nump">20.4<span></span>
</td>
<td class="nump">19.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">18.9<span></span>
</td>
<td class="nump">15.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_FinanceLeaseCost', window );">Total finance lease costs</a></td>
<td class="nump">39.3<span></span>
</td>
<td class="nump">34.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_VariableAndShortTermLeaseCost', window );">Variable and short-term lease costs</a></td>
<td class="nump">15.0<span></span>
</td>
<td class="nump">12.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease costs</a></td>
<td class="nump">110.9<span></span>
</td>
<td class="nump">102.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_CashFlowLesseeAbstract', window );"><strong>Cash paid for amounts included in the measurement of lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash outflows from operating leases</a></td>
<td class="nump">55.2<span></span>
</td>
<td class="nump">49.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash outflows from finance leases</a></td>
<td class="nump">18.0<span></span>
</td>
<td class="nump">15.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash outflows from finance leases</a></td>
<td class="nump">15.8<span></span>
</td>
<td class="nump">12.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for operating lease obligations</a></td>
<td class="nump">44.9<span></span>
</td>
<td class="nump">53.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-use assets obtained in exchange for finance lease obligations</a></td>
<td class="nump">$ 10.1<span></span>
</td>
<td class="nump">$ 11.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_CashFlowLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Flow, Lessee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_CashFlowLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_FinanceLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_FinanceLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_FinanceLeaseCost1Abstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Cost1 [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_FinanceLeaseCost1Abstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_VariableAndShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Variable And Short-Term Lease, Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_VariableAndShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763214530952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Preferred Stock - Narrative (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 17, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 31, 2017 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>lease_renewal_option </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 27, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Proceeds from issuance of preferred shares | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 248.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember', window );">Conversion of Series A Preferred Stock into Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in USD per share) | $ / shares</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Preferred stock dividend rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_TemporaryEquityThresholdTradingDays', window );">Trading days | lease_renewal_option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_TemporaryEquityThresholdConsecutiveTradingDays', window );">Consecutive trading days | lease_renewal_option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_TemporaryEquityThresholdSharePrice', window );">Threshold share price (in USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Stock | Conversion of Series A Preferred Stock into Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Shares of common stock issued in conversion (shares) | shares</a></td>
<td class="nump">22,609,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_MajorityShareholderMember', window );">Bain Capital Private Equity, L.P. | Series A Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued during period (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">310,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchase price per share (in USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Proceeds from issuance of preferred shares | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 310.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_TemporaryEquityThresholdConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Threshold Consecutive Trading Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_TemporaryEquityThresholdConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_TemporaryEquityThresholdSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Threshold Share Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_TemporaryEquityThresholdSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_TemporaryEquityThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Threshold Trading Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_TemporaryEquityThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage rate used to calculate dividend payments on preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockByUniqueDescriptionAxis=sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_MajorityShareholderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_MajorityShareholderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763216197112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Preferred Stock - Summary (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance</a></td>
<td class="nump">$ 434.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance</a></td>
<td class="nump">434.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionOfDividends', window );">Dividends accrued</a></td>
<td class="nump">10.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityDividendsAdjustment', window );">Dividends declared</a></td>
<td class="num">(5.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationsOfTemporaryToPermanentEquity', window );">Redeemable preferred stock conversion to common stock</a></td>
<td class="num">(439.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance</a></td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationsOfTemporaryToPermanentEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying amount of a financial instrument subject to a registration payment arrangement recorded as temporary equity prior to adoption of FSP EITF 00-19-2 and the carrying amount reclassified to permanent equity upon the adoption of FSP EITF 00-19-2. Recorded as a cumulative effect adjustment to the beginning balance of retained earnings. Does not apply to registration payment arrangements that are no longer outstanding upon adoption of FSP EITF 00-19-2.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90193-114008<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationsOfTemporaryToPermanentEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of accretion of temporary equity during the period due to unpaid dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDividendsAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accretion of temporary equity during the period due to cash, stock, and in-kind dividends. This item is an adjustment to net income necessary to derive net income apportioned to common stockholders and is to be distinguished from Temporary Equity, Accretion of Dividends (Temporary Equity, Accretion of Dividends).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDividendsAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763295335976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives and Hedging Activities - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>lease_renewal_option </div>
<div>interest_rate_cap</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>lease_renewal_option </div>
<div>interest_rate_cap</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Amount estimated to be reclassified as a reduction to interest expense over next 12 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative notional amount</a></td>
<td class="nump">$ 1,537.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,537.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Amount of unrealized losses recorded in OCI</a></td>
<td class="num">(6.5)<span></span>
</td>
<td class="num">$ (0.2)<span></span>
</td>
<td class="num">$ (6.4)<span></span>
</td>
<td class="num">$ (3.3)<span></span>
</td>
<td class="num">$ (7.3)<span></span>
</td>
<td class="nump">$ 25.2<span></span>
</td>
<td class="num">(13.1)<span></span>
</td>
<td class="nump">$ 14.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative notional amount</a></td>
<td class="nump">435.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 435.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Amount of unrealized losses recorded in OCI</a></td>
<td class="nump">$ 55.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfInterestRateDerivativesHeld', window );">Number of interest rate swaps | lease_renewal_option</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative notional amount</a></td>
<td class="nump">$ 435.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 435.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Derivatives in cash flow hedging relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative notional amount</a></td>
<td class="nump">$ 1,200.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_ThreePayFixedInterestRateSwapsMember', window );">Three Pay-fixed Interest Rate Swaps | LIBOR | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeVariableInterestRate', window );">Variable interest rate of derivative instrument (percent)</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_ThreePayFixedInterestRateSwapsMember', window );">Three Pay-fixed Interest Rate Swaps | Derivatives not designated as hedging instruments | LIBOR | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeVariableInterestRate', window );">Variable interest rate of derivative instrument (percent)</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_ThreeReceiveFixedInterestRateSwapsMember', window );">Three Receive-fixed Interest Rate Swaps | Derivatives not designated as hedging instruments | LIBOR | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeVariableInterestRate', window );">Variable interest rate of derivative instrument (percent)</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">Interest Rate Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfInterestRateDerivativesHeld', window );">Number of interest rate swaps | interest_rate_cap</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">Interest Rate Cap | Derivatives in cash flow hedging relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative notional amount</a></td>
<td class="nump">$ 337.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 337.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeVariableInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Variable interest rate in effect as of the balance sheet date related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeVariableInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfInterestRateDerivativesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of interest rate derivative instruments held by the entity at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfInterestRateDerivativesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_ThreePayFixedInterestRateSwapsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=sgry_ThreePayFixedInterestRateSwapsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_ThreeReceiveFixedInterestRateSwapsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=sgry_ThreeReceiveFixedInterestRateSwapsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763215642312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivatives and Hedging Activities - Interest Rate Swaps and Interest Rate Caps Outstanding (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">$ 17.6<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative liability, notional amount</a></td>
<td class="num">(66.6)<span></span>
</td>
<td class="num">(61.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative notional amount</a></td>
<td class="nump">1,537.5<span></span>
</td>
<td class="nump">1,200.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapOneMember', window );">Pay-fixed swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">435.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapTwoMember', window );">Pay-fixed swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">330.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapThreeMember', window );">Pay-fixed swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">435.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_InterestRateCapOneMember', window );">Interest rate cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">168.8<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_InterestRateCapTwoMember', window );">Interest rate cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">168.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapFourMember', window );">Pay-fixed swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">165.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapFiveMember', window );">Pay-fixed swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">120.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapSixMember', window );">Pay-fixed swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">150.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_ReceiveFixedSwapOneMember', window );">Receive-fixed swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative liability, notional amount</a></td>
<td class="num">(165.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_ReceiveFixedSwapTwoMember', window );">Receive-fixed swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative liability, notional amount</a></td>
<td class="num">(120.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_ReceiveFixedSwapThreeMember', window );">Receive-fixed swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative liability, notional amount</a></td>
<td class="num">(150.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapSevenMember', window );">Pay-fixed swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">330.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapEightMember', window );">Pay-fixed swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">330.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapNineMember', window );">Pay-fixed swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">240.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapTenMember', window );">Pay-fixed swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 300.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_InterestRateCapOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=sgry_InterestRateCapOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_InterestRateCapTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=sgry_InterestRateCapTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapSixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapSixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_ReceiveFixedSwapOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=sgry_ReceiveFixedSwapOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_ReceiveFixedSwapTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=sgry_ReceiveFixedSwapTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_ReceiveFixedSwapThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=sgry_ReceiveFixedSwapThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapSevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapSevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapNineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapNineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapTenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapTenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763211324936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivatives and Hedging Activities - Derivatives and their location on the condensed consolidated balance sheets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">$ 17.6<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative liability, notional amount</a></td>
<td class="nump">66.6<span></span>
</td>
<td class="nump">61.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_DerivativeLiabilityNotionalAmountFinancingComponent', window );">Derivative liability, notional amount, financing component</a></td>
<td class="nump">49.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Derivatives not designated as hedging instruments | Other long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">15.8<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative liability, notional amount</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Derivatives not designated as hedging instruments | Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative liability, notional amount</a></td>
<td class="nump">15.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Derivatives in cash flow hedging relationships | Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative liability, notional amount</a></td>
<td class="nump">51.0<span></span>
</td>
<td class="nump">61.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">Interest Rate Cap | Derivatives in cash flow hedging relationships | Other long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative liability, notional amount</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_DerivativeLiabilityNotionalAmountFinancingComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative Liability, Notional Amount, Financing Component</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_DerivativeLiabilityNotionalAmountFinancingComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763295200184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives and Hedging Activities - Pre-tax Effect of Derivatives on AOCI and Statement of Operations (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax', window );">Amortization of accumulated OCI related</a></td>
<td class="nump">$ 5.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Other income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Gain recognized in income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives in cash flow hedging relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Loss recognized in OCI (effective portion)</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
<td class="nump">29.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives in cash flow hedging relationships | Interest expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Gain recognized in income</a></td>
<td class="nump">$ 6.6<span></span>
</td>
<td class="nump">$ 5.6<span></span>
</td>
<td class="nump">$ 18.1<span></span>
</td>
<td class="nump">$ 14.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from discontinuance of cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763294246040">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Summary (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to Surgery Partners, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (22.9)<span></span>
</td>
<td class="num">$ (61.6)<span></span>
</td>
<td class="num">$ (70.8)<span></span>
</td>
<td class="num">$ (121.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic', window );">Less: Amounts attributable to participating securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(10.0)<span></span>
</td>
<td class="num">(10.3)<span></span>
</td>
<td class="num">(29.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to common stockholders</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (22.9)<span></span>
</td>
<td class="num">$ (71.6)<span></span>
</td>
<td class="num">$ (81.1)<span></span>
</td>
<td class="num">$ (150.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding- basic (shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">80,726<span></span>
</td>
<td class="nump">48,883<span></span>
</td>
<td class="nump">68,350<span></span>
</td>
<td class="nump">48,736<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding- diluted (shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">80,726<span></span>
</td>
<td class="nump">48,883<span></span>
</td>
<td class="nump">68,350<span></span>
</td>
<td class="nump">48,736<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Loss per share:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in USD per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (0.28)<span></span>
</td>
<td class="num">$ (1.46)<span></span>
</td>
<td class="num">$ (1.19)<span></span>
</td>
<td class="num">$ (3.09)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in USD per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (0.28)<span></span>
</td>
<td class="num">$ (1.46)<span></span>
</td>
<td class="num">$ (1.19)<span></span>
</td>
<td class="num">$ (3.09)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Loss per share:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive (shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,974<span></span>
</td>
<td class="nump">810<span></span>
</td>
<td class="nump">1,927<span></span>
</td>
<td class="nump">285<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Restricted shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Loss per share:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive (shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,461<span></span>
</td>
<td class="nump">986<span></span>
</td>
<td class="nump">1,444<span></span>
</td>
<td class="nump">848<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in those periods.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 65<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2793-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 66<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2814-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763214851608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 17, 2021</div></th>
<th class="th"><div>Feb. 01, 2021</div></th>
<th class="th"><div>Jan. 27, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_SaleOfStockLineItems', window );"><strong>Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale price to public (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Underwriting discounts, commissions and other related costs related to offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.7<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember', window );">Conversion of Series A Preferred Stock into Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_SaleOfStockLineItems', window );"><strong>Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember', window );">Conversion of Series A Preferred Stock into Common Stock | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_SaleOfStockLineItems', window );"><strong>Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Shares of common stock issued in conversion (shares)</a></td>
<td class="nump">22,609,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=sgry_PublicStockOfferingMember', window );">Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_SaleOfStockLineItems', window );"><strong>Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Stock sold in offering (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds from stock offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 260.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Underwriting discounts, commissions and other related costs related to offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=sgry_PublicStockOfferingFirmSharesMember', window );">Firm Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_SaleOfStockLineItems', window );"><strong>Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Stock sold in offering (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Additional Shares Granted to Underwriters</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_SaleOfStockLineItems', window );"><strong>Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Stock sold in offering (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_SaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_SaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockByUniqueDescriptionAxis=sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=sgry_PublicStockOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=sgry_PublicStockOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=sgry_PublicStockOfferingFirmSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=sgry_PublicStockOfferingFirmSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763294251720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Current Liabilities - Summary (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Right-of-use operating lease liabilities</a></td>
<td class="nump">$ 40.5<span></span>
</td>
<td class="nump">$ 39.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Interest payable</a></td>
<td class="nump">37.0<span></span>
</td>
<td class="nump">24.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_CostReportLiabilitiesCurrent', window );">Cost report liabilities</a></td>
<td class="nump">28.5<span></span>
</td>
<td class="nump">16.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_PayablesToCustomers', window );">Amounts due to patients and payors</a></td>
<td class="nump">28.0<span></span>
</td>
<td class="nump">20.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_TaxReceivableAgreementLiabilityCurrent', window );">Tax receivable agreement liability</a></td>
<td class="nump">21.2<span></span>
</td>
<td class="nump">21.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserveCurrent', window );">Accrued legal settlement</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">32.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Accrued expenses and other</a></td>
<td class="nump">53.1<span></span>
</td>
<td class="nump">62.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 208.3<span></span>
</td>
<td class="nump">$ 217.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_CostReportLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost Report Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_CostReportLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_TaxReceivableAgreementLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax Receivable Agreement Liability, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_TaxReceivableAgreementLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_PayablesToCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount payable to customer by broker-dealer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher SEC<br> -Name Rule 15c3-1<br> -Number 240<br> -Section 15c3-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_PayablesToCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 55<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=116646759&amp;loc=d3e15243-108350<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763294249448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsLineItems', window );"><strong>Guarantor Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Professional, general and workers' compensation insurance reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22.9<span></span>
</td>
<td class="nump">$ 21.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EstimatedInsuranceRecoveries', window );">Expected insurance recoveries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.5<span></span>
</td>
<td class="nump">10.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Payment under settlement agreement</a></td>
<td class="nump">$ 30.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm', window );">Projected tax savings period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal effective tax rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrentAndNoncurrent', window );">Long-term tax receivable agreement liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43.2<span></span>
</td>
<td class="nump">43.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount', window );">Net long-term tax receivable agreement liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39.9<span></span>
</td>
<td class="nump">37.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent', window );">Current portion of tax liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21.2<span></span>
</td>
<td class="nump">$ 21.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_FederalFundsEffectiveSwapRateMember', window );">Federal Funds Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsLineItems', window );"><strong>Guarantor Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate', window );">Collaborative tax agreement, basis spread on variable rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember', window );">LIBOR | Materially More Restrictive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsLineItems', window );"><strong>Guarantor Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember', window );">LIBOR | Not Materially More Restrictive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsLineItems', window );"><strong>Guarantor Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Tax Agreement, Interest Rate, Basis Spread on Variable Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Tax Agreement, Projected Tax Savings, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Income Tax Liabilities, Net Of Discount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Income Tax Liabilities, Net Of Discount, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EstimatedInsuranceRecoveries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts expected to be recovered under the terms of insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EstimatedInsuranceRecoveries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_FederalFundsEffectiveSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_FederalFundsEffectiveSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualRiskOrUncertaintyByNatureAxis=sgry_MateriallyMoreRestrictiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualRiskOrUncertaintyByNatureAxis=sgry_MateriallyMoreRestrictiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualRiskOrUncertaintyByNatureAxis=sgry_NotMateriallyMoreRestrictiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualRiskOrUncertaintyByNatureAxis=sgry_NotMateriallyMoreRestrictiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763211239048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Revenues and Operating Income by Reportable Segment (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 559.2<span></span>
</td>
<td class="nump">$ 496.1<span></span>
</td>
<td class="nump">$ 1,614.9<span></span>
</td>
<td class="nump">$ 1,311.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="nump">76.4<span></span>
</td>
<td class="nump">61.1<span></span>
</td>
<td class="nump">225.2<span></span>
</td>
<td class="nump">165.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract', window );"><strong>Reconciliation of Adjusted EBITDA:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Income (loss) before income taxes</a></td>
<td class="nump">9.4<span></span>
</td>
<td class="num">(33.0)<span></span>
</td>
<td class="nump">26.5<span></span>
</td>
<td class="num">(61.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to non-controlling interests</a></td>
<td class="num">(31.1)<span></span>
</td>
<td class="num">(27.3)<span></span>
</td>
<td class="num">(98.6)<span></span>
</td>
<td class="num">(75.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">25.2<span></span>
</td>
<td class="nump">24.1<span></span>
</td>
<td class="nump">76.1<span></span>
</td>
<td class="nump">69.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest expense, net</a></td>
<td class="nump">54.2<span></span>
</td>
<td class="nump">51.5<span></span>
</td>
<td class="nump">160.9<span></span>
</td>
<td class="nump">147.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Equity-based compensation expense</a></td>
<td class="nump">4.1<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">13.4<span></span>
</td>
<td class="nump">9.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts', window );">Transaction, integration and acquisition costs</a></td>
<td class="nump">10.2<span></span>
</td>
<td class="nump">7.5<span></span>
</td>
<td class="nump">31.0<span></span>
</td>
<td class="nump">30.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">33.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">33.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation', window );">Loss on disposals and deconsolidations, net</a></td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">7.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts', window );">Litigation settlement and other litigation costs</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">(Gain) loss on debt extinguishment</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">9.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_BusinessCombinationGainLossOnAcquisitionEscrow', window );">Gain on escrow release</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemNetGainLoss', window );">Hurricane-related operating losses</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="nump">76.4<span></span>
</td>
<td class="nump">61.1<span></span>
</td>
<td class="nump">225.2<span></span>
</td>
<td class="nump">165.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Transaction and integration costs</a></td>
<td class="nump">10.2<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
<td class="nump">24.7<span></span>
</td>
<td class="nump">15.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Start-up costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
<td class="nump">6.3<span></span>
</td>
<td class="nump">14.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Other litigation costs</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
<td class="nump">3.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Litigation settlement</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Surgical Facility Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenues</a></td>
<td class="nump">542.1<span></span>
</td>
<td class="nump">478.6<span></span>
</td>
<td class="nump">1,563.7<span></span>
</td>
<td class="nump">1,262.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="nump">96.9<span></span>
</td>
<td class="nump">82.5<span></span>
</td>
<td class="nump">287.5<span></span>
</td>
<td class="nump">229.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract', window );"><strong>Reconciliation of Adjusted EBITDA:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="nump">96.9<span></span>
</td>
<td class="nump">82.5<span></span>
</td>
<td class="nump">287.5<span></span>
</td>
<td class="nump">229.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Ancillary Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenues</a></td>
<td class="nump">17.1<span></span>
</td>
<td class="nump">16.7<span></span>
</td>
<td class="nump">51.2<span></span>
</td>
<td class="nump">46.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
<td class="num">(3.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract', window );"><strong>Reconciliation of Adjusted EBITDA:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
<td class="num">(3.9)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Optical Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract', window );"><strong>Reconciliation of Adjusted EBITDA:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">All other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="num">(20.5)<span></span>
</td>
<td class="num">(21.2)<span></span>
</td>
<td class="num">(61.3)<span></span>
</td>
<td class="num">(61.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract', window );"><strong>Reconciliation of Adjusted EBITDA:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="num">$ (20.5)<span></span>
</td>
<td class="num">$ (21.2)<span></span>
</td>
<td class="num">$ (61.3)<span></span>
</td>
<td class="num">$ (61.0)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_BusinessCombinationGainLossOnAcquisitionEscrow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Gain (Loss) On Acquisition Escrow</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_BusinessCombinationGainLossOnAcquisitionEscrow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Integration Related Costs, And Merger Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Earnings Before Interest Taxes Depreciation And Amortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Disposition of Assets And Deconsolidation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_GainLossOnDispositionOfAssetsAndDeconsolidation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) Related to Litigation Settlement And Other Litigation Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemNetGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of (gain) loss for an event or transaction that is unusual in nature or occurs infrequently, or both.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125520798&amp;loc=SL114871939-224231<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=114868883&amp;loc=SL114871943-224233<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemNetGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=sgry_SurgicalFacilityServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=sgry_SurgicalFacilityServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=sgry_AncillaryServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=sgry_AncillaryServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=sgry_OpticalServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=sgry_OpticalServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763294351256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Assets and Cash Purchases of Property and Equipment by Operating Segment (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 5,631.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,413.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Total cash purchases of property and equipment</a></td>
<td class="nump">43.5<span></span>
</td>
<td class="nump">$ 27.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Surgical Facility Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">5,124.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,962.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Total cash purchases of property and equipment</a></td>
<td class="nump">42.0<span></span>
</td>
<td class="nump">24.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Ancillary Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">32.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Total cash purchases of property and equipment</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">All other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">474.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 415.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Total cash purchases of property and equipment</a></td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="nump">$ 3.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=sgry_SurgicalFacilityServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=sgry_SurgicalFacilityServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=sgry_AncillaryServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=sgry_AncillaryServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139763208454632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>Oct. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Surgical Facilities, Existing Markets</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Combined purchase price</a></td>
<td class="nump">$ 31.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=sgry_SurgicalFacilitiesExistingMarketsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=sgry_SurgicalFacilitiesExistingMarketsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>67
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M#'<QS"B+99J>PK$C:BT9KMA 5MD^;67[>K8$A1Y<=2-D[2AHT)F[+BQ$8>K
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M41#6#:]P"NMQ"O&E]KQF5?'J<G1I+]&(!/C,49=5-+98<-@G_]#KZG^$6+]
M,J\5BWKMY)5FU3:'?-#.3NVX,].'=M@GCB!TV<4X&LM@>( N?#%#*&TF1QDJ
M&1_8^LBJC"ND!6*;35[ W+A#M.W[9.TL@W@Y_#MWQ&ZR# ?NGKK1,P@3KQMU
MZ303F]E!<626'BRG:HL*#M6))T+:7D^&E82#Q=^*=ICA<+# 3E7WG,-^T'T2
MU7:FN2Q-T<0AG-=(LY\^O=3.=Y!TSE>ZTRP:Y*93O3WOL!]X368L.M4>H3;.
MXM!>U8U5?)(=1T3VR,-^YC79T2/-!32*!XF@%>>PBS =0S+NV8>3-Q5,$%?/
M$%P:X.RKFG#/+>P'5U>/[-GK6#&";2!AG-@KWF$6AJ.^]^3"?G2!1'F 90X*
MI6ASYC.O^"8?F2R;3@L:A-X,8S=)XB *!W]C@=O3#?OQ]IFO\XQ);D &NRE9
M@PQ\:O*H<:H+Z*TX<EF9![ JMY*-E+'8IE.*K6K"887#Y5A@DYYAQ,^PTY)G
ML#!=4HG-(A*F5G"W9B?!C4>BF_2\(GY>_0H>V'P>9"W1U S%()$^.T%+;.XD
MH36^+JOH36N'#+9+?E2=5F^7QMHF3QS9@'*9094^MBYZ0)&W ^H9RK>"*]5)
M[Z? J=QF$%DL<7 >KFX[,E8CDQY6Q \K;TEP:=@=NS%,K#V;RPRRY$A11GJ$
M$3_"SCE[2:U-*H-[2ZW#C"Z#L9#L>4;\F[DOHIIEHM(FH9L1ANJ70\6NU=__
MEA),WD,6Y+P< Q*QMW"FMK+$.\S"\17>,Y/XF?FM$X=@&]+F;*5%]@/-T(J;
MG3.Z>X_4#K(]9/:#WL%N^O]@,T,@<PH)H7N8*V70)B02!ZU@![ VHS%#E:AX
MS82VP>E^YCTRXU/NZ^W/D14'#DVNVJ%K=D$1C8+X\BZH]728<,/S4;2Q7G<^
M,HH]UDGJ+6E69L!VHEASJ?Y1[_?TJZ^F(3UIR:6-Y,FD3-%5&(086"N;P7)/
M#6D&^JVSXQS-Y>71])F<GGSU)*9^$M^+LH2%\%><I>&HM_66],3=E$RC.)W2
M-*X?QN$T2O!T$2:7UQ>UN6\3U&DTLKYH3WWJI_[=>IV;  %PFG.C&>Q4,[;/
M :1.H=B:%PS)XERIJR(8/1.D/=^IG^]W@[.-YC@@$R7DEITYMS\">H1R'V3:
M#)]%"XN7K=G0N5DR4I30P8FK'_3?N&;P4UVWYEGN+*&H3>I9'!)KX^2RBR@>
MR]6T)SKU$[VIG%8'N>7R%3TQJ2O(-U/TL<J")F+.4I#3"YO9"RB5SJM7AQG&
M\=AI$>W13OUHOP1+2$<S/S"IC?'%,K:.]5QF23(:BCWMJ9_VS22\>;03.Q3C
MF)QKM>&>IF3L?(7V<*=^N#=:!]53G?/>K'UA?31P'A2X[%P'!?/!%R;S>>\S
MD]N\4E"1;J!A&"Q@E&3SQ:RYT6)??W1Z%EJ+LK[<<0:RC0$\WPBA?]V8[UC=
M=\O;/P%02P,$%     @ :3AC4YOM9X6< P  A@T  !@   !X;"]W;W)K<VAE
M971S+W-H965T,RYX;6REE]N.VCH4AE_%BGHQ(W63,X<*D!B@:J5VBH9V]Z+:
M%R888HT3I[8SM'WZO>)D0D)"8*8(@9VLP_<[RUG)^,#%HPP)4>A7Q&(Y,4*E
MDG>F*8.01%CV>$)B.+/C(L(*IF)ORD00O-5.$3,=R^J;$::Q,1WK8RLQ'?-4
M,1J3E4 RC2(L?M\1Q@\3PS:>#SS0?:BR ^9TG. ]61/U+5D)F)EEE"V-2"PI
MCY$@NXDQL]_-;3]ST!;_4G*0E3'*I&PX?\PF'[<3P\J("".!RD)@^'LB<\)8
M%@DX?A9!C3)GYE@=/T=_K\6#F V69,[9=[I5X<08&FA+=CAEZH$?/I!"D 8,
M.)/Z%QURVP$8!ZE4/"J<@2"B<?Z/?Q4+47&PO3,.3N'@7.O@%@ZN%IJ3:5D+
MK/!T+/@!B<P:HF4#O3;:&]30.+N,:R7@+ 4_-9U_N5\L[]?+!8+1^LNGCXO9
M5YC<S3[-[N=+M/ZP7'Y=HYL5%B16(5$TP.P6_8.^K1?HYLTM>H-HC#Y3QN":
MR+&I "D+; 9%^KL\O7,F_9HD/>1:;Y%C.7:+^[S;?4$"<+>UNU5W-V$ARM5P
MRM5P=#SW'(["BD"1*L1WZ#V-<1Q0S-"*2ZJ+[L=L(Y6 TONO(YE;)G-U,N],
MLED0I%'*(.,6"@\V(>326>";"-BH0OU&.-XB\C.E24;5MKYYCJ'.D>W9IZGC
M>V/SJ;J(N4V_8F,/1SVWM*KA>R6^UXG_0+8$;BD;1H"6[(@0H /J-7A\BV0(
M]2(13E7(!?T#)V[R0[=M$O(\?@7/M2WXG*BX:%:3X9<R_+^50:5,+TCP&VRG
M]$V++OI^2=__6WJX=TL%943C?:>$_D4)38LN"8-2PN#5$F!(HD1OBB?,4M+&
M/6AL@%/N0:/\/=?K^>W8PQ)[V(F].F5-L,@AT0W<$K/[(^S@_"*TKG<>?E3E
M[EGV"?H%HQKYJ"0?O8S\9;MUU*@"Q\H_)^Q7&-;X;>O8LZQ7*;ABHQ:1N\J\
MTZ1.7.FR]JN(K]V<1?A.["Z3.O:Q'=I.)_:<1Q'LO5=6>!'\0HE?LJJC'YNK
MW=U=Z^@O*_$B=.U.9[47^56F=0G'!FMW=]A6"=?4>+-3#AW/'[I#_Y2^:>E;
M7M\>6/TS\,>V:G?WU5;XJ\N]V2W/*6A:GE%@5AZ2LS>4SUCL:2P1(SMPM7H#
MB"'RA_Y\HGBBGYLW7,%3N!Z&\*)$1&8 YW><J^=)]BA>OGI-_P=02P,$%
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MMS(^E7;K1V>Y!V&>_V0/46XRE<-N#&;1F P-H>4$WI=2,)C<:#TD8+Z#JX:
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MR/ZC<X%M&VA]%)*EA3%DD,8T?^*W0H<+ _"C-W * Z=JX-TP< L#][,1O,+
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MRYD,KA4!=RN"9XEHCG"GF:B?=(#:]FIZY6YZ/9:(;IIMYZW,$8V P+"?<LC
MMJ>DJ9>[J?>(\IDCC$>!DIMVPMH]TX3'.U;F_\\!$H)->0Y7[3P*'0<$^,XY
MP(YU^S,.D& V#CG<]B?$!V)VA.!\,V<RYI!%PP#J9P36XX%9VSD&"SB@H"F"
MD\*ZGN*:O+F;O(^BGSGD=HM^MB#M.H!K'<#=.N"0^KEIJDL_(S"HGSD4$YA^
M;F!N_8S4A>IG!.?0SUPK&![^>/W,M33A1SB3R>$Y!\)L*EAH@2*.F)A HY:
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MY\8UM''0<_<,B"_EM*23(D-T*Z3F_]@+/B^6RTV.'#09#Z+9\5_+I>Z,\6Q
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M-4U/G\NE0K7;I"1#E_QIW_"$6&&ZVS.0#T1S6;(DXIDDMP?[F0A1;0GEC<E
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MD1O@D._<O.F.\/&9-0@M]\7E5;(%N-Y387@46K?G]"#]8.J8!H,M]J0'S=C
MDV)<T&0TX#9"6P^$:P<!"4\KXTI2*<E60LQB51^&1N)59GFF1, K90D:K<4/
M3O:H>>+H-%JU+G-+]-Y4473FC:<-(&D'=XX)*PT<E $ZD@T5T!Y \D2P'1@"
M\L );F)4WESA(&:@'FU@P?>&9'<S[!G"V&@:E@D$_\/&\'8Q%H:@8E>OOTB)
M=J4-R<D%K(8&(IH#262^ JEBP)(FM8YQ$P4\:3JZ2Q5I3X*YI3I9J_+W#2&%
MS(\R90,E]&>]_&;+DG"W N<;,6F:3W0[?6N\)1(XJF3MLE6][G()H>2T&.^Q
MQ/+T!UC&K<7=3R+%,.!/'1DS1#,:QSP9_?33W>@TI'$U83^HM+.+^A'QT(\N
M>O2!_JHE24BMECEO-I%!S0#*GA*).6C9<%PA%BR6,]NF$-^$_ UY";Q_?^N(
MZO,5AYMZ\GTI6RE$Y2B)/;N8E'XI"9>//M.*9.#92?:X?13;IPQ%%4L@X4T5
M4)EXI?+KL RS?I: +Q*=O*><3:@W5G=8S,1ATL#WB&7-?#J9A@(O%!".W E_
M!=G(RHNA!$B1Q"#2ES@8-EEM7F#:8L8J]*>)L-L>LXFGHH(,$_\=R(KG)60<
MSCNV0>E"3'I^!EJ-!),0L%6J'"(L-'Z\L_H5&^+<E$B<JX9ZW"NSRH]SEA [
MF'%!5#"P:I[K($J"%,&>U$RX;D7.-MV+0C^&D>&=0+RY6S0B&ZPCG>2BYUB?
M%2XF&\B_:,=KYJU)0ARN,M4+DBC"%XPW*%F/49L-COQ3-&N'V=3T\$%JM8NV
M8BD#F88L_WLD93(!#[ML90QA )8Y"Z6M$&Z\8EZ+^:S!4O]<>5RML.-$%IZC
M-@ AGFXOVN84%WE_&F)BJ: [[VPS.]+8^AIVG-#M#C29$L[8IEX0O1U4[;3,
M^[SJFF(?/28.HA(BQJ_),V7S/"63GX&D?:C9)2+?:I.L2#3C5\=UWO(5+RV(
MDQWZ:3$U$$6GI35AW8"W 1MS$#Z[YXU0DQG*!Q1B86=EH4)M"VGO 9)DZ&Y'
M.BHV^H<V9BBUB-EA\_-6L?*EWY)4 =*]8BR39B(+G&%V"QFT8(Z:K+-Y),('
MA5E@[#T6F)4)=P<NQ@,1AQ>&$CR/8\-/DH*3Y(>^T<D^P1,4P_A@U=Y,QA@O
MSMSW,1AI9[@.!@D6*%LVR-3_&4@9>3Y5X:7"A/'1B.=DU4)M_.(/=0KC@AD0
M\_R/-,S3]$L0ZZ-I'8=Q?E<=DT87-?;PX[%:[$>EA'35JOV;@_<1R%%'?($H
MRHHL+!9K\XNO. _$,0JR.N"&Y\RQ;W^^([[G868SNX^<+;&3IHAKDG%3$%T7
M8_4['1K8VG>R@CCF8OK(5)I\$>7%<C3_K).*PJRZ%AI!Y+_*L*PS @2B)IG=
M)P^@CL:)UV[QAY'@N8N]PX!+:I6AYU]-CB:GAQ7Y.(I#LQ+2D('CJ"'R0."D
M[QI.8Z*_N3A&]&I./D*I_X?6CXB5@OR?ER!(AX+' 11U[Y\*8\K/G]VYQ941
M*QM6D>RS\Y"]\G\4.3J@MTV"0I+,F;N"O=0E<GTT-J  ]G$*<F,TG$93(&6$
ML+AQ4ELD\V^'\0;(MF)E)_#4Q%3OO&@K]$Q*2H_N]7[C <72+W-+W<^R56-W
M8Y,&Q-.7VY>3&TNTFM_K,<;C5$$;4G>R&8PI@+,PI5GEK4\U@&B2_W=20RR$
MW$@LFP14WE:\FX59YTTAN2R70F/S=&V+M)P)J3)K93)D5<8B]-4]A<7! K41
M':;\[Q*"GCR;+UC.6V04"8E+U**D]VE>6"<VV-1)\GM*)AXNO+=R\1T9+XRC
M?U::]MY.X42OL5.<C'Y__VYT&N<F DR+ULZYOD_H@2:M]T&8CCFTL>8W?O$U
MCD$YX!V41UJ32_*FHC]?8^H?;^_>T-R#=[VM,I>_3*YGQ JC7GGEZ##\R/"0
M]5D#RQHY%F007<B".6[ =FF<H]*41IH0/KZV@?%\&2:50C]&2TS<[!+V3A=-
M52\TYZ,99T6*R$63V4 K!V:YO&&E1H7;$ZU%8$^F_UBU)+X^KBG'/9D8T0RM
MS-/(JNKJHY5*8D0.E,4)RMM*21TN^(GY;,WX=55E+!ZU#H3L-8ZJR)UCE&.>
M.FON&&3.]GU*/=-@.."ITE7L[Q?SR\E5K/_G5_Z7(0N@=3@()=K1A<DTLYO)
MK#?-S/\23S-)?D2%S^]IT9FX:O@]UT<)N__*:42Z[][>ET8E5O9.R\>JP(C^
M/:L'=RUM!0QM*)O:8M.30JTYY!"6)]!M[8.4$W!J$P%,=K@TQ] @]<IS8NO9
M&<;#*Y49KJXC9N&.&<.O2+-TLEJ7Q\G+78?$M98XV 082_0*SB?H94,N)K)P
M^]>20KO\)ODSI'HR>TTJ7ZJL. 97L0E2<X UMW7^KC"0$X 9.'/I*;Z?48\G
MF+^F36((;5":4!C/X_*VU0)EABR:K7WC$.9P-$Y,SB.)0*.-X)(Z^\TZ4X@9
M6.:.I\/034Z$!K]D: D#"P>!'H[B4?&4(>U8;KFP#V6>/M+.L"L!-G2/G5:B
M0=M"8D:5I3GBL%3B0Q+RKPV!:#0*)=$ID:D<-<DP3[6SQ4%AI<B8+NZ,N#8:
M72K3MJN-2W>3."&*QW4F3"T_(TNVWH?^T!,K2WI"BVL,X6AR, L?L *:2.).
M \4B8Y<?Y[GN32.1V,;NG'N&S#FI+O'6(B#+ZX#-&E7FNA,$0K'4NDKX?K;C
MQLFW_JHY$Z[1L"P:]\!$]Z9@9A:MLBNI$!"+R,'F]'7RULX@0>M0%L:B/9+H
MCUXJ<Q LW %$M]@6K8@\7B2S\<79^>1"/]U,SN73_&PRU=_.Z#?2$/">&QFG
M*^U(4M@'-YCT"08YNYKR@_[O9?!W1C].OSC.%=U_<7[!S[F_US>3,_R]N9Q<
M]P2_LZ4E29(N4%;!.L>)3)5,EJTD4_P8>_<X.2]C\7"4_@N;7XGWO>\(\.YK
M/J:?[18-AO(3Q"VBFQZGXMYJSW2U*)23N%^O=\&& X.B9EF 5KMQM9]Z ;8
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M QIT9LJ.T%IR]QS*\_-:A*4<'@@.?$C#!/BQZF\KPJ6(1>/I@>X$VLD=K/A
MA<=/-L*)!7QE88_A](T=!DS&RST*1UF%T$.>^66QWR<5>)+,_+'C'&5T<EC
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MT@'L5P;=LWL@ ;N/5-=_ %!+ P04    " !I.&-3>VBX7_X#  !U#@  &0
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M=ZK+>)7X+AXO9.^967/EV[TAU3Q]1;/7Q$M.7#C=A8O%2CNZIH3/ENZ%:+P
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M:310IBMHORWU(]0F)8 WBK1JWYS4'*0V%JDJX>KRL5N8GO)<5YB^?.T !]W
M"R0RRRIR%0N9!1S5MD$.4Q6:0\K[VP M8%%MB3AV>$;7$@1<F?E*GQGL420D
M%F%A4V MD *C2KS,UJ&X-;6VQ6NQGEI-(M<3Z7'5IX@>&,@6>6!.GDT\@M='
MG,6XKD4@]-)"4"M(4P:])YB7OD+U%JIG7$?N:GN7J&U,#@/Q*\JD[L>7.W)P
M*C,&TWQ 457V31U<6XD-%;;J1+":M%8'$-]D06*<KXO07I5=O:S3QAJOU 4
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M@VZ%6RU8%]75;HBI^-"?6\/!N/7\Q*1X1_?07<YDXJ-Z8J]@PS/F1 /.>$"
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MH\8U<WI%HN8)-+Y1)$/M!R_0OTLO_P%02P,$%     @ :3AC4SK9V$+M @
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M\QY= $R#;,YO,$* \1]D^3=02P,$%     @ :3AC4]7>\\_L$0  \#(  !D
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M]V.\DQ4M?E]&,K4I-+%-E-?X!'%4 V!AP<;*E.O";>FS6I,=;&9DZS5$(-E
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MN'8=SK/]%J4"5P/O/%HWUJH>/_7/;LQ%D<^I$^5L5^[Q@/"U7A]HLOVR^"8
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MI@/87REE^P<2L/WK=_5?4$L#!!0    ( &DX8U/ KRV910(   @%   9
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M7UU.$ORH=XOJT?F\NCR_O)B@]R@)XQ'1>_05PIA7KYT-<-@FR^:#UT';CC\
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MH(C Q38BFD'H(TL$.\%69H@PAXI\SA!EVM*W.U[E*":B(;5<"S ^T8N864F
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M)$6R[LB,91?DG$4,#XC,&UI;Q@628]-C>231B^$,6/J:$IALBZGJACH2ITD
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MVK>>,GJ/+^X!!'^"S#C[+*I?R+).D]KXYRE>%-TXZKTUH%2#%YE47\7'**J
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M(^%&O_> G1KIOLYS2_#.&7'2FNN]&)W4N?3F$^]73#/$'A3!V&'TI#?E<#Z
MIW&HLU3R4K4T^G=#KU51!AC.8#>]ED&1".S+ 8]BX&6>)L$CY,V-,O@R32I
M6H'DB)U2GI:T6CR5+@J)RQ&+F?/T0,LW4H0&I>Q $8VH=%']TI?AE<0(T0]/
M( *45QN2CH% 7[,S4RLA7MV01]UV<I^!S55!KXWF5:%\) S!$HU*((^C;C#P
MXVCK12@8H"L&$NGJ(JJ$)X:E>3EXJP5,F(,0[B^'C@72L""@/O*P+"F;(Y #
M,*L?C:U+Q[*0L=>PAXW38OD-HOG4ZT/SP>XGEZ^GUYE5',+BS@^.\!%_@=_B
MT*<<#4][C[H@3A!JMB1]A,7O3;_YA'1DIUA FW3'U4@@+R/"L-$?[V2PO<V
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M O@>7[Z+O^ &Z6^1O/Q_4$L#!!0    ( &DX8U-(S9:O& 8   D1   9
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MBF80=O=_4E*C%(EB80#1 Z@T5^P5"[MIG/32IC?L)74OBGM!,Q=C+NOE:7
M 5[.0JTD*>U@9@E@("$)B?/ ;WQLL[4VQ&3PK)P<Z],D]?O:=C#LQ=0.L]Z
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M36CNX$OUT42.2W<I-U:3E5.<G<W3^YH;[CIDX/"6K02:HTED"=HY1.D69M'
M)&_ G,&EDK8P\$%FF+V,CXA2RRO9\5HD>P%OL IA$+^#)$[Z>_ &;9T#CS=X
M V]1&](8 TM5KKADS4C(#.;&T.AWV@ _YRMC-8W+KSUYAVW>H<\[?*L.>D59
M+1#4NDEEFEP:,Y_^@K,5%Y08C;/7Y>ON-<W:F\0]W+&I6(K3@%ZF0?V P>RV
M0&!YKC%GEDZEJB4E)[O@-$=,<_%$KRI5N>1_B R];T"6%C1<O^F8"D;-(M*L
M(<VZI$6'-&M(^WCK4G8'BFE2&+()>OPT7US2# OA;$=CN%66"4A)X!GJYDH.
MH!\/PAC.&=?PP$3M.R>5[)&?U03$90Y<6J1"B=?P)!S"_+G,SCUF3K%^QB'H
MX1EY?Z'[?E75&):UUBA;PP&<A&=PI6GY:?ODBT9RK4KG,PA'\%&I;$.E$.8Q
MB7Z9]=2Z5QLB7/EJB*= 6A@[S%&8P%=JD0:A9-ZC"LJ=*0[[+8-N<P\IY@@N
M6O<,5Q8.R?MH?\87&*?._?]:]*_!CSI+ID2=^U5JZ/IHKII]TVK;;3UOEM2S
M>[/J+YG..8V'P#6%QN'I<0"Z69^-8%7E5]9*65J _EC0%P>U<R#[6BF[$UR"
M]ALV^PM02P,$%     @ :3AC4SC-KZHI P  L@8  !D   !X;"]W;W)K<VAE
M971S+W-H965T,C(N>&ULA55M;],P$/XKIVA(JS3RWJ:MVDI[ 3$)T+0-^(#X
MX";7UL*Q@^VLP*_G[*19A]CXXOCEGL?/G>\NB[W2W\T.T<+/6DBS#';6-O,H
M,N4.:V9"U:"DDXW2-;.TU-O(-!I9Y4&UB-(XGD0UXS)8+?S>C5XM5&L%EWBC
MP;1US?2O"Q1JOPR2X+!QR[<[ZS:BU:)A6[Q#^ZFYT;2*!I:*UR@-5Q(T;I;!
M>3*_R)V]-_C,<6^.YN \62OUW2VNJV40.T$HL+2.@='G 2]1"$=$,G[TG,%P
MI0,>SP_L;[WOY,N:&;Q4X@NO[&X93 .H<,-:86_5_AWV_HP=7ZF$\2/L.]NT
M"*!LC55U#R8%-9?=E_WLXW $F,;/ -(>D'K=W45>Y16S;+70:@_:61.;FWA7
M/9K$<>D>Y<YJ.N6$LZOW2FY?WZ.NX0K7%D[OV5J@&2TB2^3.)"I[HHN.*'V&
M: 8?E+0[ V]DA=53?$2B!F7I0=E%^B+A'38A9/$9I'&:O,"7#9YFGB][AL_[
M=\5-*91I-<+7\[6QFK+BVPOD^4">>_+\.;%=3H/:@(^H/43T7X%\D<I5X=PT
MK,1E0&5F4#]@L#H_5(V[00PW5,ZGC1)46@9.N:0,$8*2W8SF0/&S6*]1^R!>
M8=DODC,ZDEQ196))@:C 4PG%))PF(SB!Y&R<Y>&XG\W"'"9A,8Y?$<#C6GE
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M +U^Z/2#XJP3S<F6*\F$W*_OKOP2!YP0.O>A,YE86NT^^Z)=K>RSA=+?S!S
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M)@9<CY2RY8045-^&1O\"4$L#!!0    ( &DX8U,&D'.P*00  /L(   9
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M<FMS:&5E=',O<VAE970R-RYX;6Q]56UOVS@,_BN$-QQ68/-KTJ5=$B!--]R
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M=$%A&FAS?(,0'(S_CN5/4$L#!!0    ( &DX8U/?\F%9@P8  &X2   9
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MI ["..CW">?JO# !BME__#]02P,$%     @ :3AC4W;(\I[= @  3P@  !D
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M*=$\%7T3&\S(;UQVC25H50X,XBFZB&->,$78!BTY)3$!B3ZB>RP(7E- "Z9
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MPTS_1: P#GH]Y5SM)@; _9=,_@)02P,$%     @ :3AC4S&1WS^X P  3 P
M !D   !X;"]W;W)K<VAE971S+W-H965T-# N>&ULM5=1CYLX$/XK%NI#*S4!
M0T*251)I-]N]J]2]6S5M[^%T#PY,B+6 4]MLMO^^8R# -N!6I[M]V(#C[YMO
M/L;#9'D2\E$= #1YSM)<K9R#UL<KUU71 3*FQN((.7ZS%S)C&F]EXJJC!!:7
MH"QU?<\+W8SQW%DOR[4'N5Z*0J<\AP=)5)%E3'Z[@52<5@YUS@L?>7+09L%=
M+X\L@2WHS\<'B7=NPQ+S#'+%14XD[%?.-;W:T(4!E#N^<#BISC4QJ>R$>#0W
M[^.5XQE%D$*D#07#CR?80)H:)M3QM29UFI@&V+T^L]^5R6,R.Z9@(]*_>*P/
M*V?ND!CVK$CU1W'Z'>J$IH8O$JDJ_Y-3M7<Z<TA4*"VR&HP*,IY7G^RY-J(#
M0)Y^@%\#_!\!DP% 4 .",M%*69G6+=-LO93B1*39C6SFHO2F1&,V/#>/<:LE
M?LL1I]?7T=>"*VXL561$MM73)*]O03.>JC>X]GE[2UZ_>D->$9Z3>YZF9N_2
MU1C=<+A1'>FFBN0/1%J0>Y'K@R+O\ACBEW@753?2_;/T&]]*N(7CF 3>6^)[
M/NW1L['#;R%"."WAGD5.T#@9E'S! -\?>.:84J 5UB::*B&^LM!.&MI)23L9
MH/U-B/B$IO<97B'#$FG.Z],Z"&DP#I?N4]>':MN\NVT2SIM-+V1-&UE3JZQM
M(1,>L93<L8BG6#^@WI)WSUQIGB?DGLE'-,*2?MC$":VNWA0*5Y0BG4(E?W_
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M"U56HVMUH\6QG/YV0N,L65X><-P':3;@]WLA]/G&!&A^0*R_ U!+ P04
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MV<<M7)*I- ;P?BW@8U0#<ZNJK]VS?P%02P,$%     @ :3AC4^%>F/#M!0
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M>CZ51@#&YP+:97EC/M%4WR''_P-02P,$%     @ :3AC4Z")?GG@ P  *PT
M !D   !X;"]W;W)K<VAE971S+W-H965T-#,N>&ULG5?;;MLX$/T50NA#"S2Z
MRY? -I X#3; !ALTV^[#H@^T1%E$*=)+TG&V7]\AI<BR)"MI7RQ1GCDZ9SB<
M&2T.0GY7!2$:/9>,JZ53:+V[]#R5%J3$RA4[PN&?7,@2:UC*K:=VDN#,.I7,
M"WU_XI68<F>UL,\>Y&HA]II13AXD4ONRQ/+_:\+$8>D$SLN#SW1;:// 6RUV
M>$L>B?ZR>Y"P\AJ4C):$*RHXDB1?.E?!Y3J8& =K\962@VK=(R-E(\1WL[C+
MEHYO&!%&4FT@,%R>R)HP9I" QW\UJ-.\TSBV[U_0;ZUX$+/!BJP%^X=FNE@Z
M,P=E),=[IC^+PQ^D%I08O%0P97_1H;;U'93NE19E[0P,2LJK*WZN ]%R )QA
MA[!V"+L.\1F'J':(K-"*F95U@S5>+:0X(&FL <W<V-A8;U!#N=G&1RWA7PI^
M>O4G@1@H=('L#?KT#/D!5\PSM,:J0+>PS^B.5_EBXO[^AFA,F?H /E\>;]#[
M=Q_0.T0YNJ>,@8%:>!IX&70OK3E<5QS",QSFZ%YP72CTB6<D._7W0$\C*GP1
M=1V. CZ2G8LB_R,*_3 8X+-^N[L_0B=J8AQ9O&@\QO]>;926D+??1C#C!C.V
MF/$9S+]V1,*&\"UB=N-2H?1@Z"N8B84Q9_IIE4S<R<)[:L=CP"AVYXW1"<.D
M89B,JKZE'/.4M/E=C@B?-+"34>%7I9":_JB24>05?(:P4F0X !7<M*4M]-VX
M$X#**&D9!6?D3QN>TU&>=UP3291&0+,* :-X0QG5E SRG/9X!K/6'E0\!XP2
M=SK,=-8PG8TR_5MHS%#>WZXAEK,>@6CN1AV6 T;Q.9;SAN5\E.57+"%^K"I-
MJH DN(  EZ_QG?<W-NFPG?=C&K9.R G;P#_65?\-47V%78UQ\N[ [^WZD)D?
MNN$9CJW:'XP>45OA=YAF".H[PJ78<ZV@EJ=L#X78%'5=$%2"AKTDT+MU<^#:
MR3QVJH/PR"5\8T%+#2N8.')H/0KE4I1(G%:[X5B&O2 E22M&=2C[5O'<G9V)
MY+'"!]'OLS\Y6L/<HWZ:SKK,HU\X^\&QCP3CC:0JT[_//!YBU>,^8!6>:S#!
ML<,$R2AW.W1>B/QB;T86VP&0V,!XPJOL)<]I@?F6V/3NY! 8,KJU;6186-)/
ME+A_,OM62716V+''!>--[I>$G5;NUV1->JT>"D[0E35@%;A)1Y;7&CM+(K=V
M&E=0[:",5,-:\[29^*_LG-MY?FV^!.PX>X2I/B/NL=Q2KD!;#I"^.X5XRVHR
MKQ9:[.QPNQ$:1F5[6\#7#)'& /[/A= O"_."YOMH]1-02P,$%     @ :3AC
M4T*_/+%O!   U!$  !D   !X;"]W;W)K<VAE971S+W-H965T-#0N>&ULO5AM
M3^,X$/XK5L5)('%-[+ZR*I6@L.R>=D\5A;L/I]/*)-/6(HFSMMLNTOWX&R<F
M":4)7:3NES9Q/,\\,YYY'&>TD>I1+P$,^1%'B3YO+8U)/WB>#I80<]V6*23X
M9"Y5S W>JH6G4P4\S(SBR&.^W_=B+I+6>)2-3=5X)%<F$@E,%=&K..;JZ1(B
MN3EOT=;SP*U8+(T=\,:CE"]@!N8^G2J\\PJ44,20:"$3HF!^WKJ@'VY8QQID
M,_X2L-&5:V)#>9#RT=Y\#L];OF4$$03&0G#\6\,$HL@B(8_O#K15^+2&U>MG
M](]9\!C, ]<PD='?(C3+\]:P14*8\U5D;N7F$[B >A8OD)'.?LG&S?5;)%AI
M(V-GC QBD>3__(=+1,6 G=48,&? M@PZ@QJ#CC/H;'N@-09=9]#=,NC5Q=!S
M!KUM#]T:@[XSZ&_'4.=AX P&V6+EV<V6YHH;/AXIN2'*SD8T>Y&M;V:-*R(2
M6XHSH_"I0#LSOH40L+@?(B!3+ )0"D(R,S)X)+^3/[E2W)8*.;X"PT6D3\@1
M\8A><@6:B(3<)\+H4QS$ZZ\BBK"Z],@S2,S">X$C<9F38#4DOO(G0@>GA/F,
MEOCY[PZT23/:Q6K1)AUJX>C@?G9%CH].]D"]>HNC>D9EU*'N0+EN1IE!BBA^
MCA(!]M W!0EL>/1-IK8W]R#ZL=G%'SQI$_8JFSN ;IJ!KB H(O:;>7E8=47I
ML:+T6(;?J<&_@SB5"O6/7']?"?-$_OF",\AG ['^MP&_4^!W,OQN#?Y4R0 @
MU&2N9$R$UBN>!$#DG*1%I;M*_H\<[:J('+^?X5M-7X]9=]CNC+SU#EK=@E:W
MD=9$QC%JL+8]=DI2KLB:1RML,=M.6%<IJ)S6B:75M'[7N:.S"C^_[=."7EXM
M^TRZ>6/2BT![1:"]-_)?9#F/U24;-T1M>!**9$&.\S$;:GV8N9M>E=P6_:89
M+[CW"^[]-Q8I68/*]ENLEQDH@<0O7DFD2(PD;D&SD8:R'12N!P=IBV&!/_Q%
M]7<Y_(FJ.2OHG372J\MU0^34+S<[_R"YI97ME/Y,T9-0K$4(24AP(\4<8W(#
M2,SNG:,9F6)N_=^:2);"2UDCU)WB6?>%_,EJWZY]:"=!]JK-6$V?T5*D:;-*
M8Z=I"%;96X9Y)Z_.*UZ=.EZE2M-FF;Y;8M$O9>3V"-PS1/ ND79^AA5V75;#
MKI16^FNT]9+N+9VTU$[ZEGB6@HC.#Z"EM!13>A@UI:6<TF8]G;G,STE04=;L
M?0-CPWH)ROCW6Y+AZS9C??_,]^M6IM16VBRNEW@V)1.>"L,C7 "QMJ*4)^:4
M?&E/VTCL'0+,2@%FAQ%@5@HP:Y;)637[X4K93L!N%3+<*_L3!_]"3*A?FWM6
M>=MM%MWI2@5+%#2G)(6"O$-3)LY555-H/<52B]F!WY@GSL'P9?:V>'F5XZK]
MWH%'JX5(-.K]'*W\]@"3K_)/"/F-D6EV@GV0!L_#V>42> C*3L#G<RG-\XT]
M%!<?<L;_ U!+ P04    " !I.&-3H-O+>=,"  !/"   &0   'AL+W=O<FMS
M:&5E=',O<VAE970T-2YX;6R]EDMO&C$0Q[^*M<HAD9I]\8X *814S2$2@J8]
M5#V8W0&L>.V-;2#Y]AU[E\TV@6VD2+VP?LW_-S-^#,.]5(]Z V#(<\:%'GD;
M8_*K(-#)!C*J?9F#P)F55!DUV%7K0.<*:.J,,A[$8=@-,LJ$-QZZL9D:#^76
M<"9@IHC>9AE5+Q/@<C_R(N\P,&?KC;$#P7B8TS4LP#SD,X6]H%))609",RF(
M@M7(NXZN)E%L#=R*'PSVNM8F-I2EE(^V<Y>.O-!Z!!P28R4H?G9P YQ;)?3C
MJ13U*J8UK+</ZE]=\!C,DFJXD?PG2\UFY/4]DL**;KF9R_TW* /J6+U$<NU^
MR;Y8VT5BLM5&9J4Q]C,FBB]]+A-1,XA/&<2E@4M$4("<EU-JZ'BHY)XHNQK5
M;,.%ZJS1.2;LKBR,PEF&=F8\AQ1PGY<<R SS 4I!2A9&)H_DDBR*K2+G4S"4
M<7U!S@@3Y)YQCAG5P\"@!U8G2$K:I*#%)V@#<B^%V6AR*U)(_[8/T//*_?C@
M_B1N%%Q [I-6^(7$81P]+*;D_.RB0;959:7E9%LG9.]$@D=<@XV\:%W8P+]#
MEDME,W+[M&7FA?R:2\X)'H\]5>GO!G"[ K<=N'T"/($U$X*)-1XU3D4"QW)<
M2'2=A+UUNW&[U?8[PV!WA-RIR)U&,N[(/["%?:>&#8\CNQ6RVXA<@&*@R?7;
MD]>0QUXEW?N_&]BOP/W/;V AT?O8!@XJ\J"1/&4[EH)(-;YTB=J^O5X%>?".
M'(5^ZS@X"E_?D/"#Z!023M5Q=BE2AU]V_.@$O/: 18WPV@N65^=(NQ<LD6('
MRA40([&79=C2[X]8Z5_TWK]V:^#W3G@8OWH8?_)JE0+]AKL5U-[X#-3:53*-
M06V%*9[[:K2JEM=%C7A=7I3:>ZKPD&K"886FH=_#.ZV*ZE5TC,Q=Q5A*@_7'
M-3=8\4'9!3B_DM(<.A90_8<8_P%02P,$%     @ :3AC4SEJW%2<!0  LQP
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M?H/:*327&2S#U*Z/+45W(I(9M85MEO[/7^&7T)VAF?ZK!6>WPMEU.'MG6X\
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M5=8 [B=2FL>)?4E0O12:_0=02P,$%     @ :3AC4UPV>![% P  00T  !D
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M/V3F RTR>\;9" TG)GNYAX,YDV8"/-\*H9\'YMA4'/5G_P)02P,$%     @
M:3AC4V$)]4,: P  # D  !D   !X;"]W;W)K<VAE971S+W-H965T-3(N>&UL
MC99=;YLP%(;_BH5ZT4HKGPF0*HG4)II6:=6J9MTNIETX<))8-9C9IDG__6R3
M4!(([4V"X;SG/.<]@!EO&7\1&P")=AG-Q<3:2%G<.(Y(-I!A8;,"<G5EQ7B&
MI5KRM2,*#C@UHHPZONN&3H9);DW'YMPCGXY9*2G)X9$C4689YF]W0-EV8GG6
MX<0366^D/N%,QP5>PP+D<_'(U<JILZ0D@UP0EB,.JXEUZ]W,/%<+3,0O EO1
M.$:ZE25C+WIQGTXL5Q,!A43J%%C]O<(,*-69%,>_?5*KKJF%S>-#]J^F>=7,
M$@N8,?J;I'(SL6(+I;#")95/;/L-]@T-=;Z$46%^T;:*C5P+):60+-N+%4%&
M\NH?[_9&- 3>X(S WPO\SPJ"O2 PC59DIJTYEG@ZYFR+N(Y6V?2!\<:H53<D
MUV-<2*ZN$J63TQ]R QS-2LXAE^@[P4M"B20@T#5:5*-%EW.0F%!QI<X]+^;H
M\N(*72"2HP="J9J%&#M2H>B$3K(O>U>5]<^474!AH\#]@GS7]SKDLW[Y'!(E
M]XS</98[RH#:!;]VP3?Y@EX7FMW/B4@H$R4'].=V*217]]O?GDI!72DPE09G
M*IGGY)JMKDL!2#V,'$N2KQ$%=2LB^@[096F5.329]>/Y.AVX]G#LO#:-:P<%
M(]NO@XZ@!S7TH!?Z/I? 04A4X#>\I- %5V48-NM&)VA52-0(\0<-_B.T88TV
M[$6;,87%H6!<?F3?L%T^;MG7#O)">]3-&-:,82_C;<;*7 J4EH D4R8J0KW&
M>:H=9;P3-VP9ZL<GL&&[(_<<;%3#1KVP/_%.^9D >=631GC- 3+];CBX^]8%
M&[5)O,9=5^%^$'2$&]>X<;^W2<)+2-4#M,84"9"2&MPNR+CEJ'M"&+<( _\<
MX:@F''V*$'9JZQ50C9WI%TX7XZA%, QL[P2S'13ZC: C3,]]WPG<_LDSB6GG
MJ]QMO5-\-[:#$ZI]6'PTW^B$RFEL5?H[X0'S-<F%FM]*J5P[4N/AU=9;+20K
MS.ZU9%+MA>9PHSY7@.L =7W%F#PL](98?P!-_P-02P,$%     @ :3AC4]RK
MLBH!!   X X  !D   !X;"]W;W)K<VAE971S+W-H965T-3,N>&ULM5=;;]I(
M%/XK(ZO5)E**+Q@"%4%J8+,;*6DCHG8?5OLPV >8[=CCG1D@2/OC]\S8L2'
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MH[A>1=A4>3YV;8MRIGAV_&O0\6]-7_X%4$L#!!0    ( &DX8U,,/Y#\Y0$
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M$U!+ 0(4 Q0    ( &DX8U,'04UB@0   +$    0              "  0
M  !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ :3AC4]=%R_?M    *P(
M !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%
M  @ :3AC4YE<G",0!@  G"<  !,              ( !RP$  'AL+W1H96UE
M+W1H96UE,2YX;6Q02P$"% ,4    " !I.&-3:/:J+$,%  !R%0  &
M        @($,"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%
M  @ :3AC4RD[)/\U!P  PQP  !@              ("!A0T  'AL+W=O<FMS
M:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( &DX8U.;[6>%G ,  (8-   8
M              " @? 4  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"
M% ,4    " !I.&-3!->)6\D(   J)P  &               @('"&   >&PO
M=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ :3AC4V"^H9Z7 P
M4@L  !@              ("!P2$  'AL+W=O<FMS:&5E=',O<VAE970U+GAM
M;%!+ 0(4 Q0    ( &DX8U.C5R6'"@L  +Q(   8              " @8XE
M  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " !I.&-3 :6*
MPG\'  #>'@  &               @('.,   >&PO=V]R:W-H965T<R]S:&5E
M=#<N>&UL4$L! A0#%     @ :3AC4[8MP>CB)@  DWP  !@
M ("!@S@  'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( &DX
M8U/V=;!.N 0  *\+   8              " @9M?  !X;"]W;W)K<VAE971S
M+W-H965T.2YX;6Q02P$"% ,4    " !I.&-3]#IN*9@'  "P$@  &0
M        @(&)9   >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0
M   ( &DX8U-[:+A?_@,  '4.   9              " @5AL  !X;"]W;W)K
M<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @ :3AC4R(SP\O"!   UPH
M !D              ("!C7   'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q0
M2P$"% ,4    " !I.&-3_I7_+WH+  #E)@  &0              @(&&=0
M>&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( &DX8U.BFJK;
M, 8  *,.   9              " @3>!  !X;"]W;W)K<VAE971S+W-H965T
M,30N>&UL4$L! A0#%     @ :3AC4SK9V$+M @  308  !D
M ("!GH<  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " !I
M.&-3U=[SS^P1  #P,@  &0              @('"B@  >&PO=V]R:W-H965T
M<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( &DX8U-=6N[M3@<   $4   9
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M970R,2YX;6Q02P$"% ,4    " !I.&-3.,VOJBD#  "R!@  &0
M    @('4Q@  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    (
M &DX8U--TWN9E0,  "X(   9              " @33*  !X;"]W;W)K<VAE
M971S+W-H965T,C,N>&UL4$L! A0#%     @ :3AC4V2QX+:E @  J04  !D
M             ("! ,X  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"
M% ,4    " !I.&-34#\-JIT%   G$@  &0              @('<T   >&PO
M=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( &DX8U,&D'.P*00
M /L(   9              " @;#6  !X;"]W;W)K<VAE971S+W-H965T,C8N
M>&UL4$L! A0#%     @ :3AC4Y>*BCOX @  1P8  !D              ("!
M$-L  'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    " !I.&-3
MW_)A68,&  !N$@  &0              @($_W@  >&PO=V]R:W-H965T<R]S
M:&5E=#(X+GAM;%!+ 0(4 Q0    ( &DX8U.U,N$PP0(  (0(   9
M      " @?GD  !X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%
M  @ :3AC4XF?;7AU P  !PP  !D              ("!\><  'AL+W=O<FMS
M:&5E=',O<VAE970S,"YX;6Q02P$"% ,4    " !I.&-3=LCRGMT"  !/"
M&0              @(&=ZP  >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+
M 0(4 Q0    ( &DX8U,M\5[J\P,  #82   9              " @;'N  !X
M;"]W;W)K<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @ :3AC4\VMT]5G
M P  SP\  !D              ("!V_(  'AL+W=O<FMS:&5E=',O<VAE970S
M,RYX;6Q02P$"% ,4    " !I.&-3:OA,:R@%  "I&P  &0
M@(%Y]@  >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( &DX
M8U.U.W3M.0(  &X$   9              " @=C[  !X;"]W;W)K<VAE971S
M+W-H965T,S4N>&UL4$L! A0#%     @ :3AC4\3T;T6> @  -P8  !D
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M=#0P+GAM;%!+ 0(4 Q0    ( &DX8U,0N/ A( 0  ((/   9
M  " @=D. 0!X;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @
M:3AC4^%>F/#M!0  DQP  !D              ("!,!,! 'AL+W=O<FMS:&5E
M=',O<VAE970T,BYX;6Q02P$"% ,4    " !I.&-3H(E^>> #   K#0  &0
M            @(%4&0$ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4
M Q0    ( &DX8U-"OSRQ;P0  -01   9              " @6L= 0!X;"]W
M;W)K<VAE971S+W-H965T-#0N>&UL4$L! A0#%     @ :3AC4Z#;RWG3 @
M3P@  !D              ("!$2(! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX
M;6Q02P$"% ,4    " !I.&-3.6K<5)P%  "S'   &0              @($;
M)0$ >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( &DX8U-O
M:!HIN 0  )8>   9              " @>XJ 0!X;"]W;W)K<VAE971S+W-H
M965T-#<N>&UL4$L! A0#%     @ :3AC4\K=_*7U P  (!(  !D
M     ("!W2\! 'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( &DX8U/<J[(J 00  . .   9              "
M@?5$ 0!X;"]W;W)K<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ :3AC
M4[B:^;;J!P  E2@  !D              ("!+4D! 'AL+W=O<FMS:&5E=',O
M<VAE970U-"YX;6Q02P$"% ,4    " !I.&-3+8B*4XH#   &#0  &0
M        @(%.40$ >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0
M   ( &DX8U,28:X6/ (  -\$   9              " @0]5 0!X;"]W;W)K
M<VAE971S+W-H965T-38N>&UL4$L! A0#%     @ :3AC4QV7,UD7 P  9A$
M  T              ( !@E<! 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !I
M.&-3EXJ[',     3 @  "P              @ '$6@$ 7W)E;',O+G)E;'-0
M2P$"% ,4    " !I.&-38B5+\E4$  !:)0  #P              @ &M6P$
M>&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ :3AC4PP_D/SE 0  ?R$  !H
M             ( !+V ! 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L!
M A0#%     @ :3AC4X_AMVG3 0  -B$  !,              ( !3&(! %M#
G;VYT96YT7U1Y<&5S72YX;6Q02P4&     $  0 !W$0  4&0!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>299</ContextCount>
  <ElementCount>368</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>81</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>10</UnitCount>
  <MyReports>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Organization and Summary of Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPolicies</Role>
      <ShortName>Organization and Summary of Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2114102 - Disclosure - Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/Acquisitions</Role>
      <ShortName>Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2118103 - Disclosure - Long-Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/LongTermDebt</Role>
      <ShortName>Long-Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2122104 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2125105 - Disclosure - Redeemable Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/RedeemablePreferredStock</Role>
      <ShortName>Redeemable Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2129106 - Disclosure - Derivatives and Hedging Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/DerivativesandHedgingActivities</Role>
      <ShortName>Derivatives and Hedging Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2135107 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2139108 - Disclosure - Other Current Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/OtherCurrentLiabilities</Role>
      <ShortName>Other Current Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2142109 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2144110 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2148111 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Organization and Summary of Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies</Role>
      <ShortName>Organization and Summary of Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPolicies</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Organization and Summary of Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesTables</Role>
      <ShortName>Organization and Summary of Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPolicies</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2315302 - Disclosure - Acquisitions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/AcquisitionsTables</Role>
      <ShortName>Acquisitions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.surgerypartners.com/role/Acquisitions</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2319303 - Disclosure - Long-Term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/LongTermDebtTables</Role>
      <ShortName>Long-Term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.surgerypartners.com/role/LongTermDebt</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2323304 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.surgerypartners.com/role/Leases</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2326305 - Disclosure - Redeemable Preferred Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/RedeemablePreferredStockTables</Role>
      <ShortName>Redeemable Preferred Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.surgerypartners.com/role/RedeemablePreferredStock</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2330306 - Disclosure - Derivatives and Hedging Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesTables</Role>
      <ShortName>Derivatives and Hedging Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.surgerypartners.com/role/DerivativesandHedgingActivities</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2336307 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.surgerypartners.com/role/EarningsPerShare</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2340308 - Disclosure - Other Current Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/OtherCurrentLiabilitiesTables</Role>
      <ShortName>Other Current Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.surgerypartners.com/role/OtherCurrentLiabilities</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2345309 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.surgerypartners.com/role/SegmentReporting</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2404401 - Disclosure - Organization and Summary of Accounting Policies - Organization (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesOrganizationDetails</Role>
      <ShortName>Organization and Summary of Accounting Policies - Organization (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Organization and Summary of Accounting Policies - CARES ACT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCARESACTDetails</Role>
      <ShortName>Organization and Summary of Accounting Policies - CARES ACT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2406403 - Disclosure - Organization and Summary of Accounting Policies - Variable Interest Entities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails</Role>
      <ShortName>Organization and Summary of Accounting Policies - Variable Interest Entities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2407404 - Disclosure - Organization and Summary of Accounting Policies - Carrying Amount and Fair Value of Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails</Role>
      <ShortName>Organization and Summary of Accounting Policies - Carrying Amount and Fair Value of Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2408405 - Disclosure - Organization and Summary of Accounting Policies - Schedule of Revenues by Service Type (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails</Role>
      <ShortName>Organization and Summary of Accounting Policies - Schedule of Revenues by Service Type (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2409406 - Disclosure - Organization and Summary of Accounting Policies - Schedule of Revenues by Sources (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails</Role>
      <ShortName>Organization and Summary of Accounting Policies - Schedule of Revenues by Sources (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2410407 - Disclosure - Organization and Summary of Accounting Policies - Cash, Cash Equivalents and Restricted Cash (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails</Role>
      <ShortName>Organization and Summary of Accounting Policies - Cash, Cash Equivalents and Restricted Cash (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2411408 - Disclosure - Organization and Summary of Accounting Policies - Rollforward of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesRollforwardofGoodwillDetails</Role>
      <ShortName>Organization and Summary of Accounting Policies - Rollforward of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2412409 - Disclosure - Organization and Summary of Accounting Policies - Schedule of Non-Controlling Interests - Redeemable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofNonControllingInterestsRedeemableDetails</Role>
      <ShortName>Organization and Summary of Accounting Policies - Schedule of Non-Controlling Interests - Redeemable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2413410 - Disclosure - Organization and Summary of Accounting Policies - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesIncomeTaxesDetails</Role>
      <ShortName>Organization and Summary of Accounting Policies - Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2416411 - Disclosure - Acquisitions - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/AcquisitionsNarrativeDetails</Role>
      <ShortName>Acquisitions - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2417412 - Disclosure - Acquisitions - Summary (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/AcquisitionsSummaryDetails</Role>
      <ShortName>Acquisitions - Summary (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2420413 - Disclosure - Long-Term Debt - Summary (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/LongTermDebtSummaryDetails</Role>
      <ShortName>Long-Term Debt - Summary (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2421414 - Disclosure - Long-Term Debt - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails</Role>
      <ShortName>Long-Term Debt - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2424415 - Disclosure - Leases - Lease Expense and Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails</Role>
      <ShortName>Leases - Lease Expense and Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2427416 - Disclosure - Redeemable Preferred Stock - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/RedeemablePreferredStockNarrativeDetails</Role>
      <ShortName>Redeemable Preferred Stock - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2428417 - Disclosure - Redeemable Preferred Stock - Summary (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/RedeemablePreferredStockSummaryDetails</Role>
      <ShortName>Redeemable Preferred Stock - Summary (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2431418 - Disclosure - Derivatives and Hedging Activities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails</Role>
      <ShortName>Derivatives and Hedging Activities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2432419 - Disclosure - Derivatives and Hedging Activities - Interest Rate Swaps and Interest Rate Caps Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails</Role>
      <ShortName>Derivatives and Hedging Activities - Interest Rate Swaps and Interest Rate Caps Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2433420 - Disclosure - Derivatives and Hedging Activities - Derivatives and their location on the condensed consolidated balance sheets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesandtheirlocationonthecondensedconsolidatedbalancesheetsDetails</Role>
      <ShortName>Derivatives and Hedging Activities - Derivatives and their location on the condensed consolidated balance sheets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2434421 - Disclosure - Derivatives and Hedging Activities - Pre-tax Effect of Derivatives on AOCI and Statement of Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails</Role>
      <ShortName>Derivatives and Hedging Activities - Pre-tax Effect of Derivatives on AOCI and Statement of Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2437422 - Disclosure - Earnings Per Share - Summary (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails</Role>
      <ShortName>Earnings Per Share - Summary (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2438423 - Disclosure - Earnings Per Share - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/EarningsPerShareNarrativeDetails</Role>
      <ShortName>Earnings Per Share - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2441424 - Disclosure - Other Current Liabilities - Summary (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails</Role>
      <ShortName>Other Current Liabilities - Summary (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2443425 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.surgerypartners.com/role/CommitmentsandContingencies</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2446426 - Disclosure - Segment Reporting - Revenues and Operating Income by Reportable Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails</Role>
      <ShortName>Segment Reporting - Revenues and Operating Income by Reportable Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2447427 - Disclosure - Segment Reporting - Assets and Cash Purchases of Property and Equipment by Operating Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails</Role>
      <ShortName>Segment Reporting - Assets and Cash Purchases of Property and Equipment by Operating Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="sgry-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2449428 - Disclosure - Subsequent Events - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/SubsequentEventsNarrativeDetails</Role>
      <ShortName>Subsequent Events - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="sgry-20210930.htm">sgry-20210930.htm</File>
    <File>a2021q3exhibit311.htm</File>
    <File>a2021q3exhibit312.htm</File>
    <File>a2021q3exhibit321.htm</File>
    <File>sgry-20210930.xsd</File>
    <File>sgry-20210930_cal.xml</File>
    <File>sgry-20210930_def.xml</File>
    <File>sgry-20210930_lab.xml</File>
    <File>sgry-20210930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>72
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "sgry-20210930.htm": {
   "axisCustom": 0,
   "axisStandard": 26,
   "contextCount": 299,
   "dts": {
    "calculationLink": {
     "local": [
      "sgry-20210930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "sgry-20210930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "sgry-20210930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "sgry-20210930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "sgry-20210930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "sgry-20210930.xsd"
     ],
     "remote": [
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 505,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 5,
    "total": 5
   },
   "keyCustom": 47,
   "keyStandard": 321,
   "memberCustom": 41,
   "memberStandard": 38,
   "nsprefix": "sgry",
   "nsuri": "http://www.surgerypartners.com/20210930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.surgerypartners.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2118103 - Disclosure - Long-Term Debt",
     "role": "http://www.surgerypartners.com/role/LongTermDebt",
     "shortName": "Long-Term Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2122104 - Disclosure - Leases",
     "role": "http://www.surgerypartners.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sgry:RedeemablePreferredStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2125105 - Disclosure - Redeemable Preferred Stock",
     "role": "http://www.surgerypartners.com/role/RedeemablePreferredStock",
     "shortName": "Redeemable Preferred Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sgry:RedeemablePreferredStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2129106 - Disclosure - Derivatives and Hedging Activities",
     "role": "http://www.surgerypartners.com/role/DerivativesandHedgingActivities",
     "shortName": "Derivatives and Hedging Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135107 - Disclosure - Earnings Per Share",
     "role": "http://www.surgerypartners.com/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2139108 - Disclosure - Other Current Liabilities",
     "role": "http://www.surgerypartners.com/role/OtherCurrentLiabilities",
     "shortName": "Other Current Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2142109 - Disclosure - Commitments and Contingencies",
     "role": "http://www.surgerypartners.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2144110 - Disclosure - Segment Reporting",
     "role": "http://www.surgerypartners.com/role/SegmentReporting",
     "shortName": "Segment Reporting",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2148111 - Disclosure - Subsequent Events",
     "role": "http://www.surgerypartners.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Organization and Summary of Accounting Policies (Policies)",
     "role": "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies",
     "shortName": "Organization and Summary of Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i882aa7da35e6452cbe7ffa904416e6cd_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i882aa7da35e6452cbe7ffa904416e6cd_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2303301 - Disclosure - Organization and Summary of Accounting Policies (Tables)",
     "role": "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesTables",
     "shortName": "Organization and Summary of Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2315302 - Disclosure - Acquisitions (Tables)",
     "role": "http://www.surgerypartners.com/role/AcquisitionsTables",
     "shortName": "Acquisitions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2319303 - Disclosure - Long-Term Debt (Tables)",
     "role": "http://www.surgerypartners.com/role/LongTermDebtTables",
     "shortName": "Long-Term Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2323304 - Disclosure - Leases (Tables)",
     "role": "http://www.surgerypartners.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2326305 - Disclosure - Redeemable Preferred Stock (Tables)",
     "role": "http://www.surgerypartners.com/role/RedeemablePreferredStockTables",
     "shortName": "Redeemable Preferred Stock (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2330306 - Disclosure - Derivatives and Hedging Activities (Tables)",
     "role": "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesTables",
     "shortName": "Derivatives and Hedging Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2336307 - Disclosure - Earnings Per Share (Tables)",
     "role": "http://www.surgerypartners.com/role/EarningsPerShareTables",
     "shortName": "Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2340308 - Disclosure - Other Current Liabilities (Tables)",
     "role": "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesTables",
     "shortName": "Other Current Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2345309 - Disclosure - Segment Reporting (Tables)",
     "role": "http://www.surgerypartners.com/role/SegmentReportingTables",
     "shortName": "Segment Reporting (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i882aa7da35e6452cbe7ffa904416e6cd_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "sgry:NumberOfSurgicalFacilitiesOwned",
      "reportCount": 1,
      "unique": true,
      "unitRef": "surgical_facility",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404401 - Disclosure - Organization and Summary of Accounting Policies - Organization (Details)",
     "role": "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesOrganizationDetails",
     "shortName": "Organization and Summary of Accounting Policies - Organization (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i882aa7da35e6452cbe7ffa904416e6cd_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "sgry:NumberOfSurgicalFacilitiesOwned",
      "reportCount": 1,
      "unique": true,
      "unitRef": "surgical_facility",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i882aa7da35e6452cbe7ffa904416e6cd_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i882aa7da35e6452cbe7ffa904416e6cd_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sgry:ProceedsFromGovernmentAssistance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Organization and Summary of Accounting Policies - CARES ACT (Details)",
     "role": "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCARESACTDetails",
     "shortName": "Organization and Summary of Accounting Policies - CARES ACT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sgry:ProceedsFromGovernmentAssistance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i882aa7da35e6452cbe7ffa904416e6cd_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "sgry:VariableInterestEntityNumberOfFacilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "surgical_facility",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406403 - Disclosure - Organization and Summary of Accounting Policies - Variable Interest Entities (Details)",
     "role": "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails",
     "shortName": "Organization and Summary of Accounting Policies - Variable Interest Entities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i882aa7da35e6452cbe7ffa904416e6cd_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "sgry:VariableInterestEntityNumberOfFacilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "surgical_facility",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i962fa35551cd479c8e9aed5680bfb517_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407404 - Disclosure - Organization and Summary of Accounting Policies - Carrying Amount and Fair Value of Long-Term Debt (Details)",
     "role": "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails",
     "shortName": "Organization and Summary of Accounting Policies - Carrying Amount and Fair Value of Long-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i962fa35551cd479c8e9aed5680bfb517_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "ic18ae544123642ddbc9fb91be061be82_D20210701-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408405 - Disclosure - Organization and Summary of Accounting Policies - Schedule of Revenues by Service Type (Details)",
     "role": "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails",
     "shortName": "Organization and Summary of Accounting Policies - Schedule of Revenues by Service Type (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "ic18ae544123642ddbc9fb91be061be82_D20210701-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409406 - Disclosure - Organization and Summary of Accounting Policies - Schedule of Revenues by Sources (Details)",
     "role": "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails",
     "shortName": "Organization and Summary of Accounting Policies - Schedule of Revenues by Sources (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i69813463e96b4ad5ad2215be2f949b59_D20210701-20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "ia9055b0c653648f0919c1c9b458ca340_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashAndInvestmentsNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410407 - Disclosure - Organization and Summary of Accounting Policies - Cash, Cash Equivalents and Restricted Cash (Details)",
     "role": "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails",
     "shortName": "Organization and Summary of Accounting Policies - Cash, Cash Equivalents and Restricted Cash (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "ia9055b0c653648f0919c1c9b458ca340_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashAndInvestmentsNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "ia9055b0c653648f0919c1c9b458ca340_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411408 - Disclosure - Organization and Summary of Accounting Policies - Rollforward of Goodwill (Details)",
     "role": "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesRollforwardofGoodwillDetails",
     "shortName": "Organization and Summary of Accounting Policies - Rollforward of Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "ia9055b0c653648f0919c1c9b458ca340_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412409 - Disclosure - Organization and Summary of Accounting Policies - Schedule of Non-Controlling Interests - Redeemable (Details)",
     "role": "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofNonControllingInterestsRedeemableDetails",
     "shortName": "Organization and Summary of Accounting Policies - Schedule of Non-Controlling Interests - Redeemable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i723b8483c8a44fa3831eba25ac4e8771_I20191231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413410 - Disclosure - Organization and Summary of Accounting Policies - Income Taxes (Details)",
     "role": "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesIncomeTaxesDetails",
     "shortName": "Organization and Summary of Accounting Policies - Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416411 - Disclosure - Acquisitions - Narrative (Details)",
     "role": "http://www.surgerypartners.com/role/AcquisitionsNarrativeDetails",
     "shortName": "Acquisitions - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i18304528b10e4cf5ad801229a9076ceb_D20210101-20210930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:NumberOfBusinessesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "surgical_facility",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:LaborAndRelatedExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i882aa7da35e6452cbe7ffa904416e6cd_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417412 - Disclosure - Acquisitions - Summary (Details)",
     "role": "http://www.surgerypartners.com/role/AcquisitionsSummaryDetails",
     "shortName": "Acquisitions - Summary (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i28bb531c0e434976827266bc64ff25c5_D20210101-20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i882aa7da35e6452cbe7ffa904416e6cd_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420413 - Disclosure - Long-Term Debt - Summary (Details)",
     "role": "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails",
     "shortName": "Long-Term Debt - Summary (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i882aa7da35e6452cbe7ffa904416e6cd_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i882aa7da35e6452cbe7ffa904416e6cd_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421414 - Disclosure - Long-Term Debt - Narrative (Details)",
     "role": "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails",
     "shortName": "Long-Term Debt - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "ia69846ae143244c7b534d9be52a586b8_I20210503",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424415 - Disclosure - Leases - Lease Expense and Cash Flow Information (Details)",
     "role": "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails",
     "shortName": "Leases - Lease Expense and Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "ib3af38d809db4b7a8d26a05b63fa42b5_D20210101-20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427416 - Disclosure - Redeemable Preferred Stock - Narrative (Details)",
     "role": "http://www.surgerypartners.com/role/RedeemablePreferredStockNarrativeDetails",
     "shortName": "Redeemable Preferred Stock - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "if6b9767d8d5b496f900fae3b3d1d446a_D20210101-20210930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:PreferredStockDividendRatePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "ia9055b0c653648f0919c1c9b458ca340_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityCarryingAmountAttributableToParent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428417 - Disclosure - Redeemable Preferred Stock - Summary (Details)",
     "role": "http://www.surgerypartners.com/role/RedeemablePreferredStockSummaryDetails",
     "shortName": "Redeemable Preferred Stock - Summary (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:TemporaryEquityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i57cb9c1772694302ba3eea3dd06765c8_I20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityCarryingAmountAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431418 - Disclosure - Derivatives and Hedging Activities - Narrative (Details)",
     "role": "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails",
     "shortName": "Derivatives and Hedging Activities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i882aa7da35e6452cbe7ffa904416e6cd_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432419 - Disclosure - Derivatives and Hedging Activities - Interest Rate Swaps and Interest Rate Caps Outstanding (Details)",
     "role": "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails",
     "shortName": "Derivatives and Hedging Activities - Interest Rate Swaps and Interest Rate Caps Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "if49ae29f929f42ada509df5619f333a8_I20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i882aa7da35e6452cbe7ffa904416e6cd_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433420 - Disclosure - Derivatives and Hedging Activities - Derivatives and their location on the condensed consolidated balance sheets (Details)",
     "role": "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesandtheirlocationonthecondensedconsolidatedbalancesheetsDetails",
     "shortName": "Derivatives and Hedging Activities - Derivatives and their location on the condensed consolidated balance sheets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i00ee4c8851df48caa969c447c0623250_I20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "sgry:DerivativeLiabilityNotionalAmountFinancingComponent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434421 - Disclosure - Derivatives and Hedging Activities - Pre-tax Effect of Derivatives on AOCI and Statement of Operations (Details)",
     "role": "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails",
     "shortName": "Derivatives and Hedging Activities - Pre-tax Effect of Derivatives on AOCI and Statement of Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "role": "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i4166c342f2fd476b8d5d425e40276b6f_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437422 - Disclosure - Earnings Per Share - Summary (Details)",
     "role": "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails",
     "shortName": "Earnings Per Share - Summary (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i1dfc84c1f55d48fdbe932272d2d40dc1_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "if7415e8f12eb4b0f857512e10ff2b1df_I20210127",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438423 - Disclosure - Earnings Per Share - Narrative (Details)",
     "role": "http://www.surgerypartners.com/role/EarningsPerShareNarrativeDetails",
     "shortName": "Earnings Per Share - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "if7415e8f12eb4b0f857512e10ff2b1df_I20210127",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:SaleOfStockPricePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i882aa7da35e6452cbe7ffa904416e6cd_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLiabilityCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441424 - Disclosure - Other Current Liabilities - Summary (Details)",
     "role": "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails",
     "shortName": "Other Current Liabilities - Summary (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i882aa7da35e6452cbe7ffa904416e6cd_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLiabilityCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i882aa7da35e6452cbe7ffa904416e6cd_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SelfInsuranceReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443425 - Disclosure - Commitments and Contingencies (Details)",
     "role": "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i882aa7da35e6452cbe7ffa904416e6cd_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SelfInsuranceReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446426 - Disclosure - Segment Reporting - Revenues and Operating Income by Reportable Segment (Details)",
     "role": "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails",
     "shortName": "Segment Reporting - Revenues and Operating Income by Reportable Segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i882aa7da35e6452cbe7ffa904416e6cd_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447427 - Disclosure - Segment Reporting - Assets and Cash Purchases of Property and Equipment by Operating Segment (Details)",
     "role": "http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails",
     "shortName": "Segment Reporting - Assets and Cash Purchases of Property and Equipment by Operating Segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i07b5831fa25c4593977edb314caf0810_I20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i0613206f307d4141bf872d310477a2cb_D20211001-20211031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449428 - Disclosure - Subsequent Events - Narrative (Details)",
     "role": "http://www.surgerypartners.com/role/SubsequentEventsNarrativeDetails",
     "shortName": "Subsequent Events - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i0613206f307d4141bf872d310477a2cb_D20211001-20211031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i5e1addbe96484bc7b75825f9c8dc7a58_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "role": "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "ie870b4adc63f46feb66eb8a8c8e4d011_D20200101-20200331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "sgry:NoncashInterestIncomeExpenseNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Organization and Summary of Accounting Policies",
     "role": "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPolicies",
     "shortName": "Organization and Summary of Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2114102 - Disclosure - Acquisitions",
     "role": "http://www.surgerypartners.com/role/Acquisitions",
     "shortName": "Acquisitions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20210930.htm",
      "contextRef": "i6aa17db36ba04903893d4cddc5066609_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 81,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.surgerypartners.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.surgerypartners.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.surgerypartners.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.surgerypartners.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.surgerypartners.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.surgerypartners.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.surgerypartners.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.surgerypartners.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.surgerypartners.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.surgerypartners.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.surgerypartners.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.surgerypartners.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.surgerypartners.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.surgerypartners.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.surgerypartners.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.surgerypartners.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.surgerypartners.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.surgerypartners.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.surgerypartners.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.surgerypartners.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.surgerypartners.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.surgerypartners.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.surgerypartners.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.surgerypartners.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.surgerypartners.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.surgerypartners.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.surgerypartners.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.surgerypartners.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.surgerypartners.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "sgry_A2017SeniorSecuredCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2017 Senior Secured Credit Facility [Member]",
        "label": "2017 Senior Secured Credit Facility [Member]",
        "terseLabel": "The Revolver"
       }
      }
     },
     "localname": "A2017SeniorSecuredCreditFacilityMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2017 Senior Secured Credit Facility, Sixth Amendment, New Term Loans",
        "label": "2017 Senior Secured Credit Facility, Sixth Amendment, New Term Loans [Member]",
        "terseLabel": "New Term Loans"
       }
      }
     },
     "localname": "A2017SeniorSecuredCreditFacilitySixthAmendmentNewTermLoansMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_A2017TermLoanMaturing2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2017 Term Loan, Maturing 2024 [Member]",
        "label": "2017 Term Loan, Maturing 2024 [Member]",
        "verboseLabel": "Senior secured term loan"
       }
      }
     },
     "localname": "A2017TermLoanMaturing2024Member",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_AncillaryServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ancillary Services [Member]",
        "label": "Ancillary Services [Member]",
        "terseLabel": "Ancillary Services"
       }
      }
     },
     "localname": "AncillaryServicesMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails",
      "http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_BusinessCombinationGainLossOnAcquisitionEscrow": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Gain (Loss) On Acquisition Escrow",
        "label": "Business Combination, Gain (Loss) On Acquisition Escrow",
        "negatedTerseLabel": "Gain on escrow release"
       }
      }
     },
     "localname": "BusinessCombinationGainLossOnAcquisitionEscrow",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Integration Related Costs, And Merger Costs",
        "label": "Business Combination, Integration Related Costs, And Merger Costs",
        "terseLabel": "Transaction, integration and acquisition costs"
       }
      }
     },
     "localname": "BusinessCombinationIntegrationRelatedCostsAndMergerCosts",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/AcquisitionsSummaryDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long Term Debt",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long Term Debt",
        "negatedTerseLabel": "Long-term debt"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/AcquisitionsSummaryDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Liability",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Liability",
        "negatedTerseLabel": "Right-of-use operating lease liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/AcquisitionsSummaryDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Right Of Use Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Right Of Use Assets",
        "terseLabel": "Right-of-use operating lease assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingRightOfUseAssets",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_CashFlowLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Flow, Lessee",
        "label": "Cash Flow, Lessee [Abstract]",
        "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:"
       }
      }
     },
     "localname": "CashFlowLesseeAbstract",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Tax Agreement, Interest Rate, Basis Spread on Variable Rate",
        "label": "Collaborative Tax Agreement, Interest Rate, Basis Spread on Variable Rate",
        "terseLabel": "Collaborative tax agreement, basis spread on variable rate (percent)"
       }
      }
     },
     "localname": "CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Tax Agreement, Projected Tax Savings, Term",
        "label": "Collaborative Tax Agreement, Projected Tax Savings, Term",
        "terseLabel": "Projected tax savings period"
       }
      }
     },
     "localname": "CollaborativeTaxAgreementProjectedTaxSavingsTerm",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sgry_ConversionOfSeriesAPreferredStockIntoCommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Conversion Of Series A Preferred Stock Into Common Stock",
        "label": "Conversion Of Series A Preferred Stock Into Common Stock [Member]",
        "terseLabel": "Conversion of Series A Preferred Stock into Common Stock"
       }
      }
     },
     "localname": "ConversionOfSeriesAPreferredStockIntoCommonStockMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareNarrativeDetails",
      "http://www.surgerypartners.com/role/RedeemablePreferredStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Coronavirus Aid, Relief, and Economic Security Act CARES Act, Government Grant Received, Repayments",
        "label": "Coronavirus Aid, Relief, and Economic Security Act CARES Act, Government Grant Received, Repayments",
        "terseLabel": "Repayments of grants received"
       }
      }
     },
     "localname": "CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCARESACTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Coronavirus Aid, Relief, and Economic Security Act CARES Act, Government Grants, Deferred Accelerated Payments",
        "label": "Coronavirus Aid, Relief, and Economic Security Act CARES Act, Government Grants, Deferred Accelerated Payments",
        "terseLabel": "Deferred accelerated payments"
       }
      }
     },
     "localname": "CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCARESACTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_CoronavirusAidReliefandEconomicSecurityActCARESActGovernmentGrantReceivedAcceleratedPayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Coronavirus Aid, Relief, and Economic Security Act CARES Act, Government Grant Received, Accelerated Payments",
        "label": "Coronavirus Aid, Relief, and Economic Security Act CARES Act, Government Grant Received, Accelerated Payments",
        "terseLabel": "Accelerated payments"
       }
      }
     },
     "localname": "CoronavirusAidReliefandEconomicSecurityActCARESActGovernmentGrantReceivedAcceleratedPayments",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCARESACTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_CostReportLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost Report Liabilities, Current",
        "label": "Cost Report Liabilities, Current",
        "terseLabel": "Cost report liabilities"
       }
      }
     },
     "localname": "CostReportLiabilitiesCurrent",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_DebtInstrumentBasisSpreadOnVariableRateFloor": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Basis Spread On Variable Rate, Floor",
        "label": "Debt Instrument, Basis Spread On Variable Rate, Floor",
        "terseLabel": "Debt instrument, basis spread on variable rate, floor (percent)"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRateFloor",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sgry_DebtInstrumentCovenantMaturityMinimumAmountOfOtherExistingDebtRemaining": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Maturity, Minimum Amount Of Other Existing Debt Remaining",
        "label": "Debt Instrument, Covenant, Maturity, Minimum Amount Of Other Existing Debt Remaining",
        "terseLabel": "Maturity covenant, minimum amount of Borrower's 6.750% senior unsecured notes due 2025 not repaid, repurchased or redeemed or refinanced"
       }
      }
     },
     "localname": "DebtInstrumentCovenantMaturityMinimumAmountOfOtherExistingDebtRemaining",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_DebtInstrumentCovenantMaturityMinimumMaturityDateForOtherExistingDebtRemaining": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Maturity, Minimum Maturity Date For Other Existing Debt Remaining",
        "label": "Debt Instrument, Covenant, Maturity, Minimum Maturity Date For Other Existing Debt Remaining",
        "terseLabel": "Maturity covenant, minimum maturity date for borrowings after August 31, 2026 by no later than April 1, 2025"
       }
      }
     },
     "localname": "DebtInstrumentCovenantMaturityMinimumMaturityDateForOtherExistingDebtRemaining",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sgry_DebtInstrumentQuarterlyAmortizationPercentPerAnnum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Quarterly Amortization, Percent Per Annum",
        "label": "Debt Instrument, Quarterly Amortization, Percent Per Annum",
        "terseLabel": "Quarterly amortization in aggregate principal amount, percent per annum (percent)"
       }
      }
     },
     "localname": "DebtInstrumentQuarterlyAmortizationPercentPerAnnum",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sgry_DeferredEmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Employee-related Liabilities, Current",
        "label": "Deferred Employee-related Liabilities, Current",
        "terseLabel": "Deferred accrued payroll and benefits"
       }
      }
     },
     "localname": "DeferredEmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCARESACTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Income Tax Liabilities, Net Of Discount",
        "label": "Deferred Income Tax Liabilities, Net Of Discount",
        "terseLabel": "Net long-term tax receivable agreement liability"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNetOfDiscount",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Income Tax Liabilities, Net Of Discount, Current",
        "label": "Deferred Income Tax Liabilities, Net Of Discount, Current",
        "terseLabel": "Current portion of tax liability"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_DerivativeLiabilityNotionalAmountFinancingComponent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Liability, Notional Amount, Financing Component",
        "label": "Derivative Liability, Notional Amount, Financing Component",
        "terseLabel": "Derivative liability, notional amount, financing component"
       }
      }
     },
     "localname": "DerivativeLiabilityNotionalAmountFinancingComponent",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesandtheirlocationonthecondensedconsolidatedbalancesheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Before Interest Taxes Depreciation And Amortization",
        "label": "Earnings Before Interest Taxes Depreciation And Amortization",
        "terseLabel": "Adjusted EBITDA"
       }
      }
     },
     "localname": "EarningsBeforeInterestTaxesDepreciationAndAmortization",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_EffectiveIncomeTaxRateReconciliationCoronavirusAidReliefAndEconomicSecurityActCARESActAndTaxSettlementAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Coronavirus Aid, Relief, and Economic Security Act (CARES Act) And Tax Settlement, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Coronavirus Aid, Relief, and Economic Security Act (CARES Act) And Tax Settlement, Amount",
        "negatedTerseLabel": "Tax benefits related to CARES Act and Settlement Agreement"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationCoronavirusAidReliefAndEconomicSecurityActCARESActAndTaxSettlementAmount",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_FacilitiesAmbulatorySurgeryCentersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facilities, Ambulatory Surgery Centers [Member]",
        "label": "Facilities, Ambulatory Surgery Centers [Member]",
        "terseLabel": "Facilities, Ambulatory Surgery Centers"
       }
      }
     },
     "localname": "FacilitiesAmbulatorySurgeryCentersMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesOrganizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_FacilitiesSurgicalHospitalsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facilities, Surgical Hospitals [Member]",
        "label": "Facilities, Surgical Hospitals [Member]",
        "terseLabel": "Facilities, Surgical Hospitals"
       }
      }
     },
     "localname": "FacilitiesSurgicalHospitalsMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesOrganizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_FinanceLeaseCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Cost",
        "label": "Finance Lease, Cost",
        "totalLabel": "Total finance lease costs"
       }
      }
     },
     "localname": "FinanceLeaseCost",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_FinanceLeaseCost1Abstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Cost1 [Abstract]",
        "label": "Finance Lease, Cost1 [Abstract]",
        "terseLabel": "Finance lease costs:"
       }
      }
     },
     "localname": "FinanceLeaseCost1Abstract",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sgry_GainLossOnDispositionOfAssetsAndDeconsolidation": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) On Disposition of Assets And Deconsolidation",
        "label": "Gain (Loss) On Disposition Of Assets And Deconsolidation",
        "negatedLabel": "Loss on disposals and deconsolidations, net",
        "negatedTerseLabel": "Loss on disposals and deconsolidations, net"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssetsAndDeconsolidation",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) Related to Litigation Settlement And Other Litigation Costs",
        "label": "Gain (Loss) Related to Litigation Settlement And Other Litigation Costs",
        "negatedTerseLabel": "Litigation settlement and other litigation costs"
       }
      }
     },
     "localname": "GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill, Written off Related to Sale of Business Unit and Deconsolidation",
        "label": "Goodwill, Written off Related to Sale of Business Unit and Deconsolidation",
        "negatedTerseLabel": "Divestitures and deconsolidations"
       }
      }
     },
     "localname": "GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesRollforwardofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_GrantRevenue": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 8.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant Revenue",
        "label": "Grant Revenue",
        "negatedTerseLabel": "Grant funds",
        "terseLabel": "Grant funds"
       }
      }
     },
     "localname": "GrantRevenue",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCARESACTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_HealthcareOrganizationPatientServiceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Healthcare Organization, Patient Service [Member]",
        "label": "Healthcare Organization, Patient Service [Member]",
        "terseLabel": "Total patient service revenues",
        "verboseLabel": "Patent service revenues"
       }
      }
     },
     "localname": "HealthcareOrganizationPatientServiceMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Medicare Accelerated Payments And Deferred Governmental Grants",
        "label": "Increase (Decrease) In Medicare Accelerated Payments And Deferred Governmental Grants",
        "terseLabel": "Medicare accelerated payments and deferred governmental grants"
       }
      }
     },
     "localname": "IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_IncreaseDecreaseInSettlementPayments": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Settlement Payments",
        "label": "Increase (Decrease) in Settlement Payments",
        "negatedTerseLabel": "DOJ settlement payments"
       }
      }
     },
     "localname": "IncreaseDecreaseInSettlementPayments",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_InterestRateCapOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Cap One",
        "label": "Interest Rate Cap One [Member]",
        "terseLabel": "Interest rate cap"
       }
      }
     },
     "localname": "InterestRateCapOneMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_InterestRateCapTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Cap Two",
        "label": "Interest Rate Cap Two [Member]",
        "terseLabel": "Interest rate cap"
       }
      }
     },
     "localname": "InterestRateCapTwoMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_LineOfCreditFacilityMaximumBorrowingCapacityIncrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Maximum Borrowing Capacity, Increase",
        "label": "Line Of Credit Facility, Maximum Borrowing Capacity, Increase",
        "terseLabel": "Increase in outstanding commitments"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacityIncrease",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_MateriallyMoreRestrictiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Materially More Restrictive [Member]",
        "label": "Materially More Restrictive [Member]",
        "terseLabel": "Materially More Restrictive"
       }
      }
     },
     "localname": "MateriallyMoreRestrictiveMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare Accelerated Payments And Deferred Governmental Grants, Current",
        "label": "Medicare Accelerated Payments And Deferred Governmental Grants, Current",
        "terseLabel": "Medicare accelerated payments and deferred governmental grants"
       }
      }
     },
     "localname": "MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Controlling Interest, Acquisitions And Disposals Of Interests Held By Non-Controlling Interest Holders, Net",
        "label": "Non-Controlling Interest, Acquisitions And Disposals Of Interests Held By Non-Controlling Interest Holders, Net",
        "terseLabel": "Acquisition and disposal of shares of non-controlling interests, net"
       }
      }
     },
     "localname": "NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_NoncashInterestIncomeExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash Interest Income (Expense), Net",
        "label": "Noncash Interest Income (Expense), Net",
        "negatedTerseLabel": "Non-cash interest expense, net"
       }
      }
     },
     "localname": "NoncashInterestIncomeExpenseNet",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_NotMateriallyMoreRestrictiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Not Materially More Restrictive [Member]",
        "label": "Not Materially More Restrictive [Member]",
        "terseLabel": "Not Materially More Restrictive"
       }
      }
     },
     "localname": "NotMateriallyMoreRestrictiveMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_NotesPayableAndSecuredLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes Payable and Secured Loans [Member]",
        "label": "Notes Payable and Secured Loans [Member]",
        "terseLabel": "Notes payable and other secured loans"
       }
      }
     },
     "localname": "NotesPayableAndSecuredLoansMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_NumberOfSurgicalFacilitiesOwned": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Surgical Facilities Owned",
        "label": "Number of Surgical Facilities Owned",
        "terseLabel": "Number of surgical facilities owned"
       }
      }
     },
     "localname": "NumberOfSurgicalFacilitiesOwned",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesOrganizationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sgry_NumberOfSurgicalFacilitiesOwnedConsolidated": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Surgical Facilities Owned, Consolidated",
        "label": "Number Of Surgical Facilities Owned, Consolidated",
        "terseLabel": "Number of surgical facilities owned, consolidated"
       }
      }
     },
     "localname": "NumberOfSurgicalFacilitiesOwnedConsolidated",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesOrganizationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Surgical Facilities Owned, Majority Interest",
        "label": "Number Of Surgical Facilities Owned, Majority Interest",
        "terseLabel": "Number of surgical facilities owned, majority interest"
       }
      }
     },
     "localname": "NumberOfSurgicalFacilitiesOwnedMajorityInterest",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesOrganizationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sgry_OneMonthLondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One Month London Interbank Offered Rate (LIBOR) [Member]",
        "label": "One Month London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "One-month LIBOR"
       }
      }
     },
     "localname": "OneMonthLondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_OperatingAndFinanceLeaseExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease, Expense",
        "label": "Operating And Finance Lease, Expense",
        "terseLabel": "Lease expense"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseExpense",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_OpticalServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Optical Services [Member]",
        "label": "Optical Services [Member]",
        "terseLabel": "Optical Services"
       }
      }
     },
     "localname": "OpticalServicesMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_OtherPatientServiceRevenueSourcesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Patient Service Revenue Sources [Member]",
        "label": "Other Patient Service Revenue Sources [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherPatientServiceRevenueSourcesMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_OtherServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Services [Member]",
        "label": "Other Services [Member]",
        "verboseLabel": "Other service revenues"
       }
      }
     },
     "localname": "OtherServicesMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_PayFixedSwapEightMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pay-fixed Swap Eight",
        "label": "Pay-fixed Swap Eight [Member]",
        "terseLabel": "Pay-fixed swap"
       }
      }
     },
     "localname": "PayFixedSwapEightMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_PayFixedSwapFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pay-fixed Swap Five Member",
        "label": "Pay-fixed Swap Five [Member]",
        "terseLabel": "Pay-fixed swap"
       }
      }
     },
     "localname": "PayFixedSwapFiveMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_PayFixedSwapFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pay-fixed Swap Four Member",
        "label": "Pay-fixed Swap Four [Member]",
        "terseLabel": "Pay-fixed swap"
       }
      }
     },
     "localname": "PayFixedSwapFourMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_PayFixedSwapNineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pay-fixed Swap Nine",
        "label": "Pay-fixed Swap Nine [Member]",
        "terseLabel": "Pay-fixed swap"
       }
      }
     },
     "localname": "PayFixedSwapNineMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_PayFixedSwapOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pay-fixed Swap One Member",
        "label": "Pay-fixed Swap One [Member]",
        "terseLabel": "Pay-fixed swap"
       }
      }
     },
     "localname": "PayFixedSwapOneMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_PayFixedSwapSevenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pay-fixed Swap Seven",
        "label": "Pay-fixed Swap Seven [Member]",
        "terseLabel": "Pay-fixed swap"
       }
      }
     },
     "localname": "PayFixedSwapSevenMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_PayFixedSwapSixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pay-fixed Swap Six Member",
        "label": "Pay-fixed Swap Six [Member]",
        "terseLabel": "Pay-fixed swap"
       }
      }
     },
     "localname": "PayFixedSwapSixMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_PayFixedSwapTenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pay-fixed Swap Ten",
        "label": "Pay-fixed Swap Ten [Member]",
        "terseLabel": "Pay-fixed swap"
       }
      }
     },
     "localname": "PayFixedSwapTenMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_PayFixedSwapThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pay-fixed Swap Three Member",
        "label": "Pay-fixed Swap Three [Member]",
        "terseLabel": "Pay-fixed swap"
       }
      }
     },
     "localname": "PayFixedSwapThreeMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_PayFixedSwapTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pay-fixed Swap Two Member",
        "label": "Pay-fixed Swap Two [Member]",
        "terseLabel": "Pay-fixed swap"
       }
      }
     },
     "localname": "PayFixedSwapTwoMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_PrivateInsuranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Private Insurance [Member]",
        "label": "Private Insurance [Member]",
        "terseLabel": "Private insurance"
       }
      }
     },
     "localname": "PrivateInsuranceMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_ProceedsFromGovernmentAssistance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Government Assistance",
        "label": "Proceeds From Government Assistance",
        "terseLabel": "Proceeds from grants received"
       }
      }
     },
     "localname": "ProceedsFromGovernmentAssistance",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCARESACTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_ProductsAndServicesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Products And Services [Line Items]",
        "label": "Products And Services [Line Items]",
        "terseLabel": "Products And Services [Line Items]"
       }
      }
     },
     "localname": "ProductsAndServicesLineItems",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesOrganizationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sgry_PublicStockOfferingFirmSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public Stock Offering, Firm Shares",
        "label": "Public Stock Offering, Firm Shares [Member]",
        "terseLabel": "Firm Shares"
       }
      }
     },
     "localname": "PublicStockOfferingFirmSharesMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_PublicStockOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public Stock Offering",
        "label": "Public Stock Offering [Member]",
        "terseLabel": "Public Offering"
       }
      }
     },
     "localname": "PublicStockOfferingMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_ReceiveFixedSwapOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receive-fixed Swap One Member",
        "label": "Receive-fixed Swap One [Member]",
        "terseLabel": "Receive-fixed swap"
       }
      }
     },
     "localname": "ReceiveFixedSwapOneMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_ReceiveFixedSwapThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receive-fixed Swap Three Member",
        "label": "Receive-fixed Swap Three [Member]",
        "terseLabel": "Receive-fixed swap"
       }
      }
     },
     "localname": "ReceiveFixedSwapThreeMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_ReceiveFixedSwapTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receive-fixed Swap Two Member",
        "label": "Receive-fixed Swap Two [Member]",
        "terseLabel": "Receive-fixed swap"
       }
      }
     },
     "localname": "ReceiveFixedSwapTwoMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "label": "Redeemable Noncontrolling Interest, Decrease From Distributions To Noncontrolling Interest Holders",
        "negatedTerseLabel": "Distributions to non-controlling interest\u2014redeemable holders"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofNonControllingInterestsRedeemableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interest, Increase (Decrease) from Redemptions or Purchase of Interests",
        "label": "Redeemable Noncontrolling Interest, Increase (Decrease) From Redemptions Or Purchase Of Interests",
        "terseLabel": "Acquisition (disposal) of shares of non-controlling interests, net\u2014redeemable"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofNonControllingInterestsRedeemableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_RedeemableNoncontrollingInterestPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interest [Policy Text Block]",
        "label": "Redeemable Noncontrolling Interest [Policy Text Block]",
        "terseLabel": "Non-Controlling Interests\u2014Redeemable"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestPolicyTextBlock",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sgry_RedeemableNoncontrollingInterestRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interest [Roll Forward]",
        "label": "Redeemable Noncontrolling Interest [Roll Forward]",
        "terseLabel": "Non-Controlling Interests - Redeemable [Roll Forward]"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestRollForward",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofNonControllingInterestsRedeemableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sgry_RedeemablePreferredStockTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Preferred Stock [Text Block]",
        "label": "Redeemable Preferred Stock [Text Block]",
        "terseLabel": "Redeemable Preferred Stock"
       }
      }
     },
     "localname": "RedeemablePreferredStockTextBlock",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/RedeemablePreferredStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sgry_SaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock",
        "label": "Sale Of Stock [Line Items]",
        "terseLabel": "Sale Of Stock [Line Items]"
       }
      }
     },
     "localname": "SaleOfStockLineItems",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sgry_SaleOfStockTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock",
        "label": "Sale Of Stock [Table]",
        "terseLabel": "Sale Of Stock [Table]"
       }
      }
     },
     "localname": "SaleOfStockTable",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sgry_SelfPayRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Self-Pay Revenue [Member]",
        "label": "Self-Pay Revenue [Member]",
        "terseLabel": "Self-pay"
       }
      }
     },
     "localname": "SelfPayRevenueMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_SeniorUnsecuredNotesDue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes Due 2025",
        "label": "Senior Unsecured Notes Due 2025 [Member]",
        "terseLabel": "6.750% senior unsecured notes due 2025",
        "verboseLabel": "6.750% senior unsecured notes due 2025"
       }
      }
     },
     "localname": "SeniorUnsecuredNotesDue2025Member",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails",
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_SeniorUnsecuredNotesDue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes, Due 2027",
        "label": "Senior Unsecured Notes, Due 2027 [Member]",
        "terseLabel": "10.000% senior unsecured notes due 2027"
       }
      }
     },
     "localname": "SeniorUnsecuredNotesDue2027Member",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_SurgicalFacilitiesExistingMarketsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Surgical Facilities, Existing Markets",
        "label": "Surgical Facilities, Existing Markets [Member]",
        "terseLabel": "Surgical Facilities, Existing Markets"
       }
      }
     },
     "localname": "SurgicalFacilitiesExistingMarketsMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsNarrativeDetails",
      "http://www.surgerypartners.com/role/AcquisitionsSummaryDetails",
      "http://www.surgerypartners.com/role/SubsequentEventsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_SurgicalFacilitiesNewMarketsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Surgical Facilities, New Markets",
        "label": "Surgical Facilities, New Markets [Member]",
        "terseLabel": "Surgical Facilities, New Markets"
       }
      }
     },
     "localname": "SurgicalFacilitiesNewMarketsMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_SurgicalFacilityServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Surgical Facility Services [Member]",
        "label": "Surgical Facility Services [Member]",
        "terseLabel": "Surgical Facility Services"
       }
      }
     },
     "localname": "SurgicalFacilityServicesMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails",
      "http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_TaxReceivableAgreementLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Receivable Agreement Liability, Current",
        "label": "Tax Receivable Agreement Liability, Current",
        "terseLabel": "Tax receivable agreement liability"
       }
      }
     },
     "localname": "TaxReceivableAgreementLiabilityCurrent",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_TemporaryEquityThresholdConsecutiveTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Threshold Consecutive Trading Days",
        "label": "Temporary Equity, Threshold Consecutive Trading Days",
        "terseLabel": "Consecutive trading days"
       }
      }
     },
     "localname": "TemporaryEquityThresholdConsecutiveTradingDays",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/RedeemablePreferredStockNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sgry_TemporaryEquityThresholdSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Threshold Share Price",
        "label": "Temporary Equity, Threshold Share Price",
        "terseLabel": "Threshold share price (in USD per share)"
       }
      }
     },
     "localname": "TemporaryEquityThresholdSharePrice",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/RedeemablePreferredStockNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "sgry_TemporaryEquityThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Threshold Trading Days",
        "label": "Temporary Equity, Threshold Trading Days",
        "terseLabel": "Trading days"
       }
      }
     },
     "localname": "TemporaryEquityThresholdTradingDays",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/RedeemablePreferredStockNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sgry_ThreePayFixedInterestRateSwapsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Pay-fixed Interest Rate Swaps Member",
        "label": "Three Pay-fixed Interest Rate Swaps [Member]",
        "terseLabel": "Three Pay-fixed Interest Rate Swaps"
       }
      }
     },
     "localname": "ThreePayFixedInterestRateSwapsMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_ThreeReceiveFixedInterestRateSwapsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Receive-fixed Interest Rate Swaps Member",
        "label": "Three Receive-fixed Interest Rate Swaps [Member]",
        "terseLabel": "Three Receive-fixed Interest Rate Swaps"
       }
      }
     },
     "localname": "ThreeReceiveFixedInterestRateSwapsMember",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_VariableAndShortTermLeaseCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable And Short-Term Lease, Cost",
        "label": "Variable And Short-Term Lease, Cost",
        "terseLabel": "Variable and short-term lease costs"
       }
      }
     },
     "localname": "VariableAndShortTermLeaseCost",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_VariableInterestEntityNumberOfFacilities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entity, Number of Facilities",
        "label": "Variable Interest Entity, Number Of Facilities",
        "terseLabel": "Number of facilities included in VIE"
       }
      }
     },
     "localname": "VariableInterestEntityNumberOfFacilities",
     "nsuri": "http://www.surgerypartners.com/20210930",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r114",
      "r236",
      "r241",
      "r249",
      "r376",
      "r377",
      "r384",
      "r385",
      "r474",
      "r553",
      "r563",
      "r564",
      "r573",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by consolidated entity or group of entities.",
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r114",
      "r236",
      "r241",
      "r249",
      "r376",
      "r377",
      "r384",
      "r385",
      "r474",
      "r553",
      "r563",
      "r564",
      "r573",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity or group of entities consolidated into reporting entity.",
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r114",
      "r171",
      "r184",
      "r185",
      "r186",
      "r187",
      "r189",
      "r191",
      "r195",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r243",
      "r244",
      "r246",
      "r248",
      "r249",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r114",
      "r171",
      "r184",
      "r185",
      "r186",
      "r187",
      "r189",
      "r191",
      "r195",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r243",
      "r244",
      "r246",
      "r248",
      "r249",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r254",
      "r289",
      "r327",
      "r329",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r537",
      "r539",
      "r554",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_PayablesToCustomers": {
     "auth_ref": [
      "r575"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount payable to customer by broker-dealer.",
        "label": "Broker-Dealer, Payable to Customer",
        "terseLabel": "Amounts due to patients and payors"
       }
      }
     },
     "localname": "PayablesToCustomers",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r198",
      "r307",
      "r308",
      "r491",
      "r536",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesOrganizationDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r198",
      "r307",
      "r308",
      "r491",
      "r536",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesOrganizationDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r254",
      "r289",
      "r316",
      "r327",
      "r329",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r537",
      "r539",
      "r554",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r254",
      "r289",
      "r316",
      "r327",
      "r329",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r537",
      "r539",
      "r554",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r35",
      "r477"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r7",
      "r25",
      "r203",
      "r204"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r28",
      "r55",
      "r56",
      "r57",
      "r525",
      "r544",
      "r545"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r54",
      "r57",
      "r65",
      "r66",
      "r67",
      "r116",
      "r117",
      "r118",
      "r382",
      "r540",
      "r541",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r26",
      "r336",
      "r477"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r116",
      "r117",
      "r118",
      "r333",
      "r334",
      "r335",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income (loss) to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings": {
     "auth_ref": [
      "r292",
      "r297"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from dividends legally declared (or paid) in excess of retained earnings balance.",
        "label": "Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings",
        "negatedTerseLabel": "Preferred dividends"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AirlineProductsAndServicesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of each product and service or each group of similar products and services of an entity by various financial or nonfinancial attributes.",
        "label": "Products and Services [Table]",
        "terseLabel": "Products and Services [Table]"
       }
      }
     },
     "localname": "AirlineProductsAndServicesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesOrganizationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive (shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r96",
      "r220"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 7.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Impairment charges",
        "verboseLabel": "Impairment charges"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r108",
      "r179",
      "r186",
      "r193",
      "r211",
      "r236",
      "r237",
      "r238",
      "r240",
      "r241",
      "r242",
      "r243",
      "r245",
      "r247",
      "r249",
      "r250",
      "r376",
      "r384",
      "r442",
      "r475",
      "r477",
      "r506",
      "r522"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Assets",
        "totalLabel": "Total assets",
        "verboseLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails",
      "http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r9",
      "r11",
      "r50",
      "r108",
      "r211",
      "r236",
      "r237",
      "r238",
      "r240",
      "r241",
      "r242",
      "r243",
      "r245",
      "r247",
      "r249",
      "r250",
      "r376",
      "r384",
      "r442",
      "r475",
      "r477"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesandtheirlocationonthecondensedconsolidatedbalancesheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r403",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesandtheirlocationonthecondensedconsolidatedbalancesheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Base Rate"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "terseLabel": "Organization and Summary of Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r326",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsNarrativeDetails",
      "http://www.surgerypartners.com/role/AcquisitionsSummaryDetails",
      "http://www.surgerypartners.com/role/SubsequentEventsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r326",
      "r328",
      "r360",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsNarrativeDetails",
      "http://www.surgerypartners.com/role/AcquisitionsSummaryDetails",
      "http://www.surgerypartners.com/role/SubsequentEventsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsNarrativeDetails",
      "http://www.surgerypartners.com/role/AcquisitionsSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": {
     "auth_ref": [
      "r364"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.",
        "label": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value",
        "terseLabel": "Fair value of non-controlling interests"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r359"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Start-up costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r366",
      "r367",
      "r368"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Combined purchase price"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/SubsequentEventsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/Acquisitions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationIntegrationRelatedCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.",
        "label": "Business Combination, Integration Related Costs",
        "terseLabel": "Transaction and integration costs"
       }
      }
     },
     "localname": "BusinessCombinationIntegrationRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": {
     "auth_ref": [
      "r363"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/AcquisitionsSummaryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": {
     "auth_ref": [
      "r363"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/AcquisitionsSummaryDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities",
        "negatedTerseLabel": "Current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net [Abstract]",
        "terseLabel": "Net assets acquired:"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r363"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/AcquisitionsSummaryDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r362",
      "r363"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/AcquisitionsSummaryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r363"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/AcquisitionsSummaryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "terseLabel": "Aggregate acquisition date fair value",
        "totalLabel": "Aggregate acquisition date fair value"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r437",
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Carrying Amount"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r5",
      "r32",
      "r98"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r17",
      "r99",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash, Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r93",
      "r98",
      "r103"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r93",
      "r443"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "auth_ref": [
      "r423"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months",
        "negatedTerseLabel": "Amount estimated to be reclassified as a reduction to interest expense over next 12 months"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r106",
      "r108",
      "r132",
      "r133",
      "r134",
      "r138",
      "r142",
      "r150",
      "r151",
      "r152",
      "r211",
      "r236",
      "r241",
      "r242",
      "r243",
      "r249",
      "r250",
      "r287",
      "r288",
      "r290",
      "r291",
      "r442",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareNarrativeDetails",
      "http://www.surgerypartners.com/role/RedeemablePreferredStockNarrativeDetails",
      "http://www.surgerypartners.com/role/RedeemablePreferredStockSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r228",
      "r229",
      "r230",
      "r233",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation.",
        "label": "Common Class A [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareNarrativeDetails",
      "http://www.surgerypartners.com/role/RedeemablePreferredStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r116",
      "r117",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in USD per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.surgerypartners.com/role/EarningsPerShareNarrativeDetails",
      "http://www.surgerypartners.com/role/RedeemablePreferredStockNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r24",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending Balance, stockholders' equity (shares)",
        "periodStartLabel": "Beginning Balance, stockholders' equity (shares)",
        "terseLabel": "Common stock, shares outstanding (shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValueOutstanding": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.",
        "label": "Common Stock, Value, Outstanding",
        "terseLabel": "Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 82,458,385 and 50,461,706, respectively"
       }
      }
     },
     "localname": "CommonStockValueOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r60",
      "r62",
      "r63",
      "r72",
      "r516",
      "r533"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss attributable to Surgery Partners, Inc."
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r60",
      "r62",
      "r71",
      "r374",
      "r375",
      "r395",
      "r515",
      "r532"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Less: Comprehensive income attributable to non-controlling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r60",
      "r62",
      "r70",
      "r373",
      "r395",
      "r514",
      "r531"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r160",
      "r161",
      "r201",
      "r439",
      "r440",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r160",
      "r161",
      "r201",
      "r439",
      "r440",
      "r546",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r160",
      "r161",
      "r201",
      "r439",
      "r440",
      "r546",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r160",
      "r161",
      "r201",
      "r439",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Service revenues as a percentage of total revenues"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r160",
      "r161",
      "r201",
      "r439",
      "r440",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r104",
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationVariableInterestEntityPolicy": {
     "auth_ref": [
      "r383",
      "r387",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).",
        "label": "Consolidation, Variable Interest Entity, Policy [Policy Text Block]",
        "terseLabel": "Variable Interest Entities"
       }
      }
     },
     "localname": "ConsolidationVariableInterestEntityPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConversionOfStockByUniqueDescriptionAxis": {
     "auth_ref": [
      "r100",
      "r101",
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by description of stock conversions.",
        "label": "Stock Conversion Description [Axis]",
        "terseLabel": "Stock Conversion Description [Axis]"
       }
      }
     },
     "localname": "ConversionOfStockByUniqueDescriptionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareNarrativeDetails",
      "http://www.surgerypartners.com/role/RedeemablePreferredStockNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConversionOfStockNameDomain": {
     "auth_ref": [
      "r100",
      "r101",
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The unique name of a noncash or part noncash stock conversion.",
        "label": "Conversion of Stock, Name [Domain]",
        "terseLabel": "Conversion of Stock, Name [Domain]"
       }
      }
     },
     "localname": "ConversionOfStockNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareNarrativeDetails",
      "http://www.surgerypartners.com/role/RedeemablePreferredStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConversionOfStockSharesIssued1": {
     "auth_ref": [
      "r100",
      "r101",
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Shares Issued",
        "terseLabel": "Shares of common stock issued in conversion (shares)"
       }
      }
     },
     "localname": "ConversionOfStockSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareNarrativeDetails",
      "http://www.surgerypartners.com/role/RedeemablePreferredStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r187",
      "r189",
      "r195",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "verboseLabel": "All other"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r158",
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r18",
      "r19",
      "r20",
      "r107",
      "r114",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r272",
      "r273",
      "r274",
      "r275",
      "r455",
      "r507",
      "r509",
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails",
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Debt instrument, basis spread on variable rate (percent)"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails",
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r20",
      "r269",
      "r509",
      "r521"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r41",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Stated interest rate (percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails",
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails",
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r42",
      "r107",
      "r114",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r272",
      "r273",
      "r274",
      "r275",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails",
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r42",
      "r107",
      "r114",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r272",
      "r273",
      "r274",
      "r275",
      "r293",
      "r294",
      "r295",
      "r296",
      "r451",
      "r452",
      "r455",
      "r456",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails",
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r258",
      "r270",
      "r272",
      "r273",
      "r453"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "negatedTerseLabel": "Less: unamortized debt issuance costs and discounts",
        "terseLabel": "Debt issuance costs and discount, net of issuance premium"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails",
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": {
     "auth_ref": [
      "r258",
      "r451",
      "r452",
      "r453",
      "r454",
      "r456"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount (premium).",
        "label": "Debt Instrument, Unamortized Discount (Premium), Net",
        "terseLabel": "Unamortized fair value discount (premium)"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r340",
      "r341"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Long-term deferred tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r96",
      "r109",
      "r347",
      "r352",
      "r353",
      "r354"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r96",
      "r174"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r397",
      "r398",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "Derivative asset, notional amount"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesandtheirlocationonthecondensedconsolidatedbalancesheetsDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesandtheirlocationonthecondensedconsolidatedbalancesheetsDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r52",
      "r404",
      "r406",
      "r412",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesandtheirlocationonthecondensedconsolidatedbalancesheetsDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r425",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivatives and Hedging Activities"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeLiabilityNotionalAmount": {
     "auth_ref": [
      "r397",
      "r398",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative liability.",
        "label": "Derivative Liability, Notional Amount",
        "negatedTerseLabel": "Derivative liability, notional amount",
        "terseLabel": "Derivative liability, notional amount"
       }
      }
     },
     "localname": "DerivativeLiabilityNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesandtheirlocationonthecondensedconsolidatedbalancesheetsDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r398",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeVariableInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable interest rate in effect as of the balance sheet date related to the interest rate derivative.",
        "label": "Derivative, Variable Interest Rate",
        "terseLabel": "Variable interest rate of derivative instrument (percent)"
       }
      }
     },
     "localname": "DerivativeVariableInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r113",
      "r396",
      "r399",
      "r401",
      "r402",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Instruments and Hedging Activities"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives in cash flow hedging relationships"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesandtheirlocationonthecondensedconsolidatedbalancesheetsDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r73",
      "r121",
      "r122",
      "r123",
      "r124",
      "r125",
      "r129",
      "r132",
      "r138",
      "r141",
      "r142",
      "r146",
      "r147",
      "r427",
      "r428",
      "r517",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Net loss per share attributable to common stockholders",
        "verboseLabel": "Loss per share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]",
        "terseLabel": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareBasicLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r73",
      "r121",
      "r122",
      "r123",
      "r124",
      "r125",
      "r132",
      "r138",
      "r141",
      "r142",
      "r146",
      "r147",
      "r427",
      "r428",
      "r517",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective tax rate (percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesIncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r111",
      "r343",
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Federal effective tax rate (percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": {
     "auth_ref": [
      "r337",
      "r343"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount",
        "negatedTerseLabel": "Tax benefits related to vesting of restricted stock awards"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued payroll and benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue from External Customer [Line Items]",
        "terseLabel": "Revenue from External Customer [Line Items]"
       }
      }
     },
     "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r65",
      "r66",
      "r67",
      "r116",
      "r117",
      "r118",
      "r120",
      "r126",
      "r128",
      "r149",
      "r212",
      "r292",
      "r297",
      "r333",
      "r334",
      "r335",
      "r349",
      "r350",
      "r426",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r540",
      "r541",
      "r542",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r260",
      "r272",
      "r273",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EstimatedInsuranceRecoveries": {
     "auth_ref": [
      "r34"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of amounts expected to be recovered under the terms of insurance contracts.",
        "label": "Estimated Insurance Recoveries",
        "terseLabel": "Expected insurance recoveries"
       }
      }
     },
     "localname": "EstimatedInsuranceRecoveries",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r430",
      "r437",
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r260",
      "r272",
      "r273",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r325",
      "r431",
      "r481",
      "r482",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r260",
      "r272",
      "r273",
      "r430",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r260",
      "r272",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r260",
      "r272",
      "r273",
      "r317",
      "r318",
      "r323",
      "r325",
      "r431",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r260",
      "r272",
      "r273",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r325",
      "r481",
      "r482",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r433",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FederalFundsEffectiveSwapRateMember": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap having its variable-rate leg referenced to Federal Funds effective rate with no additional spread over Federal Funds effective rate on that variable-rate leg.",
        "label": "Fed Funds Effective Rate Overnight Index Swap Rate [Member]",
        "terseLabel": "Federal Funds Rate"
       }
      }
     },
     "localname": "FederalFundsEffectiveSwapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails",
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r459",
      "r463",
      "r469"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails": {
       "order": 2.0,
       "parentTag": "sgry_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest on lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r461",
      "r465"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Operating cash outflows from finance leases"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r458",
      "r468"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Finance lease obligations"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r460",
      "r465"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "terseLabel": "Financing cash outflows from finance leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r459",
      "r463",
      "r469"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails": {
       "order": 1.0,
       "parentTag": "sgry_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization of leased assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "auth_ref": [
      "r231"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 10.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.",
        "label": "Gain (Loss) Related to Litigation Settlement",
        "negatedTerseLabel": "Litigation settlement"
       }
      }
     },
     "localname": "GainLossRelatedToLitigationSettlement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r96",
      "r276",
      "r277"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 9.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "(Gain) loss on debt extinguishment"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r215",
      "r216",
      "r477",
      "r505"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/AcquisitionsSummaryDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, end of period",
        "periodStartLabel": "Goodwill, beginning of period",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsSummaryDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesRollforwardofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r217"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Acquisitions, including post acquisition adjustments"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesRollforwardofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesRollforwardofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GovernmentContractMember": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Formal agreement with government or its agency.",
        "label": "Government Contract [Member]",
        "terseLabel": "Government"
       }
      }
     },
     "localname": "GovernmentContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GuaranteeObligationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Guarantor Obligations [Line Items]",
        "terseLabel": "Guarantor Obligations [Line Items]"
       }
      }
     },
     "localname": "GuaranteeObligationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r401",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesandtheirlocationonthecondensedconsolidatedbalancesheetsDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesandtheirlocationonthecondensedconsolidatedbalancesheetsDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r110",
      "r355"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "Income (loss) before income taxes",
        "totalLabel": "Income (loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r68",
      "r96",
      "r176",
      "r210",
      "r512",
      "r529"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedTerseLabel": "Income from equity investments"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.",
        "label": "Income (Loss) from Equity Method Investments, Net of Dividends or Distributions",
        "negatedTerseLabel": "Income from equity investments, net of distributions received"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r223",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r112",
      "r127",
      "r128",
      "r177",
      "r342",
      "r351",
      "r357",
      "r535"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense (benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r64",
      "r338",
      "r339",
      "r344",
      "r345",
      "r346",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationDispositionOfBusiness": {
     "auth_ref": [
      "r343"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the disposition of a business not qualifying as a discontinued operation.",
        "label": "Effective Income Tax Rate Reconciliation, Disposition of Business, Amount",
        "negatedTerseLabel": "Tax benefits related to the sale of partnership interests"
       }
      }
     },
     "localname": "IncomeTaxReconciliationDispositionOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses": {
     "auth_ref": [
      "r343"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible impairment loss.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount",
        "terseLabel": "Tax expense attributable to impairment of goodwill"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxSettlements": {
     "auth_ref": [
      "r343"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax settlements. Including, but not limited to, domestic tax settlement, foreign tax settlement, state and local tax settlement, and other tax settlements.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Settlement, Amount",
        "terseLabel": "Tax expense related to settlement payment"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxSettlements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, net of acquisitions and divestitures:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedTerseLabel": "Other operating assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/RedeemablePreferredStockSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsNetIncludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.",
        "label": "Intangible Assets, Net (Including Goodwill)",
        "terseLabel": "Goodwill and other intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetIncludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of nonoperating interest income (expense).",
        "label": "Interest Income (Expense), Nonoperating, Net",
        "negatedTerseLabel": "Interest expense, net",
        "terseLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrent": {
     "auth_ref": [
      "r14",
      "r15",
      "r38"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest Payable, Current",
        "terseLabel": "Interest payable"
       }
      }
     },
     "localname": "InterestPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCapMember": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract in which the cap writer, in return for a premium, agrees to limit, or cap, the cap holder's risk associated with an increase in interest rates. If rates go above a specified interest-rate-level (the strike price or the cap rate), the cap holder is entitled to receive cash payments equal to the excess of the market rate over the strike price multiplied by the notional principal amount.",
        "label": "Interest Rate Cap [Member]",
        "terseLabel": "Interest Rate Cap"
       }
      }
     },
     "localname": "InterestRateCapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesandtheirlocationonthecondensedconsolidatedbalancesheetsDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesandtheirlocationonthecondensedconsolidatedbalancesheetsDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r6",
      "r48",
      "r477"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "terseLabel": "Investments in and advances to affiliates"
       }
      }
     },
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LaborAndRelatedExpense": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.",
        "label": "Labor and Related Expense",
        "terseLabel": "Salaries and benefits"
       }
      }
     },
     "localname": "LaborAndRelatedExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r467",
      "r469"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease costs"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Lease Expense and Cash Flow Information"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r37",
      "r108",
      "r187",
      "r211",
      "r236",
      "r237",
      "r238",
      "r241",
      "r242",
      "r243",
      "r245",
      "r247",
      "r249",
      "r250",
      "r377",
      "r384",
      "r385",
      "r442",
      "r475",
      "r476"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r31",
      "r108",
      "r211",
      "r442",
      "r477",
      "r511",
      "r528"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r40",
      "r108",
      "r211",
      "r236",
      "r237",
      "r238",
      "r241",
      "r242",
      "r243",
      "r245",
      "r247",
      "r249",
      "r250",
      "r377",
      "r384",
      "r385",
      "r442",
      "r475",
      "r476",
      "r477"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r20",
      "r509",
      "r521"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Amount of line of credit outstanding"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r36"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r36"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Availability on line of credit instrument"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationReserveCurrent": {
     "auth_ref": [
      "r44",
      "r231",
      "r232"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.",
        "label": "Estimated Litigation Liability, Current",
        "verboseLabel": "Accrued legal settlement"
       }
      }
     },
     "localname": "LitigationReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded to other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded to Other Party",
        "terseLabel": "Payment under settlement agreement"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement, Expense",
        "terseLabel": "Other litigation costs"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails",
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r20",
      "r259",
      "r271",
      "r272",
      "r273",
      "r509",
      "r524"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "terseLabel": "Long-term debt, less current maturities",
        "verboseLabel": "Total long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-term Debt and Lease Obligation, Current",
        "terseLabel": "Less: Current maturities",
        "verboseLabel": "Current maturities of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, including portion classified as current.",
        "label": "Long-term Debt and Lease Obligation, Including Current Maturities",
        "totalLabel": "Total debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-term Debt [Text Block]",
        "terseLabel": "Long-Term Debt"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails",
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r42",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails",
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MajorityShareholderMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Owner that controls more than 50 percent of the voting interest in the entity through direct or indirect ownership.",
        "label": "Majority Shareholder [Member]",
        "terseLabel": "Bain Capital Private Equity, L.P."
       }
      }
     },
     "localname": "MajorityShareholderMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/RedeemablePreferredStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r47",
      "r108",
      "r211",
      "r236",
      "r241",
      "r242",
      "r243",
      "r249",
      "r250",
      "r442",
      "r510",
      "r527"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Non-controlling interests\u2014non-redeemable"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r297"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedTerseLabel": "Distributions to non-controlling interests\u2014non-redeemable holders"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash (used in) provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r93",
      "r94",
      "r97"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r4",
      "r59",
      "r61",
      "r67",
      "r69",
      "r97",
      "r108",
      "r119",
      "r121",
      "r122",
      "r123",
      "r124",
      "r127",
      "r128",
      "r135",
      "r179",
      "r185",
      "r189",
      "r192",
      "r195",
      "r211",
      "r236",
      "r237",
      "r238",
      "r241",
      "r242",
      "r243",
      "r245",
      "r247",
      "r249",
      "r250",
      "r428",
      "r442",
      "r513",
      "r530"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss attributable to Surgery Partners, Inc.",
        "totalLabel": "Net loss attributable to Surgery Partners, Inc."
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Attributable to Parent [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NetIncomeLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r59",
      "r61",
      "r67",
      "r127",
      "r128",
      "r380",
      "r394"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Net income attributable to non-controlling interests",
        "negatedTerseLabel": "Less: Net income attributable to non-controlling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Redeemable Noncontrolling Interest",
        "terseLabel": "Net income attributable to non-controlling interests\u2014redeemable"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofNonControllingInterestsRedeemableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r121",
      "r122",
      "r123",
      "r124",
      "r129",
      "r130",
      "r137",
      "r142",
      "r179",
      "r185",
      "r189",
      "r192",
      "r195"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Net loss attributable to common stockholders",
        "totalLabel": "Net loss attributable to common stockholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest": {
     "auth_ref": [
      "r282",
      "r380",
      "r381"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.",
        "label": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest",
        "terseLabel": "Net (loss) income"
       }
      }
     },
     "localname": "NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r116",
      "r117",
      "r118",
      "r297",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non-Controlling Interests\u2014 Non-Redeemable"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives not designated as hedging instruments"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesandtheirlocationonthecondensedconsolidatedbalancesheetsDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfBusinessesAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of businesses acquired by the entity during the period.",
        "label": "Number of Businesses Acquired",
        "terseLabel": "Number of facilities acquired"
       }
      }
     },
     "localname": "NumberOfBusinessesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfInterestRateDerivativesHeld": {
     "auth_ref": [
      "r398",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of interest rate derivative instruments held by the entity at the reporting date.",
        "label": "Number of Interest Rate Derivatives Held",
        "terseLabel": "Number of interest rate swaps"
       }
      }
     },
     "localname": "NumberOfInterestRateDerivativesHeld",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfStatesInWhichEntityOperates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of states the entity operates in as of the balance sheet date.",
        "label": "Number of States in which Entity Operates",
        "terseLabel": "Number of states in which entity operates"
       }
      }
     },
     "localname": "NumberOfStatesInWhichEntityOperates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesOrganizationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.",
        "label": "Operating Costs and Expenses",
        "totalLabel": "Cost of revenues"
       }
      }
     },
     "localname": "OperatingCostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r179",
      "r185",
      "r189",
      "r192",
      "r195"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r464",
      "r469"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease costs"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r458"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "verboseLabel": "Right-of-use operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r458"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Right-of-use operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r462",
      "r465"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash outflows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r457"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "verboseLabel": "Right-of-use operating lease assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "terseLabel": "Non-cash lease expense"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r187",
      "r189",
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r13",
      "r14",
      "r15",
      "r38"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses and other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r49",
      "r477"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r53",
      "r55"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "negatedLabel": "Amount of unrealized losses recorded in OCI",
        "terseLabel": "Derivative activity",
        "verboseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r53",
      "r55",
      "r405",
      "r409",
      "r422"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Loss recognized in OCI (effective portion)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r55",
      "r58",
      "r410"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "Gain recognized in income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax": {
     "auth_ref": [
      "r411"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from discontinuance of cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Reclassification for Discontinuance, before Tax",
        "terseLabel": "Amortization of accumulated OCI related"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCostAndExpenseOperating": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.",
        "label": "Other Cost and Expense, Operating",
        "terseLabel": "Other operating expenses"
       }
      }
     },
     "localname": "OtherCostAndExpenseOperating",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other current liabilities.",
        "label": "Other Current Liabilities [Table Text Block]",
        "terseLabel": "Summary of Other Current Liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherIncomeMember": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other revenue.",
        "label": "Other Income [Member]",
        "terseLabel": "Other income"
       }
      }
     },
     "localname": "OtherIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r12",
      "r13",
      "r38",
      "r477"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities Disclosure [Abstract]"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other liabilities.",
        "label": "Other Liabilities Disclosure [Text Block]",
        "terseLabel": "Other Current Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OtherCurrentLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesandtheirlocationonthecondensedconsolidatedbalancesheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesandtheirlocationonthecondensedconsolidatedbalancesheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonrecurringIncomeExpense": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 11.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other expense (income) that is infrequent in occurrence or unusual in nature.",
        "label": "Other Nonrecurring (Income) Expense",
        "terseLabel": "Other income"
       }
      }
     },
     "localname": "OtherNonrecurringIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OverAllotmentOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.",
        "label": "Over-Allotment Option [Member]",
        "terseLabel": "Additional Shares Granted to Underwriters"
       }
      }
     },
     "localname": "OverAllotmentOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r81",
      "r84"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other investing activities"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedTerseLabel": "Payments of debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsMinorityInterest": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.",
        "label": "Payments of Ordinary Dividends, Noncontrolling Interest",
        "negatedTerseLabel": "Distributions to non-controlling interest holders"
       }
      }
     },
     "localname": "PaymentsOfDividendsMinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Preferred Stock and Preference Stock",
        "negatedTerseLabel": "Payment of preferred dividends"
       }
      }
     },
     "localname": "PaymentsOfDividendsPreferredStockAndPreferenceStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "negatedTerseLabel": "Payments of equity offering costs",
        "terseLabel": "Underwriting discounts, commissions and other related costs related to offering"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.surgerypartners.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r82",
      "r369"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Total consideration"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Payments for acquisitions, net of cash acquired",
        "terseLabel": "Payments for acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsNarrativeDetails",
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchases of property and equipment",
        "terseLabel": "Total cash purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Payments to Noncontrolling Interests",
        "negatedTerseLabel": "Receipts (payments) related to ownership transactions with non-controlling interest holders"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockDividendRatePercentage": {
     "auth_ref": [
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage rate used to calculate dividend payments on preferred stock.",
        "label": "Preferred Stock, Dividend Rate, Percentage",
        "terseLabel": "Preferred stock dividend rate (percent)"
       }
      }
     },
     "localname": "PreferredStockDividendRatePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/RedeemablePreferredStockNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r23",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in USD per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r23",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.surgerypartners.com/role/RedeemablePreferredStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r23",
      "r477"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.01 par value; shares authorized - 20,000,000; shares issued or outstanding - none"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r8",
      "r10",
      "r213",
      "r214"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from equity offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Borrowings of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMinorityShareholders": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.",
        "label": "Proceeds from Noncontrolling Interests",
        "terseLabel": "Receipts (payments) related to ownership transactions with non-controlling interest holders"
       }
      }
     },
     "localname": "ProceedsFromMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r87",
      "r91"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other financing activities"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfProductiveAssets": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Proceeds from Sale of Productive Assets",
        "terseLabel": "Proceeds from disposals of facilities and other assets"
       }
      }
     },
     "localname": "ProceedsFromSaleOfProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductConcentrationRiskMember": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence.",
        "label": "Product Concentration Risk [Member]",
        "terseLabel": "Revenue Source"
       }
      }
     },
     "localname": "ProductConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfessionalFees": {
     "auth_ref": [
      "r547",
      "r548"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.",
        "label": "Professional Fees",
        "terseLabel": "Professional and medical fees"
       }
      }
     },
     "localname": "ProfessionalFees",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r4",
      "r59",
      "r61",
      "r67",
      "r92",
      "r108",
      "r119",
      "r127",
      "r128",
      "r179",
      "r185",
      "r189",
      "r192",
      "r195",
      "r211",
      "r236",
      "r237",
      "r238",
      "r241",
      "r242",
      "r243",
      "r245",
      "r247",
      "r249",
      "r250",
      "r373",
      "r379",
      "r381",
      "r394",
      "r395",
      "r428",
      "r442",
      "r519"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r221",
      "r459",
      "r463"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization",
        "terseLabel": "Accumulated depreciation on property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r51",
      "r222",
      "r463"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "terseLabel": "Property and equipment, net of accumulated depreciation of $254.0 and $189.3, respectively"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r205",
      "r207",
      "r208",
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]",
        "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]"
       }
      }
     },
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]",
        "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]"
       }
      }
     },
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesandtheirlocationonthecondensedconsolidatedbalancesheetsDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesandtheirlocationonthecondensedconsolidatedbalancesheetsDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationsOfTemporaryToPermanentEquity": {
     "auth_ref": [
      "r286",
      "r424"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the carrying amount of a financial instrument subject to a registration payment arrangement recorded as temporary equity prior to adoption of FSP EITF 00-19-2 and the carrying amount reclassified to permanent equity upon the adoption of FSP EITF 00-19-2. Recorded as a cumulative effect adjustment to the beginning balance of retained earnings. Does not apply to registration payment arrangements that are no longer outstanding upon adoption of FSP EITF 00-19-2.",
        "label": "Reclassifications of Temporary to Permanent Equity",
        "negatedTerseLabel": "Redeemable preferred stock conversion to common stock"
       }
      }
     },
     "localname": "ReclassificationsOfTemporaryToPermanentEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/RedeemablePreferredStockSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock": {
     "auth_ref": [
      "r186",
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.",
        "label": "Reconciliation of Assets from Segment to Consolidated [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Assets from Segment to Consolidated"
       }
      }
     },
     "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r185",
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Schedule of Segment Revenue and Operating Income"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "auth_ref": [
      "r280",
      "r281",
      "r283",
      "r284"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "terseLabel": "Non-controlling interests\u2014redeemable"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofNonControllingInterestsRedeemableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityPreferredRedemptionValue": {
     "auth_ref": [
      "r285"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redemption value, as if currently redeemable, of redeemable noncontrolling interest for preferred shares, units or ownership interests classified as temporary equity and the election has been made to accrete changes in redemption value to the earliest redemption date.",
        "label": "Redeemable Noncontrolling Interest, Equity, Preferred, Redemption Value",
        "terseLabel": "Redeemable preferred stock, redemption value"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityPreferredRedemptionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.",
        "label": "Redeemable Noncontrolling Interest [Table Text Block]",
        "terseLabel": "Schedule of Rollforward of Noncontrolling Interest - Redeemable"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r324",
      "r471",
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/RedeemablePreferredStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r324",
      "r471",
      "r473",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/RedeemablePreferredStockNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedTerseLabel": "Principal payments on long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndInvestmentsNoncurrent": {
     "auth_ref": [
      "r549",
      "r550"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The noncurrent cash, cash equivalents and investments that is restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits classified as long-term; that is not expected to be released from such existing restrictions within one year of the balance sheet date or operating cycle, whichever is longer. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes noncurrent cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.",
        "label": "Restricted Cash and Investments, Noncurrent",
        "verboseLabel": "Restricted invested assets included in other long-term assets"
       }
      }
     },
     "localname": "RestrictedCashAndInvestmentsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted shares"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r27",
      "r297",
      "r336",
      "r477",
      "r526",
      "r543",
      "r545"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r116",
      "r117",
      "r118",
      "r120",
      "r126",
      "r128",
      "r212",
      "r333",
      "r334",
      "r335",
      "r349",
      "r350",
      "r426",
      "r540",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "auth_ref": [
      "r170",
      "r171",
      "r184",
      "r190",
      "r191",
      "r198",
      "r199",
      "r201",
      "r306",
      "r307",
      "r491"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.",
        "label": "Revenue from Contract with Customer, Including Assessed Tax",
        "terseLabel": "Revenues",
        "verboseLabel": "Total revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r105",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r466",
      "r469"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for finance lease obligations"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r466",
      "r469"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for operating lease obligations"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Net proceeds from stock offering"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Stock sold in offering (shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Sale price to public (in USD per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r160",
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r360",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsNarrativeDetails",
      "http://www.surgerypartners.com/role/AcquisitionsSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.",
        "label": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Carrying Amounts and Fair Values of Long-Term Debt"
       }
      }
     },
     "localname": "ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Summary of Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": {
     "auth_ref": [
      "r396",
      "r399",
      "r400",
      "r401",
      "r402",
      "r408",
      "r412",
      "r418",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Schedule of Derivative Instruments [Table Text Block]",
        "terseLabel": "Schedule of Interest Rate Swaps and Interest Rate Caps Outstanding"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable": {
     "auth_ref": [
      "r132",
      "r133",
      "r138",
      "r142",
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The table contains disclosure pertaining to an entity's basic earnings per share.",
        "label": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]",
        "terseLabel": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": {
     "auth_ref": [
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table]",
        "terseLabel": "Revenue from External Customers by Products and Services [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r218",
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Rollforward of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGuaranteeObligationsTable": {
     "auth_ref": [
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure about the type or nature of guarantees, for example performance, indemnification, payment and other guarantees, and related information such as term, origin and purpose, triggering event, maximum exposure, and carrying value. Represents the guarantor's disclosures which include the information about each guarantee, or each group of similar guarantees, even if the likelihood of the guarantor's need to make any payments under the guarantee is remote. This excludes disclosures for product warranties.",
        "label": "Schedule of Guarantor Obligations [Table]",
        "terseLabel": "Schedule of Guarantor Obligations [Table]"
       }
      }
     },
     "localname": "ScheduleOfGuaranteeObligationsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock": {
     "auth_ref": [
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of interest rate derivatives, including, but not limited to, the fair value of the derivatives, statement of financial position location, and statement of financial performance location of these instruments.",
        "label": "Schedule of Interest Rate Derivatives [Table Text Block]",
        "terseLabel": "Schedule of Effect of Interest Rate Swaps"
       }
      }
     },
     "localname": "ScheduleOfInterestRateDerivativesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r179",
      "r182",
      "r188",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r179",
      "r182",
      "r188",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Financial Information by Reportable Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "auth_ref": [
      "r376",
      "r377",
      "r384",
      "r385",
      "r386",
      "r388",
      "r390",
      "r391",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table]",
        "terseLabel": "Schedule of Variable Interest Entities [Table]"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": {
     "auth_ref": [
      "r157",
      "r160",
      "r161",
      "r162",
      "r439",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]",
        "terseLabel": "Schedule of Revenues"
       }
      }
     },
     "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Secured Debt"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails",
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r166",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r184",
      "r185",
      "r186",
      "r187",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r195",
      "r201",
      "r226",
      "r227",
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r166",
      "r168",
      "r169",
      "r179",
      "r183",
      "r189",
      "r193",
      "r194",
      "r195",
      "r196",
      "r198",
      "r200",
      "r201",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReporting"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, Other Significant Reconciling Item, Consolidated [Abstract]",
        "terseLabel": "Reconciliation of Adjusted EBITDA:"
       }
      }
     },
     "localname": "SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SelfInsuranceReserve": {
     "auth_ref": [
      "r43"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.",
        "label": "Self Insurance Reserve",
        "terseLabel": "Professional, general and workers' compensation insurance reserve"
       }
      }
     },
     "localname": "SelfInsuranceReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails",
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series A preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series A Preferred Stock [Member]",
        "terseLabel": "Series A Preferred Stock"
       }
      }
     },
     "localname": "SeriesAPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/RedeemablePreferredStockNarrativeDetails",
      "http://www.surgerypartners.com/role/RedeemablePreferredStockSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Equity-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued, Price Per Share",
        "terseLabel": "Purchase price per share (in USD per share)"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/RedeemablePreferredStockNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r3",
      "r166",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r184",
      "r185",
      "r186",
      "r187",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r195",
      "r201",
      "r218",
      "r224",
      "r226",
      "r227",
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r22",
      "r23",
      "r24",
      "r106",
      "r108",
      "r132",
      "r133",
      "r134",
      "r138",
      "r142",
      "r150",
      "r151",
      "r152",
      "r211",
      "r236",
      "r241",
      "r242",
      "r243",
      "r249",
      "r250",
      "r287",
      "r288",
      "r290",
      "r291",
      "r292",
      "r442",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareNarrativeDetails",
      "http://www.surgerypartners.com/role/RedeemablePreferredStockNarrativeDetails",
      "http://www.surgerypartners.com/role/RedeemablePreferredStockSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r46",
      "r65",
      "r66",
      "r67",
      "r116",
      "r117",
      "r118",
      "r120",
      "r126",
      "r128",
      "r149",
      "r212",
      "r292",
      "r297",
      "r333",
      "r334",
      "r335",
      "r349",
      "r350",
      "r426",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r540",
      "r541",
      "r542",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r116",
      "r117",
      "r118",
      "r149",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r45",
      "r262",
      "r292",
      "r293",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "terseLabel": "Preferred share conversion (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r23",
      "r24",
      "r292",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Stock issued during period (shares)",
        "verboseLabel": "Equity offering (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.surgerypartners.com/role/RedeemablePreferredStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r23",
      "r24",
      "r292",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Equity-based compensation (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r46",
      "r292",
      "r297"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "terseLabel": "Preferred share conversion"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r23",
      "r24",
      "r292",
      "r297"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Proceeds from issuance of preferred shares",
        "verboseLabel": "Equity offering"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.surgerypartners.com/role/RedeemablePreferredStockNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r23",
      "r24",
      "r297",
      "r330",
      "r331"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Equity-based compensation"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r24",
      "r29",
      "r30",
      "r108",
      "r206",
      "r211",
      "r442",
      "r477"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Surgery Partners, Inc. stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r66",
      "r108",
      "r116",
      "r117",
      "r118",
      "r120",
      "r126",
      "r211",
      "r212",
      "r297",
      "r333",
      "r334",
      "r335",
      "r349",
      "r350",
      "r371",
      "r372",
      "r393",
      "r426",
      "r442",
      "r444",
      "r445",
      "r449",
      "r541",
      "r542",
      "r576"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending Balance, stockholders' equity",
        "periodStartLabel": "Beginning Balance, stockholders' equity",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/SubsequentEventsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r450",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/SubsequentEventsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r450",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/SubsequentEventsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r450",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/SubsequentEventsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r450",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/SubsequentEventsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r478",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SuppliesExpense": {
     "auth_ref": [
      "r518"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense associated with supplies that were used during the current accounting period.",
        "label": "Supplies Expense",
        "terseLabel": "Supplies"
       }
      }
     },
     "localname": "SuppliesExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxesPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r19",
      "r508",
      "r523"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.",
        "label": "Taxes Payable",
        "terseLabel": "Long-term tax receivable agreement liability"
       }
      }
     },
     "localname": "TaxesPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityAccretionOfDividends": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of accretion of temporary equity during the period due to unpaid dividends.",
        "label": "Temporary Equity, Accretion of Dividends",
        "terseLabel": "Dividends accrued"
       }
      }
     },
     "localname": "TemporaryEquityAccretionOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/RedeemablePreferredStockSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityByClassOfStockTable": {
     "auth_ref": [
      "r16",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table of capital stock that is classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. This table may include a description by series, value, shares authorized, shares issued and outstanding, redemption price per share and subscription receivable.",
        "label": "Temporary Equity, by Class of Stock [Table]",
        "terseLabel": "Temporary Equity, by Class of Stock [Table]"
       }
      }
     },
     "localname": "TemporaryEquityByClassOfStockTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/RedeemablePreferredStockNarrativeDetails",
      "http://www.surgerypartners.com/role/RedeemablePreferredStockSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [
      "r236",
      "r241",
      "r242",
      "r243",
      "r249",
      "r250"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Redeemable preferred stock - Series A; shares authorized - 310,000; shares issued or outstanding - none and 310,000, respectively; redemption value - $\u2014 and $434.5, respectively"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.surgerypartners.com/role/RedeemablePreferredStockSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity Disclosure [Abstract]",
        "terseLabel": "Temporary Equity Disclosure [Abstract]"
       }
      }
     },
     "localname": "TemporaryEquityDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityDividendsAdjustment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accretion of temporary equity during the period due to cash, stock, and in-kind dividends. This item is an adjustment to net income necessary to derive net income apportioned to common stockholders and is to be distinguished from Temporary Equity, Accretion of Dividends (Temporary Equity, Accretion of Dividends).",
        "label": "Temporary Equity, Dividends, Adjustment",
        "negatedTerseLabel": "Dividends declared"
       }
      }
     },
     "localname": "TemporaryEquityDividendsAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/RedeemablePreferredStockSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Temporary Equity [Line Items]",
        "terseLabel": "Temporary Equity [Line Items]"
       }
      }
     },
     "localname": "TemporaryEquityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/RedeemablePreferredStockNarrativeDetails",
      "http://www.surgerypartners.com/role/RedeemablePreferredStockSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Authorized",
        "terseLabel": "Redeemable preferred stock, shares authorized (shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Issued",
        "terseLabel": "Redeemable preferred stock, shares issued (shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Outstanding",
        "terseLabel": "Redeemable preferred stock, shares outstanding (shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquityTableTextBlock": {
     "auth_ref": [
      "r16",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity [Table Text Block]",
        "terseLabel": "Schedule of Activity Related to Redeemable Preferred Stock"
       }
      }
     },
     "localname": "TemporaryEquityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/RedeemablePreferredStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic": {
     "auth_ref": [
      "r136",
      "r139",
      "r140"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.",
        "label": "Undistributed Earnings (Loss) Allocated to Participating Securities, Basic",
        "negatedLabel": "Less: Amounts attributable to participating securities"
       }
      }
     },
     "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnusualOrInfrequentItemNetGainLoss": {
     "auth_ref": [
      "r78",
      "r79",
      "r175",
      "r358"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of (gain) loss for an event or transaction that is unusual in nature or occurs infrequently, or both.",
        "label": "Unusual or Infrequent Item, or Both, Net (Gain) Loss",
        "terseLabel": "Hurricane-related operating losses"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemNetGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnusualRiskOrUncertaintyByNatureAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by nature of risk and uncertainty, for example, but not limited to, threat of expropriation of its assets by a foreign government, rapid technological obsolescence in the industry, risk of natural disaster from earthquake or weather events, and availability of or continuation of a labor force at a reasonable cost.",
        "label": "Unusual Risk or Uncertainty, Nature [Axis]",
        "terseLabel": "Unusual Risk or Uncertainty, Nature [Axis]"
       }
      }
     },
     "localname": "UnusualRiskOrUncertaintyByNatureAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnusualRiskOrUncertaintyNatureDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of the unusual risk or uncertainty, such as the threat of expropriation of its assets by a foreign government, rapid technological obsolescence in the industry, risk of natural disaster from earthquake or weather events, and availability of or continuation of a labor force at a reasonable cost.",
        "label": "Unusual Risk or Uncertainty, Nature [Domain]",
        "terseLabel": "Unusual Risk or Uncertainty, Nature [Domain]"
       }
      }
     },
     "localname": "UnusualRiskOrUncertaintyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r153",
      "r154",
      "r155",
      "r156",
      "r163",
      "r164",
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Variable Interest Entity [Line Items]",
        "terseLabel": "Variable Interest Entity [Line Items]"
       }
      }
     },
     "localname": "VariableInterestEntityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "auth_ref": [
      "r376",
      "r377",
      "r384",
      "r385",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Primary Beneficiary"
       }
      }
     },
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails",
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails",
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r131",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (shares)",
        "verboseLabel": "Weighted average shares outstanding- diluted (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Denominator:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r129",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (shares)",
        "verboseLabel": "Weighted average shares outstanding- basic (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Weighted average common shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 10
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "65",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2793-109256"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "66",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2814-109256"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8475-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2420-110228"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=116646759&loc=d3e15243-108350"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(3)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "24(b)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "740",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120384911&loc=d3e23163-113944"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2AA",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6759068-111685"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6228884-111685"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624186-113959"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90193-114008"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28567-108399"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.14)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(k)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413209&loc=SL6242269-115581"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r556": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r557": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r558": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r559": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r560": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r561": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r562": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r563": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r564": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "01"
  },
  "r565": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "02"
  },
  "r566": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(ii)",
   "Subsection": "01"
  },
  "r567": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)",
   "Subsection": "01"
  },
  "r568": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "01"
  },
  "r569": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "02"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r570": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "01"
  },
  "r571": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "02"
  },
  "r572": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(C)",
   "Subsection": "02"
  },
  "r573": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "01"
  },
  "r574": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "02"
  },
  "r575": {
   "Name": "Rule 15c3-1",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15c3-1"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=125520798&loc=SL114871939-224231"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>73
<FILENAME>0001638833-21-000146-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001638833-21-000146-xbrl.zip
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MK<XJMWW*(U[]K_R&;U/\5S)G_P%02P,$%     @ :3AC4[,/<F@,"   6B,
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M&1BHE9 #N;0*ZQZ5T)ET&3IH2TB\@:2W1-.T0#>G.$VP>+X:AN^XVL15_W_
M%;!4%I@Y L$R4TT$%8KCL%D9ET6*&YY3*X5_)ZH2J!/1L)*6)B))$DF4F$S"
M(>%3J270ZAS;6TLCEH7OT9HD42D40'1IA(!?SGI[$FXSEBH]LPOH&9A(Z[#!
M<XS3S6 W6ME<09!=&+-A[7<0;8)HL!M$X[6(O[ U0.I*2]M8IZG$2Y^%2\8-
M^'QC_F2L@/+" $$6*VDS$B>Q'"F,:(RNA;2)TK;">41N1JN0^-+H! 3>MNP
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M[BD/>*F_]AN^.O'?OYS^ 5!+ P04    " !I.&-35_;>OPT%   #&   %0
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MGW@Y$:95=##99>8C4RG'"-(2AIX@C9E% \JH.F27%FXA9BE$JV&.%E,F%*U
MT(;KF$"56F7FE06FN#-<Q7H[V/F;HX6XE&"TEBE:)/2(YG*')BHO/8) +FN1
M'UR;HZ4S1XN9@^H-VBH)D3)DPYS1*5E0,J .R<D:>-;;3-V[6E\RD:K]_OG@
MYNE\M?0RT44@NALL,PI06UOVV0X4SVD0B1S/&M;EMY"U,%J+F4DG(3H7G(NB
M&"WI$B:5$PI5IM"K%5BQ:-%&:S&K7ZK$A>&!^MF <-Y+"O:$S2%RQB6P-:QK
MHU5?Z=;.DA!3W."T!XRJ;"7)E4\B.W!>N?J[Y!F4]M;2'47C@\TI<J+-H%QR
M67,>G(Y!2F/T"G#H52C:7@W3M1 !]Q%BRLHQ;AF8S%&6>5%)ZN@"-ZLPDV8)
M3-="G%*T)AG.C4LY@%3!9Q45.),2EQ&=7".[-EVU%G#&T5CA8W !(7/B8,Q(
MBA;1\6+"8OU]\UU*4VOI?4 [D:('X5.$H#7&4$0D22:"#[G>LTOF#N%"M%!X
M,!8!;.81N"EI26>",5R3QXG"UJ Z;;DF5"]F.5JB?SF(,H%:@(O16DY4T-C(
M4O @TT^'XIH8U%>89?+6:PNH(P#XY+P0/$CG7<:DI:I!3>-RF:2%% ^"0F F
M&XPZ 6/*1<*1\QR4]T[JGP_%M4FJKS#+@)XY[R/&LG&U=UHA>5@F 95S+-3:
MORZRQF/^WH6"370 &(%8+WU&K33C5BBC6>*A#HOEKJ=1+ZMQ6HA$"\V"-\)
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MO%'9IZ22^C1[=HEQ7!ZO<R\ *1-\V8#4".U ,N%1IH0REL57M0IV^><<+"5
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M*-^$%'33H=)-X05*L"89G]>]>I.LMJY9 )^4YUZ[IL^!D5TE"^NBS,UHRK8
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M]N/VQ17CXVG[B_1[<J/TLMSB?GXU2A.4;WZYC:U+=X%OVCP9H$ ^37ZM'+
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M&4Q&98;!R>DP':?^J/MWZO0&HSJ2>^%5_>>=Z"(CO$U\-,=G7T0ZF<GW[+)
M=_HHW_0[2G4OC??SH?M0>6XAGIL?U<U=-FA.9<B9E@:5C(+3JK0[RJ4J+QNK
MP]J&N(KF_E5=(2N X)LK(A7!]X+@64TE*F)#9!Z"9:F4&44PVB5$L'<I4I=%
MYJBIT"O,B7M!\"-SDKQ,8X=_C B>W W=<76-/"A]Y$)\VV[8QV4;76*WK:E
M*X$M1&#SD[Q]=,KRG('@Z0."&P6><E\ZI*C(LV!*B1+X9.OS,<_K,UCUA;07
MM8WK(!6UC:-V5NV0R:& 4@1&8QG+X#@X@S]42BIYY;1CDQ[C](I(ZKV@MDG?
M")/KNN5ZQ^%@['J=@[/AVS3\V'GAAN-^&HZ>=% #7Y]69<VT];QO1XD?#/%R
M8#PX?5J6>33H=6.G+-,#)+][R!FYW*EUVB>Z4MQ"%/?7?!]W&61(W)36@6A9
M1:[!)6J1\90*E 1-$EO;T%*M\X:"T-?#P /RG3Q24#<5W:F@7AK4LWI+T)X'
ME0/XX-'&X#:!TQD?1:%59H[Q$-8V*)576!MM!/4C<Z?L#?IP:2!1IWL^D6AT
MW@8 Q07#S].+JK/E 6@NN]W^8(C4=C%<JE+< A2']SJGM[ DJ0FAM)=-!(0S
M'JSB%KA.1"M/Z:3QE+9HQ+0H=EWAV4X=I,)S27C.:B"*T!P%E: 9%ZB!* +>
M20T&30W%E%&VM*322BV?VUK=)\NY3ZJ?I#5T=B=9K_/VUDX_],[*JKX8#,LE
M?CUNZ^KIF)4A%V+(^0%ZVO*DB=&@&,T@B#)@E)*03.9HN@5"(R])LE*RY9-D
MJ^MEI7CB]EPOE0KN@ IFE:6LA4E1>>"D5%B7UIV.9@+2:$6$)S1%O;:!A\/Z
M?%.G-A)!D^Z:!Z-&];K.=WO=<;=TT>K'YM2J']B"/WK?N:BG"_24X[+&P1FB
M>2KN)0BT;6+XQZ(60R,KLRI'RIVHGK]_P<AF/U;'_Y(GR<Z<4JD8\X[S#,&6
MOC%1:[ 2#7!4%3@-RI3Q$6L;\@G^MKSKOT$8W;,_K7)HY=#6]-^N''JW'#JG
MC4NK5>8<D$L-B"0X^!@)L*QI#-DZ&E7A4$'Y.EL!#IUHZS]-++R+QCF7FFU?
M^JR0BL%WCL*-__7#GV8&<ESC;8V!U_P(O&PRVCFE3G\PQL\;#Q"Y#DW;4D>'
MJ(VI/YH^FBSGI+PN=_NN'[H3GRC^X00O?+3^S5L\_R)1K)/3P6A2H?ITF'JN
MM"+Z^7TWCH\O*.32N\Y%3+Z\Q7F\@K/QM]_25A%0<BT9T)FF3)=^EJN=<E1P
MP7*7C)1$<(V4283-/(NH4H[>O*%J[>)-QY^'OY^ZMPG\,+F_P&6\P:>N]]Y]
M'*W]]-4ZG'3[%Q>D$%ESR_S-5<GY)JNB9Q9%7[$H4X0BP0^&;K('D!'2L+P*
M+\FUY5(ZQ\-RK/W7CZ6CT0@N_-$9Y,ZS<B(B</[W)S<[K^?>2>*J!4"2>/7R
M^?;+H\Z+S9>'>]LO#YYT=O:>K7?:PVU77_:S_;VM[;V#[:T./CK8_WUG:_,0
M?SDXQ']VM_<.#SK[OW;V7VR_W#S<P1>TX'8F'_BTE.YWPS5N\)^O+@C["1Z'
MO9X;CCK=?@>_NH<;=?2DDSZ$A(?>:1I.._IVW F>K6-\YJ+!;[\S/AZ<X57%
MT;\67H ;\.OD%/U"]9-C.Y1+/QVEIQ</?H[=T6G/?7S:[4]N>O*FGT_<\"TR
MU?GY4 Z5F5-[\GW3I[]PV#J9\MBYM^W\F\^?7I\\-:.#3)\39ITS^<VGR3J]
MX7-<BQN]\WL72\FZ5:9>;+U8JZ^W9W_@@?YAZ&F!E]JYEUYAYT\)XF[,VA^>
M'E.G-1[NJ;.+KSL>=;;QS(^= R33=.*133EY<@U7]:HNS1[^Y;HK<X<;[9)_
MZUOVX!4F8;N7NOB4KQ,4N<X-/[:%(TU =$77IFZJ1C;5.;O->#SL9$5:1WCU
M*^_B*QN*[;<Y"/(R_9WZ9^EF7;66C#2M?L1H)2,_HE1+<L$RRZ7$RILHHV R
M"<+P-Y7?;$VBYYI0N%Z]R/D>_'4X."D.M7()?W;'Q\_.1K@<:?@Y36MS-$KX
M_[%-38;VNA>!G]^.=]GKWN[A+[V]Y[MT?^L/N;^UC?_MO']]\OID]QW^^^ZW
MWOYA[^1+X&?[_=XA?O_6'V)O*WS<.YQ\Q_'>NU=D]_ _[_:?O^[N/_^#OG[W
M2LP&?G8/-^G>\S_(WM9;LE?&E4_N9YOA9WS8^W-7O#[9$:^W_G.R=WB<=S^2
MCY.@SP'YL/LN?-A]^\8RGJG.%(BT H0O0Z9H%,"C(C&K7#HSKVU(:1N+^CR@
M"'CEI?;<V@*\Q"FA!&E(9HU\Q$N*CPN$T,R-8TG9"2^1"UXBE9=:P$MDAI<H
MSXXYK4"R4NE&O0;#$@=EO9>4JVQ<7ML05BV?'5IYJ?+2G?"2<H[JZ+GRC@A+
MN+$\BA!CD$0I1>RYOD2_HR\MD#)32>O628O-D%8A)6^(!RZ- L%E A=T *UC
MUDQ$ZKPNU2V*BE8UEZZT56GK.[1%J<O,.&T<&GN:>&$EGL+6))JB(_Y<G:+?
M4:<J;;6)ML0,;7GK;9#(4QR/)A!$9[ R69!.1-3"A$@E]X\^X?2JEF\/OG"Y
MS0RT?YI*AE+_;2=]."W)>Z.GMUJE7#]CM3[CD?40.G ]-[RH1?.IGW)W?"L>
M[6N5ZSZ&7B2-^X!_=WXPW.S'EVG2U'5[2GOUB%_@B-\[F'/S&L*#(8I"S%R"
MR)H GOH"@H[,42.\\!Z/>,66;WC8/KND@O6V'*,5K$V ==;W*1D)968T^-+@
M2UAEP E7]'%-H[2)94L1K(+6+E\K#-8&O(45K,V#==;G9[3FEC$%+)D 0N(9
MZPR/D S792)UY,:L;0AE*EA7&:S+^\@J6)L'ZZRG*[,@&2,:1# "1$(-V)+,
M\1%-AB470G!K&]R:5F4[/++9CP=GIZ>][@TST1[U=+C[M-LOI%:9Z@9,U9TS
MV*DI?6FR N0H!T)E#=[8 (12XX,3]MQ@)XUUQWJ@S?!6&J6-&^P5I4NA=-92
M]X1$K[6#E&-$Y5\D\%(%"(1'[Z,7/D\L=;9\W*RBM+4H;=Q2KRA="J6S)CIJ
M]R$Z%4$*C:J_#AZ<<AZ"IY82)JSQJ9CH#23E5)2V%Z5-F^@5I4NA=-8V9Y(G
M/"D->*L)"",)N(A6.HF<4,2L) ;/4F[8\K9Y@RA]9 'V%\-!3J,1KKGK38+L
M)RF62^OD=#NE8]7#>%L&^V51_HK2J_RU"'_-5U*1K%)DQH*-$BWV)"V8'!UH
MSK74.EJKR[!CU:H4NHK2EAOL%:7+H7368M<>#73#)62?! B"M@!2J0)-"7=,
ME7+',MRX@<&?%:6M16GC!GM%Z7(HG;78 V&&1B6 .Y.+]YN")2R"52%'?)2%
M,L7[;6M0?95AVK3%7F&Z'$SGPNF)*31'*"!G:A!>4#"!<N H#J\"I<E%A"DW
MZZ)%,'UDX?3?DQNEB_*1&E-_"";ZZ.WPX]//I3^;_?CKI$=WFHBRNAL7YZ[]
M9W/FNE>H1EB+A@ >':AB, &>VP!.D$0<ZAZ2Y+4-QI>GKAH3:"UB&S/7*V*;
M1^RLZ5[284PV94Q<4B!228E)1@+/+%CI$R?,(F)IC>*M,&(;,]TK8IM'[*P9
M3]$*,)(Q<-ES$,))\-$K4-DH2P*WDJ)]H$S-CEEEQ#9EQ5?$-H_8N580"E7?
MP$,QX2D(I%6P-#$PA$INN,@A!D2L6-[O5F/P-^X),3Y.P\Y@KC-$#;\_!-O^
MPA<YD>*SP6B,1'9.7I^YK;+8(BPV7^T>&,]2.0TEN0\$5PD,(P:85#DZYK.S
M?&V#BU7L'5@1>UNA^(K8YA [%Y:GEB3'."1-'2)6$/"E(U62*?.0H@P)]0ZV
MDEV(*V)O*RQ?$=L<8F=M>QZ5]-X+0)M H6V/-H.3+H%TF1,GE4'C;FW#FG59
M$;NZB&TZ0E\1VQQB9VU[8ARUE 6(U"%L8T2S/ID(B46J&2,IV;BV87BK6M,V
M&:QG<EVWW+8O6[_,DQTN,XVE0<_D-6?9KQJO-6_M7Y!8$?#H"[G5%*2%>M<>
M;HYWNU\/K@_$6(,:!TAE$[*:EF!3"J -DUYQQ0@7:QN"J\9<EK<[F+Y-(%]Y
MG#?O(Z@X;PCG>\^^QGDR(8@4."C&#8CD#!A?Y.*%I%E;3W,JY8'-A?\7&7%8
MH=YVJ-_M\(W* XWQP,QYKTRVJ)DI2$$1$#)%<&AP@F'.!^V8<%*49O5HC:ZK
MR@25">YYGD5E@J:88']&(_ L&)(C!RV)*<UW#%A&)&H$F6J.&IQFKC !4;JQ
M)-Y;9X)'ELOP//41'M-6 BZ>=/O=T;C Y>]4TQH>I*/C7*#(<YM?B;/F9]V$
M]+;GW!VF)#(XE2"'TAL\2P4N"0N!YU*_3*@2<FV#R1IV66'4-NZVJ*AM%K6S
MS@N1E62.* B2<A 4E1;C601CO46Q"2N*T8*HK>D-JXO:QM,;*FH;1NW,69M2
M+/0:@:;2-U!D!I9[#CQD$Y@+P96Y>+IV]%EIU#:=XE!1VRQJ9]T"*<?D&2K'
MCOF2F.0E/L(#-Q!ILJ1X$AN'J.6MZO#SR'H2;*73(4+$3< WL?U/!GAQGR9_
MN.^<AY6FL\8-_LNBQ,>]5!X4<KLDT<II"W':SIS5[[4UT6H%"46']D,)>F2;
M ?^L!5H/W+/0C/U0"RE;"]W&K?X*W5N [JSI+YFR/(@ P98H158"C',$[7\N
ML\^&^C+(@S50BU2AVUKH-F[Z5^C>!G1G3EV=K>)>,9#:6A"&*;!9,[ RJTRY
M)IS$B?U?H;O"T&W:_J_0O07HSCH!LDDJ4!7!2![PU/423.EC0(4RS#/N299K
M&\HN[P1H:Q\#WFX/P$X_#$Y2)P\')YWT?V?=\<=.M_]W&HU/4G]<8_X+K^<_
M[],',!7F[X/1Z%>4Y_9$G+MI?#R(.U]D6CEM(4[;G7,"H*T0J0X$0BP9T,YG
M<"H+D$YHJ:GV-J(ZPJ[(?_Y7#42L &P;M_\K;&\#MG.Q?Z)1&+FH(D:"2$J#
M2\P"DRQE3ZS%#;:VP:\P(BIL5P&VC=O^%;:W MO91#N>DN>2@J !8:N) 1\E
M!R>UC]H19X-8V[BJO4&%[4K MFF[O\+V-F [9_BC3A0L2\ CT2 "M6!4<F")
M,<Y'QYE%V.HK2H/N!;:/+.Y?=G\'<1>[H]/!"($R"?XC:@;]22G%Q/DU>M+I
MIW'- FAW%L (;Q<??=6<];GK]HN(]_M;$P%WRW7LY\W1*$U*G[:^%G0ENX7(
M[H_YW@>9*2-0/5&YF!99)?#4*^ YY6C1N B\C$FJ#=%7&,H-> 4JE.\>RK->
M F^C83134-P3$)YF0/%9T"8FBOH&49FM;9!6]5VN4&Y=ED"%\CU >>94%B*+
M*=\ZB:>R31F\%@%XBB92'[R<9/RLDPKEU87R\MZ#"N6[A_*L-\$Z+BFC%*S2
M#(2@!%S HSGQ+'5@1KKLBS>A30E CZR#P.$0WWL.R.),Z"(*WPZGE06AM-RH
MN03M=B1\[27]Y6R$US,:/1N<^&Y_(L:=+Q)]F7ING.*DE4HEMX7([=6<]T Y
MM!D3X\!T*&&.TC\EQ0"!I.Q\J2^@=&V#DEJ4O,( ;CRIH +XU@ \ZS.(I#0_
MC1:QRQ(($PEX5#E!1I2@L,X$EM8V9*N&+U?\MLYG4/%[5_B=.8 M<R+I7'H5
M6U%:FB:P@B8P,EAOB+71RTEIT-).OPK@]@*XZ3R#"N!; _"L>X#$$!GG'HPA
M$03WM!0(93 B2BXX/A-*_$VVJD'((TLYV#DY==UA2:[IA&,W?'O_,Q56FLX:
M< A<;JZ:NQ]2A$]I.)BEN8G/\XMPGTUE6REM(4H[NN04.)+[AZ_>6(]&H H:
M:#8,4'(4# T>$MJ#7M$L?*!KR%Z&4?9SB[R>%<<M]PM4O#:"UR\^@/ >U^ -
ME4H)A2BEV5D0*A!P)6#A4/5(3A"IF%W;X'SY?J 5K*T%:\.S#>JA>]L@[EX"
M<7$$E*QE1Q48GA,>NHZ!=2&#XCR@)A5LM+H>NH\ QTW[ BI>&\'K_N5#]]WF
MFR!M<,3@H6M"F3S@,W@:$A#-A>%$JVQBZP[=1Y87\'SHT.3/>#\U ^!!&_S3
MQ*<BS9?3H9B5OFYLXT_=EBY'%(.08'3)-8Y(9-XF!U0K2E1"5;(T$FA(W:BA
MA]9"][9*!RI6F[#OS['*N3>"*$@BA_.QAYDRB-F10))*1J!];ULUL[GBM*TM
M!"H^FS/=I_AD-'OA,P(2K340"@]43XP&*@57*6;-=8GADRNR_6N?@)7 9E,V
M>\5F<V;Z>?_.X)2BQD%*#,UT:P-8%D49$JZE=3$;$29F^GR":VT&< <H*]4L
M_^KT+GH")#_NX-7BG9QU1\?%7U4C]0^J#6"1YZB4)Z71?G_[*TGNYRT4;V6T
MA1@MS,\!$+F<+*4+D:6H;60!ACL+0?BH@LL*?Y8JX66:$M7XP"H;[->+\U4D
M-XWD6;N>R\"I20IH"?0)ERAXSDH$4&IBLPF2BQKR6WU(-U_S7S%\:QB>+?0G
MD@69(WB)IH4(%A]%38 (;G3P(FDABF^N3=7!%;^M"]G7(_E^X#SG+O")9)L\
M6*(D",8(V! U9(W'LTA4)]5<6*P&]F_<0[ [[KZ=UO>/TGC<2S?V%#QJ'V>;
M0OR7.:Y0W'F1TN'@BZP//HNZ\MQ"//=VSHE BQ=!3[P&2B#/&5WJEP2HTI \
M*.X"3S7\O_JPOE-O0H5UT[">]2A8U#E-$!0D8ZQ,*PO@.-HE2H=,0[!.Q>8\
M"A76K87UG14#5%C?"JQGG0Q*"6L"A4",*Z-_ U@\HL$IK:V5''$N*ZP? :P;
M[RA8<7R;.)X;3(!@C40CCD/I%2!%!.LE 2E%-M8&!#8KO;K;U&SKD24D[(^/
MT[#3G<SIJ*D'+4\]^ :9362X-^@/4S@;#G$%IV-7MC^<IOZHIE0MQF)_S?<,
MI)I;Z1W$I$J;<F?!"IZ!.ZYSM([2J&H"PL,";AM=!A7&C<)XWE<@N0_!0N9)
M@T@H+]1!&,B,+"R-X<'4@N.'BN<[KBRH!_&=('@V$]!PDH@4D-%\0 0S"T:K
M )FD:)3*E@E5IHK.SS>O!_%* /?6W $5N(T"=]8/D)1&!9H:B)."/CR&P0@G
M@ J;M>):9":+'V"^Y^>] +?)Y (FUW7+70"'@['K=0:GJ73+[+_MI.FNO_<6
M GXPC&D(X\'IT[*:DQ$?G;(:#Y#F[K-$8?]"LN=T5GNA+,1G[S;G/ )19N*2
M32 =<V4&80E-D  A)J*%)-FSO+:!I],5(U=OYMF\'A8>4-SBFS>T\OANO,M@
MQ?>R^)YU%62ADLNQM @1:&@8Q<$+YX Q)S,:C4+GB/C65XU4;AC?%>(/$.(-
MIR/TSTX@#L9P_HJ*_\;Q/W.^:RDC#\H"]5:#B)* 9Q+Q3[T@3G#)*>*?/D$C
M=/EV9Y4!5I$!FBV1J QPRPPP-P11B" CTQ -BR 4$6"#+]W# MI@R2M?\H7I
M$X;V_=*E3G?% $VF-CP O\9G5)RG-W3N.[_A\=+A[?DTIH[:DLI5.6\ASMN>
M\VH0Q8DQ3@))E( 0+H*+F8 5SB2.!BJS;FU#\>6-GD7Q\( B,(\7X[?GUZ@8
MOS'&9ST;BAKFE/"0$T>]QF<'7LH,I0%JMHE9;3SJ-::Q+LX5XZN$\<8G+U:,
M-X#QF7,\2V69DPRR+NT92]<DJZ5"B5B1N+11V#+CV.CEAZ16D*\BR)N>R%!!
MOCS(9QT447%%1"(0A"YS5+T"4Z:IJ"@%)T'ZF,3:AE'+SU&]*XPWE'719H]$
MF4DZ3*/Q18K%DTX_U38.#[3JXD*87Z6*[0WZGQ-I]E*M(%N,YG;F?!)&4VL3
M$4"M5J7Y8QD7+1T$I8/Q@3L5PMJ&%&UI9UOQVS!^FY_74/%[B_B=:_FH D+8
M!6#>(7XI]P6_$5B(6E&E8Q 9\4N7*IZJ^&TO?F^OV*+B]S;P.W/^RN),<,R"
M9[QT8I $C)$"O!;6$"<STR4.JL@5PU@J@%<"P+=6=%$!? L GO43>$)%<-;C
M :P, M@Z<#Q'H#X+%87@*$4$L-#KIAT ?F1)"M/-W_EGF0CQKXY/>3!,%_D*
M8_?AAE48U0_:QJ2%+^[/7X>#DV?X7=W^&2[?N7]TT!_],I'_]'6'1?I;^&"$
M:U=Y<"$>W)U/;N "38WD0%F10!B7P<?(2Q=(F90V(G->^E;7D,BCH8*VN"$J
M*=P5*<QZ)RA/@HI2EYJH+<WL&5@?45?*5B;IC6&93(9E+3/(KA+"0R&$^TR$
MJ#1PAS0PHQM89J@P2 .4F@!".P].6PTN9<JT]RH1L;;!5$V*>CQ<T!87266%
MNV*%6<\)6@8L.Q' DLA Q&(Q)(HBM%%DSZ.EFJUM*'I%_4?[E(-'D5QQX32Y
M2*_H_-.G?LK=\9P\JHNX_7X29+-SG_ O4RE61EN(T?Z8]X$X0Z7- 7Q(97:7
MCV!U(;BDI0JR=,MW;6O'6\':\BJ-"M9FP#KKF]!!2\*< :ZH ^&Y0YP2CC^L
M$-:@T%2)O%[1[*Z"M=5@;4OV1(5M(["='5T15*(J>4A"H]7 8P1G%8>$?[8N
M<T*\O1JV-5UB)1![R[Z BMAE$3M72<&\<YQQ8%H0$(KC&:LC!><$)_@4DU:4
M#(FVI"@^L@2)O32^R(>8)DG4A(B5,?1?# ?(8+4>;&$6>S5GVTN&%D%2#$(L
MS1M*;VPGR@0M$? 9KJWU:FW#+&_;UQ#&0T%V._(;*L9OC/%9EX#3 A5)X4 P
MJD $E\'Y3" D%$QF/.@<UC:X:*(!?L5WZ_%]G^D*%=4W1_7L5 L$LXDF0:31
M@R@_'(D"I*0Z:$N,4GYM@UV5H%V/[A6%=CL\#A7D-P;YW 0,GT407@/UVH#P
MU()AC@+1.BFAO=+4K6T(=45OM?8=W8\@F>#W-!H][5SR/;CQ>-CU9V/G>ZDS
M'G100E!@.!ST>M,6D]-BIGN?FK':9->X"P)%_"7):O.2D \'>X/^)0E?5*M5
M*ER("H_F/16!BDDXDRFJ0>@@P7.=@42;\>"RPFJ-5LQR>54U1-)>##>>@E Q
M?-L8GINE*:E+I1\V5S:C.J,=^!PRQ,"XYQF5&CFU66J8<S4QW+A#H6+XUC$\
MZW>@94Q53,"S2B!0HP(3C87D4(21>R\#6]NP9BF3I&*XQ1ANNL]CQ?!M8WC6
MK4!#0$4J2:#1E$%5+H'Q.N C0[R-WECGUC:T7*J L>8N+).[4'(6YKP'!V?#
MMVGXL?/"#<?]-!P]Z2!PUFMFPT/V*WS#B?H5*5;"6XCPPISS0"4I!!$2@B4:
M!$>;PQ!K(&>1E,I!.YO1\&!+M:.J<9)5A/CMI3A4B"\#\5G?0LK.FY0%$*H)
M"(T_O/(>G+6&(OX5SVE2=_D00B45X@_,*U$A?AL0GYVOR:(*(2:P,4_,%@56
M>@><2)]T=I$GA68+6:HG787X2D+\UK(=*L27@?BL9X('J[+R"5RP$80S%HQ)
M 925 8_QZ$S0:QN4/8QC_-%D/&R>X%V,YQT6IZY<:/=T.D]SE,+9L#ONWK [
MY:/VT-ZM4^+R$.'<_9 B?$K#P2SUO>K'[F@J\!2WW;"/2SJ:.'%[O4%P^,?#
MP8O+.^#@\P;XQ8UJKYD%V?+MG%LC,\FM2J@+R<!!I*#!1^,A^M*!"AE4A;RV
M\=__91AE/]>"[X>%^'O-C:C0OF-HS[HS0H[!:"%!ZS*H2W #1@D&@AD>DDN!
M*HZ*$&E+B*9"NGU.B0KI^X7TS&G-HJ;.> :$EQX/P1'P3%G@F3#EJ0YF,D27
MU.RG585TTYD3%=)W#.EY=X6(1N@ WB0'^#B#L9*"T49))?"H#G9M@]FVS)FK
MB113OT08G)P,RM4,PE_'@UY,PUL9F'&[#MFVK?8_;LW_ML V;_D1<$<)(YM_
MNVYOFD+W;++5#R[M]$K]BU/_7W.^EZ"I##0F2(%($%8(,#010/D:[I53J*\_
MMI22RG>5[^XE>Z;R7>-\-Y=?$QG*S$@H;@D0221P.4B@J.MF&E(TI=^9?AB!
MN<IWE>_:ZK6K?'<_?#<;6Y,Z$)T5.*$4",THV!!1;)'XTHV!"8=\9Q[&'(?*
M=Y7OVNK2K'QW+WPWZ\K$4TLKFS7X@,(2QENPW%!PW G*F+)&Y;4-*A]&=N6Y
MH_/B0B[V-YO06=.!C3OZC$N+QG%9XN"L>#-G5ZU>Y:.^RH8\_&T^ES][]4\3
M OS8#>?;+-V1?[]^QHI^1D.)NP\E3C;1H&XC)W?I>'_;5NKZ-L%5=_APU?X7
M:7A0F+;9<!;[IO9_D<QP\;U?Z_BDZO@_UO$_[<Q/<@L^)F,9>!L=B,P=E!:2
MD*+G)(88K8]K&V2=+:/BMR\#J;+0:K/0DD&FRD*WRT)SJ<TNR(B2 26C!N&)
M!..4 B>3*:-RE=&TS+H2J]5!JK+0:K/0DJ&?RD*WS$)S_625R9YZD(:4 @OG
MP9F(OSH=:>1X@)CB[URGR^3O5!:J+'3'++1<0*:RT.VRT&S4A;&4*1<.-&6I
M]-]38-":!JN])(R'H$M-"%\G+6&ANW8OQ^[?%Y]]_A%07O^4B8E3[7YPN=7M
ME8*+SH4 &KT$N6[D-:[BY]/!J%OVP=-AZKEQ]^_T<PD3 %^GY>VSZ^E&J7P"
M<@K]LF]P<>\V/V"%#Y>K[G#E#I<[<_>=(ZP>+PL=+[MS#C\7E2F.$7!,^M(@
M0(%U4@'S#-4#HY/V>6F'WW=JA%J:IU1YJ#VWUFJ'7^6AF_'0W. 'M+6E,A2H
M5K8,JU/@B,)?+;/9N"C=U-A>RN57>:CRT(JZ_"H/W9"'9O0AD4GRA@70MG15
MD4*#$]P"M\%1@XIMTGQIIU_EH<I#*^KTJSQT,QZ:<_MI[G2F ISF11\R#!R/
M'(C,5'M*E!!T:;=?@SST"!I9_CGY)<6.PXMR;]/G'-*R[T>=P=EX-';]<C>W
MVKRR?L9J?<8CZ[@RB0IU;C77^AJ-KA]>&ZEO'OI3^FFXBPC_NL-K_^P$XF ,
MYZ^850(NF'%S2HQ[9R<^#??S1"$8[7_AQ:\C@KRJ!M=0#5[-N6PU5US&("!S
MAR8*&B9@M*(@K9:2L1R41Q/%D">:S3M+%FSIVCY+I:*\N=X9%>7M0?FL0Y0Y
M22FW&BB/$817'%S*!IQB3@=MHXIZ;4.8)\;,=X.L*%\AE"_;,:*BO$4HGSG+
M.0_1B*@@<>Y *,'!ZY!!"^=1EH%YCRA7Y@F7\VV<*\I7">5+]DFH*&\/RF>=
M>58'&:Q/H"CG((B,B/+DP6FI:'949,HG9SFJ]BU"^5W[]&HJ7ZM2^1YUU^X'
MZ&XYWZES'%[I>R'Z/IIOY!IL< Y-L6PD*Z:8!D,YQ5]-YE$AG[/8E,.E??4@
M%><M<[A4G#>$\UF7BT_24Z\L^!P(",D"V,@S1"TD22$[3U53+I>*\S;CO!4N
MEXKSIG ^<YY;(Z61&M&M9 #!A0$7LP)FF>/!&J:H;,KI4G'>:IRWP>E2<=X0
MSN=F[V1FM><>J'4)SW,EP(DL(&D5C4XR&)*;<KLT74'YTZ13W87=?LDS<N*&
M;[M]F+ZE-/W[^2M?B?T:G^_.1N-N_CC]4[<?4W_\%&SSOA2Q+G_HR&#?=F2P
M=2&NZ<AH]++--:YY;>-V?#_Z6M]=^"P/!N/^8)P>) OTTK]??GS]9SSU3*C=
MD^U/KT]>?=A]_HH<?7J%C/"7V#W$_][]@N\\^EC^W3UY)??_?(V(?LO?"*VX
MUZ4)C"GS:P."V5D?('H?/=&!.R\*!T\7Z.6@2.9X/#Y]^M-/[]^_7__@A[WU
MP?#M3\C=_*<A/OW3Q6O7-@Z/<45/3A'OG4'NG.+?^N.NZ_4^=F)A9-R<E^91
M%Y[OX).EI61W$$>=4R1K?$.*G?=NU,%/+"?+J!O3$/_D4W!GH]09XU<@+23\
MBO>#LUYYHN/P6^#S-W3[^*(!OO3\<]<G1'1QD1M?N^^N3P.4K\LKF> <^!O_
MZX<_??O3+[TOE)L<-LT7UP/>04IE9?'SQ@,\R=U9[)8%QX5&(AM-'TTZ Y=!
M=IW<[;M^0 GB5>(?3O#"RW+.W.*U[O_\*F0AI7G*>M^-X^,+?>/2N\Z%0;Z\
MQ7F\/#S<O_F6;RWT?<N'DFL)B,VXER_]+%<[Y:O@@N4NH=)-!-?6"S2I,L\B
MJI2C-V^H7;MXT_'P2P#@;0(_3.XO<!EO\*GKO7<?1VL_?8T"A,#Y!6F&5SR[
MS-]<E9R;H&Q]U1$WD0UJ@(.AF^P!5!+2<'J,_:]KRZ5TCH=% ?ZO'TM'(U%.
MFN8B1SXKNC.BZG]_<AM72?X^&>2J!4 &>?7R^?;+H\Z+S9>'>]LO#YYT=O:>
MK7?:0WQ77_:S_;VM[;V#[:T./CK8_WUG:_,0?SDXQ']VM_<.#SK[O^)3NR]>
M;O\;7[?SG^UR7_N[VYU__KY_</"O%MS?Y .?=L?X9>$:=_S/5Q?T_J03![V>
M&X[*V8A?W<.=.UK\CF[ H-/FT)_)?-)9.Y1K.1VEIQ</?H[=T6G/?7S:[4_N
M8O*FG[\^CJ\(RDV^;_KT%Y9:)U.F.H^QGG_S^=/KDZ=F#(_I<T*M,T:_^319
MO^ES4H@;O?-[%TOINB#??OJ17"RWLEXLN=X%_2#O8(%*C!^^U,Z]] HGUY0@
M[L;+]</S82+P0SR^4V<77W<\ZFSCJ1X[!^D4=5Z?AAU.GERCO&)5EV8/_W+=
ME;G#C7;)8;O 9)-V+W4)?5RGD.<Z-_S8%HXT =$579NZJ1K95%=/.++?&7!T
MCX17O_(NOO(15&F7V3_=R5BXSC_+#*"Y:O@F8JA+QTW;MFHKW"-W@5F%RZ9Q
MRMF([XOA('?'93YA:Z8/[A^<AW%.MM\?O=M[MW>R^^GHW2;9^_3RK_W#M^+H
MT_'QT>%OQWM_ON[N;NVPW>>_?0GFGI20#5[;87RWQW8^[1^^?/?ZL-<]^O3K
MN[W#7_&:CN3K/X_>OSXYDK/!7+PVO*Z_/NRQ77[T;E?N/=_K[?_YV[O=/W?I
M[I^O_WK]KM=[7<) [WIY]R/Y. GD'I /N^_"A]VW;R1S@23%($1*0"1FP8E
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M$W,V6$:M]5%R2\ &Z;AC"H-F(*@L^-1D?")3^$0]QYXD?$K2RT6;N$/&<8.
M1165\I)@L[8A)7UXAE%!J()0/R>KG/$@%6#'J7:< ]4D**V)5LHP2Z6Y':)*
M5GF#L(I-855(,*1- !2,2%S*:XDLCQ0Y3 GA:3US87)2^1RH6N5RX@6EGB=*
M16ZU"J$"*BZBMP1;8,9A" JKP I*K01*B2F4XC;Q)L$D4L19Q$6B5<9;BC)=
MUB[M0!#)V@8C\W*V"TPU2)>?,4PMD@:MC&**<2\!N#7&< 'I00<7-2CLB[G7
M9'#Z>EWP?)<?')T<2XR%S'7.O/4)G<!C9+3TR$I)K @&C*/)WM/RX4UJ"T05
MB/HY56\H<YIKYK7E/%JF&0%GJ;">0[+Y2(&H9D/49"G&!%$T@+! %0(:".*:
M"&2CD4AHKSVPJ+43:QM&LW7>((A:4G^9%>FINP_#UB^=WF#P:ZN=E.#L]EC.
M9]D/_'Y="+\C\=*UO4BI2*E(J4BI2.EGN1\EX43+Z#"FW$9J2:+-WEM';52:
MAJHW(\:D[LV(,;NS'S*1@]V*%.1\HA]2Z/Y5/DCATP_FT_M;,_Y(83R(:!0*
M1&%4-8QP3BG$J"-.1**-(&L;5,T)05FX$F]1].99QY@SK#Q5$0/GSEH-,BAG
MA;(^.*WA#GI>U+LYZCWCT8LQ6!5!(8^3S<PE4\AA%9"C,EBJM-;,KFT0]G"'
M7E'RYN[FH!7.#4F\9)'+"$Y*<-IJKX$'3$C9S5=5W2>]8Q]WCCEA $%9!#Y(
MQ)5GR B-D_83JH3B049>J?L2&I4\B5_L.SZYYOO%:K<Q<K8N_WEV#MU!52JK
MY.'<GH=C00()7D=&,.=46TX9< +&A$1>H_D1=BV6D%-Y^7<'@PL(VQ?]#&7I
M%GNA3LZI'M]DZ6U-"*_DZ2P"6H<S>3HVL&@ "^2%\XFB.((,$P9Y38PV8"(P
MR-65*7F&:3K/6]/OYQ<J4FH('L\ADEZ"P@EV=8R<6&LY@\"2C$5Z3NQ=W$)W
MPMO_V,X%_ !N"T>\$]Q.Q_0[E3939Q7"FE'$8\1("^*08-JK8#GF(<$M?7@C
MYJ+&!6R+E(J4BI2*E)Z>N#S< U:(RT^V$V\ZM_:..98XR2Q)R&*#N$T<Q@3#
MD5'$^ZB"(:1QS.5E!7Z][4.$?A]"*[0_MP-TP^TUUYZE4[X$0A0I%2D]P0'7
MLOT2FR&W+JO:<!WUKFL)YRK"N]U1#>'M,<;M=G>^>A@,#N*X&.R.[7?3; _*
MGK_(GM^><588Q; 7FB/JG4:9 "!'?$16<JZROSB(N+9A2G3*"NEU0=\BI2*E
M(J67(Z6?'*I3F$P#F,R4]^+],1 ;%54:Y:)OB(N8&[5KC4+PW!FLA,5-HC(O
M*S*G[G?A;_2[Z'ROW\6S]*<6KW>14I%2D=++D=(BS$PQBXWVSG$07 FL#<5:
M.*>IC,J+!P115[O/C69+US'56W9P^GNG]^5/""?P1Z)D^<7-W*/V'?B.'0S:
M,<UE%6W=#4?V:^%IB_"TV3)RV%C&,!:(1XX1IT0@@P4@&P1EDDO* EO;H&*=
M/JOZ3,];S0L8%RD5*:VD,Z-LF8W;,J=<&_XXT,"D$ XI 0QQ30URGEKDF=9"
MTAB#$4W:,U]64,:F_W\7[4'E]FO9;@[-&)SW!K;3ZL5QM_/T+ D%363DM=KC
M'HVO6EVXO?W;L_37%J]ZD5*1TDI&<4S1A<%)__+U?J\[T7UVG&L\ 8N#Q .V
M1Z@X.(A7[6G_A$YX<SG_ZW_6E0#WH20M+T(?#K9F8CP ,QN5Y8@Q31"WD2#K
MTC,0Q!BGI$RF=VZ"\Y""R$7K"S87*14IK:*4GJ*:3]DWF[=OSM3V89$;$FU$
M(1B#N *"C.06J>@82$*MT7%M@SR\$&[1^,9J_-+"A8K&-U'C;SC:/AUS$QRG
MSN:6MDGCJ>+(>2\048*'8(D4G,VGRD^G\2\KD"@I1UWS*BM+:]B[W:\V(E_Y
M_>NR6*U1@?D2=U0.?HJ4BI2*E(J4BI2*E(J4EG/"L/1RQWOM;J]?]0*J:=TV
M^#[8 ?S>[YW=X(*W-00:64?%-%K$-#J<=89P3D02H$*"4X(XD("T 8^(D=8Q
M+*V*86V#\ =5/BVJW5S57GKB5%'MIU+M2:_'MYUC,%JHZ#B*DC+$A4NJK0 C
M08#PZ!5FVC9)M9<47M1D-\<;V[%=#RT[;.W9OC]M,?*JE=7J(8%"KM=/^H*&
MO?/7>>H'O4X[M/*MK"!R+5;C6 KG/)%2.ANY=4*G[4L$B$8$QYD/N4?A@TL;
M;_7.SGK=JFY57<[XX&(X&-INGME2PWB1MH1'F\-K^I$Q:N\8:(S24HRD 4 \
M&D &*$=@0!$AK,.,YN[SKP1Y<'FJA=3EB0]J'E'GFX:)=V^WNMB]KR;.S1*T
M>X)<:<3:$,2[P<K>'TLLM 2O4< YGSTRBYRW :7EGHQL+@UC(9]%S>:S%[@K
M</?\X0XS3(.3+BJEN=7".$Y<H@+*4@,VV )WC8:[_<.;<"<(9N!C1#[*'*5*
M)7(J.!0C$\ Y$Q+XVH848IT5P"N ]UP ;R'G.@6=["!EK0B) F@;M7&)XB6X
ML\I;=SOBW9+D5Z#O::!OBND%YD%01Q&S'B,NA4;.$8^$P$8Q:B11<FU#B64T
M%2N@5T#OR6]Z$=#3S@ABF29$>&XLME0X'$P@-I$^;7@!O=4 O8,IOB>]P(2
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MJR]OT?(E[^=<1@F:.1'2"@A"F>"H(,+[K-'4D;*?KZR^3[K._KH\QBYI=V"
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M@9K(P751R!^RZ^ODVT*UET"U3R8<J7MX?_O#L?1&,!T] A4QXM8+Y'!02,G
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MJ*WCVB&C->1J)H8)EH-&EY8>VB"2NRID9#_7F,X4=EQ<N@5?SW-,T?>[N+W
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MZ,6#%LAB&1$C@1.K;1)<LJL(+5Z0%5+71E*2HL7+T^)I-F(A,HL9($8C0]R
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M/YPMFE:TOMVI8J6KKV7:W^GDU9YNZ'/;PV"]=70*\S[_JO7EM.U/<W!IYR)
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M\9UUB9F@$E+,,L2=U<@:(Q$+BE@2M64.;SW55ZF?-]U8O["):\M!]VZUO";
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MY>68"60\#<["=T3C6W;+;0@6['9 &2ZA<\TATK+ ELXB#2,MB,1*#LXL#CP
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M@_:E. *P9PBP B>E4K3<9;S8D/X)+5X\/+S@-A%MO5&9#X/ ED9+%=>$1Y8
M.EKWSCWBQ;)[Q^4%XM$B:HQ%G N,3*(*:2VDM0P6QY.,%Z3%BQ8O[L@>T327
M'M/,"L&E5Q8S)7WDY3@B^M1Z=^X1+Y:].YCF(G'&(>]]0-Q:@FS  ADOB-%4
MAY!3[MG7GS<_$+RXI?"=2NS99GMYCDKRS=D%H7;W[22_=@#G0\18R93"*6BB
M&84]GCBLM"4L4O@'=G[2^GSN#6-7RT$*X8,,AB#E<UD312R")=*(<,LQCT%8
MKK:>&GUK03TWB6W^[A"XA9IOK,X)&ZT#M"&.<1F9DZ"Z42DB3H)[XEIWT3U"
MS4HXD!9$1>V15EHC[I-&EG(&H*-YT%I1V"H*U'QU :46:EJHN76H23@:3@R+
M7G'&B)/&Q:B5=%$QPUWK:;I'J%GV-$6,);,DH! I!H!Q FG-/ I6R."\4)ZT
M6DT+-1L*-8QZ*0(Q1C'%M=/6.<(#<UACRCAEK9/J'J%FQ4GEHV/48=!E;$!<
M:X*T"0Y%X<&$2B+:9%JH:>.3IA,^+!4<;\5CU3K^KY\X@I/3C(@0%.:.,K \
M! U$)A,XD2:U3JE[P]3NBE/*.J("8PHYF0!3513(9'3%6!M'K)8VT*VGI TL
M:/'BSL+ I3&>6FIHY-Q[["PEV5?*E8V:*-)ZENX1+Y8]2T'XR*EE2/O< R!9
MC(P-& &&<.&B(23PC!>TQ8L6+^X(+X@S1&'E<&XXP:A6"=C0&>5,!)UC?7'+
M%B^^#5XLNX<D)E[JW$;9I-R;*/=LIT0B3Y1-";1!'GFK7[1X<8=XH3PHN58F
M)Q4H&-&9)"7'7$2FO5+)M3Z>>\2+E=X?24B1,$,.M#_$L0G(9/,DE\<5C&:+
M,K1X<4>!2&:SW3E'"U6 -\1O7I?\94##,)CD L*9#A>[#A\\W/K<%5EP3BB3
MG(;@/.S\AKB()?REZ17NGS4ML5O O37 72TUI$%!R[D_.96$YJ@D@YPP @EB
MG0:,I%YE!U N5GV[7O6O$ISO$:I;C-H8C**8)..(H)$S>%ZPPC-##(TQ*J:Q
MNL+EU&+4W6+42H-;DIB.Q"%M<CB3)AHY@S7RV'(6'/PO'_RU&-5BU$:3^F88
MA8VD5A-CM Q<<NF(D\+[I*WDH%G9*]Q<+4;=+48M.[J(M$%PQI#D.>.N'*1Y
M%U'P7#FO PXLM!C58M2#PBA%08V*F)M$/(\$,(I)DP2/B4DAM;["M=9BU-UB
MU+)S3=M$J>,!Z>08XL0K9$PTB'HIM75&*M]BU.VYY2YO!KRVC>[5_4$7^XA%
MKY(-W&41Y$QY$QQSVC >M8%[^-;WTW2X//!)=PRO]Y?3FUY6^G^GTVE6XMMR
M0=T?M#NM>-7I+C07+CT,2_^_JOCY>2?%JG-@TQNR]%>L6BJ6[I+U#'-#P:KS
M(=Q0MT(,Y=KY=IVEO6&8#'-7QJJI:"P]/T=K:JY_L,/\3]5/,K^JZ2:9VZ\-
MTI2F37O'[8Z;C#N34=5KL>I_F1N#]GI-9\8RG,FH;M<&9!^<E<Z?\.SA8'"Z
MW;&E0RG(ZWG]0>D'F3LT_N^D>Y8[0FYW3DL;SAX,^>RLU\VM//N38>GZ/!K;
ME$IOQ.J:TBMQ1I,P@!'T!V/X,SR='V.>08JC$5R>*9#IW=#/G5?-42LB_Y__
MTI2HGT>%7''0AP'WXP@N@%M[@^/N:)P;:U8=H>UX7)/M[.1\U(59P.55:]6\
M$*[;R]U,0Q<F/(:AY/9V$_AN>O&HZ9;9+'#IJKG4;'.G\Z_!1^"C86EO.LH_
M%<JL+.;V0FO5^>68SL#.]8Q=*= VWRZVHEDA4V'%>GP?NJ/N>+3:('LZ(R!S
MWB5\'LT9C.#4^KD"<'G90M<>]P> *+XSAE&-.@7YJV68$6:IX>6#Z'EX$4X5
M7IEV[0VYZ^%ES8"G#7AW.K]?<MFTG7A>J;X= Q[,"?2L82O(3M.9=9&!5OL(
MET:MG;-!%R:1.PH#;6:]A!>:! ]S=]IAW2-X_J$G-HOGW&#G>PZGR;"(U5*"
M>>;5T<)3SH:@-@YA@1I" 1=-QLUM,_S;OI20LU;-LY[&(U!!.\&>U]U7Y]![
MNCPU27-[V#F"/D2&G6^Q&V)N7@N7C-9W+)[Q&VA_H]$"_*SP',!Y'&?BU4UY
M<Z_<P:Q-K@V9#G5OX (9(U^U!RX-<R]J8#QM*ET_=%3Z6U_OP=/1+UQ^/(Q5
M'^3M\JCF<A !T$RZ-:#!/C\># L6YW;6L)\"L^UT?IWU [[I+!L\&(9JXYYK
MW0TTJS2$G<[WR7 WU.W6Q^WOW*U>=^$8US>YOT\ML[.>0-,=O&I%7?7U!AZS
M 408^#4K9!^FW;NK?1X &SX+C8S!IC'HH]P?.]MBA7OG],;2Y'T>DJUO1#2K
M?QG]R]=9IP,Q/8WCDP&(_=QP,G2N44CG>M//E+G!QW[6)+NYT1H(TW:E_\V>
MM;8+^1J=I RN>OS\V+O56W(G[^ZPOKG>DKP]RWR0%;-LAXXK]7&U&_>\_;;N
MDSGQK-=/<%C@L\&H//-)U=7^0YQU!/['HL%62S.>W6(=K,QD?/$MZQH;5^-V
MPY^>7@@?%]UV:YQ-\+58VRQ1>>[ODV$SF#-@ >2&T?Z-;(*Q/K&]C_9\M/73
M(B("^-7/5A1>ODRQ"R>8TI=,4%W5L0[F5R%NR"A?6.1)D9E\%0S);LI0.B?#
M[-W[KV[PUAMFHQ8"<Z:,X]G/P!(/,J;@]#L%ZD)IF@UR_6MV# (6_,]/]F(V
M6]REE@H?W0WC7=D]L?#=J]<O?WOV\DWG]]V71P?/7K[:[KPX^/5B]6Y#1GUP
M>/3L5>?HL//KX<'>LX-7S_;R3Z\.__-B;_<(?GG^XF#WX-<7N__IO#J"#_:?
M'1R]VH YW7"K_>%UWTX AF/X<1TZK'6D,6Z<HEIC[S"71%DCN/!81RR#$TXN
M.]*PC=A@1SS%B5LOG;=21"*U5UHS16[@2%NO;-V/,K^>.%=[#>UH%,>5ACV*
M<RIQ=A%59F.S<2[LJ7-[**BRD^$P>TG6;=G9$P16Y>FD-^ZB\VB'M:J[QI&2
M=WV@5B_Z<:6LPVTPHY/L6K&C[LP-M*K,C!95H>$PZ]"U[CUO+(-Y"QI 8^N$
M/);ZS"$#6Y[@5,7*YHN% 4Z=>,5E5VD:E;*U:-8O*O)3/6<=359,Z(H .YWG
M@TJM&I>NW_F;?FYR7:@PZL35)M>=?-BR7;NK5AT/O=%@YL0;G(TKI]O29<U*
M9%T0=,=8K! P0D(OKVECZ-5K5+N&3LL(1@W19IZBYB7 '&'B@?QGDR$\HOCV
M!L-C"[0J[+EHTH&F$XH)=MW;\UKN15_3@51TV%FGJLVCR%H1,=R*:(PPN>RR
M--R)'(',+%:.XA#C,GYXPTD4B5$A(S=8Z:!HL!A^ R@QT7TU?FR0=R"!- X^
M9N*7 XY.AHJL9(]/+JP26-RMM7>Y6.^5K(RRZ"T*VZ7%!HLJO\A:"[;*.MOB
MAS#(#L]B9  ]>MD3]..3:VHHY-*EJ9M KUF9FC"-%E^.N3*(V;-1?-+\\#,8
M_V<]>_ZDVR^$+C?]O#@ <;9RRE5>5WT]TVEW<*77UJ'@]9OKKW?*5TMG=M5W
MDNU0IB_\&N^0+_Q.\XM?>MF=EPU6[6@B[F"L@M-;'ZO8 ;WAD=/U+L::Z:JN
M]=0K4B-NT/?YZA 2LMQ0?H8?WW-/^:.B<>Q7BL:S547C)JDHMTEOLTSN:Y5H
MV6Q:YR"^Z\0Y?54_] =*.'Q?C'C#=?DNZ+E[FGVZ=\Z*#Y%TUPE4?)2$:7GJ
MEGCJ057M6C_ABR(FGGQ1%/!U$^6O\8Q;X\UVD ]SD+>9C*UVE-@4.5T?\?K[
ML/LAA\-T^Z/),,?:W$64_DU(MS;"?M.H]M]?TP=WLT.@+\P=F(S"<MU5SZF.
MA.+$'(_*Z>@)EUAIH7R0'E^1)([$<M[ RVJ3>#X<G/Y:A]O\U1V?_#H9 3GB
M\$5Q=P,9=T>C"/\/1_;3-)U ?M?9!,?GAW^]9F].7_Y]^-O+]V^/_F!O_CHX
MV?_K#7]S]/KCV[T_3^!/[^W[/]A*-L'>"_'V*'3?_O8'?_O;0>]@+YR\H<\^
MO7U_<G)P],O?!W\]AS]_GL+GZWJ8!J<L#RPB+J)$W#B)C* )!9V,$U@:F4N!
M474+Q3INIR5TV\?]C@I^1B&IHQ8[[CA+RBJ.D]8L-[@%5KBJXL.C++#SS:1V
M.9=:&YV$)!BIE#CB(5BD=9"(,JND$\XFR;:><O/U%?QN1VCO/96G561:1>9B
M149:3BD@F_7)<2FX-I@+Z5GBVBJ3Y!65)%I%YAX@<3EU.QC&='(&6<L,XC97
M'W/)HD0IB3P8)0A (A6J560>MB*#'5&$>&\IC]P19QV(+/%!6PFZ#0MM)>)[
ME-KE9&;G9-!")V1\-C^L#,A*;1"QP4IC(PX>;ST5]-:Z07SOBLPMN8Z_$^_4
M;SG$L)\C[-KZJG>H_T0-AG]TW%.2N&/&6I<\(92 )I1;0+6.G$U#TM7&I#9A
M19.DR 6P"SDA AFK&4J,$&(Q(8E8T'^X_OJR$+=3=;65Y#O2?Z@SS%+/E4\<
M6S!A0HS$>!5DLCCPUI%SCU*[[,@1CC 1E$-894<. ]7',.\1%=YR([7W J26
MBTT1VGO7?UK N-VMWT3*+55>82^XUDYC$SS'TJM$G2*Z=7UL'HBLM&=0B@BN
M&)(.P]9O H"(BQ;A&!GC7 OGXM93HF^A4W"[]6^()*_=^IU7QJ3H612$$V9-
M\LH+$:E,A'DG6M?'/4KMBNLC*-C>M456L(1XS%*K,44"I):[R*C7>NLITSMB
M,X3VWK?^QQ68\RKV$CJSY_==-?,!8>:J]N,,#M0FH:TQ7$J01FH$9I$G0PFG
MK>-CXW!TM?DE-HY0%17B3D?$=<1("Z&02A+V/<Q,H RT'[%C-L.%W KR'06P
MF(1=P"*F$,"0!EEV(-HAX:"X4*(-8+E/H5T)8!$I<FPQBB:?UF(9D0$#!25!
MI58BT.C!9*&;(K/WKONT>'&[&[\.FEHN%9$A<D&T]=@)S;$@!FSI<)6EU&[\
M]X ARVX/C@WF*1*D"2&(<R^0U0DCXY)*QBI+2(*-W[0!'P]&D-?W*E-2LABT
M!2F&G83 T@?AF+.<6L*NC-YJ-_Z[%-IEKX?A2>9"]<BQ$F_.);+&1D258!JD
M5UG-MY[R6ZM=_[UO_-\Z57"NB$K]")2O?R*+P^1^*%(5RKR34IUB1XMKC&%-
MM<><48;8#EE3VR67I*K* ?Y EHN=M9[OVU?FB /4*"?=,?&DL%$R1LT%\U9Z
M,#!:+\ZF[0NK'2Q=**JW1;F\'^(J:&0#]4A1'S#Q)D<Q@#(G=\AF>,-;0;X;
M92Z8P(WA7F,EN)5::YQCT9B5G$:PU5HOSCT*[;(7AWD%-C2C2 D3$+<D1Y\Q
MC["P1CHC(B?J5KPX#^0$J\6+V]WX*>/!&&],H'GC9R;:*%*T5&B54NWR;;TX
M&X4ARUX<PP@F+G&D1:*(.T.1-HPAJQD'[.?6X)#C5K\^E;'=^#=$D-=N_$)$
M0A7QF$C%J7&.!<ZH3CX ?S".6R_./0KMLA?'*L%L= Z1B#T(;0C($BN1H)KA
M1"0+7F4O3KOQWW[H"N$[&QZZ<G1I^=_[/M>Z=E&Q[QQEUZ0Y&PU(*ED$Y9S;
M(,# ID2X2)/AQ@G3^DDV#'D/5^NU6),(:+D!&<Y!78HN@>(D&5(6^Z D)K!S
M;CT5XO;JM=RD"-_W<B3V6#!@O8LEMS)/,1 N&!<FFB0)\48&SYA2\BIWZ2/M
M]_S-)'[9R>*<U98;AJC-<<($?K*6*,0UI3A&$[VC=]+O^4XD_MY5L19MOF5\
M;> A)F$PT9BK1("#'9>1R6 \45?68F@UCGO GV4'#>'2Z10T2B$!_FA"D&%&
M(8(3EX*50&FP];3Y^NRB5N/X[C%@O<:A552$*!.3YTQXET00W*@8"0NV/J"]
M& 9:C>-N)7[9N\.%)\DQBDC@ G$ ;&2#XDAR[0+UR1EC6XUC8T-X[BU"YU8\
M/:W+_'JJ%296:>J"-][R1(P&BXW9**PA6<4*K3-GTX!VM6:+D%QB;P2RC@;$
ML=%($\V0],$G[C%S.75)/>BT[4UYQF/'$RX-C<%QZF+@7DH;?-;%(L/4.Y_:
M0A ;B"?+IIHV1@?M/.(V&L2IEF"J"8<T,UHH2H)F:NNIW&$MGMQIVP>*OX\C
MNKL\DKNFRC]K(MX)@TGNM]G,_>LLYDTC^(T++=\B?1[,%D6D](S31%/@2CH=
M1.!41(XI_"93J_)NV!:U?[0[WN_B3V6;.GK!X,^[((G3G'IDB'&YXAD%[9<%
M)(DRW!&!<6Y=+L3MU:Z_/4G:%'_C/3^CA?86VF^[E1#!! .2BZ0 TAFU5EF/
M,4E,6QJE::V/#83V@R5HAY5Q/ :%B(@6<:XH<H1A9*V+V-!@$M6Y*\DM)/&T
MT+[.?/FI-)]O<@WG4CD7V]%G/*T_R821:YMGED^Z_0"_/2&ZO*@\?3J\BK(P
MM)X]&\4GS0\_A^[HK&?/GW3[!1'*33\O#F!-SF1Y7?7USW7_\'R^4.%(;9;5
M;[ZZO;AD.Y3I[Z07^EWU;1><WDG?=O;(Z7H78\UT5==ZZC=LBTW)<B/>&7Y\
MS[UX#^"3SCY<=C+J/ . "YU7\6P<\[EUA^'M^^I"_D"[NI,[[Q?]0 F'[XL1
M'V+_[;9U^2VU+F]YJN6IV^:I!Q4@LW["OU^0#/7D3F-D'F\3]W:0MS7(QU5U
M^_=A]X,=QTZW/YH,;=_'MHOL77C 'Z0/FSJNM.5<)Q(X4;F$C5%>*2*]2X'J
M^GB2M,>35_FP3_]]LG_Z0KSY_/+]V].W?Q\>O3PY>'_,#X[V^>%?KS^]/7K]
M"7[',)[NL@_[S>FS\S?O>^\/?H,WG/XA#GY[1@_WCLG^YV/Q]NAY[^ H_Y[G
M_N_<CW(Y(D\GBZVW$7G"&.):"V2PMXC;H+G'G'ELMIXJ@[^^*\/M%"ALBXK>
M3<J")AHG3W/76,I-"%H38IG2 4?O.(M7"/-C+$?Q[:1V.44R1W](&1.RVFO$
MH]!(&\N1IM(FQK *5.:#I[:+;*O(M(K,U8?QT6DG=>[&S#EWT3A*B6?&F62C
M9$UQ=-(>QF\.)"Z' CLOE&"4(2>%0EQQAFRP%AGJC%1124Y D9%Z8SIKMXK,
MW2@R7%B.55(VR C/$R: .!.2O'#.,'F5,+>*S%U*[7+FI8B4,<<$BL1@Q).4
MR%*7D,(AJL0XDQAO/17TUE*MOW=%YI9<Q]^)=^JW 0RF?QJO=^K0ID)]J?[C
MK</&N6 #X0'#ABEL[J'.N!7&8-\Z<C8-25=3*RW6S N+41(83,) 0!,*WB-.
MJ/*2N"!XVGJJ,/YZ_6>#DZ$>ER2O[PYCN36<V\ M_,VME4)BHJE0$D?B7>O(
MN4>I77'D$!RL"AQY"DH09XX@36-$)GA05B.ED>:ZHK?0'N:!%!9M >.6SW D
M]DY1Q1W\+W)O>(P\2.T-<2*XT+H^-@]$EET?5!LA@V0H$4T0M]H@;1E#BB=.
M;:*<.P-&%!9?7R*SW?HW1)+7=X3UV'JF,,,V\<B(#HQYGP*U6;8I;UT?]RBU
MRZX/ITT4G.3&<$GG7B(:V92/7Z5346,#NIK8>LK,IC0 NO>M_W$%YKR*O83.
M[/E]U_)\0)BYII$:QIPQ005C#/9-#X#(2(B)"&(BY:EU?&P:CG97'!\IZ'SB
MG?/K/49@\A+X*6HD!)=*<$$M\V!"R4UIK=T*\AWU4\$I^0CJ#H@P3])JBB4)
M#@OOC?*1M7Z/>Q3:9;^'Q4Y0YQV"]<#9[Q&1C<DARFR4U')/M+B51FH/Y-BG
MQ8M;/O%@ 4O%O2<I@ X.YC+1F,%&8F&_,%ZW;H_-PY!EMX?$27F%*6( \HC[
MQ)#6+,#&3QF-7"6. 4,XN[7&(.W&?]^"O';C5RH(SXR.G"E.%#8RI1BQ4XI;
M)DT;\'&?0KM2:MO+Y()BR!*N$)=2(\LB1BR1((3.HJRWGFZ,S-[[QO^M4P7G
M:JC4CT#Y^B>R.$SNAR)5L>V&++<Z +&CQ37&\//98-3-7/AD&'N "Q_BSSFC
M#+$=LJ:TB[.CF)^P]?0'\N-T-4N)FM;S?0?*7-!2"BM]T&#Y66>L M4 + QL
M3=+&7&7YM<K<-]\7SE?#5X!1&;<8&8PMXD[P7$4KH<"IHPST<VQ$KI*X*0?A
MK2#?4><4K)2/,B3E'+?)6JQH"L:8E!2G5K9>G'L4VF4O#K8B>.(,"AI4.*ZY
M0=8Y@ASE!C-/2,(I*W-?G3KX0$ZP6KRXW8T_NF2UT\E2Q;@@SNJ4#/;. 7XP
M)]J\G0W$D)5N:T':"'8?LD+$'+P"*@"L*L*)41.2=-*$K:>2;LHQ>"O(=[/Q
M&\N9X<0[XCVWQAKOM0J1$VTP9;:-7;E/H5WQXD2ML.<*.>LXXH9+I W5H =@
MX 4C@J*Y1>*.V@R9O?>-_S9#5PC_/GIMG%U0 >J^S[4>2V/*575)>&RYB08G
MSSGF7D=!K>(LF6 ]H.\U_"1I,#RU8WC6I_$3@'$4!F-47]'J4M\6E@]7B[G(
M: 1WT2$6N$9<*HLL(QX1&XW/'4BU-EM/R;8P[+OH9-E"Q'T$$2L=2>#>ZLAY
MQ,8F3V@(P$?>));(%2CQ.'O7?CN97_;!^*B<(]0B3W+OVD 2,A9+I#2+P3#I
M+,=M[]I-#K1Y+&BS)@K')"&<9BJHR"T#5DV8Q.0("]I<K^Y*JY!L$C@M.W>L
M$4QS)7,G[5+> 2,;942PQ%I0K0FG+BLDU-R"D[A52+Y[B%BKD%B2,$T11X5Y
M3E"T4KC F8Z*6\IHN@(E6H7D;F5^V3=$F'4F.H.PIBD?"N4>SY:"$4*)LLG1
M8&FKD&QL -"]Q??<BI^H=;A?3_/2+,D0L#4T,*Z(U4+F<!DL:8A,Q*NJ?;8G
M9]\<:%<KOGBCA4W$(LX21YPXC#1LBJ@HT;E\:W YAX)\?1+%!I^<;<HS'CN@
M,.*,(DHD[P3'"JPZ:P+12FOG X]M0L4& LI*'0GBC<CA=TKC"*@"?UDF %J"
M4909#:J<!,U-[[ 64.ZT;03%W\<1WUT>Z5U3Z6][+K<]EZ^[1TEKB0HN^\1Q
M#E#4A@7N0_ "2REQ>_[Y76U@N2'S_G)#YI2PEEHC':E$7 B/M$T"">N4U!A'
M%D+V-TK";RVUN&W)?,O/:)&_1?[;1GY";*+:*FT9IPH[;H1QSNA(8K#8M0=-
MWQOR'RPAOP)#!2>!D;',(6XI0<;!3TGQB+F,22>6D9\1<FNUQ%OD7S!^?AKG
MSO?33$<@<9;!;G]2CED64DM/[?"XVV\HE\5](=F4L)G]T^V'V!\_0=5GMXTT
MZBJDH0W2S,^E$E%O.(DB,2ID!'52Z: H@ G\)ITWT548!/?$L)N!0U#MG30Q
M2NIX$MH0ZZ(F6AG.@$%=G2ZZ0K>[R'N]SKP7UT3L,%[HOY865\^M<O)W1T"4
MT[-A%V"O,T@=VX\C^&+4M5/_OST>QIA+OH^V.W8"_#%P79"I7M?"O]WQ^7:G
M%\?C.!SE^\^&@W&LX-_VX8GE)6?V?##LC,_/XFAGE9Z=Q8S<"@D.)@#,77\+
M]L+22:,=G>SV0_[GV?].NA\ XV%B+V'2\+9Q#.N__QV PI]_GSM!+_[KY?G;
MO\*9HUS"&+J'1R_(V_?^_.T1C.TW>/[[O^G;TQ?T[=';DS='?WQ^\_GXX_YO
M;]/^>R\./O_Q#GC(*)L2$D%[Q#F/R#D7$%4B1Q%$JSG=ZD38+\^ T./A)&Y=
M@BT2&+W^),.P7-3UWL.6W$WG=ZV_K+3(+:B2%WV[D__NS*U]X>,9@Y3O%SGV
MZ^:Z@*I$WT-.?YG\T4GL_ I(8/OG6>A&W9 EVO9ZG1.XJG<.\@XT"9UN_P/0
MHL!!YR,H41W; 35L,@0@R/(_/@&PZ)S"ZTX #X8 #2.X[B3V.V>3H3^Q&6;&
M@XZ+'9_I'&=TWNG,#^'4=OMC^#/J=.%%Y=J\#DLW=9SMY1ZI,-!Q&6?'#V/H
MCCO_.[$9FCJIVX?ON[:7^ZF.N^-)1IP,0@]N_7;'G;WH8P[7Z#"RW<EJ\W:A
MU_8*J0LIAS.6+M\/X]E@F'_+J]KMPTK&S @PK;QFF26RMF3S%:,Q_)-9(*]X
MN3GU!A]AJ8HB#5/Z[QN8 M9@(1SV4C" DX0-,9YXX[C0'HP#_.Y%G@JAC'R5
M!; $\"]F;'PPZ/O)< @_?N]*_Y=#_9'_!'_>!:NC%38A;S1'G!J%G,0:!>8T
M 0V4"DNVGN(UYPT=X.A>7FG@B#G.FD.+;8"!K@<Q'N:0@M2+]06UCM ;@&(#
M6L1IQX()-L[,=!D+UH+?&9W$6&/'*%[PYLS:\$WN0;_*]B>Q5T9AO0?CH#RS
MP%I^-R@S'[JCC!A%-9H;X^ LYF"E_C$ '&#:3$>JGF='H#WY"A2!2SMP=6'6
M_'30X&&ZXQG6_3.K8&"@VD8R!P[PI>A&HWEAG+ZC0LIF(M5EL5"U#"9T KP9
MAI9OZ@-0-' <X<VA\RJ>C6N8P 4FR!(<_K2@@=VU0O820 MP"0R56LLZ@J?_
MTAOXOQ^;#(*ZM?_YQ3L@(./"4J056,_<)8JL( )D4&O"G.)8T65+AH%J+QC0
M5^+$L63&:TTCV#R6&RUY>A#JV2Y(Z"3+R(QE'N(^WLQR.)UE)PT'IR#-W6%
M9W8(F%(,JE$-I1FW0*[[L6S'@ JP 18$/#T#>0)E"*P[7X 4%*6"9O-0/+O>
M%>P85&!STAV-!\/LY^B,86L,E6XWCUFC"1 T?W\R&)UUQ[ K_Y__TI2HGRM<
M!7+U8HU.17.K'6^@F'4^ C!&-$@I6Y3P78;("QZ>K,]&9C>6#>$X]@%W>]MY
MU$"9+J _W T*Y\C#3Q/ D.U.51 *7GO2/:M5U(9<\"J = ]7PL2S$@.3['K8
M/?XZR18MJ*?]X^I%,ZH,8_?438:C"MTO6HEAS HK;!%G R!Q8Q?/S:D3/YT!
M.4;P&:BJ^8/1!%:@>>7'P02V#="*3[O]K+_DL9;[8:<<#.-V?4%_ !N,_1 K
MI1OX"ZZ,*<&#\[IE37FF\.:-LY3(RFHX;!:3WKAL8_76]5#5X#7B4\R9437[
MV<>C:C%3#)FE"G,4O1;VV0@4A.]_F&W5^V!5^"PN^;+JEVYAIN.A/1W]N)UE
M[$.^&<R,R;#L\X/AL>UW/U>D!HX%:1R<QX8-JUQ<8+U]VX<7%N;*HGP,M\2:
M2YK3_%I=7QKX\;05WVS$>80C6)1N@@'"%V!I+<K5;/&W.VXR!I;IA '<F!G+
MQ5X7WEB]N[!>]@[-/ZXVKH;=T=]92QL GS4&0[X!]* U@]KI+$1W%Y-A[CGE
M9F#/+!UYO',>HU%^?Z][VBWH%+V=P!MJ'.H!/X)V4\+3\V=%FJJ[=CJ7ZS.7
M.D)K9A(\NT!7:LQ][(;Q27/:,7=7+2AX=HMUH*M.QA??,B=!F3AQ6,O+T_]Q
MPY^>7BB9%]UV:V)&\+7DC. E(L_]?3*<52P\CL@-H_T;V02#?6)['^WY:.NG
M1;0!8*D?KBB\?9ED%\XPI=MPM:[3-BHT"WEO+3SRI$!!54/P?^RF#*5S,LQJ
M^']U@[?>,!NU$)@S!<8SJ..))1YD3,'I=VKKZ5'!0A"5? 26L>=_?K(7\]GB
M#L 6(?]N.$]?2PM\]?KE;\]>ONG\OOORZ.#9RU?;G1<'OUZ\DVW(J \.CYZ]
MZAP==GX]/-A[=O#JV5[^Z=7A?U[L[1[!+\]?'.P>_/IB]S^=5T?PP?ZS@Z-7
M&S"G\L G6;GK^FO,\H?7?3L)&:Z7JVPVGOW5@PIL(S;8$4_!=+%>.F^EB$1J
MK[1FBBR;.HI8:J,4GA'&(XF&JA@$ESIAK45NSO<P%)GUU+K:T%ND%O')D1BH
MX8'S*+U5.";C<T<5IX.TBW[?904D*Y.])0TX.T+6Z%A94YBX]_4F7MUHS[(#
M!7YPH/Y:?[*J..]T_C7X"#K'<'NZO\_KS"=V-+4;:E6^6U3H54L(-"2P0 :=
M#YG8E;70*&+9N3*$C:A1'9HZ**ZHUIW3HLWUFN.NQJK*(!LK';QC3ZOY5KH[
M?'T&7V</RW2&EUEH6;=J/.K9>3I3J'8ZN_63\W6^!SI5'CP86Y-QOKPH-G7;
MH4XWK= &F'+F>)IZK5:&D0V ?'E-FY#-E(H&M<4VFM$(]-ALC UFY&A(L>"?
M!U7RK'AK\L+#U;6U!__FL9Y.G<Q@F$[ ""Q:Z_31Q:U6Z+=,^YW.[XM%:D9+
M=F=%_2&82$.0."!M'\'LAUG5/)]:M;WBC,YWK3,CRVB!IP:]QL=7&82C8H96
MCY@GX2+[9SX?3$!,:T]=/J-8HLU,HQYFGWM>6:!.-M<:1IFNZ=0,N/B4^0'9
M9NLA[48057REC6.A8L%N7++L*VE:\&;DH^=R.IW%8;N3QUSLD)[MGI:;9_;^
M_..G2:B%-0J$->!18^#BPH,IUSO/Z+D.(0$ZRA/@O1G$+F#-F&$K-IP)(Y@?
M4$&YX^*Y'L?CP? \VU;3;V."48ZGIS"= *Q71!*FX*?XL )1V3U=L^%V\<R
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M!8PH)VPL$'_G6YXM[\62H9/-UT>?9\H/C_;?.<:4PBF@X#18'\H[9#V1R(1
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M;"_K.47L=Z=XN#'5[G3"W]=/ME,^V$;-<WT #+UHG!]RS*160B(JM40<2X)
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M'V8.]9\,]Z5NNUTDI-:*SF+92](OW!^%CP08H=N9].9<LT8Y.SI^/\L*[[@
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M(_C#D=LWCX]\!I[$M>S,1HN"%20!%5P%XPU5SG IF4LV&..=5IKH<)7LL$
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M' #<SP?V>C)4O5=$JG,<<&%P<"=W!9U-H-_IA*;]_HS9]8@VWA]BZ3S I4#
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M7;GD+";!"LV5="[PY#4W"@LF EECQ50%>FL!O;D(E=(N2JV1]28A[AA%SO&
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M*Q8O*&19BI!+4 3;%@]%$\WII^VFXOFGJ<3;LWZQ?2$."A_RU4'E[XX.I#^
MH[2]4#N-@^-N@-4?7>3+A5;?9RDU_GH:#H9PJ?C]+/I,#][VCS,MQ=;98'34
MY]TAG&#7^TRO"5;6:XT.>F)5_5JOU8\UZ[IPSOG"_4&O]366*QX]1E[X=BT_
MXDW7&&;Z'!.L;?MAVQ84#Q<XZW5/RB5>K:[;N;ILL1_.YI_#NW!LY0-=_7KT
MF#.W"UF$PT]2KWLZ2<*C/9S9]DS")8=\Z^9UM5N#5AP]T TG-$'@Y0G=B<:G
M0'!:XY'6$A4<D\YB;C#3A@7N0_ "2RFQ.=PMK%;X!UV;K]/ZS$=_',.P'??3
MM6:SUX%C'!9@M-?Y"-M9 --^>MOJ &JT;/N?;K^5]_@MK/[?O/@F+.G/=M=_
M?9S*3SO^SX>++Y_#F:-<PO7YE]VON+[[]?O!*:QO]]]6_>3K^9?F#FWL!GA=
MAW4<731H(S6:;UCC_-#X( QW NQ/XQ!7%.Q/%Q/"3.:>;];+:+9J$33$,]AZ
MV-NXM5[L>C!I5B!7M]WNGA?04O#1&;!$IIT9 N]GCNP"FH0K0BOY"KX&WP'J
M&?'M*I+K-^ C>*HV_+#_^\MU"@?8S_)QQMI,J0W"OK:!S^/+\8L_ %O/VO;B
M9:M3;$_QHS^F;PB"9589+&Y8?OS'>2L,CK.]LXU+FV?DZQW=>?3Q=O'1C&I;
M?L;DMC'BQH_Q-KGE9^R65_W18HG>-MK<PV(%YVM?K-X6BCZ2C:W6>G]KE4M=
M]2>!FA5LIP?ZJIG[ZH:%S]1")]''>#:8BI\MTZG[J6[&+BC*Y5Z08B_P*K'$
M^Z6[1[%_?X\4D760T(0S9%EGTF9O3I$%TU\FMO_3YWT^FS9NR QV8T54%5'=
M+U$]J?3[FR3<M0'9Z0[ H.S#DL;.T>,8CK(QVKKV8CQT+M*-)+<JZ5:+?-2+
M?*PK? :-$O;F0C*W0XU?4Q.V:;NW/SB.V877.4(Y. $PO*Q$7W>NR-//^7B2
MN1LA::N5#()*R:40.G%LG6&$4&*3QZO/?GJR^?JG7T[V=]^VZ^_>L/KNWL7^
M[GO<N/SKN'[ZZ?S+:5TT*-QC]]]VX_,;/)NC 9_S^N=/YP=-?UX_V>.-W?>L
M?OKFXDOSS].#RZ\L/T_C\R=RT/R0ZA=S@W0)Y4%APY'!GB-.4T#6:(R()E(E
MXKDW>9"NV-9/K_ZYPIT*=ZJI3 ^/270&DQ@Q3"KED3+$(ZZ]0]HRB8PRWBA)
MI4[Q"7>>J6#I2<*2D]0RQ02.W')*@G9>.>%\TD8JJ^/ZAL55:M*=(6EV]#9C
M+@A.&&(Z:L1M$,A%+5  #2FZ0*0-3WGT=@5)%215FM+#P]+W^FR3/F$%,0!$
M<(H&<"DRY R1B$J1K&6$1KV13?J>5$3C?KV/OZ9^>M-V;];[V%XIWEHUV;BU
M2%!.DD0IB 3*N4B&$*:32#H*H_U()%0=AC9 '#1>SSGS9**>*<D0C3:"-" 1
M.>XC8I')Y%4RAJY/2]W@[AL5$]^6B2O][5X9=M;3I>&(#),:U#<E$ ]*(1=L
M0,J12#GQ-CI=>-]EQ:U/EEN5E)0S[)U@F#,F370R:$*=<YX&)BO'T 9Q\)QC
MR-%D*$A;073(#80Q,@XS))B17'*5[>E*Y%9,7+E2-HR1YUPIBE+KC;%(&-"@
M@9,-TB%9%*V1Q-K(N%:;R,DC5\KX7B,"E@6;;DHC@.H:U35^2;.)I^)2_'F2
M=*M35OBG=O?\*C^Z%\LR^_YQ:W.\C=4UJFLL?8TJ+?DQI247-?F;%1VHC?=R
MK<L2VW2)A?UQ-FJB\;($XF_QCYR.C^BVGN\6D'N<Y MLO?J-_#[=Y>!>R."Y
M#V3B@@>?HE-"$"ZH,Q9;%8G 7C/MDZLB&QMCG<VG*4<=B(U<(V:90MS(A*R5
M$1$GM)4V"<'7-^)[\_)O*B:^,Q-7[I1[9=C9R(:100FK/:)$B#RN.B&'N4.!
M:B^CP-)BL_5*D"<]5^VY<RN<LF">.<N%XT%[YZ+23!(OF<=.\"JRL4$</!O9
MP!I[XH&#%<XIKUH9X."HD/819#&W$LZM$KD5$Z\^=J<2N6MAV+D(!DW8.Y(,
MLLP9Q)FUP+%8(4F4)YA':I+<>B4W2^8^*;?M,@X?7R6"/E 9>A7+7G)P"M8Q
M:6Q3K@E626JOC-2.L!P$]>H6Z6.5>G8WM-^?R/6$/3@']<QA&AT(9C"P:,@>
MD8AL;K"O)"8"Q(#WRF^](G>OVZZ23IX@HU9))P_"Q'2"B;\W=@XYB3HYEY!D
M42(>L48NJ#R(GBDO$W&@N&UBSDG%R.ME9(,9Q89;SCCE7D?+L!;42&NC"$SZ
MRE&R04S,9YC8)*T8BQQY;#3B*3#DK'/(4$YX N(-AE9,7#%QE0*Z88P\X4 Y
M(O7F^T.*'<8A>!#"G").9!;'3B GC'(15"DNUN?R7'\*Z%W3/HI[J\UV!S2[
M ]O>E'29:G#B)K5HJ 8GKF7X;:4YWK\/9Q1B4\IB3:1!)G*'.!,@:K2,\!\%
MECU5/A"Y]8JHNY?_K9%%-KP5386/%3X^"#Y62OEZ763CG@8T.*U50@G_?_;>
MO*FM8]L;_BHJ[GV>FU31G)X'Y[Y4$6/GD,= ;)/KLO]Q]0BRA<35$(P__;NZ
M]]: )&P&@07>YU020-J]>UCKUVM>Q"*NC$3.:X=\$+G$8] )@TPN98.1#48V
M&+E2C%Q-\^W&*OFP5LEQ8GJ22B?#$,FE4[D *5-;AY&FAE.C,55R=8GI#70V
MT-E YTJ@LQ$O'\KF6P7-Z8 C<XPCS11&G !86I(P$ADRL3:>D]4&S?U(D"R&
MXG^5=K;;M^BH6T\!9:RJFZM_KXTQNI\>[.I:G8QG$NL>_.V7-TML,9YW(?=6
M'K<[MJ5[\J3/945-XV:7K7;7=T8!)O.?-XG5Q3%RK[4@(7% &FLD$#!7'DO*
MJ+AFZ?ONZ!2%WA#5WQACTN"X?_%]0*H;BG>/G_=.SWK=^/@AZO:=Q'?]U\/7
M'UWD%#-*D'"1(<Z<1%HQ@ 5M@^,V4NG-QC8W6WP!8<9]L*O$_AA:PU[5@7N\
MR7#\]2YG6LH?G=D+5$3N37C(1SBH7"( 3JRT3UO(/)YK3/^O2YWIJ]\SA;6[
MHU)8X!)>U-0N>(:&A<S720?L_[-QZ:D:7O#T$>L YD;#JQ]9:-I7P\GV?[O^
MO[:O[!!^U6,KPP&"KP5#1,YM\LR_3R:%6\[L<42N'^UG9!-,]IGMG-N+P<:_
M+F,TP'$]N,HIR?-;=N4*4UH%TBW4I<A(5_89P*+7+S3R#.Z\V*]2F__;KLM4
M6B?]#)'_T0[>>L-LU$)@SA3(9)B;Q!(/,J;@]$<%,%VZQ -'/<_H6KH-VJOI
M[/*]R99UF7SP>B&%\-[^_>:/%V_>M_[:>7-T\.+-V\W6WL'SK1_'+]>;]<'A
MT8NWK:/#UO/#@]T7!V]?[.:?WAZ^VMO=.8)?7NX=[!P\W]MYU7I[!'_8?W%P
M]'8-UE0&?-8>PLO\-5;YR]]=.PIM /7YY/_R[SG<K2Y.9:D)PG(6%./)>&=\
M< DK;)0"?4-/5)0:OR\+!]):HH)CTEF@>,RT88'[$+S 4DIL/NX6X0#^CZ92
MPF5UY*T_B6'4B8=IG-/P!FZ2F;(TA7&.X)6_=WK^\\]VWQ^!^K+SD5/AN28!
M:2L)XL'#3R !(- J6+ 18Y#/-EH1A**S3*#]4=RXOAANOB]R$[UZ>=M<ZZ++
MTFWJ=3J]\RQM%#6C=094DA&T$D[Z$0WMEU9,*?J)R+)$+&G9;BB9,BV@_?R=
M+$W:[L5_P2?>CTY'E3AT^'RO^F8O+WT0RT]%9RH?#X;PG]-:..J=Q>I2&+1^
M:7?'DM7@UV?7Q/4E^M R<*E6/9%UBC8'V]^!M<1GXQ]^"^W!6<=>/&MWRRZ6
MAWZ[_#ZQ6#*DO*_Z>'KQ;^'J\J_C?^HWUQ]OE8_F5-/J,T:WF*97?HRWR)6?
M?6M8T/<8X[<:]MN?,2-6/UFRQ?'5'S>3O<MDJ;CMA'[(9-FUAOU.J-T-(L-6
M^56S\-5'T>_\"&3RV-J'[YT,6B\ PL/4'-)B>/,:<7Y/=6L.X"_7W9G5T^2C
MV*)7/5_N\U50R8S'Z#K=R!_%_F0A_CJ1LJMJO_Z4-@XW1-40U?T2U9,J?/#]
M>K7=WK 5X@"F5%0S.Y@4K6UW!Z $GU9FMMNG]7_?<_:C"YZNC"F:23[-2?X$
MQ6__L.WLS?*]XRX\%'(9ZW;7]T[C*G)Z'L'ZJW(FJUMRTZGUI^C4:J57 B?"
M50P\,6T$#TE)911GT@9=V^[5)=O];6(R"WUF8VL_GL3N *[NO4*KKWJ#P7,[
M.'G9Z9W_&R[NF!DY__%-]!T[&+13N]+&?H_PHGADOSQVMW\5F?3IQ=?]H_V+
M_:][^/!H!][UYF3_4XY,^K/]X?3%^?[IF\_[1R\['S[M\/G()'CN"SSW=?_3
M:[$/ZSKXX\5%CDQZ?_KGZ?NCG8L/?[S^LO_N?T[W=T]R;]>O\[W!@E8D,H<H
MLP)Q2SERC@9DM8C1XJ2I,4^X_EX#9$\2R*27EDAJ ,0BE]RYX+ST7IA #:7)
M%2##8R###9 ]/B C<T!F&2'2&XL<EQIQ91DR43.4O*>&!.ED6,L>U0V0-4#V
M#2"SB29,HPTF<I]KP%@<N< ^L4083TNC*;X5ZMT UH\"+#8'6%X%89F7R&/-
M$8^:(,<D130H1Z3(=Q4 %MZB#5@U8/4HP"HH " ?"8Y.<R>=T1J RG'*I:<L
MIEKJ(HW4]6A!3,PW8/ F)&<Y$I)EJ8LF9&7P*&<$6,\Y 1E\':6NY>TLQ8W:
M63Z&1F?-&$]WC"=EQ_]AK2B_(ZHT8S1C7#G&DW*N+Q?_LO0TYTG+X="_5+'5
M.>_KK-?/'/CK7;SJ]XFS-SF,)Z9L+%OA4U$V!->8)RTQ399;)JQV1BKN!:-!
M.NZNX:NZHU)1*1'SJL5.-S1ZQ<WTBH/V@EM*<(^YH!1)IRWB5A-D+-%(.>95
MB"XPI[)QA*Q1?=0&KQJ\NAJO//6<"9S3M#U7W&AKG'52T\@\)_HZ+JD&K]8&
MK^:]3UIXPJVGR%"B$)<\]TD)$FG-E1-PQ#2YC6VZQ1J\:O#J4>"5TC%:XC2F
MS'$<N&:<,:X$)4E1S,3]>YX:O%H=7LT[G[A.3DF>D,<>(ZXT0!4CN1Y13#9)
M95CB&]OB[N6(&KQJ\.IA\$H9$H04(CN?)/PK"A6)2T;AY B^CO.IP:NUP:MY
M/Q,G0>H@-"*&@3X(%Q$"]5\@[JVA HXX6@ORE;F[MWS]&F9<&WN^59CG(6R$
M-=W'T$K]WNE""85V=]BK8]*7V0];]U)$36S1:ZQA26&IG%"!Z)9>K(_@["!6
M=8=F*K_5556>=EK!I,5L_'*6"V%LMKIQV.07- $BU\TO8$0Q*P(H$9Z;2*R)
MVB@+V,ZYP/$Z^05-(,@Z7-"+>03.J10$DRC R2+0(C2R1CM$5 R!B9@")1O;
MJZN?WT2S-6!UOV#EI+9>Y6Z+Q''#L95,4,<,=XPSI]C]&VP;L%H16,U;:Q4Q
MWL*9(4,E@!77"3D30*4((@FC;=0L9NM' U8-6#T.L(K4$A<MMRHD3AC1&;5(
M8!P+C4EH\@0>#UC-FVJ!Q+00AB%I8R[T:#G2WB84C ^"!**TRNW;]-U]X0U:
M-6CU(&B%O;(8!"GO$P8]4%B!F32>!H^5$NX!;+4-6JT(K>8-M<R9Y"-)<' !
MT$I[AS1<0J 6"A,MTS%9#VC%UTJV:AI6/-C;ES>LV!NWH;"GV1K\M:I&W4L+
M-N29#@4AHME*3UWX8^R?MJM?EQ7[A>%NTN6"$RD]XS31%+B2#I2#P*F(O#2U
MDNF&Q3"N:'=Q8P2;1ZZ7O?YN>S"NXMWU\<E V5TJ9'\YV/DH1"#)L(",IA1Q
M+P/2) 8$,E/"ECI*@\Y:WC<:8F2JN@G-W*KX>4,S:T S^T<[XO#H[R_[1^^_
M[G_]3 ]??PQ!.4437&!4JMS;#GY2BB.L%0^4*/@?"-YZR4TVH1_8U5)7?%A*
MT&9JZN:*JZ>]4G$U7JZX>KDU3VZL,CBK?&2=BULU4*D.\'N-*+C9N.FE1^C2
M&V[5M]E\.?CE+0[45JMUSPT)7M@^G-OQX*_8?WMB^VO3>N#P[9A)/#XX?=G9
M/SKI[._F[[PY_?!I7QR\>_GYP]$^/SP*GV ,<?AN[^L\DQQ\?4W?O_O[RV%A
M*)C/'Q].@0'(^W=O.OM?CP4P!\SW,\PA,\GG\\.=CRPH%8C'B&'@">Y20D9P
MB8R)P!8:*,S@"AB!'F/8R6A&29"22F,8]]S: )#,&;<^JJ($L/E6!>,M;\&>
MM\JF+Q+]+$<L[63Q_9=>GJ0#0A'&XP2LP15C1DL6-<BP</FKI/3&K0OWKU<'
MA=_M +@DPU%HYY9(H17'VWT&VSW(V]W*_\!=X&OI*WN]P[A/0C4ZW*46Y&I[
M'%MP4^6:T2!BE8=!V!H-!T-X0U5Z$\;W)WGL=B],WYN]_X,AL%&K=U:2^#;A
M;OT'I+;<5*$:)G_WW/;[MCN$3^N^5+"'N=O"8 1C#J(?]=O#-GPW?FF#P)>?
M.(%IM>ST)>-&$-TEZ]QJ'4T;/Y1&5[ A@[S<[V_1:% Z4&2 /^^A<L>V3N/P
MI!>J4>?_FO>G>D-^;LF [;SBZ0>VTZFK3X\'&)[87."TDG3SFA?'R'<.O 3N
MF-E-/+-9_VF?52VZ9G8-).Q>OQQ3M;OM_NQW<U.P?-0E_1)HOPV4&ZH1016#
M_>ZWW:7=V5I@RP=I%#./T(7"=[IAMSJ\M6H8\R-0^^#U1\ ]H7*(>J+1(QZ,
M1D81CJ2(QMC@A,;ZU@UCUAKN=DH"8]>W.^V)8IF9MIO)T@Z!7PJ?QVZOJ(^]
M@F/7 H"J#<V@]4O(+5?ZA4O&+5\V 9 \R':SD%IZ%PY^&S-F.Z-I;P1+"X-?
MG[4NL\Z56V_FA+&E1:ES'8/'TB.&JRU.;M>IXREU,GE4DVW:KBSQ=#S2+B!-
M@Y0U:Y#RI/H1-(T<FNX@#5&MR\8]H>X@WS4/5@@^%O*?W:5 R1-M!=%,LFFJ
M<1TUNN*D.&QU<JJ/'59FGZ)?#GNMMZ/^<>Q?M/ZR_6$W]D'SW>OZK3M%NOS8
M6)[K[<>CC.6YWM)^>5@_>?;BPT_SYCT@N*E#<VT\D[<TW]6!.>^_O/_T@G\X
M"J>'?WPX^0"??SC]\^3]NQ?G\,_%AT_PS+N7GV#,D_G G(-/+]OY70?T/?]P
M^O(TS^W]Z<N3]T>_PS]_GA[0 QAG_\OA'R]SI<XO<X$Y,@K.<\JD-U@ASGQ"
M&AN-4N)1RN25-0DD!+IE%MR9"Z6]F@C"!G5^,.JP[!D D!%) =HP:JVR'F.2
MF+8T2G.-[(P&=5:/.O-I83%9IV/B"!.5ZTS OYQT#EEC- %(DBS%C6U)E@11
M-*BS1JS9H,ZJXKL:U%D]ZBSD=]$@O0\1F9 TXMI*9(2SB&'AHDHVL"@WMA7>
MT@WJ-*BS_JA#B$U46Z4MZ%D*.VZ$<<[H2&*PV%TC7:)!G=6CSGRB%O-&)NDB
MLMZ$7+/4(*VC1]((#\).L-JKC6U"UT;8>6CK[^KKTUR/UU[%P>#9./AB'%15
M)1%<&19U3\5HM+A#-1JV19:$8MRD' V]V>$NO236#DI_7$['U1UJ_IX-CAL'
MIV60W1E3WU'OKUG:>SLAO1*ZUF#Q#;#XX/F"M<O!Z7)F$_(!6Y1+-H LJ!12
M,BA#X [%:G5M3=>OQN'39O@'MA,UG/TC.7O>HD2=YT(8B3P'I@8E/-NQHT-<
ML6@TDUPY#%(67E*Z]/I"5L/1Z\O1*[#!-!S](SEZWEH33 *]5@B$L5:(X^21
M3ERA$*A103C,B"\<O5@\O>'H)\'1=[=O-!S](SEZWA)BB2"1*HMLQ!0X6C+D
MO* H_ST%HQW6_(IJO3^$HW_FX)UQJEC.PSOI=4+L+_31^]XV7#M \FD:G:^_
M_">#V \4\[/SCVUW2NI>[WDAT[<S5-H@]8V1^NV"G413BZTB$NDH$^(4&^2<
M)4@I1:.15'O%5A45=),XZG5VHS5P][/!W0,%&S5PMVJX6ZA2G02@&R,@CCJ
M.X4#L@;@COJHC$])@$2YL:U6XJ%KX*Z!N_59]QI&.35PMVJXF[>L88_AJ@H6
M*(H"W#EID$["(V6$$"#"4TO"QK8F2TK'-G#7P-W/ G</$U[5P-VJX6[>[$@Y
MIH)%CYQP 7'!!=)<<V1Y]#YP1HD&N"-B)7&?]XYWM5%R/)&:O*LB.C\V)9+!
MBD)OE V(:YRXV<SRX6?YI SIR_/)=Z=EHFZ74?X=^:098PW'^%DB9=_5=1U;
MX[J.B]4<T9+*:(\R6)8VP;*S<G%UTBOV\[ ;U;,>4]].17P'I:;H82H%'0>'
M4Q*\+"RS1EC^KK!\N!@ARQ/FW,:(#-&Y!Q:WR$0>$"5!)*D2X90]2G*I2WXN
M4$U#,'<CF!14% 8S1*75B#.!D3-&H6PJ#%:E)+W>V-9X4]%%ZWD38OV4KXF[
M^L>::V)MN'[!8P;'A96(B&J#X9H@'EEL M+42^.D"Y&11TDNS35Q/P03/;:8
M&8L\(01Q801R<+B($SCHF#@<MMS8YGI3Z\5XWN::>,K7Q%W]BLTUL39</^]I
MY-3B@)- ON3B$!:1LUPC J>M3-2:FO HR:6Y)NZ'8'SNOR6L0\9( =J$TP@4
M1((TDT(PY410:6-;ZDW0,YIKXN>Z)N[HCVWX?HWX?L%'*PDGA"GD+>&(2ZJ1
M=8JB0"/Q-!IKG'J4!-/(%?=!+DYK(KRV2.(4<OTXB732##'AG),L<BE=T284
M6VNCTW)GOKF1,_\Q.,J:,1Z_\_$'.-5S?-2T3]*=*K6O2_1$,\8UQGCH>)$?
MY5=?;+CXI%SF3>'!)Q(9.VZ?N%J_+KTR0'9IV\:)S(P;F?G[=0AK>;G(S4=[
M#/[YJ!F3WEB-E* &=*SHD+:2Y/H:PA-GD@WBVV73?C0=U-IW0PEWI 0CDN7.
M$&0XZ%#<YGPWQR*RE"M'#%4)3F@;;]'%@.CU*%'95,9M+JAK -,=/<H-,-T[
M,%U<!J:DA3 ^$20LR>9_P9&)02/LO85[12B7$W'7F1(:464E=)!XX(1PE!R<
M",<J(2,X1]P)1Q((*H:3C6VRQ:]AW6LNJ#5"\>:"6J4ONX&E^X6E@SFY&7.M
MF1<,!99 @X)C0G I2>2,HPDT'XO-MZ+>UH .&D%E-93@C&(TV82(!.6)@QR!
M; !=RK 8?.+8,I%S2K?(8H&DYH)J+JC'<T'=S8?>7%#W#$MS<C-F3*L 8.2I
ML(@GSY"./B(K(AR9RZ:Y6UY0#T4'S06U&DJ('$X_48P2]Z!!.8US<SV.K'>!
M*NN(,&QCFVWA=;V@UJS.03/&(QKC9Z@WD'&R_4^<;4XTDX[=ZO:&K7;7=T8A
M!OBA-3R)N:;OV6AH"^;W4E7W=Q)=T;*#_*5VOP7;&CT\/6C9[K =ZA<U50U^
MEC&>5&#1<E&XU%AJ]<XR*RS4M6Z"KJ=R'PG):Y @DA"!ZQ1<-(Q210,-' =/
M5INZO3.#-]/:^R^^5##VLM\[?3Z%L,,T+SONE%9N36SMC43'UPO>8>HBI\$%
MA'-:-_?4($.%0IX+&9Q-)$6[L4TVC>)K%$K;9%RLG/D]P\YYKK&*D5N#'8DB
M*F8-44D93:Z1D-OP]QKP]YQJ:&7@G'&)F**@&J;@D0Z<(AII9 (41Y)SMS59
M3+!JN/L)<7?TRE+OO="><*Z9C<D"HR=)F82K/JTVC[)A_1_!^O-NB^2Q=T%Y
MA$&$0]R2@ RF#E%NF"-*"YK3K.!JIZIA_J?,_)0 YV,G /@)E\(Y);W2T@7I
MA3&<7R,WKN'O->#ON:M=8,&QQAP%*XKH[I!-3*"0K, R!2QSKW&JQ1IQ]Y,R
MUBWGS3<QMYWS.<&CXL9;F1RNZU)][- 4I4N8LZ"CX,Q;8R6V3G"AJ'92A\;D
M\-AQZ^\%DX,2R1,?&7+6>E!)F$;.:XP"(\I039-)-,LE7"ZV)+@A<JU?#$7#
M_%/F#QH;BV-4)ADN*0BKV&D>/+8D:6=E8W)X'/P])Y<XS'A*)C=8\L#?R@*G
M"TV0!L8G5G@99-S8-GHQG+?A[B?$W53Y:+GRC ?*7>1:QA0$-982'E)DC<GA
M\;/^O,F! ^%0"KR>N_PB$.@2THX[Y+72"4OM@TGE:N=W]B8TS+_.S,]4#(Q9
M8FG4'';!R&B-]%XR';!QL3$Y/ [^GKO::4XI3D0B2ZU G,/];IW22!'**3,Q
M8F4WMC5?3"7]<=Q=3 [_*KVNQS4+X%_C5Y_:_G&[BZI'<H^3\3M1MBL\(VQ+
MC!FSW0VQ.WR&JK^MF@O5][B0EK!>\NN]5(VXSMLO[XS88CSOPEX5=S1HP::V
M88/"H&6][X]BR-=W"45Z"R^#+^RT_NK'%/M]^*C$9&RUCK[Q:2OTX,\YM.G,
MYN-MG]EAS-%-0";M0=7 '+Z; YOB8.MR48HK#]BL_0'3=3O@?$;MTS/@XQQ'
M=M8;PAZU;:=ST0I+PM+RF<.'.=2LW0-:.(.[ 1Z @SJWU6G"/3$ 0LGG[**W
MHT$L1%('HIWW1IW\00E'0Y,WP+%'ZT_J8>=.N\::@]$I?.J_<_KU7TK/+GKY
MSOTT&@S;Z>(2,1"]>DKX[H5;*.&PV_K3=D>V?]&B:K.59>3-LE/YHK/=BU;>
MUGX)^!OV8+LR7\3^>3Z'[G'+'O=C/(6OM*KZ+O"G_*W6V<AUVAY.$E@M_Q&.
M]&8WNPHD<1V"B=QQ$Y0.B2HBL#2@WT4[MM@1JM#XA]F;?>_@Y8WD^K=P7Q^F
M @B7J^SM#0: ,7O=HSYL<37SQQY'WHG_?G/QX5TX<Y3+@Z^OZ?MW?\-5_/?Y
M09[/'Q].][]^)N_?O>GL?ST6<%7#?#_#' [@JM[[<O#Z(^8)IZ@CLCE/C2?!
MD%5!H\B,(LX(CVWN;+PI,-X$TEVXH\>=?G[)5/9__T-3BG][V>Z?MJH=+W\A
MO_V::6:&#O.?B?IMD"-.3WN92^"L-EO_>8O$@Z0X$1$$#!I!:\!)"R7@9X)3
MHHZ$]''O2I*Z3#4SS17_LOW#_EN0"V/X']L9Q>FK?UYB80?''TD J2NXA(A1
M&%0U8I"S 0.QP)Y'YJ0W*I<%P8M&V'PAM_[)FSF-*-YLV6&&%P#@F)$F$\@$
M:QZ0&.@W .2O/+GF_(_V+PYW/D9-N1" $]00BKBF#CD.Y^]%Q$X+;KSA&]L,
M;]%%_^'TV+=:>]U6EAKRWR]?3\< S/G>SW^;7$VQGP/-ZV#<3"=GH[X_L2 #
MC,Y:U34V'LUV;G@S64VB<@RF[Q*/06NB"*$^:<N,L+RYF7X(L<'\=SZ:Q*26
ML/$^J9R@) !L<N9:L(9CH10SLH2B$"J^>3,!E,S>,AES,GD-X&!JZ)E/<6C-
M7&!;+9"I7D;7+T(56293Y:R)3AR3[;RP!,0Z& %59TH]/VF#/#K[[* 'DNL-
MJQ9CF:S2VF'/>):&I0;V2Y'YF(3WMB99.K:1P@\-R=X[R;X_A_N16VUPMF):
M)1SB(-\BIQS/YZ!SUG["/+>ZVI0W)-E?JD2=(I!?)L]2&S+_K4;':H!?-T&"
M'XPZ180'->BX7S)Y^CT?8QA\]W)=+<'E/M>WH[?GM=97['-OHH^@U87#I03W
M2#M?WX'@_!? 2&(D=L(RN(&% ((C EFB*6+Y5E-,>>S,QC:5>&LQB[.RKH$.
MVH'?RIT,I]Z-%3F<MX<54(UQ[#+D 3V.BM7EDOX8V@.?3::#S4*^[<$@9\\4
M$NW!T_U*K8S9ZCT8KCD9_F4OLB8\J$DQ@YWM^O@\S_PGIKKCKZ S.J%UT@1P
MC2J.N*$2:9,D2LSC*(DQ(62/#=VZ*D:T)KK-^D(\CW#U]J/O'7?;7W,36: 9
M(*9^MNT D8W\."%Q@F#]&@R6&'4RS;2[(UME*E_7K"/7V:KSWW/+JHC.$16$
M\3C)F+ABS&C)HM;>.1U44KI8@_8M""U++4$P8#:!Y^WN="YEADXOH2O-K)7Y
MZ S.XPLPSS!V+FXHQ 0JN?=8!6DY#]Z;%#B1QBJ@'9.2KIE9D%KNAA_NX.A]
M7M8Z*%Z>LH!9"8;\Q.R\(PZ/_OX"TLO%X='GK.&!7)V4!Y7.6E#S>6[%ID5P
M"$MI;: :5",)%PK=DDOJ EQB[BMDF2T@JM@ZZ UC2VRU-M[$$.-I]K/,TU@Y
MX%8:]<O-D:^64;E/MA:YO'6E(;]F(\&S"7^A>/5Y.PQ/QJ[*F:=JB,#31ZP#
M07TTO/J1&>SPQ<9:(\7V?[O^O[:OG-]5CZT,8 B^%L(0-0>D,__.TZW8PEMO
MF(U:",R9,HYC#DI:XB%':3C]4="-\4,GD[H,9_8X(M>/]C.R"5;XS';.[<5@
MXU^7P1EPN)Z1RA;V^7V^<EM26H5G8R&%/GLVRN$ HO0J ?19D76JBN;_;==E
M*JV3?@;4__C^Z8"R?%08#3CR><9BD&[^^U_V:N)<='/>.[GJ:VS&QO;;O]_\
M\>+-^]9?.V^.#EZ\>;O9VCMX?K4W;TUF?7!X].)MZ^BP]?SP8/?%P=L7N_FG
MMX>O]G9WCN"7EWL'.P?/]W9>M=X>P1_V7QP<O5V#-94!G[6'\#)_C57^\G?7
M@J8*<L5\S?]ODY>\EIOMP4MIE#7IK=98O*G]A2LHSG=90CG,M]RKMG7M3O&)
M[L)]U^D-1OUX!*_YO5,NQ!\IG)#]]E@X^?QE_],+&.^8'L)S^T=OVOM_O!8'
MN\=T_^O?],/N2WCGR].#/][C>>$$..!B_^C@]'#WO8 Y?CGX8^_\P^YG#+]_
M/3CZ\'G_W1[>?P?O_?0F:[CD8[2&,>L$BKD?+/<L9?TV(<&#BR(P14 <:=7"
M0 P[PY(>@(/10DN?"&=).FZB5L(0)G)Z,GP_@KQWEIFH/P(L+UO?>I[UV>ZP
M-7,&"S[B2_2\5";_[KNW'X*.ZK7,+*4 _T],21<?@TU 2)J#))L3GR3CN>89
M1U)'R^!/@F(]3QG71JNUUAYW6H/1Z6FV7L/%7]EA?$WLG2F%E&H^.12CT^F=
M#[+%L54+\H-?G]T@4&86P\D5(D.)JYH*VWV097(,5\>>#>*S\0^_@<A_UK$7
MS]K=LJ;RT&^77[BDZTQY7_7Q5(C<PI4@62>1U6^N/]XJ'\U%EU6?*;JEL+GR
M8[Q%;OF9YK=[\EN3)7C+"/:8)BNO->QWTO]N4.7H%E]=$F5;D?'#A-E^5[*L
MBA7%LV',KID6PYM%X<S7PS7*<3W5#=F-OMX/,MD/?&D_;MY7\7[HK$:_ I=G
MP^P.;(?6>'_6Y94_0;VO-_EGU$LHAQ;VSHK/J7O<ZL0<9M"9E0EO4>/N.V4'
M[EQJ8-TV\_HEDI>M\'%F-"SZJ[3.342"92#W<T&]BRHE:S#G1$;I0QV+-)_%
M(!9$^C$UOLK$.!;J+VHA?UV,U[>5ZNOTA)TO^_3#IP^?=L[??PHG^[MO3@^.
MWIP<'!WS@Z_[_,.[%U_W=W<N#M\=M.?3$_9WX5VG!Z?[N[^W#^B+<QB7'/SQ
M@ASN'K/]KR>=]T?[Y_N[>^(]_3/MM_'%7*/@E'1PSGODH\O91Z!;:4L)(MQQ
M:;DC.M=IYWAKG2HB-,#3 ,_5P ,8(X3#'K3:7*<)&V(\\<9QH;UE'!?@P82R
M!?]X SSW!SQX#GALI$%[B9$,%H"'.(\<3QYE?VB2U/I(<OUMLT77"'A^@E(L
M>R5#8I SB"ZRR>%>JQK_7%F?]R<CC0_MK^K,&HBZ.40=/%^0C2254F@L$4 5
M0SQQA>" -&*&*4R]EI)$@"BU=>="D$UB]MJRZ*JDB89%5\&B\U($ME9$;S&*
MN4<OYUX@HY1!GAA*HM:8,K&Q3?G=U9?5=^YXRO:D'"?:ZL>S7G]XW^:CG[1J
MY>J%B<%Q_^)9/K@WY=QFW*<-6-T"K-Y.Y8G#(T\.=CXFXQ/GPB.)740<@"O'
M#2LD%+<ZV,"!2'/QR:=H:VFX=$7R1,.E*^92/,>E)"BAF96(49,0UY@AZSQ!
M4MA$G=**&[>Q3>25*26-8>)>>*PJ1S1HA5%)ECZS0//Y]YQ><V8O>OW;21>-
M'O1 TD5_^*S6?09'O>>C 2PZ]M<FE^AQH-6B_R9XSC0V&"4"X@2WQB-C24).
MZJ@820[GE'20*1H;Q=/ES3O+% UOKH(WYXT3BB>C(G"D,T0BCI/-15TYTE8Y
MB2UG)";@S:N34QOCQ+UPUI']4F=0ED#,:=FGL:7BHK%3K+,DD34@.,,WDR/<
M&9]@XZ2]"X)=+$@742@300]" O.8.V%%P#(*/RG,<!16:I?-JV2MG+0-OZZ9
M=-'PZWWQZ[S$P2B(%(Y99#6QB -WPD\X(4U<LD0XD1A;.WY]:-O%M])I[]6
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M93@)*@%0& ?IYNR03N7&RQ&1V=V=!QQG3E1A-< (>1VMLUZG74)$0LQQ+I6
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MATR67FO8?Q5^J'@"V"[S^/^WP3:FL<JEY_PSW"(%U<;CW>:K9N&K].Q+:RE
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M6;KZ$7VEG[ ZL&R%3T7B7WEWZ(HX7P%ICOMBM;LCV+;#L]@O"#]1!_+W*F4
M?AC WC62_XTD__<+?JQH%3.<.D22TXAC09 A)@<.ILB\((RDL+%M[N[&6K]
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M"_\_>V_:W+:1+0S_%93&N=>N(AFL!&G/N$KQDM$\D>2QE)MWYDNJ 31(Q"#
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MZ;2[JH/-P_TN!HK[;4OO6Y:F<:;VU;/W5DO3%Z6"'/P4EH8!'24#ZONJUV.
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MKAC_0H,\\O"O$4.!<89;(^$"9I-8"T0K?8!_G-&F4P!AR!+$%."XJ< &V.B
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M/1KW8X,>#Z!'XU]Z^L0OO:,?;8,]>>ZF&<_*=L1I-^/9@8W:X&:#FPUN[@?
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MF+K5IIE[PK(6=C\C)@9KI(H+0A2+WXM^B]3(D7J;94#.U(Z4*+=B 46KLHS
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M(!!R'/"=!C@'&1^%@\1)>\)9<E(S[(OI%[NEUF(7&TP0JV/S6L0F)F:S5(Y
M2YL19%/?V7K'U#:=W'4T(\B>;;/-"+)F!-GA3=)J1I U(\A>^I4G,(+L"\L"
M["&5HN7D\F>=1;(.V([35W(XW@ZM9?6-(^CIV>#<(>&<WC^&7E_[C#ZBQ'TK
MW/ZD ZFZMO:\QB;6_<+LI'<TXV#V?%Z#J'G?I>K8!.F:(-V3)^GN/E374$M#
M+2]*+4^8 ;Q[:CG@P/:#(:EE/IGIL+!>A(7)4-\X\JO-!I+)!GM*('DJ:(N!
M4-HK1FR])("3*,Y$88JN=\P?IH*[*1MQ@*<;A#CPJ1:M56![6<#"< ++^2G/
MQ H:1L8]OFP!"34,J=)B,QN;CB!7.Z/WNH#O61$'GE2!X  @Y68IGNJ!N' ]
ML"QBQ%B4GL"=NB*[>/L!8^4D(L;%P.3]B!S/CF\64=U7<B;Q]@B2AN=NC2!7
MP'O$P4/"_?,4N '\ \,O;,#K=]*B<2M3MU1P# *OW>O8/RS*59FZA)Z&O&I!
MADH+@_AA#!</&Z<Y=>,D=KF7)X@.03:47Q:;2%D(7R0\RY,(EB;8EH!,>,CP
MK)014$*->P70ZIDQ2\E=8JAE @J/8P'(M[0R7'05FL<P;^TIR1W4ZA'F@+S.
ML^6/+,HP$'MRDA_?+]W?LL>V1KN:NA+QZMWI+=;_.RS#8V- I[8#Z/*MS7S8
M[%L6WK-)>O;C-(L%;BH7MW5X^RS(EI[0]S<YH?U8Y \.*%@XSC834X?>@O[&
M$_P5;(GMRU:48<+]?YS]+?!<YO8-QGN6I9J&W7=,U>S[AF]Z7>Y[3N]W^^S]
M+:6O !%]@!>*.9!L?3Q;A)Y'+3/KP\#/IX>!?Y*M"3L[%***LL*T<BE9<03W
MML0JSHI^BDQ]4.8,5CC2E!@R.[W'I9#5Z2X40B>B_,T-G#ZO#9S><<;O0[.P
M2>-"W-5*?,.?O,)QPD_ 9EP#D: %>)>.N8O8%4YF4V:G=+V<DF.7:%B@9$RM
M^PB*>P\>N2)<.+NYBHIE=8Q31NYB8L;'J=FD'^=FDU[Q;+?<&M&KS U_=)BJ
MP'U]@7MB*BV\T'P!#ZKU -UB"E:&<31HAX#>@&0I6/]I9Z-=V#4"7*C* ]6$
M.3JE .U?6;5?#Q@01RR4<-3@<6LN3S+\6.RH?@),Y&<13^'7:< 4)P?;A:=P
M=W7?Q:MNS4(L3E%?ORQ!GDIAE\Z-@(N#X@,N/ WF!C[#  YL$(&M =98R!Q4
MN&(PX8C=6+475CQA7<B?!#'.3N^\J$WO1*-_QPI3O5#C%8[%+.\53?/')H\^
MV1]A/:W,9$H^S2(BE5]4VP3TBY$>/1 [83RF88>@3&4!Z5(5#=0/B710EW#W
M_"$A=Q+X+&:Z?<:9;H=8&55W*8'.P04_&H^3^#M@3P9:C_)*QC!JA(#Q!<0
MX)H#/'\JO"W__.=-1_F)]&[D[#G("/0L%=\19@CFQ_)L&"?$;*?WD(\]XID!
MK D<FO90>,5 "T(/&OQK4 W2JW9-+K(_<[@W?T(8CFZV040;)44N#[.:FZSV
M+158X7BYDO:\#8#946KS_:15A4/1IJ&W 55_AD?\/"' @2!Q\S2E(Z6<*U<Q
MP =>?7:=#%A4J(@(Z)M\!%2%7GWEW"7?(Y[H"TAN%W"N7;G&OD@?XUDA8$'
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M#O>2H'J%&WEM=OIO?GCB%G2C[HU:4\/90'%=<!8O@,^2(ORG:S_,^^A0A4K
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M2[=#P@MPP%&7'ZI*9=2>H]?5OO"KBZBPP2I^=9A^PT>5,,*J/!6F0E">NT;
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M*PQ]>"7S:H\"R0= V@!1O.@@E%</"\)3;% UOYRF"B"R<F$B"X0>G30HL+(
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MV'2*/X>7D,J0MLJN,%6MF/"D1+4BNK+! : U5<[C*;QX3)H]-3X "(ID)RP
MS2/Z@DHT6>)-U?4M*6"KU:_AUS<\"N"5-QP@  ])N?"Y*F>;KP()O'^</5X5
MU-?.ME.]\^("DC#\*\?R!.6\ O*7)([@;U>4 1YAT>D7@5=4.(J1EJLXXXK6
M4<ZNDP&+@K\JY]]-/H)#31 YZP "KNHB5K>5QZ!W5M:;+V[_414JE8U TJIP
MG(<IOP<ZDTU$@J(\6)2L8B:*FZ>I+/><[D* _Q+T)+Y-:*/A1 G2-,=BV'FB
MDE2ZZ NL=IWP3*S(O<UIQ5R;5I;T,=@-L5S %2E&1U'^C;T$@HPX'H$-/@B+
M?W^$>PEC4<]]3N7ZERSY!N#[&J3?CI">?A.%V&GN_ &L'#%^),Z;P'F5<1+
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M66HH WY%$#@B=?;YA#C6OP47Q#&&_FQ&^(*9;5UGON-9SN25V98.*ZF"ZBR
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MPC-_1E<YWH$UF7I]\YL;0A7IQD-0+V^,!XU_#B*].(:^'(\_MN<W:5?5"?1
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M.UN\U[QDS5 "SP&%]R(J18.*K"WWE,95T&.4VEZ6Z,>2VB_4ZYMX/Z6TRK\
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MVNZ')W]BU4T;Q7<*+BS3%89=?.PVWWBZ.CDZ&JX)TS4>G?U]U8)-^;!>-!?
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M)2T_P#F;AL^_+^9IPW"AK2-$M'1(:4G5)P:>7%.PT;H@C0D,8Q<6?1/:F!R
MK@1J*Z1N@?BO\) K@I$,$# Z%U"1:7"H-7AEHR;SP_).>]\W8QJ3N=^7+6W$
MTM#.SXA'==NZ(EG,US15]-W#5_,U+G&U/AWR\[!<?J9WGQW5C>Y)%#Q+53>5
MBB9ER$N D)2'Y(C62NB"G5(+[H-V3+Y 5VIU%V4STKW'H^/%,BP_7P?IV7J]
MG,:3=1W(^\6;<*I"$T:-*8,O"@FF,> S35-*%KW4S&%.71AW9ZC;T,U\#W3K
M*\2.VT6OYFEV4B.X;Q;+03 7L%[_[$Q"UB:C%& ]+=]*TVH>)&.@R>Y+RLC
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MXSOF/SP&:G2?_V:ZY>>3U72.J]7SQ5&<S@<@U74X/ U_;U(Y!QMKDD***&K
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M@M=2 %-6"<VDS;FCQW0CKCO6ESP:DG20RI8QB\W[]4<DK^7O?_G_4$L#!!0
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M?0WCV;*/T;2\G4X^?\+9R4N,BT'">=N"V4=X;R>!K87[0@PI:6EE%EX7&V-
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M). &SL]'G(RGLW?3!:ZRX8SR5B:REL!&0\LKA?D8/1,F>6^3%MHU:HV_#N5
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MRK/OM_IN=&[%Q4"\=#8RJXPE#\0BB]QIDD-RA7Y80&Z\9^[VJ,/6]D/DV<#
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M<;+X(AWCSCC:0(VGO3D8EHR$8A1*'MIT]ML/:;8W< ;DS#:Z:%'^#L<XO]B
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MW)@:10MDS#I0P0B#HLU$HOM0[;K_O#NM[#\JJV?@^5-FF$=6J@!%2V9DKI4
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M&X02;\/\ :O\".P-U",5N'%E.3@FD&PL&.8#H8W:)0W*9V[:M #:#N?3)M,
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M/FYSF.2_8_Y<+>':QY.>@/,^6N-M^XC^+G)V6MS:C8YQWH-)A9PLV@?(I?*
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M8"9B*D$6)HPIM7H66-#HF(.<R58NAJLVS2 ZP1O>7-A5C]/62NCSWF*V&'V
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MK,.G]E=>MNT2U@K,B*<B:U-XD)R.61V,\1%\D9$7H4&..GS^;MS[VRG,8+)
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MI+\=5#LZRONU,F^'7[7.7LS(62J1V3K=M&X#<M ABA3(8U>86)'%R39M^A\
M=7ED&DM#.]AS<A1WRTU_O]--G]F8B]>ESBEB"E2F+ZZ0.5Q,,")[R8-JU+Y\
M"+S+8]3X6MO!K:-COC\7E3YP3^_EE_6+JR)3G5.6QI$LDB"I,*;!"8_THW),
M%).C:/,T/ +L5-V$VM]R;*RH<S<9ZI9WLU??A[)[D:W&4Z%(0G,&WD0ZA",M
M(VAZ>CL26["*''LU*)!''_$=U^BG;9[MQW#^FN]&6E^,*OTQ"RUW(MK,[!J
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M(T@%#\)0N7!!WZ[S]LI,C7^VFG<[;D;?8Z#,2&HL^ <FL8T98,N.$X, -K:
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M(3&DL<<@PM+3:](81BD*9<)PH/ZU*OIA*'AJO/SIX_7;CY\^WG]\?P>N/]^
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M<?:XNXHA:B.!MA)49E8SR(ZA0)D%=DV] K0RUFT)Q0&'8H"-=+=ZOL*V^R!
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MV6/!4839]VG/*:[\AQ3/IA7!K\]T3;4C)._88OY0%T[6'2I@(0J6BQ1P17,
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MD1LSH^U^O?HYUV_HMR^_EV8GMIXK=% E?,O*S9KRS2PO"HXRA0'*L!GQ&&-
MA4H!@]!T9$1%AJU2'/Q5F-KKNII1J!:K/^MB^DBUJN^U+O@/MYC$8UWL0I1A
MT1[XU:N5KP="MNI'["5Z8RR(YLM?HJT1>]T+HC]:.P*&,?X@!HUJ/-08-<CQ
MA^DXYKGB3HXAT'JC67JO,<RGC7PL;_^:ES,(:9)!S7NY)-3TF\T (9P 2 3!
M!8TQRNQ2NRZ*F!RO[6L956KJQTDK:KOQ>AG,GB@B"$2#QP'.Z-C[<KT =!&)
MOGJ/1/2_C@FDX_;C.%V]YFW=IOY/>FZYFIZOS20L4\:X>9D1S2P\%0@(16,
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M6CX +>@QVM"_FC*?RF6A#VLI'_=[@#LFX/1";T<](0$=F'DJ5:-&UW ,8XM
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MW>L[M]_$VZ7X-G]8SM6<4_V&XGSUO#2)HY7@N2QWCY%$!43Z?0&R0IJW")2
MJ"(!:9H4A4 )T<ZH6V-A?V6F]E:Y6S_0Y?R?=1==DQ_S[?GQT51MF2RHK1E1
M:X=K.^(K5LWR?&VDM1CZ_,V883#?-Z1>CYTIYQ8D^F.0K*40L ;ND7R%0B/W
M4;X>NM->RP'N><TAX7?ZUX>_GN2RE&_E4JKY9B:8A(BE"#":Z_ >:O\<*UF
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M'"5[H1:49MTT&)4ZO< YID._F_CDZQ^F<;TTS2;:WB=0YA11G(,\AT@3&L\
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MPQ'TN3\2,>JC?MZ\XZ?[PJ>N#BOI>JG#U?)>KMN67G.N_8[W\\6S:2-UV*N
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M]*A4Y0;',6LY7NW1N=7<1=^Z]78_:1_X43;5Y5_D9I9RC!7.M=M38!VD,98
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M[YAC&\YH,:6!#9=!<AS5T'$C7R=Q/?^I_<Z?LMJVH7SS7=^HV7@510QC*7*
M45R8K#JSKPT3(%G!H114)6Y3K;J$38TV=[I&K;*.F]I6$-LZ?F& &]S5\\#,
MPZOK!R.P']<A<&3/K=_T4U_-XIH0Z1E[1]G?5^<WRF:0IFD6YP6(<5&U4<>
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MI=DH9C& @F- D[@ &.<XBYEV/6+:+,&'I7B-!6C%#KAG4'_!1\?>+B(*A>;
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M@8G7 LQQBF(Y 3>,DW=6\LNX>C9@G'3XK&Z^NCWD':V_O9LO?VQ5N\T)%28
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M4P S2%9(EK(E,JB25,95Z5TYBZ5>4J^T]J9."G5_VON]Q](TS@\,C'9L]K5
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MI))@&\B47K-3XL39^_$_SH?Q?'D#\>02IHN+LHS9$)@T1$1:AA0P39PQFN2
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MD+&K*B>5Y+HS1K["-$RZ0,ERA_UC/%OZ98NM]MT5(#]JQ8^V)DL&C@@)L+3
MWC(@*"7#63#!T\WJJ5]\5+_;4?=(Z5:V+6/%K+'O<!T8'8@NL]"DU$ "-1(E
M%TW&7V;/7TR>;_:H?@]H#HF5763;@.MRR[O['?P,F2JB>N-GPV7U6)(A)1\D
M<<J6"E9JB.<Z$FXBZ"2LQ;BO=IKY,<+Z!59UG[A+M;2$LG?#61Q-"C_EB'1Y
M4+6N'6-,Z,QB(#Q8C$"UP?7(1"9" 1H=%2&D.NF<3:AK)K>\/QR>@EI7NFD
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M.B[6X4;"-572* 6LSAZ\.8V-I&;Z &$E1;Z:2U7KZ]23O&JN.PO?5RWR%Z6
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MC,OMI?4-7YH-6"J)$#(3Z1;+"H,J$V1V@?.D,]T(+8]__H^1O]]*CY-NA=I
MXN+7R5<,M!=WUB;CA2>W+F*,TDIF<6O6'L-AZC0) MT[):E7UFMK*\403U'T
M8R3[=X%3I[KHV]9\@5'^Y+^OW+SUB05((TNIF:!0KB4"$&]E)"GDR% TSO*T
MD:5Y[-/[*74YF)W96Z!](V)QBG%7)BMF5@F5-4\RBB1X)J&DW:1($G=MS8@%
M+K603EN]64_P#1_83[+^8+BI(?8FH'3O0,Q@:  B6.(@"'3VF"&.>4Z<53QG
MJZP*>G/8M'^:N+-SNZ_PFCA-?.ZF4/1*AV 482EAF(B[(G$H'P*,1R8B=:!D
M%9=EWRM^]=K*=YU\Z5H-#7C SUX24L'@9LJ)]SJ4FSR2A$AQ>2@J-#5.JUQG
M$. />5-O*\5O<U-O"RVT *C5F>53U\,$Q66&?T9\4A@A<C#$TYP(5SJJ:,%(
M7V?$] N$-0:L70%P'U@=:J,%<+UTM8=R;3 B1*? EXGK7&3B0Z;$)*-5 I&C
M/-#EXETNZ]4;FG' G7!WA30)L/N7?;1V#"(EVFA*I)/H/ :!?J/GEE&,2K7Y
MOW?N]L7!UG?NME!* R![_-)7LC)Q22WA 22105CBE<G$,JF<%($R!U60]4/>
MN=M&XQO=N=M&_ U@Z F+_N&Z4LQ+H#;C"@,.>7T/*&B2(P\T,Z62J^.\OT19
MOU6BU7;"3A72 ,!NE2.N\_'_&,[/UP[E^W$<7:7A^.QH-@/\+YWZ;P/!I=8*
M[;LHO?ZD!%TF)FB2;/#"H<\J<IT4Q [$-ED7LB-:)H=579NIL-O5K+X0G7(@
M)I>0221-@I* P9/PD6H)6=6I<]N[YOC0R;!N$->9,EY-:?%;/SLO_Q__GZOA
M5W0XQO,9_L%GF,VGPSB'5'YWD!KC;0CII]AX9U$U576<=8XAITQ"&7P@I18D
M.,U(1G<4N$L<8ITA3TU4'=_5%C[Y_?@KOK1XQD<T#E?38J,&1G/NHPNEFUG9
M9:0B/AE!C'"*2JL%&J%*#L(F]+V&2N1M</C0<>A<BQWZ"GV;],^3T2A/IG_Z
M:9KD7R>3].=P-#J(#7_VR?T8[<V%T925]C1[JK@D69:9;I&CDZ.D(-X@=#6-
M/NLZ Z>:L-)K/17E_;)4WB"[B.9!&Y) H;WP^)UW4!H.197 6*5=G8SY(\2\
M!ON[#<(>EL#MIY\&T@9K%@9)4VX\AI$Q1(E>/Z/$"68(@)<<9.EG52<$6U/0
M+YCV5N43T-A*KCOCX1*FPTE"=$_GG:+B***/CT2\NYJ6O63QE$&0PIE41D)
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MJ80FUKA43LL83S8ED>L<(#U!4+^ JXN")Z*4?532*+*6;L2Z?WE.,N3%Q0K
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MVCTWSJY"]<+K='-AP:E,1X'81.DHS L[CDI[[E/CAKFGQ,HALNTN='E_/:9
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M)Z(EY+/9[1M+/HDZ9\-%!AM2]0#6@]<F@_+$;]$L1'F*<9>/4]CG6)CAK.1
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MPR#&3"ZZA+K1/M AMPPM\FRY^>6,[*?T%?/E.9Z5!XFX.6C%UB6H+H,LJ5Z
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M!.>]A&!<\+Y$GFR;"H\7VORZE^[W:7[=1Q%CMZ!MVNEJ5'4VVSQA6H-&J:Q
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M3+7PPPD' 44"SU5(UJ-3L<V]Y*X4CHBQ0</I)AKI$6FWNA>R9BQ85L"(VKW
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M'9:8W\R_5;[6!XPQD0LWJ^5I2 ?,,&(+&61A8BY)D.@:95H/TC/NN+:QX3>
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M !$              ( !J14  '-G<GDM,C R,3 Y,S N:'1M4$L! A0#%
M  @ :3AC4T6+EI,U$P  "L\  !$              ( !BE," '-G<GDM,C R
M,3 Y,S N>'-D4$L! A0#%     @ :3AC4[:2(*)?'P  Q3(! !4
M     ( ![F8" '-G<GDM,C R,3 Y,S!?8V%L+GAM;%!+ 0(4 Q0    ( &DX
M8U,$ATZYQUD  'W2 P 5              "  8"& @!S9W)Y+3(P,C$P.3,P
M7V1E9BYX;6Q02P$"% ,4    " !J.&-3%E$4"X[N  #%PPD %0
M    @ %ZX ( <V=R>2TR,#(Q,#DS,%]L86(N>&UL4$L! A0#%     @ :CAC
M4^,Y4DM4E   .J(& !4              ( !.\\# '-G<GDM,C R,3 Y,S!?
=<')E+GAM;%!+!08     "0 ) %,"  #"8P0    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
